Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Interneurons,0.7580233371997471,2.213937679601266,0.0,0.0,0.0,110/271,12.82%,NPY;ETV1;L1CAM;SHISA6;PCDH8;NTNG1;SYT4;CHST1;PLPPR5;KCNMA1;OLFM3;NRIP3;TRIM9;KCNC2;HTR5A;PCSK2;PIANP;GRM5;FGF12;ADCY8;KCNQ5;CTNND2;SNAP25;RAB3C;LMO3;SYNPR;PDE1A;NRXN1;SCRT1;RIT2;DLGAP1;ST8SIA3;MAP2;GABRG2;CACNG2;NCALD;NOL4;GRM1;CLVS2;RELN;LRRTM1;SYT1;CDK5R2;TMEM196;ABAT;RGS7BP;CACNB1;GAD2;ADCYAP1R1;SRGAP1;SULT4A1;VSTM2A;OPCML;HIVEP2;NEFM;FCHSD2;CA10;GAD1;SLC35F1;PNOC;PLCB4;NRGN;ASTN1;GABRA4;PACSIN1;KCNIP2;SNCB;CDH22;TMEM179;CAMKV;TMEM132D;SYT13;CACNA1B;SHISA9;GDA;ADGRL2;LYPD1;DLX1;NDRG4;MAPK4;TIMELESS;CELF4;ATP2B3;BRINP1;C11ORF87;SH3GL2;VEGFD;CELF3;PRKCG;NOS1;EML5;RAB15;SYT7;IGSF21;KCNQ2;GAP43;CACNA1I;CPNE5;NCAN;GABBR2;POU2F2;NRSN2;TMEM59L;PTPRO;SV2B;ADCY1;PSD2;CACNA1E;ACTL6B;PTPN5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8678042067940072,-2.199216787667557,0.0,0.0,0.0,68/105,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;HELZ2;RPL15;RPS11;RPS15;RPL27A;RPL35A;RPL32;RPS28;RPS25;RPS27;PNRC2;RPL8;RPL30;RPS24;RPL7A;RPS15A;RPS19;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPL28;RPS9;RPL6;RPL27;RPLP0;RPL35;RPL36;PYM1;RPS26;RPS4X;RPL13A;RPL24;RPL38
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.8207842425458494,-2.1265368446842507,0.0,0.0,0.0,89/192,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;EEF1B2;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;EEF1A1;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;MRPL51;RPL15;RPS11;RPS15;RPL27A;RPL35A;MRPL52;RPL32;RPS28;RWDD1;RPS25;MRPL34;RPS27;MRPL32;RPL8;RPL30;RPS24;RPL7A;RPS15A;RPS19;RPS20;RPL7;MRPL24;RPL14;MRPS21;RPL34;MRPS2;SARS1;RPL9;MRPS5;RPL37;RPL28;MRPS7;MRPL36;AARS1;RPS9;RPL6;MRPL57;RPL27;TARS1;TRMT112;AIMP1;RPLP0;TMA7;HARS2;RPL35;NARS1;RPL36;MRPL9;MRPL27;RPS26;RPS4X;RPL13A;RPL24;RPL38
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.802801286885495,2.1223051360726988,0.0,0.0,0.0,66/111,14.75%,KCNIP1;CHST1;OLFM3;KCNC2;HTR5A;GRM5;CTNND2;SNAP25;SYNPR;PLPPR4;SCRT1;ST8SIA3;MAP2;GABRG2;SYN2;GFAP;CLVS2;SPHKAP;CDK5R2;TMEM196;RGS7BP;GAD2;ADCYAP1R1;SULT4A1;NTRK2;VSTM2A;OPCML;CA10;GAD1;LRRC3B;LRFN5;ASTN1;CAMK2B;SNCB;CDH22;TMEM179;CADM3;UBE2QL1;DLX1;NDRG4;MAPK4;HS6ST3;ATP2B3;BRINP1;C11ORF87;SH3GL2;CELF3;KCTD16;IGSF21;NEUROD6;PHYHIP;PTPRT;GAP43;NCAN;GABBR2;ASIC2;TMEM59L;ABCC8;PSD2;ACTL6B;PTPN5;BRINP2;GRIA2;STMN2;ZNF536;SEMA3C
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.7869451536083845,2.1207323227262767,0.0,0.0,0.0,62/120,13.60%,NPY;PDE10A;PRSS12;SHISA6;KCNIP1;SYT4;OLFM3;KCNC2;HTR5A;GRM5;SNAP25;RAB3C;SYNPR;PLPPR4;NRXN1;SCRT1;RIT2;ST8SIA3;GABRG2;GFAP;CLVS2;SPHKAP;LRRTM1;GABRA1;TMEM196;RGS7BP;SPOCK1;GAD2;ADCYAP1R1;SULT4A1;SCN2A;VSTM2A;OPCML;CA10;LRRC3B;NRGN;ASTN1;SNCB;CDH22;TMEM179;CADM3;SCN3B;ATXN1;CELF4;ATP2B3;BRINP1;C11ORF87;SH3GL2;CELF3;NEUROD6;GAP43;GABRG1;NCAN;ASIC2;NEGR1;MRTFB;SERPINI1;PSD2;ACTL6B;PTPN5;BRINP2;GRIA2
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8753101325632634,-2.104356618752417,0.0,0.0,0.0,68/88,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;SRPRA;RPL15;RPS11;RPS15;RPL27A;RPL35A;RPL32;RPS28;RPS25;RPS27;RPL8;RPL30;RPS24;RPL7A;SRP14;RPS15A;RPS19;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPL28;RPS9;RPL6;RPL27;RPLP0;SEC62;RPL35;RPL36;RPS26;RPS4X;RPL13A;RPL24;RPL38
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.8428239299560641,-2.097449488373862,0.0,0.0,0.0,80/142,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;EEF1A1;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;MRPL51;RPL15;RPS11;RPS15;RPL27A;RPL35A;MRPL52;RPL32;RPS28;RPS25;MRPL34;RPS27;MRPL32;RPL8;RPL30;RPS24;RPL7A;RPS15A;RPS19;RPS20;RPL7;MRPL24;RPL14;MRPS21;RPL34;SARS1;RPL9;MRPS5;RPL37;RPL28;MRPS7;MRPL36;RPS9;RPL6;CARNS1;RPL27;RPLP0;HARS2;RPL35;RPL36;MRPL9;MRPL27;RPS26;RPS4X;RPL13A;RPL24;RPL38
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.7728962930287868,-2.0812642099565624,0.0,0.0,0.0,97/278,10.65%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;ORC1;RPS8;RPLP1;RPS16;RPSA;RPL23A;PAX8;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;POLR2L;EEF1B2;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;EEF1A1;RPL10A;RPS5;RPS7;RPL18;RPL12;PTMA;THAP1;RPS14;KIN;MRPL51;RPL15;RPS11;RPS15;RPL27A;RPL35A;POLR2G;PTH;MRPL52;RPL32;RPS28;RPS25;MRPL34;HOXD3;RPS27;MRPL32;RPL8;RPL30;RPS24;RPL7A;POLR2K;RPS15A;RPS19;RPS20;POLD3;POLR2I;RPL7;MRPL24;RPL14;MRPS21;RPL34;SARS1;RPL9;MRPS5;GRWD1;RPL37;MLF1;RPL28;MRPS7;MRPL36;RPS9;RPL6;RPL27;POLR2A;RPLP0;HARS2;RPL35;RPL36;MRPL9;MRPL27;MCM4;RPS26;RPS4X;RPL13A;RPL24;RPL38;HUS1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8754201151692446,-2.076082971289895,0.0,0.0,0.0,68/85,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;RPL15;RPS11;SEC61B;RPS15;RPL27A;RPL35A;RPL32;RPS28;RPS25;RPS27;RPL8;RPL30;RPS24;RPL7A;SRP14;RPS15A;RPS19;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPL28;RPS9;RPL6;RPL27;RPLP0;RPL35;RPL36;RPS26;RPS4X;RPL13A;SEC61A2;RPL24;RPL38
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8790155048965336,-2.0733587352309337,0.0,0.0,0.0,67/87,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;RPL15;RPS11;RPS15;RPL27A;RPL35A;RPL32;RPS28;RWDD1;RPS25;RPS27;RPL8;RPL30;RPS24;RPL7A;RPS15A;RPS19;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPL28;RPS9;RPL6;RPL27;RPLP0;TMA7;RPL35;RPL36;RPS26;RPS4X;RPL13A;RPL24;RPL38
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.7661418147281899,2.068251344654176,0.0,0.0,0.0,67/146,12.82%,SHISA6;PCDH8;SYT4;KCNMA1;OLFM3;NRIP3;HTR5A;GRM5;CTNND2;SNAP25;RAB3C;SYNPR;PDE1A;NRXN1;SCRT1;RIT2;HCN1;CADPS;DLGAP1;ST8SIA3;GABRG2;CACNG2;CLVS2;LRRTM1;GABRA1;TMEM196;ABAT;GAD2;ADGRB1;ADCYAP1R1;SULT4A1;PRKG1;SLC24A3;VSTM2A;OPCML;HIVEP2;CA10;GAD1;LRRC3B;SHANK2;CLSTN3;ASTN1;SNCB;CDH22;TMEM179;PDE1B;CACNA1B;GRIN1;SEZ6L;CELF4;ATP2B3;BRINP1;C11ORF87;CELF3;ATP2B2;IGSF21;KCNQ2;GAP43;CACNA2D2;NCAN;DLG4;ATP1B2;ASIC2;SRRM4;PSD2;ACTL6B;PTPN5
prerank,PanglaoDB_Augmented_2021__Neurons,0.7041007868562806,2.0577188212446096,0.0,0.0,0.0,88/264,12.82%,NPY;AQP1;ZCCHC12;SYT4;IGF1;KCNMA1;OLFM3;HTR5A;PCSK2;GRM5;LUZP2;SNAP25;RAB3C;SYNPR;PDE1A;CBARP;DGKB;NRXN1;SCRT1;RIT2;CADPS;DLGAP1;ST8SIA3;GABRG2;CACNG2;NCALD;NOL4;VSNL1;CLVS2;LRRTM1;GABRA1;CDK5R2;TMEM196;ABAT;RGS7BP;GAD2;ADCYAP1R1;SULT4A1;SCN2A;VSTM2A;OPCML;NEFM;CA10;GAD1;NRGN;CLSTN3;ASTN1;PACSIN1;OGFOD1;SNCB;GNG2;CDH22;TMEM179;CACNA1B;TESC;SCN3B;ADAM12;STX1A;TMEM191C;PCLO;NDRG4;CELF4;ATP2B3;BRINP1;C11ORF87;SH3GL2;CELF3;SCN1A;EML5;MIAT;PNMA8A;KCNQ2;FBLN2;RIN1;GAP43;CACNA2D2;NCAN;DLG4;ATP1B2;GABBR2;NECAB2;NRSN2;SRRM4;TMEM59L;TMEM130;PSD2;ACTL6B;PTPN5
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8521851084503549,-2.0487119456526255,0.0,0.0,0.0,69/97,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;SRPRA;RPL15;RPS11;RPS15;RPL27A;RPL35A;RPL32;RPS28;RPS25;RPS27;RPL8;RPL30;RPS24;RPL7A;SRP14;RPS15A;RPS19;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPL28;RPS9;RPL6;RPL27;RPLP0;SPCS1;SEC62;RPL35;RPL36;RPS26;RPS4X;RPL13A;RPL24;RPL38
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.8148457396448668,-2.048288732633954,0.0,0.0,0.0,71/161,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;RPL10A;RPS5;RPS7;RPL18;RPL12;RPS14;HELZ2;RPL15;RPS11;RPS15;RPL27A;RPL35A;POLR2G;RPL32;RPS28;RPS25;RPS27;PNRC2;RPL8;EXOSC8;RPL30;RPS24;RPL7A;RPS15A;RPS19;RPS20;DDX5;RPL7;RPL14;RPL34;RPL9;RPL37;RPL28;RPS9;RPL6;RPL27;RPLP0;RPL35;RPL36;PYM1;RPS26;RPS4X;RPL13A;RPL24;RPL38
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.7599021871770336,2.0462478912054376,0.0,0.0,0.0,64/130,12.82%,ADAMTS5;NTNG1;SYT4;KCNMA1;OLFM3;HTR5A;PCSK2;TRNP1;GRM5;SNAP25;RAB3C;SYNPR;NRXN1;SCRT1;VWC2L;HCN1;CADPS;ST8SIA3;GABRG2;GRM1;PAK3;SLC1A2;CLVS2;SPHKAP;GABRA1;TMEM196;GAD2;ADCYAP1R1;TNR;SCN2A;VSTM2A;OPCML;NEFM;CNTN4;CA10;FAM135B;PCDH15;ASTN1;GRIA1;STX3;CACNA1B;TRPM3;SCN3B;CNTNAP5;CACNG3;SEZ6L;CELF4;ATP2B3;CACNA2D3;C11ORF87;GRM6;CELF3;SCN1A;LIN7A;GNB3;ATP1B2;ATCAY;STRIP2;SRRM4;SV2B;AMPH;TMEM130;ACTL6B;PTPN5
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.7800284967002693,-2.0379385732871955,0.0,0.0,0.0,89/182,14.78%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL10;RPL21;RPL3;RPL41;RPL13;RPS6;RPL10A;RPS7;RPL18;RPL12;RPS14;RPL15;RPS15;RPL27A;RPL35A;POP5;RPL32;SBDS;RPS28;RPS25;WDR74;RPS27;NOC2L;RPL8;EXOSC8;RPL30;RPS24;RPL7A;DCAF13;RPS19;RBIS;RIOK2;SURF6;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;RPL9;UTP3;RPL37;RAN;RPL28;MRPL36;RPS9;RPL6;IMP3;LTV1;RPL27;RPLP0;METTL17;NOP53;RPL35;RPL36;NIP7;RRP36;NOC4L;RPL13A;NOP56;RPL24;RPL38;EXOSC5;NPM1;RPLP2;RRP9;PELP1;DHX29;NOL6;DKC1;RPF2;UBA52;RRP1B;POP4;WDR3;NOM1;ZNF622;ESF1;DDX52;PIH1D1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.7612410520199363,-2.0309938635765565,0.0,0.0,0.0,97/320,10.59%,RPL18A;RPS12;RPS18;RPS23;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;PAX8;RPL29;RPL5;RPS27A;RPL19;RPS2;RPL11;PRPF4;RPL23;RPS3;POLR2L;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;EEF1A1;RPL10A;RPS5;RPS7;RPL18;RPL12;PTMA;THAP1;RPS14;MRPL51;RPL15;RPS11;RPS15;RPL27A;RPL35A;POLR2G;MRPL52;RPL32;RPS28;RPS25;MRPL34;HOXD3;RPS27;MRPL32;RPL8;RPL30;RPS24;RPL7A;POLR2K;RPS15A;RPS19;RPS20;SRSF7;POLR2I;RPL7;MRPL24;RPL14;MRPS21;MPHOSPH10;RPL34;SARS1;RPL9;MRPS5;RPL37;MLF1;RPL28;RBM15B;MRPS7;MRPL36;RPS9;RPL6;RPL27;SRSF9;POLR2A;SRSF3;RPLP0;TFIP11;HARS2;RPL35;RPL36;MRPL9;MRPL27;RPS26;RPS4X;RPL13A;RBMS2;RPL24;RPL38
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.7833242470146191,-2.0250384090119242,0.0,0.0,0.0,73/164,12.90%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL10;RPL21;RPL3;RPL41;RPL13;RPS6;RPL10A;RPS7;RPL18;RPL12;RPS14;RPL15;RPS15;RPL27A;RPL35A;POP5;RPL32;SBDS;RPS28;RPS25;WDR74;RPS27;RPL8;EXOSC8;RPL30;RPS24;RPL7A;DCAF13;TSR3;RPS19;RIOK2;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;RPL9;UTP3;RPL37;RPL28;NSA2;RPS9;RPL6;IMP3;RPL27;RPLP0;NOP53;RPL35;RPL36;RRP36;NOC4L;RPL13A;NOP56;RPL24;RPL38;EXOSC5;RPLP2;RRP9;PELP1;NOL6;DKC1;UBA52;RRP1B
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.8047109774332776,2.0161840477889332,0.0,0.0,0.0,63/105,14.60%,OLFM3;KCNC2;HTR5A;GRM5;SNAP25;SYNPR;GRIN2B;NRXN1;SCRT1;RIT2;CADPS;TMEM132B;ST8SIA3;GABRG2;NOL4;GRM1;SLC1A2;CLVS2;SPHKAP;GABRA1;TMEM196;GAD2;ADCYAP1R1;TNR;SCN2A;VSTM2A;OPCML;CA10;GABRA2;ASTN1;CDH22;GRIA1;CACNA1B;TRPM3;GRIN1;SCN3B;CNTNAP5;NDRG4;CACNG3;MEIS2;CELF4;ATP2B3;C11ORF87;CELF3;SCN1A;FUT9;KCTD16;NEUROD6;GAP43;GABRG1;NCAN;ASIC2;ATCAY;SRRM4;TMEM130;PSD2;ACTL6B;PTPN5;BRINP2;GRIA2;SLC1A1;STMN2;DIRAS2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.7780963970929277,-2.00751754369797,0.0,0.0,0.0,73/190,12.90%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL10;RPL21;RPL3;RPL41;RPL13;RPS6;RPL10A;RPS7;RPL18;RPL12;RPS14;RPL15;RPS15;RPL27A;RPL35A;POP5;RPL32;SBDS;RPS28;RPS25;WDR74;RPS27;RPL8;EXOSC8;RPL30;RPS24;RPL7A;ADAT1;DCAF13;RPS19;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;SARS1;RPL9;UTP3;RPL37;RPL28;AARS1;RPS9;RPL6;IMP3;RPL27;RPLP0;NOP53;RPL35;RPL36;RRP36;NOC4L;RPL13A;NOP56;RPL24;RPL38;EXOSC5;RPLP2;RRP9;PELP1;NOL6;DKC1;UBA52;RRP1B
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7952000739399997,-1.9939918690869778,0.0,0.0005927982623897333,0.01,72/151,12.90%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL10;RPL21;RPL3;RPL41;RPL13;RPS6;RPL10A;RPS7;RPL18;RPL12;RPS14;RPL15;RPS15;RPL27A;RPL35A;NIFK;POP5;RPL32;SBDS;RPS28;RPS25;WDR74;RPS27;RPL8;EXOSC8;RPL30;RPS24;RPL7A;DCAF13;RPS19;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;RPL9;UTP3;TRIR;RPL37;RPL28;RPS9;RPL6;IMP3;RPL27;RPLP0;NOP53;RPL35;RPL36;RRP36;NOC4L;RPL13A;NOP56;RPL24;RPL38;EXOSC5;RPLP2;RRP9;PELP1;NOL6;DKC1;UBA52;RRP1B
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.7202102461206756,1.9851616198194397,0.0,0.0,0.0,74/155,15.96%,PCDH8;KCNH7;ZCCHC12;SYT4;PLPPR5;OLFM3;RIMS4;ATRNL1;DACH1;SNAP25;SCRT1;DCLK1;ELAVL2;ST8SIA3;MAP2;LINGO2;NOL4;CLVS2;RELN;SLITRK5;EFNB3;LZTFL1;SYT1;PURG;DACT1;NRG1;CNR1;ADCYAP1R1;SULT4A1;ZDBF2;FAT3;OPCML;NEFM;SLC35F1;PNOC;ASTN1;SNCB;TMEM179;CAMKV;CACNA1B;ADAM12;TMEM200C;NDRG4;MAPK4;BRINP1;SH3GL2;CELF3;FUT9;FAM171B;KCNQ2;GAP43;B3GALT1;TMEM170B;PNMA2;CACNA2D2;NCAN;NEFL;TMEM59L;INSYN2A;ACTL6B;PTPN5;RGMB;GRIA2;STMN2;MEGF10;ZNF536;CHN1;DIPK1B;ABCC5;ACHE;NBEA;TCEAL1;NLGN1;PAK5
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7551351779748091,1.959407741731987,0.0,0.0,0.0,53/114,13.77%,NPY;SHISA6;KCNIP1;SYT4;KALRN;SNAP25;RAB3C;AKAP12;SYNPR;CNTN1;PLPPR4;RAPGEF4;NRXN1;DCLK1;CADPS;ST8SIA3;MAP2;CLVS2;LRRTM1;TMEM196;RGS7BP;ADCYAP1R1;SULT4A1;VSTM2A;OPCML;SLC26A4;ASTN1;RGS4;CDH22;TMEM179;CADM3;CACNA1B;RIMBP2;STX1A;PCLO;LIFR;NDRG4;MAPK4;BRINP1;CELF3;KCTD16;FAM171B;PHYHIP;GAP43;P2RY1;UNC5D;ASIC2;CPE;DPYSL3;ACTL6B;PCSK1;GRIA2;LRP4
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7445986317639419,1.9440672764336917,0.0,0.0011909291679578862,0.01,53/111,14.64%,KCNT2;ROBO2;ANGPT1;ZNF423;SYT4;OLFM3;PCSK2;RNF150;ASB4;RAB3C;PCDH18;ZNF385D;PLPPR4;NRXN1;FGF14;CADPS;ST8SIA3;PAK3;CLVS2;COL11A1;PDGFRA;TMEM196;RUNX1T1;GAD2;PDZRN4;PRKG1;OPCML;NEFM;CNTN4;ASTN1;SULF1;GRIA1;TRPM3;RIMBP2;MEST;SCN3A;CELF4;PTPRN;C11ORF87;CELF3;KCTD16;GAP43;GNB3;UNC5D;NREP;AMPH;TMEM130;PCSK1;THY1;GRIA2;PDZRN3;STMN2;ZNF536
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.8152255661803632,1.941472524658648,0.0,0.0021653257599234294,0.02,12/66,7.88%,MFNG;TGFB2;DLK2;EGFR;ENHO;HEY1;SRC;KAT2B;DTX1;TP63;TSPAN14;NOTCH4
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7471793142095026,1.9386733188048542,0.0,0.001984881946596477,0.02,53/122,13.70%,EPHA3;RND2;ROBO2;PCDH8;SYT4;OLFM3;ATRNL1;CTNND2;SNAP25;RAB3C;SYNPR;NRXN1;SCRT1;DCLK1;ST8SIA3;NOL4;PAK3;CLVS2;PURG;GAD2;ADCYAP1R1;SULT4A1;SLITRK3;VSTM2A;FAT3;OPCML;HIVEP2;SLC35F1;ASTN1;TMEM179;CAMKV;CACNA1B;SCN3B;PCLO;NDRG4;MAPK4;CELF4;ATP2B3;CELF3;FUT9;KCNQ2;BCL2;SOX5;GAP43;ROBO1;NCAN;ATP1B2;SRRM4;NOTCH3;ACTL6B;PTPN5;GRIA2;SLC1A1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.7416640639591499,1.922426543672213,0.0,0.0027482980799028137,0.03,54/108,13.73%,PCDH8;MYT1;ZCCHC12;SYT4;OLFM3;RIMS4;ATRNL1;CTNND2;SNAP25;NRXN1;SCRT1;ST8SIA3;GABRG2;NOL4;KCNB2;CLVS2;LRRTM1;CDK5R2;TMEM196;GAD2;ADCYAP1R1;SULT4A1;SCN2A;VSTM2A;CADPS2;ASTN1;SNCB;CDH22;TMEM179;KCNJ6;CAMKV;SYT13;CACNA1B;RIMBP2;TENM1;MAPK4;HS6ST3;CELF4;CELF3;PRKCG;NEUROD6;KCNQ2;GAP43;CACNA2D2;NCAN;MAPT;CNTFR;TMEM59L;ADCY1;ABCC8;ACTL6B;PTPN5;GRIA2;PRR36
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.7574092215829165,1.9147080513434824,0.0,0.0034026547655939604,0.03,18/54,8.43%,SRGN;FGL2;CSF2RA;PTPRC;TLR2;CSF1R;ADGRE2;CLEC5A;BIRC3;TNFRSF1B;ITGAM;C3AR1;CIITA;CYSLTR1;LILRB1;WDFY4;LY86;LAPTM5
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.7602634084923817,1.9113872759865225,0.0,0.0031758111145543627,0.03,41/108,9.52%,ETV1;SHISA6;SYT4;FGF12;KALRN;CNTN3;PLCXD3;SNAP25;LMO3;CNTN1;PLPPR4;RAPGEF4;NRXN1;SORBS2;FGF14;SYBU;ST8SIA3;MAP2;THSD7A;NOL4;FAM149A;TMEM196;CARTPT;RGS7BP;NTRK2;PDZRN4;CNTN4;ABCC9;CADPS2;PBX1;PPARGC1A;SYT13;RIMBP2;ADGRL2;PCLO;LIFR;MAPK4;SERTM1;SYT7;MAOB;PTPRT
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.675398095674501,-1.8971479360996448,0.0,0.008299175673456267,0.11,97/332,10.59%,MSRB1;RPL18A;RPS12;RPS18;RPS23;CKAP4;RPS13;RPS3A;RPS8;RPLP1;RPS16;RPSA;RPL23A;RPL29;RPL5;TMEM208;RPS27A;RPL19;RPS2;RPL11;RPL23;RPS3;RPL10;RPL21;RPL3;RPL41;RPL13;RPS21;RPS6;EEF1A1;RPL10A;RPS5;RPS7;TGM1;RPL18;RPL12;RPS14;MRPL51;RPL15;RPS11;RPS15;RPL27A;RPL35A;MRPL52;RPL32;RPS28;RPS25;MRPL34;UBL5;RPS27;MSRB2;MRPL32;RPL8;RPL30;RPS24;RPL7A;LGALS1;RPS15A;RPS19;VWA1;RPS20;RPL7;MRPL24;RPL14;MRPS21;TF;RPL34;SARS1;RPL9;MRPS5;B4GALT7;ARAF;RPL37;RPL28;MRPS7;F5;MRPL36;RPS9;RPL6;AFP;RPL27;RPLP0;MELTF;SPCS1;HARS2;RPL35;RPL36;MRPL9;MRPL27;FDXR;SEC11C;RPS26;TTF1;RPS4X;RPL13A;RPL24;RPL38
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.905188396476451,-1.8875758246458838,0.0,0.010892668071411349,0.16,4/21,4.58%,CYP1A2;CYP2E1;GSTP1;GPX4
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.8635653308908399,-1.8815693860953373,0.0,0.011228296499382008,0.18,5/34,4.70%,CYP1A2;CYP2E1;CBR1;GPX4;DAGLA
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7029733831503335,1.8762621306128935,0.0,0.007443307299736786,0.08,50/119,9.99%,NPY;ROBO2;SHISA6;KCNIP1;SYT4;NPTX2;PCSK2;FGF12;CTNND2;SNAP25;RAB3C;CNTN1;RAPGEF4;NRXN1;CADPS;ST8SIA3;NOL4;KCNB2;PAK3;CLVS2;LRRTM1;TMEM196;GAD2;SULT4A1;WSCD2;VSTM2A;CNTN4;CA10;EFNA5;ASTN1;CAMK2B;CDH22;TMEM179;PIR;SYT13;CACNA1B;RIMBP2;SCN3B;UBE2QL1;MAPK4;SEZ6L;CELF4;SERTM1;SH3GL2;CELF3;MAFB;IGSF21;PTPRT;GABRB3;HOPX
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.7140750942339453,1.8613031295409028,0.0,0.014010931387739832,0.14,65/149,14.75%,SHISA6;KCNIP1;SYT4;NMNAT2;TAFA1;CYB561;OLFM3;ATRNL1;KALRN;SNAP25;CASZ1;CNTN1;PLPPR4;NRXN1;SCRT1;DCLK1;ST8SIA3;MAP2;CLVS2;LRRTM1;CDK5R2;TMEM196;CARTPT;RGS7BP;DMKN;ADCYAP1R1;SULT4A1;NTRK2;VSTM2A;OPCML;TOX;NEFM;CA10;EFNA5;ASTN1;TMEM179;CADM3;CACNA1B;RIMBP2;SCN3A;PCLO;NDRG4;MAPK4;ATP2B3;BRINP1;CELF3;EML5;KCTD16;GAP43;FSTL5;NCAN;ASIC2;CNTFR;CPE;TMEM59L;TTBK2;CACNA1E;ACTL6B;GOLGA7B;RGMB;GRIA2;SCN7A;STMN2;ZNF536;ZDHHC2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.78913827287531,-1.858217608357011,0.0,0.016137286031720516,0.27,7/64,7.46%,CYP1A2;CYP2E1;GSTP1;GPX4;DAGLA;ACOT1;ELOVL1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.6926617278419986,1.8571875967377187,0.0,0.013232546310643177,0.14,51/118,14.64%,RND2;IGFBP3;PCDH8;KCNIP1;ZCCHC12;BTBD17;PLPPR5;DCX;RIMS4;KLHDC8A;CTNND2;PROM1;SCRT1;DCLK1;MAP2;GFAP;ISG15;CLVS2;EFNB3;CDK5R2;PTPRZ1;ADCYAP1R1;SULT4A1;OPCML;NYAP1;SLC35F1;ASTN1;CAMKV;MEIS3;SOX9;TMEM200C;DLX1;MAPK4;CELF3;KCNQ2;GAP43;HOPX;NCAN;NKAIN1;CNTFR;SEMA5B;TMEM59L;FABP7;ACTL6B;MGAT5;GRIA2;CSPG5;STMN2;MEGF10;SRRM3;ZNF536
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6972774654030265,1.8562720968359372,0.0,0.013162901330060844,0.14,71/187,14.50%,NPY;CHRM3;KCND2;GRIK2;GLRA3;NPTX2;HTR5A;PTCHD1;ZACN;GRM5;KCNQ3;GABRA6;SNAP25;GRIN2B;GRIK1;NRXN1;KCNMB4;RIT2;UNC13C;DLGAP1;GABRG2;SYN2;GRM1;SLC1A2;GABRA1;SYT1;CACNB1;GAD2;GABRB2;GAD1;GABRA2;PNOC;GPR176;NRGN;GABRA4;KCNIP2;SNCB;GRIA1;CACNA1B;GRIN1;NPTX1;HTR3B;CHRNA5;GLRB;CHRM5;KCNQ2;PCDHB13;GABRB3;CAMKK1;GABRG1;GABRR2;HTR2C;DLG4;GABBR2;ASIC2;CHRM1;PRKAR1B;GLRA2;HOMER1;HTR1E;AMPH;CACNA1E;CACNB2;HRH2;HCRTR2;GRIA2;SLC1A1;RPS6KA3;NLGN4X;GABRD;DOC2A
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7223115347005736,1.8554424861748113,0.0,0.012504756263557803,0.14,46/97,14.64%,RND2;ZNF423;PCDH8;RIMS4;CTNND2;SCRT1;CACNG5;NOL4;CLVS2;EFNB3;PURG;CDK5R2;PTPRZ1;ADCYAP1R1;SULT4A1;OPCML;SLC35F1;ASTN1;SNCB;TMEM179;CAMKV;CACNA1B;SOX9;TMEM200C;PCLO;NDRG4;MAPK4;CELF3;KCNQ2;GAP43;NCAN;UNC5D;NKAIN1;ATP1B2;CNTFR;SEMA5B;CPE;TMEM59L;HES1;GRIA2;LRP4;CSPG5;WNK2;MEGF10;SRRM3;ZNF536
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.7180550410530869,1.8544252105092154,0.0,0.01190929167957886,0.14,61/135,17.06%,SCN9A;SHISA6;SYT4;OLFM3;GRM5;ADCY8;SNAP25;RAB3C;SYNPR;PRKX;PLPPR4;NRXN1;DCLK1;ST8SIA3;MAP2;ADD2;FGF13;CLVS2;SPHKAP;LRRTM1;TMEM196;RGS7BP;ADCYAP1R1;SULT4A1;SCN2A;VSTM2A;OPCML;NEFM;CA10;LRFN5;ASTN1;TMEM179;CADM3;CACNA1B;SCN3B;NDRG4;MAPK4;ATP2B3;BRINP1;C11ORF87;SH3GL2;KCTD16;GAP43;NCAN;ASIC2;PIEZO2;PHF24;ACTL6B;PTPN5;GRIA2;SCN7A;STMN2;ZNF536;ZDHHC2;PRUNE2;PAK5;CALCB;ELAVL4;NFASC;RUFY3;ASXL3
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.7285533274908311,-1.8511348653978188,0.0,0.018345546225534904,0.31,77/188,18.20%,LSM7;RPS2;RPS3;EEF1B2;RPS6;RPS5;EIF3D;EIF2S2;RPL18;CYC1;SF3A1;LSM2;PSMD7;DDX18;PCNA;ERH;PSMD8;PPM1G;CDK4;RANBP1;SRSF7;USP1;TFDP1;CCT7;SNRPB2;CCT2;RPL14;RACK1;PHB2;RPL34;RAN;VBP1;NDUFAB1;RPL6;HSPE1;SRSF3;RPLP0;APEX1;CSTF2;PSMD3;SNRPD1;KPNA2;PSMB3;MRPL9;PRDX3;H2AZ1;MCM4;ILF2;EIF3B;NOP56;SNRPD2;DDX21;PPIA;EIF4G2;NPM1;RRP9;PSMA7;YWHAQ;RSL1D1;COPS5;POLE3;IMPDH2;TYMS;NHP2;COX5A;EPRS1;SNRPG;EIF3J;MRPS18B;UBE2L3;XRCC6;TRIM28;VDAC1;ETF1;DUT;TUFM;SSB
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.8115544298574177,-1.8487754710708688,0.0,0.017843227697930973,0.31,25/44,13.59%,RPSA;RPL23A;RPL5;RPL11;RPL10;RPL3;RPS5;RPS14;RPS15;SBDS;RPS28;RPS27;RPS19;MRPS2;MRPS7;RPL6;RPLP0;NOP53;MTERF3;RPL24;NPM1;RPS27L;DHX29;RPF2;RSL24D1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.6859706962779291,-1.8465537867374227,0.0,0.018179146713285157,0.32,74/233,17.34%,LSM7;SNRNP25;PRPF4;POLR2L;CRNKL1;ZMAT2;SF3A3;PPIL1;SF3A1;POLR2G;RBM22;LSM2;DNAJC8;UBL5;PPIE;PDCD7;POLR2K;GEMIN6;GTF2F1;CSTF2T;SRSF7;DDX5;SF3B5;POLR2I;SNRPB2;RNF113A;DDX41;SF3B6;SNRNP27;SNRPC;GPATCH1;RBM15B;PNN;FRG1;SRSF9;POLR2A;SRSF3;TFIP11;CSTF2;SNRPD1;PHF5A;PPWD1;SNRPD2;SNIP1;HSPA8;PRPF6;SF3B4;IK;POLR2E;DDX46;SNRPB;RBM8A;PUF60;WBP4;PRPF8;SNRPE;SRSF8;PRPF3;DHX38;MAGOHB;GPKOW;HNRNPH2;SF3A2;ALYREF;POLR2C;FIP1L1;POLR2D;DHX8;SNRPG;EFTUD2;WBP11;SNRNP200;PTBP1;BUD13
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.7410623407765613,-1.840949058939884,0.0,0.01923899815210316,0.33,35/93,13.54%,MRPL58;EEF1B2;EEF1A1;MRPL51;MRPS10;MRPL52;ZNF598;MRPL34;MRPS26;MRPL32;MRPL54;MRPS22;MRPL24;RACK1;MRPS21;MRPS2;MRPS5;MRPL40;MRPS7;MRPL36;MRPL57;MRPL14;MRPL50;MRPL9;MRPL27;GADD45GIP1;MRPL47;MRPL4;MRPL15;MRPL43;MRPS34;CHCHD1;MTRES1;AURKAIP1;MRPL35
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.8063045521847866,-1.8392037349247332,0.0,0.01948502114637558,0.35,21/39,11.68%,RPS16;RPSA;RPS6;RPS5;RPS7;RPS14;RPS15;RPS28;RPS25;RPS27;RPS24;TSR3;RPS19;RIOK2;SURF6;MRPS7;LTV1;METTL17;RRP36;NPM1;RPS27L
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.7703251517014743,-1.8338585917145553,0.0,0.021093738170034678,0.36,10/35,6.36%,RPS8;RPS16;RPS14;TSR1;RPS28;DCAF13;TSR3;RPS19;RIOK2;UTP3
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.776673718298891,1.8316860608852636,0.0,0.01623994319942572,0.19,18/53,9.69%,TGFB2;PDGFB;P2RY12;NCKAP1L;IL12A;EPHA4;RNASE10;SYK;PPP3CA;ADGRG1;CITED2;PTPRJ;STX3;TPM1;NPNT;VIT;CHRD;FBLN2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.9467988848558034,-1.8304391517198615,0.0,0.021245889724048044,0.37,2/12,1.75%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.6625427091957645,-1.8153872330912022,0.0,0.02649352234218731,0.43,80/276,17.34%,LSM7;SNRNP25;PRPF4;POLR2L;CRNKL1;KIN;ZMAT2;SF3A3;PPIL1;SF3A1;POLR2G;RBM22;LSM2;DNAJC8;UBL5;PPIE;PDCD7;POLR2K;GEMIN6;GTF2F1;CSTF2T;SRSF7;DDX5;SF3B5;POLR2I;SNRPB2;PRPF18;RNF113A;DDX41;SF3B6;SNRNP27;SNRPC;GPATCH1;RBM15B;PNN;FRG1;SRSF9;POLR2A;SRSF3;TFIP11;CSTF2;SNRPD1;PHF5A;PPWD1;SNRPD2;SNIP1;HSPA8;PRPF6;SF3B4;IK;POLR2E;DDX46;SNRPB;RBM8A;PUF60;AURKAIP1;WBP4;PRPF8;SNRPE;SRSF8;PRPF3;DHX38;MAGOHB;GPKOW;HNRNPH2;SF3A2;ALYREF;POLR2C;FIP1L1;POLR2D;DHX8;SNRPG;PRKACA;SUPT5H;GTF2H2;EFTUD2;WBP11;SNRNP200;PTBP1;BUD13
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.7314364668404759,1.81384784783172,0.0,0.021747402197491827,0.26,38/100,9.52%,KCNT2;SSTR1;KCNIP1;SYT4;PCSK2;DEPP1;CNTN3;GPC6;SNAP25;RAB3C;FAP;PLPPR4;RAPGEF4;SORBS2;FGF14;LDB2;CADPS;ST8SIA3;NOL4;KCNB2;TMEM47;DDAH1;TMEM196;PTGER3;RGS7BP;RUNX1T1;CNTN4;RGS4;TMEM179;SYT13;RIMBP2;DNALI1;SH3GL2;CELF3;MAFB;FNDC4;SYT7;PTPRT
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9469002011175606,-1.811604879534039,0.0,0.02827867266511024,0.44,2/11,1.75%,CYP1A2;CYP2E1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7373766899920429,1.8100955856765695,0.0,0.02282614238585948,0.29,48/103,14.18%,KCNC2;HTR5A;PCSK2;SLC4A10;SYNPR;NRXN1;HCN1;UNC13C;CADPS;ST8SIA3;CACNG2;FGF13;SLC1A2;XKR4;GABRA1;SLC24A4;GAD2;RPH3A;WSCD2;TNR;VSTM2A;FAM135B;UNC80;CDH22;KCNJ6;PDE1B;SCN3B;ADCY2;CNTNAP5;CACNG3;SEZ6L;CELF4;KCNB1;CELF3;ATP2B2;SCN1A;ATP1B2;SRRM4;MYT1L;SV2B;CACNA1E;ACTL6B;C4ORF50;CACNB2;PKD2L1;ZNF493;GRIA2;KCNT1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.666043062824268,-1.7994519961343853,0.0,0.03349310182501993,0.53,92/256,20.80%,LSM7;SNRNP25;PRPF4;POLR2L;CRNKL1;ZMAT2;SF3A3;PPIL1;SF3A1;POLR2G;RBM22;LSM2;DNAJC8;UBL5;PPIE;PDCD7;POLR2K;GEMIN6;GTF2F1;CSTF2T;SRSF7;DDX5;SF3B5;POLR2I;SNRPB2;RNF113A;SNUPN;DDX41;SF3B6;SNRNP27;SCNM1;SNRPC;GPATCH1;RBM15B;PNN;SMN1;FRG1;SRSF9;POLR2A;SRSF3;TFIP11;CSTF2;SNRPD1;PHF5A;PPWD1;SNRPD2;SNIP1;HSPA8;PRPF6;SF3B4;IK;POLR2E;DDX46;SNRPB;RBM8A;PUF60;WBP4;PRPF8;SNRPE;SRSF8;PRPF3;DHX38;MAGOHB;GPKOW;HNRNPH2;SF3A2;ALYREF;POLR2C;FIP1L1;POLR2D;DHX8;SNRPG;EFTUD2;WBP11;SNRNP200;PTBP1;BUD13;YBX1;SLU7;SUGP1;POLR2J;SNRNP35;WDR77;PLRG1;CASC3;DDX1;ESS2;DDX23;RBMX;STRAP;SYF2;SRPK3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8805202721891077,-1.7963256020805334,0.0,0.03405523810832054,0.55,1/21,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.8017978447301777,1.796295203657324,0.02631578947368421,0.02810592836380611,0.33,9/19,16.70%,DNAH7;DNAH3;RSPH9;DNAH2;TEKT3;TEKT5;RFX3;CFAP44;DRC1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6865343316212877,1.7947976578273372,0.0,0.02702493111904434,0.33,51/128,12.82%,ALDH1L1;CHL1;EGFR;SHISA6;KCNIP1;BTBD17;HTR5A;GRM5;ADCY8;SYNPR;GRIN2B;PLPPR4;RAPGEF4;NRXN1;ST8SIA3;GFAP;SLC1A2;CLVS2;GRIN3A;SPHKAP;RGS7BP;PTPRZ1;ADCYAP1R1;NTRK2;TNR;SCN2A;VSTM2A;OPCML;CA10;SLC4A4;LRRC3B;ASTN1;CADM3;GRIA1;TRPM3;ADCY2;C11ORF87;ATP2B2;SCN1A;VIM;GAP43;HOPX;GABRG1;P2RY1;SPARCL1;NCAN;ATP1B2;CDC42EP4;FABP7;PSD2;PTPN5
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.7503493870411017,-1.7921427512817485,0.0,0.03513317701763153,0.57,31/79,13.54%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MRPS22;MRPL24;MRPS21;MTRF1L;MRPS2;MRPS5;MRPL40;MRPS7;MRPL36;MRPL57;MRPL14;MRPL50;MRPL9;MRPL27;GADD45GIP1;MRPL47;MRPL4;MRPL15;MRPL43;MRPS34;CHCHD1;AURKAIP1;MRPL35
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.881111259810588,1.7903603314917822,0.0,0.028229432129372112,0.35,2/12,3.01%,TGFB2;HEY1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.7724323655337739,1.786840782338012,0.0,0.029347897353247904,0.39,6/24,6.67%,CHRM3;KCNJ3;NEDD4L;KCNJ4;KCNJ6;ANO6
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6806609553375509,1.7721128507873636,0.0,0.0369598707297275,0.51,37/95,14.62%,PCDH8;RIMS4;PIANP;GRM5;SCRT1;GNG3;CLVS2;EFNB3;CDK5R2;SULT4A1;OPCML;NYAP1;GAD1;ASTN1;SNCB;TMEM179;CAMKV;CTXN1;GRIN1;NDRG4;BRINP1;C11ORF87;CELF3;PRKCG;KCNQ2;PHYHIP;GAP43;NCAN;ASIC2;TMEM59L;PSD2;ACTL6B;GRIA2;PRR36;CSPG5;STMN2;SRRM3
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.9619036972543418,-1.7715929535029393,0.0,0.05273992282809305,0.72,1/12,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.8017561485421705,-1.7667009479700873,0.0,0.05601943579582979,0.75,6/23,10.94%,SELENOS;SEC61B;TMED9;RANGRF;TMEM129;LMAN1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.7087961407823169,1.7662152313446324,0.0,0.040491591710568126,0.54,33/87,14.38%,CTF1;IFNA2;PDGFB;BMP6;ANGPT1;PTPRC;IGF1;CD44;CSF1R;GRM5;PARP14;IL12A;CSPG4;EPHA4;HGF;RELN;SRC;TNK2;EFNA5;PTPRJ;LRP8;CRLF1;TNFRSF1A;SOCS3;TEC;DLG4;PARP9;LYN;GHR;HES1;PTPN11;HCLS1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.640629921842482,1.763167890093754,0.0,0.04225877692753789,0.59,35/175,11.34%,ROR1;TGFB2;PDGFC;PDGFB;EGFR;ANGPT1;FLT1;TRIM5;JCAD;PTPRC;IGF1;CD44;CSF1R;CHI3L1;LRRK2;RIT2;DIRAS1;PDGFRA;NTRK2;ADRA1A;PRKCZ;ARRB2;PTPRJ;NPNT;BMPER;TENM1;NDRG4;TIRAP;LAPTM5;CD4;ROBO1;HTR2C;P2RY1;CX3CL1;NECAB2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.9180001889631266,1.7615193665917663,0.0,0.04279901697348652,0.61,3/14,3.61%,TP73;MEF2C;PIM1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.7346935475330432,-1.7572388086839585,0.0,0.0646329741841897,0.8,42/94,19.09%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MRPS22;MRPL24;MRPS21;MTRF1L;MRPS2;MRPS5;MRPL40;MRPS7;MRPL36;MRPL57;MRPL14;MRPL50;MRPL9;MRPL27;GADD45GIP1;MRPL47;MRPL4;MRPL15;MRPL43;MRPS34;CHCHD1;AURKAIP1;MRPL35;EARS2;MRPS18B;MRPS18A;MRPS18C;NOA1;MRPL22;PTCD3;MTIF2;TUFM;MRPL20;ERAL1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.6920556708016662,-1.7518417349939992,0.0,0.06859024600709444,0.82,48/123,17.23%,RPSA;RPL23A;RPL5;RPL11;RPL10;RPL3;RPS5;EIF2S2;CRNKL1;RPS14;RPS15;RPS28;RPS27;EIF2S3B;EIF5;GEMIN6;RPS19;PRPF18;SNUPN;SNRPC;MRPS7;SMN1;RPL6;SRSF9;RPLP0;NOP53;SNRPD1;RPL24;RPL38;SNRPD2;ABT1;KHDC4;PRPF6;RPS27L;DHX29;SNRPB;PUF60;RPF2;SNRPE;RSL24D1;EIF4B;SF3A2;POLR2D;NLE1;SNRPG;BRIX1;SNRNP200;TRAF7
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.7450483805045628,-1.7507338527674712,0.0,0.0675790019124296,0.83,32/85,13.54%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MRPS22;MRPL24;MRPS21;MTRF1L;MRPS2;MRPS5;MRPL40;MRPS7;MRPL36;MRPL57;MRPL14;TRMT112;MRPL50;MRPL9;MRPL27;GADD45GIP1;MRPL47;MRPL4;MRPL15;MRPL43;MRPS34;CHCHD1;AURKAIP1;MRPL35
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.730223041146947,1.7493101124470012,0.022727272727272728,0.05377225637143183,0.7,18/47,14.03%,DPP10;KCNIP4;KCNIP1;KCNMA1;KCNJ3;NEDD4L;KCNMB4;KCNJ4;KCNIP2;GNG2;KCNJ6;KCNMB3;GABBR2;KCNIP3;GABBR1;KCNN4;KCNMB2;FHL1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.744981031478934,-1.7486719275570934,0.0,0.06708500336043816,0.84,38/79,19.09%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MRPS22;MRPL24;MRPS21;MRPS2;MRPS5;MRPL40;MRPS7;MRPL36;MRPL57;MRPL14;MRPL50;MRPL9;MRPL27;GADD45GIP1;MRPL47;MRPL4;MRPL15;MRPL43;MRPS34;CHCHD1;AURKAIP1;MRPL35;MRPS18B;MRPS18A;MRPS18C;MRPL22;PTCD3;TUFM;MRPL20;ERAL1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.6933338296044745,1.7482938441499343,0.0,0.05254099270402438,0.71,56/108,20.67%,ZNF423;SHISA6;KCNIP1;PLPPR4;DCLK1;MAP2;GFAP;CLVS2;EFNB3;TMEM47;PURG;RGS7BP;RUNX1T1;PTPRZ1;ADCYAP1R1;NTRK2;FAT3;OPCML;LRRC3B;SLC35F1;ASTN1;CADM3;TMEM200C;NDRG4;MAPK4;BRINP1;C11ORF87;GAP43;BOC;NCAN;CNTFR;SEMA5B;CPE;NOTCH3;DPYSL3;PTPN5;GRIA2;LRP4;PDZRN3;STMN2;MEGF10;ZNF536;GJA1;NLGN1;NFASC;ASXL3;ADGRL3;LRCH2;ATP1A2;DOK5;NOVA1;AQP4;DKK3;PAX6;LRRC4C;LY6H
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7099528044647043,1.744413808942083,0.0,0.05410221077294397,0.74,48/98,11.59%,ROBO2;ZNF423;SHISA6;KCNIP1;DCX;SNAP25;RAB3C;CNTN1;NRXN1;DCLK1;CADPS;TMEM132B;ST8SIA3;PAK3;CLVS2;LRRTM1;PURG;RUNX1T1;ADCYAP1R1;SULT4A1;FAT3;OPCML;NEFM;SLC35F1;ASTN1;TMEM179;CADM3;GRIA1;CACNA1B;TRPM3;SCN3B;TMEM200C;NDRG4;MAPK4;DENND2A;BRINP1;SH3GL2;KCNQ2;GAP43;GABRB3;PNMA2;NCAN;UNC5D;NEFL;ATP1B2;ATCAY;SEMA5B;SRRM4
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.780223912255313,1.742326608704649,0.0,0.05590750816246742,0.77,18/40,11.83%,GRM5;GRIK1;LRRK2;MEF2C;NRXN1;CACNG5;CACNG2;GRM1;RELN;SYT1;TSHZ3;CACNG3;GRM2;GRM6;CACNG8;DGKI;GRM8;HOMER1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.722418186545351,1.7340489848264833,0.022727272727272728,0.061799567634571374,0.78,10/46,6.70%,NRCAM;GPM6A;DCX;MEF2C;FGF13;RELN;SPOCK1;NTRK2;ASTN1;KIAA0319
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.8913682744533976,1.7265617713862318,0.0,0.06988873801437068,0.81,1/12,0.51%,NCEH1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6567666053123427,1.7254821288859767,0.0,0.0684020855442478,0.81,67/125,13.85%,KCND2;SYT4;OLFM3;KCNC2;HTR5A;GRM5;KCNQ3;ADCY8;SNAP25;RAB3C;SYNPR;GRIN2B;NRXN1;SCRT1;SORCS3;RIT2;ST8SIA3;MAP2;GABRG2;KCNB2;GRM1;GFAP;CLVS2;SPHKAP;LRRTM1;GABRA1;TMEM196;GAD2;ADCYAP1R1;OXTR;VSTM2A;OPCML;CA10;LRRC3B;NRGN;ASTN1;SNCB;CDH22;GRIA1;CACNA1B;CACNG3;SEZ6L;CELF4;ATP2B3;BRINP1;C11ORF87;KCNB1;EMX1;CELF3;IGSF21;NEUROD6;KCNQ2;GAP43;SATB2;GABRG1;NCAN;DLG4;ASIC2;SRRM4;PHF24;PSD2;ACTL6B;PTPN5;KCNN4;BRINP2;GRIA2;DAB1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.8247571798343784,1.72297275711418,0.0,0.06966935632553634,0.81,2/26,0.40%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.7257747617470213,-1.7221789896304818,0.0,0.1025060346694463,0.89,30/76,17.06%,SMIM20;NDUFB3;NDUFS6;SURF1;SDHAF1;DMAC2;NDUFA2;NDUFA12;UQCRFS1;NDUFA1;SAMM50;NDUFB4;NDUFS8;NDUFAB1;NDUFB2;UQCC3;NDUFS5;NDUFAF3;FOXRED1;NDUFAF8;NDUFV3;NDUFB10;NDUFB11;FASTKD3;TMEM126A;LYRM7;NDUFAF4;TMEM126B;NDUFA3;NDUFA5
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.9236478112727452,1.7220370944371306,0.0,0.06826057426100078,0.81,4/11,6.02%,TGFB2;PDGFRA;ID2;RARB
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7791177929120994,-1.7212077791271372,0.0,0.10221090039940874,0.9,30/57,15.07%,RPS16;RPL5;RPL11;RPS6;RPS7;RPS15;RPL35A;RPS28;RPS25;WDR74;NOC2L;RPS24;RPS19;RBIS;RIOK2;SURF6;BYSL;RPL7;RPL14;MRPL36;LTV1;METTL17;NIP7;RRP36;RPL38;NPM1;RPF2;NOM1;ZNF622;RPL26L1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.8937962710052823,1.720047038549271,0.0,0.0683366498756787,0.82,4/12,7.14%,PPARG;PDGFB;NFATC4;SOX9
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.8554403646166938,-1.7197941767961076,0.017543859649122806,0.10171810184389987,0.9,3/15,9.23%,SELENOS;SEC61B;TMEM129
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7937621579446473,-1.7166478738687847,0.0,0.10436213409371255,0.93,15/53,12.22%,CYP1A2;CYP2E1;CYP3A43;HSD17B10;HSD11B1;TSPO;DHCR24;NPC1;FDXR;LIPA;AKR1D1;SLC22A24;SRD5A1;RDH16;CYP4V2
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.7998152533016342,-1.715956571275614,0.0,0.10222155402671743,0.93,8/33,6.01%,RPS27A;UBC;UBB;ANAPC15;MAD2L1BP;PHB2;CDC26;CDC23
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.6343793422904227,1.7144148557094674,0.0,0.07394839252203618,0.82,23/108,11.34%,ROR1;PDGFC;PDGFB;EGFR;ANGPT1;PTPRC;CD44;CSF1R;CHI3L1;PDGFRA;NTRK2;ADRA1A;PRKCZ;ARRB2;NPNT;BMPER;NDRG4;TIRAP;CD4;HTR2C;P2RY1;CX3CL1;NECAB2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6232507626780042,1.7111061115270465,0.0,0.07795172735724346,0.85,83/240,14.55%,NPY;CHRM3;KCND2;GRIK2;GLRA3;SHISA6;CBLN2;NPTX2;HTR5A;PTCHD1;ZACN;GRM5;KCNQ3;GABRA6;SNAP25;GRIN2B;GRIK1;NRXN1;KCNMB4;RIT2;UNC13C;DLGAP1;GABRG2;SYN2;GRM1;SLC1A2;GABRA1;SYT1;CACNB1;GAD2;GABRB2;FCHSD2;GAD1;GABRA2;PNOC;GPR176;NRGN;GABRA4;KCNIP2;SNCB;GRIA1;SNPH;CACNA1B;GRIN1;RIMBP2;NPTX1;HTR3B;CHRNA5;STX1A;DNAJC5;GLRB;CHRM5;LIN7A;KCNQ2;PCDHB13;GABRB3;CAMKK1;GABRG1;GABRR2;HTR2C;DLG4;SYN3;GRIK5;GABBR2;ASIC2;CHRM1;PRKAR1B;GLRA2;HOMER1;HTR1E;AMPH;CACNA1E;CACNB2;HRH2;HCRTR2;GRIA2;SLC1A1;RPS6KA3;RAB3A;NLGN4X;GABRD;DOC2A;TBC1D24
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.8761890270248973,-1.7044429896690552,0.0,0.1173740559531672,0.97,4/15,1.86%,RPL5;RPL11;RPL23;RPS7
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.6534328404182946,1.7010582788843065,0.0,0.08892271120752215,0.89,50/113,14.51%,RND2;EGFR;PCDH8;MYT1;ZCCHC12;NTNG1;SYT4;BTBD17;PLPPR5;DCX;RIMS4;GRM5;SCRT1;EPHA4;ELAVL2;NOL4;CLVS2;EFNB3;PURG;CDK5R2;CNR1;ADCYAP1R1;SULT4A1;NYAP1;NEFM;SLC35F1;ASTN1;PBX1;TMEM179;CAMKV;CACNA1B;TMEM200C;LRP8;MAPK4;CELF3;KCNQ2;GAP43;NCAN;UNC5D;NKAIN1;CNTFR;SEMA5B;TMEM59L;ACTL6B;DRAXIN;PRR36;DAB1;CSPG5;POU6F2;STMN2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6264058640832353,1.7009622647563911,0.0,0.08698960878996731,0.89,49/120,14.64%,KCNIP1;CHST1;VCAN;ADCY8;CTNND2;SNAP25;CSPG4;PLPPR4;SCRT1;DCLK1;ST8SIA3;MAP2;GFAP;CLVS2;PDGFRA;LRRTM1;ADCYAP1R1;TNR;OPCML;NYAP1;CA10;LRRC3B;SLC35F1;PCDH15;ASTN1;SNCB;TMEM179;CADM3;NDRG4;MAPK4;BRINP1;C11ORF87;ATP2B2;IGSF21;PHYHIP;GAP43;NCAN;ATP1B2;CNTFR;KCNIP3;TMEM59L;PSD2;PTPN5;BRINP2;GRIA2;CSPG5;STMN2;MEGF10;ZNF536
prerank,PanglaoDB_Augmented_2021__Microglia,0.6993388011191947,1.6934712692280622,0.0,0.09780822528334979,0.91,31/81,12.36%,CX3CR1;SLA;SLCO2B1;FGL2;PTPRC;FOS;P2RY12;CSF1R;C1QB;CYFIP1;OTULINL;LCP2;TNFRSF1B;ITGAM;C3AR1;MERTK;CD53;CSF3R;LILRB1;SLC2A5;WDFY4;LY86;APBB1IP;LAPTM5;MAFB;CD4;P2RY13;GPR34;AEBP1;AOAH;SASH3
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7534207485713112,1.691619145550556,0.02127659574468085,0.09899598708649927,0.92,12/30,8.36%,NPY;GLRA3;SSTR1;GPR149;SORCS3;PNOC;CYSLTR2;CYSLTR1;NMUR2;SORCS1;NXPH2;GLRB
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.7884291006194605,1.6885132989694682,0.0,0.10305183004370277,0.93,11/26,13.00%,NPY;CHRM3;SSTR1;NPY1R;HTR5A;CNR1;CHRM5;HTR2C;CHRM1;HTR1E;HRH2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.63477533319257,1.6857562764980205,0.025,0.10503995261388553,0.93,28/121,11.76%,NPY;ETV1;TGFB2;L1CAM;GPM6A;FRY;DCX;MEF2C;MAP2;LGI1;NTRK2;B4GALT6;CNTN4;TENM3;PBX1;STX3;PTPRM;GPRIN3;TENM1;SH3GL2;TENM2;UNC5A;MAPT;CDK5R1;ATCAY;LYN;SRRM4;MYT1L
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6629481222826697,1.6840317047604239,0.0,0.10648307854682275,0.94,39/97,13.60%,CHL1;SLCO2B1;SHISA6;SSTR1;P2RY12;CSF1R;CHI3L1;C1QB;GRM5;SYNPR;SLC8A1;PID1;LRRK2;NRXN1;GFAP;SLC1A2;TMIGD3;RGS7BP;NTRK2;OPCML;CA10;CADM3;SEZ6L;EDNRB;IGSF21;MAOB;TMEM176B;PTPRT;LYVE1;IL33;SPARCL1;TGFA;PHF24;SCN4B;MTURN;PDK4;RASSF4;PLXDC2;GRIA2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.8681932991092232,1.6814260092192201,0.0,0.10764167479619355,0.94,4/19,6.91%,TGFB2;PKP2;NRG1;TPM1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.5979559604594028,1.6810075986676538,0.0,0.10650951426642227,0.95,40/158,14.31%,ROR1;PDGFC;PDGFB;EGFR;ANGPT1;RPS6KA6;PTPRC;CD44;CSF1R;CHI3L1;LMO3;PTPRR;PTPN6;SPRED3;PDGFRA;SYK;NTRK2;ADRA1A;PRKCZ;ARRB2;EPHB1;NPNT;BMPER;NDRG4;TIRAP;CD4;FBLN1;SEMA6A;HTR2C;P2RY1;DUSP10;CX3CL1;NECAB2;LYN;TIMP3;MTURN;PTPN11;DUSP6;ITGB1BP1;WNK2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.658172814338131,1.6791021075856183,0.0,0.10784525243174188,0.95,22/93,10.68%,ROR1;EPHA3;EGFR;FLT1;PTPRC;CSF1R;EPHA4;MET;LCP2;RELN;PDGFRA;NTRK2;MERTK;EPHA6;AXL;EPHB1;EPHB3;F2;CD4;SPDYA;CAMKK1;MAPT
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.7090263395672267,1.6754114813929653,0.0,0.11151427663605659,0.96,9/58,6.79%,CREB3L1;TGFB2;CLDN5;PPARG;ADAMTS9;STAB1;ADGRB1;SULF1;PTPRM
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.5975564902178812,1.6752448821012553,0.0,0.1097356161904052,0.96,62/147,14.62%,DPP10;PCDH8;ZCCHC12;SYT4;PLPPR5;OLFM3;PIANP;FGF12;KLHDC8A;SNAP25;GALNT14;SCRT1;NELL1;ST8SIA3;CLVS2;SYT16;LRRTM1;PURG;CDK5R2;TMEM196;GRIP1;DTX1;ADCYAP1R1;SULT4A1;OPCML;GALNTL6;NYAP1;NEFM;CA10;SLC35F1;ASTN1;SNCB;TMEM179;CAMKV;CACNA1B;NKAIN3;NDRG4;MAPK4;ATP2B3;BRINP1;C11ORF87;SH3GL2;CELF3;KCNQ2;CCDC184;GAP43;CPNE5;NCAN;MTUS2;NEFL;ASIC2;CNTFR;BBC3;TMEM59L;PSD2;ACTL6B;PTPN5;GRIA2;EFNA3;POU6F2;STMN2;SRRM3
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.650467718205041,-1.674014001819005,0.0,0.1831608770723255,0.97,68/180,17.78%,CYB5A;COX7C;NDUFB3;CYC1;ATP6V1F;NDUFS6;SURF1;SLC25A4;HCCS;MRPL34;GRPEL1;ACAA2;ATP6V1G1;ECHS1;NDUFA2;GPX4;SLC25A11;COX5B;MRPS22;ATP1B1;TIMM10;UQCRFS1;NDUFA1;ATP5F1B;SLC25A5;COX7B;PHB2;MPC1;SLC25A6;HSD17B10;NDUFB4;TIMM8B;IDH3B;NDUFS8;NDUFAB1;COX6A1;NDUFB2;ECH1;CYB5R3;PDHB;UQCRQ;PRDX3;ETFB;ATP5MC3;BAX;COX4I1;MRPL15;ATP6AP1;COX6B1;ATP6V0E1;MGST3;UQCR10;ATP5PF;HADHA;MRPL35;TIMM50;NQO2;COX5A;LRPPRC;ATP5PB;NDUFA3;ATP5PD;NDUFA5;TIMM13;UQCRB;ISCU;VDAC1;TIMM17A
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7480053025519161,-1.673161290325157,0.01639344262295082,0.18126154141344253,0.97,24/53,13.31%,COX7C;NDUFB3;CYC1;NDUFS6;NDUFA2;COX5B;NDUFA12;UQCRFS1;NDUFA1;COX7B;NDUFB4;NDUFS8;NDUFAB1;COX6A1;NDUFB2;UQCC3;NDUFS5;UQCRQ;COX4I1;NDUFV3;NDUFB10;NDUFB11;COX6B1;UQCR10
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.6356759008675046,1.6718626911232817,0.0,0.11554102278608966,0.97,47/111,14.51%,NPY;KCNIP1;SYT4;OLFM3;PCSK2;CTNND2;SNAP25;RAB3C;NRXN1;SCRT1;CADPS;ST8SIA3;NOL4;KCNB2;CLVS2;LRRTM1;CDK5R2;TMEM196;GAD2;SULT4A1;VSTM2A;OPCML;CA10;ASTN1;CDH22;TMEM179;SYT13;CACNA1B;RIMBP2;SCN3A;CELF4;PTPRN;SH3GL2;CELF3;PTPRT;GAP43;NCAN;UNC5D;ASIC2;CPE;TMEM59L;ABCC8;ACTL6B;PCSK1;GRIA2;VEGFA;STMN2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.8368577206737761,1.6707665370545164,0.0,0.1151915971076507,0.97,5/21,6.91%,TGFB2;PKP2;HEY1;MEF2C;TPM1
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.9188379393008479,1.6703542990417781,0.0425531914893617,0.11485401636746391,0.97,1/6,0.13%,LPL
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.9465152602806036,-1.6676825275461438,0.0,0.1934630062545694,0.99,1/12,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.8025421464945786,1.6672980424152093,0.018867924528301886,0.11770349943317106,0.97,4/16,13.60%,TGFB2;HEY1;BMPR2;OLFM1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.7594754403043367,1.6656469681728836,0.0,0.1175310424771553,0.97,16/40,12.66%,CHRM3;NPY1R;HTR5A;P2RY12;ADCY8;AKAP12;GNAL;ADCY2;CHRM5;RGS1;GRM8;CHRM1;ADCY7;HTR1E;ADCY1;GABBR1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.9513643706080983,-1.6621423503628472,0.0,0.2033298039996785,1.0,1/7,0.05%,PM20D1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.7565712765313615,-1.6609548744410028,0.0,0.20324151489676942,1.0,11/48,7.62%,RPS27A;UBC;CENPX;RNF8;UBB;FAAP100;EME1;USP1;MUS81;RAD51AP1;DCLRE1B
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.8446822239481045,-1.658975953064652,0.017543859649122806,0.20384850247926953,1.0,10/17,11.68%,RPSA;RPS5;RPS14;RPS15;RPS28;RPS27;RPS19;MRPS7;ABT1;RPS27L
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7479410444357665,-1.6589663328207849,0.01694915254237288,0.1998576998913958,1.0,24/54,13.31%,COX7C;NDUFB3;CYC1;NDUFS6;NDUFA2;COX5B;NDUFA12;UQCRFS1;NDUFA1;COX7B;NDUFB4;NDUFS8;NDUFAB1;COX6A1;NDUFB2;UQCC3;NDUFS5;UQCRQ;COX4I1;NDUFV3;NDUFB10;NDUFB11;COX6B1;UQCR10
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.731799317237489,-1.6568057182007943,0.0,0.20166996886498728,1.0,10/37,8.10%,PAX8;POLR2L;PTMA;THAP1;POLR2G;HOXD3;POLR2K;POLR2I;MLF1;POLR2A
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6813681377882047,1.656725923652641,0.0,0.13157846452437935,0.97,38/88,15.36%,KCND2;AQP1;KCNH7;KCNMA1;SLC9C2;KCNC2;KCNQ3;KCNQ5;KCNJ3;KCNMB4;HCN1;KCNV1;KCNJ4;KCNB2;SLC24A4;SLC24A3;ABCC9;KCNIP2;KCNJ6;KCNK6;KCNH5;KCNB1;SLC9A9;KCNC3;SLC9A7;KCNS1;KCNQ2;KCNMB3;KCNK10;KCNH3;ABCC8;KCNN4;KCNMB2;PKD2L1;KCNG3;ATP1B3;NALCN;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.7707158251375298,1.6556901361848066,0.0,0.13119124485123376,0.97,9/35,10.24%,TGFB2;ROBO2;ENHO;SRC;KAT2B;TP63;TSPAN14;NOTCH4;ROBO1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7034415019785788,-1.653586156159107,0.0,0.20715393396685935,1.0,23/62,20.21%,VAMP8;PSMD7;PSMB6;PSME2;PSMD8;PSMB4;HLA-C;PSMD3;PSMB3;HLA-B;CHUK;PSME1;B2M;PSMA7;PSMD13;PSMB8;PSMD2;VAMP3;CYBA;PSMC5;PDIA3;IKBKG;PSMA4
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9445121472771183,1.6534463450189678,0.0,0.1332352006652885,0.97,2/10,0.04%,KLRF2;CLEC2A
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.9600915542891045,1.6533429772185724,0.0,0.13118542834736097,0.97,1/10,0.01%,MFNG
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.9728200130532692,1.6516569699156523,0.0,0.13136309610202138,0.97,1/7,0.01%,MFNG
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.7216623730025834,-1.649960772186375,0.0,0.21242697733404403,1.0,23/70,16.66%,RPS27A;UBC;POLR2L;COPS6;UBB;POLR2G;PPIE;PCNA;POLR2K;POLD3;POLR2I;POLR2A;POLD4;ZNF830;POLR2E;GPS1;UBA52;ERCC8;COPS5;POLR2C;POLR2D;RFC1;GTF2H2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.7552013790187498,1.649512278599544,0.0,0.13437947029494954,0.97,13/28,19.29%,STON2;SYT1;PACSIN1;SNCB;STX1A;SYT7;AMPH;RAB3A;NLGN4X;TBC1D24;NLGN1;OPHN1;SYT5
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.8223078761685806,1.64930021600407,0.0,0.13240330161414143,0.97,5/24,8.85%,NPY;TGFB2;RARB;EPHB3;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.7789234905491785,1.6481203307130101,0.02040816326530612,0.13203779905620042,0.97,7/31,10.20%,CREB3L1;SORBS1;ADGRB1;GRIN1;F2;VIM;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.7685363865408492,-1.6477621105401397,0.017857142857142856,0.2143692735275779,1.0,6/34,3.76%,RPL5;RPL11;RPL23;RPS7;PDCL3;UBXN1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.779778419301269,1.6469543806561542,0.0,0.13270353585816444,0.99,4/25,1.62%,TGFB2;PPARG;PDGFB;FOS
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.705575213853704,-1.644897255938206,0.0,0.21639332126345223,1.0,23/60,20.21%,VAMP8;PSMD7;PSMB6;PSME2;PSMD8;PSMB4;HLA-C;PSMD3;PSMB3;HLA-B;CHUK;PSME1;B2M;PSMA7;PSMD13;PSMB8;PSMD2;VAMP3;CYBA;PSMC5;PDIA3;IKBKG;PSMA4
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.9030158066253857,-1.644394404349829,0.0,0.21411873237517165,1.0,2/8,1.12%,DDIT3;SELENOS
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.8022245048671495,-1.6432954288885546,0.0,0.2129627757635117,1.0,11/29,10.70%,RPS8;RPS16;RPS21;RPP40;RPS14;TSR1;DCAF13;RPS19;UTP3;RRP36;ABT1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.765173863485178,-1.64195792184363,0.016129032258064516,0.2134489743383664,1.0,29/51,17.23%,RPL23A;RPL5;RPL11;RPL10;RPL3;RPL10A;RPL35A;WDR74;NOC2L;RPL7A;SURF6;RPL7;RPL14;NSA2;RPL6;RPLP0;NOP53;NIP7;RPL24;NPM1;RPF2;RSL24D1;RSL1D1;ZNF622;NHP2;RPL26L1;NLE1;BRIX1;TRAF7
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.8413314954937261,-1.6414868304380468,0.018518518518518517,0.21119971196588705,1.0,3/17,9.23%,SELENOS;SEC61B;TMEM129
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.6962280838229897,-1.6379628571843934,0.0,0.21816985541577402,1.0,24/62,19.04%,POLR2L;POLR2G;ADRM1;POLR2K;GTF2F1;POLR2I;ELOC;ELOB;POLR2A;POLR2E;ELOF1;NELFE;CTR9;POLR2C;POLR2D;NELFCD;SUPT5H;GTF2H2;CCNT1;POLR2J;RTF1;CTDP1;CCNK;EAF2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7909211267702791,1.6375108750550427,0.0,0.15113058877888103,1.0,6/26,10.24%,TGFB2;ROBO2;HEY1;CITED2;BMPR2;ROBO1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.8468268696370794,1.6374525720265984,0.02,0.14919695965250185,1.0,4/13,5.45%,NPY;MAP2;NTRK2;B4GALT6
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.7147079319493611,1.6373442886336744,0.0,0.14731630666657136,1.0,6/35,6.70%,L1CAM;NRCAM;TRIM46;MAP2;TWF2;KIAA0319
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.8803489101657334,1.6368830814245898,0.0,0.1469349095061554,1.0,3/11,5.87%,PIM1;VSTM2A;FNDC5
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.9601263313230219,-1.633334087841834,0.0,0.22352446480508878,1.0,2/8,1.75%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8343648428162458,-1.6330080062341203,0.0,0.22026828549714253,1.0,1/19,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.715818879459908,-1.6309692530561428,0.017241379310344827,0.21828149350661957,1.0,22/50,17.06%,NDUFB3;NDUFS6;DMAC2;NDUFA2;NDUFA12;NDUFA1;NDUFB4;NDUFS8;NDUFAB1;NDUFB2;NDUFS5;NDUFAF3;FOXRED1;NDUFAF8;NDUFV3;NDUFB10;NDUFB11;TMEM126A;NDUFAF4;TMEM126B;NDUFA3;NDUFA5
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.715818879459908,-1.6309692530561428,0.017241379310344827,0.21828149350661957,1.0,22/50,17.06%,NDUFB3;NDUFS6;DMAC2;NDUFA2;NDUFA12;NDUFA1;NDUFB4;NDUFS8;NDUFAB1;NDUFB2;NDUFS5;NDUFAF3;FOXRED1;NDUFAF8;NDUFV3;NDUFB10;NDUFB11;TMEM126A;NDUFAF4;TMEM126B;NDUFA3;NDUFA5
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.6495442330519569,1.6307760853129825,0.021739130434782608,0.16053725184072304,1.0,13/83,7.88%,TGFB2;PKP2;PDGFB;FGF12;HEY1;MEF2C;PDLIM7;KAT2B;ID2;CITED2;KDM6A;SOX9;NOTCH4
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.5821300098059112,1.6299145347391504,0.0,0.16030533405538386,1.0,32/125,10.53%,CREB3L1;EPSTI1;ADAMTS5;PLSCR4;PPARG;EGFR;ZNF423;AQP1;TLR2;MPZL1;OLFML1;FAP;POSTN;PDGFRA;COL5A3;LOX;OLFML2B;ROBO4;PPARGC1A;ADAM12;EPAS1;MEST;ZBTB16;STAT6;PXDC1;FBLN5;COL15A1;ARNT;MAOB;ACVR1C;C3;PDE3B
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.9077833771580928,1.629889469227636,0.0,0.1582234466001191,1.0,1/12,0.13%,LPL
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.7569800834244659,-1.6298544900211418,0.0,0.21798303604812475,1.0,18/56,13.22%,ORC1;RPS27A;UBC;UBB;PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;MCM4;PSME1;MCM3;UBA52;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.9298825699558193,-1.6291693929302455,0.02040816326530612,0.21705536376731774,1.0,4/9,1.86%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.9061464376294076,1.6267739193455795,0.021739130434782608,0.16321836930089487,1.0,2/11,0.72%,LPL;PPARG
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.7696443308052207,-1.626303892544383,0.021739130434782608,0.22168858655005147,1.0,6/18,10.33%,RPS13;SAP18;SRSF7;SRSF9;RPS26;TMBIM6
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.7360748728810658,1.6260504652281162,0.022222222222222223,0.1638658234899015,1.0,15/37,14.38%,CTF1;IFNA2;IGF1;CSF1R;PARP14;IL12A;CRLF1;TNFRSF1A;SOCS3;PARP9;LYN;GHR;HES1;HCLS1;VEGFA
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.6672820520605467,-1.625585947802391,0.02,0.22023782608067524,1.0,5/102,2.12%,CYP1A2;F11;CYP2E1;GJB1;AQP9
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.7215890965245918,1.6236048573521218,0.021739130434782608,0.1682187449740514,1.0,13/33,20.55%,MX1;STON2;SYT1;PACSIN1;SNCB;DNM1;STX1A;AMPH;NLGN4X;NLGN1;OPHN1;SYT5;ITSN2
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.6789289150976793,-1.6230675588746444,0.0,0.22468797668872037,1.0,27/98,16.66%,RPS27A;UBC;POLR2L;RAD23A;COPS6;UBB;POLR2G;PPIE;PCNA;POLR2K;POLD3;POLR2I;PARP1;POLR2A;POLD4;PNKP;HUS1;ZNF830;POLR2E;GPS1;UBA52;ERCC8;COPS5;POLR2C;POLR2D;RFC1;GTF2H2
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.7605604607283039,1.621799757468596,0.0,0.16952362106857316,1.0,11/27,14.89%,GRIK2;SHISA6;MCTP1;SLC4A10;CAMK2B;NETO1;SHISA9;DLG4;RAB3A;ZDHHC2;NSMF
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7981446942008485,-1.6199361696674182,0.01818181818181818,0.22985108278224528,1.0,2/28,0.72%,CYP1A2;CYB5A
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6464034988437612,1.6199310610862045,0.0,0.17050620038811684,1.0,30/76,11.84%,RND2;PCDH8;MYT1;ZCCHC12;SYT4;BTBD17;PLPPR5;RIMS4;MEX3A;OGDHL;KCNB2;CLVS2;EFNB3;PURG;CDK5R2;SULT4A1;NYAP1;NEFM;ASTN1;TMEM179;CAMKV;CACNA1B;CELF3;KCNQ2;GAP43;NCAN;NKAIN1;CNTFR;GRM8;TMEM59L
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.8268958016811864,-1.619782365856122,0.0,0.2271602941477458,1.0,7/14,12.84%,FTSJ3;NIFK;DDX18;RPL7L1;RPL7;RPL35;RPF2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.6752432572352246,1.6196431845778625,0.043478260869565216,0.16888236514294358,1.0,17/59,16.15%,TGFB2;BMP6;RAB27B;IGF1;CADPS;CADPS2;FRMD4A;STX1A;KCNB1;TGFB3;PLA2G10;SYTL4;RAB3A;BAIAP3;ACHE;EXPH5;NMB
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7599523421701331,1.6189438717824374,0.0,0.16786430176930203,1.0,12/31,12.34%,GABRA6;GRIN2B;LRRK2;MEF2C;GABRG2;GABRA1;GABRA2;GABRA4;ARRB2;GRIN1;GABRG1;INSYN2A
prerank,GO_Biological_Process_2021__natural killer cell activation involved in immune response (GO:0002323),0.9782627480468951,1.6187562276737975,0.0,0.16616964625859446,1.0,2/5,0.56%,KLRF2;IFNA2
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6797533026887557,1.617475599236658,0.0,0.1675609643289584,1.0,18/43,15.02%,GLRA3;GABRA6;GABRG2;GABRA1;GABRB2;GABRA2;ANO5;GABRA4;ANO6;GLRB;GABRB3;GABRG1;GABRR2;GLRA2;CLCN3;SLC1A1;GABRD;ANO4
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.7535289897014509,-1.6171764638901007,0.01694915254237288,0.23109113107638082,1.0,11/33,11.91%,LCK;DDIT3;RPS3;RPS7;UBB;RACK1;SOD1;SEPTIN4;BAX;FIS1;EIF5A
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5817316933091414,1.617075820664857,0.0,0.16673008351410404,1.0,18/161,7.96%,MFNG;IGFBP3;TRIM5;PLSCR1;MDFIC;RGS20;IGFBP4;PLCB1;LRRK2;TMEM204;SRC;DTX1;TSPYL2;SULF1;RGS4;LIFR;GPHB5;GIT1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7010568596128607,1.6154165891289411,0.019230769230769232,0.16754208067407533,1.0,24/55,13.60%,BEGAIN;SHISA6;NPTX2;GRIN2B;CAPN1;MEF2C;DLGAP1;CACNG5;CACNG2;RELN;CAMK2B;NETO1;GRIA1;GRIN1;SHISA9;NPTX1;CACNG3;DAPK1;CACNG8;DLG4;NEFL;DLGAP3;SHANK1;GRIA2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.9295122815429542,1.6153383365001928,0.0,0.16565958538560258,1.0,3/7,3.15%,PPARG;IGF1;E2F3
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.9363287899648102,1.6147570817005017,0.03636363636363636,0.164877527030614,1.0,2/5,1.77%,FLI1;P2RY12
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.9230495079800449,1.6132992061227636,0.0,0.16555224147985997,1.0,2/6,4.56%,SLC2A9;CARMIL1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.5733318051087013,1.6104008456873977,0.0,0.16944850878879053,1.0,38/104,14.18%,ADAMTS5;MMRN2;PLSCR4;AQP1;CLDN16;IGF1;CGNL1;FSTL1;DACH1;ENC1;SORBS2;LDB2;POSTN;PDGFRA;TMEM47;ROBO4;NRGN;COL4A1;EPAS1;PXDC1;PLXNA2;EDNRB;MAOB;IL33;PAMR1;ARVCF;C3;SPARCL1;LAMB2;ADGRF5;CX3CL1;CDH6;PRICKLE2;SLC11A2;TIMP3;WLS;SYNPO;KCNT1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.8418525571309488,1.6094235536998451,0.0,0.1695473353092732,1.0,5/14,10.20%,CREB3L1;CIITA;F2;VIM;TGFB3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.7505919624283234,1.6090609096330357,0.017857142857142856,0.16837711321447132,1.0,8/25,15.19%,IGFBP3;PLCB1;MEF2C;SOX9;BOC;RBM24;SRA1;ZFP36L1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.7622511724547716,1.607465821547085,0.0,0.17061627343059818,1.0,7/22,10.24%,ROBO2;HEY1;TNFRSF1B;SOX9;TNFRSF1A;BMPR2;ROBO1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.7050494755384741,-1.6073718429166763,0.018518518518518517,0.2570439132195483,1.0,4/50,3.38%,CYP1A2;GPC4;AWAT2;GPC2
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.6925201333685079,-1.6055700112679527,0.0,0.25897975594703254,1.0,18/71,13.22%,RPS27A;UBC;UBB;ANAPC15;PSMD7;PSMB6;PSME2;PSMD8;CDC26;CDC23;PSMB4;PSMD3;PSMB3;PSME1;UBA52;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.7962135345951146,1.6049227251702323,0.0,0.17479366642215224,1.0,6/22,10.24%,TGFB2;ROBO2;HEY1;CITED2;BMPR2;ROBO1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.8421260998406725,1.604792961928764,0.0425531914893617,0.17348277467262813,1.0,7/13,10.24%,TGFB2;ROBO2;HEY1;TNFRSF1B;TNFRSF1A;BMPR2;ROBO1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.6001068571847387,1.6046544194772816,0.0,0.17195558904698047,1.0,17/123,6.43%,ROR1;PDGFB;EGFR;FLT1;TRIM5;JCAD;PTPRC;IGF1;RIT2;PTPN6;PAK3;SYK;NTRK2;ADRA1A;PRDM15;PTPRJ;EPHB1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.615855011381783,1.6041404036036706,0.0,0.1714216226606048,1.0,29/100,10.77%,NCEH1;CX3CR1;SLA;PPARG;SLCO2B1;FGL2;PTPRC;TLR2;STAB1;CSF1R;PARP14;CLEC5A;NR4A3;MRC1;LCP2;TNFRSF1B;SYK;ITGAM;C3AR1;CD53;CSF3R;LILRB1;WDFY4;LY86;MARCHF1;LAPTM5;LYVE1;RGS1;GPR34
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7685203467063284,1.6025584951003033,0.02702702702702703,0.1723274506035061,1.0,6/21,9.66%,KCNJ3;NEDD4L;PIM1;KCNJ4;KCNJ6;BCL2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.6182740432130619,-1.6019085687698535,0.017857142857142856,0.2668072827993575,1.0,42/167,16.10%,TUBA1A;TPX2;RPS27A;UBC;UBB;ANAPC15;SSNA1;PLK4;PSMD7;PSMB6;MAD2L1BP;DYNLL1;PSME2;PSMD8;TUBB4B;RIOK2;TUBB4A;TUBG1;DCTN3;CDC26;CDC23;NEK6;PSMB4;HMMR;CEP131;PSMD3;PSMB3;PSME1;DYNC1H1;AKAP9;UBA52;HAUS6;PSMA7;TUBB;PSMD13;PSMB8;CENPF;PSMD2;DYNC1I2;DCTN1;HAUS1;PRKACA
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.7480879544035454,1.600302388388076,0.0,0.17651692717157974,1.0,10/23,19.29%,STON2;SYT1;PACSIN1;SNCB;STX1A;AMPH;NLGN4X;NLGN1;OPHN1;SYT5
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.7424890717743136,1.5999652803001128,0.02564102564102564,0.17537015786987695,1.0,8/29,9.67%,LPL;TLR2;CSF1R;SYK;C5;WNT5A;TIRAP;IL33
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.7018422103264584,1.5986834055222687,0.0,0.1760956429902777,1.0,4/32,3.17%,KANK2;FSTL1;FAP;PRKX
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8836691110624116,1.5985284372609825,0.0,0.17440241565383274,1.0,7/11,10.08%,GABRA6;GABRG2;GABRA1;GABRB2;GABRA2;GABRA4;GABRG1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.6968939622443866,-1.5969467470333063,0.0,0.2774137788447314,1.0,25/64,19.04%,POLR2L;POLR2G;ADRM1;POLR2K;GTF2F1;POLR2I;ELOC;TCEA2;ELOB;POLR2A;POLR2E;ELOF1;NELFE;CTR9;POLR2C;POLR2D;NELFCD;SUPT5H;GTF2H2;CCNT1;POLR2J;RTF1;CTDP1;CCNK;EAF2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.8138978314174741,1.5952172580074673,0.0,0.18102123352959867,1.0,5/15,6.28%,PDGFC;PDGFB;NR4A3;PDGFRA;PTPRJ
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6369271568982153,1.5951963470560158,0.023255813953488372,0.1793134860434704,1.0,47/106,10.59%,DACT2;ETV1;BCHE;KCNT2;SHISA6;SSTR1;KCNIP1;SYT4;NPTX2;PCSK2;KALRN;SNAP25;RAB3C;CNTN1;PLPPR4;RAPGEF4;NRXN1;SORBS2;CADPS;ST8SIA3;GABRG2;PPP1R1A;NOL4;KCNB2;FAM149A;SORBS1;LRRTM1;TMEM196;RGS7BP;GAD2;VSTM2A;CNTN4;ASTN1;CDH22;TMEM179;PPARGC1A;SYT13;RIMBP2;MAPK4;CELF3;SYT7;IGSF21;MAOB;PTPRT;GABRB3;SPARCL1;UNC5D
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.7279143862418076,1.5942574336103283,0.020833333333333332,0.17975239310766222,1.0,10/38,7.73%,LPL;CDS1;PPARG;LMO3;PIM1;ID2;VSTM2A;FNDC5;ZFP36;ZBTB16
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.9014330437865895,1.5939621233614072,0.0,0.1785291039744275,1.0,3/10,7.14%,TGFB2;HEY1;SOX9
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6355948836151646,1.593801169943857,0.0,0.1773282605133623,1.0,35/97,15.36%,KCND2;KCNT2;KCNH7;SLC9C2;KCNC2;KCNQ3;KCNQ5;KCNJ3;HCN1;KCNV1;KCNJ4;KCNB2;SLC24A4;SLC24A3;ABCC9;KCNIP2;KCNJ6;KCNK6;KCNH5;KCNB1;SLC9A9;KCNC3;SLC9A7;KCNS1;KCNQ2;KCNK10;ATP1B2;KCNH3;ABCC8;KCNN4;PKD2L1;KCNG3;ATP1B3;NALCN;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.8482396498676434,-1.593146201275079,0.0,0.28741355753338016,1.0,1/10,1.71%,SFRP1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.7462688143661064,-1.5931176164866412,0.03773584905660377,0.2801503788232096,1.0,11/30,16.66%,POLR2L;POLR2G;POLR2K;GTF2F1;POLR2I;POLR2A;POLR2E;POLR2C;POLR2D;SUPT5H;GTF2H2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.7462688143661064,-1.5931176164866412,0.03773584905660377,0.2801503788232096,1.0,11/30,16.66%,POLR2L;POLR2G;POLR2K;GTF2F1;POLR2I;POLR2A;POLR2E;POLR2C;POLR2D;SUPT5H;GTF2H2
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.7085086443288995,-1.5929531611571301,0.01694915254237288,0.2768142772095856,1.0,13/44,15.45%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;NQO1;PSMA7;PSMD13;PSMB8;PSMD2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.8052633476452673,1.59262948084868,0.0,0.17918070663366373,1.0,3/15,3.62%,PPP1R3C;PID1;PYGL
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.6739709924750713,1.5920215413250167,0.0,0.1791758297738441,1.0,9/52,10.53%,TGFB2;CLDN5;PPARG;STAB1;ADGRB1;SULF1;PTPRM;SEMA6A;PDE3B
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5893818812109421,1.5908039039358106,0.0,0.18023436961505507,1.0,35/147,12.75%,ROR1;EPHA3;NTNG1;PLPPR5;CAMK1D;LRRK2;EPHA4;RIT2;ZNF804A;PAK3;TWF2;RELN;SPOCK1;SIPA1L1;NTRK2;TOX;TENM3;CAMK2B;WNT5A;NDRG4;EPHB3;RTN4RL2;KNDC1;FUT9;CSMD3;CDK5R1;ATP1B2;CX3CL1;PRKD1;TRPV4;LYN;PTPRO;DPYSL3;SERPINI1;KANK1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9639010285292551,-1.590520450359347,0.018867924528301886,0.27937100110772156,1.0,1/9,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.7274529197828257,1.5902014780309741,0.0,0.17969329481134474,1.0,7/34,7.33%,TGFB2;PPARG;PDGFB;FOS;NFATC4;SOX9;TEAD1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.6835141786831647,1.588506726682288,0.027777777777777776,0.18104212702377337,1.0,4/34,6.44%,MYO7A;SYT4;MYO1B;MYO5C
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.6784630068356581,-1.5875040732687482,0.0,0.28534820062439137,1.0,42/134,16.41%,DAD1;ZNF707;SF3A3;POLR2G;EDF1;SURF1;POLR3GL;NT5C;PCNA;BCAM;ADRM1;EIF1B;POLR2K;GPX4;GTF2F1;POLD3;POLR2I;MPG;MRPL40;PRIM1;VPS28;GMPR2;POLR2A;POLD4;NME3;TAF13;POLE4;TMED2;ITPA;POLR2E;RAE1;MPC2;NELFE;ERCC8;IMPDH2;TYMS;ALYREF;POLR2C;POLR2D;SNAPC5;NELFCD;SUPT5H
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.9265508539034626,1.5872450939667675,0.0,0.18350665092359772,1.0,1/7,0.27%,TGFB2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8061759309953545,-1.586408966294473,0.01818181818181818,0.28662518911253837,1.0,14/20,17.23%,RPL23A;RPL5;RPL11;RPL10;RPL3;RPL6;RPLP0;NOP53;RPL24;RPF2;RSL24D1;NLE1;BRIX1;TRAF7
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7040027388661376,1.5856344084719924,0.0,0.18633934826237614,1.0,13/42,9.06%,IL1RAPL2;ROBO2;TLR2;GPC6;MEF2C;NRXN1;SLITRK3;LRFN5;CLSTN3;EPHB1;EPHB3;SLIT1;IL1RAP
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.5729966376833959,1.5848057932871382,0.0,0.18657890298006882,1.0,34/152,9.67%,FLI1;MMRN2;APOLD1;CLDN5;PLAC8;PLSCR4;PDGFB;SRGN;AQP1;GPM6A;FLT1;CHST1;STAB1;NOSTRIN;SEMA3D;RHOJ;CASZ1;HEY1;LDB2;POSTN;PTPRB;PDGFRA;LOX;ROBO4;COL4A1;RASIP1;ACKR1;EPAS1;LIFR;NOTCH4;COL15A1;EDNRB;LYVE1;IL33
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.8684789996574878,1.5837893542389507,0.0,0.18782365945505303,1.0,4/11,4.64%,TGFB2;P2RY12;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.8072238214913485,1.5835664183923004,0.02040816326530612,0.18714601210766782,1.0,2/12,3.01%,ADAMTS9;HEY1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.7215587402525208,1.5835371815266421,0.02127659574468085,0.18558646200677056,1.0,13/32,10.20%,TGFB2;BMP6;SLC8A1;MEF2C;BMPR1B;ADGRV1;NELL1;ISG15;ANO6;ZBTB16;WNT5A;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.7742243396048167,1.5835253852067983,0.0,0.18415111349166982,1.0,6/25,11.25%,TRIM5;BIRC3;SAMHD1;LRP8;TIRAP;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.9507808612419402,1.5824967938255285,0.0,0.1856678096275327,1.0,2/5,3.15%,PPARG;E2F3
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.8530659744925674,1.5822906558701897,0.0,0.18483607980744748,1.0,4/13,7.08%,SLC2A12;SLC23A1;SLC2A9;SLC5A9
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.7683845207179637,1.5822873628034095,0.0,0.18334546626061327,1.0,5/24,10.04%,CREB3L1;ADAMTS9;RHOJ;BMPER;SEMA6A
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5791067671688793,1.581950353011529,0.0,0.18292672019833128,1.0,51/140,12.88%,ALDH1L1;SHISA6;KCNIP1;GRM5;ADCY8;LUZP2;SNAP25;SYNPR;PLPPR4;RAPGEF4;NRXN1;GFAP;SORBS1;SLC1A2;SPHKAP;RGS7BP;PTPRZ1;ADCYAP1R1;NTRK2;OPCML;CA10;SLC4A4;LRRC3B;ASTN1;SLC6A11;CADM3;SNPH;SOX9;TEAD1;MAPK4;BRINP1;C11ORF87;ATP2B2;SOCS3;EDNRB;SLIT1;DIO2;IGSF21;PHYHIP;VIM;GAP43;GABRG1;SPARCL1;NCAN;ATP1B2;CNTFR;PHF24;FABP7;PSD2;PTPN5;SCN4B
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6894228038526664,-1.5815575456809765,0.01694915254237288,0.30187001636342736,1.0,14/47,15.45%,PSMD7;PSMB6;PSME2;PSMD8;BCKDK;PSMB4;PSMD3;PSMB3;PSME1;NQO1;PSMA7;PSMD13;PSMB8;PSMD2
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.7488197652870472,1.5809941295536547,0.0,0.1831762482144748,1.0,7/23,14.60%,TMEM204;MEF2C;DMD;SGCZ;NEBL;MRTFB;MEGF10
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.7764684031460305,1.5802547353368896,0.0,0.18323429875509523,1.0,5/18,6.63%,GRIN2B;NFATC4;PRKCZ;SHANK2;TSHZ3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.8890408879048766,1.5797517742232396,0.0,0.18338448359726509,1.0,2/13,0.72%,LPL;PPARG
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7460226471515584,1.5795426749866597,0.0,0.18270145917741523,1.0,7/25,10.68%,NPY;MAP2;SPOCK1;NTRK2;TOX;KNDC1;MAPT
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.6515198220909073,1.5790345492027573,0.02631578947368421,0.1821205527615598,1.0,28/65,15.12%,SCN9A;SLC23A1;SLC8A1;NEDD4L;SLC5A4;HCN1;FGF13;SLC24A4;SCN2A;SLC24A3;SLC4A4;SLC6A11;ANO6;SCN3B;SLC5A9;SCN3A;SCN1A;SLC6A8;SLC6A15;ASIC2;SLC6A4;SCN4B;PKD2L1;SLC5A12;SCN7A;SLC6A7;ATP1B3;NALCN
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.8165650967216541,1.5781361095913824,0.022727272727272728,0.1830030851220782,1.0,7/14,14.46%,LPL;PID1;IRS1;SOX9;GLDC;PDK4;UCP1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.7413618201734583,-1.5775876478320632,0.07017543859649122,0.31141668717540655,1.0,3/29,0.75%,LCK;CRTAM;PRELID1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.9700763381708507,-1.5765553555393739,0.0,0.3104868075481286,1.0,1/7,0.10%,NGF
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.7136016052396852,1.5759608376053718,0.022222222222222223,0.18739090014004012,1.0,9/20,19.73%,EPHA3;MCTP1;LILRB1;PRKD1;LGALS3;SNX33;PROM2;RUBCN;SCAMP5
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5992830366591759,1.5752493032719244,0.0,0.18839962175814978,1.0,48/122,14.07%,SCN9A;AQP1;SLC23A1;KCNMA1;KCNJ3;SLC8A1;NEDD4L;KCNMB4;SLC5A4;KCNV1;KCNJ4;KCNB2;FGF13;SLC22A16;PKD1L3;SCN2A;SLC4A4;ABCC9;SLC22A3;KCNIP2;KCNJ6;ANO6;TRPM3;GRIN1;KCNK6;SCN3B;SLC5A9;SCN3A;TRPM1;SCN1A;TRPM2;KCNS1;TMEM63C;TRPC6;KCNMB3;PANX2;PIEZO2;KCNH3;SLC11A2;ABCC8;KCNN4;KCNMB2;SCN4B;SLC7A8;PKD2L1;SLC1A1;SLC5A12;SCN7A
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.8098610544486997,1.5737827563085065,0.0,0.19072641749534505,1.0,3/15,10.20%,TGFB2;SRC;TGFB3
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.8508614831275008,-1.5722669113192609,0.0,0.32038678181249775,1.0,1/10,0.17%,TYRP1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.6359303722727838,1.5720421684311496,0.0,0.19434199681564615,1.0,31/74,13.60%,SHISA6;FGF12;GRIN2B;CAPN1;MEF2C;FGF14;CACNG5;CACNG2;FGF13;RELN;CACNB1;CAMK2B;NETO1;DMD;GRIA1;GRIN1;SHISA9;CACNG3;NOS1;DAPK1;CACNG8;CAMK2D;KCNS1;DLG4;NEFL;HOMER1;SHANK1;CACNB2;JPH4;ANK3;GRIA2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.7468410770721952,1.5720163674730319,0.03773584905660377,0.19317571650846296,1.0,12/27,14.60%,IGF1;MYH11;SLC8A1;DMD;SGCZ;NEBL;DYSF;ALPK2;HES1;ALPK3;VEGFA;MEGF10
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.771167316593662,-1.5714076155426682,0.018867924528301886,0.3196613526638155,1.0,5/25,11.45%,PM20D1;SPHK2;CYB5R3;DDAH2;NQO1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.9710154013680578,-1.5711002902585038,0.0,0.3167833078084045,1.0,1/7,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.721752036873313,1.5702009045875858,0.022727272727272728,0.19637291900853027,1.0,5/25,6.25%,DPP10;KCNIP4;KCNIP1;FGF12;KCNIP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.6667369547811575,1.569273635136996,0.0,0.19771150172402294,1.0,25/66,14.38%,PDGFB;BMP6;EGFR;ANGPT1;PTPRC;IGF1;CD44;CSPG4;HGF;PTPN6;RELN;SRC;TNK2;PRKCZ;EFNA5;PTPRJ;LRP8;DMTN;BST1;TEC;GHR;SAMSN1;PTPN11;HCLS1;VEGFA
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.9415018621229434,1.5676067743971194,0.0,0.2004016779750716,1.0,1/9,0.27%,TGFB2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.858579126204849,1.5659560544250453,0.022222222222222223,0.20313848950595942,1.0,2/10,3.01%,ASB4;HEY1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.7230956753697483,1.5654992044322549,0.018867924528301886,0.202289032429726,1.0,11/31,14.50%,SYT4;RIMS4;LRRK2;RIMS2;SYT1;SYT13;RAB15;SYT7;SYT17;RAB3A;DOC2A
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.8402879819149514,1.5644350283276034,0.022727272727272728,0.2039675870756041,1.0,7/15,8.57%,ADAMTS5;IGF1;MEF2C;ADAMTS15;ADAM12;JAM2;NOS1
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.9653597324846537,-1.564311866047652,0.0,0.33896071430352276,1.0,1/5,0.19%,BMP5
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6344853074260246,-1.5642222516371864,0.015384615384615385,0.33547112333370993,1.0,20/74,13.73%,DDIT3;RPS27A;UBC;UBB;ATF3;PSMD7;PSMB6;PSME2;PSMD8;ELOC;ELOB;PSMB4;PSMD3;PSMB3;PSME1;UBA52;PSMA7;PSMD13;PSMB8;MAPK7
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5800365398667905,1.564029163025973,0.022222222222222223,0.20404031199278463,1.0,43/146,21.11%,PDGFB;RPS6KA6;HIPK4;CAMK1D;LRRK2;PRKX;STK32B;PRKCZ;HIPK3;CAMKV;MAPKAPK3;PRKCG;MAPK12;PLK1;CAMK2D;MKNK1;DYRK2;CDK5R1;CSNK1D;PRKD1;AKT3;TTBK2;DMPK;RPS6KA3;CDC7;DYRK3;VRK3;DYRK1B;PRKCE;CAMK4;STK38;GAS6;PRKCD;STK38L;TNKS;MKNK2;ULK1;CSNK2A1;MAPKAPK5;PAK2;VRK1;SGK1;MASTL
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.6289425948349457,1.5639379620182539,0.0,0.20295417903948976,1.0,34/78,17.10%,DACT2;SYT4;BTBD17;ENHO;OGDHL;CAMSAP3;ST8SIA3;LRRTM1;SYT1;FTCD;TMEM179;SYT13;RIMBP2;TMEM74B;CELF3;LRRC75B;SYT7;CARMIL3;ARVCF;CACNA2D2;GRIK5;CNTFR;SEMA5B;ABCC8;ACTL6B;PRR36;WNK2;STMN2;SEMA4G;PDE9A;KCNH2;PLPPR1;CACNG4;CPLX1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.8380926313516425,-1.563674334371849,0.041666666666666664,0.3342470202551342,1.0,3/18,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),-0.9926728296695212,-1.5624003399795219,0.0,0.336206823206212,1.0,1/5,0.19%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.8768288149615292,1.5617720341839119,0.0,0.2073859413168043,1.0,3/13,3.61%,IGF1;MEF2C;PIM1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.803364265557648,-1.5617355850569257,0.0,0.33491189572560603,1.0,1/13,0.70%,TRMT10C
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5775726212659851,1.5616691647062833,0.0,0.2062102011368175,1.0,42/165,11.14%,CREB3L1;ROR1;NCEH1;CDH9;SLA;GRIK2;PLSCR4;SLCO2B1;AQP1;GPM6A;RAB27B;CHST1;ADAMTS9;C1QB;KCTD12;SYNPO2;PID1;LDB2;HGF;POSTN;MRC1;HS3ST1;PDGFRA;STK32B;OLFML2B;SLC4A4;TIAM2;TRANK1;MEIS2;ZDHHC13;COL15A1;EDNRB;MAOB;TMEM176B;LYVE1;DGKI;IL33;BMPR2;RGS1;SPARCL1;GPR34;ADGRF5
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.7085049254331088,-1.5603656485884911,0.0,0.3360283256720697,1.0,11/41,9.66%,P2RY10;CXCR4;CD38;AMPD1;PPIB;CD9;TMEM156;ITGAL;SSR4;REN;ZNF165
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.7057649704120541,1.559501582729621,0.02040816326530612,0.20950631485299956,1.0,14/27,16.92%,SCN9A;CACNA1G;CACNG2;SCN2A;CACNA1B;SCN3B;SCN3A;SCN1A;CACNA1I;YWHAH;CACNA1E;SCN7A;KCNH2;CACNG4
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.9657082113253501,-1.5594832704293966,0.0,0.3355487764394265,1.0,1/7,0.19%,BMP5
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.8977869978364229,1.5583739649499109,0.0392156862745098,0.2112289909384764,1.0,3/10,7.14%,TGFB2;HEY1;SOX9
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7960594050183593,-1.557657499003593,0.018518518518518517,0.33888300666613086,1.0,12/25,14.96%,RPL10A;FTSJ3;NIFK;DDX18;RPL7L1;RPL7A;RPL7;NSA2;RPL35;RPF2;RSL1D1;NHP2
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.6271200945098016,-1.5571824987506246,0.017543859649122806,0.33710053766409986,1.0,35/132,16.10%,TUBA1A;TPX2;SSNA1;PLK4;PSMD7;PSMB6;DYNLL1;PSME2;PSMD8;TUBB4B;CDK4;TUBB4A;TUBG1;DCTN3;PSMB4;DBF4B;HMMR;CEP131;PSMD3;PSMB3;PINX1;PSME1;DYNC1H1;AKAP9;HAUS6;PSMA7;TUBB;PSMD13;PSMB8;CENPF;PSMD2;DYNC1I2;DCTN1;HAUS1;PRKACA
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.9453264906129262,1.5557684688314601,0.0,0.21764430364760562,1.0,2/9,0.40%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.7977029017362438,1.5553102528967153,0.018867924528301886,0.21770185190270155,1.0,7/18,13.69%,IFNA2;PTPRC;MEF2C;CD70;BCL2;HELLS;IFNK
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7660387601966973,1.5550769468367123,0.024390243902439025,0.21657559570942747,1.0,1/16,0.72%,PPARG
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7937015858104014,-1.5543991352397166,0.03773584905660377,0.3428067665933772,1.0,4/18,4.13%,EIF3D;EIF2S2;EIF2S3B;EIF5
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.7777036563822303,1.5538372870382484,0.06382978723404255,0.2180497285807103,1.0,3/22,3.01%,DLK2;EGFR;HEY1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8536472946768057,1.5538001877093952,0.041666666666666664,0.21670240546370945,1.0,3/10,3.01%,TGFB2;ROBO2;HEY1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.7994741452463497,1.5532937939315627,0.04,0.2166872421180517,1.0,4/19,9.78%,PDGFB;EGFR;CCND1;SPDYA
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.9597844035036776,1.5527065953238626,0.0,0.2171332792676765,1.0,1/5,0.27%,TGFB2
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.770445672908657,1.5524448253443883,0.05172413793103448,0.21627579056568533,1.0,6/17,9.12%,PKP2;FGF12;CACNA1G;SCN3B;SCN1A;CAMK2D
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.7715340268568905,1.5521731852357514,0.0,0.21535336992563303,1.0,3/18,10.20%,TGFB2;ABCB4;TGFB3
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.6975038099618746,1.5512862217839496,0.0,0.21670388341005836,1.0,8/42,7.88%,TGFB2;MEF2C;HGF;LOXL3;LEF1;SOX9;WNT5A;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7775226956427876,1.5509349745057628,0.0,0.21698879242603744,1.0,10/29,10.88%,PDGFB;CSF1R;GRM5;EPHA4;RELN;SRC;NTRK2;LRP8;DLG4;TGFA
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6865670126184051,1.5508345612494776,0.022727272727272728,0.21585591169236684,1.0,8/39,7.88%,TGFB2;HEY1;HGF;LOXL3;LEF1;SOX9;WNT5A;NOTCH4
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.6559122254580403,-1.5502432901489447,0.03278688524590164,0.3557747632136201,1.0,25/65,21.74%,POLR2L;POLR2G;WDR74;POLR2K;GTF2F1;POLR2I;RAN;POLR2A;KPNA2;POLR2E;POLG;TOPBP1;DDX24;HNRNPH2;POLR2C;POLR2D;PTBP1;LSM1;POLR2J;PDE12;DDX1;RBMX;EXD2;NT5E;DXO
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7708869135269365,-1.549868464189891,0.02,0.3536278754459715,1.0,13/30,12.14%,NDUFB3;NDUFS6;NDUFA2;NDUFA12;NDUFA1;NDUFB4;NDUFS8;NDUFAB1;NDUFB2;NDUFS5;NDUFV3;NDUFB10;NDUFB11
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.706512100878319,-1.5498672154075694,0.020833333333333332,0.35012660935244705,1.0,6/59,4.58%,CYP1A2;CYP2E1;DEGS1;DECR2;ACSM6;GPX4
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.5758058267740211,1.5492521043927772,0.0,0.220284910694322,1.0,40/100,14.64%,L1CAM;CHL1;ZNF423;SHISA6;AQP1;KCNIP1;CHST1;CNTN1;PLPPR4;RAPGEF4;NRXN1;DCLK1;GFAP;SORBS1;RGS7BP;PTPRZ1;ADCYAP1R1;NTRK2;ASTN1;CADM3;ACKR1;SORCS1;MAPK4;EDNRB;IGSF21;PHYHIP;MAOB;PTPRT;SPARCL1;CNTFR;CX3CL1;INTS6;PTPN5;SCN4B;TSPAN7;THY1;STMN2;MEGF10;NOS2;ZNF536
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6495133770020401,1.5491514258988697,0.0,0.2192191838796553,1.0,21/59,15.02%,GLRA3;SLC4A10;GABRA6;GABRG2;GABRA1;SLC26A9;GABRB2;GABRA2;ANO5;GABRA4;ANO6;GLRB;SLC26A7;GABRB3;GABRG1;GABRR2;GLRA2;CLCN3;SLC1A1;GABRD;ANO4
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.7762259045517856,1.5486152678526486,0.02127659574468085,0.21962779625039297,1.0,5/21,5.07%,PDGFB;FLT1;P2RY12;PDGFRA;IRS1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5801686005190695,1.547943939325379,0.0,0.22003142554343869,1.0,41/127,13.91%,ADAMTS5;PLSCR4;ANGPT1;MFAP5;AQP1;PPP1R3C;FSTL1;MYH11;SYNPO2;PCDH18;LDB2;POSTN;OBSCN;PDGFRA;KAT2B;TMEM47;SMTN;LOX;PRKG1;IRAG1;COL12A1;LMO7;SULF1;CCDC80;COL4A1;TPM1;MAP3K7CL;FBLN5;COL15A1;FBLN2;PAMR1;LAMB2;MYLK4;PRRX1;NOTCH3;DMPK;TIMP3;THY1;COL5A1;VASN;SYNPO
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8889732080438206,1.5462543454959718,0.022727272727272728,0.22411121615207494,1.0,2/10,3.61%,MEF2C;PIM1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.83514972454655,1.5461628977324413,0.04081632653061224,0.22290463402681637,1.0,4/11,8.74%,NR4A3;IRS1;PPARGC1A;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.7428721979747347,1.5458062174802667,0.022727272727272728,0.22228300697752879,1.0,15/31,14.38%,CTF1;IFNA2;IGF1;CSF1R;PARP14;IL12A;CRLF1;TNFRSF1A;SOCS3;PARP9;LYN;GHR;HES1;HCLS1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.7044911614406394,1.545079873562843,0.0,0.223086553069254,1.0,8/24,10.20%,IGFBP3;PPARG;IL12A;MEF2C;PRKG1;TPM1;NDRG4;TGFB3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.635097627754562,1.5444187091922583,0.0,0.22359871301363146,1.0,14/80,5.20%,ROR1;TGFB2;PDGFC;PDGFB;EGFR;FLT1;IGF1;PIK3AP1;HGF;PTPN6;PIP5K1B;PDGFRA;SRC;NTRK2
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.8628267746284742,1.5437919005584009,0.0,0.22403479288995995,1.0,3/6,6.85%,SHISA6;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.7830912235255865,1.5435461028278896,0.043478260869565216,0.22369967763045204,1.0,3/19,6.98%,TLR2;BIRC3;IRAK3
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.875710820706148,1.5431365248215545,0.04081632653061224,0.22329921899210362,1.0,4/10,9.91%,TGFB2;HEY1;SOX9;BMPR2
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.8671773407417618,1.5431260971620746,0.0,0.22200847206151342,1.0,2/15,3.70%,TGFB2;BMPR1B
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.884091215554716,-1.5430083879170668,0.022727272727272728,0.37395109210985295,1.0,1/9,0.28%,LCK
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.6664910129054473,1.5421179095683633,0.0,0.2242232157603468,1.0,11/42,12.27%,NUDT11;IMPA2;PLCB1;INPP5D;INPP4B;PLCB4;NUDT3;NUDT4;ITPK1;IP6K3;PLCB3
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.5871285189975854,1.5411421014770277,0.04878048780487805,0.22586822334012707,1.0,31/133,11.84%,TGFB2;CTF1;CX3CR1;NRCAM;GPM6A;TAFA1;DCX;HEY1;BHLHE40;MEF2C;MET;WNT8B;FGF13;RELN;SPOCK1;NTRK2;ASTN1;KIAA0319;SNPH;WNT5A;EMX1;ATP2B2;FUT9;FZD3;NEUROD6;MAPT;CDK5R1;CX3CL1;TUBB2A;MYT1L;ANOS1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.5815238021772245,1.540921529336768,0.0,0.22526154546203422,1.0,34/131,15.73%,PPARG;KCNMA1;CELF2;MMP16;KALRN;F3;BHLHE40;MET;LAMC1;COL11A1;DDAH1;INPP4B;CDON;IRS1;SIPA1L1;CITED2;PLCB4;MAP2K5;RGS4;PTPRM;ADGRL2;ATXN1;ICA1;FBLN5;ADORA2B;AKT3;AMPH;SCAF8;LTBP1;CAP2;APBB2;PRKCE;ACVR2A;GJA1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.9178068499153998,-1.5396853697092956,0.0,0.3836958694854246,1.0,1/9,0.19%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.6420781313350996,1.539312124477066,0.0,0.22876605486196677,1.0,7/51,10.95%,TGFB2;BMP6;IGF1;TLR2;FRMD4A;TGFB3;SYTL4
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6022398299108161,1.5390909527579084,0.0,0.22794919523778187,1.0,21/97,9.51%,CX3CR1;KCNMA1;TLR2;STAB1;CSF1R;CHI3L1;C1QB;KCTD12;PID1;LRRK2;CLEC5A;MRC1;TMIGD3;C3AR1;OLFML2B;IL13RA1;EPHB1;IRAK3;DYSF;MAFB;TMEM176B
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.9618036529128443,1.5387534575542048,0.0,0.2274741243155314,1.0,1/5,2.72%,CAMSAP3
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.8060382737910002,1.5379052669429571,0.0,0.22905537663723344,1.0,3/13,5.87%,PIM1;VSTM2A;FNDC5
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.7756635367093173,-1.5376411931603975,0.01818181818181818,0.3849236717117335,1.0,10/20,15.87%,POLR2L;TINF2;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;DAXX;POLR2C;POLR2D
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.7756635367093173,-1.5376411931603975,0.01818181818181818,0.3849236717117335,1.0,10/20,15.87%,POLR2L;TINF2;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;DAXX;POLR2C;POLR2D
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.5956039299660337,1.5374898209118524,0.0,0.2291058211507933,1.0,47/112,14.60%,TGFB2;KCNT2;ZNF423;VCAN;FSTL1;PCDH18;PLPPR4;DCLK1;LDB2;MAP2;GFRA1;COL11A1;EFNB3;TMEM47;RGS7BP;RUNX1T1;ADCYAP1R1;PRKG1;OPCML;LRFN5;CRYM;ASTN1;PBX1;CADM3;ADGRL2;TMEM200C;MEST;LIFR;MAPK4;BRINP1;FNDC4;DIO2;GAP43;BOC;PAMR1;CACNA2D2;CNTFR;SEMA5B;CPE;DPYSL3;PRICKLE2;THY1;LRP4;SCN7A;PDZRN3;STMN2;MEGF10
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7690320444240939,1.5370189162644783,0.0,0.22909027566047024,1.0,13/24,16.92%,SHISA6;MEF2C;CACNG5;CACNG2;RELN;SHISA9;CACNG3;CACNG8;SHANK1;NLGN1;ADRB2;GSG1L;CACNG4
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7847878630407633,1.5367787584129595,0.024390243902439025,0.22881458767977744,1.0,5/17,10.99%,SLC2A12;SLC2A9;SLC2A5;SLC5A9;SLC45A1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9128779965232581,-1.536224750573491,0.018867924528301886,0.3789956890878361,1.0,2/9,1.52%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9128779965232581,-1.536224750573491,0.018867924528301886,0.3789956890878361,1.0,2/9,1.52%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9128779965232581,-1.536224750573491,0.018867924528301886,0.3789956890878361,1.0,2/9,1.52%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.7862206630595988,1.5360982866718145,0.018518518518518517,0.22970693571100748,1.0,8/21,11.50%,SYT4;RIMS2;SYT1;SYT13;SCIN;SYT7;ARHGAP17;SYT17
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.8512739563722189,1.5360197551798487,0.020833333333333332,0.2285296511486754,1.0,5/14,10.20%,CREB3L1;VSIR;F2;VIM;TGFB3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.6788065429269029,-1.535445852734403,0.0392156862745098,0.3784880942454229,1.0,15/52,13.97%,H1-4;POLR2L;POLR1F;POLR1G;POLR2K;H1-2;MYBBP1A;SPHK2;MYO1C;SMARCA5;POLR1H;DDX21;POLR2E;ELOF1;PADI2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.8106329541466623,1.5354294676004567,0.0,0.22858156610804584,1.0,4/19,10.63%,LPL;PPARG;NFKBIA;PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.6863859269009269,1.5352536570723576,0.019230769230769232,0.22774132110253476,1.0,7/33,10.53%,EGFR;ADGRB1;IRAK3;GIT1;BANP;PRKCG;PDE3B
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.8834844869883223,1.5343100755608743,0.0,0.22969729590506888,1.0,3/9,7.27%,RELN;CAMK2B;LRP8
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.7387057546683552,-1.5334882425335923,0.0,0.3834219161136795,1.0,8/29,12.04%,POLR2L;POLR1F;POLR1G;POLR2K;CAVIN1;POLR1H;TTF1;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.8066042536579137,1.5316668065766563,0.04,0.2362324577076251,1.0,4/16,9.78%,PDGFB;EGFR;CCND1;SPDYA
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.6513972509974854,1.5310774212024019,0.03125,0.23643078008090238,1.0,26/65,15.12%,SCN9A;SLC9C2;SLC8A1;HCN1;SLC24A4;SCN2A;SLC24A3;SLC4A4;SLC6A11;ANO6;SCN3B;SCN3A;SCN1A;SLC9A9;SLC9A7;SLC6A8;SLC6A15;ATP1B2;ASIC2;SLC6A4;SCN4B;PKD2L1;SCN7A;SLC6A7;ATP1B3;NALCN
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.8228537143281749,1.5301070132948826,0.0,0.23799877665420158,1.0,3/13,6.65%,PPARG;NR4A3;PPARGC1A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7548153310002848,-1.5295721521855805,0.01818181818181818,0.39679031800930087,1.0,5/30,7.29%,LSM7;POLR2G;LSM2;EXOSC8;NT5C3B
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6481674130274868,-1.5295489591634939,0.017543859649122806,0.39346984666118545,1.0,17/65,13.22%,RPS27A;UBC;UBB;PSMD7;PSMB6;PSME2;PSMD8;ELOC;ELOB;PSMB4;PSMD3;PSMB3;PSME1;UBA52;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.7305837940419343,1.5291579831296092,0.0,0.23911624700404432,1.0,8/26,15.88%,NTNG1;ADGRG1;CAMK2B;SEMA6A;CX3CL1;NSMF;IGSF10;PHACTR1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.5485458096705664,1.52910734460499,0.0,0.23806242124256602,1.0,61/196,15.36%,SCN9A;KCND2;KCNH7;SLC9C2;KCNC2;RYR3;TRPC4;KCNQ3;TRPC7;KCNQ5;SLC8A1;CACNA1G;HCN1;KCNV1;KCNJ4;KCNB2;SLC24A4;SCN2A;SLC24A3;SLC4A4;ABCC9;SLC6A11;ANO6;TRPM3;KCNK6;SCN3B;KCNH5;SCN3A;TRPM1;KCNB1;SCN1A;SLC9A9;KCNC3;TRPM2;SLC9A7;KCNS1;KCNQ2;TRPC6;TRPC3;KCNK10;SLC6A8;SLC6A15;ASIC2;TRPV4;KCNH3;SLC40A1;SLC11A2;SLC6A4;ABCC8;SLC30A3;KCNN4;SCN4B;PKD2L1;SCN7A;SLC6A7;UCP1;KCNG3;ATP1B3;NALCN;SLC39A11;KCNH2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.7132902725331994,-1.5288548898960193,0.019230769230769232,0.3931459060177999,1.0,11/33,17.60%,POLR2L;POLR1F;POLR1G;POLR2K;CAVIN1;POLR1H;TTF1;POLR2E;TCOF1;GTF2H2;RRN3
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.5841920660488871,1.5277150767232808,0.0,0.24094829815642796,1.0,33/114,14.54%,L1CAM;CX3CR1;NRCAM;GPM6A;NTNG1;CBLN2;C1QB;GRM5;CYFIP1;CTNND2;GPC6;LRRK2;NRXN1;UNC13C;PAK3;CACNB1;SLITRK3;LRFN5;SHANK2;SNCB;PPFIBP1;AGRN;PCDHB13;MAPT;CX3CL1;CACNB2;ANK3;RAB29;LRP4;NLGN4X;FARP1;PDZRN3;APBB2
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.8760873443947303,1.5265784148625767,0.03571428571428571,0.2436213564607183,1.0,2/10,5.28%,ADGRB1;CD53
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8170774792256394,-1.5258993477634024,0.0,0.40156362293670844,1.0,4/11,6.39%,EYS;CACNA2D4;CNGB1;GNA11
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.8280610087215382,1.5258925881540364,0.017241379310344827,0.24395819435463834,1.0,5/14,9.91%,BMPR1B;SOX9;ZBTB16;SOX5;BMPR2
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.7439905406780094,1.5250022626934587,0.0425531914893617,0.24550067771964343,1.0,4/21,9.45%,MX1;PEX11A;DNM1;CORO1C
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.7410096725879963,1.5249692412701141,0.02857142857142857,0.2444412191202449,1.0,12/32,15.60%,L1CAM;NRCAM;HEY1;ADGRG1;ETS2;SLIT1;CDK5R1;CNTFR;TLE3;THY1;VEGFA;ACHE
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.6046018982125603,1.5246207975630526,0.023255813953488372,0.2441105565879506,1.0,27/90,15.95%,TGFB2;RHBDF2;BMP6;IGF1;KCNC2;SNAP25;IL12A;RAPGEF4;STXBP5L;ITPR1;FRMD4A;STX1A;RSAD2;CLOCK;KCNB1;PICK1;SYT7;TGFB3;CACNA2D2;SYTL4;ABCC8;CACNA1E;RFX3;NOS2;ACHE;EXPH5;ITPR3
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.8807677196499671,1.5236763195498382,0.0196078431372549,0.246165059016895,1.0,1/7,1.38%,SYT4
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.7921613615787676,1.5235860104908607,0.045454545454545456,0.24511810785282456,1.0,1/10,1.52%,MLIP
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.8156417236895085,-1.5226919414936197,0.02,0.41409278273297434,1.0,2/18,2.78%,SMIM20;SURF1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8060834499485747,-1.5225572867742718,0.05263157894736842,0.4108807404539598,1.0,5/15,7.94%,H1-4;NOC2L;H1-2;CHAF1B;BANF1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.8593636986511897,-1.5220092158704406,0.02040816326530612,0.4100643980192365,1.0,2/11,2.05%,LACTB2;RPP40
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6528537902646883,1.5214526484315367,0.041666666666666664,0.2498592977131446,1.0,12/56,5.20%,ROR1;TGFB2;PDGFC;PDGFB;FLT1;IGF1;PIK3AP1;HGF;PTPN6;PDGFRA;SRC;NTRK2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.8387259119187218,-1.5212165119208256,0.0,0.40947288788866426,1.0,2/16,2.78%,SMIM20;SURF1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.7161944424530255,-1.5209961454933736,0.0625,0.40707805383163215,1.0,9/29,10.82%,TBPL2;PRIM1;TCEA2;SMN1;POLR2A;SMARCA5;TAF13;TTF1;TAF7
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.6197498493979842,-1.5209923550968143,0.034482758620689655,0.40368573671636854,1.0,27/91,18.98%,SNRNP25;PRPF4;SF3A3;PDCD7;SRSF7;PRPF18;RNF113A;MPHOSPH10;YJU2;SCNM1;SNRPD1;SNRPD2;PRPF6;RP9;SF3B4;SNRPB;RBM8A;WBP4;PRPF8;PRPF3;MAGOHB;DHX8;SNRPG;PTBP1;SLU7;LSM1;SNRNP35
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.8322248990653639,-1.5209548507334658,0.016666666666666666,0.40048666741579453,1.0,8/13,13.61%,TRMT10C;RPP25;RPP40;POP5;HSD17B10;RPP25L;POP4;POP7
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.8362459147788831,1.5195634108472764,0.0,0.2540257781900318,1.0,4/13,10.20%,CREB3L1;F2;VIM;TGFB3
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.6670058063447352,1.5189712298611162,0.0,0.2541816469259135,1.0,11/41,12.27%,NUDT11;IMPA2;PLCB1;INPP5D;INPP4B;PLCB4;NUDT3;NUDT4;ITPK1;IP6K3;PLCB3
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.9124586382027762,1.5177866177757313,0.02564102564102564,0.25631119458683865,1.0,3/6,7.78%,PDGFRA;ID2;EPHB3
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5936669012595112,1.5168275721236026,0.023255813953488372,0.2581888186456271,1.0,14/84,10.24%,PDGFC;PDGFB;EGFR;FLT1;CSF1R;LRRK2;DIRAS1;SRC;TENM1;WNT5A;CCND1;IRGM;SPDYA;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.9147470799714575,1.5164172047047364,0.0,0.2569086142609151,1.0,2/6,2.68%,PPARG;PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.9147470799714575,1.5164172047047364,0.0,0.2569086142609151,1.0,2/6,2.68%,PPARG;PARP14
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.9129224185808285,1.5162549587002931,0.0,0.25596429772568535,1.0,1/8,0.72%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7329527309911673,1.5159229157153804,0.0,0.255766216547146,1.0,6/21,7.75%,PDGFC;PDGFB;AQP1;IGF1;PDGFRA;WNT5A
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.9048809310493481,-1.5146578053338682,0.0,0.42359808949682104,1.0,1/8,1.69%,RNF8
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.7349648857221727,1.5145587003543235,0.02040816326530612,0.2585614463703827,1.0,8/22,17.28%,CHI3L1;BASP1;LOXL3;DNAAF1;VEGFA;FGF9;DISP1;CHD7
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7688697767001789,1.514331698271318,0.046511627906976744,0.258015927756159,1.0,7/19,10.48%,CSGALNACT1;VCAN;CHST15;CSPG4;CHST3;CHST11;NCAN
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.8051119175641903,1.514161997735683,0.04,0.25764326788497366,1.0,2/12,3.13%,HEY1;CACNA1G
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.7333799897658555,-1.514003001057976,0.017543859649122806,0.42359532421104423,1.0,5/28,11.62%,LSM7;LSM2;EXOSC8;NT5C3B;EXOSC5
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.667941076503096,-1.5139493090516836,0.03773584905660377,0.4202461617228379,1.0,25/60,22.51%,TRMT10C;RPP40;POP5;TSEN34;ADAT1;SARS1;AARS1;URM1;CSTF2;C2ORF49;QTRT2;TRMT10A;POP7;TRMT1;FAM98B;TRMT6;SSB;CTU2;NSUN2;RTRAF;DDX1;AARS2;TRMT10B;ELP5;KARS1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.832272092096619,1.513662944342036,0.07317073170731707,0.2579975524604093,1.0,3/12,7.00%,PKP2;NEDD4L;SCN3B
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7633123726918347,1.5130250130690481,0.04081632653061224,0.2590686380715829,1.0,3/11,4.56%,ACTN1;CARMIL2;CARMIL1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6935461376303061,1.5126245202480957,0.043478260869565216,0.25979899256562766,1.0,10/28,16.08%,PDGFB;FLT1;P2RY12;PDGFRA;IRS1;PRKD1;PIK3R1;AMBRA1;WASHC1;TNFAIP8L3
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.8355886094246937,1.5125981948575107,0.02857142857142857,0.25882128829905027,1.0,5/12,11.59%,C3AR1;SLA2;GPLD1;CR1;LYN
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.7338870360861992,-1.5124415300472778,0.0425531914893617,0.4232579593462696,1.0,1/19,0.10%,NGF
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.6628322074982222,1.5116341089747052,0.022222222222222223,0.2600923747086007,1.0,22/51,17.09%,FGL2;PTPRC;TLR2;CSF1R;NCKAP1L;LCP2;ITGAM;CD53;CIITA;LILRB1;WDFY4;LY86;LAPTM5;AOAH;SASH3;CLEC7A;HLA-DMA;HAVCR2;ACHE;PIK3R5;SPI1;CD80
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.8518220461158988,-1.5109490691177798,0.05172413793103448,0.42549741944863084,1.0,2/9,0.92%,PRELID1;IFNLR1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7031524796644889,1.5100498573597343,0.02,0.26374458742446333,1.0,11/25,15.91%,LRRK2;NRXN1;RIMS2;RELN;PRKCZ;GRIN1;DLG4;TMEM25;SHANK1;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.7153148502911556,1.509279041476748,0.023255813953488372,0.2654148050226143,1.0,10/31,9.25%,SNAP25;UNC13C;RIMS2;SYT1;STX3;SNPH;STX1A;PCLO;DNAJC5;SYT7
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.7927977710148131,-1.5090558434600467,0.07272727272727272,0.43025017822075634,1.0,1/18,0.10%,NGF
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.639762204167344,1.5084539453847334,0.0425531914893617,0.2671776839246696,1.0,14/63,10.57%,DACT2;NTNG1;ATRNL1;ACTN1;MEF2C;LAMC1;RELN;EPHB3;NTN4;LAMB4;ANTXR1;GRHL2;KIF14;LAMB2
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.8171380278056086,1.5083033660575869,0.0,0.2665106354240891,1.0,4/16,10.24%,TGFB2;ROBO2;BMPR2;ROBO1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.7028357890763256,1.5082489453330028,0.019230769230769232,0.26552914004872685,1.0,7/27,14.60%,MEF2C;ID2;CDON;MAPK12;BOC;MAPK11;MEGF10
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),-0.9742312657114345,-1.5082037916235616,0.0,0.43097359923018586,1.0,1/6,0.19%,BMP5
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.8925976116389123,1.5077876128632925,0.041666666666666664,0.2646509262128635,1.0,2/7,7.28%,MX1;DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.8925976116389123,1.5077876128632925,0.041666666666666664,0.2646509262128635,1.0,2/7,7.28%,MX1;DNM1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.8645314596632557,-1.5070684570572865,0.0196078431372549,0.43245782075172884,1.0,5/9,12.44%,CRYAB;PFDN2;VBP1;PFDN1;PFDN6
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.8876374716833288,1.506900202838904,0.043478260869565216,0.2662727914022654,1.0,1/8,4.55%,PDGFRA
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9870816414358564,-1.5063986783588044,0.0,0.4321316933355805,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.8980794497464364,1.5059598034907895,0.09836065573770492,0.26830007775051234,1.0,2/6,5.49%,PDGFB;ADGRG1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.7441113348749668,1.5059290048031135,0.01818181818181818,0.26728002422984665,1.0,6/20,10.21%,CSGALNACT1;NDST3;B3GALNT1;FUT9;B3GALT1;B3GNT6
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.7076880954965611,-1.5057086416677816,0.018867924528301886,0.4315571350197258,1.0,7/31,12.04%,POLR2L;POLR1F;POLR1G;POLR2K;CAVIN1;POLR1H;POLR2E
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7562156356404099,1.5054977368425293,0.0,0.2676210261271302,1.0,7/25,10.48%,CSGALNACT1;VCAN;CHST15;CSPG4;CHST3;CHST11;NCAN
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.8710734774584585,1.5053065731270892,0.07894736842105263,0.2671823698548996,1.0,3/8,5.07%,LPL;PID1;IRS1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.7313015622565543,1.505182658036872,0.02,0.2662319577201092,1.0,6/24,7.22%,CSF1R;PRKX;MEF2C;MET;COL4A1;RASIP1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.7715871791780605,-1.5041139191381625,0.03571428571428571,0.4355809777704925,1.0,5/21,5.50%,PARP2;TINF2;MBD4;MPG;PARP1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.748382433031373,-1.503936342965158,0.0196078431372549,0.43367872880091013,1.0,5/21,12.17%,TYRP1;RAB32;GPR143;TRAPPC6A;BLOC1S4
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.739785490166539,1.5039349126707502,0.023255813953488372,0.269139725327724,1.0,7/22,9.67%,LPL;TLR2;CSF1R;C5;ACKR1;WNT5A;IL33
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.8491718494785319,-1.5038234434757434,0.0,0.42460047305815224,1.0,1/11,0.30%,PANK1
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.8491718494785319,-1.5038234434757434,0.0,0.42460047305815224,1.0,1/11,0.30%,PANK1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.8491718494785319,-1.5038234434757434,0.0,0.42460047305815224,1.0,1/11,0.30%,PANK1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.5858531332997322,-1.5035171949013788,0.017543859649122806,0.4229550697231507,1.0,23/153,10.33%,CYP1A2;CYB5A;F11;JUP;CYP2E1;DCXR;AQP9;CBR1;SERPINE1;PMM1;SLC35B1;ENPEP;HES6;BPHL;CROT;COMT;HSD11B1;ECH1;GSTM4;AP4B1;NPC1;TMBIM6;DDAH2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.7345094535799939,-1.5035099363110784,0.05555555555555555,0.4198901779135627,1.0,10/25,20.43%,PRPF4;SF3A3;MPHOSPH10;PRPF6;SF3B4;PRPF8;PRPF3;SLU7;LSM1;DDX23
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.9519997630227519,-1.5028241018819475,0.0,0.41997411285677244,1.0,1/5,2.63%,GREM1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.7706422489839058,1.5025945579299234,0.0625,0.27171585651777347,1.0,8/17,14.38%,MYH11;SLC8A1;SORBS2;PDGFRA;MYLK3;ALPK2;ALPK3;VEGFA
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.8794692057515205,1.5019564518677633,0.038461538461538464,0.272335981954814,1.0,2/6,6.50%,ISG15;UBA7
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.9156398398975919,1.50116507236146,0.022222222222222223,0.273812352956445,1.0,3/6,6.67%,PLSCR4;PLSCR1;ANO6
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.8880661401585328,1.5010516192125027,0.0851063829787234,0.2733586145266046,1.0,1/10,0.13%,LPL
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9760465510359833,-1.501044941072733,0.020833333333333332,0.42556987256958956,1.0,2/5,1.75%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.8023517254633056,1.5008843242761472,0.06382978723404255,0.2726574542337337,1.0,5/14,12.87%,LPL;VSTM2A;C3;PLA2G10;SCARB1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.8721189447636254,1.500534616971671,0.06976744186046512,0.2725626545322103,1.0,4/12,5.65%,MYH11;SLC8A1;SMTN;ADRA1A
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.5964287687072286,1.4995009364158425,0.0,0.2752092801101006,1.0,10/52,11.17%,IFNA2;PTPRC;LAT2;NHEJ1;MEF2C;BLNK;PTPRJ;CD70;BCL2;ZAP70
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.5459496453672298,1.4993118612276635,0.02127659574468085,0.2746580393602875,1.0,47/116,16.61%,FIGN;ZNF423;CHST1;PPP1R3C;CBS;GPC6;PLPPR4;DCLK1;GFRA1;EFNB3;NR2F1;TMEM47;CHST3;TENM3;MEIS3;COL4A1;ADGRL2;TEAD1;EPAS1;LIFR;NDRG4;NOS1;TNFRSF1A;FNDC4;NUAK1;VIM;EPB41L1;ANTXR1;GAP43;BOC;CNTFR;CPE;TMEM59L;DPYSL3;PRICKLE2;ABCC8;GPC1;THY1;LRP4;CAP2;PDZRN3;SRRM3;GJA1;SMARCA1;FRZB;GFRA2;NFASC
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.9380115887720487,1.4985686509874072,0.0,0.27569268996004337,1.0,1/7,0.71%,VSIR
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.7225467241110741,1.4984676818374412,0.02,0.27504558345936464,1.0,7/27,9.91%,IGF1;CSGALNACT1;CHST8;NDST3;BMPR1B;CHST11;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.7806124464470237,1.4980211693860421,0.038461538461538464,0.27518795383059796,1.0,8/14,15.91%,SYT4;CACNA1G;STX1A;KCNB1;RAB15;CACNA1I;RAB3A;NLGN1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.6070468941014515,-1.4979429228708,0.018518518518518517,0.43526527734190845,1.0,26/95,18.11%,ORC1;EIF3D;FTSJ3;TSR1;CHD4;DDX12P;USP19;BRPF1;RFWD3;EIF3B;DDX21;MCM3;NOL6;POLG;PRPF8;DHX38;ILF3;TOPBP1;NAT10;EFTUD2;SNRNP200;PTBP1;YBX1;DDX11;NOP14;PDCD11
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.7591349389542746,1.497786183485562,0.037037037037037035,0.2749386886519169,1.0,7/22,12.63%,MEF2C;NRG1;CDON;MAPK12;BOC;MAPK11;OLFM2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7406908391629229,-1.4977788264743883,0.07407407407407407,0.4331351472956647,1.0,6/24,8.91%,RPS27A;UBC;UBB;PCNA;POLD3;POLD4
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.7854371932357115,1.496782762069724,0.046511627906976744,0.2777538475800555,1.0,9/19,11.59%,PPARG;CSF1R;IKZF1;AXL;LILRB1;PDE1B;PIR;TRPM2;LYN
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.7817414159504941,1.4964443280586142,0.04081632653061224,0.2774477667303514,1.0,1/18,0.13%,LPL
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.7187848339085725,1.4957159317070605,0.07692307692307693,0.27806026362806185,1.0,4/18,10.24%,ROBO2;HEY1;SOX9;ROBO1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.625024055046472,-1.4955086418823818,0.015384615384615385,0.4421197222404884,1.0,25/111,13.22%,ORC1;RPS27A;UBC;UBB;PSMD7;H2AX;PSMB6;PSME2;PSMD8;PARP1;CHAF1B;GRWD1;PSMB4;SMARCA5;PSMD3;PSMB3;MCM4;PSME1;H2BC21;MCM3;NPM1;UBA52;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.6073331090319807,1.495438422865136,0.02,0.277803436961144,1.0,18/91,11.04%,EPHA3;RND2;CAMSAP3;BAIAP2;ARHGAP18;PEAK3;PAK3;TWF2;SPEF1;RHOQ;EFNA5;RHOF;DIAPH1;DMTN;ARHGAP17;BST1;MAPT;SMIM22
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.7466907790985862,-1.4947713183853564,0.06349206349206349,0.4419311046115462,1.0,4/26,5.50%,RPS27A;UBC;UBB;PARP1
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.9596441556155534,-1.4940966560481157,0.0,0.44214573846517,1.0,1/6,0.17%,TYRP1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.8403114509732156,1.493921726996538,0.1,0.2818532364166997,1.0,2/10,2.76%,IL12RB2;IL12A
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.6378434920827953,1.4928681977764697,0.02127659574468085,0.28406042514131497,1.0,7/44,7.96%,LPL;CX3CR1;CARD18;IGF1;HSPB1;WNT5A;GIT1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.7177103309408401,1.4921118344025504,0.020833333333333332,0.2851112896517505,1.0,3/21,6.90%,PNLDC1;ZFP36;CNOT11
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.5981305811760784,1.4915226602082405,0.0,0.28591751849782576,1.0,19/69,10.12%,ADAMTS5;PCOLCE;CPED1;ANGPT1;ITGA11;AQP1;FSTL1;FAP;PCDH18;LDB2;POSTN;PDGFRA;PRKG1;CCDC80;COL4A1;COL15A1;FAT4;FBLN2;PAMR1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.7432367853602065,1.4914948610029715,0.04081632653061224,0.2848344820281885,1.0,4/13,14.04%,NR4A3;ANO6;C3;ACSL5
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7693296241025931,-1.4911972938612554,0.08771929824561403,0.45247560521035535,1.0,4/22,3.74%,RPS27A;UBC;UBB;PCNA
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7720282055280815,1.491091625488202,0.046511627906976744,0.28460393895686487,1.0,6/15,12.86%,CHRM3;KCNMB4;OXTR;ADRA1A;BMPR2;KCNMB2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.8095381773787104,1.4906435480742883,0.06,0.285262563054383,1.0,3/12,6.45%,AQP1;KLF9;ZFP36
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.6838659640150402,1.4903822579140675,0.04081632653061224,0.2847065042149321,1.0,4/31,5.97%,MYO7A;LRRK2;CLVS2;HOOK1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.8222378974562301,1.4902821112852636,0.021739130434782608,0.2840157537126024,1.0,1/11,0.11%,CD59
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.886408441122702,1.4895066997824848,0.022222222222222223,0.28577684026462297,1.0,3/8,7.88%,ZEB1;SPRED3;NOTCH4
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.7157211346096007,-1.489398484423003,0.020833333333333332,0.45752734461013317,1.0,14/35,17.67%,MRPL51;TEFM;MRPS21;MRPS2;MRPS7;MRPL57;TFB2M;MRPL47;MRPS34;MRPS18B;MRPS18A;NOA1;TFAM;PTCD3
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7549903448513337,-1.489234232932826,0.1,0.45477239670088054,1.0,4/24,5.50%,RPS27A;UBC;UBB;PARP1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8943045157299158,1.488673096825458,0.047619047619047616,0.287754236798473,1.0,4/7,9.37%,PPARG;IL12A;E2F3;CDKN2A
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.8198645124742601,1.4885514515895055,0.0,0.2873345642538392,1.0,4/13,6.86%,GRIK2;SHISA6;SLC4A10;SHISA9
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5732943498933644,1.4881509072143233,0.0,0.28742003176117714,1.0,33/99,12.00%,BEGAIN;CX3CR1;GRIK2;NPTX2;NRG3;GRM5;MCTP1;GRIK1;LRRK2;MEF2C;KCNMB4;DLGAP1;CACNG5;GRM1;RIMS2;LGI1;RELN;SYT1;CLSTN3;CACNA1B;NPTX1;LRP8;SNCAIP;GRM2;GRM6;MCTP2;DGKI;DLG4;SYN3;GRIK5;GRM8;HOMER1;DLGAP3
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.5855615285453613,1.488036285577715,0.0,0.28691392779199143,1.0,18/76,6.91%,ADAMTS5;PLSCR4;AQP1;PPP1R3C;FSTL1;FAP;PCDH18;LDB2;POSTN;GFAP;PDGFRA;TMEM47;PRKG1;COL12A1;SULF1;CCDC80;COL4A1;TPM1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.644770137705119,-1.4876740724352855,0.03773584905660377,0.45873832782943497,1.0,23/51,17.62%,PLK4;WDR74;DDX18;CDK4;BYSL;MYBBP1A;MPHOSPH10;GRWD1;HSPE1;NIP7;MCM4;TFB2M;NOC4L;NOP56;EXOSC5;NPM1;RRP9;TCOF1;NDUFAF4;PUS1;IMP4;RRP12;TMEM97
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7733598963912804,-1.4873534640442372,0.07936507936507936,0.4573399074452633,1.0,4/20,5.50%,RPS27A;UBC;UBB;PARP1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.5581107108711523,-1.4863035770114692,0.01639344262295082,0.45898288774194224,1.0,56/196,19.36%,PAX8;POLR2L;PTMA;THAP1;POLR3K;POLR2G;TBPL2;GTF3C6;POLR3GL;DRAP1;HOXD3;BTF3;TEFM;POLR2K;GTF2F1;DDX5;TFDP1;POLR2I;PARP1;ELOC;MLF1;TCEA2;ELOB;SMN1;NFIC;POLR2A;SMARCA5;TAF13;IRF9;TFB2M;TTF1;ABT1;DDX21;TAF7;POLR2E;NELFE;CTR9;TAF11;RO60;POLR2C;POLR2D;NELFCD;SUPT5H;SNAPC3;GTF2H2;CCNT1;TAF9B;TFAM;ATF4;POLR2J;SNAPC2;RTF1;CTDP1;CCNK;EAF2;GTF2A1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6874042847597346,1.485700497849345,0.05660377358490566,0.2922531121673078,1.0,15/37,11.83%,GRIK2;GRM5;GRIN2B;GRIK1;PLCB1;GRM1;GRIN3A;GRIN1;TRPM1;GRM2;KCNB1;GRM6;CDK5R1;GRM8;HOMER1
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.9585209495614442,1.4856794697818405,0.0196078431372549,0.2911912037563695,1.0,1/5,0.13%,LPL
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.6864833561297099,1.4849220557210077,0.03773584905660377,0.2929236345943208,1.0,4/29,5.97%,MYO7A;LRRK2;CLVS2;HOOK1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8630931331224703,1.4849158390502912,0.020833333333333332,0.29186718969614506,1.0,3/13,1.77%,ITGA11;PTPRC;P2RY12
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6247272859045729,1.4843092760360554,0.022727272727272728,0.29278123814515217,1.0,8/52,6.29%,EPHA3;MCTP1;NEDD4L;RIT2;STON2;SRC;PACSIN1;LILRB1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.7101627077302773,1.4842936619563005,0.05357142857142857,0.2917332084941613,1.0,3/24,3.12%,NRCAM;IGF1;PLCB1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.6918208214511709,1.4840916954052465,0.046511627906976744,0.2914013302415913,1.0,8/33,7.76%,IGFBP3;PPARG;PDGFB;IGF1;IL12A;NR4A3;ID2;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.8374673906412178,1.4840867678245981,0.017857142857142856,0.2903220660555113,1.0,3/10,5.57%,DNAJB1;BAG3;CITED2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.7193048138817281,-1.4839856265976241,0.0847457627118644,0.4665010325921733,1.0,7/34,8.91%,RPS27A;UBC;UBB;PCNA;POLD3;PARP1;POLD4
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.7625634181583597,-1.483637318843989,0.07407407407407407,0.46497080962658244,1.0,4/20,1.86%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.9126566232265751,1.483545184366069,0.04081632653061224,0.2916238361095399,1.0,3/7,7.88%,APOLD1;ZEB1;NOTCH4
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.9298493391311168,1.4834886339662396,0.03773584905660377,0.2907268262956016,1.0,1/5,0.72%,PPARG
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.7447737951940794,1.4832744617816704,0.01694915254237288,0.29022900199354634,1.0,6/21,12.21%,AQP1;ADCY8;ADCY2;PRKAR1B;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6955732156922027,1.4832678587723989,0.0,0.2891697720592633,1.0,8/23,13.51%,ADAMTS9;PTPRG;PTPRR;ADGRB1;PTPRM;CORO1C;DUSP10;NR2F2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.5942611755784676,1.483223504680971,0.02564102564102564,0.28829147167620534,1.0,13/67,10.68%,TGFB2;L1CAM;CBLN2;GRM5;CTNND2;PAK3;SNCB;TJP2;PPFIBP1;AGRN;GRHL2;TGFB3;MAPT
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.9134849653524536,1.482986215947573,0.0,0.2879373310790932,1.0,1/9,0.27%,TGFB2
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.7292998280182666,-1.4826855249345403,0.058823529411764705,0.4657777619849513,1.0,6/21,14.96%,LACTB2;TRIR;RNASE1;TOE1;POP7;NHP2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.6307299878579729,1.4821730516630824,0.044444444444444446,0.2890045439354841,1.0,16/74,9.62%,EPHA3;RND2;CSF1R;BAIAP2;ARHGAP18;PEAK3;PAK3;TWF2;PDGFRA;RHOQ;EFNA5;RHOF;TRPM2;DMTN;ARHGAP17;BST1
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.9208776303414196,1.4816067544813625,0.017857142857142856,0.2898498831080236,1.0,1/6,1.49%,DCX
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.8274399825063931,-1.4810647967500814,0.03636363636363636,0.47107191983914987,1.0,5/12,12.44%,CRYAB;PFDN2;VBP1;PFDN1;PFDN6
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.9478808109991343,1.4798527361184757,0.0,0.2946589263947415,1.0,1/6,0.27%,TGFB2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.5812263082254807,1.4791074763934773,0.02631578947368421,0.2964988296369437,1.0,29/109,9.61%,CD59;FLI1;TGFB2;KITLG;FGL2;ANGPT1;PTPRC;MGST1;CD44;TLR2;STAB1;CSF1R;C1QB;PROM1;HGF;MRC1;MAFF;C3AR1;CSF3R;ADGRG1;ROBO4;WDFY4;IRAK3;TAL1;DYSF;LMO2;P2RY13;TMEM176B;LYVE1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.8982162064957406,-1.4787958806229504,0.05084745762711865,0.4786389970133719,1.0,2/7,2.78%,POLR2L;GTF3C6
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8206851834394013,1.4782988090412035,0.022727272727272728,0.297817055631319,1.0,7/14,9.02%,NRXN1;CACNG5;CACNG2;RELN;TSHZ3;CACNG3;CACNG8
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.8910710754868791,1.4781639693986002,0.0,0.29743667127402096,1.0,4/6,9.94%,PLSCR1;UHRF1;ITGAM;SETMAR
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.7370952312413867,1.4777920227282424,0.07547169811320754,0.29747979817294334,1.0,7/28,6.21%,SCN9A;MYO7A;TTC8;ADGRV1;PNOC;PCDH15;GNAL
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5695213972386493,1.4774501419506418,0.019230769230769232,0.29743875311004525,1.0,26/77,13.86%,ADAMTS5;ITGA11;AQP1;SEMA3D;FSTL1;RHOJ;MYH11;SYNPO2;FAP;PCDH18;POSTN;PDGFRA;RUNX1T1;PRKG1;COL12A1;SULF1;CCDC80;COL4A1;COL15A1;FAT4;PAMR1;PRRX1;SFRP4;RBMS3;THY1;COL5A1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8861163495499166,1.477241449532749,0.0,0.2971890611409293,1.0,3/7,3.57%,NPAS2;MEF2C;NR4A3
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.9368000498663795,-1.4770412102857209,0.05660377358490566,0.48367807268869323,1.0,1/7,0.19%,BMP5
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.5463879908220473,1.4766128007757722,0.0,0.2985234687094435,1.0,45/149,18.83%,MPPED2;FKBP5;CD44;FOS;NPY1R;IGFBP4;BHLHE40;MREG;BCL11B;SYBU;CA12;REEP1;GFRA1;PEX11A;ABAT;SLC24A3;ABLIM1;CCND1;BCL2;OPN3;MAPT;ITPK1;CCN5;SULT2B1;ADCY1;KAZN;SCARB1;HES1;OLFM1;SLC1A1;FARP1;TJP3;SLC27A2;NBL1;CHPT1;GJA1;TIPARP;RBBP8;PAPSS2;PRSS23;TPD52L1;WWC1;SIAH2;ELF1;DHRS3
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.691978903760957,1.4765934572303114,0.04081632653061224,0.2974833172505256,1.0,9/21,14.45%,LRRK2;UNC13C;CACNB1;PPFIBP1;AGRN;CACNB2;ANK3;LRP4;PDZRN3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.6227222088843177,-1.4762760692486387,0.0,0.4839785104761142,1.0,29/116,14.11%,ORC1;RPS27A;UBC;UBB;PSMD7;PSMB6;PSME2;TEFM;PSMD8;POLD3;PRIM1;PSMB4;PSMD3;POLD4;PSMB3;MCM4;POLE4;PNKP;PSME1;DDX21;MCM3;BLM;UBA52;POLG;PSMA7;PSMD13;PSMB8;TOPBP1;POLE3
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.9186121471822182,1.4758946515555047,0.024390243902439025,0.29884878808443205,1.0,1/5,4.90%,ITGAM
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.7039078494980137,1.4758793722153305,0.07547169811320754,0.2978559178546574,1.0,8/22,10.76%,IGF1;CSGALNACT1;CHST8;BMPR1B;SULF1;CHST11;BMPR2;HS3ST4
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.9249113744531483,1.475291801871602,0.020833333333333332,0.29830722331193393,1.0,1/5,0.51%,NCEH1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.8216106851903452,-1.474817938021172,0.037037037037037035,0.48792889431112685,1.0,3/10,9.49%,NDC80;CHAMP1;MIS12
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.6221227711908699,-1.4747320299719526,0.03636363636363636,0.48539803720127334,1.0,21/76,16.10%,TUBA1A;TPX2;SSNA1;PLK4;DYNLL1;TUBB4B;TUBB4A;TUBG1;DCTN3;HMMR;CEP131;NPM1;DYNC1H1;AKAP9;HAUS6;TUBB;CENPF;DYNC1I2;DCTN1;HAUS1;PRKACA
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.5686342335230694,1.4745477414189856,0.046511627906976744,0.2998604128394306,1.0,42/108,16.61%,FIGN;ZNF423;PTPRG;GPC6;PCDH18;DCLK1;GFRA1;TUSC3;EFNB3;LRRTM1;TMEM47;RUNX1T1;CHST3;TENM3;PBX1;MEIS3;COL4A1;ADGRL2;TEAD1;LIFR;DENND2A;FBLN1;NUAK1;EPB41L1;ANTXR1;BOC;DZIP1;NGFR;CNTFR;CPE;DPYSL3;PRICKLE2;THY1;LRP4;CAP2;FARP1;PDZRN3;GJA1;AGAP1;FRZB;GFRA2;NFASC
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8501085621579889,1.4741388511661526,0.05454545454545454,0.3001794067181521,1.0,2/7,4.57%,MET;SRC
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.8889060707208238,1.4739186699540714,0.0,0.2996426561838067,1.0,1/5,0.13%,LPL
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.7588545958696626,-1.4737685831891127,0.10638297872340426,0.4868162426094471,1.0,2/15,0.28%,P2RY10;LCK
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.8820151004030218,-1.4733902601897084,0.02127659574468085,0.4827778143295234,1.0,1/7,0.17%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.8820151004030218,-1.4733902601897084,0.02127659574468085,0.4827778143295234,1.0,1/7,0.17%,TYRP1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8401601818982098,1.4732889927241055,0.019230769230769232,0.3006488532171235,1.0,5/11,9.66%,IFNA2;PTPRC;MEF2C;CD70;BCL2
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.5808636651094413,1.4728253294007272,0.023809523809523808,0.3010830418518615,1.0,30/91,14.53%,ADAMTS5;IGFBP3;PLSCR4;PPARG;PPP1R3C;FSTL1;FAP;SLC8A1;PCDH18;LDB2;HGF;POSTN;GFAP;RELN;PDGFRA;TMEM47;COL12A1;SULF1;COL4A1;ANTXR1;PAMR1;LAMB2;NGFR;PRRX1;TIMP3;THY1;COL5A1;VEGFA;PDZRN3;CYGB
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.535967899819939,1.4727212972225916,0.0,0.3002268057872211,1.0,35/187,10.63%,LPL;TGFB2;IGFBP3;CDS1;PPARG;NRCAM;BMP6;KITLG;IGF1;ASB4;BRINP3;LMO3;PLCB1;MEF2C;BMPR1B;HGF;NELL1;ZEB1;ID2;CDON;LEF1;ZFP36;NPNT;TP63;SOX9;DLX1;ZBTB16;BRINP1;MAPK12;SOX5;BOC;BMPR2;MAPK11;TGFB3;PLA2G10
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5726736846764576,1.4722992392112595,0.0,0.30069959025307025,1.0,35/101,16.72%,IGFBP3;PLSCR4;EGFR;AQP1;IGF1;PPP1R3C;HSD11B2;KIAA1217;POSTN;PDGFRA;TMEM47;COL12A1;SLC22A3;COL4A1;VIT;EPAS1;LIFR;NOS1;MAFB;FBLN1;MAOB;PAMR1;SPARCL1;LAMB2;ADGRF5;CPE;PRICKLE2;TIMP3;SYNPO;PDZRN3;GJA1;FRZB;ALDH1A1;GAS6;TACC2
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.7166684512124498,1.472218518857786,0.02,0.2999702796876474,1.0,2/19,1.61%,TGFB2;ADAMTS9
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.7098732751699802,1.4721874681755784,0.10256410256410256,0.2990068650120351,1.0,6/15,15.42%,PTPRC;ZFP36;LAPTM5;CR1;SFTPD;HAVCR2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6569305039907024,1.471877476661221,0.0,0.29900261643529324,1.0,11/44,10.82%,TGFB2;PTPRG;RHOJ;PTPRR;SRC;SOX9;BMPER;CORO1C;BMPR2;VIL1;DUSP10
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.8590478414672579,1.4714694598434843,0.02127659574468085,0.29935448786609187,1.0,5/11,9.99%,PKP2;ADAMTS9;ID2;TPM1;HOPX
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.669120803289303,1.471284888849864,0.0,0.2989942036906189,1.0,5/34,6.28%,IFNA2;PTPRC;NHEJ1;BLNK;PTPRJ
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5386871241277619,1.4712233521463889,0.0,0.2982432516984963,1.0,34/194,10.96%,ROR1;EPHA3;IFNA2;EGFR;ANGPT1;FLT1;IGF1;CSF1R;NCKAP1L;LRRK2;EPHA4;HGF;MET;PDGFRA;NTRK2;MERTK;EPHA6;SLC4A4;EFNA5;AXL;EPHB1;SOX9;EPHB3;VEGFD;F2;KNDC1;CCND1;IRGM;PFKFB3;CD4;ARNT;C3;P2RY1;CSNK1D
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4950879970673556,1.4712014459392895,0.0,0.29741888957685103,1.0,85/420,15.96%,EPHA3;TGFB2;IGFBP3;PDGFB;EGFR;FLT1;RPS6KA6;TLR2;MAP3K21;CSF1R;MAP3K5;HIPK4;CAMK1D;LRRK2;PRKX;PEAK3;EPHA4;DCLK1;PIM1;BMPR1B;CDKL4;PTPN6;STK17B;PAK3;HUNK;PRKG2;RELN;PDGFRA;SRC;SYK;STK32B;NTRK2;MERTK;PRKG1;PRKCZ;HIPK3;CAMK2B;EPHB1;CAMKV;IRAK3;MAPKAPK3;MYLK3;EPHB3;AURKC;PRKCG;PICK1;DAPK1;MAPK12;PLK1;CAMK2D;NUAK1;BMPR2;ACVR1C;TEC;MKNK1;DYRK2;CDK5R1;CSNK1D;CDK12;ZAP70;PRKD1;LYN;AKT3;PRKAR1B;IP6K3;TTBK2;DMPK;TNIK;PDK4;RPS6KA3;CDC7;DYRK3;MAK;STK17A;WNK2;CDK19;VRK3;DYRK1B;PRKCE;ACVR2A;TSSK3;LMTK3;CAMK4;FES;PAK5
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.8304076818052881,1.4711909288292904,0.0,0.29644374567659904,1.0,1/9,0.60%,CX3CR1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.9177312932559305,1.4711464646902073,0.02040816326530612,0.2956306522813105,1.0,2/7,3.53%,CSGALNACT1;NDST3
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.7865580402966039,1.4710170789600676,0.04081632653061224,0.29521078072180823,1.0,3/18,4.29%,RIMS4;LRRK2;RIMS2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.7522455325089089,-1.4706543481288203,0.05660377358490566,0.4925864390574591,1.0,3/21,2.29%,PDE3A;CGAS;GPR62
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.713170195894865,1.4700034212173911,0.0425531914893617,0.2973069601437722,1.0,10/34,11.26%,BMP6;IGF1;MEF2C;BMPR1B;HGF;NELL1;NPNT;TP63;BMPR2;PRKD1
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.9302321267429985,-1.4687176839141471,0.0,0.4996103755420673,1.0,2/6,5.93%,OOEP;FBXO43
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.5656540601645096,-1.468190334091275,0.08064516129032258,0.49880045598839257,1.0,24/119,17.19%,TUBA1A;NES;PKMYT1;SSNA1;PLK4;DYNLL1;TUBB4B;USH1C;TUBB4A;TUBG1;KDM8;DCTN3;CEP131;CCNB2;DYNC1H1;AKAP9;HAUS6;TUBB;DYNC1I2;DCTN1;HAUS1;PRKACA;FBXL15;PLK3
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.7246692609350972,-1.4681717197886928,0.057692307692307696,0.4958633225733331,1.0,7/25,6.04%,P2RY10;LCK;S100B;STMN1;H2AX;PCNA;TUBA1B
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.6465734838820943,-1.4673289897092465,0.01818181818181818,0.49706134301379135,1.0,20/66,16.66%,POLR2L;POLR3K;POLR1F;POLR1G;POLR2K;CSTF2T;SMN1;LSM10;POLR2A;CSTF2;CAVIN1;POLR1H;TTF1;POLR2E;SNRPB;SNRPE;SSU72;FIP1L1;SNRPG;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.8570718300109472,-1.4660796009874846,0.05660377358490566,0.5001112725353765,1.0,3/10,10.81%,BMP5;SOD1;ERLIN2
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.684643282129887,1.4660497933022563,0.0,0.30890929712564585,1.0,9/32,14.38%,TGFB2;HEY1;TBX19;FLRT2;SOX9;ALPK2;HES1;OLFM1;VEGFA
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.8368183523493032,1.4658030008083336,0.0,0.3085659057108948,1.0,1/10,0.27%,TGFB2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.9025427697201904,1.4656568828406769,0.05555555555555555,0.3082630161434399,1.0,3/6,6.79%,ROBO2;EPHB1;PTPRM
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.8876119091665601,1.4653072529655977,0.07142857142857142,0.308152922209103,1.0,3/7,9.79%,EGFR;CCND1;OPN3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.7267803906788907,-1.465043989843347,0.07017543859649122,0.5027347710897213,1.0,6/28,8.11%,POLR2L;POLR3K;GTF3C6;POLR3GL;POLR2K;SNAPC1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.6005677673106796,1.4647860767291538,0.022222222222222223,0.3094513393930187,1.0,15/54,13.18%,PLSCR1;KCNMA1;ZACN;PAM;NEDD4L;PPP3CA;SNCB;BCL2;ANXA11;MAPT;TRPC3;HOMER1;SLC11A2;SLC30A3;HAMP
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.6604391916279277,-1.464718989185454,0.0625,0.5009595982538924,1.0,6/42,5.51%,CXCR4;KLK6;TNFRSF21;MPZ;DEGS1;PMP22
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.6395672035013534,-1.464553310165841,0.016666666666666666,0.4987708077704502,1.0,13/53,15.45%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;NQO1;PSMA7;PSMD13;PSMB8;PSMD2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.7555975501628398,1.4644534552348976,0.034482758620689655,0.30933816222498467,1.0,6/14,13.58%,P2RY12;RYR3;ABCC9;P2RY1;TRPC3;P2RY11
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.557759760297102,1.464114074353192,0.044444444444444446,0.3095659691187038,1.0,17/95,14.79%,CDS1;PLEKHA2;CSF1R;PLCB1;INPP5D;PIP5K1B;INPP4B;PLEKHA4;PLA2G10;IP6K3;PLA2G4A;PIK3R1;TPTE2;PLCB3;PIP4K2A;PGAP1;INPP5E
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.9350632488530911,-1.4638867304124163,0.03773584905660377,0.49690121934521486,1.0,1/5,1.13%,JUP
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.9350632488530911,-1.4638867304124163,0.03773584905660377,0.49690121934521486,1.0,1/5,1.13%,JUP
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.6017090764479145,-1.4638731883103884,0.01639344262295082,0.4940617838060994,1.0,24/86,21.08%,RPS27A;UBC;COPS6;UBB;NDC80;PARP1;RFWD3;RAE1;GPS1;UBA52;HMGA2;PADI2;COPS5;POLE3;SOX15;TCF7L1;EZH1;HMGN4;CETN2;MSH3;CDAN1;COPS7A;XPC;FAM50A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6525962306290669,1.4636820506128,0.02127659574468085,0.30994308472422955,1.0,7/31,6.91%,PPARG;PDGFB;IGF1;MEF2C;NR4A3;PRKG1;TPM1
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.9657231005213981,1.4635245333489608,0.017857142857142856,0.3096040149255816,1.0,1/5,0.61%,CARD18
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.7183152771452801,1.4634940597090147,0.08333333333333333,0.3088551210109649,1.0,2/24,0.40%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.6991632494566247,1.4634383836734384,0.043478260869565216,0.30814825555875835,1.0,8/24,17.10%,SNAP25;STX1A;PCLO;DNAJC5;SYT7;RAB3A;NLGN1;CPLX1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.7727471609377518,-1.463359979233605,0.07142857142857142,0.49389526138511886,1.0,4/17,7.43%,RASL11A;POLR2L;POLR2K;DHX33
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.8389796981422327,1.4628476285122096,0.019230769230769232,0.309567150596053,1.0,4/10,6.69%,PPARG;CSF1R;PDE1B;PIR
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.8606717931268182,1.4623754158755096,0.06,0.3097899860575809,1.0,2/10,1.49%,MYO7A;DCX
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.7911249611045473,1.4623712793384618,0.04,0.30886489073342566,1.0,6/15,12.21%,ADCY8;CYSLTR2;ADCY2;PRKAR1B;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.7102121229728067,-1.4621236436952836,0.06451612903225806,0.4970127804442735,1.0,9/39,9.99%,RPL5;RPL11;RPL23;RAD23A;RPS7;PDCL3;ARAF;PYHIN1;CCDC22
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7091175171169198,-1.4615620635095312,0.08620689655172414,0.4973910454181542,1.0,7/36,8.91%,RPS27A;UBC;UBB;PCNA;POLD3;PARP1;POLD4
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.620183999434912,1.4608904318021818,0.020833333333333332,0.31270186605110933,1.0,7/51,4.09%,PDGFC;PDGFB;EGFR;FLT1;MAP3K5;LRRK2;DIRAS1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.6615145197848505,1.4587394063014392,0.03773584905660377,0.3183530099902238,1.0,9/41,8.84%,CTF1;ITGA11;UTRN;IGF1;MEF2C;SMTN;DMD;SGCA;MAPK12
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.735603050424873,-1.4585501140218233,0.09259259259259259,0.5099588448734383,1.0,3/17,10.81%,RAN;SOD1;ERLIN2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.6624968317226033,1.4582284408617052,0.044444444444444446,0.3189491531663213,1.0,12/43,18.58%,PPARG;PID1;NR4A3;TMEM120B;PPARGC1A;MAFB;ZNF516;BBS2;UCP1;TMEM120A;MKKS;TRIM32
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6806534183581296,1.4569401966514084,0.041666666666666664,0.32213538046173734,1.0,3/31,5.20%,IGF1;EPHA4;NTRK2
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.7932776988287635,-1.4564545060000775,0.041666666666666664,0.5168542183302485,1.0,3/14,12.06%,PANK1;CROT;PPCDC
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.720894244978123,1.456448703488685,0.022222222222222223,0.32264347091556306,1.0,8/29,9.26%,RIMS4;MCTP1;LRRK2;MEF2C;KCNMB4;RIMS2;SNCAIP;MCTP2
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.8156024407040284,-1.4562957131762118,0.05454545454545454,0.5145030399549876,1.0,3/10,8.07%,BUD23;RIOK2;TRMT112
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.7166228560377786,-1.4560756527119445,0.08695652173913043,0.5125880975017686,1.0,5/32,5.22%,CYB5A;EMC6;EMC4;SEC61B;EMC7
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.6273686595581099,-1.4552616113062966,0.0,0.5141860862603669,1.0,12/56,13.90%,ZDHHC12;SELENOK;ZDHHC16;DPM3;PGAP2;ZDHHC14;HHAT;PIGO;PIGF;PGAP4;PIGW;DPM2
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.847836619918019,-1.4545799507281756,0.03773584905660377,0.5144135791074387,1.0,2/11,3.31%,PAX8;HOXD3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.5430823467914316,1.4545553793643644,0.0,0.3280864622459591,1.0,17/112,6.28%,CX3CR1;PDGFB;EGFR;KITLG;ANGPT1;P2RY12;CHI3L1;PIK3AP1;F3;HGF;MET;PDGFRA;SRC;NRG1;IRS1;AXL;PTPRJ
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7164494246274297,1.4545089086690046,0.061224489795918366,0.32730642968617646,1.0,8/25,10.48%,CSGALNACT1;VCAN;CHST15;CSPG4;CHST3;HEXB;CHST11;NCAN
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.7867892067106226,-1.4543968501186788,0.07692307692307693,0.5124853129381859,1.0,10/20,15.58%,FTSJ3;TSR3;BUD23;METTL5;TRMT112;TFB2M;DKC1;MTERF4;NHP2;NAT10
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.8788118032623278,1.454390622364966,0.019230769230769232,0.3266754796471147,1.0,5/8,12.12%,HEY1;TMEM204;MEF2C;EDNRB;MRTFB
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4924445965580903,1.454371250279143,0.0,0.32576050412962837,1.0,69/303,15.38%,CLDN5;PDGFC;VSIR;PDGFB;EGFR;FLT1;NTNG1;IGF1;OSGIN1;CSF1R;SEMA3D;MCTP1;DACH1;CARMIL2;CAMSAP3;F3;PRKX;EPHA4;LDB2;HGF;TMIGD3;PDGFRA;CARMIL1;SRC;PLXNA4;PPP3CA;SRGAP1;CITED2;ROBO4;LEF1;SULF1;CAMK2B;PTPRJ;TPM1;CHRD;PLXNA2;CORO1C;PTPRT;SEMA6A;KIF14;ROBO1;VIL1;AMOTL1;DUSP10;NGFR;SMIM22;CX3CL1;SEMA5B;SEMA4B;ZNF304;DPYSL3;TTBK2;FGF17;TMSB15B;KANK1;ZMYND8;MGAT5;CLEC7A;CDH13;THY1;VEGFA;PTPRK;SEMA4G;SEMA3C;FGF9;WASHC1;NTRK3;IGSF10;LAMB1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.816567397779514,-1.4540069669036142,0.03389830508474576,0.5111578307264246,1.0,1/11,1.88%,ARPC5
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5624499018176498,1.453882264180931,0.0,0.32635763765303755,1.0,26/102,12.21%,BMP6;EGFR;AQP1;SYT4;FOS;RYR3;ADCY8;LRRK2;MEF2C;ADGRV1;SYT1;MT1M;SYT13;WNT5A;CPNE8;TRPM2;DMTN;CAMK2D;SYT7;GPLD1;CPNE5;DLG4;SYT17;ADCY7;GLRA2;ADCY1
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.9105108037355483,1.4534907876492782,0.022727272727272728,0.32627167565404785,1.0,1/5,1.17%,CLDN16
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7521557616492763,-1.4533921545086543,0.10909090909090909,0.5119304352583851,1.0,4/21,3.74%,RPS27A;UBC;UBB;PCNA
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.8246298926621607,-1.452939116601136,0.05454545454545454,0.511414628601015,1.0,1/8,0.63%,DDIT3
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.7513643455764935,-1.452782764645741,0.10204081632653061,0.5094552177959767,1.0,3/22,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.7283052668854967,-1.452665172859729,0.05172413793103448,0.5077348317276612,1.0,8/22,20.86%,TRMT10C;RPUSD2;DKC1;PUS1;PCIF1;TRMT6;NSUN2;VIRMA
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.7062412292503552,1.4526224111712513,0.11363636363636363,0.327755117121823,1.0,7/18,20.00%,AQP1;SCN2A;YBX3;TRPV4;ZFP36L1;CAPN3;PKD2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7712104902459703,-1.4525350692040593,0.0847457627118644,0.5055110459947131,1.0,8/23,14.04%,RPS27A;UBC;COPS6;UBB;PARP1;GPS1;UBA52;COPS5
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.6174784120339268,1.4520463658451548,0.05128205128205128,0.32937190272029293,1.0,12/65,8.69%,EPHA3;EPHA4;PLXNA4;SIPA1L1;NTRK2;PRKG1;EFNA5;RASIP1;EPHB3;NOS1;NGEF;PLXNA2
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.8935392277087669,1.4517133799297726,0.038461538461538464,0.329561291775965,1.0,1/7,1.41%,IGF1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.8247471858047609,1.4516205503789341,0.05,0.32879539996083595,1.0,1/11,0.13%,LPL
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.562041610279799,-1.451281118081439,0.06557377049180328,0.5081083856327,1.0,24/118,17.19%,TUBA1A;NES;PKMYT1;SSNA1;PLK4;DYNLL1;TUBB4B;USH1C;TUBB4A;TUBG1;KDM8;DCTN3;CEP131;CCNB2;DYNC1H1;AKAP9;HAUS6;TUBB;DYNC1I2;DCTN1;HAUS1;PRKACA;FBXL15;PLK3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.8021618809201992,1.4510747054374975,0.06818181818181818,0.3295491274529618,1.0,1/7,1.52%,MLIP
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),0.9477857499287318,1.4507213761915798,0.0,0.32987684032815784,1.0,1/5,1.00%,MFAP5
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.807446987348715,1.4504695946660882,0.057692307692307696,0.32978229753892635,1.0,3/10,8.04%,CX3CR1;SYK;DYSF
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.919208063665766,1.4504398727384773,0.0,0.3289898170722371,1.0,4/8,6.21%,PTPRC;TOX;AXL;PBX1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7627581469439049,1.4503690593092902,0.1111111111111111,0.3284457284262801,1.0,9/15,19.72%,CBARP;NEDD4L;SLC43A1;CAMK2D;HAMP;KCNH2;BIN1;CAV3;ATP1A2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5614996587383609,1.4497283836325199,0.044444444444444446,0.329849186460639,1.0,31/89,14.02%,FIGN;MEX3A;PTPRG;GPC6;TUSC3;GPR161;EFNB3;NR2F1;DDAH1;ADAMTS15;CHST3;TENM3;MEIS3;KIAA1549;CTXN1;ADGRL2;SOX9;TEAD1;LIFR;GLRB;EPB41L1;ANTXR1;BOC;DZIP1;GTF2IRD1;KCNIP3;LYPD6;PCGF2;NR2F2;LRP4;CAP2
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6540111628516714,-1.4496506978358765,0.017857142857142856,0.5142478853827124,1.0,13/55,15.45%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PINX1;PSME1;PSMA7;PSMD13;PSMB8;PSMD2
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.7511442523804526,1.4494729873788432,0.10869565217391304,0.3300327836669339,1.0,6/16,18.51%,PPARG;SORBS1;F2;EEF1A2;HSD17B13;MLXIPL
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.791526156765439,1.4493223337816197,0.037037037037037035,0.32874463824178524,1.0,1/7,3.14%,LRRK2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.791526156765439,1.4493223337816197,0.037037037037037035,0.32874463824178524,1.0,1/7,3.14%,LRRK2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.7720498601698835,1.4493165425999033,0.08928571428571429,0.32779724735348037,1.0,8/18,15.51%,MYH11;SLC8A1;MEF2C;NRG1;ALPK2;ALPK3;VEGFA;KDM6B
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.8469980038130809,-1.448829477710936,0.07692307692307693,0.5154472561313121,1.0,1/14,0.92%,IFNLR1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.7829837102622536,1.448788027080743,0.04,0.3282241853414967,1.0,4/14,14.46%,PPARG;NFKBIA;ABCA1;ABHD5
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.9455475114811431,1.4486133966026173,0.0,0.3278296996152267,1.0,2/5,0.27%,CD59;TGFB2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5458821906738631,1.4482015292514092,0.023255813953488372,0.3282881317845052,1.0,22/90,10.57%,FIGN;EGFR;KITLG;PTPRG;FSTL1;LRIG3;LAMC1;DDAH1;ADAMTS15;CHST3;MYO1B;COL12A1;TENM3;COL4A1;ADGRL2;TEAD1;LIFR;WNT5A;CCND1;NUAK1;ANTXR1;LAMB2
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.8271786476660659,1.4481659858579075,0.0,0.32762427480915524,1.0,6/13,10.20%,TGFB2;LILRB1;IRAK3;WNT5A;LAPTM5;TGFB3
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.7696329910681778,1.4472547049184579,0.07407407407407407,0.33011067874332656,1.0,5/15,12.21%,ADCY8;ADCY2;PRKAR1B;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.8459856940865549,-1.447020953261402,0.018867924528301886,0.520975432916811,1.0,2/11,4.68%,DDIT3;EIF2AK1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.8678146127869946,1.4465570010908064,0.03571428571428571,0.3313684500759874,1.0,1/9,0.36%,REP15
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.6586440302529248,-1.4465058197168852,0.037037037037037035,0.5204768743781859,1.0,13/36,16.10%,LSM2;GEMIN6;SNUPN;SNRPC;SMN1;SNRPD1;SNRPD2;PRPF6;SNRPB;PRPF8;SNRPE;PRPF3;SNRPG
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.8159614730792815,1.4463906882998603,0.044444444444444446,0.3312061485464799,1.0,1/14,0.13%,LPL
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.5022581172519345,1.4461831117577872,0.0,0.33094411949026886,1.0,44/217,10.57%,CREB3L1;ADAMTS5;TGFB2;PDGFB;MFAP5;ITGA11;CD44;ADAMTS9;ST7;ITGB4;MMP16;VCAN;CAPN1;TNC;ADAMTS10;ADAMTS7;POSTN;LAMC1;COL11A1;ADAMTS17;COL5A3;ITGAM;LOX;ADAMTS15;TNR;ADAMTS6;FLRT2;LOXL3;COL12A1;COL4A1;NPNT;ADAM12;VIT;COL20A1;P3H2;JAM2;FBLN5;COL15A1;PAPLN;COL7A1;AGRN;COL9A1;NCAN;LAMB2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.7088836507201294,1.4457992629996457,0.041666666666666664,0.3317540606359089,1.0,10/24,16.54%,PDGFB;FLT1;P2RY12;PDGFRA;IRS1;F2;PRKD1;AMBRA1;TNFAIP8L3;EEF1A2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.8717025353351209,1.445774677947559,0.0,0.3308581369133421,1.0,1/6,0.27%,TGFB2
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.5865630437718319,1.4447285581728886,0.0,0.33415875676360235,1.0,30/86,16.49%,DACT2;CDS1;ZNF423;SHISA6;KALRN;PROM1;SPON1;PBX1;SYT13;NPNT;RIMBP2;ZBTB7C;EPHB3;NEBL;LRRN1;MAOB;PTPRT;APCDD1;HOPX;SEMA6A;SPARCL1;SH3BGRL2;SCN4B;ANK3;WNK2;PDZRN3;NOS2;PDE9A;FRZB;TNFRSF19
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6415328325811003,1.4444459508743506,0.061224489795918366,0.3342563313744752,1.0,15/37,24.96%,FLT1;SYK;LOX;COL4A1;RASIP1;HES1;SLC1A1;VEGFA;EGFL7;KDR;CYP1B1;TGFBR3L;NF1;RASA1;CCBE1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.8646097035580064,-1.444155828342888,0.01818181818181818,0.5300940482187827,1.0,1/10,1.18%,VPS25
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.956471109247959,-1.443310851839237,0.0,0.5312729881871625,1.0,2/6,3.51%,MSRB1;MSRB2
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.9172304039710732,1.4430323770075895,0.07142857142857142,0.3387531855524653,1.0,2/7,5.28%,ADGRB1;CD53
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.7405962677555118,-1.4426171938077572,0.05084745762711865,0.5322315575107983,1.0,2/21,0.99%,MEIOSIN;FSHR
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5897508201288657,-1.4417889573125864,0.03636363636363636,0.5337614834383397,1.0,10/64,9.45%,POLR2L;CGAS;POLR3K;GAPDH;POLR3GL;POLR3D;POLR2K;DDX41;DHX33;CHUK
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.9203792850780407,1.4412244899524465,0.0,0.3442807976955263,1.0,2/7,4.87%,TGFB2;NRG1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8142930835676558,-1.44065756281707,0.03389830508474576,0.535730369965647,1.0,6/11,13.61%,RPP25;RPP40;POP5;RPP25L;POP4;POP7
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.8719412367907817,-1.4406072209790162,0.03636363636363636,0.5332425795336083,1.0,2/8,6.11%,TRMT10C;HSD17B10
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.8011234013732788,1.4403096185257742,0.057692307692307696,0.34711308428518384,1.0,5/9,17.93%,ADCY8;ADCY2;ADCY7;ADCY1;ADCY10
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.7923336551540102,-1.4395596534908877,0.06382978723404255,0.5352763896185364,1.0,3/15,5.21%,TINF2;MBD4;MPG
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.9197008077697314,1.4390306972981375,0.0,0.35032346158276323,1.0,2/7,3.21%,SYT4;CBARP
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.7414216583461434,1.4390054231171503,0.05128205128205128,0.3495246236619257,1.0,3/16,9.46%,MMRN2;TMEM204;ARNT
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.6161707175718774,1.4384960334092007,0.07142857142857142,0.35049208553982497,1.0,11/41,10.20%,BMP6;SRGN;SLC8A1;MEF2C;BMPR1B;ADGRV1;NELL1;ISG15;ANO6;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6539273542178969,-1.4378912761731437,0.05454545454545454,0.5409516614213136,1.0,13/50,15.45%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PINX1;PSME1;PSMA7;PSMD13;PSMB8;PSMD2
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.778100958827689,1.4378032960987046,0.1346153846153846,0.35190980741706385,1.0,5/14,13.67%,FSTL1;TMEM204;SULF1;SFRP4;LRIT3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.5977537015933357,1.4376901046441235,0.044444444444444446,0.3515025816708398,1.0,7/47,8.08%,TRIM5;BTBD17;PLSCR1;MX1;ISG15;ZFP36;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.8922897037023536,1.43767039249243,0.0,0.3505797738176027,1.0,4/9,6.29%,CX3CR1;PTPRC;ARRB2;LILRB1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.8494440409151129,-1.4375413051669992,0.07272727272727272,0.5398917403961598,1.0,1/10,0.43%,KLK6
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.6115139560523021,1.4370961640928948,0.045454545454545456,0.3516952613343383,1.0,9/60,7.75%,LPL;CDS1;PPARG;LMO3;ID2;RUNX1T1;ZFP36;ZBTB16;WNT5A
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.6453151617718804,1.4370446521075835,0.023255813953488372,0.3507447336010023,1.0,2/31,4.12%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.766973052776742,1.4370381546951374,0.05660377358490566,0.34983143052304694,1.0,6/17,12.21%,ADCY8;CYSLTR2;ADCY2;PRKAR1B;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.9218722939849031,-1.4369987026969575,0.03278688524590164,0.5399701531618172,1.0,1/6,1.69%,RNF8
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.8949424380250282,1.436726595391146,0.0,0.3500115213248271,1.0,2/6,9.42%,NCKAP1L;NUAK1
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.9295997709831793,-1.436617429679391,0.03571428571428571,0.539245955594139,1.0,1/5,2.91%,EXOC7
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.8219827521745822,1.436447565301332,0.0975609756097561,0.35044607365967173,1.0,5/12,14.93%,PPARG;IRS1;GPLD1;PPM1K;PRKCE
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.6483956623415131,-1.4357296807183304,0.03773584905660377,0.5407631149151576,1.0,18/61,19.82%,EIF1;POLR2G;ATF3;EIF5;EIF1B;MIF4GD;EIF3B;EIF4G2;NPM1;EIF4B;POLR2D;RPS6KB2;EIF2AK3;MTIF2;ATF4;TPR;EIF5B;DDX1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.8916226940854419,1.4356504661411111,0.03773584905660377,0.35259782558282543,1.0,2/8,5.28%,ADGRB1;CD53
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6888181817145135,1.4356479442401717,0.047619047619047616,0.3516575647146046,1.0,7/19,20.16%,MFAP5;TENM3;SHROOM2;COL5A1;VEGFA;FBN1;RARG
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.572882414716788,-1.4352272789909994,0.038461538461538464,0.5405582700610534,1.0,25/155,12.03%,CRYAB;RPL5;RPL11;RPL23;RPS7;USP27X;GAPDH;PPIB;PDCL3;ATP1B1;PFN1;CCT7;CCT2;PHB2;GBA3;USP19;PYHIN1;ZSWIM7;NOP53;OTUD3;CCT6A;GLMP;PER3;FKBPL;SAXO1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.7500403843561659,1.4345660795077506,0.0,0.3541747328751351,1.0,10/24,11.50%,SYT4;CACNA1G;CBARP;SYT1;SYT13;STX1A;KCNB1;SYT7;CACNA1I;SYT17
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.8710121119015782,-1.4344110777107284,0.02,0.5396037491191777,1.0,2/9,4.61%,CA6;TAS2R40
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.8710121119015782,-1.4344110777107284,0.02,0.5396037491191777,1.0,2/9,4.61%,CA6;TAS2R40
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.854021020022041,1.4342863333601286,0.05555555555555555,0.35408819744403036,1.0,2/9,6.93%,ROBO2;NPNT
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.6801854930356179,-1.4342454024355134,0.03225806451612903,0.5381154189024993,1.0,16/40,24.14%,SEC61B;GRPEL1;SEC62;SEC61A2;GRPEL2;ZFAND2B;TOMM20;TIMM50;TIMM17A;DNAJC19;TIMM23;PEX10;TIMM44;PEX16;DNAJC15;TOMM40L
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.9316642752652924,1.4341813482822936,0.02,0.35359254105797233,1.0,3/5,6.11%,PTPRG;PTPRR;TENM3
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.9235727010346018,1.434081133104608,0.04,0.35300523147332163,1.0,1/5,0.72%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.9144312168599077,1.4340239277945996,0.0,0.35220163130291376,1.0,2/7,1.61%,CREB3L1;ADAMTS9
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5286464656591715,1.4337466087990596,0.0,0.35230873102502186,1.0,52/163,16.43%,PLSCR4;EGFR;KITLG;PTPRG;FSTL1;DACH1;KIAA1217;LRIG3;MET;THSD7A;LAMC1;TMEM47;DDAH1;SRGAP1;MERTK;CHST3;MYO1B;COL12A1;CADPS2;SULF1;COL4A1;TPM1;ADGRL2;TEAD1;LIFR;NEBL;NTN4;MAFB;FAT4;NUAK1;EPB41L1;ANTXR1;LAMB2;MAPT;CPE;PTPRO;PRICKLE2;ADCY1;KANK1;CDH13;NR2F2;NLRP3;DOCK5;SYNPO;CAP2;VEGFA;APBB2;LAMB1;GJA1;PALLD;SMARCA1;DOCK1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7037483081193299,1.4336851627542222,0.025,0.3516046899536397,1.0,6/18,6.94%,TP73;PRNT;CAPN1;TXNDC8;SYCP3;GCNA
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.7618845938182799,-1.433661137832785,0.041666666666666664,0.5385113003889158,1.0,2/13,1.34%,LCK;RPS3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.6980306354248424,1.433418820295889,0.06818181818181818,0.3520859260779933,1.0,6/26,6.79%,PPARG;FLT1;IL12A;MEF2C;SULF1;PTPRM
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6450697364221529,-1.4329447553850276,0.037037037037037035,0.5392525128009784,1.0,15/44,18.80%,TMEM11;TIMM10;ATP5F1B;SAMM50;TIMM8B;UQCC3;ATP5MC3;APOO;ATP5PF;ATP5PB;CHCHD6;ATP5PD;TIMM13;TIMM9;TIMM29
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.9254193325222017,-1.4329300585500195,0.022222222222222223,0.5367443615786482,1.0,1/6,0.19%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.7274954847732894,1.432910832065867,0.06382978723404255,0.35275073844669264,1.0,5/22,9.46%,PDGFB;IGF1;SLC4A4;PFKFB3;ARNT
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.749427491742258,1.4325601993623684,0.08333333333333333,0.3529171656423772,1.0,7/13,21.89%,PIK3AP1;ITGAM;TIRAP;PRKCE;LBP;LY96;SCIMP
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.761224089507579,1.4324150817284667,0.02040816326530612,0.35255822803768816,1.0,3/17,7.83%,CSGALNACT1;NDST3;HS6ST3
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.9126619890121851,1.432217332281404,0.0,0.3524781056793185,1.0,1/9,0.72%,PPARG
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.8188745393487712,-1.432155921743732,0.0625,0.5380248007194819,1.0,1/9,1.12%,SELENOS
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7901477155270196,1.4320561894686976,0.057692307692307696,0.3520914558155905,1.0,1/11,0.27%,TGFB2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.8697084065408937,1.4318648528958278,0.07142857142857142,0.35123249461157957,1.0,1/5,3.01%,HEY1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.8697084065408937,1.4318648528958278,0.07142857142857142,0.35123249461157957,1.0,1/5,3.01%,HEY1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7506938752442882,1.431541015353004,0.10416666666666667,0.35143070946030913,1.0,4/12,14.38%,JCAD;RHOJ;AKT3;VEGFA
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.7060435183088618,1.4311697902754683,0.038461538461538464,0.3516886747010328,1.0,5/20,14.99%,CHI3L1;LOXL3;DNAAF1;VEGFA;FGF9
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.8172876956690575,1.430279327535307,0.0392156862745098,0.35391505731756107,1.0,5/14,9.26%,MCTP1;MEF2C;KCNMB4;SNCAIP;MCTP2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.7796316497270398,-1.4300546304373618,0.017857142857142856,0.5453744013985545,1.0,7/17,18.60%,TPX2;NUMA1;ANKRD53;RAE1;DYNC1H1;DCTN1;PARP3
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6844491898531491,-1.429892305493019,0.06,0.5436721458377474,1.0,20/42,22.81%,GRPEL1;TIMM10;SLC25A6;TIMM8B;AIP;TSPO;FIS1;GRPEL2;TOMM20;TIMM50;TOMM7;TIMM13;TIMM17A;DNAJC19;TIMM9;TIMM23;PINK1;TIMM44;RALA;DNAJC15
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.9215875338360294,-1.4298229085917054,0.03333333333333333,0.5416443739758465,1.0,1/7,1.69%,RNF8
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.6383875797675131,-1.4292988697087445,0.0784313725490196,0.5408799127546179,1.0,7/48,6.81%,ARHGEF16;GPRC5C;S100A16;GJB1;CLDN2;TMEM125;LAMB3
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7461471418891057,-1.4288403339752944,0.09523809523809523,0.540347686721096,1.0,6/15,9.47%,PDE6A;METAP2;FNTA;CNGB1;CALM1;GUCA1C
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.571401971738073,1.4286305083252437,0.021739130434782608,0.35869940193289934,1.0,21/71,14.52%,L1CAM;NRCAM;NTNG1;BAIAP2;PLPPR4;PAK3;SLITRK5;ADGRB1;SLITRK3;CNTN4;EPHB3;RTN4RL2;SLITRK4;GAP43;MAPT;CDK5R1;NREP;VASH2;ANK3;RAB3A;PARD3
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5115467328921426,1.4284070685222925,0.0,0.358334004080493,1.0,52/199,18.61%,TGFB2;PDGFC;VSIR;PDGFB;EGFR;FLT1;PTPRC;IGF1;CSF1R;SEMA3D;NCKAP1L;CARMIL2;F3;HGF;PDGFRA;CARMIL1;SRC;PPP3CA;LEF1;SOX9;DMTN;BMPR2;SEMA6A;VIL1;SMIM22;SEMA5B;SEMA4B;ZNF304;TMSB15B;MGAT5;CLEC7A;CDH13;DOCK5;VEGFA;SEMA4G;SEMA3C;NSMF;PRKCE;WASHC1;NTRK3;LAMB1;CASS4;DOCK1;FERMT1;ARHGEF7;RUFY3;SEMA7A;KDR;EDN1;GPER1;TRIM32;FERMT3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5597360674061256,-1.4283486873274331,0.03508771929824561,0.5400819412361382,1.0,4/106,3.60%,CYP1A2;PDZD11;LDHC;GLYAT
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.8004890120673225,1.4283305805029987,0.0425531914893617,0.3576396380140197,1.0,4/13,7.87%,TGFB2;CAMSAP3;SCEL;CELF4
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.8775049278680027,-1.4281012451868056,0.0,0.5388881782585055,1.0,3/6,6.89%,MEIOSIN;OOEP;RAD51AP1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.5207703720858871,1.4280891592003935,0.0,0.3573987432506361,1.0,49/152,15.73%,CD59;IGFBP3;PCOLCE;MFAP5;CD44;VCAN;FSTL1;FAP;IGFBP4;TNC;POSTN;CTHRC1;LAMC1;COL11A1;COL5A3;ID2;SPOCK1;BASP1;LOX;OXTR;COL12A1;RGS4;COL4A1;TPM1;ADAM12;CRLF1;MEST;WNT5A;FBLN5;FBLN1;COL7A1;VIM;FBLN2;SLC6A8;PRRX1;CDH6;DPYSL3;TIMP3;SFRP4;GPC1;THY1;COL5A1;CAP2;VEGFA;MAGEE1;SNTB1;ECM2;NNMT;GJA1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.555028895505581,1.427705263839896,0.0,0.357518133134694,1.0,37/112,16.03%,IGFBP3;CD44;FSTL1;OLFML1;FAP;PCDH18;TNC;POSTN;COL11A1;PDGFRA;LOX;OLFML2B;COL12A1;SULF1;CCDC80;COL4A1;NPNT;WNT5A;NOD1;SOCS3;IL33;PAMR1;LAMB2;ALPL;PRRX1;CX3CL1;CCN5;TIMP3;SFRP4;THY1;NLRP3;LRP4;COL5A1;NNMT;GJA1;TNFRSF10A;PALLD
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8440355745859023,1.427668937768952,0.01818181818181818,0.35674148910858783,1.0,3/10,5.48%,IFNA2;TRIM5;CIITA
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.817646238416621,1.4275702188627315,0.058823529411764705,0.3562664605946016,1.0,4/8,9.85%,GABRG2;GABRB2;DIAPH1;GABRB3
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6764428156914077,1.4274822045297237,0.018518518518518517,0.355615607409669,1.0,5/35,10.68%,EPHA3;CAMSAP3;EFNA5;DIAPH1;MAPT
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.9038517795685375,1.4273102193038987,0.03389830508474576,0.3556493696849358,1.0,3/6,8.39%,NR4A3;PTPRN;SGPP2
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.7209819206354395,1.4271809732234186,0.020833333333333332,0.35526924211388844,1.0,5/19,14.99%,CHI3L1;LOXL3;DNAAF1;VEGFA;FGF9
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5448119495086247,1.4270457984988236,0.0,0.3548025610282454,1.0,35/104,15.29%,ADAMTS5;PLSCR4;ANGPT1;AQP1;FSTL1;SYNPO2;FAP;CSPG4;PCDH18;LDB2;POSTN;PDGFRA;INPP4B;MYO1B;ROBO4;ABCC9;COL4A1;COL15A1;VIM;FBLN2;PDZD2;PAMR1;SPARCL1;ALPL;PRRX1;ADGRF5;NOTCH3;ANGPT2;TIMP3;THY1;VEGFA;CYGB;TNS1;ECM2;ASPN
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.68933796991907,1.4269464501894933,0.06,0.35424996756515187,1.0,6/21,15.91%,RELN;CAMK2B;LRP8;CPEB3;SHANK1;NLGN1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.8006566218103142,-1.426825871113108,0.1,0.5426327094350021,1.0,1/9,6.73%,RAN
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6615772684304019,1.4262956975083356,0.09259259259259259,0.35610542115785065,1.0,4/22,5.88%,MMRN2;JCAD;RHOJ;MAP2K5
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.6617993854142693,1.4261009665364015,0.023809523809523808,0.3549435951560758,1.0,3/28,10.03%,TGFB2;PRICKLE1;GRHL2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.6617993854142693,1.4261009665364015,0.023809523809523808,0.3549435951560758,1.0,3/28,10.03%,TGFB2;PRICKLE1;GRHL2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.6081177793627,-1.4260262832834216,0.12962962962962962,0.5436882196744238,1.0,17/54,16.69%,RPS27A;UBC;UBB;DYNLL1;UFC1;PHB2;CFTR;TEX264;DYNC1H1;ATG14;UBA52;SQSTM1;UFL1;MAP1LC3B;ARL13B;DYNC1I2;PARK7
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.8698173706908507,1.4255256569420625,0.04081632653061224,0.3563760901378134,1.0,3/9,4.24%,MX1;SHMT2;ISG15
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.6516243132245673,1.4253658952034145,0.06976744186046512,0.3560297271136538,1.0,7/29,10.37%,CD59;C1QB;C3AR1;C5;F2;CR1;C3
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7510108863591063,1.425150528013368,0.06,0.35597481334215647,1.0,6/14,11.65%,CHRM3;PLCB1;CHRM5;AGRN;CDK5R1;CHRM1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.8491166489175995,-1.4248017979294985,0.04,0.5477455944481135,1.0,1/7,2.97%,PTPRU
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.6418423193971032,-1.4247801055766747,0.046875,0.545369178506375,1.0,18/48,19.58%,GRPEL1;TIMM10;SAMM50;SLC25A6;TIMM8B;AIP;TSPO;FIS1;GRPEL2;TOMM20;TIMM50;TOMM7;TIMM13;TIMM17A;DNAJC19;TIMM9;TIMM29;TIMM23
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.7079172079924717,1.424550038856898,0.10526315789473684,0.35713422014853596,1.0,2/15,7.28%,MX1;DNM1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.6573413948586657,-1.4243770372216273,0.03636363636363636,0.5450884022368754,1.0,8/44,10.76%,LCK;DDIT3;RPS3;HYAL2;RACK1;SEPTIN4;BAX;FIS1
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.8983407058918729,-1.424055716873609,0.0625,0.543831572733121,1.0,2/5,2.29%,CGAS;GPR62
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.8694457668228988,1.4237648631404403,0.047619047619047616,0.3595567989168736,1.0,1/7,0.27%,TGFB2
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5635341407392892,1.423541804414483,0.023809523809523808,0.3594649971691242,1.0,29/83,13.39%,CX3CR1;FGL2;PTPRC;PLSCR1;CD44;TLR2;MX1;SELL;CSF1R;VCAN;MRC1;LCP2;TNFRSF1B;ITGAM;C3AR1;CD53;CSF3R;LILRB1;LY86;DYSF;LAPTM5;P2RY13;RGS1;LYN;PILRA;AOAH;SASH3;NFKBIZ;CLEC7A
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6964940780455889,1.4235179175252408,0.04,0.3587423018949767,1.0,6/21,15.91%,MEF2C;GRIN3A;CAMK2B;CPEB3;SHANK1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.8308252315133822,1.4233165495483004,0.0425531914893617,0.35879603995231213,1.0,3/11,10.20%,BMP6;KIAA0319;TGFB3
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.860222917370685,-1.4230528288465876,0.0,0.546554843155835,1.0,1/8,0.10%,NGF
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.7125552730197018,1.4223695543251542,0.09259259259259259,0.361848262782408,1.0,11/21,14.26%,TGFB2;P2RY12;NCKAP1L;SYK;TESC;PDE3B;LYN;ACER2;RAC3;PTPN11;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.7394483332623545,1.4223383580115176,0.0392156862745098,0.36118203498091195,1.0,8/16,17.36%,VSIR;BCL6;CR1;DUSP10;CBFB;KAT2A;NFATC2;TNFSF4
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5897204566561077,1.4215535660705223,0.05,0.3627075683129018,1.0,16/60,19.90%,HIPK4;GALNT3;LRRK2;GALNTL6;HIPK3;CAMK2D;DYRK2;CDK5R1;PRKD1;DYRK3;DYRK1B;PRKCD;CDC42BPA;TNKS;ULK1;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.609237241086148,1.4215333097517668,0.0,0.36187233432091764,1.0,15/57,11.65%,SYT4;KCNJ3;NEDD4L;KCNJ4;SYT1;KCNJ6;SYT13;NKAIN3;PER1;NOS1;SYT7;YWHAH;NKAIN1;SYT17;CHRM1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.5639197173879532,-1.4203142237456559,0.0,0.5587752348453043,1.0,20/112,13.22%,RPS27A;UBC;UBB;PSMD7;PSMB6;EXOSC8;PSME2;PSMD8;PSMB4;APEX1;PSMD3;PSMB3;YWHAB;PSME1;HSPA8;EXOSC5;UBA52;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.6363011771109796,1.419981003105298,0.04081632653061224,0.366189503069236,1.0,9/36,8.81%,PTPRG;PTPRR;RNASE10;SRC;CITED2;EFNA5;TENM3;EPHB3;FUT9
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.862555218766415,-1.4198852071875885,0.038461538461538464,0.5584415148203696,1.0,1/8,0.63%,DDIT3
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6931160817499695,-1.4196264570526413,0.01818181818181818,0.5573982837507172,1.0,9/25,16.52%,ATP5F1B;SAMM50;UQCC3;ATP5MC3;APOO;ATP5PF;ATP5PB;CHCHD6;ATP5PD
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.8059708389688539,-1.4188296291600675,0.08,0.5594850267041563,1.0,1/13,0.10%,NGF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6996435475795104,1.4188071400384787,0.08163265306122448,0.36955491598124446,1.0,9/20,17.36%,TLR2;PLCB1;SYK;TIRAP;LAPTM5;MAPK11;CLEC7A;IL16;TNFSF4
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.8741800421714142,-1.4183079021460714,0.08928571428571429,0.5595763342379342,1.0,2/8,2.78%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.7424223243875352,1.4177324632220842,0.019230769230769232,0.3719753230983354,1.0,8/17,15.91%,NRXN1;RIMS2;RELN;PRKCZ;GRIN1;DLG4;SHANK1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),0.9193653286184517,1.4174916870641014,0.023255813953488372,0.37078528824514695,1.0,1/5,0.72%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),0.9193653286184517,1.4174916870641014,0.023255813953488372,0.37078528824514695,1.0,1/5,0.72%,PPARG
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.8549731655610875,-1.4174761722938205,0.0847457627118644,0.5606515159403104,1.0,2/8,4.01%,TGM1;KRT10
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.515150469288013,1.4174702963817443,0.0,0.3699149002445715,1.0,44/196,13.49%,TGFB2;BMP6;JCAD;PTPRC;IGF1;TLR2;ENHO;LMO3;F3;LRRK2;NRXN1;SORBS1;RIMS2;RELN;SRC;KAT2B;DACT1;IRS1;LOXL3;CITED2;PRKCZ;AXL;SULF1;GRIN1;RAB34;TP63;TSPAN14;LY86;NOTCH4;DMTN;ARNT;ROBO1;C3;DLG4;NECAB2;HOMER1;PIK3R1;MN1;KANK1;SHANK1;CDH3;MGAT5;WLS;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.7939765371439345,1.416982835402969,0.0851063829787234,0.37033155719308686,1.0,4/10,10.20%,TGFB2;LILRB1;IRAK3;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.663551444484257,1.4166719866839164,0.06818181818181818,0.3707462671465157,1.0,6/20,14.26%,PID1;LZTFL1;RHOQ;DMTN;BCL2L1;ITGB1BP1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.8038102104659066,1.4164882266884196,0.06,0.3706038319868946,1.0,2/9,3.62%,PPP1R3C;PYGL
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.6698135276535904,1.4154471561142845,0.02,0.3732316620325691,1.0,16/35,14.07%,SCN9A;KCND2;CACNA1G;KCNMB4;SCN2A;DMD;SCN3B;SCN3A;KCNB1;SCN1A;CACNA1I;KCNMB3;YWHAH;KCNMB2;ANK3;SCN7A
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.8868472526027235,1.4152053376812084,0.046511627906976744,0.37322228008369296,1.0,3/6,6.74%,SNAP25;UNC13C;SNPH
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.7321141050743604,1.4150723089043626,0.045454545454545456,0.3728821279119992,1.0,3/15,3.42%,PPARG;FLT1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.7900715675798717,-1.4149282638043814,0.07142857142857142,0.5705070467170864,1.0,1/10,0.19%,BMP5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6515652636615769,1.414279890907331,0.02564102564102564,0.37460635721908564,1.0,11/47,4.64%,EPHA3;PDGFB;EGFR;FLT1;CSF1R;EPHA4;PTPN6;RELN;PDGFRA;SRC;SYK
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8601991547088652,1.414250415550169,0.04081632653061224,0.37385297198751705,1.0,4/7,10.63%,LPL;VSTM2A;C3;PLA2G10
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.5856760890080249,-1.4141300565219181,0.05263157894736842,0.5717364888318863,1.0,17/61,18.06%,OST4;DAD1;DPM3;PMM1;B4GALNT2;MOGS;B4GALT7;DDOST;LMAN1;ST3GAL1;DPM2;DPAGT1;MAGT1;ALG5;MGAT4B;ALG3;ALG12
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7667795934775018,1.4140141689408805,0.07017543859649122,0.3738422480106881,1.0,8/16,17.35%,BMPR1B;SCIN;SOX9;ZBTB16;SOX5;BMPR2;KAT2A;MBOAT2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.689471840406695,-1.413927732517445,0.06557377049180328,0.570316574313162,1.0,2/26,3.51%,MSRB1;MSRB2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.673455124630552,-1.413908178364677,0.04081632653061224,0.568043994949442,1.0,10/34,16.33%,MBOAT1;DOLK;SPHK2;ABCA8;IDI1;DPAGT1;GPAT2;AGPAT5;FADS1;GPAM
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.677692061792832,-1.413706017872812,0.07142857142857142,0.5670644224680678,1.0,9/28,15.47%,OST4;DAD1;DPM3;B4GALNT2;DDOST;LMAN1;DPM2;MAGT1;ALG5
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.7137764805123482,1.4134228903364179,0.0425531914893617,0.3750334283500407,1.0,4/18,9.11%,TGFB2;CGNL1;ARHGAP25;SYNGAP1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.7677461644583494,-1.41316531927995,0.16326530612244897,0.5674990043155136,1.0,5/13,11.30%,VPS25;VPS28;CHMP5;TMEM50A;SNF8
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.8545437105117979,1.412873281943218,0.0,0.3762191570631262,1.0,4/9,10.20%,TGFB2;LEF1;WNT5A;TGFB3
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.5877253011521995,-1.4124759788597885,0.06896551724137931,0.56919366985112,1.0,21/69,19.36%,POLR2L;POLR2G;POLR2K;GTF2F1;POLR2I;PHAX;INTS14;POLR2A;SNAPC1;TAF13;POLR2E;TAF11;POLR2C;POLR2D;SNAPC5;SNAPC3;CCNT1;POLR2J;SNAPC2;CCNK;GTF2A1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.8615495260067603,1.4122768541321342,0.06521739130434782,0.37712756985333057,1.0,2/7,7.28%,MX1;DNM1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),0.8671535023389007,1.4115781362262807,0.12727272727272726,0.3787100497651957,1.0,3/5,9.61%,AQP1;SCIN;GPLD1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.9061189976889952,1.4115564088905594,0.0,0.3779305448226355,1.0,2/5,9.40%,SLA2;CD70
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.7877494671533732,-1.411387876619536,0.10638297872340426,0.5716907570469382,1.0,5/15,14.58%,EMC6;EMC4;EMC7;MMGT1;UBL4A
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.8679804705359421,-1.4111914310582758,0.03773584905660377,0.5702719284189235,1.0,1/9,1.47%,BUB1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.7947552245480807,-1.4111851861508196,0.09090909090909091,0.5679874863345923,1.0,1/9,3.23%,ACTN2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.7790450543359931,1.4110127973116813,0.09259259259259259,0.37893691802233687,1.0,6/17,11.50%,SYT4;NEDD4L;RIMS2;SYT1;CPNE5;SYT17
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.8128371606045851,-1.410546158527628,0.07407407407407407,0.5686111332870462,1.0,1/12,2.08%,CGAS
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.5904729476912588,-1.4104829001232477,0.08620689655172414,0.5666195262216189,1.0,21/68,19.36%,POLR2L;POLR2G;POLR2K;GTF2F1;POLR2I;PHAX;INTS14;POLR2A;SNAPC1;TAF13;POLR2E;TAF11;POLR2C;POLR2D;SNAPC5;SNAPC3;CCNT1;POLR2J;SNAPC2;CCNK;GTF2A1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.9139836064865006,1.410097230853147,0.05128205128205128,0.3820673213041363,1.0,1/8,0.72%,PPARG
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.696594068568798,1.4092315150145442,0.0625,0.38453839319344474,1.0,4/18,6.30%,ALDH1L1;SHMT2;GGH;FTCD
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.8576493101632927,1.4091860007855983,0.06451612903225806,0.3837796066473296,1.0,2/8,4.87%,TGFB2;NRG1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6455867614862731,1.40909775905546,0.0196078431372549,0.3831848050971014,1.0,2/34,0.80%,PDGFC;PDGFB
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.8260063147018919,1.4090606096143388,0.06976744186046512,0.3824057536844145,1.0,1/8,1.00%,MFAP5
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.801578993884524,1.4086874585165168,0.07692307692307693,0.38290903807361826,1.0,3/9,13.89%,ZMYND10;RSPH9;DNAAF1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7235631054238166,1.408645644762006,0.044444444444444446,0.38232016280290887,1.0,4/20,6.88%,PID1;NR4A3;PPARGC1A;ACSM1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7630153686394372,1.4081221391130607,0.1,0.38282139601639575,1.0,1/15,0.27%,TGFB2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7704328322429341,1.4081107587660178,0.1,0.38199714689564723,1.0,5/11,14.38%,MYH11;SLC8A1;ALPK2;ALPK3;VEGFA
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5882195179077337,-1.4080287764716635,0.08928571428571429,0.5760094537697639,1.0,12/76,13.13%,POLR2L;CGAS;POLR3K;GAPDH;POLR3GL;POLR3D;POLR2K;DDX41;DHX33;POLR2E;NLRX1;GPATCH3
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.894924994590098,1.4077370428239555,0.0196078431372549,0.3824440607435491,1.0,1/6,0.80%,PDGFB
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.7945332325121225,-1.4071101960122394,0.15384615384615385,0.5788509048722277,1.0,1/8,1.56%,PRR7
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.6934919847515958,1.4067376324386704,0.05357142857142857,0.38523396824584627,1.0,4/21,9.45%,EPHA3;CAMSAP3;EFNA5;CORO1C
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.7611976402328838,1.4065007992527319,0.08928571428571429,0.38527741625657436,1.0,3/11,8.73%,KITLG;TAL1;TPO
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.7284600623628994,1.4057683893672346,0.05454545454545454,0.3871306753463102,1.0,5/14,12.06%,TRPC4;TRPC7;TRPC6;TRPC3;SLC11A2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.7955818199468514,1.4053260822865248,0.06,0.38751002926629674,1.0,2/10,1.61%,ROBO2;ADAMTS9
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.8244527092641619,-1.4053140811578697,0.05454545454545454,0.5860672861036348,1.0,1/9,0.63%,DDIT3
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8808174978335458,1.4052901611360198,0.02127659574468085,0.3867385771736925,1.0,2/5,4.05%,PLCB1;RNASE10
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.752283743014872,-1.4052837377151506,0.06521739130434782,0.5838404219802885,1.0,1/18,0.19%,BMP5
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.5725357892541233,-1.4052240805145528,0.05660377358490566,0.5817951768554164,1.0,7/78,6.80%,CDKN1C;RPS27A;UBC;FAM89B;UBB;BAMBI;IL17RD
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5588242394774022,1.40517116997145,0.044444444444444446,0.3863353373080013,1.0,26/87,12.86%,SYT4;KCNMA1;RYR3;ADCY8;MEF2C;KCNMB4;ADGRV1;SYT1;PPP3CA;KCNIP2;SYT13;WNT5A;CPNE8;TRPM2;DMTN;CAMK2D;SYT7;GPLD1;CPNE5;ANXA11;KCNMB3;TRPC3;SYT17;HOMER1;ADCY1;KCNMB2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.6446703486814249,1.4031201243862763,0.06666666666666667,0.39230454927905295,1.0,13/30,15.36%,KCNMA1;KCNJ3;KCNMB4;KCNJ4;GNG2;KCNJ6;KCNMB3;GABBR2;GABBR1;KCNN4;KCNMB2;FHL1;KCNH2
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.9692028257649412,1.4029351280611213,0.018867924528301886,0.39217634801053264,1.0,2/5,1.81%,ANGPT1;CSGALNACT1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.8456417114589921,1.4029243544894712,0.06382978723404255,0.3914273497903321,1.0,1/10,0.44%,SCN9A
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.7004826202749428,1.4028893455144693,0.06666666666666667,0.39068160102011085,1.0,4/26,6.67%,PLSCR4;PLSCR1;ABCB4;ANO6
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.691806962815801,1.4027998361002594,0.11363636363636363,0.39006796903763485,1.0,2/19,5.20%,IGF1;NTRK2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8468841134675203,1.4027264359586051,0.06666666666666667,0.3895855977946035,1.0,5/7,11.25%,CX3CR1;C1QB;ITGAM;C3;CX3CL1
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.8451604161117592,-1.4023168548699196,0.08333333333333333,0.594501973931247,1.0,2/10,8.80%,BCKDK;NPL
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.8868138356844081,-1.4020645357772052,0.04,0.5933747877586456,1.0,1/6,1.12%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5341822854718784,1.4014595032020216,0.02702702702702703,0.3932632911950589,1.0,29/146,16.51%,CREB3L1;TGFB2;CLDN5;IFNA2;PDGFB;IGF1;PARP14;MEF2C;ID2;SLC24A3;CITED2;SH3GL2;ROBO1;DLG4;PARP9;MAPT;RIN3;RBMS3;OLFM1;MOV10;ZNF148;SFMBT2;VEGFA;NOS2;NOCT;HAVCR2;TCEAL1;TIPARP;SPI1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7722684341347374,-1.4014384019691295,0.0425531914893617,0.5943636203013561,1.0,7/19,14.92%,FTSJ3;BUD23;METTL5;TRMT112;TFB2M;MRM3;MTERF4
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.7103136845603844,1.4010888409260132,0.04081632653061224,0.39367252130496055,1.0,6/20,9.45%,ROBO2;TLR2;SRC;SLIT1;DMTN;CORO1C
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7455391068529286,1.4009485638633343,0.14285714285714285,0.393364415304888,1.0,4/12,15.58%,IRS1;PPARGC1A;GPLD1;NNMT
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.5354529134712634,-1.400762066433874,0.034482758620689655,0.5951832950874414,1.0,23/137,13.22%,RPS27A;UBC;UBB;PSMD7;PSMB6;EXOSC8;PSME2;PSMD8;PSMB4;APEX1;PSMD3;PSMB3;YWHAB;PSME1;HSPA8;EXOSC5;NPM1;MEX3D;FASTKD3;UBA52;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.8441664172207262,1.4007190397123637,0.045454545454545456,0.3931851372928198,1.0,3/8,10.52%,GRIP1;WNT5A;DLG4
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8378318098459492,1.4002382758701393,0.05357142857142857,0.39379548876385223,1.0,2/8,6.93%,ROBO2;NPNT
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6102101189174638,1.4001593359688695,0.04,0.39328594783223325,1.0,14/31,18.27%,GRIK2;RIMS2;LGI1;SYT1;CARTPT;CLSTN3;DLG4;HOMER1;WLS;RAB29;NMB;CD80;KCTD13;EDN1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.5265766641657075,1.4001061028082977,0.044444444444444446,0.3927532362414305,1.0,20/113,9.98%,TGFB2;DLK2;TEX15;CLDN16;NUDT11;MX1;KLHDC8A;HSD11B2;CAMK1D;BMPR1B;C5;CLSTN3;PTPRJ;SNCB;ZBTB16;RSAD2;NOS1;KCNQ2;TENM2;CKM
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.671472646137337,1.3999111801218465,0.12244897959183673,0.3927284891023755,1.0,10/31,10.20%,BMP6;SLC8A1;MEF2C;BMPR1B;ADGRV1;NELL1;ISG15;ANO6;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.8835075097284387,-1.3998442182071125,0.1016949152542373,0.5949771965433821,1.0,1/6,2.35%,ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.8835075097284387,-1.3998442182071125,0.1016949152542373,0.5949771965433821,1.0,1/6,2.35%,ANAPC15
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.8137039480649303,1.3993705465303343,0.10869565217391304,0.3938897296820033,1.0,3/9,12.83%,BMPR1B;BMPR2;SFRP4
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.6915723656608077,1.399091586994729,0.13636363636363635,0.3940641100995534,1.0,3/16,6.44%,MYO7A;MYO1B;MYO5C
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.7302246480897729,1.3989434311219031,0.1111111111111111,0.39353425227266603,1.0,4/12,16.35%,YBX3;ZFP36;TIRAP;ELAVL4
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.785973573928447,1.3988314589508353,0.09615384615384616,0.393031697619112,1.0,6/12,10.70%,EPHA3;NRCAM;EPHA4;CNTN4;EPHB3;CDK5R1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.8190226000637966,1.3985256966688522,0.11538461538461539,0.3933068596701254,1.0,2/6,6.20%,AQP1;IPCEF1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6534439396139495,1.3978508008480384,0.06666666666666667,0.39472935315333707,1.0,14/31,15.36%,KCNMA1;KCNJ3;KCNMB4;KCNJ4;GNG2;KCNJ6;NOS1;KCNMB3;GABBR2;GABBR1;KCNN4;KCNMB2;ANK3;KCNH2
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.8144706719032512,-1.3978325724417031,0.04081632653061224,0.6025201538929249,1.0,2/9,0.44%,LCK;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5603573982635709,1.397614336759964,0.018867924528301886,0.39465100461198566,1.0,23/79,12.37%,ROR1;EPHA3;PLPPR5;CAMK1D;RIT2;ZNF804A;TWF2;RELN;NTRK2;TOX;TENM3;PACSIN1;CAMK2B;LRP8;WNT5A;NDRG4;FUT9;ATP1B2;CX3CL1;PRKD1;LYN;DPYSL3;SERPINI1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.5864767068296125,-1.3974837436536869,0.0392156862745098,0.6022466944646041,1.0,2/75,0.10%,PM20D1;NGF
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.604571169206293,1.3971691674947155,0.09302325581395349,0.39541831914827186,1.0,5/34,8.08%,BTBD17;PLSCR1;MX1;ISG15;RSAD2
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6466116182993747,1.39709814497476,0.044444444444444446,0.39491707429970146,1.0,9/38,13.49%,EGFR;SRC;SOX9;KIF16B;VIL1;ERBIN;TGFA;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.8928655186083594,1.3969949918390105,0.06521739130434782,0.39451695139794085,1.0,1/5,0.72%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.8881761023009364,1.3969226293479438,0.09090909090909091,0.3939208241649912,1.0,1/5,2.67%,LMO3
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.8630820913093158,-1.3968199281081726,0.020833333333333332,0.6025454948873477,1.0,1/5,6.16%,TMEM107
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5617308477035201,1.396521487443405,0.06666666666666667,0.395053149669177,1.0,18/64,9.02%,GRIK2;ADCY8;GRIN2B;NRXN1;CACNG5;NFATC4;CACNG2;RIMS2;LGI1;RELN;SYT1;ADRA1A;PRKCZ;SHANK2;CLSTN3;TSHZ3;CACNG3;CACNG8
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.7485716383978516,-1.3957656829668954,0.06451612903225806,0.6059344915654267,1.0,3/16,7.41%,AMPD1;POLD3;GMPR2
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.7805001565967247,1.3957280936888719,0.020833333333333332,0.3967221275823346,1.0,5/14,12.71%,IGFBP3;PLCB1;MEF2C;BOC;RBM24
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.632601195964387,-1.3956221657433712,0.10714285714285714,0.6042680105877892,1.0,4/28,13.55%,COPE;TRAPPC3;GABARAPL2;COG2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.533771147236728,-1.3954655546869852,0.030303030303030304,0.6025514715369757,1.0,73/265,21.33%,RPS27A;UBC;PARP2;CENPX;RAD23A;RNF8;UBB;FAAP100;H2AX;PCNA;UBXN1;EME1;MBD4;ENDOV;USP1;POLD3;MGMT;MPG;PARP1;MUS81;RAD51AP1;DCLRE1B;ALKBH2;SMARCA5;APEX1;NOP53;POLD4;KPNA2;RFWD3;PNKP;HUS1;BRCC3;TEX264;NPM1;BTG2;BLM;UBA52;HMGA2;KAT5;NUDT1;ERCC8;TOPBP1;ACTR8;UBE2A;ABRAXAS1;MEN1;REXO4;GTF2H2;PARK7;ADPRS;TRIM28;MDC1;ATR;MGME1;RAD9B;PRIMPOL;PARP3;EXO1;CETN2;MSH3;NSMCE4A;SMC1A;UBE2N;DDX1;PRKDC;FANCF;EXD2;CHRNA4;OGG1;XPC;WDHD1;ATRIP;FAM111A
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.9175330060352781,-1.395239034843084,0.0,0.5988772198519919,1.0,3/6,6.75%,FUCA1;GLA;GBA3
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.9175330060352781,-1.395239034843084,0.0,0.5988772198519919,1.0,3/6,6.75%,FUCA1;GLA;GBA3
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.9503048730158986,1.3948416719548216,0.0,0.39926821177309746,1.0,1/5,0.91%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.7434632159990167,1.3947886260274727,0.06521739130434782,0.3985201863888704,1.0,4/12,13.09%,SRC;BCL2;ZNF304;PDK4
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.6730992879435741,1.3942721511354887,0.13043478260869565,0.399584858407225,1.0,10/28,10.20%,BMP6;SLC8A1;MEF2C;BMPR1B;ADGRV1;NELL1;ISG15;ANO6;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.6021432371026247,1.3941147031630636,0.10256410256410256,0.3995469741353793,1.0,12/43,18.32%,ABCC4;SLCO2B1;ABCB4;SLC6A11;SLC16A14;SLC6A8;NCOA1;SLCO1A2;ABCC11;SLC16A2;SLC16A7;RXRA
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6952652544520448,1.394022793741383,0.05405405405405406,0.3990952203543124,1.0,4/23,3.76%,LPL;VCAN;FSTL1;POSTN
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.6163216806421334,-1.3936205989942332,0.078125,0.6046630753727875,1.0,15/46,21.68%,TINF2;PCNA;POLD3;PARP1;DCLRE1B;APEX1;POLD4;HUS1;BLM;XRCC6;ATR;PARP3;PRKDC;SMC6;TERF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.582738754521155,1.3932944347180645,0.06521739130434782,0.40058968461799743,1.0,14/64,14.38%,ANGPT1;ADAMTS9;RHOJ;ADGRB1;PTPRM;BMPER;WNT5A;GPLD1;BMPR2;PRKD1;SCARB1;NR2F2;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.5327374077093617,1.3931308564451035,0.06521739130434782,0.4005499853290536,1.0,28/123,17.69%,TGFB2;PDGFB;PTPRC;CSF1R;GRM5;EPHA4;PAK3;LCP2;RELN;SRC;LRP8;IRGM;CD4;SPDYA;CAMKK1;KIF14;DLG4;TNIK;VEGFA;RPTOR;PAK5;ADRB2;CASS4;CDKN1A;GAS6;PARP16;PRKAG2;PRKCD
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.7426022705692954,-1.3931038854078666,0.10869565217391304,0.6050376733537206,1.0,3/23,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.6364157896562048,-1.3930232539957395,0.06382978723404255,0.6031656453341938,1.0,6/53,6.80%,RPS27A;UBC;FAM89B;UBB;BAMBI;IL17RD
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6825474368875569,1.3927409153498864,0.06818181818181818,0.40113980023166845,1.0,2/20,1.07%,TGFB2;AQP1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6468981043266737,1.3927131198582332,0.046511627906976744,0.40035028601553846,1.0,7/27,14.38%,FLT1;HSPB1;VEGFD;SEMA6A;PRKD1;ITGB1BP1;VEGFA
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5073605719095934,1.3925826157604808,0.022727272727272728,0.40007023364901045,1.0,45/188,14.97%,SCN9A;ACBD7;CYB561;CFAP126;FGF12;TTC9;ABHD3;SYBU;MAP2;EFNB3;CDK5R2;CARTPT;NRG1;SPOCK1;SPEF1;NYAP1;CNTN4;EFNA5;MACROD1;GNAL;MEIS3;CTXN1;TESC;PCLO;NDRG4;MORN5;MEIG1;SYT7;EPB41L1;CCDC184;FSTL5;FLRT1;NRSN2;CPE;TMEM59L;SCN4B;GOLGA7B;GPC1;ARL6;PRR36;EFNA3;CAP2;CSPG5;SRRM3;EBF2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.765347013043752,1.392546165058408,0.057692307692307696,0.3993823068303214,1.0,4/13,14.00%,TGFB2;LILRB1;LTBP1;CD200
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.8256709615071652,1.3922452050009644,0.07692307692307693,0.3995855486523213,1.0,4/11,7.14%,APOLD1;PRKX;MAFF;SOX9
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5972848391469776,-1.3921999041278192,0.0625,0.6049210962279764,1.0,8/57,7.71%,VWA3A;ARMC3;SPAG6;TUBB4B;CNGA4;DCDC2B;RSPH4A;TTC29
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.747651874955382,1.3921131557608668,0.12962962962962962,0.3991170265896689,1.0,2/12,5.58%,CHST1;CHST3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.6768117035226497,-1.3916462740321505,0.1,0.6054736840590667,1.0,3/33,2.89%,BMP5;SFRP1;SERPINE1
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8928167952535324,1.3916186066247194,0.047619047619047616,0.40013306904159335,1.0,1/5,4.37%,SPRED3
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.6099198511581563,1.391488174135526,0.044444444444444446,0.399760792851595,1.0,17/52,12.36%,SLA;PTPRC;IKZF2;SIGLEC10;NCKAP1L;LCP2;TNFRSF1B;ITGAM;C3AR1;CD53;CSF3R;ARHGAP25;LY86;LAPTM5;SELPLG;AOAH;SASH3
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.8197887237594668,1.3913719466342824,0.0,0.3993661871829975,1.0,7/10,9.85%,GABRG2;FGF13;GABRA1;GABRB2;GABRA2;WNT5A;GABRB3
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.7929427105669441,-1.3911154543206876,0.14285714285714285,0.6061134233603335,1.0,2/11,4.87%,PPIB;CFL1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5488248291411764,1.3911001290777687,0.030303030303030304,0.3998051432312113,1.0,33/103,14.45%,SLC2A12;EGFR;AQP1;CGNL1;SLC4A10;GPC6;KIAA1217;EFNB3;TMEM47;DDAH1;SHANK2;CADPS2;SLC13A4;ADGRL2;SOX9;TEAD1;DNALI1;CHRD;DIP2C;FNDC4;SYT7;EPB41L1;HTR2C;LAMB2;CPE;SHROOM3;NOTCH3;CDC42EP4;PRICKLE2;SHROOM2;FARP1;CHMP1A;PDZRN3
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.8118331112036282,-1.3910961532831614,0.1111111111111111,0.6040224864235944,1.0,3/9,8.55%,DCLRE1B;APEX1;TFIP11
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5928940016121045,1.3910068177180979,0.06818181818181818,0.39936457397217234,1.0,14/54,19.90%,HIPK4;LRRK2;HIPK3;CAMK2D;DYRK2;CDK5R1;PRKD1;DYRK3;DYRK1B;PRKCD;CDC42BPA;TNKS;ULK1;CSNK2A1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.8743185013169419,-1.3907796746549992,0.1346153846153846,0.6032746244086936,1.0,1/5,1.29%,RPL23
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.8536699615354357,1.3907674669782102,0.06976744186046512,0.3994466400122762,1.0,2/6,7.75%,ROBO2;WNT5A
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.8424240195239892,1.390745068570031,0.08333333333333333,0.39879586443700876,1.0,2/5,9.84%,CAMK2B;FRMPD4
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.6769661813863638,1.3906700292005998,0.047619047619047616,0.39828916272555914,1.0,3/19,8.08%,RHBDF2;IL12A;RSAD2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7294483246371648,-1.3901955820970837,0.05084745762711865,0.6038552386751765,1.0,5/15,13.61%,POP5;ADAT1;SARS1;AARS1;POP7
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.6176187138992111,1.3900777868490528,0.09090909090909091,0.3997144280519521,1.0,14/57,11.04%,EPHA3;RND2;BAIAP2;ARHGAP18;PEAK3;PAK3;TWF2;RHOQ;EFNA5;RHOF;DMTN;ARHGAP17;BST1;SMIM22
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.6190987310847583,-1.389772263404504,0.043478260869565216,0.6038923641667311,1.0,18/67,12.07%,ARHGEF16;TEAD2;TEAD3;KDELR1;NOC2L;RPL8;LRRC59;TUBG1;EPHB4;SLC25A1;MRPS2;SLC52A2;PSMD3;TUBA1C;EIF3B;MBNL3;EIF5A;SAPCD2
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5819336142452186,1.3897342610085037,0.0,0.40038239976020046,1.0,22/57,18.99%,GLRA3;GABRA6;GABRG2;GABRA1;GABRB2;GABRA2;ANO5;GABRA4;ANO6;GLRB;GABRB3;GABRG1;GABRR2;GLRA2;CLCN3;SLC1A1;GABRD;ANO4;ANO3;GABRB1;SLC37A3;SLC12A5
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6780652924203321,1.3894209790760232,0.08333333333333333,0.40076641980787525,1.0,14/23,18.27%,GRIK2;RIMS2;LGI1;SYT1;CARTPT;CLSTN3;DLG4;HOMER1;WLS;ANK3;NMB;CD80;KCTD13;EDN1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.7671944659685092,1.3890499333879618,0.06818181818181818,0.40138290523217157,1.0,3/10,7.62%,ALDH8A1;BCO1;RDH13
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.6205190075597058,1.3890045622032112,0.09302325581395349,0.40078269234629804,1.0,7/32,10.37%,CD59;C1QB;C3AR1;C5;F2;CR1;C3
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.7639292270827598,1.3888786253447813,0.06,0.40062763986685046,1.0,1/8,3.01%,HEY1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.7146117964121743,1.3887467550554382,0.058823529411764705,0.40033363104928077,1.0,5/14,12.21%,GUCY1A1;ADCY8;ADCY2;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.820739483475016,1.3887305337639084,0.0625,0.39959968358789655,1.0,3/8,16.53%,HEY1;SOX9;GAS6
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.551736637906047,1.3887142247389748,0.02,0.39882225229686946,1.0,29/70,24.18%,ABCC4;SLCO2B1;SLC1A2;SLC24A3;SLC4A4;ABCC9;SLC22A3;SLC15A2;ATP1B2;SLC7A8;SLC1A1;SLC2A13;SLC29A2;ABCC5;LEPR;SLC16A2;SLC16A7;LRP1;SLC29A4;ATP1A2;SLC28A2;ABCB1;SLCO1C1;SLC6A6;SLC6A1;SLC7A2;SLC7A1;SLC8A2;SLC6A9
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.563213585812223,1.388608393654908,0.044444444444444446,0.39841783756789156,1.0,9/60,7.95%,CREB3L1;MMRN2;PPARG;VWC2L;BMPR1B;SULF1;BMPER;DLX1;CHRD
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.7195246461828779,-1.3881765126939112,0.058823529411764705,0.6102282371982717,1.0,4/20,3.86%,RPS21;RPP40;FTSJ3;EXOSC8
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.8642784401933145,1.388054227697694,0.045454545454545456,0.3993536316506841,1.0,1/7,2.47%,CBS
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.9109814542613812,1.3880533734745126,0.041666666666666664,0.39858118748888394,1.0,2/5,6.42%,AQP1;YBX3
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.8851369168947933,-1.3879760565617971,0.05660377358490566,0.608933423696499,1.0,1/8,1.47%,BUB1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.6259229876066554,-1.387695498689707,0.05084745762711865,0.6080924575593885,1.0,18/56,20.86%,TRMT10C;FTSJ3;HENMT1;BUD23;RBM15B;METTL5;TRMT112;METTL2A;TFB2M;TRMT10A;METTL6;MTERF4;PCIF1;TRMT6;TRMT13;NSUN2;MEPCE;VIRMA
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.5028200122588843,1.3876671317563953,0.044444444444444446,0.39905323490820516,1.0,43/155,20.26%,PDGFB;RPS6KA6;HIPK4;GALNT3;CAMK1D;LRRK2;PRKX;POGLUT2;STK32B;PRKCZ;HIPK3;CAMKV;MAPKAPK3;PRKCG;MAPK12;PLK1;CAMK2D;MKNK1;DYRK2;CDK5R1;CSNK1D;PRKD1;AKT3;TTBK2;DMPK;RPS6KA3;CDC7;DYRK3;VRK3;DYRK1B;PRKCE;CAMK4;STK38;GAS6;PRKCD;STK38L;TNKS;MKNK2;ULK1;CSNK2A1;MAPKAPK5;PAK2;VRK1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.639165390593214,1.3875388185949908,0.046511627906976744,0.39872033183884825,1.0,7/35,8.54%,EGFR;TIMP4;NELL1;ADGRB1;IRAK3;BANP;PRKCG
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.7883587874321673,1.3871344553519134,0.045454545454545456,0.3990299787178894,1.0,1/8,2.29%,ASB4
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.8640936406045187,1.3869063081429687,0.11764705882352941,0.3991784272562104,1.0,1/6,0.56%,IFNA2
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.7116050637450947,-1.3868888163794029,0.06666666666666667,0.6100041792155364,1.0,6/21,17.46%,CRYAB;TMEM109;HRAS;MEN1;XRCC6;ATR
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.5794351703691971,-1.386880523657659,0.07547169811320754,0.6078999032301867,1.0,22/85,16.10%,KIN;SF3A3;SF3A1;LSM2;SRSF7;DDX5;PRPF18;RNH1;LSM10;PCBP3;SRSF9;SF3B4;SNRPB;AURKAIP1;NUDT12;PRPF8;SNRPE;PRPF3;SF3A2;NUDT16L1;SNRPG;PRKACA
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.6779906018593198,-1.386871744751944,0.07272727272727272,0.6057811727441205,1.0,9/27,15.47%,OST4;DAD1;DPM3;B4GALNT2;DDOST;LMAN1;DPM2;MAGT1;ALG5
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.8350088842771901,1.3865340272717719,0.06382978723404255,0.399303492291167,1.0,3/8,14.01%,SHMT2;GDA;SHMT1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.7154242826909659,-1.386462380945581,0.08,0.6056937119145354,1.0,3/23,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.7787722735128433,1.3858120142532775,0.0784313725490196,0.400976514695419,1.0,11/18,20.55%,SYT4;NEDD4L;RIMS2;SYT1;CPNE5;SYT17;OSTN;RNF157;SYT3;UNC13A;ITSN2
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.7324316898298975,1.3852756266367743,0.14285714285714285,0.40191586652990946,1.0,7/15,11.65%,CHRM3;PLCB1;LYPD1;CHRM5;AGRN;CDK5R1;CHRM1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.9018020736454743,1.3852155197895815,0.045454545454545456,0.40142252487967145,1.0,3/5,6.29%,PTPRC;NCKAP1L;LILRB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.6632818594676756,1.3850702189055288,0.08108108108108109,0.40124803639828244,1.0,8/22,18.74%,IGF1;MLIP;NR4A3;CAMK2D;PDE9A;RGS2;EDN1;CAV3
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.8245488067442139,1.3849759154635664,0.08771929824561403,0.4008256290715184,1.0,4/8,16.00%,CARMIL1;RAB34;MAPKAPK3;SNX33
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.9284316870559639,1.3849179154628348,0.07317073170731707,0.4002018224825146,1.0,1/5,0.13%,LPL
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.7213068361576134,-1.384585743035277,0.08888888888888889,0.6123918049571413,1.0,5/16,17.46%,CRYAB;TMEM109;HRAS;XRCC6;ATR
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.831983335309086,-1.3844867009183,0.08928571428571429,0.6107148644180439,1.0,2/8,4.87%,PPIB;CFL1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7857768297402283,1.3839400017377559,0.019230769230769232,0.4029798129762979,1.0,6/14,10.63%,LPL;VSTM2A;MEST;NFKBIA;C3;PLA2G10
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.5171196780911611,1.3836537920899765,0.02127659574468085,0.40323063998121256,1.0,47/124,14.91%,PLSCR4;ZNF423;CD44;TLR2;PPP1R3C;FSTL1;SYNPR;PCDH18;PLPPR4;DCLK1;LDB2;POSTN;COL11A1;PDGFRA;TMEM47;RGS7BP;NTRK2;OPCML;CRYM;CADM3;COL4A1;ADGRL2;LIFR;BRINP1;EDNRB;FNDC4;IL33;COL9A1;BOC;PAMR1;SPARCL1;DAPL1;PRRX1;SPC25;CPE;DPYSL3;PRICKLE2;TIMP3;SCN4B;HES1;THY1;LRP4;COL5A1;VEGFA;PDZRN3;MEGF10;CNR2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6261967449271217,-1.3834389350950234,0.08620689655172414,0.6137630789864434,1.0,13/40,19.91%,TINF2;PCNA;POLD3;PARP1;DCLRE1B;APEX1;POLD4;HUS1;BLM;XRCC6;ATR;PARP3;PRKDC
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.6516389806855165,1.3834019186643856,0.06521739130434782,0.4037048026975885,1.0,11/30,17.36%,TLR2;PLCB1;SYK;LILRB1;IRAK3;TIRAP;LAPTM5;MAPK11;CLEC7A;IL16;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.7809141336172898,-1.3832086221369155,0.12,0.6127269873079882,1.0,1/7,3.23%,ACTN2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.8410297639849568,1.3831535445279317,0.09230769230769231,0.404042867527667,1.0,4/10,12.71%,TGFB2;SOX9;SOX5;RBM24
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5528543014116858,1.3831369775502813,0.0625,0.4034635644618302,1.0,16/79,7.78%,ROR1;EPHA3;EGFR;FLT1;CSF1R;EPHA4;LDB2;MET;PDGFRA;TSPYL2;NTRK2;MERTK;EPHA6;AXL;EPHB1;EPHB3
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.7948917061688308,1.3825748123487178,0.12195121951219512,0.4045813864405245,1.0,2/10,7.28%,MX1;CRLF1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.49551308741127564,1.3824209856084702,0.0,0.40427036671557326,1.0,36/156,10.57%,ADAMTS5;PDGFB;MFAP5;ITGA11;CD44;ADAMTS9;ST7;ITGB4;MMP16;VCAN;TNC;ADAMTS10;ADAMTS7;POSTN;LAMC1;COL11A1;ADAMTS17;COL5A3;ITGAM;LOX;ADAMTS15;TNR;ADAMTS6;COL4A1;NPNT;ADAM12;VIT;JAM2;FBLN5;COL15A1;PAPLN;COL7A1;AGRN;COL9A1;NCAN;LAMB2
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.7430368887618222,1.3823225002628585,0.14583333333333334,0.4040493828230253,1.0,3/11,7.08%,RELN;LOXL3;VIT
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.8354750653654117,-1.382320825075749,0.1276595744680851,0.6156035602487266,1.0,4/10,11.54%,EMC6;EMC4;EMC7;MMGT1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.6144222471912861,-1.3822083151395916,0.07692307692307693,0.6139100570585648,1.0,5/45,4.87%,MSRB1;CFL2;FLII;MSRB2;CFL1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8694759559648816,-1.3819738609736965,0.09259259259259259,0.6129982196744639,1.0,1/6,0.25%,CXCR4
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5787704592369551,1.3817567384041298,0.06521739130434782,0.40533728869210955,1.0,11/69,5.55%,NRCAM;NTNG1;BAIAP2;PLPPR4;MEF2C;MAP2;PAK3;SLITRK5;ADGRB1;SLITRK3;CNTN4
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.5447068816139075,1.3813920366676926,0.04,0.4058677749908521,1.0,29/72,24.18%,ABCC4;SLCO2B1;SLC1A2;SLC24A3;SLC4A4;ABCC9;SLC22A3;SLC15A2;ATP1B2;SLC7A8;SLC1A1;SLC2A13;SLC29A2;ABCC5;LEPR;SLC16A2;SLC16A7;LRP1;SLC29A4;ATP1A2;SLC28A2;ABCB1;SLCO1C1;SLC6A6;SLC6A1;SLC7A2;SLC7A1;SLC8A2;SLC6A9
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7739500745419564,1.381084164894776,0.1702127659574468,0.40628581707624495,1.0,1/11,0.42%,DPYS
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7710236703520165,1.3809131805009573,0.04,0.40630533446829875,1.0,5/15,6.85%,GRIN2B;LRRK2;MEF2C;ARRB2;GRIN1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6954052974997019,1.3808938240322248,0.04,0.4056423618846574,1.0,8/15,23.32%,PCLO;WNT5A;LRP4;NLGN4X;NLGN1;PTEN;IL1RAPL1;CEL
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.799239440397117,1.380736373977813,0.11764705882352941,0.4047185255308816,1.0,4/9,13.49%,SORBS1;IRS1;PRKCZ;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.799239440397117,1.380736373977813,0.11764705882352941,0.4047185255308816,1.0,4/9,13.49%,SORBS1;IRS1;PRKCZ;PTPN11
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.8885703728033272,1.380514246993238,0.05128205128205128,0.4038233215387474,1.0,3/5,9.94%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.8885703728033272,1.380514246993238,0.05128205128205128,0.4038233215387474,1.0,3/5,9.94%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.8993770512042667,1.3804998733694962,0.18867924528301888,0.4023903634771051,1.0,1/5,0.80%,PDGFB
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.8993770512042667,1.3804998733694962,0.18867924528301888,0.4023903634771051,1.0,1/5,0.80%,PDGFB
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.84506041970305,1.3800420201814023,0.022222222222222223,0.40252972022999145,1.0,2/5,7.75%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.84506041970305,1.3800420201814023,0.022222222222222223,0.40252972022999145,1.0,2/5,7.75%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.48724466238242126,1.3800275383828415,0.020833333333333332,0.40184115452658997,1.0,59/212,14.75%,EPHA3;L1CAM;NRCAM;ROBO2;NTNG1;SEMA3D;CYFIP1;BAIAP2;PLPPR4;DOK6;EMB;NRXN1;EPHA4;PDLIM7;GFRA1;PAK3;LGI1;RELN;SLITRK5;EFNB3;SRC;ADGRB1;SLITRK3;TNR;EPHA6;B4GALT6;CNTN4;ROBO4;EFNA5;DOK4;EPHB1;WNT5A;EPHB3;NTN4;SLIT1;SLITRK4;SEMA6A;ROBO1;UNC5A;UNC5D;DOK1;PLA2G10;CDK5R1;SEMA5B;SEMA4B;ANOS1;PTPRO;NOTCH3;PIK3R1;GPC1;ANK3;PTPN11;DRAXIN;RAB3A;DAB1;EFNA3;PARD3;SEMA4G;SEMA3C
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.7049495422437564,-1.3799557414784729,0.16326530612244897,0.6210455056188112,1.0,4/25,5.05%,RPS27A;UBC;UBB;LACC1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.8526786641505372,1.3797484745242052,0.05555555555555555,0.40195480465540484,1.0,6/9,10.12%,SYT4;CACNA1G;SYT1;STX1A;KCNB1;CACNA1I
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.8393908004890921,1.3797208615004564,0.1320754716981132,0.40135607448406796,1.0,4/6,16.00%,CARMIL1;RAB34;MAPKAPK3;SNX33
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7722745697020788,-1.3796664453129381,0.1,0.6204271124620684,1.0,4/7,11.65%,RPS15;RAN;LTV1;NPM1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.5999126891365827,1.3795339645870173,0.041666666666666664,0.401276368653875,1.0,11/54,4.64%,EPHA3;PDGFB;EGFR;FLT1;CSF1R;EPHA4;PTPN6;RELN;PDGFRA;SRC;SYK
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.721350450257182,1.3795134178488857,0.0625,0.40063803074424403,1.0,7/18,12.00%,BEGAIN;NPTX2;DLGAP1;CACNG5;NPTX1;HTR2C;DLGAP3
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.7261906009195659,-1.378713729259062,0.0851063829787234,0.6228333743508131,1.0,2/20,8.03%,ABCA13;PLEKHA3
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.7074658081612695,1.3784130041107892,0.08,0.4038859243117717,1.0,6/18,15.19%,MAFF;ZFP36;CBFB;SULT2B1;SFRP4;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.7264355880722346,1.3779398100936036,0.16666666666666666,0.4045732036760531,1.0,3/12,7.00%,TGFB2;ADRA1A;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.8013787844455884,1.37792362044887,0.1,0.4039110038041728,1.0,2/13,1.89%,P2RY12;CSF1R
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5627842800822458,1.377875157192543,0.08888888888888889,0.40348594839146656,1.0,13/64,11.26%,PPARG;BMP6;IGF1;MEF2C;BMPR1B;HGF;NELL1;NPNT;TP63;SOX9;CHRD;BMPR2;PRKD1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.6694375169592522,1.3773604720722843,0.125,0.4045750429252281,1.0,1/24,0.27%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7863598719590004,-1.3770507612696559,0.09090909090909091,0.6288805864557334,1.0,4/16,6.42%,SFRP1;FTH1;GSTP1;B4GALT7
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.8114366982729827,1.3769987252765206,0.18518518518518517,0.4051498496208158,1.0,2/7,14.11%,CHI3L1;CTBS
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.8360353905981748,1.3765066026332315,0.11363636363636363,0.40644438234798014,1.0,2/6,11.02%,AQP1;SLC14A1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7464762333107517,1.375625761477153,0.09090909090909091,0.40889980827251543,1.0,1/15,0.12%,DACT2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.8181249439694933,-1.374519792216072,0.07407407407407407,0.6389524135891718,1.0,1/9,1.12%,PDZD11
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.7397773659895331,-1.3744905808008931,0.13333333333333333,0.6369687187758774,1.0,3/16,15.90%,POLR2G;POLR2D;RPS6KB2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.5125761744000197,1.3741294992195974,0.02631578947368421,0.4136522181068643,1.0,23/108,11.84%,TGFB2;CTF1;MYO7A;MEF2C;MET;WNT8B;ID2;SPOCK1;NTRK2;TENM3;PBX1;SNPH;TENM1;WNT5A;EMX1;ATP2B2;FUT9;FZD3;NEUROD6;TENM2;CDK5R1;MYT1L;ANOS1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.791132446335615,1.3740713044395145,0.10526315789473684,0.41317218137290695,1.0,1/9,0.29%,MMRN2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.7876506151705105,1.3739875755165625,0.04081632653061224,0.41269384388402564,1.0,2/14,6.91%,PKP2;TPM1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.7304325196676833,-1.3735443056024574,0.09090909090909091,0.6398998639228343,1.0,1/10,1.69%,RNF8
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.523387338508405,1.3731865870482263,0.02702702702702703,0.41442651752824244,1.0,28/121,10.12%,ADAMTS5;PLSCR4;PDGFB;NOSTRIN;ACTN1;FSTL1;RHOJ;AKAP12;FAP;PCDH18;MEF2C;LDB2;POSTN;MRC1;PDGFRA;TMEM47;ROBO4;COL12A1;LEF1;SULF1;CCDC80;COL4A1;TPM1;PAWR;COL15A1;FAT4;HOPX;PAMR1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5890371102609685,1.3731540649536134,0.10256410256410256,0.4138006267713987,1.0,5/38,10.03%,CERS3;GRHL1;SCEL;COL7A1;GRHL2
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.73946246456886,1.3728204012506648,0.07547169811320754,0.41426722712168856,1.0,2/14,5.58%,CHST1;CHST3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.6880780734766355,1.3726943253731103,0.13636363636363635,0.4139786997019161,1.0,8/19,20.48%,GRIN1;F2;TRPC3;CX3CL1;THY1;CAPN3;GPER1;PLCG1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.5395371457060639,-1.3726510429320422,0.046875,0.6423117868209078,1.0,24/133,12.63%,CA6;CBR1;HCCS;ACAA2;AADAT;ECHS1;LGALS1;HMGCL;BLVRA;BPHL;HSD17B10;IDH3B;ERP29;GPD1;DHCR24;ECH1;APEX1;PDHB;H2AZ1;PSME1;KMT5A;IDI1;RDH16;EHHADH
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.7188944382644554,-1.3726188416971148,0.09803921568627451,0.6403090671260624,1.0,7/22,18.74%,RASL11A;NCL;DHX33;PIH1D1;DDX11;EIF2AK3;ATF4
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.6864148062806672,-1.3724700274506298,0.1276595744680851,0.6389813828317242,1.0,3/14,8.07%,SAP18;SRSF7;SRSF9
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.8290669318654181,1.3718268557425728,0.08695652173913043,0.4165118063726396,1.0,3/8,11.59%,CSF1R;IL12A;LYN
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.6578284527930631,-1.3716576837874264,0.11320754716981132,0.6406853697051635,1.0,12/35,13.25%,NUTF2;GEMIN6;PHAX;SNUPN;RBM15B;SMN1;SNRPD1;NXT2;SNRPD2;NPM1;SNRPB;SNRPE
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.88586740289716,-1.3711842101637859,0.06779661016949153,0.6414194584851448,1.0,1/5,4.23%,SLC39A6
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.8124497605941614,1.371023728590033,0.12280701754385964,0.41838947651900515,1.0,5/10,7.17%,BEGAIN;NPTX2;DLGAP1;CACNG5;NPTX1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.6202050170820657,1.3709523220554638,0.08888888888888889,0.41782458990522475,1.0,4/24,8.24%,BHLHE40;ID2;PER1;CLOCK
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.5004250865654554,1.3707966530809315,0.022222222222222223,0.4178020616804437,1.0,26/115,14.87%,PKP2;DPP10;KCNIP4;RAB3C;ANK1;KCNB2;FGF13;PACSIN1;TESC;RAB34;SCN3B;FYB1;TSPAN14;ZDHHC23;KCNB1;TNFRSF1A;RAB15;P2RY1;KCNIP3;TNIK;CACNB2;ANK3;RAB3A;ITGB1BP1;ZDHHC2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.7169808371779391,1.3707287926161802,0.0975609756097561,0.41730241036823973,1.0,7/19,15.90%,PPARG;PARP14;IRGM;SOCS3;PARP9;PIAS1;NLRC5
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6989156377753042,1.3704317255663387,0.057692307692307696,0.4174672749453765,1.0,6/15,15.91%,NRXN1;CNTN4;ASTN1;CDK5R1;NLGN4X;NLGN1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.5030451396571273,1.3702495536485395,0.05263157894736842,0.4172594017110781,1.0,31/100,16.56%,KALRN;CAMSAP3;PROM1;SORBS2;SYBU;SORBS1;ABAT;PRKCZ;SHANK2;HOOK1;MYO5C;SYT13;CHDH;ZBTB7C;MAPK4;NEBL;ABLIM1;SYT7;MAOB;PTPRT;SPARCL1;SH3BGRL2;HAMP;ANK3;WNK2;BAIAP3;PDE9A;MAL2;AGAP1;PLPPR1;USP54
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.5935788686796131,1.370065553089779,0.08,0.41732056927106576,1.0,11/48,9.26%,RHBDF2;MCTP1;RAB3C;MEF2C;KCNMB4;RIMS2;SYT1;STXBP5L;SNCAIP;RAB15;MCTP2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.8134118213287334,1.3697297282904393,0.15217391304347827,0.4176287769089687,1.0,3/7,17.79%,BIRC3;SLC15A2;SLC15A4
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5772290206777247,-1.36958316029779,0.06557377049180328,0.6463529054103636,1.0,15/84,13.22%,ANAPC15;PSMD7;PSMB6;PSME2;PSMD8;CDC26;CDC23;PSMB4;DBF4B;PSMD3;PSMB3;PSME1;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.8796224870159506,-1.3695275021274924,0.11363636363636363,0.6424267129972502,1.0,2/5,6.12%,RAB32;CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.8796224870159506,-1.3695275021274924,0.11363636363636363,0.6424267129972502,1.0,2/5,6.12%,RAB32;CD63
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.7635098374951298,-1.3694852526248855,0.03636363636363636,0.6406855487326173,1.0,2/11,2.63%,BMP5;GREM1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.8328287215612651,1.369388179361071,0.11627906976744186,0.41793591992636064,1.0,1/5,11.51%,TRPV4
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.8749820440100043,-1.3693633052818033,0.08,0.6390904176072588,1.0,2/5,3.24%,CCDC78;PLK4
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.7496945401276567,1.3690653912400708,0.12244897959183673,0.41820093730686664,1.0,5/15,17.83%,KAT2B;PBX1;NOTCH4;NOTCH3;WWC1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.5656561996142753,-1.368979203260105,0.09803921568627451,0.6389290941613306,1.0,13/74,12.04%,POLR2L;POLR1F;POLR1G;POLR2K;MYBBP1A;SPHK2;DNMT3B;MYO1C;SMARCA5;POLR1H;ZNF335;DDX21;POLR2E
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.6072468149927069,1.3683525316281526,0.07317073170731707,0.41987939890618486,1.0,10/33,15.88%,CTNND2;MAP2;PAK3;EPHB1;EPHB3;DLG4;SHANK1;LRP4;FARP1;PHACTR1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.7784984825887654,1.3679781768153785,0.10204081632653061,0.4203243305674044,1.0,3/12,3.57%,PDGFB;IGF1;NR4A3
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.614352016890942,1.3674517599269447,0.047619047619047616,0.42154398473377247,1.0,11/31,14.31%,PKP2;FGF12;NKAIN3;SCN3B;PER1;NOS1;YWHAH;NKAIN1;SCN4B;ANK3;WNK2
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.6739986770605351,-1.3672426501304815,0.08620689655172414,0.6447388636898298,1.0,12/28,24.14%,GRPEL1;GRPEL2;TOMM20;TIMM50;TIMM17A;DNAJC19;TIMM23;PEX10;TIMM44;PEX16;DNAJC15;TOMM40L
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.9129529806837207,-1.3666877610264558,0.0,0.6450674390818596,1.0,1/5,2.40%,DCTD
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7709181986631422,1.3662768254029327,0.09523809523809523,0.424982257880862,1.0,3/11,7.00%,ADRA1A;TPM1;SCN3B
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.523343440732367,1.3659588836988323,0.06521739130434782,0.42551797382317497,1.0,8/89,7.43%,KLRF2;SRGN;PTPRC;ISG15;TNFRSF1B;IGF2BP2;PER1;ACKR1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.842527788825407,1.3657092641762063,0.13333333333333333,0.4256047548698643,1.0,4/6,9.85%,GABRG2;GABRB2;DIAPH1;GABRB3
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.7857485989948592,1.3653623982955796,0.10204081632653061,0.4258941242550586,1.0,3/7,10.33%,TBC1D8B;SULF1;TMEM63C
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.9065195182286239,1.3652736173474431,0.0851063829787234,0.42543311518631627,1.0,2/5,1.77%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.7147402211674779,1.3651405378912187,0.09302325581395349,0.42521630563929275,1.0,2/17,5.20%,IGF1;NTRK2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.7473433453783764,-1.365023887650441,0.14583333333333334,0.6519108891188018,1.0,3/13,11.62%,EXOSC8;TRIR;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.9031250056415586,1.3649853725075227,0.07407407407407407,0.4250809720004258,1.0,1/5,3.42%,MEF2C
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.8398077541072378,1.3649782522620748,0.10526315789473684,0.42436171485660107,1.0,3/5,15.47%,BMP6;VEGFA;ADD1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.722308324135545,1.3649151755637834,0.0784313725490196,0.42382594105636384,1.0,7/14,19.12%,NR4A3;LILRB1;WNT5A;LAPTM5;CAMK4;SEMA7A;TICAM1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.6672417237749916,1.3648557300338742,0.08333333333333333,0.42333214049551904,1.0,7/21,18.54%,KCNMB4;NOS1;EDNRB;KCNMB2;ITGB1BP1;EDN1;GPER1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7884744500984547,-1.3646633400919377,0.0851063829787234,0.6515250627736976,1.0,3/9,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.8782565514035654,-1.3645001133177974,0.05,0.6502430570648761,1.0,2/5,3.08%,FSHR;COL9A3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.6801738065886159,-1.3644558461307075,0.12,0.6483895661071704,1.0,7/27,16.69%,BMP5;SERPINE1;ICAM1;FAIM;FADD;TMBIM1;PARK7
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.8010164814006966,1.3644273713752018,0.11764705882352941,0.4242033558190732,1.0,1/10,1.89%,CSF1R
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8763564052674484,1.364278637315159,0.1111111111111111,0.4239507681767392,1.0,3/6,9.66%,CHRM3;PIM1;BCL2
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.840175190320851,1.3642037570011984,0.10638297872340426,0.42347922578072955,1.0,4/6,12.55%,SULT4A1;SULT2A1;SULT2B1;UST
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.7521410351351222,1.3640758851134218,0.12727272727272726,0.4231289544649032,1.0,4/11,8.57%,KCNC2;GUCY1A1;DDAH1;NOS1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.7546044076992589,1.3638754789086682,0.05,0.4232578195085109,1.0,1/12,3.01%,HEY1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.7901351154897782,1.3630384123936203,0.05555555555555555,0.4250364566377911,1.0,4/10,13.58%,P2RY12;RYR3;P2RY1;P2RY11
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6711770417930367,1.3629453207007434,0.11627906976744186,0.4244670042796565,1.0,11/26,17.66%,MEF2C;BMPR1B;SULF1;SOX9;GPLD1;SOX5;BMPR2;CREB3L2;SNX19;CCN3;RUNX2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7540448902165284,1.362517938484192,0.1346153846153846,0.4253856314234931,1.0,3/11,4.64%,LPL;PPARG;SYK
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.8880746528828507,1.3620679685842745,0.045454545454545456,0.4264396867857174,1.0,2/5,7.27%,RELN;LRP8
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.559129092256542,1.3619951300558863,0.0,0.42592999064974746,1.0,18/70,10.86%,TGFB2;PDGFB;KITLG;MFAP5;FLT1;PTPRC;CSF1R;PRKX;TOX;ZBTB16;WNT5A;NOTCH4;TAL1;ETV6;TIRAP;TPO;SELPLG;ARIH2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.5747524424044695,-1.3616056167785358,0.07547169811320754,0.6599157821105557,1.0,22/58,19.23%,POLR2L;RAD23A;POLR2G;PPIE;POLR2K;GTF2F1;POLR2I;POLR2A;KPNA2;PPIA;POLR2E;NELFE;NR5A2;POLR2C;POLR2D;FKBP6;NELFCD;SUPT5H;CCNT1;POLR2J;CTDP1;PDE12
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.7440859729477306,1.361434802137431,0.043478260869565216,0.42709795872741335,1.0,6/15,14.38%,CX3CR1;TAFA1;LRRK2;FZD3;CX3CL1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.6175114420054628,-1.3613849379072416,0.09523809523809523,0.6594310311136165,1.0,2/44,0.16%,NGF;P2RY10
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.6383383162766827,1.3613574018496266,0.044444444444444446,0.4266282290438225,1.0,3/16,5.31%,PID1;LZTFL1;RHOQ
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.8468945569416644,1.361273536996247,0.09523809523809523,0.4261207450302119,1.0,2/8,8.83%,PARP14;SOCS3
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.590689760856754,1.3605612950972665,0.11627906976744186,0.4280085634102353,1.0,13/56,12.07%,FLT1;NCKAP1L;CYFIP1;BAIAP2;SRC;AXL;SULF1;MAPKAPK3;HSPB1;VEGFD;MAPK11;PRKD1;PIK3R1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.5846850772767355,1.3604484273535302,0.09259259259259259,0.42775511792539994,1.0,25/89,16.53%,TGFB2;PDGFB;ANGPT1;IGF1;CHI3L1;ADCY8;PAK3;NRG1;ADCY2;WNT5A;TIRAP;KIF14;TNFRSF10B;PRKAR1B;ADCY7;ADCY1;TNIK;GHR;ITGB1BP1;VEGFA;NTRK3;TNFRSF10A;PAK5;ADRB2;GAS6
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.8758507454241689,-1.3598208414583333,0.061224489795918366,0.6648996812347335,1.0,2/6,6.11%,TRMT10C;HSD17B10
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.7565669485670738,1.3591256194061283,0.11627906976744186,0.4319807113331642,1.0,2/10,2.57%,CBS;SHMT2
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.6955590756836086,-1.3589732772712508,0.1206896551724138,0.6665877087940327,1.0,7/31,7.53%,ARHGEF16;KRT86;S100A16;TNS4;HR;LAMB3;CDSN
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5599729255185337,-1.3589699995406213,0.04,0.6645305571280309,1.0,7/87,3.47%,VWA3A;CFAP61;S100B;ARMC3;RGS22;SPAG6;AK8
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.5806891600368783,-1.3585481964098025,0.0,0.6646062612519213,1.0,12/91,8.50%,PM20D1;PLAAT5;PDZD11;ORMDL2;GLYAT;ACSM6;DBI;ORMDL1;PLPP2;ACOT1;SMPD2;DHFR
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5966478755469851,-1.358232450235804,0.11320754716981132,0.66200700070155,1.0,14/51,20.91%,POLR2L;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;RAE1;NUP37;POLR2C;POLR2D;POLR2J;TPR;NUP210;POM121C
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5966478755469851,-1.358232450235804,0.11320754716981132,0.66200700070155,1.0,14/51,20.91%,POLR2L;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;RAE1;NUP37;POLR2C;POLR2D;POLR2J;TPR;NUP210;POM121C
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.7814746274976786,-1.3579796116756109,0.13636363636363635,0.6611676619853492,1.0,3/9,14.55%,FUCA1;SMPD2;SGPL1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.8104476930392993,-1.3577179157126944,0.09615384615384616,0.6602824165801805,1.0,5/10,15.20%,EIF2S2;EIF2S3B;EIF5;DHX29;EIF4B
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8233318571445445,1.3575924282868619,0.11764705882352941,0.43683672349274916,1.0,3/6,12.65%,IGF1;BAG3;ALOX12
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.7366017661159863,1.3573052364325824,0.11764705882352941,0.4372132924134753,1.0,4/13,10.03%,DACT2;MET;COL15A1;GRHL2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.8291571477082842,1.3570755389632114,0.045454545454545456,0.4371215996705554,1.0,4/10,15.47%,CLDN5;TNFRSF1A;VEGFA;ADD1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.6248088167362276,1.3570435821693996,0.09523809523809523,0.4366222205658325,1.0,7/33,11.82%,GLRA3;KYNU;IRAK3;GLRB;TRPM2;RNF139;GLRA2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5482718181771667,1.3564819846680138,0.043478260869565216,0.4372882425343736,1.0,39/93,18.42%,PDE10A;FIGN;ADAMTS9;RNF150;PTPRG;FSTL1;AKAP12;PCDH18;GPR161;TMEM47;RUNX1T1;FLRT2;CHST3;TENM3;COL4A1;TPM1;ADGRL2;LIFR;PPFIBP1;DENND2A;PAPPA;FBLN1;ANTXR1;DZIP1;AMOTL1;CSRP2;DPYSL3;RBMS3;THY1;FARP1;APBB2;LAMB1;GJA1;NFASC;TACC2;SLC16A2;WWTR1;SLIT3;ABI2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.7368586052683872,1.3564398681496208,0.1320754716981132,0.43684831056848705,1.0,3/14,9.62%,CSF1R;CAMK1D;BST1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.857661441104298,1.3563037653647376,0.11320754716981132,0.4366418061417021,1.0,2/5,10.62%,KYNU;ALPL
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.7064637659711799,-1.3562774393352885,0.13725490196078433,0.6652069335810191,1.0,3/14,6.65%,CENPX;EME1;MUS81
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.61905069193735,1.355634479027288,0.1276595744680851,0.43801872947274406,1.0,6/31,5.65%,EGFR;FLT1;P2RY12;PDGFRA;NTRK2;ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5800787258076864,1.3555308774098975,0.1,0.43773391666931033,1.0,6/36,9.06%,CX3CR1;NRXN1;CLSTN3;EPHB1;EPHB3;IL1RAP
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.8223057416026586,1.3553685903551047,0.09090909090909091,0.43766165933289164,1.0,2/6,14.48%,KLF9;PTPRK
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.8491549532270446,-1.3548512985318797,0.08163265306122448,0.6702789894066666,1.0,2/6,5.49%,LIMA1;SOAT2
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.8452058469997266,1.3547937991664454,0.1111111111111111,0.4391839434869211,1.0,5/7,15.27%,ANGPT1;TJP2;SH3GL2;VEGFA;TJP3
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.8152966436643901,1.354607943083501,0.12,0.4391862942899121,1.0,3/5,17.79%,BIRC3;SLC15A2;SLC15A4
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6948012441569661,-1.354491772063771,0.1875,0.6698295048884382,1.0,3/13,8.07%,SAP18;SRSF7;SRSF9
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.5090011658175095,1.3544489833780182,0.05,0.439073756906917,1.0,19/96,8.17%,IGFBP3;COBLL1;PLSCR4;EGFR;PPP1R3C;FSTL1;F3;KIAA1217;LRIG3;POSTN;CDON;LOX;COL12A1;SULF1;CCDC80;COL4A1;EPAS1;NTN4;PXDC1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.7637402219681215,-1.3543243177234774,0.09259259259259259,0.6688025672654893,1.0,1/9,0.58%,PDE3A
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.7360615798259684,1.3542079881475622,0.03636363636363636,0.439305669483791,1.0,3/16,4.81%,RIMS2;TNFRSF1B;CARTPT
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.887453091955993,1.3540241045066366,0.1320754716981132,0.43930781391113166,1.0,1/5,5.42%,BAG3
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.6367477606298615,1.353607382174309,0.11904761904761904,0.43967199394336415,1.0,7/32,10.37%,CD59;C1QB;C3AR1;C5;F2;CR1;C3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.7164471110863553,1.3536002249115515,0.1111111111111111,0.43898866694294275,1.0,1/13,0.76%,RNFT1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.8079957381080831,-1.353521569760922,0.1702127659574468,0.668898515457602,1.0,3/7,6.09%,EYS;CACNA2D4;CNGB1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.8079957381080831,-1.353521569760922,0.1702127659574468,0.668898515457602,1.0,3/7,6.09%,EYS;CACNA2D4;CNGB1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.8840616630130371,1.3534494001846826,0.1509433962264151,0.4387823717543082,1.0,2/5,4.57%,NPY;SRC
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7815484870203449,1.3532641999151251,0.14285714285714285,0.43867155275799075,1.0,2/7,10.04%,IL12A;SEMA6A
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.9326152830641169,-1.3532089597717905,0.0392156862745098,0.6684336069524716,1.0,2/5,0.99%,PAX8;FSHR
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.8358811442833305,1.353027973866533,0.11538461538461539,0.4388261578022245,1.0,4/8,11.62%,NCKAP1L;MEF2C;LYN;DOCK11
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.7437736370259065,-1.3530145790889063,0.09433962264150944,0.6671988947570501,1.0,4/14,13.09%,OOEP;CFL1;DYNC1H1;LLGL1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4856499362730076,1.3529198541098961,0.05405405405405406,0.43862110292264805,1.0,21/120,14.46%,TRIM5;IGF1;LRRK2;TNFRSF1B;DACT1;IRS1;SLC4A4;AMER1;LAPTM5;IRGM;ABCD2;DAPK1;PFKFB3;ARNT;GPLD1;TRIM22;PRKD1;MOV10;PFKFB2;GTPBP1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.8589479470341526,1.3527731054306809,0.14893617021276595,0.4385110663761255,1.0,2/5,4.64%,NCKAP1L;SYK
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.6878931512582863,1.3526544243668495,0.11904761904761904,0.4382883151508302,1.0,8/21,15.91%,CGNL1;MPP4;TJP2;PCLO;DLG4;SHANK1;TJP3;NLGN1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.6715723804539696,-1.3524713693290344,0.03571428571428571,0.667611532917434,1.0,11/32,19.10%,TPX2;CHMP2A;NUMA1;CHMP5;ANKRD53;RAE1;DYNC1H1;CHMP3;DCTN1;PARP3;TPR
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.7983641516875071,-1.3524479599731702,0.057692307692307696,0.665742530963553,1.0,3/10,10.82%,SELENOS;GSTP1;TAF7
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7288790315133037,1.352402382469448,0.14,0.4382732222366344,1.0,6/14,14.25%,CSGALNACT1;VCAN;CSPG4;NCAN;UST;CSPG5
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),0.8286430623016395,1.3520772635825098,0.1,0.43857751125363914,1.0,2/6,7.12%,ABCC4;NMUR2
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.8000833280765289,1.3517552323296436,0.14035087719298245,0.43904963499045846,1.0,3/10,7.22%,P2RY12;SRC;RASIP1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.48184553386174667,1.3515238250910444,0.03125,0.43935174634899177,1.0,36/155,10.57%,ADAMTS5;PDGFB;MFAP5;ITGA11;CD44;ADAMTS9;ST7;ITGB4;MMP16;VCAN;TNC;ADAMTS10;ADAMTS7;POSTN;LAMC1;COL11A1;ADAMTS17;COL5A3;ITGAM;LOX;ADAMTS15;TNR;ADAMTS6;COL4A1;NPNT;ADAM12;VIT;JAM2;FBLN5;COL15A1;PAPLN;COL7A1;AGRN;COL9A1;NCAN;LAMB2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.6569670807464032,-1.3514291399873413,0.1320754716981132,0.668454140627223,1.0,4/23,7.08%,ANAPC15;RIOK2;CDC23;NEK6
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5717591845859976,1.351405164382065,0.04081632653061224,0.4391855115305918,1.0,10/54,9.91%,PPARG;ZNF423;FSTL1;VWC2L;BMPR1B;SULF1;BMPER;DLX1;CHRD;BMPR2
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8210460378554523,-1.3513592726112262,0.10909090909090909,0.6667661167917757,1.0,2/10,4.92%,H1-4;H1-2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.7157528706100442,-1.3513421592879151,0.10344827586206896,0.6648670972954106,1.0,10/16,24.14%,GRPEL1;GRPEL2;TOMM20;TIMM50;TIMM17A;DNAJC19;TIMM23;TIMM44;DNAJC15;TOMM40L
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.8664636694781103,1.3513412507227363,0.13333333333333333,0.4387771320065528,1.0,2/6,7.28%,MX1;DNM1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.723742942445325,-1.3512865340362374,0.07692307692307693,0.6633220202722641,1.0,11/21,19.97%,ISCA2;CIAO2B;CIAPIN1;CIAO1;GLRX5;NFS1;ISCU;NFU1;LYRM4;NUBP2;ISCA1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7398047252973525,1.3512799738955363,0.12195121951219512,0.4383141184981778,1.0,4/14,9.19%,SLC9C2;SLC8A1;SLC9A9;SLC9A7
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.842350662996975,1.350495159009778,0.0425531914893617,0.440383276388927,1.0,1/7,0.27%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6052078069243364,1.3504678966173826,0.14285714285714285,0.43982630566407227,1.0,10/28,15.09%,SEMA3D;TRIM46;MAP2;KIAA0319;SEMA6A;SEMA5B;SEMA4B;SEMA4G;SEMA3C;DIP2B
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.7080015999373932,-1.3503979433590982,0.12903225806451613,0.6659844384546494,1.0,6/21,15.66%,TUBA1A;TUBA1B;MYO10;TUBA1C;TUBB;DYNC1I2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.7182614468604844,-1.3502395612117082,0.09615384615384616,0.6648345509437091,1.0,11/22,19.97%,ISCA2;CIAO2B;CIAPIN1;CIAO1;GLRX5;NFS1;ISCU;NFU1;LYRM4;NUBP2;ISCA1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.7417343660673152,-1.350164794762274,0.12,0.6632060560104086,1.0,5/13,8.36%,ORMDL2;ORMDL1;RACK1;SPHK2;SMPD2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5457484440433377,-1.3500559386277053,0.08196721311475409,0.661853210996276,1.0,6/74,2.35%,WNT9A;RPS27A;UBC;GPC4;SFRP1;UBB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.737818020213289,-1.3499802099648563,0.10638297872340426,0.6602428507426675,1.0,4/11,19.45%,SELP;RHOA;ETS1;ALOX5
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.8185685098678556,1.3495278009887175,0.15,0.44275852618097855,1.0,4/8,9.57%,NRCAM;KCNIP2;PICK1;AGRN
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6697245845984201,1.349429838230197,0.0625,0.4424959370401533,1.0,4/20,9.04%,NUDT11;NUDT3;NUDT4;NT5C1A
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.7579898038038696,1.3490457499765678,0.16666666666666666,0.44314030515178293,1.0,2/6,10.33%,ANO6;TRPC6
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5721600624385434,1.3489481466207833,0.08163265306122448,0.4427486902087155,1.0,14/50,17.83%,ZNF423;HEY1;SORBS2;KAT2B;DTX1;PBX1;NOTCH4;SUSD5;NOTCH3;HES1;DTX2;GMDS;JAG2;WWC1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.4947764883644747,1.3488931674784475,0.04878048780487805,0.4422292396435568,1.0,39/155,21.94%,CDS1;PLEKHA2;PLSCR1;ABHD3;DGKB;INPP5D;PIP5K1B;INPP4B;LPCAT4;SLC44A5;ETNPPL;PLEKHA4;GPAT4;PLA2G10;PLA2G4A;PIK3R1;TPTE2;PIP4K2A;ABHD5;INPP5E;CHPT1;ACHE;ACP6;PIK3R5;ETNK1;CHKA;AGK;PTPN13;ABHD8;PTEN;BMX;CSNK2A1;DGKE;PIK3C3;MTM1;DGKA;PTDSS2;GPAT3;PLEKHA1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.910088216241786,1.3488545631082152,0.03508771929824561,0.44169298785652905,1.0,1/6,0.27%,TGFB2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.805732545573829,-1.3484109044515233,0.08,0.6668928904209509,1.0,3/10,7.04%,CXCR4;DEGS1;SOD1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8572713166408679,1.3482007407347654,0.0851063829787234,0.4431800301872911,1.0,2/5,10.68%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.732222474278885,-1.3479445098272642,0.09803921568627451,0.6671721715525608,1.0,2/14,5.92%,ADPRM;ENTPD2
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8624109737687208,1.347691386523102,0.1,0.4441853842771739,1.0,3/6,9.67%,PDGFRA;SOX9;SOX5
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.7391265097456725,-1.3472663922989798,0.09259259259259259,0.6688131081629136,1.0,1/15,0.70%,TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.5734231141842706,-1.3471614503978926,0.10714285714285714,0.6672966509166086,1.0,22/84,17.68%,TRMT10C;RPL5;EIF3D;POLR2G;EIF2S3B;PASK;METTL5;USP16;RPS9;PYM1;RPS4X;NPM1;RPS27L;EIF5A;FASTKD3;CIRBP;EIF5A2;NAT10;POLR2D;RPS6KB2;PCIF1;JMJD4
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.7187976343283362,1.3467396354741175,0.16666666666666666,0.4468732677921975,1.0,11/16,14.07%,SCN9A;CACNA1G;KCNMB4;SCN2A;SCN3A;SCN1A;CACNA1I;KCNMB3;KCNMB2;ANK3;SCN7A
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6280284996142503,-1.3459605704055082,0.08771929824561403,0.6718765314551098,1.0,14/47,15.87%,H1-4;POLR2L;TINF2;CGAS;POLR2G;POLR2K;H1-2;POLR2I;POLR2A;POLR2E;BLM;DAXX;POLR2C;POLR2D
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.8884981456424488,1.3458258062269597,0.05128205128205128,0.4488577275731903,1.0,3/6,10.36%,C3AR1;GPLD1;CR1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.7482429967193236,-1.3458066951216248,0.11320754716981132,0.6705022586237795,1.0,6/13,18.31%,RPUSD2;PUSL1;DKC1;NHP2;PUS1;GAR1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.8846377623381528,1.345790433227302,0.0392156862745098,0.44829715596917785,1.0,3/6,8.64%,DACT1;SPEF1;PLEKHA4
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6595828315205792,-1.345753379635866,0.08888888888888889,0.6669990903468117,1.0,3/23,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6595828315205792,-1.345753379635866,0.08888888888888889,0.6669990903468117,1.0,3/23,2.35%,RPS27A;UBC;UBB
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7262744596664544,1.3456389638271613,0.06382978723404255,0.44745430451163876,1.0,4/13,15.19%,ZFP36;CPEB3;NANOS3;ZFP36L1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7262744596664544,1.3456389638271613,0.06382978723404255,0.44745430451163876,1.0,4/13,15.19%,ZFP36;CPEB3;NANOS3;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8796675275541692,1.3455286551268804,0.041666666666666664,0.4471529927876075,1.0,2/5,10.81%,MLIP;TRPC3
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5787486636442701,1.3455026490444666,0.022222222222222223,0.4464895115359184,1.0,13/37,14.31%,RPS6KA6;PTPRC;LMO3;PTPRR;SPRED3;FBLN1;SEMA6A;DUSP10;LYN;TIMP3;DUSP6;ITGB1BP1;WNK2
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8450555753597278,1.3454616693596533,0.04081632653061224,0.4459730642202111,1.0,2/7,7.47%,CHRM3;LYPD1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.8449465216937215,1.3453924624435294,0.06976744186046512,0.44551248433561347,1.0,3/5,12.41%,KCNMA1;ANO6;CLCN3
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.8670183063149234,1.345310296749062,0.14,0.4451255893167024,1.0,3/5,12.88%,PER1;CLOCK;CDH3
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.8109144606399614,-1.345185273698887,0.05172413793103448,0.6676486990787848,1.0,2/11,7.41%,AMPD1;GMPR2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.7144205122907364,-1.3451124532764347,0.10714285714285714,0.6661612337888695,1.0,4/17,13.90%,DPM3;RXYLT1;SDF2L1;DPM2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.856507843809809,1.3448936962436282,0.15555555555555556,0.44593079587489753,1.0,2/5,11.59%,PLSCR1;LYN
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.8036189168323071,1.3448332268149208,0.10204081632653061,0.4454903873967729,1.0,3/9,13.19%,PRICKLE1;SOX9;SRA1
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8333987249313515,-1.3444862089187122,0.12727272727272726,0.6639108068858194,1.0,2/8,4.92%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8333987249313515,-1.3444862089187122,0.12727272727272726,0.6639108068858194,1.0,2/8,4.92%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8333987249313515,-1.3444862089187122,0.12727272727272726,0.6639108068858194,1.0,2/8,4.92%,H1-4;H1-2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.7738392291616066,1.3443829971267403,0.0625,0.44654446838445083,1.0,5/11,6.91%,PDGFB;MEF2C;NR4A3;PRKG1;TPM1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.47302338274980565,1.344218153232922,0.0,0.4463918665599008,1.0,42/217,8.37%,IL1RAPL2;CX3CR1;PDGFC;NPAS2;NRCAM;ROBO2;RPS6KA6;DCX;SLC23A1;VCAN;NHEJ1;GRIN2B;GRIK1;CHST8;PCDH18;DCLK1;RELN;ITGAM;SPOCK1;TBX6;PTPRZ1;LOXL3;ADGRG1;CNTN4;CA10;PBX1;MEIS3;GRIN1;COL4A1;SCIN;VIT;ADGRL2;NMUR2;SOX9;NPTX1;ATXN1;ZBTB16;NDRG4;MEIS2;WWP1;SH3GL2;EMX1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.8557984801281833,-1.3434848608483962,0.08620689655172414,0.6670868133502165,1.0,2/5,1.91%,SELP;CCL28
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.5453576002439918,1.3434000847317733,0.0851063829787234,0.4481947135255966,1.0,17/79,13.69%,LPL;PDGFB;BMP6;PLSCR1;TLR2;P2RY12;STX3;LY86;NFKBIA;WNT5A;F2;TNFRSF1A;IL33;CX3CL1;PUM1;NFKBIZ;IFNK
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.7008257749992148,1.3433067242906407,0.11904761904761904,0.4479147281172134,1.0,6/9,14.42%,PDGFB;FLT1;CX3CL1;PTPRO;MSMP;LGALS3
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.825796289202172,1.3430358622762462,0.12,0.4483150926407231,1.0,1/6,2.70%,MYH11
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.6471727693115794,-1.3429935347938498,0.1111111111111111,0.6673554410622159,1.0,11/33,16.72%,PCNA;MBD4;POLD3;MPG;PARP1;APEX1;POLD4;PNKP;POLG;RFC1;ADPRS
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7211648630807322,1.3429598341047193,0.13953488372093023,0.44789292621024845,1.0,6/13,10.25%,CD44;CARMIL2;TWF2;CARMIL1;DMTN;VIL1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.7165733051839159,1.34266467585578,0.15555555555555556,0.4484347509228249,1.0,3/10,6.27%,NRXN1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.49337162456359596,1.342192229657371,0.07317073170731707,0.4492063770440851,1.0,32/161,13.19%,LPL;PTPRC;PLPPR5;NUDT11;IMPA2;PLPPR3;PLCB1;LRRK2;PLPPR4;INPP5D;PTPRB;HDHD2;TNK2;INPP4B;PPP3CA;PLCB4;LPCAT4;NUDT3;NUDT4;PPA2;PRKCG;PFKFB3;ALPL;PLA2G10;DUSP10;ITPK1;IP6K3;PLA2G4A;TPTE2;PLCB3;PIP4K2A;PGM2L1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8146797512037111,-1.3416175156989343,0.10204081632653061,0.6724637622075534,1.0,4/9,10.31%,SCARF1;ADH4;AKR1D1;SNX17
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.8443264775765337,1.3415880602786197,0.04081632653061224,0.4505089516700391,1.0,1/7,0.27%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6977633351134856,1.3415010036706025,0.05,0.4502102723460467,1.0,5/14,10.20%,PPARG;MEF2C;PRKG1;TPM1;TGFB3
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.7069552668497572,-1.3414903027300427,0.09259259259259259,0.6710377804224791,1.0,2/13,8.03%,ABCA13;PLEKHA3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.5394117150416461,1.3411356251101128,0.06382978723404255,0.4505327575569253,1.0,18/75,18.27%,TGFB2;ANGPT1;SRC;SOX9;WNT5A;GPLD1;BMPR2;VIL1;PRKD1;SCARB1;DOCK5;ITGB1BP1;VEGFA;PRKCE;DOCK1;SASH1;KDR;EDN1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.646796744663581,1.3411337187128745,0.06,0.449881013922635,1.0,8/29,10.70%,LRRK2;EPHA4;RELN;SIPA1L1;CAMK2B;LRP8;NGEF;CDK5R1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.886071506041978,1.3405328456679015,0.11538461538461539,0.4512455354793545,1.0,1/6,2.47%,CBS
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.746947625352002,1.3404707850619135,0.11764705882352941,0.4507181707355875,1.0,3/10,12.32%,WTIP;ZFP36;PUM1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.8345251668819074,1.3398053261489513,0.10204081632653061,0.4523592935747728,1.0,2/5,8.11%,LPL;TIRAP
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7760135750893393,-1.3391825505187813,0.0784313725490196,0.6802572944276085,1.0,4/13,10.97%,FSHR;COL9A3;SOD1;ZNF830
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.5720426389824652,1.3391056049579608,0.0,0.4541362983751962,1.0,21/51,13.74%,FGL2;TLR2;CSF1R;ADGRE2;CLEC5A;MRC1;TNFRSF1B;ITGAM;C3AR1;CSF3R;LILRB1;WDFY4;GDA;LY86;LAPTM5;OLR1;PILRA;KLHDC4;AOAH;CLEC7A;NLRP3
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.7182209569653556,-1.339054579117591,0.19047619047619047,0.6791377779063867,1.0,3/17,7.67%,ABCA13;ABCA8;TSPO
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.7914294316163306,1.3389838911467824,0.12,0.45388804867303506,1.0,7/10,18.25%,F3;VEGFD;CDH13;VEGFA;NTRK3;IL16;KDR
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.528723529651862,1.338887412641833,0.0,0.4535002145319455,1.0,31/108,12.37%,ROR1;EPHA3;ROBO2;PLPPR5;CARMIL2;CAMK1D;RIT2;ZNF804A;TWF2;RELN;CARMIL1;PLXNA4;GRIP1;NTRK2;TOX;TENM3;CAMK2B;TIAM2;WNT5A;NDRG4;PLXNA2;FUT9;ROBO1;DLG4;NGFR;ATP1B2;CX3CL1;PRKD1;LYN;DPYSL3;SERPINI1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.713663206025577,1.3388071183495596,0.12962962962962962,0.45306098008680223,1.0,3/14,1.41%,CX3CR1;CARD18;IGF1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.5264875275990618,-1.3384104571627593,0.034482758620689655,0.6805324052234137,1.0,32/162,16.10%,SNRNP25;PRPF4;KIN;SF3A3;SF3A1;TSEN34;PDCD7;SRSF7;PRPF18;MPHOSPH10;YJU2;SCNM1;SRSF9;TFIP11;SNRPD1;RBMS2;SNRPD2;PRPF6;RP9;SF3B4;SNRPB;RBM8A;DKC1;AURKAIP1;WBP4;PRPF8;PRPF3;MAGOHB;SF3A2;DHX8;SNRPG;PRKACA
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.7600994616336162,-1.3381943911071557,0.05263157894736842,0.6798048062602615,1.0,3/12,2.63%,RPS21;RPP40;TSR1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.8375167336010709,1.337689378417153,0.14,0.4561381128905366,1.0,5/5,16.27%,ABAT;GAD2;GAD1;ALDH5A1;ALDH1A1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.8578379350576133,-1.3375971019219963,0.10416666666666667,0.6811899901811467,1.0,2/5,3.74%,RPS3;PCNA
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6400229733118744,1.3373981992721438,0.10416666666666667,0.45562194961551333,1.0,6/13,16.94%,RAB27B;MREG;BBS2;ARL6;SHROOM2;MKKS
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6400229733118744,1.3373981992721438,0.10416666666666667,0.45562194961551333,1.0,6/13,16.94%,RAB27B;MREG;BBS2;ARL6;SHROOM2;MKKS
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.7403261137469785,1.3373254082152544,0.16,0.4552170043312709,1.0,6/12,16.53%,AXL;LILRB1;TRPM2;LYN;CAMK4;GAS6
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.8736367337291311,1.3371869993143675,0.058823529411764705,0.45488278467810406,1.0,1/8,0.56%,IFNA2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.6410260307477798,-1.3369346340031785,0.08333333333333333,0.6828163745504413,1.0,4/22,12.80%,ATP6V1F;ATP5F1B;UCP2;ATP6V0E1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.8061436707567851,-1.3363709484531565,0.07272727272727272,0.6842083987961676,1.0,3/9,8.43%,H1-4;H1-2;SMARCA5
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.7172327975848918,1.3362191805427963,0.20930232558139536,0.45763970548888966,1.0,3/13,10.99%,SLC2A9;SLC2A5;SLC45A1
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.8541352403307925,-1.3356349495526842,0.12727272727272726,0.685997716032763,1.0,3/6,12.36%,TSR3;RPUSD2;DKC1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.7837781304777252,-1.3353180476347926,0.13043478260869565,0.6858035032862847,1.0,2/9,1.22%,RPL5;RPL11
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6918181779845887,1.3343003266083628,0.10204081632653061,0.46382097260380195,1.0,7/17,21.13%,NCKAP1L;RHOQ;FMNL3;FHOD1;FMNL1;FHOD3;NCKAP1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.7369786346468008,1.3341977291351703,0.14,0.462906735080989,1.0,3/14,8.11%,NCKAP1L;CAMK1D;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.7369786346468008,1.3341977291351703,0.14,0.462906735080989,1.0,3/14,8.11%,NCKAP1L;CAMK1D;TIRAP
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8467490902188437,-1.3341772685421527,0.07547169811320754,0.6891671270831284,1.0,2/6,2.56%,RPS23;PTH
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8795302863960481,1.334133714147175,0.0625,0.4624429738709513,1.0,4/8,9.67%,BMPR1B;SOX9;ZBTB16;SOX5
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8190953864734027,-1.3340437350117669,0.11666666666666667,0.6879615060278788,1.0,1/6,1.76%,DCXR
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7655203853435697,-1.3336767640386156,0.12,0.68776359046168,1.0,2/12,1.21%,CRTAM;BTN3A1
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.8811675001420247,1.3336403933492227,0.0392156862745098,0.46342828360665117,1.0,2/5,8.41%,MYH11;FBLN5
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.6896235747490084,-1.3334744612089586,0.16,0.6871229270817466,1.0,2/19,5.51%,NGF;PMP22
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7703453137542934,-1.3334255455516468,0.02,0.6854455172220999,1.0,10/18,11.91%,RPL23;RPS7;UBB;RPS15;RPS20;DDX5;RPL37;HEXIM1;PLA2R1;EIF5A
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.8118069601738307,-1.3333271621880964,0.13793103448275862,0.6823815584238656,1.0,2/7,6.58%,PTGIS;GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.8118069601738307,-1.3333271621880964,0.13793103448275862,0.6823815584238656,1.0,2/7,6.58%,PTGIS;GLA
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.8368594711703082,1.3332541014068509,0.1509433962264151,0.46415259624023386,1.0,2/5,10.68%,BAG3;MAPT
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7591078633896872,1.3332467659515286,0.1951219512195122,0.4635000084991651,1.0,3/9,11.23%,OGFOD1;P3H2;P4HA1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.7818590281614637,-1.332896416841779,0.09615384615384616,0.6827059988521761,1.0,1/9,1.52%,DPEP1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7606507559424567,1.3327428983913958,0.12727272727272726,0.4644795358662262,1.0,3/9,9.91%,PDGFRA;NOTCH4;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.7286930808837329,1.3327424884798564,0.19607843137254902,0.46381121998728203,1.0,5/10,13.48%,PKP2;SCN3B;NOS1;SCN4B;ANK3
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8321454692289758,1.3326888875177174,0.10204081632653061,0.46335015717143097,1.0,1/5,7.75%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.8296399286366366,1.332478943130513,0.09433962264150944,0.46345427190372596,1.0,1/8,0.72%,PPARG
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.8412001047969127,-1.3322752154125375,0.10416666666666667,0.6835104735389549,1.0,5/8,14.84%,RPS7;UBB;PTTG1IP;EIF5A;ARMC10
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.5414290080883257,1.3322450100755077,0.046511627906976744,0.46372870853764164,1.0,14/51,13.74%,TLR2;SELL;ITGAM;CSF3R;LY86;DOCK8;P2RY13;BST1;NR1I3;CR1;PILRA;AOAH;CLEC7A;NLRP3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.7496073678442698,-1.3321295927221664,0.1,0.6824761595258813,1.0,3/9,12.23%,SERPINE1;MELTF;PLGRKT
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.7985484784999552,1.3320402322693006,0.10416666666666667,0.4638660590389328,1.0,1/8,0.42%,DPYS
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.8343373644733257,-1.3317269634918423,0.14035087719298245,0.681162447355692,1.0,3/5,11.30%,VPS25;VPS28;SNF8
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.8343373644733257,-1.3317269634918423,0.14035087719298245,0.681162447355692,1.0,3/5,11.30%,VPS25;VPS28;SNF8
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.8805558519180376,1.3317126846606193,0.08,0.46412211002701614,1.0,1/5,0.40%,KANK2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7906654238410211,1.331677546555766,0.14285714285714285,0.46354496929716,1.0,2/8,8.74%,IRS1;ABCD2
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.8125280234367556,1.3315207524484927,0.08,0.4634275225228714,1.0,4/7,14.42%,P2RY12;EDNRB;SFTPD;LGALS3
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6846821826502592,1.3313352762698918,0.11538461538461539,0.4633612318916657,1.0,5/15,14.38%,ROBO2;BMPR2;ROBO1;HES1;VEGFA
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.6726601439709242,1.3312775131238865,0.09302325581395349,0.4628552977911323,1.0,11/30,13.39%,PTPRC;PLSCR1;TLR2;CAMK1D;SYK;MERTK;DYSF;SYT7;SCARB1;SFTPD;CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.8770529958338205,-1.3311931296666497,0.06976744186046512,0.6817025239867732,1.0,1/6,8.70%,CD81
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.7530760644752665,-1.330852127966069,0.1320754716981132,0.6795192591022388,1.0,3/10,8.32%,MGMT;MPG;ALKBH2
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.7530760644752665,-1.330852127966069,0.1320754716981132,0.6795192591022388,1.0,3/10,8.32%,MGMT;MPG;ALKBH2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.6699468038951195,1.330710595900355,0.09615384615384616,0.46431034199277244,1.0,9/25,13.39%,PTPRC;NCKAP1L;CAMK1D;MERTK;PTPRJ;ANO6;C3;SFTPD;CLEC7A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7519289257400137,1.3306645749818264,0.14035087719298245,0.46377075941453483,1.0,5/8,17.38%,CACNB1;NOS1;CAMK2D;CACNB2;BIN1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.612112570317538,-1.3306256384244148,0.12280701754385964,0.6787908683592948,1.0,10/62,8.91%,RPS27A;UBC;UBB;PNRC2;PCNA;POLD3;PARP1;MUS81;RNASE1;POLD4
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.6061700826760871,-1.3305225201629436,0.17647058823529413,0.6776587888403567,1.0,16/51,20.36%,FTSJ3;HENMT1;TSR3;RBM15B;AARS1;URM1;QTRT2;TRMT1;NAT10;JMJD6;TRMT6;SSB;CTU2;NSUN2;AARS2;MEPCE
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.8196291447789157,1.3305026491516878,0.1568627450980392,0.4637043583528244,1.0,3/5,15.19%,ZFP36;MAFB;ZFP36L1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.6789675775421438,1.3304086027051274,0.08888888888888889,0.4632680821289285,1.0,4/19,4.64%,TGFB2;NCKAP1L;ADGRE2;SYK
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7598650741686012,1.3302190259913849,0.13043478260869565,0.46325296929634047,1.0,2/10,7.41%,DNAJB1;SNCAIP
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.5273211954489478,-1.3299216187678644,0.08333333333333333,0.6790565208897322,1.0,25/115,18.77%,PRPF4;POLR2L;POLR2G;WDR74;POLR2K;GTF2F1;POLR2I;MPHOSPH10;RNASE1;PCBP3;POLR2A;TFIP11;LAGE3;RBMS2;POLR2E;DKC1;DDX24;HNRNPH2;POLR2C;POLR2D;DHX8;PTBP1;M1AP;LSM1;POLR2J
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6509687785994226,-1.3298075155838742,0.07272727272727272,0.6779935828451585,1.0,8/29,14.09%,VAMP8;LIX1;CALM1;GABARAPL2;SNAP29;ATG14;CHMP3;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to salt stress (GO:0071472),0.8339355641174321,1.3297087130532959,0.11538461538461539,0.4641939970995287,1.0,1/5,1.07%,AQP1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.6136651801040366,-1.3293638824314722,0.1111111111111111,0.6783405716481163,1.0,7/41,10.76%,LCK;DDIT3;NOC2L;RACK1;SEPTIN4;BAX;FIS1
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.8306845049276268,1.328733369777132,0.1702127659574468,0.4667906336519039,1.0,2/5,6.42%,AQP1;YBX3
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6326013164147135,1.3286290804404624,0.12244897959183673,0.4665197390942893,1.0,6/28,9.46%,IGF1;PID1;SLC4A4;PPARGC1A;PFKFB3;ARNT
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.7385065394374108,-1.3281183813242137,0.10638297872340426,0.6822304462819214,1.0,3/16,9.91%,TINF2;PARP1;PINX1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.7071626411626117,-1.3280040562556246,0.16666666666666666,0.6810828607527757,1.0,4/12,11.65%,RPS15;RAN;LTV1;NPM1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5913874092856719,-1.32776301847564,0.09090909090909091,0.6803634652605953,1.0,7/41,7.04%,FTL;SELENOS;PRDX1;PTPA;GPX4;NDUFB4;SOD1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4875405122930789,1.327410809993903,0.025,0.4698574683682375,1.0,30/129,10.59%,TGFB2;CLDN5;L1CAM;CDH9;ROBO2;CLDN16;CDH10;NTNG1;SELL;GPC6;EMB;ITGAM;SLITRK3;CDH18;CNTN4;ROBO4;LRFN5;TENM3;CDH22;CADM3;PTPRM;TENM1;FAT4;IGSF21;PTPRT;TENM2;PCDHB13;ROBO1;CDH23;UNC5D
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8588179460661498,-1.3273589118343265,0.06521739130434782,0.680363894042227,1.0,2/5,6.59%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.6546286338356835,-1.3273378436303156,0.06521739130434782,0.6786834749467956,1.0,11/36,15.91%,TPX2;KIF3B;BCCIP;RHOA;MAP10;KIFC1;KIF11;GOLGA2;WRAP73;KIF4A;ABRAXAS1
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7348330107596706,-1.3272652136388128,0.10416666666666667,0.6771163303881275,1.0,3/12,11.87%,CHAMP1;MIS12;IK
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5368187242542414,1.3272497380542374,0.04878048780487805,0.469883271576213,1.0,15/87,12.55%,ANGPT1;CHST1;MGST1;CSGALNACT1;VCAN;CBS;CHST15;CSPG4;B4GALT6;CHST3;CHST11;NCAN;ST3GAL6;GGT5;UST
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7920439338111702,1.3271068322538893,0.08771929824561403,0.4696591573273918,1.0,3/11,5.48%,IFNA2;TRIM5;CIITA
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8486492047768006,1.3268732638924792,0.12727272727272726,0.46986812940841227,1.0,3/6,9.37%,IGF1;IL12A;CDKN2A
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.8444850838261779,-1.3266892525885206,0.05357142857142857,0.6781283618923118,1.0,1/7,0.70%,TRMT10C
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.8640608452564719,1.326271986931961,0.1346153846153846,0.4710897219194081,1.0,1/5,3.75%,CBLIF
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.656045066926647,1.3261980767254766,0.17391304347826086,0.4707487564876429,1.0,4/19,3.85%,TEX15;TDRD1;MAEL;EXD1
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.7202579558518429,-1.3261652019775672,0.1956521739130435,0.6790101946099407,1.0,5/11,22.10%,TALDO1;TKT;G6PD;PGLS;RPIA
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7209001866418797,1.3260622494655683,0.12,0.47060750375548616,1.0,2/16,0.91%,RHBDF2;EGFR
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.6830857830940711,-1.3260536527889302,0.23076923076923078,0.6778284131493553,1.0,7/20,18.42%,CHMP2A;CEP131;CHMP5;NPM1;CHMP3;NAT10;PKHD1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.6016549511807733,1.3259962440901802,0.1702127659574468,0.470201992465817,1.0,8/30,14.29%,CAMSAP3;ARHGAP18;MAP2;PAK3;FCHSD2;MAPT;ARHGAP28;HCLS1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.8085946383623366,1.3258507270649842,0.12727272727272726,0.46999581893306086,1.0,4/6,8.08%,IFNA2;DENND1B;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.6592957252427083,1.3250960811202483,0.08163265306122448,0.47219846663615517,1.0,2/20,0.84%,ABCC4;SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.553674393511292,1.3246405190990573,0.09090909090909091,0.47312667346133275,1.0,11/66,6.98%,EPHA3;BMP6;MCTP1;CARMIL2;FAP;DNAJB1;CARMIL1;SRC;PRKCZ;LILRB1;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.6864423165335674,1.3245683238751698,0.13043478260869565,0.47270347375146093,1.0,5/17,7.72%,HEY1;DTX1;CNTN4;SOX9;DLX1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.7324765194798082,-1.324422314068182,0.17307692307692307,0.6836031002225926,1.0,1/10,3.49%,FLII
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.7292624848713686,-1.324393215042173,0.18032786885245902,0.6820639239262462,1.0,2/15,8.44%,HENMT1;TSN
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.8228173889714263,-1.3243709849111482,0.10909090909090909,0.6804085369297801,1.0,2/8,5.10%,CDNF;LMX1B
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.8183932634237858,1.3241990577406741,0.06666666666666667,0.47357914361690834,1.0,4/8,14.38%,JCAD;IL12A;NGFR;VEGFA
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.8413515105947789,1.3240566873950106,0.13725490196078433,0.4734845661699232,1.0,1/5,2.21%,PIK3AP1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.6449421077504027,-1.3239516863567653,0.16326530612244897,0.6806353726635311,1.0,7/26,20.71%,SFRP1;DDX5;PRMT2;RNF6;PARK7;KDM5D;PKN1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.9330258155958422,-1.3238580181252058,0.0,0.6795052795212534,1.0,2/5,6.11%,TRMT10C;HSD17B10
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.7099752928405829,-1.3227229678875976,0.12,0.6828069941116943,1.0,4/10,16.69%,PRR7;GSN;PIH1D1;PARK7
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.7650419960520458,1.322651718384354,0.14,0.47766579929138925,1.0,3/8,10.33%,TBC1D8B;SULF1;TMEM63C
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.8132367580114812,-1.322140821316747,0.18867924528301888,0.68370080972929,1.0,2/6,7.56%,SPX;NMU
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6031870397909003,1.3217501405638994,0.13043478260869565,0.4798561165344597,1.0,6/25,9.57%,NRXN1;CLSTN3;EPHB1;EPHB3;IL1RAP;AGRN
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.7468117008901887,1.3216157039033853,0.13725490196078433,0.4795572801838648,1.0,2/9,6.02%,PPARG;RARB
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.6686646237770482,1.3215027328656777,0.08695652173913043,0.4791776920720415,1.0,7/24,11.50%,SYT4;SYT1;SYT13;STX1A;KCNB1;SYT7;SYT17
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8080469756198316,-1.3212381850927395,0.1896551724137931,0.6863438673043353,1.0,3/7,11.96%,HLA-C;HLA-B;B2M
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.612145320537843,1.3211443983541626,0.1111111111111111,0.4800210260562401,1.0,4/33,13.60%,TGFB2;LEF1;TGFB3;OLFM1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.7010349705634297,1.3211333365205808,0.1111111111111111,0.47946287677211613,1.0,5/15,13.75%,NTNG1;GRIP1;WNT5A;DLG4;MOV10
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),0.8545102679334031,1.3211173605421243,0.2,0.478841261092153,1.0,2/5,2.10%,CX3CR1;C1QB
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5640780376451419,1.3210067629865985,0.125,0.4785458430483636,1.0,14/39,12.29%,GPM6A;PLPPR5;RHOQ;TENM1;TRPM2;DMTN;AGRN;TENM2;GAP43;TGFB3;DOCK11;DPYSL3;PIK3R1;ARAP1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.700323583098414,1.3206669294884887,0.14,0.47907758787769816,1.0,2/20,3.42%,CLDN5;MEF2C
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6458534608482313,1.320418546066152,0.17073170731707318,0.4791386357663174,1.0,7/23,12.86%,CTNND2;PAK3;EPHB1;EPHB3;PICK1;DLG4;SHANK1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.7387183562969766,-1.3202042050800935,0.19230769230769232,0.6891366976495708,1.0,4/10,19.62%,METAP2;NAA40;NAA11;METAP1D
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.9015482417659041,1.320053888517957,0.10416666666666667,0.4797812472976607,1.0,1/5,0.55%,ABCC4
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.7502891622897033,1.3200139613736979,0.1346153846153846,0.47926023521925815,1.0,2/9,1.77%,CX3CR1;P2RY12
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5924374133425782,1.3199684356244292,0.0975609756097561,0.478788979432054,1.0,8/37,11.04%,CREB3L1;REP15;HSD11B2;CDON;OTOGL;PDIA5;PLA2G10;SMIM22
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.8466055179497349,-1.3197179109043606,0.1702127659574468,0.6898258586670396,1.0,3/8,6.75%,FUCA1;GLA;GBA3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.767059766797791,1.3189691640647765,0.09615384615384616,0.48093609206439647,1.0,1/8,1.41%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.767059766797791,1.3189691640647765,0.09615384615384616,0.48093609206439647,1.0,1/8,1.41%,IGF1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.6022192674382828,-1.3186236077750757,0.10204081632653061,0.6932847971118954,1.0,11/43,13.46%,NDC80;CHAMP1;CDC23;CHMP2A;CHMP5;ANKRD53;MIS12;PINX1;NUDC;KIFC1;CHMP3
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5752055682387536,1.3186093602744287,0.10416666666666667,0.48141144829823224,1.0,10/36,15.91%,RND2;NCKAP1L;RHOQ;RHOF;FMNL3;TRPV4;FHOD1;RAC3;FMNL1;NLGN1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.7286861945610492,-1.3185870008257796,0.140625,0.6916787433541872,1.0,1/11,2.99%,KDELR1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7667132506455936,1.3177011170967656,0.0784313725490196,0.4836647058294644,1.0,3/10,11.10%,SYBU;MAPT;NEFL
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.9220083350045578,1.3175793345829596,0.018518518518518517,0.48338278244613225,1.0,1/5,0.22%,CHRM3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.6866621843904296,1.3173357483296946,0.10204081632653061,0.483437314058824,1.0,3/17,1.41%,CX3CR1;CARD18;IGF1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.8175151836755409,1.3173255863584954,0.19607843137254902,0.48286909575364845,1.0,1/6,3.14%,LRRK2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5940905413982587,-1.3171042361011704,0.08771929824561403,0.6965667349226158,1.0,21/51,21.70%,SLC25A4;TIMM10;SLC25A5;SLC25A6;TIMM8B;AIP;TSPO;TMEM14C;BAK1;FIS1;KIFBP;TOMM20;TOMM7;BAD;TIMM13;TIMM17A;DNAJC19;TIMM9;TIMM23;SLC25A16;TIMM44
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.6364701760936892,1.3169732067561386,0.16666666666666666,0.48321113991480014,1.0,6/26,17.71%,TM4SF20;KLF15;KCNN4;ACSL5;LGALS2;DMBT1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.7320245859514138,1.316944371487922,0.11320754716981132,0.48262882176881544,1.0,2/11,4.23%,NR4A3;WNT8B
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5371866462484534,1.3166108520353346,0.10638297872340426,0.4829702733874604,1.0,17/66,12.18%,RND2;ZNF423;RIMS4;FBN3;MEX3A;EFNB3;LEF1;CAMKV;CACNA1B;TMEM200C;KCNQ2;GABRB3;SEMA6A;UNC5D;NKAIN1;SEMA5B;VASH2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6348552001950315,-1.3164625038760875,0.14545454545454545,0.6973718948465527,1.0,15/25,18.94%,POLR2L;POLR2G;POLR2K;GTF2F1;POLR2I;POLR2A;POLR2E;NELFE;POLR2C;POLR2D;NELFCD;SUPT5H;CCNT1;POLR2J;CTDP1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.8854939721628632,1.3161793864025704,0.1111111111111111,0.48192301031666324,1.0,2/5,8.91%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.8854939721628632,1.3161793864025704,0.1111111111111111,0.48192301031666324,1.0,2/5,8.91%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.8854939721628632,1.3161793864025704,0.1111111111111111,0.48192301031666324,1.0,2/5,8.91%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.8854939721628632,1.3161793864025704,0.1111111111111111,0.48192301031666324,1.0,2/5,8.91%,RNASE10;TAC4
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.6637570010966496,-1.316048318344451,0.10714285714285714,0.6976519608396738,1.0,9/26,16.25%,CELA2A;GJB1;CPA1;CLDN2;RNASE1;CFTR;CPB1;TSPAN8;HNF4A
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.5540839482257129,-1.3157379015645803,0.1346153846153846,0.6974707228027329,1.0,20/88,16.23%,TUBA1A;SSNA1;PLK4;DYNLL1;TUBB4B;TUBB4A;TUBG1;FBF1;DCTN3;CEP131;MKS1;DYNC1H1;AKAP9;HAUS6;TUBB;DYNC1I2;DCTN1;HAUS1;PRKACA;TCTN3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.605681019856908,1.315530620474736,0.10714285714285714,0.4836214879801394,1.0,8/24,22.48%,MEF2C;TBX6;NDRG4;DNAAF1;MKKS;PKD2;BBS4;SETDB2
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.7120356763483127,-1.315075252802741,0.0784313725490196,0.6988265015997586,1.0,4/14,10.62%,ACAA2;SLC25A5;BAK1;BAX
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6440883916508979,1.3150486614861034,0.13513513513513514,0.4845740932406127,1.0,7/37,11.71%,PDGFB;ANGPT1;JCAD;RHOJ;HSPB1;PRKD1;AKT3
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.8505709869863127,1.3149736637490863,0.0975609756097561,0.4842166767816071,1.0,1/5,5.79%,SAMHD1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5595788361997717,-1.3149426417946342,0.11320754716981132,0.6978074279681621,1.0,17/82,13.56%,RPS27A;UBC;UBB;PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;UBA52;PSMA7;PSMD13;PSMB8;SQSTM1
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.8060242877025816,-1.3148852479887125,0.14545454545454545,0.6963961405418146,1.0,1/7,0.63%,DDIT3
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6407963729566117,1.3148662766804446,0.13846153846153847,0.4839860623917623,1.0,4/24,7.75%,PDGFB;IGF1;NRG1;WNT5A
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5292842704990227,1.3147854793972953,0.057692307692307696,0.4836774991501784,1.0,19/80,14.25%,ANGPT1;CHST1;CSGALNACT1;VCAN;GPC6;CHST15;CSPG4;HS3ST1;B4GALT6;CHST3;GPC5;AGRN;CHST11;NCAN;ST3GAL6;UST;HS3ST3A1;GPC1;CSPG5
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.8251578661182727,1.3145605041035884,0.19148936170212766,0.4839189258101339,1.0,4/7,11.51%,MEF2C;BMPR1B;BMPR2;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7594354664948737,1.3145145785984176,0.12,0.48350157207027067,1.0,3/8,8.43%,LILRB1;WNT5A;LAPTM5
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8031379628571023,1.3145084786518857,0.08163265306122448,0.4828975208367476,1.0,5/11,12.70%,IGF1;PLCB1;IRS1;PIK3R1;GHR
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.8531298400238918,-1.3144279064898599,0.023255813953488372,0.6969326855518667,1.0,1/7,0.63%,DDIT3
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.7461423730393709,-1.3135116496383261,0.14285714285714285,0.6990474709520532,1.0,5/13,16.41%,RNF8;HEXIM1;NELFE;NELFCD;SUPT5H
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6155378105215595,1.313296397465741,0.13725490196078433,0.4860929000239655,1.0,9/26,22.48%,MEF2C;TBX6;NDRG4;HES1;DNAAF1;MKKS;PKD2;BBS4;SETDB2
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.8074881504603277,-1.3132758178692259,0.15789473684210525,0.6983726759703923,1.0,1/7,7.67%,UBQLN2
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.8785602966325132,-1.3131730020837238,0.1320754716981132,0.6972290880356516,1.0,1/6,1.80%,EIF3D
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.5431210488257656,1.3129620864624534,0.08888888888888889,0.48634550385845043,1.0,7/55,10.95%,TGFB2;BMP6;IGF1;FRMD4A;TENM1;TGFB3;SYTL4
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6415399841875594,1.312934623523563,0.14,0.4857712782862775,1.0,8/25,15.73%,CLDN5;LAMC1;DMD;TJP2;JAM2;SLC1A1;TJP3;GJA1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8641142563620258,-1.3127450947411152,0.1206896551724138,0.6976801109884275,1.0,1/5,4.32%,DBI
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.7539617173303194,1.3123793207918624,0.14035087719298245,0.48705111044092053,1.0,4/10,11.97%,GAS2L3;BAIAP2;BAIAP2L1;DPYSL3
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7986056861508567,-1.3120150841684584,0.16666666666666666,0.6994991534016665,1.0,2/8,5.21%,TINF2;MPG
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5000813939106268,1.3119332020111985,0.06521739130434782,0.48804774819015667,1.0,30/108,14.48%,CLDN5;IGFBP3;MCTP1;PTPRG;DACH1;EPHA4;PTPRR;TMIGD3;SRGAP1;ADGRG1;CITED2;SULF1;PTPRJ;TPM1;NDRG4;CHRD;CORO1C;PTPRT;ACVR1C;ROBO1;DUSP10;NGFR;ATP1B2;CX3CL1;DPYSL3;KANK1;ZMYND8;THY1;ITGB1BP1;PTPRK
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.7683628521518416,1.3118429823656923,0.11363636363636363,0.48765987455089077,1.0,1/8,0.12%,DACT2
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.8029582434734234,1.311822502846572,0.20454545454545456,0.4870559145363183,1.0,5/6,19.68%,ADGRE2;SYK;LYN;FES;FER
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7383520939489215,1.311815917921537,0.2,0.48643803856381274,1.0,3/9,6.27%,NRXN1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.8634208716456937,1.3117428454195756,0.14893617021276595,0.48606923326509716,1.0,1/5,2.11%,GRM5
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.8979039572851182,1.3116622005030512,0.0425531914893617,0.4856704915555364,1.0,2/5,4.56%,CARMIL2;CARMIL1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.47422665211238774,1.3114818588945663,0.05714285714285714,0.4856892995334985,1.0,42/149,17.26%,FKBP5;CD44;FOS;NPY1R;IMPA2;CHST8;IGFBP4;CA12;PTPN6;ID2;PTGER3;HSPA4L;SLC24A3;TOP2A;ZFP36;TRIM29;MEST;CCND1;BCL2;OPN3;CACNA2D2;MAPT;CPE;ITPK1;CCN5;TSPAN13;SULT2B1;PLAC1;SCARB1;ISG20;OLFM1;FARP1;ACOX2;TJP3;SLC27A2;NBL1;CHPT1;RBBP8;SORD;PAPSS2;PRSS23;TPD52L1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7452554413207496,1.311385362784657,0.15384615384615385,0.48539992711101104,1.0,4/9,14.52%,PICK1;GAP43;CHRM1;PARD3
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.46257349235521555,1.3113393037114205,0.046511627906976744,0.4848958888762896,1.0,49/273,12.70%,TGFB2;CX3CR1;PDGFC;PDGFB;BMP6;EGFR;ANGPT1;PTPRC;IGF1;CD44;CSF1R;CHI3L1;CSPG4;LRRK2;HGF;LCP2;RELN;SRC;TNK2;NTRK2;INHBC;SH2D3C;EFNA5;PTPRJ;SOX9;LRP8;TENM1;VEGFD;F2;KNDC1;CCND1;IRGM;NOS1;PLK1;CD4;SPDYA;BMPR2;CAMKK1;TGFB3;TEC;C3;P2RY1;CSNK1D;CX3CL1;PRKD1;LYN;FGF17;TNIK;GHR
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.8069858194326885,1.3106006760609406,0.1111111111111111,0.48679037654928925,1.0,1/9,0.04%,CLEC2A
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.8289163316806927,1.3104259641851117,0.14,0.48688437955494757,1.0,3/6,13.31%,RSPH9;TEKT3;TEKT5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.6778294416095929,1.3103380071008774,0.20408163265306123,0.48651832238506065,1.0,7/16,20.48%,F2;CX3CL1;CACNB2;THY1;CAPN3;GPER1;PLCG1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.7358789519338753,-1.3102270860896446,0.1951219512195122,0.7050003278559802,1.0,1/12,5.46%,B4GALNT2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7034925219764808,-1.3101709629944238,0.1896551724137931,0.7035402138392634,1.0,6/15,16.52%,ATP5F1B;ATP5MC3;ATP5PF;VPS9D1;ATP5PB;ATP5PD
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.5611403532787873,-1.3100605439069128,0.13725490196078433,0.7022812988501059,1.0,4/46,0.96%,P2RY10;CXCR4;CD38;CCR3
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.8326543215751456,1.3099481102812616,0.0847457627118644,0.48720942876302825,1.0,2/6,11.54%,NCKAP1L;CBFB
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.862214424211025,1.309487829089723,0.2,0.48788347287599504,1.0,3/5,10.20%,TGFB2;IRAK3;TGFB3
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.5269470841974901,1.3094514271068607,0.07317073170731707,0.4873801278254318,1.0,17/82,13.71%,PTPRC;RAB3C;LRRK2;RIT2;STON2;RIMS2;SRC;SYK;SYT1;STXBP5L;PACSIN1;RAB15;SYT7;RNF139;SCARB1;CDH13;RAB3A
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.6601762226718418,-1.3093532988452086,0.15254237288135594,0.7046736989464351,1.0,1/18,0.16%,P2RY10
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.760011164608222,1.3091406565572274,0.18604651162790697,0.487671007944445,1.0,3/8,13.32%,CITED2;NDRG4;HES1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.6212010240994308,-1.3085043501825209,0.13725490196078433,0.7071129818558822,1.0,6/27,19.12%,RPL11;UBXN1;NOP53;MAP1A;PARK7;HFE
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.8007733639870702,1.307985370571835,0.1509433962264151,0.49117452077976653,1.0,1/7,3.18%,KYNU
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7949306034973133,1.3079642627131662,0.11904761904761904,0.49063848148129613,1.0,6/7,20.00%,ABCC9;ASIC2;ABCC8;PKD2L1;KCNJ11;PKD2
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.8322393341344898,1.3077817845123803,0.16216216216216217,0.4905291414757149,1.0,1/5,7.75%,WNT5A
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.8557856399265312,1.307586176195252,0.17307692307692307,0.4907235014874622,1.0,1/5,10.03%,GRHL2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6166823624061717,-1.3073095097573402,0.16923076923076924,0.7110656515383157,1.0,14/46,22.60%,RPS27A;UBC;UBB;PARP1;MCM4;BLM;UBA52;GTF2H2;DDX11;CETN2;DDX1;XPC;MCM6;TWNK
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7716613273106555,1.3070225063918677,0.19047619047619047,0.4919931426559862,1.0,5/10,14.25%,VCAN;CSPG4;HEXB;NCAN;CSPG5
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7750239487720545,1.3068765561431295,0.1568627450980392,0.49183710059678787,1.0,3/10,13.32%,HEY1;TMEM65;HES1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6854474360325139,1.3064916882897948,0.16666666666666666,0.492558026813648,1.0,7/18,17.35%,GRIK2;GRIK1;UNC13C;GRIK5;GRIA2;GRID1;GRIK3
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.8020938889312659,1.3063637661888698,0.14285714285714285,0.49162762057522247,1.0,2/6,8.11%,TLR2;TIRAP
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.8020938889312659,1.3063637661888698,0.14285714285714285,0.49162762057522247,1.0,2/6,8.11%,TLR2;TIRAP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.7434291300874779,-1.3063342406738254,0.17543859649122806,0.7133825066130111,1.0,3/13,7.44%,RPS3;TPT1;DDIAS
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.5511480971361657,1.3061682224189177,0.11320754716981132,0.49177394959555537,1.0,17/56,17.87%,LPL;NPAS2;PLSCR1;TLR2;MEF2C;NFKBIA;WNT5A;TNFRSF1A;IL33;CX3CL1;NFKBIZ;IFNK;IL17RA;IL16;TNFSF4;SLC15A4;NLRP12
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.8082557304242223,1.3056298843018082,0.1509433962264151,0.49288227610257057,1.0,3/7,15.22%,KAT2B;MAPT;KAT2A
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.8868810558939312,1.305355095386401,0.09302325581395349,0.4930416719301059,1.0,2/6,6.43%,ANGPT1;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.722135692633242,-1.3053351108281572,0.1111111111111111,0.7160536455479986,1.0,6/23,7.84%,RPL5;RPL11;RPL23;RPS7;PDCL3;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.7437785774834366,-1.305031377748318,0.16666666666666666,0.7160291104133468,1.0,5/14,12.66%,SFRP1;CRHBP;LOC400499;PELP1;SFR1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.8032834659868141,1.30497944933852,0.08771929824561403,0.4935756439545359,1.0,1/7,1.77%,P2RY12
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.7082626538173364,1.3047293609213293,0.24,0.49383862831320335,1.0,4/10,11.93%,PROM1;BASP1;KLF15;PTPRO
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.7500326351159865,-1.3042414797589161,0.21666666666666667,0.7179551858523399,1.0,3/10,4.58%,TAX1BP3;ACTN2;GOPC
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.7836749979658854,-1.3040026109207186,0.15,0.7157848670290125,1.0,2/7,4.74%,CXCR4;HYAL2
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.7836749979658854,-1.3040026109207186,0.15,0.7157848670290125,1.0,2/7,4.74%,CXCR4;HYAL2
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.8275730266241459,-1.3037406274057228,0.07272727272727272,0.7154573115471805,1.0,3/8,11.58%,PAX8;USH1C;EPHB2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8478379201763493,1.3033730083130517,0.06666666666666667,0.4974223875263296,1.0,3/6,11.65%,CHRM3;CHRM5;CHRM1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.8289508045764358,-1.3032994317720523,0.1836734693877551,0.7157565321114393,1.0,2/6,3.04%,SURF1;HCCS
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.591752253699454,1.3030698169041461,0.08333333333333333,0.4976500001213228,1.0,3/23,7.23%,BHLHE40;ID2;PER1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.8185329031421682,1.3028761685521624,0.13043478260869565,0.49766810731693767,1.0,1/8,0.78%,NRCAM
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6651798758484093,1.3028748172396232,0.16363636363636364,0.4970452436031492,1.0,5/15,20.86%,MEF2C;NRG1;KDM6B;SORT1;AKAP13
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.6937218841794783,-1.3027177363846587,0.13043478260869565,0.7169429117087823,1.0,1/17,1.18%,VPS25
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.8889304864999147,-1.3024406152474302,0.09090909090909091,0.7168224370318907,1.0,2/5,6.75%,GLA;GBA3
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.7737704065165651,-1.3023203750737375,0.16071428571428573,0.7158556540648592,1.0,3/11,10.41%,SEC61B;SEC62;SEC61A2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.8347718896967335,1.302241249980566,0.1346153846153846,0.49824010402978103,1.0,2/6,15.22%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.8616621468475697,1.302095865983351,0.17391304347826086,0.4980938583739967,1.0,2/5,4.46%,FGF13;RELN
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.6086737402551738,1.301841659523448,0.17307692307692307,0.4981707197836803,1.0,2/20,0.80%,PDGFC;PDGFB
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.8173337536107452,1.3017994402477817,0.14893617021276595,0.49774313581363155,1.0,2/5,6.86%,MEF2C;COL4A1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.7945053719174023,1.3017963280927547,0.1,0.49712405231137574,1.0,5/10,14.00%,PTPRC;IGF1;TNFRSF1B;CX3CL1;CD200
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.73916081962708,1.3014475311512086,0.14893617021276595,0.4973941559740632,1.0,4/13,11.25%,CX3CR1;ITGAM;MAPT;CX3CL1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.5262974529791985,-1.30130787294107,0.1206896551724138,0.7187236344537532,1.0,26/84,21.10%,SELENOS;PRDX1;NOX1;PRDX5;GSTP1;CHCHD2;PARP1;SOD1;SOD3;ETV5;VKORC1L1;RBM11;PRDX3;PRKAA2;PPIA;KEAP1;PYCR1;PARK7;CYBA;TMEM161A;ATF4;G6PD;PINK1;CCS;PRDX6;BRF2
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.783940353627539,1.3011004995016955,0.1509433962264151,0.4978852263462646,1.0,3/7,8.30%,CARTPT;STX1A;KCNB1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6293328637839585,1.3005642029165176,0.09615384615384616,0.49906868156133566,1.0,5/38,4.34%,TTC8;PTCHD1;GRM5;CYFIP1;TUSC3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.8114611560449443,-1.3005109899610299,0.11363636363636363,0.7206794333683727,1.0,2/6,14.27%,ACAA2;THEM4
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.8196205684271325,1.3001400715475886,0.0851063829787234,0.49986598765004636,1.0,4/8,11.10%,PKP2;GFAP;VIM;NEFL
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.7264979311772549,-1.3000807550712696,0.1509433962264151,0.721037616224269,1.0,3/11,15.31%,SLC31A2;CCDC22;MT2A
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.6872171595107102,-1.2996202550495215,0.12244897959183673,0.721673936764188,1.0,2/16,2.01%,CXCR4;TNFRSF21
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5955739089026097,1.2994652121959422,0.1,0.5016917928801576,1.0,5/27,4.57%,ITGB4;ACTN1;SORBS1;LAMC1;SRC
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.8764793810663196,1.2992117004404224,0.14035087719298245,0.5016458306364828,1.0,2/5,11.25%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.8240745029112433,-1.2989171043858687,0.11320754716981132,0.7234797089326898,1.0,1/6,3.96%,PDCD7
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.786562971283743,-1.2986874633001229,0.16071428571428573,0.7226966735778191,1.0,2/9,11.59%,ATP6V1G1;ATP6AP1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.5823339816348493,1.2983136826149861,0.11363636363636363,0.5040670113356647,1.0,12/44,13.71%,TGFB2;IGF1;PDGFRA;NRG1;PPP3CA;TPM1;WNT5A;DYSF;SYT7;SYTL4;SCARB1;RAB3A
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.7191545879418203,-1.2980572611502406,0.2222222222222222,0.7240660276176598,1.0,6/13,17.95%,FICD;BAK1;BAX;UFL1;COPS5;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.9054110522369576,-1.297913455738658,0.11320754716981132,0.7229894353390688,1.0,1/5,1.80%,EIF3D
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),0.8410966844561756,1.297841424462913,0.125,0.5050302336140621,1.0,1/5,1.07%,AQP1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.479956567771743,1.296857195044298,0.04878048780487805,0.5080565354524398,1.0,28/119,14.87%,PKP2;DPP10;KCNIP4;RAB3C;ANK1;KCNB2;FGF13;PACSIN1;TESC;RAB34;SCN3B;FYB1;TSPAN14;ZDHHC23;KCNB1;TNFRSF1A;RAB15;LIN7A;P2RY1;KCNIP3;TNIK;CACNB2;ANK3;RAB3A;RAB29;ITGB1BP1;ZDHHC2;ATP1B3
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.6669298891776233,-1.2967805588231052,0.12727272727272726,0.7252301828527381,1.0,3/19,6.11%,ECHS1;BCKDK;HSD17B10
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.6669298891776233,-1.2967805588231052,0.12727272727272726,0.7252301828527381,1.0,3/19,6.11%,ECHS1;BCKDK;HSD17B10
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6304743263098713,1.2964475731473142,0.16326530612244897,0.5083440968701711,1.0,7/12,21.67%,RAB27B;MREG;BBS2;ARL6;MKKS;RAB27A;BBS4
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6304743263098713,1.2964475731473142,0.16326530612244897,0.5083440968701711,1.0,7/12,21.67%,RAB27B;MREG;BBS2;ARL6;MKKS;RAB27A;BBS4
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5309374795860949,1.2963671595575936,0.1,0.5079546416863513,1.0,22/82,10.12%,ADAMTS5;MMRN2;AQP1;TLR2;FSTL1;RHOJ;FAP;PCDH18;TNC;LDB2;POSTN;PDGFRA;COL5A3;OLFML2B;ROBO4;SULF1;CCDC80;COL4A1;FBLN5;COL15A1;FBLN2;PAMR1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4722159819887341,1.2961836728829235,0.11363636363636363,0.5080471761424259,1.0,18/123,10.03%,ROR1;EPHA3;EGFR;FLT1;CSF1R;EPHA4;MET;PDGFRA;NTRK2;MERTK;EPHA6;AXL;EPHB1;EPHB3;PLK1;CD4;RFC3;GRHL2
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.8272032426376087,1.2961333204212009,0.14,0.5075862409741289,1.0,1/6,3.14%,LRRK2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.6874903698962294,1.296079132572108,0.16,0.5070537251122281,1.0,5/14,15.19%,ZFP36;CPEB3;RBM24;MOV10;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7030520398823308,1.2959891501563838,0.14285714285714285,0.5067839315453959,1.0,3/15,7.12%,CHRM3;KCNB2;NMUR2
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.5231982436485825,1.2958736510234072,0.125,0.5065873243921225,1.0,23/71,19.23%,PDGFC;PDGFB;EGFR;FLT1;LRRK2;DIRAS1;PTPRJ;IRAK3;TENM1;ROBO1;CDK12;LYN;VEGFA;DIRAS2;PIK3R5;STK38;TPD52L1;PRKCD;RGS2;EDN1;IL34;CAV3;SPRY4
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6459312771461467,1.2957232501801021,0.061224489795918366,0.5064346601699259,1.0,6/19,22.85%,IGF1;DYRK2;CLEC7A;SPPL3;FHL2;GSK3B
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8608711444918212,-1.2956271663674657,0.08333333333333333,0.7294277698659227,1.0,2/5,5.68%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.8267478915311197,-1.295605341374751,0.20689655172413793,0.7279457973711067,1.0,2/5,8.75%,CORO1B;SYAP1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.806676288887109,1.295565992354691,0.038461538461538464,0.5064270727949226,1.0,4/10,9.25%,UNC13C;RIMS2;SYT1;SYT7
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.8178167010654319,1.295492740670431,0.15384615384615385,0.5060726312626865,1.0,6/6,18.25%,F3;ANGPT2;CDH13;VEGFA;NTRK3;KDR
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.8491443837948218,-1.2951933023592461,0.14754098360655737,0.7282069650392154,1.0,3/7,10.41%,SEC61B;SEC62;SEC61A2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5608542324568973,-1.2951530039801622,0.06779661016949153,0.726734189796743,1.0,16/75,17.13%,COPE;USE1;KIF3B;KDELR1;ARCN1;TMED9;BNIP1;TMED2;ERGIC3;KIF11;TMEM115;KIF4A;LMAN2;SURF4;GBF1;RINT1
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.8980203672507281,1.2950074471312187,0.11363636363636363,0.5062025684967726,1.0,3/5,9.03%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.8980203672507281,1.2950074471312187,0.11363636363636363,0.5062025684967726,1.0,3/5,9.03%,ZFP36;PDE1B;CD4
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5648418028993362,1.2947040103978706,0.12244897959183673,0.5064545091645815,1.0,10/31,13.75%,PLCB1;PPP3CA;LEF1;GNG2;WNT5A;FZD3;FZD6;GNAO1;PLCB3;MOV10
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.5903555995482203,1.29464017971841,0.16216216216216217,0.5060010643569859,1.0,8/48,9.37%,REP15;MX1;SYK;ARRB2;LILRB1;DNM1;KIF16B;MVB12A
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.6147108669670263,1.2943872859234715,0.16666666666666666,0.5060515183411881,1.0,7/25,15.90%,PTPN6;ISG15;SAMHD1;WNT5A;PTPN11;TTLL12;NLRC5
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5498363266792269,1.2943044761511966,0.08333333333333333,0.5057287886005258,1.0,11/56,8.41%,PCOLCE;FSTL1;PCDH18;POSTN;PDGFRA;LOX;COL12A1;COL4A1;TPM1;BMPER;FBLN5
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.49176152727933164,1.2940323507811538,0.09803921568627451,0.5060517430777487,1.0,35/93,16.25%,ZNF423;ADAMTS9;PPP1R3C;FSTL1;PCDH18;POSTN;GFRA1;PDGFRA;TMEM47;RUNX1T1;PRKG1;SULF1;COL4A1;ADGRL2;LIFR;CHRD;FAT4;FNDC4;FBLN1;ANTXR1;IL33;BOC;PAMR1;LAMB2;PRRX1;CPE;DPYSL3;TIMP3;THY1;LRP4;PDZRN3;LAMB1;GJA1;SMARCA1;FRZB
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7431629932221484,-1.2938253827521375,0.125,0.7311828567568103,1.0,3/10,11.87%,CHAMP1;MIS12;IK
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6949672983876746,-1.2937705736035428,0.14814814814814814,0.7297463353657913,1.0,3/10,17.83%,NCL;PIH1D1;DDX11
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.8060908272073548,1.29357247285708,0.14893617021276595,0.5066745163245828,1.0,1/5,3.14%,LRRK2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5347071967187591,1.2934148324256811,0.04,0.506552357141847,1.0,17/59,12.21%,SYT4;RYR3;ADCY8;MEF2C;ADGRV1;SYT1;SYT13;WNT5A;CPNE8;TRPM2;DMTN;CAMK2D;SYT7;GPLD1;CPNE5;SYT17;ADCY1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.6436147799693407,-1.292849641076433,0.14,0.7325562771851887,1.0,2/25,1.38%,TEAD2;TEAD3
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5214306950695571,1.2924760093704089,0.09523809523809523,0.5085438903894988,1.0,19/68,9.26%,CHRM3;CX3CR1;EGFR;PTPRC;P2RY12;GRM5;MCTP1;LAT2;SLC8A1;LRRK2;PPP3CA;PTPRJ;NUDT4;NMUR2;IRGM;EDNRB;TRPM2;DMTN;MCTP2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5928742799889472,-1.2924008331874357,0.08333333333333333,0.7328045552712614,1.0,10/37,17.13%,ORC1;NOP53;HUS1;ZNF830;BRCC3;BLM;HMGA2;TOPBP1;ABRAXAS1;RINT1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.7797262120521704,-1.292322661454505,0.1320754716981132,0.7315362522426766,1.0,3/12,16.95%,BRCC3;BLM;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8334122780652827,-1.292310369026065,0.13725490196078433,0.7300574210101344,1.0,2/7,7.52%,PRELID1;CD274
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6349265004960091,1.292259487490991,0.25,0.508647987028528,1.0,2/19,7.14%,HEY1;SOX9
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7172186514041972,1.2922464305499717,0.09615384615384616,0.5080395564220345,1.0,2/13,0.27%,CD59;TGFB2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7829180986763887,1.291926679096916,0.1590909090909091,0.5082578352284783,1.0,5/7,19.68%,ADGRE2;SYK;LYN;FES;FER
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6690745664810125,1.291722461655642,0.1509433962264151,0.5084045352568666,1.0,12/21,15.36%,SCN9A;SLC8A1;CACNA1G;SCN2A;SCN3B;SCN3A;SCN1A;CACNA1I;YWHAH;SCN4B;SCN7A;KCNH2
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6899034304066926,-1.2915609629762947,0.2037037037037037,0.731423237870387,1.0,5/15,25.05%,CGAS;NPM1;PDE12;COLEC12;MUL1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.617088958659107,1.2914973631393962,0.1,0.5086644425956001,1.0,10/24,20.38%,TLR2;IL12A;H2BC11;TIRAP;LYG2;LBP;DMBT1;LYG1;DROSHA;CHGA
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.7304395778715181,1.2910481223918906,0.16326530612244897,0.5088850247293055,1.0,2/11,7.88%,ZFP36;NOTCH4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.7304395778715181,1.2910481223918906,0.16326530612244897,0.5088850247293055,1.0,2/11,7.88%,ZFP36;NOTCH4
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.7554641961682186,1.290934171835013,0.14634146341463414,0.5086483935641508,1.0,3/10,10.99%,MGST1;SLC7A9;SLC6A8
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.7893251810889039,-1.2907968753370669,0.23404255319148937,0.7332312745105876,1.0,2/7,5.49%,LIMA1;SOAT2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.5429018775570841,-1.2907706305905526,0.14516129032258066,0.7317583516216439,1.0,9/45,14.09%,RPL23;VAMP8;LIX1;GABARAPL2;PYM1;HSPA8;SNAP29;CHMP3;MAP1LC3B
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),0.850520998579395,1.2904465537683636,0.17307692307692307,0.5099239420811374,1.0,1/5,1.50%,SLC23A1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.621500045077136,1.289959207255768,0.13636363636363635,0.5107308203108493,1.0,9/25,15.36%,DPP10;KCNIP4;KCNIP1;KCNIP2;NOS1;KCNIP3;ANK3;FHL1;KCNH2
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.8581549361592649,1.289929906300932,0.16,0.5101968743204198,1.0,2/6,5.20%,SRC;NTRK2
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5016153625605337,-1.28946604428277,0.12727272727272726,0.7361101107011403,1.0,8/70,8.70%,P2RY10;CXCR4;LCK;EEF1B2P3;ITGAL;EVI2B;PYHIN1;CD81
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.8078385791722741,-1.2893505435199433,0.19230769230769232,0.735225041474882,1.0,3/7,7.32%,PRDX1;SOD1;SOD3
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.6517654636126139,-1.2892882093091451,0.18,0.733917252596139,1.0,2/17,3.97%,CDKN1C;DYNLL1
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),-0.8565497352790952,-1.2886010078254457,0.08620689655172414,0.7336188167807034,1.0,2/6,8.93%,ENPEP;REN
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),-0.8565497352790952,-1.2886010078254457,0.08620689655172414,0.7336188167807034,1.0,2/6,8.93%,ENPEP;REN
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.7790980765715432,1.2884088886779208,0.23529411764705882,0.5147319743070934,1.0,1/6,8.11%,TIRAP
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.7748217432513351,1.2878795641043819,0.14893617021276595,0.5155443786581327,1.0,2/8,13.89%,MET;DNAAF1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.49043574194339407,1.2878550807159954,0.07894736842105263,0.5150206892376368,1.0,24/136,14.87%,RGS7;EPHA3;LRRK2;EPHA4;PLXNA4;SIPA1L1;NTRK2;LRCH1;PRKG1;EFNA5;RASIP1;DOCK8;EPHB3;NGEF;PLXNA2;AGRN;RGS1;CX3CL1;DOCK11;ARAP1;THY1;ITGB1BP1;CHN1;GNB5
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.631368364904949,1.287840208983705,0.1590909090909091,0.5144140688733992,1.0,8/30,18.99%,CLDN16;SLC8A1;GRIN1;SLC7A8;ANK3;KCNH2;CNNM2;SLC12A5
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5118741237463064,1.2873600771303704,0.0784313725490196,0.5153781001666221,1.0,17/79,10.37%,ADAM28;ALDH1L1;CHL1;SLCO2B1;FGL2;CSF1R;C1QB;SLC8A1;LRRK2;MRC1;FMO5;IRAK3;CLMN;L3MBTL4;DDO;IL33;C3
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.684544972692209,1.2873194648793351,0.17647058823529413,0.5149124301509103,1.0,3/14,8.52%,PLSCR1;XAF1;IRGM
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5025239013923144,1.2871805091275361,0.025,0.5147553701786046,1.0,24/92,14.06%,SLC8A1;SLC1A2;SLC24A4;SLC26A9;PKD1L3;SLC24A3;SLC26A4;ANO6;TRPM3;GRIN1;GLRB;SLC26A7;SLC9A9;SLC9A7;TMEM63C;TRPC6;SLC15A2;PANX2;PIEZO2;KCNN4;PKD2L1;SLC1A1;SLC5A12;SLC25A22
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-0.8195049797870202,-1.2870639476545451,0.19230769230769232,0.7387149240405168,1.0,2/5,5.68%,ACAA2;SLC25A5
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7597833864267065,1.2870416098118311,0.17647058823529413,0.5141634475715136,1.0,1/7,3.71%,HGF
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7597833864267065,1.2870416098118311,0.17647058823529413,0.5141634475715136,1.0,1/7,3.71%,HGF
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.8604494549976115,1.286941547683491,0.05357142857142857,0.5140078146898469,1.0,1/6,1.62%,HIGD1C
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.47274690318069934,1.2868296172196205,0.07142857142857142,0.5136855927493116,1.0,28/139,9.61%,LPL;EPHA3;CX3CR1;EGFR;AQP1;SSTR1;MGST1;ADCY8;BRINP3;PID1;MEF2C;WNT8B;TWF2;TNFRSF1B;IRS1;ABCB4;AXL;LILRB1;ZFP36;TESC;SOX9;ADCY2;WNT5A;GIT1;BRINP1;IRGM;VIM;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.7296024119193583,1.2865802577055914,0.2413793103448276,0.514045050780982,1.0,5/10,16.78%,IGF1;PLCB1;IL33;SOAT1;RAMP1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7809188177317092,1.2863882239059095,0.18867924528301888,0.5141538256351518,1.0,3/9,14.24%,PPARG;NFKBIA;ABCA1
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.6065575948276691,1.2863052501665073,0.15789473684210525,0.5137493742473507,1.0,11/26,21.75%,DTX1;WNT5A;CCND1;ST3GAL6;NOTCH3;HES1;DTX2;KAT2A;FBXW11;ARRB1;NOTCH2
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.48124936356127623,1.2862060807024736,0.046511627906976744,0.5134289515256579,1.0,23/139,11.59%,EGFR;FLT1;MAP3K21;CSF1R;LRRK2;PRKX;EPHA4;PIM1;STK17B;PDGFRA;SRC;NTRK2;CAMK2B;EPHB1;MAPKAPK3;EPHB3;DAPK1;CAMK2D;TEC;MKNK1;CDK12;PRKD1;LYN
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.559591091658175,-1.2861404148454914,0.05454545454545454,0.7412344438541076,1.0,19/71,17.66%,LCK;FTL;FTH1;SLC31A2;ATP6V1G1;SLC39A6;TF;SOD1;CCDC22;SLC22A17;ATP6AP1;MT1E;CYBRD1;CYB561A3;MT2A;HMOX2;SLC39A7;HEPH;ISCU
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.583474699553929,-1.2860233984403804,0.11764705882352941,0.7401915218760349,1.0,6/35,11.16%,ZDHHC12;SELENOK;ZDHHC16;ZDHHC14;HHAT;NAT9
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.8417964198440782,-1.2857639340942357,0.14,0.7396793844944942,1.0,2/5,11.59%,ATP6V1G1;ATP6AP1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.8177201140010092,-1.2855381611868364,0.10810810810810811,0.7391518992207378,1.0,3/7,13.67%,SFRP1;MEOX1;UFL1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.801004617152881,-1.2853812821009214,0.22448979591836735,0.7382422520643107,1.0,4/7,14.03%,ORC1;HUS1;ZNF830;TOPBP1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.8582776677941424,-1.2853776653741773,0.17543859649122806,0.7367610639353812,1.0,3/5,12.83%,SEC61B;SEC61A2;ZFAND2B
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.6744267994235257,1.285246897133607,0.17307692307692307,0.5157788355863138,1.0,6/16,9.98%,CBARP;CACNB1;DIAPH1;NOS1;CAMK2D;UBASH3B
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5944756915854825,-1.2850359953630306,0.17647058823529413,0.7366083867654464,1.0,10/32,20.03%,H1-4;H1-2;USP51;RAD51AP1;KPNA2;BLM;ALYREF;SIRT6;MSH3;H1-10
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.6089611068727077,1.2850350747549655,0.14893617021276595,0.5157054878464502,1.0,1/18,1.46%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.8054599176284212,-1.284738552354779,0.20689655172413793,0.7364042615355106,1.0,1/5,3.72%,PDCL3
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7374995227239848,1.2846535006512858,0.1702127659574468,0.5165293019312128,1.0,2/10,1.17%,CLDN5;CLDN16
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.5003651215609802,1.2846320086294998,0.04878048780487805,0.5159866027006423,1.0,26/77,13.86%,KANK2;PCOLCE;PPARG;EGFR;STAB1;FSTL1;CSPG4;PCDH18;LRIG3;LAMC1;LOX;ADAMTS15;CHST3;COL12A1;COL4A1;TEAD1;FBLN1;ANTXR1;BOC;LAMB2;PRRX1;CCN5;NOTCH3;TIMP3;NR2F2;COL5A1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.5549278461525379,1.2842916496554817,0.13725490196078433,0.5165603636140107,1.0,19/53,17.02%,EPHA4;EFNB3;SPOCK1;KIAA0319;RTN4RL2;NGEF;MCF2;NGFR;TRPV4;PTPRO;DPYSL3;KANK1;THY1;RAB29;LRP4;BCL11A;STMN2;NLGN1;RUFY3
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.7944489239181216,-1.2842152003422411,0.2,0.7358256631478162,1.0,3/8,10.31%,SCARF1;AKR1D1;SNX17
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.7944489239181216,-1.2842152003422411,0.2,0.7358256631478162,1.0,3/8,10.31%,SCARF1;AKR1D1;SNX17
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.7907092767958201,-1.2841248768881852,0.22916666666666666,0.7346237061304519,1.0,2/9,12.99%,FBXO43;AURKAIP1
prerank,PanglaoDB_Augmented_2021__Basophils,0.49451947286103853,1.2840504375350945,0.08888888888888889,0.5165414604811334,1.0,21/80,10.77%,L1CAM;FGL2;CD44;TLR2;STAB1;CSF1R;CLEC5A;HGF;LCP2;ITGAM;C3AR1;CSF3R;IRAK3;SNCAIP;GRM6;CD4;P2RY13;TEC;P2RY1;ST6GALNAC5;ADORA2B
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.8703656070275261,-1.2828616444807333,0.1702127659574468,0.7386610713511905,1.0,1/5,2.83%,SBDS
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.6138504085682681,1.282702466523672,0.16666666666666666,0.5204236838110775,1.0,8/22,22.48%,MEF2C;TBX6;NDRG4;DNAAF1;MKKS;PKD2;BBS4;SETDB2
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.8360936132715232,1.2826892661826608,0.125,0.5192396353922714,1.0,5/8,10.52%,CACNG5;CACNG2;CACNG3;CACNG8;DLG4
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.8360936132715232,1.2826892661826608,0.125,0.5192396353922714,1.0,5/8,10.52%,CACNG5;CACNG2;CACNG3;CACNG8;DLG4
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.8030236364761938,1.282411331363107,0.13043478260869565,0.5194093833217704,1.0,4/5,19.48%,LRRK2;TMEM25;NLGN4X;PTEN
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.8176695162238758,-1.2823785765037452,0.24,0.7393483023874734,1.0,2/5,2.55%,SF3A3;SF3A1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7464076933775454,-1.2819245983078607,0.10344827586206896,0.7401355759691451,1.0,7/12,15.16%,COX7C;COX5B;COX7B;COX6A1;COX4I1;COX6B1;COX5A
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.7857004847384766,1.2818766678887268,0.12,0.5203034170872725,1.0,5/6,20.82%,GAD2;GAD1;BCAT2;ALDH1A1;PAH
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.43984694823504605,1.281737368246095,0.0,0.5201710919726147,1.0,71/325,12.11%,ROR1;EPHA3;PDGFC;SLA;PDGFB;EGFR;ANGPT1;FLT1;IGF1;MPZL1;CSF1R;NCKAP1L;KALRN;CYFIP1;PTPRG;GRIN2B;BAIAP2;GALNT3;PLCB1;EPHA4;NR4A3;HGF;MET;NFATC4;SORBS1;PAK3;LCP2;EFNB3;PDGFRA;SRC;TNK2;SYK;NRG1;IRS1;SIPA1L1;NTRK2;MERTK;RHOQ;FLRT2;EPHA6;EFNA5;BLNK;AXL;SULF1;PTPRJ;EPHB1;GRIN1;STYK1;DNM1;SH2D6;MAPKAPK3;ATP6V0D2;EPHB3;GIT1;KIF16B;VEGFD;NGEF;CD4;PTPRT;GPLD1;UBASH3B;MAPK11;FLRT1;CDK5R1;NGFR;ZAP70;PRKD1;LYN;ANOS1;PIK3R1;FGF17
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5936222992869602,1.2814789663689177,0.05357142857142857,0.5205711002207666,1.0,2/31,3.30%,LPL;DGKB
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7654189621678013,-1.2813871253361915,0.18518518518518517,0.7407142626327864,1.0,7/11,18.88%,CYC1;UQCRFS1;UQCC3;UQCRQ;UQCR10;UQCRB;UQCRH
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.7889999061179562,-1.2810303113498651,0.25,0.7390185877928221,1.0,2/5,17.82%,SLC25A11;SLC25A10
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.7889999061179562,-1.2810303113498651,0.25,0.7390185877928221,1.0,2/5,17.82%,SLC25A11;SLC25A10
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.7303940090528921,-1.2803190601556638,0.19230769230769232,0.7403783052129478,1.0,4/12,10.12%,HSD17B10;TSPO;FDXR;AKR1D1
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5206954731114245,1.280312404419242,0.10869565217391304,0.5235182909947594,1.0,21/78,11.97%,ROR1;FSTL1;PCDH18;TNC;ADAMTS7;GPR161;TMEM47;ADAMTS15;CHST3;EFNA5;TENM3;AXL;COL4A1;TPM1;ADGRL2;P3H2;WNT5A;ANTXR1;CSRP2;NOTCH3;DPYSL3
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.7264083540648015,1.2798086984356598,0.1111111111111111,0.5248526922833371,1.0,4/11,15.85%,CHI3L1;TIRAP;TNFRSF10B;TNFRSF10A
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.5300684115195723,-1.2797610573173215,0.1016949152542373,0.7413590833699726,1.0,32/94,28.37%,SRSF7;ENY2;RBM15B;SRSF9;SRSF3;RBM8A;RAE1;DHX38;MAGOHB;NUP37;ALYREF;FIP1L1;POLR2D;NXT1;SLU7;TPR;CASC3;NUP210;POM121C;SRSF2;UPF2;CDC40;NUP93;NXF1;CPSF4;NUP42;MAGOH;NUP58;MCM3AP;DDX39A;THOC5;NUP85
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.5960321273979079,1.2796789881331607,0.2222222222222222,0.524593422419988,1.0,7/25,17.99%,ZMYND10;DNAH7;ODAD3;DNAI2;DNAAF1;DRC1;ODAD4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.6268392567379864,1.2796746069351446,0.13953488372093023,0.5240088339014698,1.0,3/16,13.62%,PID1;RHOQ;BCL2L1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6527676490104259,-1.2796603635971053,0.13114754098360656,0.7403203442587212,1.0,5/22,12.80%,ATP6V1F;ATP6V1G1;ATP6V1G2;ATP6V1E2;ATP6V0E1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.5480098239420741,1.279600823373014,0.1956521739130435,0.5236019104955617,1.0,8/43,13.59%,IGFBP3;MCTP1;DDAH1;MAP2K5;UBASH3B;LYN;AKT3;THY1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7213641165546645,1.2795502844816904,0.17647058823529413,0.5230875235098755,1.0,1/14,0.32%,CLDN5
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.7841917128145101,-1.2794760587127902,0.16071428571428573,0.7396238882262715,1.0,4/10,12.61%,BCKDK;PGP;GCK;MST1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.7996008805286908,1.2792813249687678,0.0851063829787234,0.5233592361734928,1.0,1/7,0.42%,DPYS
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.6991179561159366,-1.2792397439610235,0.12244897959183673,0.7390146045320986,1.0,1/12,0.81%,MEIOSIN
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.790044590978923,1.279214072788487,0.22,0.5230896150204126,1.0,4/6,20.30%,TNFRSF1B;TNFRSF1A;RIC1;RGCC
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.7523155539826697,-1.2790107957997257,0.22641509433962265,0.7385929668821372,1.0,1/7,0.82%,PAX8
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7440677782150235,1.278381631559749,0.14583333333333334,0.5253455911308104,1.0,2/8,15.58%,SPRED3;NNMT
prerank,MSigDB_Hallmark_2020__Myogenesis,0.467143320648491,1.2782808143818467,0.10204081632653061,0.525087818425101,1.0,43/142,18.11%,IGFBP3;CTF1;IGF1;ITGB4;PPP1R3C;MYH11;BHLHE40;MEF2C;REEP1;PDLIM7;SORBS1;SMTN;CAMK2B;DMD;SGCA;ADAM12;EPHB3;ABLIM1;NOS1;COL15A1;PICK1;MAPK12;PKIA;AGRN;CKM;SLC6A8;GNAO1;AEBP1;DMPK;CDH13;FHL1;AGL;KCNH2;PFKM;ACHE;CDKN1A;CKMT2;TPD52L1;BIN1;VIPR1;WWTR1;MEF2D;FKBP1B
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.8534723751677769,1.2781116784777733,0.2608695652173913,0.5249653494096713,1.0,2/5,11.25%,P2RY12;CX3CL1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6795519797684688,1.2780283536693773,0.1568627450980392,0.5246413047590295,1.0,4/18,9.62%,NCKAP1L;CAMK1D;TIRAP;BST1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.5709068590604042,-1.2779842816561298,0.11538461538461539,0.7417682257289768,1.0,14/49,16.69%,RPL5;RPL11;RPS3;PRR7;UBXN1;VPS28;PINX1;SVBP;SQSTM1;UFL1;DNAJA1;SH3RF2;SMAD7;PARK7
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.6100570138185611,-1.2779050947005473,0.16071428571428573,0.7406720883359141,1.0,5/36,8.65%,DYNLRB1;KIF3B;DYNLL1;IFT81;CEP131
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6392280909732236,1.2776997181645995,0.10869565217391304,0.5250572817017036,1.0,7/33,7.27%,PDGFB;PTPRC;CSF1R;GRM5;EPHA4;RELN;LRP8
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6886570507481669,1.27748335483735,0.14814814814814814,0.5251903645303345,1.0,3/13,4.46%,TGFB2;GCM1;RELN
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.7425523918638832,1.277232835598132,0.18867924528301888,0.5253499703518729,1.0,6/11,19.12%,IL12A;AXL;ZBTB1;GAS6;AP1G1;TICAM1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6841633259375574,-1.2769842593767795,0.17073170731707318,0.7431275991637362,1.0,8/15,21.69%,RBM22;SNRPC;PRPF39;WBP4;WBP11;SNRNP200;DDX23;DCPS
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.818696204968654,1.2762569674753232,0.11538461538461539,0.5278669621396237,1.0,3/8,11.59%,MEF2C;CDKN2A;LYN
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.8316997675547764,1.276111208028315,0.18867924528301888,0.5273236535833279,1.0,2/5,3.07%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.8316997675547764,1.276111208028315,0.18867924528301888,0.5273236535833279,1.0,2/5,3.07%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6986777341496647,1.2759219706140656,0.09302325581395349,0.527199776403061,1.0,5/19,13.29%,NDST3;SULF1;HS6ST3;HS3ST4;GPC1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6118051462785741,1.275883581362633,0.10869565217391304,0.5268094512057381,1.0,6/18,18.99%,SLC26A4;SLC9A7;CLCN3;PDK4;KCNH2;SLC12A5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.8522888172025136,-1.2757204781727451,0.2777777777777778,0.7474768625169473,1.0,1/5,6.52%,NUMA1
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.7521129466703433,1.2756734666228677,0.23404255319148937,0.5271127096971543,1.0,3/6,18.27%,PTGER3;EDNRB;EDN1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.832106406557056,1.2756671180538763,0.2391304347826087,0.5265636763623404,1.0,1/5,1.99%,NCKAP1L
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.7967704714556023,-1.275470825447122,0.25,0.7471257907477739,1.0,3/7,16.87%,RPUSD2;DKC1;PUS1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5567973225708224,-1.2753262099323859,0.12121212121212122,0.7462272827988693,1.0,6/47,7.38%,DCXR;GAPDH;SLC25A11;SLC25A1;APOD;PGAM1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7853803533547922,-1.274775667858733,0.20408163265306123,0.7468594172056763,1.0,4/7,15.74%,PHB2;SPHK2;ANTKMT;DNAJC30
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.8261174464910916,1.274613115357128,0.1276595744680851,0.5292590238718199,1.0,3/8,8.11%,LPL;MAP2K5;TIRAP
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.682583220542357,1.2742506219607028,0.19230769230769232,0.529850626921553,1.0,9/18,18.12%,NTNG1;MYH11;NTN4;FBLN5;LAMB4;LAMB2;LAMB1;GAS6;PXDN
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7743151216969326,1.2740861338073548,0.14583333333333334,0.529791073514272,1.0,4/10,13.32%,PTPRC;PTPRT;MGAT5;HES1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.5689060344914968,1.2737761729410413,0.1590909090909091,0.530261543214886,1.0,6/41,7.73%,TGFB2;KANK2;ROBO2;PRKX;SULF1;ZBTB16
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.8777799141298896,1.2735784071986185,0.1956521739130435,0.5302148981211614,1.0,2/5,5.78%,SLC22A16;ABCB4
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.8339695154785297,-1.2735414201032453,0.21568627450980393,0.7506364200938068,1.0,1/6,2.97%,PTPRU
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.7179004300275446,1.2733919278034922,0.20408163265306123,0.5303666244651517,1.0,2/13,5.42%,CAMSAP3;BAG3
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.7409509530177774,-1.2729231029816237,0.19298245614035087,0.7517697517909897,1.0,1/6,3.57%,BACE2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.6986187408346972,-1.2728155203975027,0.16,0.7507701603763031,1.0,1/22,1.53%,TINF2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.787884519333539,-1.2726722462927558,0.17647058823529413,0.7499062685414123,1.0,2/9,3.86%,RPS21;EXOSC8
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5720124512067476,1.2724926344906198,0.14634146341463414,0.5327229497645763,1.0,7/38,12.23%,PLPPR5;PLPPR3;PLPPR4;SGPP2;PLPP4;TPTE2;PLPP6
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.7206868586362362,-1.2723619347281414,0.11764705882352941,0.7496867244984712,1.0,2/10,3.88%,DCTD;ERH
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.6951156796008452,-1.27219500965645,0.2413793103448276,0.7487135777027768,1.0,5/17,13.02%,NIFK;GTF3C6;POLR1G;CAVIN1;TCOF1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5526636991547652,1.2717137981497642,0.14583333333333334,0.5345860785604092,1.0,8/38,7.56%,NCKAP1L;CARMIL2;BAIAP2;CARMIL1;FCHSD2;BAIAP2L1;SCIN;TENM1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.6087704473743704,1.271644662026275,0.15555555555555556,0.5342450281880105,1.0,10/29,17.36%,VSIR;NCKAP1L;LEF1;BCL6;CR1;DUSP10;ZAP70;ZBTB1;IL12RB1;TNFSF4
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.8513466369281005,1.2716355186010357,0.1346153846153846,0.5337204993816127,1.0,2/6,11.25%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6230192862723074,1.2710653927509408,0.19607843137254902,0.5349979816322953,1.0,4/19,9.91%,ZNF423;BMPR1B;SULF1;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7612543722811641,1.2709790528138027,0.2553191489361702,0.5346313443411383,1.0,2/9,12.32%,TLR2;PUM1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.6923630757243076,1.270788840955773,0.17777777777777778,0.5347114572610914,1.0,2/11,6.40%,SLCO2B1;SLCO4A1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6309693806567302,1.270518129003764,0.18604651162790697,0.5348700031009977,1.0,1/24,0.27%,TGFB2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.794959465087626,-1.2701522597717119,0.16363636363636364,0.7563871982624598,1.0,4/10,14.13%,COPS6;GPS1;COPS5;TOR1A
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.8230283464313644,-1.2698555361100137,0.11320754716981132,0.7562705517236957,1.0,2/8,7.52%,CRTAM;CD274
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.8761851224503067,1.2697144485876672,0.1509433962264151,0.5367426150050195,1.0,1/5,1.89%,CSF1R
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5982089475545647,-1.2696888535352924,0.12,0.7555673884242895,1.0,9/31,16.48%,TMEM11;SLC25A4;SAMM50;SLC25A5;BAK1;APOO;TIMM50;BAD;CHCHD6
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5195592083391214,1.2695006743803459,0.1,0.5367417099672325,1.0,20/63,14.14%,TGFB2;PKP2;CLDN5;CDH9;CDH10;CSF1R;CTNND2;CDH18;CDH22;CADM3;TJP2;ARVCF;TGFB3;TRPV4;CDH6;CDH3;CDH13;PARD6A;CDH7;NLGN4X
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.48093401750060877,-1.269280287388009,0.07936507936507936,0.7561199954257752,1.0,71/244,21.19%,ORC1;RPS27A;UBC;PARP2;TINF2;UBB;PCNA;MBD4;ENDOV;POLD3;MGMT;MPG;PARP1;MUS81;RAN;PRIM1;RAD51AP1;DCLRE1B;TSN;APEX1;NOP53;POLD4;KPNA2;MCM4;POLE4;PNKP;HUS1;DDX21;MCM3;NPM1;BTG2;BLM;UBA52;POLG;KAT5;NUDT1;TOPBP1;POLE3;TYMS;TOP3B;UBE2A;MEN1;RFC1;REXO4;PARK7;ADPRS;HMGB1;XRCC6;TRIM28;ATR;RAD9B;PRIMPOL;PARP3;EXO1;MSH3;NSMCE4A;SMC1A;UBE2N;DNMT1;ENDOG;PRKDC;DDX23;ORC6;THAP9;EXD2;CHRNA4;OGG1;XPC;WDHD1;NT5E;ATRIP
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.783095029276245,-1.269258805249249,0.2,0.754721513787696,1.0,3/10,13.16%,PSMG2;ADRM1;PSMD13
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6437599511118705,1.2691987394996775,0.13333333333333333,0.5370280924590797,1.0,3/19,19.63%,WTIP;MOV10;TNRC6A
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6647258677098479,1.2689320400375161,0.17391304347826086,0.536686887297783,1.0,5/19,13.99%,IGF1;SLC4A4;PFKFB3;ARNT;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6647258677098479,1.2689320400375161,0.17391304347826086,0.536686887297783,1.0,5/19,13.99%,IGF1;SLC4A4;PFKFB3;ARNT;PFKFB2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6970039087212447,1.2688745363115201,0.20512820512820512,0.5363866878766388,1.0,6/13,12.86%,CTNND2;PAK3;EPHB1;EPHB3;DLG4;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.7709914740100632,-1.268795744292723,0.17073170731707318,0.7552249862845202,1.0,4/9,17.77%,SLC25A4;SLC25A5;PARK7;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.47204056456786697,1.2687536437617113,0.05555555555555555,0.5360871439127457,1.0,31/157,15.38%,PDGFC;VSIR;PDGFB;EGFR;FLT1;IGF1;CSF1R;SEMA3D;CARMIL2;F3;HGF;PDGFRA;CARMIL1;PPP3CA;LEF1;SEMA6A;VIL1;SMIM22;SEMA5B;SEMA4B;ZNF304;TMSB15B;MGAT5;CLEC7A;CDH13;VEGFA;SEMA4G;SEMA3C;WASHC1;NTRK3;LAMB1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.7715578842718656,-1.2682961737774237,0.10416666666666667,0.7559853396113281,1.0,2/10,4.34%,GREM1;GSTP1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.7304099549328567,-1.2681096866950359,0.1956521739130435,0.7552411325406942,1.0,1/8,4.59%,SPX
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6841403647480302,-1.2680690282379716,0.18518518518518517,0.753887449234235,1.0,3/20,6.80%,BMP5;SFRP1;IL17RD
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.6213337600001115,-1.267990713701768,0.2,0.7527320168477262,1.0,7/28,13.54%,VPS25;CHMP2A;VPS28;CHMP5;SNF8;CHMP3;HGS
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7152726747646615,1.2677983358105287,0.21153846153846154,0.5383337507199818,1.0,5/10,10.70%,NRCAM;EPHA4;CNTN4;EPHB3;CDK5R1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.6804300427287591,-1.2677198907062646,0.16666666666666666,0.7524960503764204,1.0,3/14,15.31%,SLC31A2;CCDC22;MT2A
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5948120862086054,1.267510903159434,0.1111111111111111,0.538499769420086,1.0,9/33,17.64%,CLDN5;CLDN16;GRHL2;PARD6A;PARD3;FRMPD2;CLDN20;MPP7;TBCD
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.6888113896915886,1.2673311456698917,0.13953488372093023,0.5384192064234412,1.0,2/16,8.16%,WNT8B;AMER1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.5981780228027572,1.266712620614543,0.08771929824561403,0.54004754302212,1.0,10/26,13.25%,DCX;PCSK2;PAK3;SYT13;SRPRB;LMO2;MAFB;AKT3;ABCC8;PCSK1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.7158606731074217,1.2667111485352605,0.17777777777777778,0.5394611721827909,1.0,3/9,15.91%,WNT5A;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.6665790491387228,1.2667010704257753,0.21621621621621623,0.5388889900998157,1.0,6/22,22.80%,MEIS2;TAL1;HES1;CUL3;DUSP3;USP22
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7822288392857062,1.2666486034559596,0.14285714285714285,0.5384728815426485,1.0,3/8,11.59%,PTPRC;CBFB;LYN
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.7723219730149584,1.2665115662703665,0.2,0.5382767839981081,1.0,4/7,21.94%,ID2;HES1;BIN1;SERPINE2
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.827978736025443,1.2664139900689566,0.1875,0.5379137366192485,1.0,5/6,16.51%,LAPTM5;DAPK1;DLEC1;RBMS3;SPI1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.7086368550106534,1.2663539870988494,0.24528301886792453,0.5368816605065809,1.0,3/12,13.19%,PPP1R3C;GYG1;PGM2L1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.7086368550106534,1.2663539870988494,0.24528301886792453,0.5368816605065809,1.0,3/12,13.19%,PPP1R3C;GYG1;PGM2L1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.7809459572041464,-1.2661905688224058,0.1956521739130435,0.7572437046915771,1.0,1/6,1.86%,TGM1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.7853584256312316,1.265596596010345,0.20408163265306123,0.5385489497128523,1.0,2/7,6.98%,LILRB1;IRAK3
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6624174573208862,1.2653273045407742,0.23809523809523808,0.538776868363122,1.0,5/18,6.21%,IFNA2;PTPRC;TOX;AXL;PBX1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.624724300572983,1.2651047024872013,0.13953488372093023,0.538773794446152,1.0,3/18,6.44%,MYO7A;MYO1B;MYO5C
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.8357651350476283,-1.2651008233515182,0.2,0.760949658521702,1.0,3/5,13.73%,RACK1;CALM1;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.7409107484085496,-1.2649859151045626,0.14285714285714285,0.7600768120628485,1.0,4/12,16.30%,RNF8;HEXIM1;NELFE;NELFCD
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6085577291828684,1.2648198367806296,0.09523809523809523,0.5391672771241346,1.0,11/25,12.29%,GPM6A;PLPPR5;RHOQ;TENM1;AGRN;TENM2;TGFB3;DOCK11;DPYSL3;PIK3R1;ARAP1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.5627135109805392,1.2646305188639237,0.10638297872340426,0.5392149037498591,1.0,11/40,15.52%,PPARG;FSTL1;VWC2L;BMPR1B;BMPER;DLX1;CHRD;BMPR2;CHRDL1;ACVR2A;NBL1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.8129534462717515,-1.2640203179697678,0.18421052631578946,0.7628232718819072,1.0,1/6,8.80%,NPL
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.8567117799352422,1.2636495653583386,0.18604651162790697,0.5416621569377588,1.0,2/5,13.32%,CHRM1;HES1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.5867832459754745,1.2635816947382614,0.1,0.5412224781920817,1.0,3/19,4.89%,MFAP5;PDGFRA;ID2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6866251120569571,1.2635236043701736,0.18,0.54093658645993,1.0,5/21,6.85%,GRIN2B;LRRK2;MEF2C;ARRB2;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.7320682492488794,-1.2631207492649434,0.1346153846153846,0.7650027507273853,1.0,5/16,15.26%,CCT7;CCT2;CCT6A;DKC1;CEP120
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5341852638982321,1.262993777413232,0.08163265306122448,0.5418218770119511,1.0,13/54,16.51%,MEF2C;NR4A3;KAT2B;ZBTB16;MEIS2;MAFB;CBFB;LYN;SETD1A;MOV10;LGALS3;FES;SPI1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.727687966323475,-1.2624247608765193,0.21052631578947367,0.7668406585464131,1.0,2/13,3.71%,ANAPC15;NDC80
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.8234807042004075,-1.2623985148828278,0.2127659574468085,0.7654880890257408,1.0,1/8,0.25%,CXCR4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.7006069985726575,1.2621404986382307,0.24489795918367346,0.5436331096253436,1.0,2/10,13.96%,PID1;ZDHHC6
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.8313367072761112,1.2621012383943457,0.1590909090909091,0.5431170257754211,1.0,4/5,16.53%,BCL11B;JAM2;GPLD1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.7563171256875504,1.2620955781319738,0.2,0.5425513093386842,1.0,3/8,19.61%,TOP2A;SETMAR;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8624870128710471,1.262076292043923,0.09836065573770492,0.542062813309342,1.0,2/5,9.37%,MEF2C;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.8297303499290632,1.2619797855586508,0.21568627450980393,0.541853787427725,1.0,2/5,9.67%,TLR2;IL33
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6472301243137105,-1.2618474476523924,0.23636363636363636,0.7662431299881374,1.0,4/14,17.83%,NCL;NOP53;PIH1D1;DDX11
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.6303028521317589,1.2616388387831974,0.2,0.5418917151509753,1.0,2/18,1.62%,TEX15;FOS
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.6303028521317589,1.2616388387831974,0.2,0.5418917151509753,1.0,2/18,1.62%,TEX15;FOS
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.7795108095922711,1.261602788494103,0.14583333333333334,0.541405987742719,1.0,3/9,10.86%,WNT5A;ETV6;ARIH2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.7361300337312631,-1.261529377322564,0.16279069767441862,0.7661748492453161,1.0,6/11,21.93%,NOC2L;CHAF1B;HIRIP3;M1AP;CDAN1;RBBP4
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.8375197796716354,1.2613394530018425,0.25,0.5415388071568077,1.0,4/6,9.91%,BMPR1B;SULF1;SOX9;BMPR2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.8077194850527954,-1.2612374693227095,0.18867924528301888,0.7659021041338624,1.0,1/6,4.80%,USP1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.5081135613505716,1.2612129531521945,0.09302325581395349,0.5413817963938787,1.0,26/87,12.95%,RYR3;TRPC4;TRPC7;SLC8A1;CACNA1G;GRIN3A;SLC24A4;SLC24A3;ITPR1;ANO6;CACNA1B;TRPM3;NMUR2;TRPM1;CACNG3;ATP2B2;CACNG8;TRPM2;CACNA1I;TRPC6;CDH23;TRPC3;TRPV4;CACNA1E;KCNN4;CACNB2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6624904649502413,1.2611622057995178,0.15384615384615385,0.5409610252257279,1.0,8/16,13.42%,LRRK2;RIT2;ITPR1;SLA2;BST1;MAPT;CLEC7A;CDH13
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.7178715198004474,1.2609906360320369,0.13157894736842105,0.5406542046561555,1.0,1/13,0.13%,LPL
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.6768405069281127,1.2609227636543234,0.2,0.5397667072080284,1.0,4/16,5.83%,IL1RAPL2;GPC6;SLITRK3;LRFN5
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.6768405069281127,1.2609227636543234,0.2,0.5397667072080284,1.0,4/16,5.83%,IL1RAPL2;GPC6;SLITRK3;LRFN5
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.7374322180521221,1.2608534959690467,0.2564102564102564,0.5393619270656798,1.0,1/7,5.79%,SAMHD1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.829896671798235,-1.260804484429459,0.15217391304347827,0.7664634533423256,1.0,2/6,10.05%,MRPS2;MTERF3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5163363977946558,1.2606529764908805,0.09523809523809523,0.539345799866978,1.0,23/61,16.78%,ADCY8;RXFP1;ADGRE2;GPR161;PTGER3;CNR1;ADGRB1;ADGRG1;ADRA1A;GNAL;GNG2;ADGRL2;ADCY2;GPHB5;GPR26;GPR12;ADCY7;ADCY1;ABCA1;CNR2;ADRB2;CALCB;RAMP1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6312800951881801,1.2606186583460453,0.2,0.5388298411753214,1.0,5/16,15.19%,ZFP36;ZBTB16;MEIS2;MAFB;ZFP36L1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.6348962163538324,-1.2605981079705053,0.19230769230769232,0.766175505415092,1.0,7/27,13.54%,VPS25;CHMP2A;VPS28;CHMP5;SNF8;CHMP3;HGS
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.569836156795705,-1.2605362532949087,0.2391304347826087,0.7649334559402615,1.0,7/43,6.59%,ARHGEF16;CXCR4;CCR3;CORO1B;CCL28;RHOG;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6686349891401003,1.2604021522780864,0.2,0.538976591473603,1.0,3/13,9.05%,ROBO2;TLR2;SLIT1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.7176106520961393,1.2596736196062783,0.16326530612244897,0.5404947853155047,1.0,3/9,8.44%,PDGFB;PDGFRA;F2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.541192861912938,1.2593055142375889,0.125,0.5410630392459714,1.0,10/49,13.69%,PLSCR1;BIRC3;PTPN6;SAMHD1;IRAK3;LRP8;TIRAP;PARP9;PTPN11;IFNK
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.6077212388285353,1.259296896364463,0.11538461538461539,0.540547442722954,1.0,4/30,3.42%,TGFB2;GPM6A;PTPRC;MEF2C
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.658272796729293,1.2590233940470736,0.24074074074074073,0.5408285329019606,1.0,3/13,12.57%,RIMS2;PTPRN;SNX19
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.7628270486162039,-1.2588898667837318,0.1568627450980392,0.7705261030158078,1.0,2/9,5.86%,AIPL1;FNTA
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.8148109249006571,-1.2588655226192282,0.17391304347826086,0.7691089455878587,1.0,2/9,1.11%,CCDC78;STAC3
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.4543746084337474,-1.2587962420375614,0.06557377049180328,0.7679306661148022,1.0,48/180,19.91%,JPT1;STMN1;PLK4;H2AX;PCNA;EXOSC8;CDK4;RANBP1;USP1;POLD3;TUBG1;PSMC3IP;RAN;RAD51AP1;PNN;DCLRE1B;HMMR;KPNA2;PHF5A;H2AZ1;MCM4;CCNB2;POLE4;ASF1B;NOP56;HUS1;MCM3;SNRPB;CDKN2C;TUBB;POP7;ILF3;CKS1B;WDR90;KIF4A;CBX5;RFC1;XRCC6;DUT;TCF19;CDC20;DSCC1;UBE2S;MTHFD2;PA2G4;SMC1A;DNMT1;PRKDC
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5656306712869981,-1.2587593382095732,0.14035087719298245,0.7666169259261745,1.0,14/40,21.07%,DEGS1;DECR2;GSTP1;GPX4;DAGLA;ELOVL1;FADS1;DAGLB;MGLL;ACOX1;ALOX5;CYP2J2;CYP4Z1;ELOVL2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6246638908536939,-1.2585708670784606,0.17647058823529413,0.7661147457663264,1.0,7/30,14.11%,ORC1;PRIM1;MCM4;POLE4;MCM3;TOPBP1;POLE3
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6214275908195948,1.25848435713655,0.16666666666666666,0.5421894418461033,1.0,5/17,16.00%,TIMP4;TNFRSF1B;GPLD1;TIMP3;SNX33
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.8129123838378088,1.258393060270279,0.14893617021276595,0.5418479603965057,1.0,3/5,14.38%,VEGFD;RIN3;VEGFA
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.5426215213878283,-1.258371639967785,0.0851063829787234,0.7655834723396363,1.0,20/63,19.59%,TPX2;KIF3B;NDC80;TUBG1;BCCIP;CHMP2A;RAN;RHOA;SGO2;MIS12;KIFC1;KIF11;GOLGA2;WRAP73;ABRAXAS1;UBE2S;CTDP1;CHMP7;SMC1A;EPS8
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.6974580327049056,-1.2583336434019068,0.14893617021276595,0.7642968971231028,1.0,2/14,6.64%,RPL23;GRWD1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7764936996924484,1.258312565013779,0.175,0.5415071896263036,1.0,2/11,4.89%,CSF1R;ID2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6927935830360241,1.2580718428288877,0.225,0.5418356322575962,1.0,2/14,4.55%,FLT1;PDGFRA
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.8009734569480083,-1.257868727241439,0.22950819672131148,0.7649279258730034,1.0,1/6,2.78%,GTF3C6
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5119994574455338,1.2577355329350348,0.1276595744680851,0.542237593959309,1.0,11/50,10.24%,L1CAM;ROBO2;EMB;CNTN4;ROBO4;TENM3;CADM3;PTPRM;IGSF21;PTPRT;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.5401120828052952,-1.2576596180737067,0.16326530612244897,0.764478798120786,1.0,15/65,12.44%,CRYAB;TPX2;STMN1;MYADM;PFDN2;PFN1;LIMA1;TUBB4A;KATNB1;VBP1;PFDN1;TWF1;HSPA8;CHADL;PFDN6
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.8703739654402516,-1.2576052467413499,0.15384615384615385,0.7618520544747848,1.0,1/5,7.14%,XG
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.8703739654402516,-1.2576052467413499,0.15384615384615385,0.7618520544747848,1.0,1/5,7.14%,XG
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.7217366949231351,1.2572466386073848,0.1590909090909091,0.5431081751220392,1.0,3/13,1.41%,IGFBP3;PDGFB;IGF1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6822715430193798,1.2571502854163799,0.1836734693877551,0.5428292171256748,1.0,5/15,11.54%,MAP2K5;LIFR;WNT5A;PARP9;CBFB
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.7136974164954583,-1.2570772589293324,0.18181818181818182,0.7628810524039449,1.0,6/13,20.25%,NIFK;POLR1G;CAVIN1;SNAPC3;SNAPC2;GTF3A
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.4845493732822549,1.2570623003544703,0.125,0.542575493600689,1.0,34/104,17.55%,RHBDF2;ADCY8;RXFP1;SRC;SYK;ADCYAP1R1;MAPKBP1;CYSLTR2;GPR176;VIPR2;CYSLTR1;LILRB1;GNG2;IRAK3;ADCY2;GPHB5;CR1;ADORA2B;LYN;PRKAR1B;ADCY7;ADCY1;GGT5;HRH2;SAMSN1;P2RY11;LGALS3;HAVCR2;ADRB2;CALCB;SPI1;RAMP1;ILRUN;VIPR1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.4912076933641142,1.2569340654771501,0.07894736842105263,0.5423961891006541,1.0,19/86,11.81%,TGFB2;DENND1B;PLSCR1;SELL;PIANP;NCR3LG1;BIRC3;SYK;SAMHD1;LILRB1;LRP8;SLA2;RSAD2;TIRAP;BCL6;C3;LYN;ADCY7;PILRA
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.6144526830806888,1.256696657698264,0.17647058823529413,0.5425617387080865,1.0,3/23,6.45%,EGFR;WTIP;ZFP36
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.8383473770004872,1.2565289427979103,0.19230769230769232,0.5424442699379697,1.0,3/5,11.59%,LILRB1;BTLA;LYN
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.5589221292702861,1.2558894335618982,0.10256410256410256,0.543824913046666,1.0,16/42,13.39%,FGL2;TLR2;CSF1R;CLEC5A;ITGAM;C3AR1;MERTK;CSF3R;LILRB1;WDFY4;LY86;P2RY13;PILRA;SLC40A1;AOAH;CLEC7A
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6964970142950458,1.2558314377594844,0.23529411764705882,0.543448820834665,1.0,6/13,16.94%,ADGRV1;COL11A1;SCN1A;PIEZO2;TMEM120A;MKKS
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.766571155154396,-1.255770252647103,0.1956521739130435,0.7670853183703435,1.0,4/8,17.33%,NELFE;CTR9;SUPT5H;CCNT1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.7832552968815488,1.255546373832647,0.16279069767441862,0.5439434198712999,1.0,4/6,19.12%,ITGAM;CAMK4;SPI1;TICAM1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.5916355159681249,1.255544377493613,0.1590909090909091,0.5433843824408052,1.0,3/27,6.09%,CX3CR1;AQP1;LEF1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.6637427215883422,-1.2553537988688104,0.17307692307692307,0.767383888879639,1.0,1/24,0.10%,NGF
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.642796430790205,-1.2551935417670768,0.21818181818181817,0.7666154145482731,1.0,3/22,8.80%,USP27X;OTUB1;OTUD3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.817599783654283,-1.25507247651008,0.11320754716981132,0.7627517934190234,1.0,2/5,10.81%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.817599783654283,-1.25507247651008,0.11320754716981132,0.7627517934190234,1.0,2/5,10.81%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.817599783654283,-1.25507247651008,0.11320754716981132,0.7627517934190234,1.0,2/5,10.81%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.5927385785214812,1.2548951969452762,0.17073170731707318,0.5447828447470596,1.0,13/39,10.72%,SNAP25;NRXN1;SYN2;RIMS2;SYT1;GAD2;GAD1;SNPH;STX1A;PCLO;DNAJC5;LIN7A;SYN3
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.8116793308266114,1.2548430280151686,0.19230769230769232,0.5444073129834153,1.0,1/5,3.14%,LRRK2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.721824588444769,1.2547881780293095,0.2,0.5440325507520732,1.0,2/8,6.45%,CX3CR1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.6683337202866019,1.254759974176322,0.18,0.543561038460369,1.0,3/17,3.57%,PDGFB;IGF1;NR4A3
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.7628924398235823,1.2547099736256815,0.23214285714285715,0.5430783132166237,1.0,3/5,22.34%,ATCAY;PRUNE2;PRUNE1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.6124400713701631,-1.254443469400766,0.12244897959183673,0.7639927857209585,1.0,4/23,7.82%,P2RY10;LCK;ITGAL;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.8078664205183129,1.2542405566251844,0.15517241379310345,0.5439955205506507,1.0,4/5,18.25%,HSPB1;PRKD1;VEGFA;KDR
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.7756648678335744,1.2534783077988103,0.2830188679245283,0.5457736720628227,1.0,4/7,16.53%,AXL;LILRB1;LYN;GAS6
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.7295627052989502,-1.2533369620695498,0.22,0.7677039286153354,1.0,2/9,7.52%,CRTAM;CD274
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.6273318298130638,1.253147304457105,0.14,0.5462249437624579,1.0,6/16,16.90%,LRFN5;WNT5A;IL33;PLA2G10;CD200;LBP
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7059231065054045,1.2529521964733132,0.24489795918367346,0.5462629583740026,1.0,5/12,14.25%,VCAN;CSPG4;NCAN;UST;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7951240085086039,1.252878615465361,0.22448979591836735,0.5459374381131054,1.0,2/6,7.36%,BMP6;LY86
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.893790166235144,1.2527142846015296,0.08,0.5458667411914285,1.0,2/5,1.77%,CX3CR1;P2RY12
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.7635727522951016,-1.2527056755803179,0.16666666666666666,0.7687054984945807,1.0,4/12,12.36%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.692978479276363,-1.252424545116588,0.17857142857142858,0.7685758341070369,1.0,3/14,13.97%,DDX5;TADA3;PADI2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5305555139900754,1.2523383216490698,0.10204081632653061,0.5464128110408197,1.0,16/74,8.11%,LPL;CX3CR1;VSIR;PTPRC;IGF1;TLR2;PTPN6;C1QTNF4;SYK;PTPRJ;LILRB1;ZFP36;IRAK3;HSPB1;WNT5A;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.7503438103758745,1.2522820636176235,0.20833333333333334,0.5460277372806506,1.0,4/10,14.00%,PTPRC;LRFN5;CX3CL1;CD200
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.7782240501629878,1.2522455989520156,0.20754716981132076,0.5456072453568357,1.0,2/5,7.88%,LEF1;STAT6
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.574018062138485,1.2517544330636128,0.1568627450980392,0.5467666706332966,1.0,9/25,18.85%,DCX;SPEF1;CFAP74;RSPH9;SPAG16;DNAAF1;DRC1;CFAP46;TOGARAM1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.7657160367840928,-1.251717488358445,0.24074074074074073,0.77008246172163,1.0,1/7,1.12%,PDZD11
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.46653093726095785,1.251630780364196,0.09090909090909091,0.5465269081591164,1.0,52/177,14.84%,EPHA3;L1CAM;ROBO2;SEMA3D;CYFIP1;DOK6;EMB;NRXN1;EPHA4;PDLIM7;GFRA1;LGI1;RELN;EFNB3;SRC;PLXNA4;TNR;EPHA6;CNTN4;ROBO4;EFNA5;DOK4;EPHB1;PTPRM;WNT5A;EPHB3;NTN4;PLXNA2;SLIT1;GAP43;SEMA6A;ROBO1;UNC5A;UNC5D;DOK1;PLA2G10;CDK5R1;SEMA5B;SEMA4B;ANOS1;PTPRO;NOTCH3;PIK3R1;GPC1;PTPN11;DRAXIN;DAB1;EFNA3;VEGFA;SEMA4G;SEMA3C;CHN1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.5542670752763018,1.2511176076051238,0.17777777777777778,0.5473702929335326,1.0,8/31,13.32%,CX3CR1;HEY1;BHLHE40;TNFRSF1B;PTPRZ1;KIF14;CX3CL1;HES1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6201305559556891,1.2508619823427294,0.22,0.5476111031837028,1.0,2/16,5.57%,MET;CITED2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.6459539480749286,1.250734885693749,0.2619047619047619,0.547491267898704,1.0,2/18,4.55%,FLT1;PDGFRA
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.680371177225046,-1.250297938527424,0.18518518518518517,0.774594723009753,1.0,2/14,0.75%,CRTAM;PRELID1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.6777950548061841,-1.250086516877081,0.12244897959183673,0.7741560789018096,1.0,1/17,1.09%,OOEP
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.7716928262058873,-1.2500654508457023,0.3023255813953488,0.7728532713031386,1.0,3/7,18.90%,UBE2D4;RNF6;UBE2S
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.770369679933244,1.2500445731234093,0.22448979591836735,0.5492546133430746,1.0,2/6,17.36%,SYK;TNFSF4
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.8060809180416136,-1.2498269104694024,0.2413793103448276,0.7710945569719356,1.0,1/5,2.32%,KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.8060809180416136,-1.2498269104694024,0.2413793103448276,0.7710945569719356,1.0,1/5,2.32%,KIF3B
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.5940383244986045,-1.2493165104821722,0.19148936170212766,0.7716897194184432,1.0,5/30,8.66%,ZDHHC12;SELENOK;ZDHHC16;ZDHHC14;HHAT
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.8525151906094365,-1.249263819105082,0.16326530612244897,0.7691752940564797,1.0,2/5,6.20%,SELENOS;PASK
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.8525151906094365,-1.249263819105082,0.16326530612244897,0.7691752940564797,1.0,2/5,6.20%,SELENOS;PASK
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.7064893308679224,1.2492404641984414,0.18518518518518517,0.5509904484511797,1.0,4/14,15.90%,ISG15;SAMHD1;TTLL12;NLRC5
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5071704586043447,-1.2490482049617377,0.14516129032258066,0.7685450155682526,1.0,21/107,13.56%,RPS27A;UBC;SFRP1;UBB;PSMD7;PSMB6;PSME2;PSMD8;HYAL2;PTGIS;PSMB4;PSMD3;PSMB3;CHUK;PSME1;ADAMTS12;UBA52;PSMA7;PSMD13;PSMB8;SQSTM1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.756609620167607,1.2485910004583083,0.23529411764705882,0.5524834116961614,1.0,4/7,21.90%,DMTN;PRKCE;ARHGEF7;DDR2
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.8105749882777388,1.2485147071867675,0.26785714285714285,0.5522037232392679,1.0,2/6,17.69%,GAS6;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.7794946854284858,-1.2484648020975806,0.16363636363636364,0.7696564125444024,1.0,2/6,8.62%,PTH;P2RY6
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.5554301687926774,1.2482727252467405,0.15217391304347827,0.5523187850354737,1.0,12/34,15.14%,PDGFB;SPOCK1;NPNT;VIT;DMTN;CORO1C;BST1;FBLN2;CX3CL1;PTPRO;THY1;ECM2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.5497139297047503,-1.2480291900020437,0.19298245614035087,0.7702782783305234,1.0,21/61,28.30%,CSTF2T;SRSF7;SRSF9;SRSF3;CSTF2;RBM8A;DHX38;MAGOHB;ALYREF;FIP1L1;SLU7;CASC3;SRSF2;CDC40;CPSF4;CSTF1;TUT4;MAGOH;CLP1;DDX39A;THOC5
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.8637922905066421,-1.2478932946919126,0.1702127659574468,0.769517195010667,1.0,3/6,7.32%,PRDX1;SOD1;SOD3
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.470448987951834,-1.2478821061300407,0.078125,0.7681722868492938,1.0,33/182,15.38%,CXCR4;DDIT3;BUB1;PRDX1;EIF2S2;GAPDH;SQLE;CCNG1;CD9;TUBG1;GLA;HSPE1;PNO1;SDF2L1;DHCR24;DHFR;MCM4;FDXR;CCT6A;SC5D;PPIA;SRD5A1;IDI1;SERPINH1;RRP9;BTG2;SLC7A11;PSMD13;SQSTM1;COPS5;SLC37A4;FADS1;EPRS1
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.8530023817375919,1.2475217735808892,0.19148936170212766,0.5539371941543594,1.0,2/5,7.05%,ANGPT1;TJP2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.4685766029600188,1.2474318140239202,0.08,0.5536449691521536,1.0,25/111,7.78%,ROR1;EPHA3;SLA;EGFR;FLT1;MPZL1;CSF1R;PTPRG;EPHA4;MET;LCP2;PDGFRA;SRC;TNK2;SYK;NTRK2;MERTK;EPHA6;BLNK;AXL;EPHB1;STYK1;SH2D6;LIFR;EPHB3
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6637463993762724,-1.2464401961757965,0.16326530612244897,0.7732724000506076,1.0,11/26,16.69%,RPS27A;UBC;UBB;DYNLL1;CFTR;DYNC1H1;UBA52;SQSTM1;ARL13B;DYNC1I2;PARK7
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.7626631446019703,1.246260561950044,0.2549019607843137,0.55652120018672,1.0,3/6,22.34%,ATCAY;PRUNE2;PRUNE1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.7516831203508588,-1.2461691940454744,0.24242424242424243,0.7730068468383869,1.0,2/6,16.87%,PUSL1;PUS1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.7145513263649756,-1.2460046343384361,0.25,0.7725234438393869,1.0,1/8,3.57%,BACE2
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.6345725673747952,1.2460032314905927,0.20454545454545456,0.556679078608886,1.0,3/19,4.77%,EGFR;NOSTRIN;DDAH1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6883816384068436,-1.2459112717048442,0.23333333333333334,0.7714593386983865,1.0,5/14,16.52%,ATP5F1B;ATP5MC3;ATP5PF;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.6586341939874432,1.245824921223076,0.20454545454545456,0.5566821301361627,1.0,5/20,11.50%,SYT4;SYT1;SYT13;SYT7;SYT17
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.7988429472099975,-1.2457574685130357,0.16981132075471697,0.7680720522921217,1.0,1/5,1.76%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.7988429472099975,-1.2457574685130357,0.16981132075471697,0.7680720522921217,1.0,1/5,1.76%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.7988429472099975,-1.2457574685130357,0.16981132075471697,0.7680720522921217,1.0,1/5,1.76%,DCXR
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.8231807396580646,1.245471128303893,0.21739130434782608,0.5571482487346748,1.0,1/6,0.80%,PDGFB
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.5486443313812976,-1.2452457544297544,0.16666666666666666,0.7687581368600517,1.0,13/39,19.89%,DPEP1;CPA1;GPX4;DAGLA;PTGIS;ABCC1;FADS1;DAGLB;MGLL;ALOX5;CYP4F22;CYP2J2;CYP4Z1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7505107715467272,1.2452057797720208,0.28205128205128205,0.5574829585227562,1.0,1/5,4.28%,FGF13
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.63086508366957,-1.2450097561650981,0.17543859649122806,0.7684315006170637,1.0,4/20,20.44%,PTPA;PPP1R35;SH3RF2;ZCCHC9
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.7770278337604036,-1.2448396881333366,0.2037037037037037,0.7677169746680039,1.0,3/6,19.46%,PRPSAP2;TKT;G6PD
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.7551850483113536,-1.244474664323086,0.13636363636363635,0.7679973744960091,1.0,1/8,1.07%,CORO1B
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.49195157736427864,1.2444176292486728,0.16666666666666666,0.5594997081107621,1.0,19/70,13.81%,PDE10A;HCN1;UNC13C;GNGT1;XKR4;MGAT4C;TNR;KCNJ6;SCN3B;KCNB1;GRM6;FAM227A;ATCAY;SRRM4;MYT1L;SV2B;ASMT;TVP23A;CDH7
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5393479686921295,1.2441896841483695,0.14285714285714285,0.5595236202222815,1.0,9/44,10.95%,RAB27B;RAB3C;CADPS;RIMS2;SYT1;STXBP5L;CADPS2;RAB15;SYTL4
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6619127318989066,-1.2438624242414,0.1320754716981132,0.7690521595951403,1.0,2/21,4.23%,LCK;SLC39A6
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6748523541026491,-1.2438141571908137,0.13725490196078433,0.767910254800943,1.0,2/19,4.23%,LCK;SLC39A6
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.7495058415166759,-1.2438006822768288,0.23636363636363636,0.7666291983737351,1.0,3/8,9.38%,PRDX1;PRDX5;PRDX3
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.4608165563269094,1.2436509929959798,0.05555555555555555,0.5606591764188629,1.0,35/156,10.12%,FLI1;ADAMTS5;IGFBP3;PLSCR4;MFAP5;IGF1;CD44;FOSL2;KLF9;FSTL1;SYNPO2;FAP;PCDH18;ADAMTS10;HGF;POSTN;CTHRC1;LAMC1;PDGFRA;TNFRSF1B;COL5A3;LOX;OLFML2B;ITGBL1;COL12A1;PBX1;SULF1;CCDC80;COL4A1;FBLN5;COL15A1;COL7A1;VIM;FBLN2;PAMR1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5563993889109969,1.2436162651887883,0.14,0.5602920032943137,1.0,7/39,6.98%,PPARG;PTPRC;PARP14;ISG15;H2BC11;SAMHD1;IRAK3
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.46075345464912304,1.243616217508746,0.15789473684210525,0.5597367089402064,1.0,22/115,10.44%,PDGFB;EGFR;AQP1;SSTR1;P2RY12;RYR3;ADCY8;LRRK2;MEF2C;NR4A3;HCN1;GABRG2;GABRB2;ABCB4;GNG2;ADCY2;CASP7;DIAPH1;TRPM2;DMTN;GABRB3;P2RY1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.4322724380618938,1.2431580018469206,0.0,0.5607271846838545,1.0,25/228,10.20%,KLRF2;TGFB2;PLAC8;PDGFC;PDGFB;PLCB1;BMPR1B;SYK;OXTR;ADRA1A;LEF1;PPARGC1A;SOX9;ACADL;EPAS1;ZBTB16;WNT5A;STAT6;KDM3A;DIO2;IL33;SOX5;PRKAB2;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.7745488372243352,1.243138846261299,0.17391304347826086,0.5602314569625034,1.0,2/5,18.99%,TRPV4;SLC12A5
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7150361690197501,1.2430960247929828,0.1891891891891892,0.5597837812393351,1.0,2/8,5.46%,GALNT3;GALNTL6
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.6913666371562163,-1.2429012638223822,0.24561403508771928,0.7686379397395553,1.0,1/13,9.45%,CHUK
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.5321334658106871,-1.2425022301180377,0.18867924528301888,0.7689428677241508,1.0,9/94,6.37%,NGF;CXCR4;LCK;DDIT3;CDK4;PFN1;CFL1;FGF6;ITPR2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.7761095992570357,-1.2422860662153887,0.16666666666666666,0.7684780438350995,1.0,1/7,4.99%,USH1C
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7903800793918945,-1.242143591107132,0.19148936170212766,0.7677732262154481,1.0,2/6,6.65%,EME1;MUS81
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.7005346427414294,1.2420236586661082,0.24074074074074073,0.562029218197381,1.0,4/9,16.17%,BMP6;NOTCH4;VEGFA;MAD2L2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.7665853941112842,1.2419402244803257,0.2545454545454545,0.5618038049319282,1.0,4/6,20.39%,ZFP36L1;PTEN;RGCC;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.8627566262303394,1.2419009524830162,0.22727272727272727,0.5613559032769374,1.0,2/5,6.28%,PTPRC;PTPRJ
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.7110453225486746,-1.241336083260017,0.24444444444444444,0.7697520903693393,1.0,3/7,17.97%,AGER;HLA-DRA;TARM1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.46859862313705486,-1.241324210466006,0.13114754098360656,0.7684526826650802,1.0,41/233,15.99%,RPS27A;UBC;RAD23A;COPS6;USP27X;UBB;PSMD7;JOSD2;PSMB6;PSME2;ADRM1;PSMD8;USP1;USP51;USP16;PSMB4;USP19;OTUB1;RHOA;OTUD3;PSMD3;PSMB3;CFTR;PSME1;BRCC3;TADA3;GPS1;UBA52;TOMM20;PSMA7;PSMD13;PSMB8;HGS;COPS5;TOR1A;KEAP1;ACTR8;STAMBP;PSMD2;ABRAXAS1;SMAD7
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.6775477230695575,1.2413088942558306,0.2,0.5624913187282979,1.0,6/14,14.42%,ANGPT1;MET;PTPRJ;CX3CL1;VEGFA;LGALS3
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.7051272827901917,1.241298832101209,0.23214285714285715,0.5619382299193222,1.0,5/9,11.44%,CHI3L1;PID1;PTPRT;SELPLG;ST3GAL6
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.5068712134306367,1.2406296848957163,0.18181818181818182,0.5635270925396008,1.0,14/65,12.42%,ROR1;MYO7A;ADGRV1;COL11A1;MYO3B;GRXCR2;PCDH15;SLC26A4;CRYM;ATP2B2;USP53;CDH23;PIEZO2;GSDME
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.6903952947586106,1.2403551773602173,0.21052631578947367,0.5636051834700795,1.0,3/11,10.52%,CAMK2B;NETO1;DLG4
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7009279460718599,-1.2402787127232822,0.17777777777777778,0.7718798907876403,1.0,5/13,22.19%,LAMTOR4;CD81;GLMP;LAMTOR5;RNF128
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.46397437706539485,1.24003323554713,0.11627906976744186,0.564010043013467,1.0,33/146,12.86%,NPY;L1CAM;GPM6A;FRY;NCKAP1L;MYO16;CTNND2;LRRK2;EPHA4;DCLK1;ADGRV1;MAP2;PAK3;LGI1;NYAP1;CNTN4;PACSIN1;EPHB1;STX3;PTPRM;GPRIN3;EPHB3;CNTNAP1;SH3GL2;UNC5A;DLG4;MAPT;CDK5R1;ATCAY;LYN;VASH2;TNIK;SHANK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.57344391723347,1.2398131045000464,0.17543859649122806,0.5640408505952158,1.0,5/29,8.44%,TM4SF20;LRRK2;TIMP4;EPHA4;F2
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.7647889089808568,-1.2396990607434821,0.2549019607843137,0.7733617902647775,1.0,1/7,2.99%,KDELR1
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),0.7936882476652651,1.239504643578636,0.2,0.5644095327792584,1.0,1/5,4.76%,SLC22A16
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.7991197044400682,-1.2392770326452625,0.2,0.7737396158854056,1.0,2/7,6.50%,CBR1;PTGIS
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.8039856326558178,1.2387702698529606,0.23076923076923078,0.5661744785382583,1.0,1/7,2.30%,PPP1R3C
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.6702556338916001,1.2380902738499266,0.22727272727272727,0.5676684832814884,1.0,4/18,6.73%,PDGFB;P2RY12;CSF1R;STX3
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.4535373208638527,1.2376367612256756,0.02564102564102564,0.5686599635840275,1.0,39/143,17.09%,NFKBIE;CD44;TLR2;FOS;FOSL2;KLF9;F3;BHLHE40;KYNU;TNC;NR4A3;BIRC3;MAFF;ID2;ZFP36;ETS2;PER1;NFKBIA;CCND1;PFKFB3;SOCS3;BCL6;OLR1;TUBB2A;TGIF1;CEBPD;TSC22D1;HES1;ABCA1;VEGFA;TRIP10;CD83;KDM6B;TIPARP;JUNB;CDKN1A;PHLDA1;KLF6;CD80
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6989543325018628,1.2373108896525973,0.20754716981132076,0.5693012862735134,1.0,1/12,1.41%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.5323211226205362,1.237262908225111,0.22857142857142856,0.5688049329844427,1.0,12/48,16.20%,FOS;MAP3K5;GRIN2B;LRRK2;ITGAM;WNT5A;MAPT;SARM1;ACER2;CIDEB;ACOX2;DDIT4
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.6216134525926944,-1.2368943573927023,0.22448979591836735,0.781908946034599,1.0,15/38,21.33%,OOEP;CENPX;PCNA;EME1;TONSL;RFWD3;ZNF830;BLM;ALYREF;ATR;DDX11;PRIMPOL;MSH3;EXD2;FAM111A
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.5147433080956383,-1.2368594236164228,0.14754098360655737,0.78075443023434,1.0,30/89,28.37%,SRSF7;RBM15B;SRSF9;SRSF3;RBM8A;RAE1;DHX38;MAGOHB;NUP37;ALYREF;FIP1L1;NXT1;SLU7;TPR;CASC3;NUP210;POM121C;SRSF2;UPF2;CDC40;NUP93;NXF1;CPSF4;NUP42;MAGOH;NUP58;MCM3AP;DDX39A;THOC5;NUP85
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.4971709215941971,-1.2367317952752594,0.18032786885245902,0.780052418915755,1.0,23/105,13.29%,RPS27A;UBC;SFRP1;UBB;ACAA2;PSMD7;PSMB6;PSME2;PSMD8;ELOC;OPRD1;PTGIS;ELOB;PSMB4;NOP53;PSMD3;PSMB3;PSME1;UBA52;PSMA7;PSMD13;PSMB8;SLC8A3
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.7679432478295236,-1.236366505587166,0.2549019607843137,0.7802204799654526,1.0,4/7,12.60%,VAMP8;CALM1;SNAP29;ATG14
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.8259585835725585,-1.2363413074360388,0.2222222222222222,0.7790466942361077,1.0,2/5,4.73%,AQP9;SLC28A1
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.6771287431685844,1.2362201650580862,0.2727272727272727,0.571333207939485,1.0,3/11,11.49%,NCKAP1L;DMTN;ALAS1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5695093350263241,-1.2361741598856681,0.16363636363636364,0.7782674034484693,1.0,4/32,8.67%,RPL11;UBXN1;GABARAPL2;NOP53
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.7709135826676027,1.2361404562923897,0.24489795918367346,0.5710904651478516,1.0,1/7,0.27%,TGFB2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.7354605724929104,1.2359736697272898,0.17777777777777778,0.571160379017317,1.0,5/11,19.62%,PGAM5;ITPK1;MLKL;TICAM1;LY96
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7294944979581688,1.2355591757580282,0.25,0.5717499614588892,1.0,1/9,3.09%,DNAJB1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.5983777922807141,1.2354351242708685,0.10909090909090909,0.5716229205971505,1.0,9/25,14.25%,P2RY12;NCKAP1L;CYFIP1;RHOJ;RHOQ;SCIN;ATP1B2;RAC3;CSPG5
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.669911580622082,-1.235346674166169,0.21153846153846154,0.7801503628876858,1.0,4/18,7.32%,PRDX1;NOX1;SOD1;SOD3
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5439417784870181,1.2353043771709096,0.1951219512195122,0.5713808373006852,1.0,5/37,8.78%,ADAMTS5;ZNF423;PGAM5;PLCL2;PLCL1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.5390611401151919,1.2351952300322004,0.1875,0.5711507399406538,1.0,7/36,8.51%,SLC4A10;SLC26A9;SLC26A4;ANO5;ANO6;SLC13A4;SLC26A7
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.7535626838014802,1.2345367695308458,0.21568627450980393,0.5725435124565071,1.0,3/6,22.48%,CITED2;DNAAF1;SETDB2
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.8195521711452368,-1.2344938828423608,0.16326530612244897,0.7819158025207615,1.0,3/7,13.51%,TRMT10C;HSD17B10;TRMT10A
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.8587388052168563,1.2342865303062285,0.2553191489361702,0.5726920870510996,1.0,2/5,5.20%,SRC;NTRK2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.7668610427041064,1.2341763651295405,0.21153846153846154,0.5725532658489914,1.0,3/6,15.83%,VEGFD;VEGFA;IL16
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.7772441059514846,1.2340992821858447,0.2916666666666667,0.5722426125343691,1.0,2/5,10.63%,PLCB1;PLA2G10
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.6501015907942304,1.233708704653199,0.15555555555555556,0.5730673212822183,1.0,5/17,11.49%,TLR2;NCKAP1L;SRC;DMTN;ALAS1
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6154502814022255,1.2337047012961837,0.18181818181818182,0.572527746253754,1.0,2/17,2.57%,ALDH1L1;SHMT2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.5796594459760099,-1.2336943590972531,0.18867924528301888,0.7838835109763048,1.0,12/30,22.50%,DDX5;PRMT2;CARM1;UFL1;RNF6;GPAM;PARK7;KCTD6;KDM5D;PKN1;CALR;UFSP2
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.7367215928189265,1.2336252440238031,0.18032786885245902,0.5722294529499087,1.0,2/6,19.92%,CAV3;TCAP
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.477594552628002,1.2335940355626958,0.13636363636363635,0.5718174395595105,1.0,15/104,7.76%,TGFB2;PKP2;PDGFB;FGF12;MEF2C;PDLIM7;KAT2B;ID2;TBX19;FLRT2;CITED2;KDM6A;SOX9;SGCZ;NDRG4
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.6749116991908373,1.2334633908984332,0.23255813953488372,0.5715889090968727,1.0,2/17,3.01%,IGF1;HEY1
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.8649227497794341,-1.2333006459716371,0.13043478260869565,0.7803155173903182,1.0,1/5,3.86%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.8649227497794341,-1.2333006459716371,0.13043478260869565,0.7803155173903182,1.0,1/5,3.86%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.8649227497794341,-1.2333006459716371,0.13043478260869565,0.7803155173903182,1.0,1/5,3.86%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.8649227497794341,-1.2333006459716371,0.13043478260869565,0.7803155173903182,1.0,1/5,3.86%,EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6974829352743421,1.233270929928226,0.2765957446808511,0.5716460006197853,1.0,4/12,3.73%,LRRK2;NR4A3;HGF;MET
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.7687311559748523,-1.2331040784792067,0.2,0.7798472504301474,1.0,2/8,8.44%,HENMT1;TSN
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.7452488999287737,-1.2330964852390347,0.20754716981132076,0.7785698529553847,1.0,5/10,18.31%,TSR3;RPUSD2;DKC1;NHP2;GAR1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.6261492132215911,1.2329716678745795,0.20689655172413793,0.5719992906121939,1.0,2/23,1.41%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.7422450000024251,1.232855049481194,0.25925925925925924,0.5717940128490726,1.0,3/9,15.86%,ABCC4;ABCC6;ABCC11
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8081642947584979,-1.2328124178713509,0.25,0.7785587016903865,1.0,2/6,8.07%,BUD23;TRMT112
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7152436985465842,1.2327111186124258,0.1702127659574468,0.57166874998307,1.0,3/11,7.80%,PDGFRA;MYLK3;NEBL
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.6589861420788161,1.232697299577677,0.2,0.57114599219049,1.0,3/18,5.20%,EGFR;FOS;MT1M
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.4520669070288496,-1.2326792922894834,0.047619047619047616,0.7777806667039633,1.0,21/251,7.04%,NGF;ARHGEF16;TNFRSF8;DDIT3;RPS27A;UBC;RPS3;SAP18;PRR7;RPS6;SFRP1;USP27X;UBB;PTPA;TNFAIP8;RACK1;MYBBP1A;SPHK2;PTGIS;PRMT2;SOD1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.6206626436406439,-1.232295427113204,0.23404255319148937,0.7780853186173354,1.0,1/16,0.43%,KLK6
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.7243738127923169,1.2322594861931426,0.23076923076923078,0.5718617075234192,1.0,4/9,18.25%,COL4A1;NOTCH4;VEGFA;KDR
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.7509085219189006,-1.231952226972253,0.25,0.7780886692664926,1.0,1/7,5.24%,PHAX
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.7515505655914702,1.2319156359365275,0.24561403508771928,0.5717933086995517,1.0,3/6,22.94%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.7515505655914702,1.2319156359365275,0.24561403508771928,0.5717933086995517,1.0,3/6,22.94%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.8010396509533726,1.2317973503559891,0.2909090909090909,0.5714761913277762,1.0,2/6,14.01%,SHMT2;SHMT1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.8118643562518431,1.231526134873226,0.17777777777777778,0.5718156486494089,1.0,3/7,12.03%,HTR5A;HTR2C;HTR1E
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.619911588009519,1.2313786336790957,0.22807017543859648,0.5717137954490807,1.0,6/25,10.93%,IGF1;GRM5;EPHA4;CACNB1;GRIN1;NGFR
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.566495698114871,-1.2311526925564236,0.1694915254237288,0.7800543755735799,1.0,10/47,15.33%,MSRB1;MAP7D3;MSRB2;GPX4;CHMP2A;CASQ2;CHMP3;GSN;RAC1;TPPP3
prerank,"GO_Biological_Process_2021__complement activation, classical pathway (GO:0006958)",0.8010761007852861,1.2309215357379433,0.17307692307692307,0.5728877277143386,1.0,1/5,2.10%,C1QB
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.8061082754009583,-1.2308963188279138,0.20689655172413793,0.7797415675362714,1.0,2/6,2.35%,UXT;UBB
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.4673726817501501,1.230665790816331,0.13157894736842105,0.5731346620797326,1.0,19/126,8.17%,MMRN2;PLSCR4;BMP6;AQP1;ITGB4;STAB1;FSTL1;POSTN;TMEM47;LOX;ROBO4;ITGBL1;COL12A1;SULF1;PTPRJ;COL4A1;EPAS1;NTN4;PXDC1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.5166388232901057,-1.2305036978297914,0.12280701754385964,0.7800953474270708,1.0,26/110,15.27%,ZDHHC12;RPL11;NACA;SRPRA;SRP14;TIMM10;KATNB1;SLC25A6;TIMM8B;AIP;MYO1C;TSPO;ZDHHC14;NACAD;SPCS1;AP4B1;FIS1;SPCS2;ZFAND2A;YIF1B;ZFAND2B;TOMM20;SPCS3;CDC37;RABGEF1;TOMM7
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.6112615242242148,1.2304823514601857,0.21568627450980393,0.5730205830085351,1.0,11/23,16.75%,P2RY12;CYFIP1;CARMIL1;SPEF1;ARHGEF6;ABLIM1;DMTN;PTPRO;CDH13;ARHGEF4;ARHGEF7
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6188626469607923,1.2298349528807901,0.14634146341463414,0.5742462334912244,1.0,4/15,11.25%,GPR35;LRCH1;DOCK8;CX3CL1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.6228762079259781,-1.2298106878370725,0.2,0.7814921485059005,1.0,5/27,8.63%,ORC1;PCNA;TFDP1;DHFR;CDK15
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.7283868827828137,-1.229695314450644,0.21052631578947367,0.780758828568596,1.0,1/6,1.29%,SELP
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.6198241356255557,1.229538618863811,0.19607843137254902,0.5746936097275906,1.0,6/29,6.85%,IGF1;GRM5;EPHA4;CACNB1;CACNA1B;GRIN1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.6565067687356949,1.229500442340786,0.16666666666666666,0.5742076218489777,1.0,3/19,5.20%,EGFR;FOS;MT1M
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.7511716650099377,1.2291426850396285,0.15555555555555556,0.5746990895329289,1.0,1/8,2.47%,CBS
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.7993974801657999,-1.2290263348775892,0.25925925925925924,0.7820013169182611,1.0,1/5,7.56%,NMU
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.7843501637076161,-1.2288977435847868,0.24528301886792453,0.7811615970883948,1.0,1/5,2.89%,SERPINE1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.4470711472702012,-1.2288811233720767,0.09375,0.7799204229881652,1.0,42/294,15.69%,DDIT3;RPS27A;SELENOS;UBC;RAD23A;UBB;ANAPC15;SEC61B;UBXN4;PSMD7;DMAC2;PSMB6;UBXN1;PSME2;PSMD8;HECTD3;CDC26;CDC23;FBXO48;PSMB4;USP19;UBQLN2;PSMD3;PSMB3;TMEM129;PSME1;ERLIN2;ZFAND2A;SPSB3;ZFAND2B;KLHL20;UBA52;PSMA7;PSMD13;PSMB8;KAT5;ERCC8;FEM1A;RNF126;PSMD2;UBE2A;UBXN8
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.7457646744844433,-1.2287541817124317,0.2653061224489796,0.7790329942942732,1.0,4/8,6.59%,NES;CFL2;KATNB1;SEMA5A
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.8229108619444218,1.2285676496636586,0.1956521739130435,0.5757727608251384,1.0,4/5,17.19%,CACNA1G;SCN4B;CACNB2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.7796553644544618,1.228533402335543,0.1956521739130435,0.5753319431998243,1.0,1/7,8.67%,TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6662437223938174,1.2282752604644163,0.22,0.5755523378342335,1.0,6/15,16.53%,NCKAP1L;SYK;AXL;ZAP70;ZBTB1;GAS6
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.6030753367441404,-1.2279674892761678,0.22807017543859648,0.7807268222131505,1.0,7/24,13.90%,DPM3;PGAP2;PIGO;PIGF;PGAP4;PIGW;DPM2
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.8235586293572835,1.2278193979634826,0.17647058823529413,0.5762755280895935,1.0,1/5,9.91%,BMPR2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5189084240445468,1.2277972801693322,0.125,0.5757907916264681,1.0,18/101,12.31%,EGFR;OSGIN1;CSF1R;CAMSAP3;ARHGAP18;PRKX;LDB2;PLXNA4;NRG1;ROBO4;DIAPH1;PLXNA2;FBLN1;KIF14;AMOTL1;TTBK2;FGF17;TMSB15B
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.5190957960797101,1.2274008519565547,0.17777777777777778,0.5764342725321933,1.0,27/64,20.18%,SNAP25;NRXN1;SYN2;SLC1A2;SYT1;GAD2;GAD1;GABRA2;SLC22A3;SNPH;STX1A;DNAJC5;LIN7A;SYN3;SLC6A15;SLC6A4;SLC1A1;RAB3A;SLC29A2;CPLX1;SLC6A16;PPFIA3;TSPOAP1;SLC29A4;ATP1A2;UNC13A;SLC28A2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.6618353899783334,-1.2273426938295788,0.21739130434782608,0.7816777707816595,1.0,1/12,0.34%,ZDHHC12
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.5711580723037194,1.2271473161099562,0.23255813953488372,0.5765078462867295,1.0,12/38,10.72%,SNAP25;NRXN1;SYN2;SYT1;GAD2;GAD1;SNPH;STX1A;PCLO;DNAJC5;LIN7A;SYN3
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.667010451705951,-1.2271306705784035,0.17647058823529413,0.7813406181214769,1.0,3/13,5.92%,AK8;CMPK1;ENTPD2
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.6775566551619755,1.2271120125404829,0.2978723404255319,0.5760799558007698,1.0,2/15,5.73%,CSF1R;C5
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.48685232004212525,1.2270413526709862,0.18,0.5757975574389281,1.0,12/78,10.65%,EPSTI1;TRIM5;PLSCR1;MX1;SELL;TMEM140;PARP14;ISG15;UBA7;RSAD2;MVB12A;PARP9
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.5263578784467902,1.2268363956485435,0.20512820512820512,0.5759159987570012,1.0,8/42,7.75%,DACT2;CERS3;ITGB4;MET;COL5A3;SCEL;TP63;WNT5A
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.45477364601937004,1.2268169526870882,0.1,0.5754232013390547,1.0,32/124,14.53%,NRCAM;GPM6A;NTNG1;NCKAP1L;MYO16;CTNND2;BAIAP2;LRRK2;PLPPR4;DCLK1;MAP2;PAK3;SLITRK5;ADGRB1;SLITRK3;NYAP1;CNTN4;PACSIN1;EPHB1;EPHB3;CNTNAP1;SLITRK4;FLRT1;DLG4;TNIK;SHANK1;ANK3;RAB3A;LRP4;FARP1;PARD3;NYAP2
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.7029145124893003,-1.2268031143310913,0.24561403508771928,0.7813921134481715,1.0,1/11,3.93%,AADAT
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6242352749709772,-1.2265301803679496,0.20408163265306123,0.7811098750409595,1.0,2/19,1.34%,LCK;RPS3
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.7761408394861881,-1.2260446777644765,0.22641509433962265,0.7815878573242794,1.0,3/8,6.59%,CFL2;LIMA1;SEMA5A
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6240859632879551,1.225909198789247,0.19230769230769232,0.5780279602803238,1.0,5/24,10.82%,IFNA2;TRIM5;CIITA;CD4;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5179735491620036,1.225407429499307,0.19444444444444445,0.5790754470120738,1.0,11/44,14.86%,MAP3K5;GRIN2B;TBC1D10A;SYK;GRIN1;NOD1;DAPK1;ACVR1C;CLEC7A;NLRP3;CIDEB
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.716072942731413,-1.225217732662276,0.25,0.7834076036756321,1.0,2/9,10.90%,B4GALT7;B3GALT6
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.7336287156767336,-1.2248847890497339,0.2391304347826087,0.7835351343418142,1.0,3/12,15.56%,OOEP;CEP120;DNAJA1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.5091859413455124,-1.224722967720003,0.20689655172413793,0.7829463542289243,1.0,5/75,7.79%,ARHGEF16;TAX1BP3;RHOG;TBC1D16;RASGRF1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.8352325387104056,-1.2246176743325832,0.24528301886792453,0.7821344346802722,1.0,2/5,6.75%,GLA;GBA3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.7880168051474835,-1.2244589383623188,0.14285714285714285,0.7815761905725326,1.0,2/7,19.91%,MSH3;PRKDC
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.7526073448829683,-1.2243775872665168,0.2777777777777778,0.7794111553900213,1.0,5/9,23.14%,AP2S1;MYLIP;AP2A1;CLTA;AP2B1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.7526073448829683,-1.2243775872665168,0.2777777777777778,0.7794111553900213,1.0,5/9,23.14%,AP2S1;MYLIP;AP2A1;CLTA;AP2B1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7059469108811718,1.224341710936897,0.28888888888888886,0.5818381386153318,1.0,5/11,14.25%,VCAN;CSPG4;NCAN;UST;CSPG5
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6417537892189268,-1.2241250683240394,0.18,0.7792149964721339,1.0,3/16,8.77%,CBR1;LRAT;VKORC1L1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7966322326186728,1.223988655557319,0.25,0.5822492547359902,1.0,1/5,14.38%,VEGFA
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.5503870530716457,1.2236954290760278,0.17073170731707318,0.5827701857912396,1.0,13/37,12.33%,FGL2;PTPRC;DCLK1;ITGAM;CSF3R;IL13RA1;CAMK2B;SOX9;P2RY13;TMEM176B;NREP;KLF3;AOAH
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5888257310320282,1.2236905161513878,0.16981132075471697,0.5822516778112469,1.0,4/21,9.10%,MDFIC;SIAH3;LRRK2;DMTN
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.7239735986854432,1.2230502155174245,0.2631578947368421,0.583522180274305,1.0,4/8,20.48%,ANO6;GPER1;RGCC;PLCG1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.7058201985615659,1.222253150601185,0.16666666666666666,0.5853747674170775,1.0,2/11,4.57%,LRRK2;SRC
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.828839356839483,1.222051473356976,0.22448979591836735,0.5852518981445585,1.0,2/5,6.91%,ADRA1A;TPM1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.726378220995588,1.2220257143218736,0.2,0.5847880470758086,1.0,5/10,15.91%,NRXN1;WNT5A;LRP4;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7974955601875179,1.2219518212078102,0.22641509433962265,0.5845669772804549,1.0,3/6,12.47%,UHRF1;UHRF2;HELLS
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.8147900076084073,-1.2217774440948745,0.2692307692307692,0.7875943977324152,1.0,3/5,12.51%,ZNF598;RACK1;MTRES1
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.7581194772377566,1.2216986760035804,0.22448979591836735,0.584840704777695,1.0,2/5,15.19%,ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.7413738414988751,1.2216855930963202,0.1951219512195122,0.5843675389208284,1.0,4/9,10.82%,VSIR;BCL6;CR1;DUSP10
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.7153029683508869,-1.2215965237243855,0.3,0.7869663832915307,1.0,5/12,22.67%,ELOVL1;FADS1;ACOX1;ELOVL2;ACAA1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.6366554248081904,1.2215326182867714,0.23529411764705882,0.584224230413963,1.0,12/22,17.19%,TRPC4;SLC8A1;CACNA1G;CACNA1B;MAIP1;CACNA1I;TRPV4;CACNA1E;MICU3;CACNB2;MCUB;CACNA1C
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.5077131623763079,1.2208084694979038,0.11363636363636363,0.5853959187962999,1.0,19/77,12.69%,RYR3;TRPC4;TRPC7;GRIN2B;SLC8A1;CACNA1G;SLC24A4;SLC24A3;ANO6;TRPM3;GRIN1;TRPM1;ATP2B3;TRPM2;MAIP1;TRPC6;TRPC3;TRPV4;MICU3
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.8213642554609443,1.220688622979145,0.19642857142857142,0.5846707631453854,1.0,1/5,3.47%,NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.8213642554609443,1.220688622979145,0.19642857142857142,0.5846707631453854,1.0,1/5,3.47%,NRXN1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.7076804409536881,-1.2206723845807286,0.3269230769230769,0.789364182114763,1.0,4/12,16.50%,STX10;TMED9;LMAN1;SURF4
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.4204221866628851,1.220509035227822,0.1,0.5846915916889753,1.0,87/348,20.51%,TGFB2;IGFBP3;PDGFB;MAP3K21;MAP3K5;LRRK2;PEAK3;DGKB;DCLK1;PIM1;BMPR1B;CDKL4;STK17B;PAK3;HUNK;PRKG2;TNK2;SYK;MERTK;PRKG1;PRKCZ;HIPK3;CAMK2B;IRAK3;MYLK3;AURKC;PRKCG;PICK1;DAPK1;PLK1;CAMK2D;NUAK1;DGKI;BMPR2;ACVR1C;TEC;MKNK1;DYRK2;CSNK1D;CDK12;ZAP70;PRKD1;LYN;AKT3;PRKAR1B;IP6K3;DMPK;TNIK;PDK4;DYRK3;MAK;STK17A;WNK2;CDK19;DYRK1B;PRKCE;ACVR2A;CERKL;TSSK3;LMTK3;CAMK4;PAK5;STK38;GAS6;PRKAG2;CDKL1;GK;PRKCD;CDK13;STK38L;CDC42BPA;GRK4;AGK;LIMK2;MEX3B;COQ8B;FER;MKNK2;BMX;ULK1;CSNK2A1;PAK2;MAP3K20;DGKE;VRK1;PGK1;CDK6
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.7772351900456909,1.2203114458874509,0.3023255813953488,0.5847342139321731,1.0,2/6,10.63%,PLCB1;PLA2G10
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4722562752404247,1.2194897604771355,0.1,0.586870699506866,1.0,25/106,17.02%,WTIP;PID1;LRRK2;NEDD4L;MEF2C;EPHA4;PAK3;SIPA1L1;EFNA5;BMPER;EPHB3;KNDC1;BCL6;LZTS1;MAPT;CDK5R1;SARM1;VASH2;TNIK;HECW1;CHN1;NSMF;PHLDB2;ARHGAP44;RUFY3
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.697568403894218,-1.219452703283898,0.2857142857142857,0.7927477159829343,1.0,3/10,12.59%,XG;ICAM1;AGER
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.7968033337184051,-1.219375269870236,0.23076923076923078,0.791762237677095,1.0,2/6,2.63%,SFRP1;GREM1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6823470207368627,-1.2193071090908565,0.26,0.7908059105611436,1.0,9/16,25.28%,TSEN34;CSTF2;C2ORF49;FAM98B;RTRAF;DDX1;ERN1;CPSF4;TRPT1
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.7595524416603565,1.2191966486293224,0.17647058823529413,0.5871727532669947,1.0,6/9,17.36%,NFKBID;PRKCZ;NFKBIZ;NLRP3;CD80;TNFSF4
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.5720142515723945,-1.2187791949609916,0.22641509433962265,0.7918948549733495,1.0,13/47,19.95%,RAD23A;UBB;PSME2;ARAF;USP19;GABARAPL2;PSME1;UFL1;RHBDF1;PRKACA;PSMC5;TMF1;PINK1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7483114569949965,-1.2184654940623452,0.20833333333333334,0.7919413706802336,1.0,2/11,4.61%,CA6;TAS2R40
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.5853943003017978,1.2184560680802226,0.21153846153846154,0.5889003217460489,1.0,3/28,8.04%,MX1;DNM1;DYSF
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.6204960594602273,1.2184437350380688,0.15384615384615385,0.5883842653639604,1.0,7/27,8.67%,RHBDF2;SYT4;IL12A;TNFRSF1B;LILRB1;RSAD2;TNFRSF1A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.581990776591122,1.2184424186966434,0.16,0.5878474184065117,1.0,2/21,1.62%,TEX15;FOS
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6104470488391356,1.2180479930021142,0.2,0.5883971738755649,1.0,8/24,13.49%,IGF1;NR4A3;SORBS1;IRS1;RHOQ;C3;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7872220225156475,1.2178925569550874,0.19230769230769232,0.5884036104967884,1.0,3/6,12.71%,NRG1;DMPK;RBM24
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5813715240334623,-1.2177969218808473,0.2033898305084746,0.7935438364643066,1.0,12/44,16.72%,PCNA;MBD4;POLD3;MPG;PARP1;APEX1;POLD4;PNKP;HMGA2;POLG;RFC1;ADPRS
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.6301147112468057,-1.2174175579176036,0.26,0.7939372097847297,1.0,4/20,11.86%,PTPA;PPP1R1B;YWHAB;PPP1R11
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4958761915383586,1.2173346283153295,0.12,0.5894611739785002,1.0,19/60,17.79%,NCKAP1L;BAIAP2;ARHGAP18;PAK3;TWF2;CARMIL1;FCHSD2;BAIAP2L1;TENM1;VIL1;CDC42EP4;ARHGAP28;KANK1;CDC42EP3;HCLS1;PRKCE;BIN1;PRKCD;SSH2
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.6914247964941513,1.2168015933702925,0.30434782608695654,0.5904193749583214,1.0,4/11,14.38%,CX3CR1;FZD3;CX3CL1;VEGFA
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.5116246777553445,1.2162625632932043,0.061224489795918366,0.591602988039243,1.0,21/64,12.98%,PTCHD1;CMYA5;PPP1R1A;SORBS1;FGF13;LRRC2;ADCYAP1R1;WIPF3;ADRA1A;SLC35F1;ANO5;MYLK3;ADCY2;NT5C1A;COL9A1;SYCP2L;MAPT;ATP1B2;CNTFR;CACNB2;ACACB
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.46242510355149047,1.2159676746962953,0.125,0.5917577899262247,1.0,20/147,6.28%,CX3CR1;PDGFB;EGFR;KITLG;ANGPT1;P2RY12;CHI3L1;PIK3AP1;F3;PHLPP2;HGF;MET;PDGFRA;SRC;NRG1;IRS1;NTRK2;AXL;ARRB2;PTPRJ
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.6276457748471037,-1.215915660164074,0.1875,0.7984143101552637,1.0,6/22,18.45%,VPS25;VPS28;SNF8;RNF126;VPS36;NEDD4
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.7904048573373131,1.2157394588072423,0.30434782608695654,0.5918799195749356,1.0,3/5,19.62%,SARM1;TICAM1;LY96
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.6265050647566727,1.2156759529125143,0.25,0.59149482008575,1.0,4/17,18.25%,IGF1;SOX9;ZFP36L1;KDR
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.46842774237263624,1.2154737508312552,0.075,0.5915199679113178,1.0,35/105,16.49%,EGFR;GFAP;EFNB3;NR2F1;DDAH1;NYAP1;CHST3;LEF1;MEIS3;SLC13A4;SOX9;TEAD1;LIFR;NDRG4;KIAA1549L;NGEF;FNDC4;NUAK1;PHYHIP;EPB41L1;ANTXR1;DZIP1;CPE;KCNIP3;TMEM59L;KAZN;GPC1;SHROOM2;LRP4;CAP2;FARP1;SRRM3;AGAP1;DOCK1;TNFRSF19
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5316644165215646,-1.2151983012025043,0.2,0.7998185351986592,1.0,6/54,8.57%,ARHGEF16;BTN3A1;S100A16;TMEM125;LAMB3;ATP2C2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.4451903830674552,1.2151433421302025,0.0975609756097561,0.5919757860547264,1.0,22/137,12.18%,TGFB2;CLDN5;PPARG;AQP1;FLT1;STAB1;CHI3L1;RHOJ;F3;ADGRB1;SULF1;PTPRM;ADAM12;BMPER;HSPB1;WNT5A;VEGFD;SEMA6A;PDE3B;PRKD1;ZNF304;VASH2
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7697252298551873,1.2150423684518066,0.25925925925925924,0.5917099834403947,1.0,5/6,22.10%,CRYM;SLC7A8;SLC16A10;SLC16A2;SLCO1C1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.7266526899961334,-1.2147782097796764,0.3,0.8004322972511112,1.0,2/7,4.59%,SCN11A;SPX
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.6764598660492547,1.214724201404651,0.3090909090909091,0.5919498381493199,1.0,2/12,6.42%,IMPA2;NUDT3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.7537873174479761,-1.2145526738191414,0.3157894736842105,0.7987249999537507,1.0,1/6,1.07%,CORO1B
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.7537873174479761,-1.2145526738191414,0.3157894736842105,0.7987249999537507,1.0,1/6,1.07%,CORO1B
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.6371322438059956,1.2144447525263518,0.21739130434782608,0.5922751704272434,1.0,3/19,4.64%,TGFB2;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.7947775331405555,-1.214420633141513,0.3333333333333333,0.7979266181499544,1.0,2/6,10.03%,AMPD1;PFAS
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6177799930490308,-1.2143587356824803,0.18867924528301888,0.7969770120491304,1.0,11/35,18.33%,OOEP;CENPX;PCNA;EME1;TONSL;RFWD3;BLM;ALYREF;ATR;DDX11;PRIMPOL
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6043466142350924,1.2141562520739058,0.24390243902439024,0.5925999165208822,1.0,5/18,5.47%,TAFA1;LRRK2;ID2;PTPRZ1;TOX
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.5523742429190576,1.2141217978808492,0.1694915254237288,0.5921201204289622,1.0,7/24,17.13%,PPP1R3C;PYGL;GYG1;PHKA2;PGM2L1;AGL;PRKAG2
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.6380528809646349,1.2138771204559369,0.09803921568627451,0.5924765512643725,1.0,5/20,12.67%,ZACN;PAM;MT1M;GLRA2;SLC30A3
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.7911398665923248,-1.2136274294742888,0.2708333333333333,0.7985367089439908,1.0,1/6,0.34%,ZDHHC12
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.4782332317354085,1.2135424403986494,0.14583333333333334,0.5928216414408872,1.0,18/72,13.75%,IFNA2;TRIM5;PTPRC;PLSCR1;TLR2;MX1;ISG15;SAMHD1;ABCC9;LILRB1;RSAD2;BCL2;AGBL4;PLA2G10;ISG20;MLKL;BCL2L1;MOV10
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.5465198471192169,1.213492864409617,0.24444444444444444,0.5918650940273572,1.0,6/41,8.08%,IFNA2;MX1;ISG15;SAMHD1;XAF1;RSAD2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.5465198471192169,1.213492864409617,0.24444444444444444,0.5918650940273572,1.0,6/41,8.08%,IFNA2;MX1;ISG15;SAMHD1;XAF1;RSAD2
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.5363302731307282,-1.2134174014808843,0.1568627450980392,0.7978827492460854,1.0,7/71,10.81%,SELENOS;SEC61B;UBXN4;USP19;UBQLN2;TMEM129;ERLIN2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.5375689031792339,1.2133901115931127,0.21818181818181817,0.591750933885311,1.0,19/58,18.61%,ITGA11;ITGB4;ISG15;SRC;SYK;ITGBL1;FYB1;FBLN1;TEC;ERBIN;PRKD1;ZNF304;THY1;CUL3;ITGB1BP1;DOCK1;ZYX;SEMA7A;FERMT3
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.6175474124878045,-1.2133770578853782,0.1724137931034483,0.7967463613512592,1.0,6/29,12.80%,ATP6V1F;ATP6V1G1;ATP6V1G2;GPR89A;ATP6V1E2;ATP6V0E1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6184740548389934,1.2133232738738404,0.19148936170212766,0.5914344029092198,1.0,8/25,13.77%,TGFB2;MEF2C;SOX9;ZBTB16;WNT5A;BMPR2;PTPN11;LRP4
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6671727199403166,-1.213164140261983,0.15789473684210525,0.7963135431463559,1.0,5/15,9.38%,PRDX1;NOX1;PRDX5;SOD1;PRDX3
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6883990436642586,1.2129100503431143,0.2708333333333333,0.5920132329018557,1.0,3/10,7.44%,SNAP25;STX3;STX1A
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.8171066320985606,-1.2128671510526996,0.325,0.7963014576116423,1.0,1/5,3.20%,PPIB
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.5160880736955799,1.2125960257361041,0.18181818181818182,0.5924101007688991,1.0,7/44,9.06%,CLDN5;NRXN1;CLSTN3;PTPRJ;EPHB1;EPHB3;IL1RAP
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.4891863027365325,1.2125364913102092,0.16666666666666666,0.5920406626210641,1.0,10/86,10.82%,EGFR;MAP3K5;PLCB1;SH3RF3;DACT1;EPHB1;PER1;TIRAP;ANKRD6;DUSP10
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.6831921284076669,1.2116590022014124,0.23404255319148937,0.5939878743059176,1.0,4/8,10.44%,RYR3;SLC8A1;TRPM2;P2RY1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.789484363275273,-1.2115686105086447,0.2777777777777778,0.8003501677750561,1.0,2/7,7.52%,PRELID1;CD274
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.6747996410926373,1.211520074029254,0.3,0.5939467330786046,1.0,5/13,17.99%,ZMYND10;ODAD3;DNAI2;DNAAF1;ODAD4
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.8042491276908404,-1.21140516907684,0.3469387755102041,0.7985552861040136,1.0,2/5,12.36%,CCT2;DKC1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.8042491276908404,-1.21140516907684,0.3469387755102041,0.7985552861040136,1.0,2/5,12.36%,CCT2;DKC1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5601134914627073,1.211383472254282,0.1388888888888889,0.5938208260000163,1.0,9/33,17.13%,CHI3L1;SPRED3;IRGM;PLK1;DMTN;PARD3;RPTOR;DDIT4;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5613675854179635,1.2113401069771264,0.20408163265306123,0.5934832338507569,1.0,3/29,7.75%,LPL;HSPB1;WNT5A
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.7718598262172187,-1.2112561145842584,0.24074074074074073,0.7978072103259526,1.0,2/7,8.55%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6845788677569808,-1.2109718296349987,0.2830188679245283,0.7975911429519056,1.0,3/11,4.97%,WNK4;HYAL2;MAGED2
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.4818387269903392,1.210803728024037,0.17391304347826086,0.5944589104593341,1.0,14/63,11.51%,CREB3L1;AQP1;MYH11;SYNPO2;POSTN;PDGFRA;COL12A1;SULF1;COL4A1;TPM1;COL15A1;PAMR1;LAMB2;TRPV4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6563758983032764,-1.2101379679958528,0.19607843137254902,0.7991892082511906,1.0,5/13,23.67%,RACK1;UFL1;ATF6B;PTPN1;NCK1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.7622441073635514,-1.2098204650449476,0.29310344827586204,0.79796385768005,1.0,2/6,9.37%,HLA-C;HLA-B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.7622441073635514,-1.2098204650449476,0.29310344827586204,0.79796385768005,1.0,2/6,9.37%,HLA-C;HLA-B
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7727099490340816,1.209804885505605,0.2962962962962963,0.5969347363265997,1.0,2/6,20.04%,NLGN1;FBXW11
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5845701102153061,1.2097056597135667,0.2,0.5967749230812214,1.0,8/22,14.31%,SLC4A10;NEDD4L;SLC4A4;UNC80;CAMK2D;SLC30A3;FHL1;WNK2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.6657543860288431,-1.2092733910044673,0.2830188679245283,0.7986514886000073,1.0,5/14,11.65%,NUTF2;RBM15B;BANF1;NXT2;NPM1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.46554302855612406,-1.2092444917722005,0.12121212121212122,0.7975595445464042,1.0,39/186,19.59%,TUBA1A;NES;PKMYT1;SSNA1;PLK4;DYNLL1;CCNB3;CCNG1;TUBB4B;CDK4;USH1C;TUBB4A;TUBG1;KDM8;DCTN3;CDC23;CHMP2A;CEP131;ACVR1B;CCNB2;CDKN2C;DYNC1H1;AKAP9;HAUS6;TUBB;DYNC1I2;DCTN1;HAUS1;PRKACA;FBXL15;PPP6C;PLK3;CCNE2;UBE2S;CTDP1;CETN2;CEP164;CHMP7;EPS8
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.6182389941357345,-1.2091796128394032,0.23076923076923078,0.7965083857565474,1.0,1/15,0.82%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.7200078359914615,1.2090594458901267,0.1836734693877551,0.5979351285294939,1.0,2/8,3.57%,PDGFB;NR4A3
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.5633873254502981,1.2090086032268703,0.1956521739130435,0.5974793534304926,1.0,7/29,10.37%,TGFB2;BMPR1B;ITGAM;PBX1;MEIS3;MEIS2;C3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6666473301431425,-1.2088996840488164,0.3090909090909091,0.7965960650176142,1.0,4/16,8.62%,STAC3;ATP1B1;CALM1;P2RY6
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.8189827646722116,1.2087422609050635,0.20754716981132076,0.5976883543722095,1.0,2/6,9.67%,CSF1R;IL33
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.7696937741290462,1.2085502381072322,0.3090909090909091,0.5978022168285154,1.0,1/6,0.71%,VSIR
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.7689746371519295,-1.208523942255809,0.2391304347826087,0.7967084034270665,1.0,4/10,12.36%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6050945727739516,1.2084321971784489,0.225,0.5975686991166778,1.0,2/14,12.94%,SGO1;PDS5B
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.5816112622213117,-1.2082833306444645,0.23076923076923078,0.796397358553586,1.0,5/30,8.78%,TAX1BP3;ACTN2;GOPC;RIC3;RANGRF
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5315190797393565,1.2080815194343475,0.18604651162790697,0.5979347371516712,1.0,11/57,13.49%,EGFR;PTPRR;SRC;NRG1;SOX9;KIF16B;VIL1;ERBIN;TGFA;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.7427148257926246,1.2078692568097456,0.22727272727272727,0.597848542719035,1.0,1/8,3.14%,LRRK2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7606732437099364,1.2074091018633555,0.21739130434782608,0.5975908691249012,1.0,2/8,7.72%,RAB27B;HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7606732437099364,1.2074091018633555,0.21739130434782608,0.5975908691249012,1.0,2/8,7.72%,RAB27B;HSPB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7606732437099364,1.2074091018633555,0.21739130434782608,0.5975908691249012,1.0,2/8,7.72%,RAB27B;HSPB1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.6946270383395355,-1.2071080465680377,0.34545454545454546,0.7995038217638588,1.0,7/15,20.04%,CHMP2A;RHOA;CHMP5;CHMP3;CNTROB;CHMP7;CEP55
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.7346596441080488,1.206997766815375,0.3191489361702128,0.5981855117791982,1.0,4/7,11.93%,PTPRB;PTPRT;DUSP10;PTPRO
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.7387790299352872,1.2069454993160096,0.23529411764705882,0.5977857979849716,1.0,2/8,7.05%,SLC2A5;TJP2
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.6726355234716928,1.2068053831690755,0.2222222222222222,0.5976479541201991,1.0,2/13,5.20%,AQP1;MT1M
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6574626943833175,1.206783996761417,0.22448979591836735,0.5971659113617399,1.0,7/13,26.98%,YBX3;CPEB3;RBM24;CPEB4;ZNF385A;FMR1;PKM
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.7331032259191348,-1.2066805741146946,0.19607843137254902,0.7999462543006783,1.0,2/8,13.04%,RANBP1;KIF11
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.7294842188696211,-1.206293894483983,0.22,0.8000776954092741,1.0,1/8,0.82%,PAX8
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.779370629363387,1.2061788221600918,0.2391304347826087,0.5982594089965675,1.0,1/7,0.80%,PDGFB
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.755360158044321,-1.2061319233680925,0.25,0.7981411104887769,1.0,4/7,22.11%,CHAF1B;ASF1B;RBBP4;NASP
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.755360158044321,-1.2061319233680925,0.25,0.7981411104887769,1.0,4/7,22.11%,CHAF1B;ASF1B;RBBP4;NASP
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8330726112067799,1.2055640236363006,0.1702127659574468,0.5995281218223688,1.0,3/5,8.24%,LMO3;PER1;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5378885695163603,1.2054841172169832,0.18,0.5991602120788123,1.0,11/44,14.51%,GRIN2B;EPHA4;SPOCK1;RTN4RL2;YWHAH;TRPV4;PTPRO;DPYSL3;KANK1;RAB29;STMN2
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.8504911159155208,-1.2051608018977145,0.16666666666666666,0.800383353767725,1.0,2/5,7.81%,RPS3;OTUB1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.7834109766998185,-1.204729366072257,0.28,0.8007350060012773,1.0,3/5,19.23%,TRIR;TOE1;PDE12
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.6432001735435302,1.2045080697524344,0.1702127659574468,0.6014244303827846,1.0,3/17,4.64%,TGFB2;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.6103960635628236,-1.2044767668879182,0.25,0.8004585674736248,1.0,4/21,20.48%,BAX;FIS1;VPS11;AFG3L2
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7770988232195226,1.2042777915192475,0.16326530612244897,0.6013984457145796,1.0,2/6,14.24%,RIT2;ABCA1
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.7724418380583823,-1.204081643581551,0.22033898305084745,0.8008581756014388,1.0,1/5,5.86%,FNTA
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.8042670238099254,-1.2040147866606115,0.25925925925925924,0.7999694341547052,1.0,1/6,0.82%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.7225912866735476,1.2039957938411128,0.24074074074074073,0.6017670600465144,1.0,3/10,8.08%,TGFB2;NCKAP1L;RSAD2
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.4892438272704745,1.2038809519524618,0.22727272727272727,0.6016059608729418,1.0,13/69,12.43%,CLDN16;KCNMA1;SLC8A1;NEDD4L;VAPB;SLC24A4;SLC24A3;ATP2B3;ATP2B2;HTR2C;ATP1B2;TRPV4;DMPK
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6611348442670466,1.2037276510135688,0.2692307692307692,0.6015073316283726,1.0,2/12,6.48%,SLC8A1;DMD
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.7234042683133525,1.2034933638798238,0.2558139534883721,0.601595280217474,1.0,4/7,25.24%,CLEC7A;IL17RA;TICAM1;STAT3
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.4946789636858266,1.203385649503354,0.13636363636363635,0.6013726687304978,1.0,20/59,16.67%,NRCAM;GPM6A;NRXN1;GABRG2;FGF13;GABRA1;GABRB2;GABRA2;SHANK2;WNT5A;PCDHB13;GABRB3;RAB29;NLGN4X;FARP1;ACHE;NLGN1;DNER;LRRC4;CBLN4
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.6881152517603584,-1.2033644539345254,0.25925925925925924,0.8012131913069025,1.0,3/12,17.02%,BACE2;NCSTN;BACE1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.4082929767458517,1.203115805708731,0.058823529411764705,0.6016570021352518,1.0,61/312,14.38%,TGFB2;CLDN5;CTF1;PDGFC;PDGFB;BMP6;EGFR;KITLG;AQP1;FLT1;PTPRC;IGF1;CSF1R;IL12RB2;CAPN1;PID1;MEF2C;NR4A3;PIM1;PTPN6;LAMC1;PDGFRA;NRG1;ID2;IRS1;TBX6;NTRK2;TOX;SHANK2;IL13RA1;LEF1;MEIS3;STX3;SOX9;CRLF1;LIFR;WNT5A;MEIS2;CHRD;VEGFD;BST1;BCL2;SPDYA;KIF14;TGFB3;CR1;TGFA;CX3CL1;LYN;ZNF304;FGF17;ACER2;HES1;CLEC7A;CDH13;CDC7;FZD9;CUL3;ITGB1BP1;HCLS1;VEGFA
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.7915425947562994,-1.2030001205083345,0.16279069767441862,0.8014388054617487,1.0,2/6,12.41%,SLC22A2;ABCC1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.505521286727781,1.202952266998618,0.13636363636363635,0.6017342631198834,1.0,15/68,14.38%,PDGFB;ANGPT1;F3;SULF1;PTPRM;WNT5A;VEGFD;ARNT;BMPR2;PRKD1;AKT3;VASH2;CDH13;NR2F2;VEGFA
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.6224725425025387,-1.202782135560591,0.3076923076923077,0.8011145458906902,1.0,4/24,15.78%,EXOSC8;TRIR;EXOSC5;NUDT16L1
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.745226545554008,1.2026888154646007,0.28846153846153844,0.6019145903045381,1.0,2/6,13.05%,SLC22A16;SLC25A20
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.45504011453106213,1.2025667204982087,0.17391304347826086,0.6017337176076736,1.0,8/73,7.61%,SRGN;PCSK4;PCSK2;MMP16;F3;TESC;TSPAN14;TASP1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.5129361691729784,1.2018663656961703,0.2,0.6030675746878783,1.0,12/42,18.20%,ADGRE2;LRRK2;TRIM46;MAP2;EFNA5;CAMK2D;LYN;PARD6A;KIAA1614;FES;WWC1;EPHA5
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.7239392613435576,1.2014226084744266,0.3181818181818182,0.6038947567408921,1.0,2/7,25.26%,RIN3;PICALM
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.6028919090619957,-1.2012761212062937,0.21818181818181817,0.805678124739893,1.0,7/27,13.90%,DPM3;PGAP2;PIGO;PIGF;PGAP4;PIGW;DPM2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5465199196857548,-1.2011647775986112,0.16666666666666666,0.8048375071359589,1.0,2/42,2.77%,PM20D1;DEGS1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.7441691847353358,1.2011501348435007,0.24489795918367346,0.6041651545842311,1.0,2/7,15.88%,UBASH3B;CAMK4
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.7577392830528381,1.2010148360957402,0.3137254901960784,0.6040035152867342,1.0,1/6,3.14%,LRRK2
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.7522058119419555,1.2009902958379335,0.29545454545454547,0.6035649556472082,1.0,3/5,14.42%,EDNRB;SFTPD;LGALS3
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5794939003199515,1.2009184902044643,0.23255813953488372,0.6032502449477632,1.0,10/29,11.10%,GRIN2B;CAPN1;MEF2C;RELN;CAMK2B;GRIA1;GRIN1;DAPK1;DLG4;NEFL
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5743343802745974,-1.2002407752280428,0.15384615384615385,0.8068913039470913,1.0,3/37,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.6375766403050636,-1.1999343383209569,0.24489795918367346,0.8067915017994167,1.0,4/18,10.76%,SELENOK;BAK1;BAX;FIS1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7367510274644526,1.1998420822268137,0.23529411764705882,0.6060005150001195,1.0,1/7,11.50%,CPE
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.6489806991156083,1.199302018615625,0.2682926829268293,0.6070973916728395,1.0,4/12,7.34%,PLSCR1;F3;ANO6;MYLK3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.718267604395885,1.1992540139220134,0.2708333333333333,0.60672930059339,1.0,1/10,1.81%,CSGALNACT1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4829841820478367,-1.1990536699175292,0.10714285714285714,0.8093210729735453,1.0,27/139,15.91%,TPX2;BUB1;STMN1;KIF3B;SBDS;PTPA;RPS27;NDC80;DYNLL1;TUBG1;BCCIP;RAN;NEK6;RHOA;SGO2;MIS12;NUDC;DYNC1H1;KIFC1;KIF11;GOLGA2;CENPF;WRAP73;NUP37;DYNC1I2;KIF4A;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7413102312489249,-1.1988267088545645,0.23684210526315788,0.809121236467097,1.0,4/7,17.83%,RPS3;NPM1;HMGB1;DDX11
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.7886630121565981,1.198786215022939,0.26,0.6075067690420707,1.0,2/6,4.86%,GRIP2;GRIP1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.684702358954373,-1.1978175097431993,0.20408163265306123,0.8115796507920507,1.0,3/12,19.45%,USP19;EIF2AK3;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5622681405324018,1.1977500901471647,0.17777777777777778,0.6102133122682327,1.0,5/24,6.79%,PPARG;ADAMTS9;MEF2C;ADGRB1;PTPRM
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.6824432569964138,-1.197517006776082,0.2413793103448276,0.8113771123890826,1.0,1/12,0.43%,KLK6
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5621326887819504,-1.1973362660616564,0.19230769230769232,0.8108499402177872,1.0,17/38,18.94%,POLR2L;POLR2G;POLR2K;GTF2F1;POLR2I;POLR2A;HEXIM1;POLR2E;NELFE;POLR2C;POLR2D;NELFCD;SUPT5H;TRIM14;CCNT1;POLR2J;CTDP1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5475916968805329,1.1972312530545612,0.19230769230769232,0.6111599486774796,1.0,9/32,14.75%,SEMA3D;MET;PLXNA4;PLXNA2;SEMA6A;SEMA5B;SEMA4B;SEMA4G;SEMA3C
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6690520419934306,-1.197195629484591,0.19298245614035087,0.8103363238726022,1.0,2/17,3.37%,NGF;BEX3
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.45352774946115687,1.197156718440292,0.08333333333333333,0.6109221920151087,1.0,34/125,15.19%,PDGFB;BMP6;EGFR;FLT1;CD44;MEF2C;BMPR1B;HGF;ADAMTS7;TWF2;NTRK2;VSTM2A;MAP2K5;ZFP36;SOX9;HSPB1;DLX1;WNT5A;NOS1;SOX5;BMPR2;SEMA6A;ACVR1C;VIL1;MAPT;PRKD1;PTPN11;WWOX;ITGB1BP1;VEGFA;STMN2;ACVR2A;NTRK3;ZFP36L1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.5848829694880037,-1.196868547952741,0.22807017543859648,0.8105568275690543,1.0,11/40,20.04%,RPS19;SUN3;CHMP2A;NUMA1;CHMP5;CHMP3;TOR1A;REEP4;TPR;CHMP7;CEP55
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.6073255386307782,1.1964885121386766,0.1590909090909091,0.6121722301333564,1.0,1/22,0.13%,LPL
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5752132675318713,-1.1960655771099458,0.21568627450980393,0.8123717667527559,1.0,16/39,25.31%,SARS1;AARS1;TARS1;AIMP1;HARS2;NARS1;EPRS1;EARS2;VARS1;TARS2;AARS2;KARS1;FARSB;RARS1;FARSA;QARS1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6134057892380125,-1.1959307734815823,0.2222222222222222,0.8105328933302482,1.0,7/24,14.34%,GLYAT;ACSM6;DBI;ACOT1;CROT;THEM4;ACOT2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6134057892380125,-1.1959307734815823,0.2222222222222222,0.8105328933302482,1.0,7/24,14.34%,GLYAT;ACSM6;DBI;ACOT1;CROT;THEM4;ACOT2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.5534461060065765,1.1957909590370086,0.18604651162790697,0.6138272867054048,1.0,10/42,12.07%,NTNG1;ATRNL1;LAMC1;EPHB3;NTN4;LAMB4;ANTXR1;KIF14;LAMB2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.47727567139075083,-1.1956594867145365,0.14754098360655737,0.8103100184883386,1.0,35/142,18.66%,TPX2;RPL5;RPL11;RPL23;RPS15;NOC2L;CHD4;CCNG1;RPS20;RPL37;BRPF1;NOP53;TTC5;TAF13;HEXIM1;HUS1;TAF7;KMT5A;PRKAA2;BLM;RPF2;SETD9;KAT5;BRD7;TOPBP1;TAF11;DAXX;PIP4P1;PLK3;TAF9B;ATR;RAD9B;ING2;EXO1;PPP1R13L
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.7854809813354513,-1.1954518302633172,0.2549019607843137,0.8100043153705232,1.0,3/6,18.33%,CHMP2A;HGS;SNX3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6258730071308694,1.1954357200552752,0.3333333333333333,0.614574369688532,1.0,6/16,18.27%,IGF1;NR4A3;CAMK2D;TRPC3;PDE9A;EDN1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.7706416994875824,-1.195413124138641,0.3275862068965517,0.8090207907216441,1.0,2/7,3.39%,DEGS1;DECR2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6336495046589008,1.1953393674760688,0.20408163265306123,0.614334511153839,1.0,2/9,10.04%,IL12A;SEMA6A
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.7593584345796751,1.195126426863798,0.21428571428571427,0.6144097998988869,1.0,2/7,8.70%,SHANK2;PICK1
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.7829562255890139,1.1950010400004412,0.28888888888888886,0.614211066963493,1.0,3/5,14.46%,PPARGC1A;ZNF516;UCP1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.5279762961464696,1.1949665997455579,0.20454545454545456,0.6137694186796404,1.0,1/35,0.13%,LPL
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7168027475731993,1.1948632938446226,0.32608695652173914,0.6135715682672823,1.0,4/7,24.83%,CPEB3;RBM24;CPEB4;FMR1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.738065632701571,1.1947434547030604,0.22448979591836735,0.6134246457727004,1.0,4/6,18.66%,DDAH1;NOS1;NOS2;ARG1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.8305506458900425,1.1946243099606466,0.25,0.6133184117430655,1.0,2/6,4.81%,FGF12;CARTPT
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.799826913522728,1.1945682728035092,0.21666666666666667,0.6130002331356427,1.0,1/5,3.07%,SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.6737979517846174,-1.194013976326377,0.21818181818181817,0.813010077649846,1.0,6/17,22.04%,PTPA;PPP1R35;YWHAB;SH3RF2;ZCCHC9;INPP5K
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.7709119103218363,-1.1939785580487192,0.28,0.8119538294429953,1.0,3/5,22.91%,CTR9;RTF1;PAF1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6617995029361562,1.1939114812182676,0.3111111111111111,0.614378153985325,1.0,4/14,13.70%,SLC23A1;SLC1A2;GPLD1;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.646173784571329,1.1938479176453314,0.21428571428571427,0.6140797850293261,1.0,8/16,14.38%,ADCY8;CAMK1D;RELN;LRP8;PRKD1;ADCY1;CD200;VEGFA
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7338239215313562,1.1935549719923706,0.28205128205128205,0.6145778888149507,1.0,4/8,19.27%,NR4A3;GNB3;LEPR;SGIP1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7759200691830415,1.1933950033200984,0.30612244897959184,0.6145113970455222,1.0,1/5,4.57%,SRC
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5889042960762354,1.1929739583542915,0.2682926829268293,0.6154709869778301,1.0,6/24,12.13%,MGST1;SLC26A4;SLC13A4;SLC26A7;SLC35F3;SLC25A19
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.44037709040161305,-1.1928654606914697,0.046875,0.8144692446277502,1.0,17/233,7.04%,NGF;ARHGEF16;TNFRSF8;RPS27A;UBC;SAP18;PRR7;RPS6;SFRP1;USP27X;UBB;PTPA;TNFAIP8;RACK1;SPHK2;PRMT2;SOD1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.5031101423318897,1.1925196542661278,0.175,0.6164390073842434,1.0,17/72,7.68%,ADAM28;PTPRC;SIGLEC10;SELL;NCKAP1L;IKZF1;BIRC3;LCP2;CD53;ARHGAP25;ABCB4;PNOC;LILRB1;WDFY4;BTLA;LY86;DOCK8
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.7812203268295599,1.1924664299471257,0.26785714285714285,0.6161200755345027,1.0,3/5,10.68%,NTRK2;SH3GL2;MAPT
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.8097469202906711,1.1918126875380486,0.21153846153846154,0.6173166794112284,1.0,2/5,17.79%,ERBIN;SLC15A4
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6304839709430883,1.1916573154267986,0.25,0.6173283593603921,1.0,3/22,3.71%,PDGFB;DACH1;HGF
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.6220673528116257,-1.191598139201176,0.24193548387096775,0.8178890901926571,1.0,2/17,6.99%,FTSJ3;NSA2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.8311149092574874,1.1915927008508513,0.24,0.616989451783329,1.0,2/5,15.51%,KDM6A;KDM6B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.6829181964881288,-1.191446482625137,0.21818181818181817,0.8162705586990897,1.0,3/9,18.59%,GABARAPL2;MAP1LC3B;BECN1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.6829181964881288,-1.191446482625137,0.21818181818181817,0.8162705586990897,1.0,3/9,18.59%,GABARAPL2;MAP1LC3B;BECN1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5382029230285188,-1.1913317447489744,0.30357142857142855,0.8154293757225047,1.0,20/46,22.91%,H1-4;H2AX;NOC2L;H1-2;CHAF1B;GRWD1;SMARCA5;H2BC21;NPM1;HMGA2;POLE3;DAXX;ANP32B;M1AP;EZH1;H1-10;CDAN1;RBBP4;BRD2;PAF1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.6586423954267904,-1.1912833093488462,0.30357142857142855,0.8144610883963386,1.0,5/13,20.04%,CHMP2A;CHMP5;CHMP3;CHMP7;CEP55
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6544859104249704,1.1911538637840857,0.26666666666666666,0.6177819961179857,1.0,1/11,0.91%,EGFR
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.45208769423999434,1.1910387374869502,0.1875,0.6175832684417711,1.0,19/108,8.91%,IFNA2;CARD18;CD44;TLR2;FOS;CSF1R;CHI3L1;ADCY8;NFATC4;TMIGD3;C3AR1;PTGER3;LOXL3;CIITA;BLNK;ACKR1;NOD1;TNFRSF1A;TAC4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6974639720549376,1.1910091535049014,0.2641509433962264,0.6171151167554929,1.0,5/8,19.72%,NEDD4L;CAMK2D;HECW1;PRKCE;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.5993749065326366,1.190788155557984,0.2631578947368421,0.6172267431251978,1.0,7/23,14.42%,PDGFB;GRIN1;GRM6;TRPC6;TRPC3;CACNB2;LGALS3
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7253304046351146,-1.1907078774873299,0.20754716981132076,0.8156467468533094,1.0,4/10,17.53%,HSD17B10;AKR1D1;SRD5A1;CYP3A4
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5707239081477117,1.1905087385048054,0.1836734693877551,0.6173282082349203,1.0,6/20,13.82%,RELN;PTPRZ1;SOX9;PICK1;GPC1;MMP24
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.47496167099867137,-1.190338660109355,0.15873015873015872,0.8158312720017122,1.0,25/150,13.87%,CDKN1C;THAP1;ANAPC15;PKMYT1;PSMD7;PSMB6;PSME2;PSMD8;BTG3;CDC26;FBXO43;CDC23;NEK6;PSMB4;PSMD3;PSMB3;CDK11A;PSME1;DYNLT3;CDK11B;BTG2;PSMA7;PSMD13;PSMB8;CKS1B
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.7816071440612752,-1.190247326370001,0.2545454545454545,0.8150071839322983,1.0,3/7,15.78%,TFIP11;HMGA2;NUDT16L1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7938960019505308,1.1902415903230008,0.23404255319148937,0.6177085496934367,1.0,2/6,9.96%,KCNIP2;RNF207
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.6603738053324274,-1.1902103566830713,0.26666666666666666,0.813986427583181,1.0,1/16,0.19%,BMP5
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6874864923077812,-1.1901618087761192,0.3170731707317073,0.8129451686444175,1.0,1/10,0.17%,TYRP1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.7749365197322634,1.189916541895957,0.3111111111111111,0.618058382324231,1.0,2/6,6.29%,ARRB2;LILRB1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5112133080759578,1.1894813115730105,0.17647058823529413,0.618875246737547,1.0,11/56,11.51%,SLC9C2;KCNJ3;SLC8A1;KCNJ4;ABCC9;KCNJ6;SLC9A9;TRPM2;SLC9A7;ATP1B2;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.7830572223727789,1.1888142863450692,0.2926829268292683,0.6195612825733203,1.0,3/5,17.36%,PRKCZ;NLRP3;TNFSF4
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.7830572223727789,1.1888142863450692,0.2926829268292683,0.6195612825733203,1.0,3/5,17.36%,PRKCZ;NLRP3;TNFSF4
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.7601292368168321,1.1887324021754855,0.2549019607843137,0.6193427137964986,1.0,5/7,23.90%,LPCAT4;PLA2G10;PLA2G4A;LPGAT1;LPCAT1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.5851487213336841,1.188714220966319,0.22807017543859648,0.6188369407556019,1.0,5/18,7.07%,NCKAP1L;CYFIP1;RHOJ;RHOQ;SCIN
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.6227478711526455,1.1886017232375468,0.23404255319148937,0.6186292461643468,1.0,5/12,11.82%,GRIN2B;GRIN3A;GRIN1;ADCY7;GLRA2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5689730139007491,1.1884808609015867,0.21818181818181817,0.6183624989040185,1.0,6/22,20.40%,ADCY8;EFNA5;GPLD1;BAIAP3;EPHA5;KLF7
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.6108823011766686,1.1877281595082554,0.30434782608695654,0.62023274541222,1.0,3/18,7.27%,RELN;CAMK2B;LRP8
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.689339712208667,-1.1876030663547326,0.2692307692307692,0.8214899937362942,1.0,1/8,4.53%,MBD4
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.8213590882046541,1.1873740783270674,0.22448979591836735,0.6203101709323596,1.0,1/5,3.57%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.8213590882046541,1.1873740783270674,0.22448979591836735,0.6203101709323596,1.0,1/5,3.57%,NR4A3
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.6441623424432109,-1.1873434927184994,0.24489795918367346,0.8212220827214715,1.0,3/17,15.50%,RNF8;PCGF1;UBE2A
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5951581660457346,-1.1873225863222605,0.20754716981132076,0.8201517771772818,1.0,8/29,12.80%,RAB32;ATP6V1F;ATP6V1G1;ATP6V1G2;MCOLN1;ATP6V1E2;RAB31;ATP6V0E1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7207900112143968,1.1872040166624636,0.2857142857142857,0.6203487874718161,1.0,2/8,3.42%,TGFB2;MEF2C
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.6357903375750794,-1.187064612269388,0.23214285714285715,0.8198864908663651,1.0,4/18,11.62%,EXOSC8;INTS14;TOE1;EXOSC5
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6619407576882301,1.1869874887781402,0.22448979591836735,0.6205056442985872,1.0,4/14,11.25%,BMP6;TRIM5;LY86;CX3CL1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.7842676846909794,1.1869477194643843,0.3018867924528302,0.6201401635135543,1.0,1/5,0.97%,SRGN
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.4657094808653698,1.1867083522020885,0.16666666666666666,0.6202477215402484,1.0,7/73,2.89%,VSIR;PRSS12;SRGN;PCSK4;PCSK2;MMP16;F3
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.49546750535679207,1.1864077064002048,0.18867924528301888,0.6205026158668107,1.0,12/68,10.35%,ROR1;MYO7A;ADGRV1;COL11A1;MYO3B;GRXCR2;PCDH15;SLC26A4;CRYM;ATP2B2;USP53;CDH23
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.45144650146686693,1.1862961422591767,0.20454545454545456,0.6203836959421541,1.0,10/102,5.48%,TGFB2;PDGFB;EGFR;PRR16;IGF1;TLR2;HGF;SORBS1;IRS1;CIITA
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.592541926825718,1.1862765015644552,0.19148936170212766,0.6199409765240297,1.0,11/30,19.48%,IGF1;MYO16;IRS1;NYAP1;PIK3R1;TPTE2;NYAP2;ZFP36L1;PIK3R5;EDN1;PTEN
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6949105743345083,-1.1860098056130652,0.2909090909090909,0.8225817924846135,1.0,1/7,5.49%,RACK1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6332272869378914,1.1853517476584288,0.21818181818181817,0.6219318565913843,1.0,6/11,23.32%,LRP4;NLGN4X;NLGN1;PTEN;IL1RAPL1;CEL
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.4273916739998133,1.1852985619757122,0.18181818181818182,0.6216160162432363,1.0,46/226,11.82%,LPL;EPHA3;CX3CR1;PDGFB;EGFR;AQP1;SSTR1;TLR2;FOS;KCNC2;P2RY12;RYR3;BRINP3;PID1;MEF2C;NR4A3;HCN1;WNT8B;TWF2;PDGFRA;TNFRSF1B;IRS1;ABCB4;AXL;LILRB1;GNG2;ZFP36;RRAGD;TESC;TPM1;SOX9;WNT5A;GIT1;BRINP1;TIRAP;IRGM;DAPK1;DMTN;VIM;GPLD1;P2RY1;MAPT;PRKD1;LYN;CPEB3;GLRA2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.5722570354357552,1.1852675523156233,0.21951219512195122,0.621192963290007,1.0,5/34,17.23%,HEY1;LEF1;NOTCH4;KAT2A;JAG2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6124161983498924,1.185114217877354,0.3111111111111111,0.6210446073564443,1.0,3/9,7.76%,F3;PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.7081072058675943,-1.1849312507162555,0.2857142857142857,0.8241185617495295,1.0,4/11,12.36%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.7081072058675943,-1.1849312507162555,0.2857142857142857,0.8241185617495295,1.0,4/11,12.36%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.4069558836431379,1.1847021492284875,0.08333333333333333,0.621698270002186,1.0,78/305,14.61%,CTF1;IFNA2;SLA;CSF2RA;TLR2;FOS;CSF1R;CHI3L1;IL12RB2;IL12A;F3;PID1;PIM1;HGF;ADAMTS7;ZEB1;INPP5D;PTPN6;TNFRSF1B;SYK;ITGAM;PTPRZ1;CSF3R;LRCH1;IL13RA1;LEF1;AXL;PTPRJ;YBX3;ZFP36;PDE1B;STX3;NPNT;IRAK3;SOX9;LRP8;CRLF1;MYLK3;STX1A;SLA2;LIFR;DOCK8;WNT5A;STAT6;CCND1;IRGM;TNFRSF1A;DAPK1;SOCS3;CD4;IL1RAP;BCL6;VIM;PTPRT;BCL2;ZFAND6;MAPK11;TEC;SELPLG;ERBIN;CNTFR;CX3CL1;ST3GAL6;DPYSL3;PIK3R1;CEBPD;GSDME;GHR;PTPN5;SYNCRIP;PTPN20;PTPN11;BCL2L1;IFNK;SHMT1;HCLS1;VEGFA;NOS2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.6816623817007532,-1.184283408999901,0.26666666666666666,0.825583039661022,1.0,5/12,19.50%,NOC2L;SPHK2;TAF7;THAP7;SET
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.7260617587935502,-1.1841795590445057,0.2545454545454545,0.8247118257201347,1.0,1/5,2.63%,GREM1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.7296068407194576,-1.18382692949646,0.3111111111111111,0.8247190559168366,1.0,2/6,11.11%,NDUFA12;NDUFV3
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.47213226884757187,1.183703650861083,0.17391304347826086,0.6237967791149387,1.0,19/79,13.75%,IFNA2;TRIM5;PTPRC;PLSCR1;TLR2;MX1;ZDHHC11;ISG15;SAMHD1;ABCC9;LILRB1;RSAD2;BCL2;AGBL4;PLA2G10;ISG20;MLKL;BCL2L1;MOV10
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7351655365659531,1.1832331130591214,0.30612244897959184,0.6240039676435194,1.0,2/9,4.97%,NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7351655365659531,1.1832331130591214,0.30612244897959184,0.6240039676435194,1.0,2/9,4.97%,NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.45745142103263214,1.1831434692164735,0.16216216216216217,0.6238344269243227,1.0,28/127,13.57%,RND2;MYO7A;CGNL1;KASH5;ACTN1;GAS2L3;CARMIL2;BAIAP2;CARMIL1;ARHGAP25;MYO1B;MYO5C;RHOF;BAIAP2L1;TPM1;SCIN;NEBL;DMTN;ARHGAP17;CORO1C;VIL1;TRPV4;SHROOM3;DPYSL3;FHOD1;RAC3;SHROOM2;CORO6
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.5559134589557969,1.1831038543705692,0.25,0.6234411947683379,1.0,5/25,9.19%,SLC9C2;SLC4A10;SLC4A4;SLC9A9;SLC9A7
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6634042495984955,1.1830373959242138,0.3,0.6231069840293381,1.0,3/10,14.06%,SLC1A2;SLC1A1;SLC25A22
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.6464656268814928,1.1829528755408385,0.2982456140350877,0.6227733189405242,1.0,3/12,10.02%,LRRK2;ISG15;MAIP1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.5431975326410898,1.1827682982819407,0.175,0.6228967533942209,1.0,9/35,11.77%,TGFB2;FOS;MAP3K5;GRIN2B;ITGAM;WNT5A;MAPT;CDK5R1;SARM1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.5252910577988291,1.1819885479995165,0.2222222222222222,0.624708834859604,1.0,15/61,14.09%,CDS1;KCNMA1;DNAH7;SHANK2;DNAH3;VWA3B;MYO5C;ZBTB7C;NEBL;MORN5;SLC9A7;GRHL2;SHROOM3;CFAP47;MUC16
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7355252449940244,-1.1815359884578562,0.3220338983050847,0.831655674872245,1.0,5/9,22.93%,ATP5MC3;VPS9D1;ATP5PB;ATP5PD;ATP5MC2
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.6361577399484362,-1.1813916974840692,0.26785714285714285,0.8310900270668075,1.0,4/21,13.90%,DPM3;RXYLT1;SDF2L1;DPM2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.6398087046080752,1.1813539726011875,0.3148148148148148,0.6260718515202711,1.0,3/12,8.04%,PLSCR1;TLR2;DYSF
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6985193449266562,-1.180894763855986,0.24489795918367346,0.831696782047405,1.0,2/8,16.66%,GBA3;NEU4
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6877227338835917,1.1806758491803375,0.2727272727272727,0.6273066771108358,1.0,4/10,18.59%,SULT4A1;SULT2A1;SULT2B1;TPST2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.6637606619615812,-1.1806656633968928,0.2916666666666667,0.8314421396723803,1.0,5/11,19.59%,CHMP2A;UBE2S;CTDP1;CHMP7;EPS8
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.7847601384976638,1.180658741498968,0.29411764705882354,0.6268547657880443,1.0,3/7,8.67%,FAP;TNFRSF1B;TNFRSF1A
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.6744760100470254,-1.1804738528472831,0.2826086956521739,0.8310737283704805,1.0,1/11,0.44%,CRTAM
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.7960874117512384,-1.1800883951277508,0.3111111111111111,0.831129292719437,1.0,2/5,4.59%,SCN11A;SPX
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7606172270122409,-1.1800296293506853,0.30357142857142855,0.8301230489991647,1.0,4/5,15.86%,RAN;PINX1;RPF2;NOL8
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.7024001283127854,-1.179897683182502,0.29545454545454547,0.8295413684483408,1.0,3/16,8.55%,TINF2;DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.5072923546029058,1.1798131052350023,0.22727272727272727,0.6287448141802032,1.0,15/42,17.36%,LPL;TLR2;C1QTNF4;SYK;WNT5A;TIRAP;IL33;POU2F2;CLEC7A;PTPN11;NOS2;IL17RA;IL16;LBP;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.6961025023639508,-1.179788605146857,0.25,0.8288588247700004,1.0,3/14,6.89%,OOEP;PARP1;RAD51AP1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.4734915631662947,1.1797255555765402,0.2222222222222222,0.6284374686534913,1.0,21/75,9.26%,LAMP5;SLA;PTPRC;SELL;NCKAP1L;TNFSF13B;IKZF1;LCP2;ITGAM;CD53;ARHGAP25;BLNK;PACSIN1;LILRB1;WDFY4;LY86;DOCK8;ETV6;LAPTM5;CD4;MCTP2
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.7613464878965741,1.1796592358250315,0.27450980392156865,0.6280823276950321,1.0,2/6,3.20%,OLAH;ABHD3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.7352877896064723,-1.1796349326846827,0.25,0.8283714195489278,1.0,1/8,5.77%,PHB2
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.8095532834653036,1.1794076876155462,0.20588235294117646,0.6282296125463419,1.0,2/5,9.61%,IRGM;GPLD1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.671128103964452,1.1792876614239962,0.2222222222222222,0.6280584348914746,1.0,3/13,17.13%,NR4A3;C3;PRKAG2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5306924760947866,-1.179153370209603,0.25,0.8287368364700597,1.0,7/51,9.20%,ARHGEF16;UXT;CD9;TMEM125;LAMB3;ATP2C2;DDR1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5875810391861054,-1.17894584988038,0.2222222222222222,0.8283076179663494,1.0,2/18,6.76%,BMP5;MYL6
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5872099830958076,-1.1787201226500237,0.24528301886792453,0.8281739478999073,1.0,4/28,8.70%,LCK;RPS3;PHPT1;CD81
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.6573289792417955,-1.178640430724957,0.18604651162790697,0.8273961556628191,1.0,3/15,9.87%,NPC2;ABCA8;NPC1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.7277996370406846,-1.1783806280931728,0.3125,0.8271511754544746,1.0,4/11,12.36%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.7455174202074607,1.178221193553945,0.26,0.6305276199190624,1.0,2/5,10.24%,PDGFB;HTR2C
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.5314315059130776,1.1781467679135746,0.22727272727272727,0.6301911927810779,1.0,5/29,8.30%,RHBDF2;IL12A;IRS1;RSAD2;KCNB1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.6926033994693955,-1.1779647383794822,0.2978723404255319,0.8275947002413712,1.0,3/7,11.25%,FNTA;BEX4;PRKAA2
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.7762312323918095,-1.1775986093132744,0.2727272727272727,0.8280482821871548,1.0,2/5,8.77%,CBR1;VKORC1L1
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.7481179447945341,-1.1775215718665686,0.34,0.8271961574364445,1.0,2/6,6.12%,RFT1;NPC2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.778554324296159,-1.177452422019067,0.21739130434782608,0.8262901874504625,1.0,4/6,19.12%,ADAM15;ATP2A3;B2M;HFE
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.6884367237133091,-1.1772035624276864,0.2978723404255319,0.8259362060428199,1.0,3/11,15.84%,CSTF2T;CSTF2;FIP1L1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.6192496872980299,1.1771128420701822,0.24,0.6328374419556504,1.0,2/12,10.22%,EGFR;TEC
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5657745189922195,-1.177018480549545,0.17857142857142858,0.825672779787948,1.0,5/43,4.99%,RPS27A;UBC;UBB;PCNA;POLD3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.7124209830597874,1.1769480065096278,0.3076923076923077,0.6327880541902463,1.0,2/9,5.88%,MEF2C;MAP2K5
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.6836213146160981,1.1766716923970308,0.27906976744186046,0.6330556869094847,1.0,3/6,20.75%,ZSWIM6;LHX6;ERBB4
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.5362861640285107,-1.176612422252411,0.23636363636363636,0.8258350887461502,1.0,12/36,21.86%,PHB2;GABARAPL2;FIS1;CISD2;ATG9A;ATG14;SQSTM1;MAP1LC3B;WDR45B;BECN1;PINK1;ATG2A
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.5648180891481869,-1.176463654839595,0.2978723404255319,0.8252709225540278,1.0,3/22,11.43%,NES;PHPT1;NOSIP
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.4766072143123336,-1.1764417578019175,0.23076923076923078,0.8242509258911699,1.0,23/92,16.90%,NGF;LCK;RPS3;PRR7;BEX3;SLC22A2;NLRP1;RACK1;HSPE1;BAX;FIS1;RPS27L;ATP2A3;MTCH1;GSN;ARL6IP5;UACA;NLRP2;DAP;BAD;FADD;ANP32B;HMGB1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.6391833883497193,1.176415877414831,0.30612244897959184,0.6326883120788827,1.0,8/14,20.50%,SORBS1;SRC;FHDC1;CUL3;PHACTR1;KCTD13;ZYX;ARRB1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.6391833883497193,1.176415877414831,0.30612244897959184,0.6326883120788827,1.0,8/14,20.50%,SORBS1;SRC;FHDC1;CUL3;PHACTR1;KCTD13;ZYX;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.6712850528285639,1.1763824847224633,0.32653061224489793,0.632265540810208,1.0,1/11,1.20%,TRIM5
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.6429079643819025,-1.176243995878809,0.32653061224489793,0.823801798963442,1.0,4/13,20.80%,CDK11A;CDK11B;PTCD2;SRPK3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.7275936117475755,1.1762433870659272,0.32608695652173914,0.6320827838779696,1.0,1/8,0.80%,PDGFB
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5656253223257317,1.1762302957271054,0.28846153846153844,0.6315942182550629,1.0,5/22,9.40%,MEF2C;EPHA4;CAMK2B;WNT5A;SLITRK4
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6471242167696937,-1.1759152552365537,0.3448275862068966,0.8238099970443833,1.0,3/14,10.33%,RPS13;RPS26;TMBIM6
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7703938485148413,-1.1758277214259454,0.3333333333333333,0.8230071426215437,1.0,1/5,13.67%,UFL1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.5612019096024906,1.1757048242306967,0.2619047619047619,0.632521023659302,1.0,9/20,21.23%,LRRK2;SHANK2;PICK1;TMEM25;NLGN4X;ACHE;GRIK3;PTEN;PRRT1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.7434935685340541,1.1755924702651082,0.3333333333333333,0.6323289511667333,1.0,3/7,15.86%,ABCC4;ABCC6;ABCC11
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4848482293551428,-1.1754987373483843,0.18032786885245902,0.8229165247654783,1.0,15/72,13.82%,PSMD7;PSMB6;AP2S1;PSME2;PSMD8;PFN1;PSMB4;RHOA;PSMD3;PSMB3;PSME1;PSMA7;PSMD13;PSMB8;RAC1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.737299392027828,1.1752583199475293,0.3541666666666667,0.6327765474942901,1.0,1/5,6.42%,YBX3
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.6600224221549205,1.175148975289133,0.3269230769230769,0.632632253287989,1.0,3/9,6.36%,AQP1;SLC23A1;SLC2A5
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.7352810703829361,1.1749739360131504,0.25,0.6316300208525523,1.0,3/5,22.16%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.7352810703829361,1.1749739360131504,0.25,0.6316300208525523,1.0,3/5,22.16%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.7352810703829361,1.1749739360131504,0.25,0.6316300208525523,1.0,3/5,22.16%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5181349114591075,-1.1748118096328448,0.2459016393442623,0.8243552359863808,1.0,15/88,13.04%,BUB1;SFRP1;PKMYT1;PLK4;USP51;FBXO43;ANKK1;NUMA1;CALM1;USP19;DBF4B;DYNC1H1;HMGA2;E4F1;KIF11
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.716063861121849,1.1747867852002594,0.2765957446808511,0.6311069856324195,1.0,4/5,28.24%,TOX;OTUD4;STPG4;USP9X
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.716063861121849,1.1747867852002594,0.2765957446808511,0.6311069856324195,1.0,4/5,28.24%,TOX;OTUD4;STPG4;USP9X
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.6970919385119223,-1.1745102051295946,0.3157894736842105,0.8241856033471595,1.0,2/11,14.78%,SPHK2;PIH1D1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.7554628420127565,1.1744731409532123,0.2962962962962963,0.6315720380353553,1.0,2/5,17.69%,SYK;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7557056628496608,1.174407927349136,0.2727272727272727,0.631258832458569,1.0,4/7,19.48%,GRIN3A;NGEF;NLGN1;PTEN
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.6778728151595801,1.1742932891574234,0.2962962962962963,0.631059817742012,1.0,6/15,17.13%,NR4A3;PPARGC1A;SOX9;ACADL;PDK4;PRKAG2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.7524737105022266,-1.1740277605403795,0.3,0.8247126249458956,1.0,1/6,0.44%,CRTAM
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5662588177127227,-1.1738935609718077,0.2857142857142857,0.8240904865536254,1.0,8/24,23.12%,UBE2D4;CDC26;CDC23;UBE2A;UBE2L3;UBE2S;ANAPC11;ANAPC2
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.4517773158583979,-1.1734351859832934,0.16071428571428573,0.8248366643104827,1.0,35/166,12.32%,TAX1BP3;RPS12;DDIT3;FUCA1;DCXR;RPL18;CLCA2;ATF3;VAMP8;PMM1;PCNA;CCNG1;H1-2;H2AJ;RACK1;NHLH2;PRMT2;BLCAP;SLC3A2;TXNIP;CD81;ACVR1B;RPL36;BAK1;PDGFA;FDXR;HEXIM1;BAX;HRAS;RPS27L;CD82;BTG2;TRIAP1;CDKN2AIP;SLC7A11
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7491065855503541,1.1732402366072001,0.25,0.6333887671811631,1.0,5/9,17.38%,EPHA4;ID2;F2;HES1;BIN1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6810079404658489,-1.1730626219542848,0.34,0.8249754852801334,1.0,2/9,4.32%,PRELID1;DBI
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5556651947330853,-1.172961732871892,0.21428571428571427,0.8242895170876006,1.0,7/38,8.00%,RPS27A;UBC;UBB;LACC1;TLR1;CNPY3;S100A1
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.695561663864857,-1.1728935862754297,0.2830188679245283,0.8234736306785381,1.0,4/10,14.03%,ORC1;HUS1;ZNF830;TOPBP1
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.693565867286568,1.1728191258856049,0.30612244897959184,0.6337937737213207,1.0,4/6,24.04%,BMPR2;NR2F2;TIE1;ACVR2B
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.7489754259733516,-1.172644201497552,0.3695652173913043,0.8222315233841935,1.0,2/7,11.62%,EXOSC8;EXOSC5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.7489754259733516,-1.172644201497552,0.3695652173913043,0.8222315233841935,1.0,2/7,11.62%,EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.7896976305545307,-1.172483586432167,0.3269230769230769,0.8218698818440933,1.0,1/5,7.43%,DHX33
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.7375431473493486,-1.1723257284069515,0.3333333333333333,0.82130171260042,1.0,2/6,11.39%,GSTP1;PPIA
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.5720279274533817,1.1720992764469886,0.21153846153846154,0.6354174220182921,1.0,2/21,3.75%,SLC23A1;CBLIF
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.4709512030078351,1.1720454549944002,0.2,0.6350646315701199,1.0,7/66,8.21%,LAMP5;E2F3;PRICKLE1;NUP62CL;SYK;SPRN;HEATR3
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5909584048943568,1.1718663423781694,0.30612244897959184,0.6350615632875902,1.0,2/18,3.74%,TEX15;ZNF93
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.46007179113594954,1.1718469608847237,0.18181818181818182,0.6345964608358331,1.0,11/86,6.38%,PKP2;CLDN5;CDH9;NRCAM;GPM6A;CDH10;CTNND2;NRXN1;CDH18;SHANK2;CDH22
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.7095625183685742,-1.171493887624043,0.36538461538461536,0.8230034052208286,1.0,1/7,0.25%,CXCR4
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.7752225937528725,1.1714676369043566,0.3392857142857143,0.6351967699067784,1.0,2/5,7.04%,CBS;DCTPP1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.6567930454371678,1.1712277505953994,0.3673469387755102,0.6353536502606628,1.0,3/9,13.48%,KCNS1;RNF207;ANK3
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5057530489383829,1.1711752708287404,0.27450980392156865,0.6349646754185572,1.0,17/61,11.12%,TGFB2;CORIN;RYR3;CELF2;SLC8A1;TMIGD3;ITPR1;ABCC9;KCNIP2;TPM1;ATP2B3;ATP2B2;NOS1;CAMK2D;TMEM65;RNF207;ATP1B2
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3988112793630807,1.171156601519237,0.075,0.6345105173940737,1.0,93/363,14.50%,IL1RAPL2;CHRM3;L1CAM;PDGFC;NPAS2;NRCAM;ROBO2;NAGLU;GPM6A;RPS6KA6;DCX;PCDHB12;VCAN;FGF12;KALRN;NHEJ1;GRIK1;CHST8;MEF2C;NRXN1;DCLK1;LDB2;MET;ADGRV1;NELL1;WNT8B;FGF13;GFRA1;LGI1;RELN;EFNB3;DACT1;NRG1;SPOCK1;TBX6;PTPRZ1;ADGRB1;MERTK;SCN2A;CNTN4;EFNA5;NRGN;SHANK2;AXL;EPHB1;GDA;SCIN;NMUR2;NPTX1;IGF2BP2;ST8SIA4;TEAD1;ATXN1;TENM1;ZBTB16;WWP1;SH3GL2;GLRB;EMX1;NRSN1;EDNRB;FAT4;KCNQ2;PCDHB13;GRHL2;SEMA6A;ACVR1C;ROBO1;NCAN;DLG4;ASIC2;CNTFR;NRSN2;NPAS1;SRRM4;CHRM1;MYT1L;FGF17;SERPINI1;FABP7;ACTL6B;WDPCP;APC2;HES1;RPS6KA3;RAB29;FZD9;FARP1;CSPG5;PRX;POU6F2;VEGFA;DOC2A
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.4651758679631942,1.1706725579587691,0.2222222222222222,0.63501507866562,1.0,15/73,8.85%,SSTR1;KALRN;CNTN3;RHOJ;SORBS2;FGF14;CADPS;PDGFRA;CNTN4;SLC4A4;GABRA2;PPARGC1A;GIPC2;DENND2A;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7121132052657809,-1.1700679660106839,0.3617021276595745,0.8270967189211841,1.0,2/8,4.32%,PRELID1;DBI
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7727780241450314,-1.1699842967969774,0.29411764705882354,0.8264151629329752,1.0,1/6,12.31%,RAE1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.6545375229903011,1.1698693154685251,0.26,0.6368984080651059,1.0,3/13,18.10%,ETNPPL;ETNK1;CHKA
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7620147702269686,1.1694984721388315,0.3783783783783784,0.6376909937688199,1.0,2/5,16.10%,SETMAR;SETD5
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.7362195094077135,1.1691245796888747,0.3333333333333333,0.6382480818616787,1.0,2/5,22.94%,CDK6;NF1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.6959694479760172,-1.1690397200681848,0.23728813559322035,0.8285597179226135,1.0,4/9,13.80%,SPCS1;SEC11C;SPCS2;SPCS3
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7433142085012523,1.1690380982906978,0.2916666666666667,0.6379710181183204,1.0,4/6,24.54%,CLEC7A;ZBTB1;IL12RB1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6332328766546276,1.1687352850819892,0.2926829268292683,0.6382369968297165,1.0,8/19,12.86%,CELF2;KCNMB4;TMIGD3;KCNIP2;TPM1;CAMK2D;DMPK;KCNMB2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.44955259329494823,1.1686243162639873,0.0975609756097561,0.638016464454173,1.0,32/127,14.00%,RHBDF2;PPARG;IGF1;SIGLEC10;ADCY8;RXFP1;SRC;TNFRSF1B;SYK;ADCYAP1R1;LRFN5;CYSLTR2;GPR176;VIPR2;CYSLTR1;GNG2;ADCY2;GPHB5;GIT1;TNFRSF1A;FNDC4;ADORA2B;LYN;PRKAR1B;ADCY7;ADCY1;AOAH;GGT5;HRH2;P2RY11;NLRP3;CD200
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.5891228624486496,-1.1685900965050906,0.23529411764705882,0.8290605282891521,1.0,4/15,12.94%,DPEP1;CPA1;ABCC1;MGST3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5469255598974357,1.1684055534217197,0.21951219512195122,0.6382166059533998,1.0,17/37,15.36%,KCNMA1;KCNJ3;KCNMB4;KCNJ4;KCNIP2;GNG2;KCNJ6;ANO6;KCNMB3;ATP1B2;GABBR2;GABBR1;KCNN4;KCNMB2;WNK2;ATP1B3;KCNH2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.8020891497476696,1.1677949125828162,0.3137254901960784,0.6392190976104992,1.0,2/5,12.02%,MAP2;TTBK2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.7965536527356993,1.1675677294309303,0.3137254901960784,0.6393620279380484,1.0,1/5,17.69%,PRKCD
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.605752958038676,-1.1675623685370686,0.25,0.8321169572434225,1.0,3/27,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.5965213472553181,1.1673044165082782,0.25,0.639476778503709,1.0,11/26,16.75%,P2RY12;CYFIP1;CARMIL1;SPEF1;ARHGEF6;ABLIM1;DMTN;PTPRO;CDH13;ARHGEF4;ARHGEF7
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.7287476506578558,1.167251364744693,0.2708333333333333,0.6390699107463141,1.0,1/6,8.06%,PTPRN
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.701742977773865,1.1671250321928517,0.40476190476190477,0.6389241944752813,1.0,5/9,12.86%,MYO7A;NRXN1;PCDH15;CDH23;SHANK1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7418957287572179,-1.166980470585695,0.36363636363636365,0.832925612765732,1.0,3/7,10.70%,RPS21;RPP40;ABT1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6801986015178374,-1.1669765590556913,0.3125,0.8318518804257682,1.0,9/15,27.65%,TSEN34;CSTF2;C2ORF49;FAM98B;RTRAF;DDX1;CPSF4;TRPT1;CLP1
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.8325666257446273,1.1669380959017681,0.275,0.6388530806757381,1.0,3/5,13.24%,PKD1L3;ASIC2;PKD2L1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.39349914478012965,1.1669217509397594,0.09090909090909091,0.6383640449588923,1.0,59/391,9.67%,CTF1;IFNA2;SLA;PDGFB;CSF2RA;TRIM5;CD44;FOS;MX1;CSF1R;TNFRSF25;IL12RB2;IL12A;F3;PLCB1;TNFSF13B;PIM1;BIRC3;HGF;ZEB1;INPP5D;PTPN6;ISG15;SRC;TNFRSF1B;SYK;GPR35;ITGAM;IRS1;PTPRZ1;CSF3R;CIITA;SAMHD1;IL13RA1;XAF1;CAMK2B;PTPRJ;STX3;IRAK3;LRP8;CRLF1;STX1A;SLA2;LIFR;NFKBIA;STAT6;RSAD2;NOD1;CCND1;TNFRSF1A;SOCS3;CD4;IL1RAP;CAMK2D;BCL6;CD70;VIM;BCL2;IL33
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.714847268465812,-1.1666298756927629,0.2978723404255319,0.8309953823681534,1.0,1/7,0.82%,PAX8
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.714847268465812,-1.1666298756927629,0.2978723404255319,0.8309953823681534,1.0,1/7,0.82%,PAX8
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.6987725915211842,1.1664623867554222,0.3404255319148936,0.6389432451068833,1.0,1/8,0.72%,PPARG
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5236786005396769,-1.1664533378010964,0.22,0.8305957101049363,1.0,16/64,15.98%,TPX2;RPS3;KIF3B;BCCIP;GOLGA8M;NUMA1;NEK6;RHOA;KIFC1;HAUS6;KIF11;GOLGA2;GOLGA8H;WRAP73;ABRAXAS1;HAUS1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.7719256957233565,1.1663229972253821,0.3695652173913043,0.6388908329227033,1.0,3/6,15.86%,SLC25A19;ABCC5;ABCC11
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.7429524551055985,1.165853600986825,0.40816326530612246,0.6398301709595997,1.0,2/5,10.37%,GNB3;C3
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.45259304706447157,1.165803237567034,0.27906976744186046,0.6394252430792235,1.0,11/96,11.73%,ARHGAP31;IGF1;ARHGAP18;RIT2;TNK2;TIAM2;RERG;CDKN2A;MAPK11;PRKD1;ZNF304
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5982322522617594,1.1657903191879269,0.3125,0.6389839303418485,1.0,8/26,8.59%,PKP2;FGF12;SLC8A1;CACNA1G;KCNIP2;DMD;SCN3B;SCN1A
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.6350258453487609,1.1657802955881362,0.27450980392156865,0.6385340565282274,1.0,2/12,2.20%,ABCC4;SLC25A41
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5577036705059042,-1.1653914302369666,0.26785714285714285,0.8333898908463084,1.0,8/27,23.94%,HLA-C;HLA-B;B2M;SAR1B;PDIA3;HFE;CALR;ERAP2
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.6991466806573374,1.1652141024882054,0.2631578947368421,0.6395631481268328,1.0,5/9,17.36%,DENND1B;PRKCZ;RSAD2;NLRP3;TNFSF4
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.6317034519419095,-1.1647571922723494,0.26,0.8348348020913484,1.0,4/16,17.01%,FOLH1B;FOLH1;ADI1;ASPA
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7292051586320288,1.1646848756889303,0.3,0.6402213638724301,1.0,7/8,27.06%,BBS2;MKKS;LEPR;UGCG;BBS4;STAT3;SIRT1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.7876038509059687,1.1646705962599582,0.3050847457627119,0.6397808018168181,1.0,2/5,7.96%,SIGLEC10;GIT1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.6969573995465954,-1.164583532649513,0.24528301886792453,0.8344638858024037,1.0,6/13,19.97%,ISCA2;CIAO2B;CIAO1;GLRX5;NFU1;ISCA1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.6573485313919931,-1.1644763015425188,0.3125,0.8337298338485304,1.0,1/10,4.59%,SPX
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5308459422505416,1.164375923931088,0.21568627450980393,0.640059903751236,1.0,3/33,7.75%,LPL;HSPB1;WNT5A
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.6999272792203616,1.1643277137572177,0.38636363636363635,0.6396938327379048,1.0,2/8,7.02%,SHMT2;MTG1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.6353612643225756,-1.164093684715732,0.22807017543859648,0.8341099344384034,1.0,3/14,12.63%,DECR2;CROT;EHHADH
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.6017560553514045,-1.163975338653212,0.23076923076923078,0.8332927790738276,1.0,4/22,5.17%,RPS27A;UBC;UBB;TLR1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7093319740312205,1.163875528334873,0.2037037037037037,0.6403959301765504,1.0,4/8,14.93%,NEDD4L;CAMK2D;HECW1;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.7330067876701599,1.1637436953544198,0.2692307692307692,0.6402140923286191,1.0,1/6,10.24%,HTR2C
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.6878368524129923,1.1633650188960531,0.27906976744186046,0.6407309194832683,1.0,2/7,11.75%,IMPA2;ITPK1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.7150551769181447,-1.163258333581543,0.34615384615384615,0.8348138676465475,1.0,1/5,2.32%,KIF3B
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.7373938242982798,-1.162838907799185,0.36363636363636365,0.8352017664907284,1.0,5/6,25.10%,MRI1;APIP;ADI1;ENOPH1;BHMT
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.7589681771468723,1.1628149740671083,0.3333333333333333,0.6417611519422711,1.0,4/5,20.86%,MYLK3;EDN1;CAV3;AKAP13
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.7281962614400639,1.1625615988509617,0.4,0.6419456869440789,1.0,4/6,24.46%,DAPK1;PRKD1;PRKCD;XRCC1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6925534049213802,1.1625446401967146,0.3333333333333333,0.6415065107032271,1.0,6/11,21.67%,SLC6A4;BBS2;MKKS;PTEN;FBXW11;BBS4
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6554509008303591,1.1624607748718112,0.32653061224489793,0.6412695519773233,1.0,2/10,16.58%,RRAGD;SESN2
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.7917376314401006,-1.162344482562465,0.28846153846153844,0.8360036295061611,1.0,1/5,3.59%,PNRC2
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.7046955009866391,1.1622957555710758,0.3404255319148936,0.6413716537507247,1.0,3/8,13.24%,PKD1L3;ASIC2;PKD2L1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6913875377470526,1.1620950809164936,0.2978723404255319,0.6409812935447932,1.0,3/10,16.58%,RRAGD;RPTOR;SESN2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6913875377470526,1.1620950809164936,0.2978723404255319,0.6409812935447932,1.0,3/10,16.58%,RRAGD;RPTOR;SESN2
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.7191531886036628,-1.1618252152921957,0.3448275862068966,0.8357651962408624,1.0,2/6,11.51%,MCM4;MCM3
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.7191531886036628,-1.1618252152921957,0.3448275862068966,0.8357651962408624,1.0,2/6,11.51%,MCM4;MCM3
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.6593690899457152,-1.1617671578919944,0.26229508196721313,0.8348567957796375,1.0,5/14,18.21%,EME1;MUS81;HUS1;MDC1;RAD9B
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5557532523170358,-1.1617592286683895,0.24528301886792453,0.8338236844674447,1.0,5/44,4.99%,RPS27A;UBC;UBB;PCNA;POLD3
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.6840430757097029,1.1614808984681217,0.2982456140350877,0.6418505444395113,1.0,1/9,2.30%,PPP1R3C
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6244200922200257,1.1614553012637616,0.23404255319148937,0.6414499638819299,1.0,2/12,6.43%,EPHA4;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.5827223092473248,1.1612796325927337,0.24489795918367346,0.6413965152117445,1.0,3/16,7.14%,SRGN;HEY1;SOX9
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.7029557851615061,-1.1610400095088285,0.2391304347826087,0.8354679714584476,1.0,4/8,19.12%,ADAM15;ATP2A3;B2M;HFE
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.7087818003958153,-1.1609239644922777,0.35294117647058826,0.8348168262673615,1.0,2/6,11.43%,GLA;NOSIP
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.6766911476461341,1.1608449247611419,0.28205128205128205,0.6414810672729732,1.0,2/9,9.03%,PLCB1;CD4
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.6766911476461341,1.1608449247611419,0.28205128205128205,0.6414810672729732,1.0,2/9,9.03%,PLCB1;CD4
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.6309700003544916,-1.1607131758326625,0.23728813559322035,0.8346524210652986,1.0,3/17,11.24%,HENMT1;TSN;SNIP1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.6935111462721752,1.16015848064076,0.32142857142857145,0.6428015164532354,1.0,3/7,15.55%,PLA2G10;PLA2G4A;CHPT1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6311006409967893,-1.1601224667280794,0.26,0.8357101391989272,1.0,4/12,8.19%,SFRP1;GREM1;ATRAID;RHOA
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.6975495630580488,1.1600357144176507,0.3404255319148936,0.6425199227068058,1.0,2/7,9.91%,TBX19;BMPR2
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.53521093766269,1.1600099651567615,0.20754716981132076,0.6421024966280336,1.0,9/36,17.64%,CLDN5;CLDN16;GRHL2;PARD6A;PARD3;FRMPD2;CLDN20;MPP7;TBCD
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.7882769305515689,1.1596135202166735,0.22916666666666666,0.6427386625362956,1.0,4/7,16.77%,CKMT1A;CKM;SLC6A8;CKMT2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6113667063573497,1.159429364124184,0.2692307692307692,0.6426935876160847,1.0,2/14,3.14%,CREB3L1;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7643988451047392,-1.1594104601621693,0.3,0.8370491783806119,1.0,3/6,12.61%,PGP;GCK;MST1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.565476026330573,1.1593620940760498,0.23076923076923078,0.6423766796665382,1.0,8/32,13.49%,PID1;SORBS1;IRS1;PRKCZ;KANK1;PIP4K2A;GRB14;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.6825355691157268,1.159343966743863,0.3469387755102041,0.6414547209968912,1.0,1/7,1.54%,MDFIC
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.6825355691157268,1.159343966743863,0.3469387755102041,0.6414547209968912,1.0,1/7,1.54%,MDFIC
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.7154554505294827,1.159288282738724,0.2962962962962963,0.6411485183488993,1.0,5/8,19.90%,NRXN1;NLGN1;LRRC4;PTEN;TMEM108
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.6827759771734738,-1.159022825266362,0.2833333333333333,0.8372607620237861,1.0,3/13,14.68%,ATF3;GSTO2;DAXX
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.6719720573442611,1.1589750008389548,0.32653061224489793,0.641818655539064,1.0,2/10,4.19%,ZMYND10;DNAH7
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.6142725024303152,-1.1589643250276778,0.2545454545454545,0.8364016262156594,1.0,4/19,13.66%,TPX2;TUBG1;AKAP9;GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.7264384224802741,-1.1587339056605928,0.27906976744186046,0.8360581190434111,1.0,4/9,17.33%,NELFE;CTR9;SUPT5H;CCNT1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.5814641324285347,1.1587288535543387,0.23529411764705882,0.6419460347495812,1.0,4/14,5.83%,NTNG1;GPC6;SLITRK3;LRFN5
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6881036337682503,-1.1586652445342212,0.30612244897959184,0.8352340632373239,1.0,3/7,20.15%,EARS2;TARS2;AARS2
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.7356857154194805,-1.1585579655240685,0.35555555555555557,0.834474797312411,1.0,1/5,4.74%,HYAL2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.6173418891495319,-1.158281777354287,0.2692307692307692,0.834521261021091,1.0,2/18,4.74%,SFRP1;HYAL2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.4925547876161709,1.1580918208240614,0.20512820512820512,0.6430837063159258,1.0,13/55,9.26%,CHRM3;CX3CR1;GUCY1A1;P2RY12;MCTP1;LAT2;LRRK2;DDAH1;NUDT4;NMUR2;NOS1;EDNRB;MCTP2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.4034110372013982,1.1579808993679657,0.1111111111111111,0.6427862130675951,1.0,34/191,13.63%,CREB3L1;MMRN2;KANK2;IGFBP3;DLK2;CX3CR1;EGFR;PTPRC;IL12A;HEY1;PID1;LRRK2;DACT1;IRS1;PRKCZ;SULF1;PTPRJ;IRAK3;NDRG4;PTPRT;BCL2;APCDD1;UBASH3B;SEMA6A;CX3CL1;LYN;NOTCH3;TMEM25;KANK1;PIP4K2A;SFRP4;GRB14;GPC1;WWOX
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6487066323707734,1.1578978952923655,0.2549019607843137,0.6425342125914993,1.0,6/10,23.32%,LRP4;NLGN4X;NLGN1;PTEN;IL1RAPL1;CEL
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.4725730699923201,1.1576422391259387,0.22448979591836735,0.6427416814098941,1.0,12/74,17.75%,TGFB2;MAP3K5;PLCB1;SH3RF3;TIRAP;ANKRD6;MTURN;VEGFA;TNFRSF19;SPI1;TPD52L1;SASH1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5313875888361917,-1.1576343748808975,0.24,0.8359438531989654,1.0,10/37,20.91%,PHAX;RAN;NPM1;RAE1;NOL6;NUP37;SSB;TPR;NUP210;POM121C
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4436081626510019,-1.157498311822601,0.15254237288135594,0.8354364671033829,1.0,40/225,15.99%,RPS27A;UBC;RAD23A;USP27X;UBB;PSMD7;JOSD2;PSMB6;PSME2;ADRM1;PSMD8;USP1;USP51;ENY2;USP16;PSMB4;USP19;OTUB1;RHOA;OTUD3;PSMD3;PSMB3;CFTR;PSME1;BRCC3;TADA3;UBA52;TOMM20;PSMA7;PSMD13;PSMB8;HGS;COPS5;KEAP1;SPATA2;ACTR8;STAMBP;PSMD2;ABRAXAS1;SMAD7
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.7278760376941813,1.1572111156604181,0.30952380952380953,0.6434795378955532,1.0,2/8,8.85%,SLC8A1;EDNRB
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.7591875561149504,-1.1571654862198848,0.3023255813953488,0.8354191512193839,1.0,1/5,0.65%,GJC1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.7427217333964324,1.1571037100985166,0.3333333333333333,0.6432545491565436,1.0,2/7,4.86%,GRIP2;GRIP1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5550309566694245,1.157042169728568,0.32075471698113206,0.6430658252321617,1.0,9/28,21.67%,ZNF423;CSNK1D;ARL6;RAB29;TULP3;ODAD4;SNX10;IFT140;BBS4
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5550541643154562,1.15692709880334,0.2,0.6427607159694333,1.0,3/33,5.86%,EPHA3;CAMSAP3;EFNA5
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.7698052198151386,-1.1567810130306009,0.2807017543859649,0.8356096177449432,1.0,1/6,4.68%,EIF2AK1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.7615096047240468,-1.1567037152700366,0.36666666666666664,0.8347933330537821,1.0,1/6,6.88%,CALM1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.45133838818033956,1.1565328450895467,0.22857142857142856,0.6433080110200222,1.0,22/94,17.33%,GLRA3;KCNC2;RYR3;ADCY8;SHMT2;HCN1;PRMT8;SLC1A2;SAMHD1;TRPM2;CARD11;ACACB;PKD2L1;MLKL;ATL2;SHMT1;TMEM120A;ZBTB1;CBR4;DISP1;TDO2;SYCP1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.768733356387671,1.1564916581889106,0.2857142857142857,0.6428687622972065,1.0,2/7,14.01%,SHMT2;SHMT1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.48090583213733606,1.1563331207034633,0.21153846153846154,0.6428152113485769,1.0,10/49,14.38%,EPHA3;CAMSAP3;SRC;EFNA5;PTPRJ;DMTN;CORO1C;THY1;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.7588411306655142,1.1560815799786044,0.36,0.6429406934093302,1.0,2/7,11.25%,PTPRC;CX3CL1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.6542140796994944,1.1559375205032052,0.35714285714285715,0.6428871688651939,1.0,2/7,15.60%,CLEC5A;ACHE
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.5995691094118923,-1.1555998752724967,0.3275862068965517,0.8377090531214558,1.0,3/18,20.48%,BAX;FIS1;AFG3L2
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.8081030086017329,-1.1554308192682952,0.3333333333333333,0.837212977382767,1.0,2/5,15.93%,VAMP8;VAMP3
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.6211915271354942,1.1551969363299677,0.29411764705882354,0.6442542627952822,1.0,2/14,2.58%,CD44;CARMIL2
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7584231378637132,-1.1550677182777107,0.35714285714285715,0.8375656246287619,1.0,1/5,3.11%,RAB7B
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.7981593347923657,1.1549992784283476,0.2916666666666667,0.6444140939333141,1.0,2/5,9.04%,SAMHD1;NT5C1A
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.7238886627460597,1.1547818063978241,0.40425531914893614,0.644573685623948,1.0,1/5,13.75%,MOV10
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.772945941797333,-1.1547413886716917,0.3333333333333333,0.8377006251289425,1.0,1/6,3.76%,UBXN1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7868155357507102,-1.1546885433003957,0.25862068965517243,0.8368971225393285,1.0,2/6,17.99%,TRMT112;ETF1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5595240437043448,-1.1542869451576598,0.24,0.8370532109457571,1.0,5/42,4.99%,RPS27A;UBC;UBB;PCNA;POLD3
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5733390207123351,1.1542739229135552,0.21818181818181817,0.6451698312883231,1.0,4/21,5.65%,EGFR;P2RY12;NTRK2;ADRA1A
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.7579482087424899,-1.1541027293911803,0.3148148148148148,0.8367667011727912,1.0,1/5,5.77%,PHB2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.47166167644656787,1.1540581284323952,0.15789473684210525,0.6452128218476401,1.0,19/74,10.12%,ADAMTS5;PCOLCE;FSTL1;FAP;CSPG4;PCDH18;TNC;POSTN;PDGFRA;TMEM47;LOX;OLFML2B;COL12A1;SULF1;CCDC80;COL4A1;COL15A1;FBLN2;PAMR1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.7403260667821606,1.1537916476070937,0.3333333333333333,0.6454871693595359,1.0,3/6,18.54%,BAIAP3;NLGN1;GPER1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.47261765424812313,1.1536476585413238,0.20588235294117646,0.645325292833102,1.0,20/88,12.73%,ADAMTS5;PLSCR4;AQP1;FSTL1;MYH11;SYNPO2;POSTN;PDGFRA;TMEM47;COL12A1;COL4A1;TPM1;COL15A1;FBLN2;PAMR1;LAMB2;PRRX1;ADGRF5;INTS6;TIMP3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.7500941802717696,-1.1535774084365,0.4,0.8364112363212729,1.0,1/6,6.01%,CDC23
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.7500941802717696,-1.1535774084365,0.4,0.8364112363212729,1.0,1/6,6.01%,CDC23
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7321765468360879,-1.1533751060452682,0.36363636363636365,0.8349625656280113,1.0,3/8,15.37%,UQCRFS1;UQCC3;LYRM7
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7321765468360879,-1.1533751060452682,0.36363636363636365,0.8349625656280113,1.0,3/8,15.37%,UQCRFS1;UQCC3;LYRM7
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.5044350355232162,1.153291860754441,0.24,0.6458835479328615,1.0,6/35,17.04%,ISG15;LILRB1;UBA7;HAVCR2;NLRC5;ILRUN
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.6732204412461174,-1.1532201629721657,0.28,0.8343533336538532,1.0,2/12,5.50%,SLC25A4;PARP1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.5407911675143589,1.1532145858125218,0.2826086956521739,0.6455884036952316,1.0,4/30,5.86%,NTNG1;CD44;WTIP;EFNA5
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5476185364506646,1.1526128822465351,0.23728813559322035,0.6467490822027032,1.0,4/20,7.34%,IGF1;MEF2C;NRG1;MYLK3
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6321414002612782,-1.1521101480097085,0.3076923076923077,0.8370121886162935,1.0,4/13,13.45%,LSM2;PRPF6;PRPF8;PRPF3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.6545966190500863,-1.1520316378743471,0.38095238095238093,0.8362999800871298,1.0,2/14,9.91%,TINF2;PINX1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.6788437018255249,1.151550355278883,0.22727272727272727,0.6492115809036842,1.0,3/9,7.95%,SOX9;WNT5A;CHRD
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6446064950509959,1.151402260939612,0.2558139534883721,0.6491538684183539,1.0,2/11,11.25%,GPR35;CX3CL1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.5845977517714765,1.1511973797671642,0.3181818181818182,0.649131659718666,1.0,3/15,7.44%,SNAP25;STX3;STX1A
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6152487173487986,1.150664655835406,0.29545454545454547,0.6501092982531473,1.0,6/16,14.38%,NRG1;OXTR;NOTCH4;TGFB3;GPAT4;VEGFA
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.6465497286637898,1.1506035477349514,0.3076923076923077,0.6498476969121944,1.0,2/10,13.24%,PKD1L3;PKD2L1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5167635555727809,1.1505385397564563,0.2857142857142857,0.6495423097732325,1.0,6/44,8.08%,TGFB2;PTPRC;PLSCR1;ITGAM;LILRB1;RSAD2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.612042464114967,-1.150432058833524,0.3191489361702128,0.8406504890141209,1.0,6/18,11.96%,PRDX1;TF;CNGB1;ACTG1;SOD1;B2M
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.6326920573353956,-1.1504047075941068,0.41509433962264153,0.8397321562241626,1.0,3/15,14.25%,AMPD1;PFAS;IMPDH2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6885060249449242,-1.1503683271265468,0.2777777777777778,0.8388363877144083,1.0,3/12,5.50%,PARP2;PARP12;PARP1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6973719057293208,1.1503189548579524,0.39622641509433965,0.649749413139603,1.0,4/9,15.91%,NRXN1;LRP4;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.7113247102475242,1.1501750000074265,0.37735849056603776,0.649594520087014,1.0,2/6,12.88%,LILRB1;CDH3
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.481298391325603,1.1500994619014697,0.225,0.649334074322323,1.0,9/37,14.03%,PKP2;ANO6;SCN3B;TRPC6;CHRM1;SCN4B;CACNB2;ANK3;FHL1
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.6855704842732422,-1.150060610993241,0.2916666666666667,0.8390283983416703,1.0,3/8,15.06%,SERPINE1;TFPI;KNG1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.7322544957484909,1.1498495104730404,0.3541666666666667,0.6496641932277956,1.0,5/7,22.10%,CRYM;SLC7A8;SLC16A10;SLC16A2;SLCO1C1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5980137430663626,1.1496978176436876,0.3877551020408163,0.6495361130163805,1.0,2/15,13.78%,EPHA4;SLC2A13
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.7912607281831961,1.1494444150178016,0.36363636363636365,0.6498128212670654,1.0,4/5,15.46%,EPHB1;SCN1A;MMP24;TMEM120A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6027528400598116,1.1493130092562627,0.29411764705882354,0.649684820415343,1.0,4/14,10.24%,JCAD;IL12A;SEMA6A;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.4608340084598576,1.1492220534437072,0.1956521739130435,0.6494516163936711,1.0,23/71,19.48%,RPS6KA6;PTPRC;LMO3;PTPRR;SPRED3;PRDM15;PTPRJ;IRAK3;FBLN1;SEMA6A;DUSP10;LYN;TIMP3;DUSP6;ITGB1BP1;WNK2;STK38;PRKCD;RGS2;GPER1;CAV3;SPRY4;PTEN
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.7589441045520299,1.1489992910786686,0.3584905660377358,0.6496926704108648,1.0,2/6,11.25%,PTPRC;CX3CL1
prerank,MSigDB_Hallmark_2020__Hypoxia,0.4092083034509882,1.1487306168048617,0.14705882352941177,0.6500386061601059,1.0,40/166,13.97%,PLAC8;IGFBP3;PDGFB;EGFR;FOS;FOSL2;PPP1R3C;AKAP12;PAM;F3;BHLHE40;NEDD4L;PIM1;CA12;HS3ST1;MAFF;LOX;CITED2;CHST3;SLC2A5;ZFP36;PPARGC1A;RRAGD;AK4;KDM3A;PFKFB3;XPNPEP1;BCL2;TGFB3;NCAN;ADORA2B;P4HA1;CCN5;CSRP2;SULT2B1;SCARB1;ISG20;GPC1;COL5A1;EFNA3
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.6274744870720546,1.1486631795316706,0.2682926829268293,0.6497267871282824,1.0,3/14,9.12%,IGF1;NR4A3;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.6159964009434736,-1.1485565450053614,0.3018867924528302,0.8430097956363537,1.0,3/26,6.89%,OOEP;PARP1;RAD51AP1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5845342192442435,-1.1484266156396903,0.2962962962962963,0.8424776612611867,1.0,10/26,21.68%,TINF2;PINX1;PPIA;DKC1;NHP2;RFC1;PPP6C;GAR1;TELO2;TERF1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5799966316200383,-1.1480960189656078,0.2641509433962264,0.8426139920056278,1.0,2/32,5.92%,ADPRM;ENTPD2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.6273827128391221,-1.1480897615733419,0.27450980392156865,0.8416393957603258,1.0,3/12,7.08%,RIOK2;CDC23;NEK6
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6370916237460217,1.1480520210601761,0.29411764705882354,0.6512105772379129,1.0,7/15,11.83%,GRM5;GRM1;TRPM1;GRM2;GRM6;GRM8;HOMER1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5723453071195763,-1.1475493884768238,0.30612244897959184,0.8425629698906012,1.0,14/35,25.31%,SARS1;AARS1;TARS1;AIMP1;HARS2;NARS1;EPRS1;VARS1;QRSL1;KARS1;FARSB;RARS1;FARSA;QARS1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.5407226276888479,1.1474352941438055,0.2553191489361702,0.6522284158124684,1.0,2/30,3.12%,RPS6KA6;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5573105141566373,1.1470542406082933,0.2682926829268293,0.6525539858702575,1.0,4/23,5.88%,MMRN2;PPARG;MEF2C;MAP2K5
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.734604342866103,1.146382554349827,0.391304347826087,0.6538664222667677,1.0,5/7,25.66%,TPO;DIO2;CTSK;CPQ;SLC5A5
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.7357350870122856,1.1462381429886537,0.3333333333333333,0.6538236056697826,1.0,2/6,8.85%,SLC8A1;EDNRB
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.6733936893730823,-1.1461466708507244,0.2909090909090909,0.8465159186925392,1.0,1/6,1.31%,EYS
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7404360738761029,1.1461371885436582,0.35555555555555557,0.6535452834008891,1.0,1/6,4.89%,ID2
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.6053343818399797,-1.1460774861709426,0.27450980392156865,0.8457312693561396,1.0,1/19,0.49%,RPS23
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6579597490707566,1.1460025654580301,0.3,0.6534504543749012,1.0,3/8,20.86%,ADRA1A;ADRB2;AKAP13
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.7334088651439593,1.1459274193868065,0.37735849056603776,0.653164100287539,1.0,4/6,24.67%,CX3CL1;ITGB1BP1;FERMT3;COL16A1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5157424556916732,-1.1457283934213789,0.24528301886792453,0.8457422667229796,1.0,7/64,7.34%,NGF;LCK;BEX3;SLC22A2;NLRP1;RACK1;HSPE1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.689347225602502,-1.1457131672369345,0.33962264150943394,0.844769780159067,1.0,5/9,14.04%,RACK1;FICD;BAK1;BAX;COPS5
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.59357983465558,-1.1455915230188276,0.3103448275862069,0.8442005689575531,1.0,6/19,17.33%,PSMG2;CCT2;PSMG3;PFDN6;BBS10;BBS12
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5851767777091512,1.1454989544799183,0.3333333333333333,0.6538619001972288,1.0,7/18,17.96%,SEMA3D;SEMA6A;SEMA5B;SEMA4B;SEMA4G;SEMA3C;SEMA7A
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6537359721167169,-1.144953874765878,0.2830188679245283,0.8454547454459933,1.0,2/15,5.93%,PKMYT1;FBXO43
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.544723392293009,1.144913943879496,0.2727272727272727,0.6549414482691406,1.0,13/26,19.82%,TRIM46;MAP2;FGF13;EFNB3;KIAA0319;MCF2;NGFR;THY1;LRP4;DIP2B;RUFY3;PTEN;ULK1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6915694766334884,-1.1448059454983985,0.42105263157894735,0.8449260766056963,1.0,2/7,14.09%,SQSTM1;MAP1LC3B
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.7327978507993738,1.144454966067368,0.2653061224489796,0.65556738884946,1.0,2/5,22.85%,AMER1;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.6467363356857436,1.1440619069422253,0.3148148148148148,0.6561837297413472,1.0,4/10,17.29%,KAT2B;CCNF;KAT2A;TMEM67
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7072671725468154,1.1439500207270208,0.38,0.6559658689692234,1.0,3/6,10.37%,NCKAP1L;ANO6;C3
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.6426215964088144,1.1439156041807392,0.34545454545454546,0.655540151475493,1.0,3/9,19.27%,TNFRSF1B;PARD3;TENM4
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6217880732156434,1.1438647674875708,0.2857142857142857,0.6552797381862019,1.0,5/15,19.48%,IGF1;ZFP36L1;GAS6;KDR;PTEN
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.49923427608737836,-1.1436810558266501,0.23214285714285715,0.8476843946898849,1.0,11/63,14.68%,H1-4;RNF8;H2AX;H1-2;CHAF1B;GRWD1;SMARCA5;H2BC21;NPM1;POLE3;DAXX
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5387591372020026,1.1432409138474846,0.25,0.6562842539236723,1.0,16/31,15.79%,UTRN;FGF12;NEDD4L;FGF14;FGF13;NETO1;DMD;SCN3B;CAMK2D;YWHAH;SCN4B;ANK3;HECW1;WNK2;PRKCE;GLRX
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6546719760457322,-1.1432280827654078,0.36,0.8483812382249145,1.0,1/8,0.69%,PLAAT5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5573520391000375,1.1427479761076405,0.26666666666666666,0.6573478946686152,1.0,5/20,17.13%,CHI3L1;IRGM;PLK1;RPTOR;PRKAG2
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5062559883577697,1.1424066761339018,0.2708333333333333,0.6576834978082026,1.0,8/39,14.13%,TGFB2;BMPR1B;PBX1;MEIS3;MEIS2;SHROOM2;COL5A1;CHRDL1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.4835247742250558,1.1421483815458817,0.21739130434782608,0.6578025526907009,1.0,13/70,9.61%,L1CAM;ITGA11;CD44;ADAMTS9;ITGB4;ACTN1;SORBS1;SRC;ITGBL1;NPNT;FBLN5;MKLN1;LYVE1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.5447602318177047,1.141932358982757,0.28205128205128205,0.6579300710843773,1.0,14/24,25.95%,PID1;SRC;SOCS3;PTPRT;SELPLG;ST3GAL6;PTPN11;SPI1;FER;JAK1;CBL;YAP1;STAT3;RELA
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6670738361010398,1.1418655278192198,0.3269230769230769,0.6576431684364544,1.0,2/8,5.43%,LOX;LOXL3
prerank,GO_Biological_Process_2021__negative regulation of meiotic cell cycle (GO:0051447),-0.7911434012178853,-1.1410845877249531,0.2962962962962963,0.8543966485337202,1.0,2/5,11.70%,FBXO43;NPPC
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.730262253339219,1.1409586320463805,0.36363636363636365,0.6595643414404272,1.0,2/6,11.83%,GRIN2B;HOMER1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.4538231153568274,1.1408719410315895,0.24444444444444444,0.6593025237490734,1.0,4/66,2.47%,LPL;PPARG;PLSCR1;CBS
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.7461111080914729,1.1408321277110185,0.3409090909090909,0.6589808062700303,1.0,4/7,19.13%,RFX3;DNAAF1;ODAD4;CFAP53
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6045878952832864,1.1402941128130168,0.3333333333333333,0.6598728558153937,1.0,9/16,25.24%,SRC;SOCS3;PTPN11;SPI1;FER;JAK1;CBL;YAP1;STAT3
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.46098625620426925,-1.140276155068659,0.2,0.8562082413615396,1.0,25/104,19.47%,RPS14;SRPRA;ATF3;H2AX;IMP3;TARS1;BANF1;SPCS1;NOP56;EXOSC5;NPM1;RRP9;DKC1;POP4;SPCS3;CKS1B;NHP2;DCTN1;FKBP14;EIF2AK3;NOP14;LSM1;ATF4;MTHFD2;YIF1A
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5263116483602711,1.1402442229984062,0.25,0.6595081972854435,1.0,10/32,14.03%,CHRM3;UTRN;FGF12;NEDD4L;SCN3B;TRPC6;YWHAH;HOMER1;SCN4B;FHL1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6345327626242381,1.1401293617432122,0.3902439024390244,0.659247175708751,1.0,1/10,2.94%,BDH2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5785263290743332,-1.1401263764619332,0.2909090909090909,0.8556499814996125,1.0,4/24,6.73%,JUP;RBM22;HYAL2;RAN
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.6143268822260664,-1.140080259074966,0.3114754098360656,0.8547555309042242,1.0,1/16,1.12%,PDZD11
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.4766133868865804,-1.1400774666353373,0.27450980392156865,0.8537442329887752,1.0,1/69,0.05%,PM20D1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.4719805373034376,1.1396862563972074,0.23404255319148937,0.6597850626896318,1.0,3/45,5.72%,ALDH1L1;SHMT2;ME3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.7524602946838783,1.1396499100174038,0.37209302325581395,0.6594469961220406,1.0,2/5,16.13%,ADGRV1;ADRB2
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.7138093809711131,1.1395598671497347,0.3137254901960784,0.6588580006244135,1.0,3/5,10.37%,NCKAP1L;ANO6;C3
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.7138093809711131,1.1395598671497347,0.3137254901960784,0.6588580006244135,1.0,3/5,10.37%,NCKAP1L;ANO6;C3
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.7093956691335989,-1.1394726894408491,0.3076923076923077,0.8548547085696873,1.0,3/6,7.08%,RIOK2;CDC23;NEK6
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.6462128064320475,1.1394559216437792,0.2857142857142857,0.658615508082878,1.0,4/11,13.89%,SOX9;SULT2B1;SFRP4;RFX3
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.7851448542441685,1.1394272428333065,0.34782608695652173,0.658202253437529,1.0,1/5,7.66%,NFKBIA
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.7422910650265714,1.1392695130492745,0.3409090909090909,0.6581572156274368,1.0,1/5,12.63%,OLFM2
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7467613287730868,1.139041444613405,0.3333333333333333,0.6583087372034638,1.0,2/6,7.02%,TSHZ3;MTG1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.6175322474107622,-1.1389573144878735,0.3392857142857143,0.8554679496633114,1.0,3/13,13.54%,CHMP2A;SNF8;HGS
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.7408773007338039,1.1388410955342843,0.3469387755102041,0.6584429672909524,1.0,4/5,13.74%,DENND1B;PRKCZ;RSAD2;NLRP3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6358135951144847,-1.1388375027458664,0.32142857142857145,0.854844734279115,1.0,3/23,7.52%,CRTAM;TNFRSF21;CD274
prerank,MSigDB_Hallmark_2020__Apical Junction,0.4047533848165082,1.1388123876101277,0.1,0.6580651443978182,1.0,28/162,13.59%,ADAMTS5;CLDN5;EGFR;PTPRC;ITGB4;MPZL1;VCAN;ACTN1;BAIAP2;CNTN1;SRC;SYK;IRS1;RHOF;CADM3;FYB1;ARHGEF6;COL9A1;MAPK11;YWHAH;CX3CL1;CDH6;AKT3;NEGR1;SLC30A3;CDH3;SHROOM2;THY1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.48710241410982197,1.1387740331157181,0.21428571428571427,0.6576793375061918,1.0,12/58,14.38%,PDGFB;JCAD;F3;WNT5A;VEGFD;ARNT;BMPR2;PRKD1;AKT3;VASH2;CDH13;VEGFA
prerank,MSigDB_Hallmark_2020__Androgen Response,0.4317816761584141,1.1383694260248245,0.21739130434782608,0.6580181811199641,1.0,10/94,8.45%,ABCC4;FKBP5;GUCY1A1;ACTN1;AKAP12;BMPR1B;INPP4B;MERTK;LIFR;CCND1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.6789624960593788,-1.138361382398903,0.288135593220339,0.8553578466395271,1.0,2/6,16.95%,ERCC8;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7545739061575887,-1.1382932687344836,0.3469387755102041,0.8546081077993177,1.0,2/5,19.95%,PARK7;PINK1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.43621522828658515,1.138203828114975,0.20512820512820512,0.6579649553238093,1.0,31/119,16.75%,ARHGAP31;CGNL1;ARHGAP10;KALRN;RHOJ;ARHGAP18;OBSCN;RELN;SRC;FAM13B;SRGAP1;RHOQ;ARHGAP25;TIAM2;RHOF;ARHGEF6;NGEF;FAM13A;ARHGAP17;MCF2;ARAP1;ARHGAP28;RAC3;ARAP2;RHOT1;CHN1;TRIP10;ARHGEF4;ARHGEF26;ARHGAP44;ARHGEF7
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5418684174138626,1.1377741454450727,0.30434782608695654,0.6587029227975068,1.0,3/22,13.89%,MET;CITED2;DNAAF1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6252534644675256,1.1377185909863818,0.23809523809523808,0.6583942672793871,1.0,6/18,20.53%,SLC8A1;GRIN1;ANK3;CNNM2;TMC8;ATP13A2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.5159092379093947,1.1375404774840199,0.24489795918367346,0.6582984146164927,1.0,4/31,4.89%,PDGFB;IGF1;NR4A3;ID2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.45500957215400584,1.1375012694206752,0.19607843137254902,0.6578971144873553,1.0,17/73,12.29%,GPM6A;PLPPR5;P2RY12;CYFIP1;CARMIL2;TWF2;RHOQ;TENM1;AGRN;TENM2;TGFB3;CCP110;DOCK11;CDC42EP4;DPYSL3;PIK3R1;ARAP1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.45951241681402616,1.1373176002569785,0.20454545454545456,0.6578187172671084,1.0,9/53,6.28%,IFNA2;PTPRC;NHEJ1;IKZF1;TOX;BLNK;AXL;PBX1;PTPRJ
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.6774365826827367,1.1370898349805587,0.35294117647058826,0.6578591007429145,1.0,4/8,21.96%,PHLDB2;FERMT1;PTEN;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.4680904149717392,1.1370565095438854,0.19230769230769232,0.6574843803358963,1.0,10/85,4.72%,TGFB2;L1CAM;EGFR;SYT4;IGF1;NEDD4L;RIMS2;TWF2;LGI1;SYT1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.4697913235338443,1.1363305049161911,0.20454545454545456,0.6587945913326098,1.0,23/63,17.87%,LPL;TLR2;NCKAP1L;PTPN6;C1QTNF4;SYK;IRAK3;WNT5A;TIRAP;IL33;EOLA1;CX3CL1;POU2F2;CLEC7A;PTPN11;CD200;NOS2;IL17RA;IL16;GAS6;LBP;TNFSF4;NLRP12
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.7746195769058861,-1.136281169167893,0.3877551020408163,0.8597218344857285,1.0,1/5,2.22%,DPM3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.7746195769058861,-1.136281169167893,0.3877551020408163,0.8597218344857285,1.0,1/5,2.22%,DPM3
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.6602482772442697,1.1361448451132363,0.2631578947368421,0.658808820760453,1.0,4/9,13.69%,IFNA2;IRAK3;RFTN1;IFNK
prerank,MSigDB_Hallmark_2020__Apical Surface,0.5038181063798629,1.13601345536067,0.2765957446808511,0.6586032701723099,1.0,8/33,15.57%,NTNG1;EFNA5;HSPB1;CX3CL1;LYN;SHROOM2;THY1;ADIPOR2
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.7613160885753382,1.136005994964007,0.2608695652173913,0.6581699608790802,1.0,1/6,3.57%,NR4A3
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.5738571453702889,1.1356417828614016,0.25925925925925924,0.6585053349036591,1.0,2/18,2.58%,CD44;CARMIL2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.7059050842680328,1.1355708712923767,0.4,0.6582582642583089,1.0,3/6,20.06%,FZD3;BCL2L1;PAK2
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.7410751216536198,-1.135242524508205,0.4,0.8628687322976334,1.0,1/7,3.89%,PIK3C2G
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6313392053416316,1.1351829084866987,0.34146341463414637,0.6589049509090139,1.0,3/12,6.92%,LRRK2;RHOQ;AK4
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7298864028454753,1.1351179276475167,0.2916666666666667,0.6586326798748705,1.0,2/5,21.97%,TSG101;SDCBP
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5458788986619008,1.1350037347362318,0.2549019607843137,0.6584281253605185,1.0,6/25,16.33%,ADCY8;EPHA4;RELN;ADCY1;ZDHHC2;NSG1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.6317735373242986,1.1349113925077168,0.38095238095238093,0.6582070387315265,1.0,3/14,9.91%,ITGB4;TBX19;BMPR2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.4702325700005336,1.1348704704125523,0.2777777777777778,0.6578349816882971,1.0,21/73,20.16%,PPARG;IL12A;WNT8B;IRAK3;SOX9;MAPKAPK3;TIRAP;NOS1;ERBIN;ALPL;GGT5;ACER2;RPS6KA3;NOS2;NOCT;RXRG;LBP;RXRA;LY96;FER;RARG
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.6875531003559345,1.1346686165447608,0.35185185185185186,0.6578833821190205,1.0,2/8,21.79%,PRKCD;RPS6KA4
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.7379755553005127,1.1345615536083018,0.3877551020408163,0.6575876121764361,1.0,1/6,8.91%,TAC4
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5350932673115234,-1.1344580633310237,0.37735849056603776,0.8644386065830884,1.0,8/44,11.23%,TAX1BP3;RHOG;CFL1;CDC42EP1;RHOA;ARHGEF1;CDC42EP5;ARHGDIA
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.5637105083399644,-1.1344440300910779,0.3137254901960784,0.8634670095013696,1.0,4/23,12.18%,PRELID1;NPC2;PRELID2;TRIAP1
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.7743576784562052,1.134283184387808,0.34,0.6578457892695821,1.0,4/5,19.37%,SLC22A3;PICK1;SLC6A4;SLC29A4
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.672058648458683,-1.134248863039573,0.3559322033898305,0.8630261891655588,1.0,4/10,24.78%,WASHC2A;RAB35;VPS35;MICALL1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.5331884962740366,-1.1342049514025385,0.28125,0.8621465216393667,1.0,8/33,18.74%,GAPDH;SLC25A11;SLC25A1;PGAM1;CRTC2;SLC37A4;SLC25A10;ATF4
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.7028154466013832,1.1339686828250544,0.30434782608695654,0.6581957931426642,1.0,2/5,24.46%,LIG3;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.479192445905498,1.1339264335850743,0.3,0.6578501773131081,1.0,12/68,14.38%,PDGFB;ANGPT1;MET;HSPB1;WNT5A;GPLD1;BMPR2;PRKD1;AKT3;SCARB1;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.49060456363504085,1.133848009406354,0.2692307692307692,0.6576305843977145,1.0,7/34,10.72%,CERS3;CERS6;ST8SIA3;B4GALT6;ST8SIA4;ST8SIA6;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.4353217805704255,1.1336370571907333,0.25,0.657678924431462,1.0,26/97,13.82%,CX3CR1;TRPC4;ADCY8;TRPC7;SLC8A1;PDGFRA;GPR35;C3AR1;PTGER3;ADRA1A;CYSLTR1;NMUR2;WNT5A;ATP2B3;F2;ATP2B2;TAC4;TRPC6;CDH23;P2RY1;DLG4;TRPC3;TRPV4;CCR9;HCRTR2;FZD9
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6028947410397298,1.1332824726880302,0.3695652173913043,0.6581784960937217,1.0,7/16,20.97%,F2;GHR;MGAT5;HES1;CRLF3;ERBB4;CYP1B1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4667921257633427,1.1332608446299126,0.2564102564102564,0.657783752641648,1.0,10/58,10.15%,KANK2;EGFR;MYO16;PLCB1;PTPN6;DACT1;ID2;CCND1;CDKN2A;KIF14
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.7777896952418246,-1.1330454292895922,0.39622641509433965,0.8650279623123899,1.0,3/6,20.48%,TXNIP;BLM;ORC6
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.5224160596096394,-1.1329779736091103,0.19607843137254902,0.8643235506311185,1.0,6/48,11.58%,CDKN1C;SERPINE1;FNTA;RHOA;ID3;RAB31
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.4762500839278793,-1.1329638596447769,0.26229508196721313,0.863338308819369,1.0,22/73,23.82%,NUTF2;SRSF7;PHAX;RAN;SRSF9;SRSF3;RBM8A;RAE1;RANBP17;DHX38;MAGOHB;ALYREF;SLU7;WASHC4;TPR;CASC3;POM121C;MALT1;CALR;SRSF2;CDC40;CSE1L
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.7259159531658272,-1.1329275105673369,0.4222222222222222,0.8624818592319784,1.0,1/5,5.49%,RACK1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.45792319747882554,1.1326861564217792,0.2727272727272727,0.6588333658451254,1.0,27/96,14.75%,DACT2;ANGPT1;IL12A;PRKX;EPHA4;SRC;PLXNA4;PPP3CA;ADGRG1;EFNA5;PTPRJ;STX3;TESC;TPM1;EPHB3;CHRD;PLXNA2;FBLN1;NUAK1;KIF14;PDE3B;LYN;CDH13;PTPN11;ITGB1BP1;VEGFA;ZDHHC2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6755052039129301,1.132451855049215,0.38,0.658452986018311,1.0,3/8,22.85%,DYRK2;FHL2;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.6755052039129301,1.132451855049215,0.38,0.658452986018311,1.0,3/8,22.85%,DYRK2;FHL2;GSK3B
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.5230937581696223,1.1322404893185876,0.23076923076923078,0.6585421890007125,1.0,4/43,7.23%,TGFB2;EGFR;EPHB1;PER1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.6272560946688223,1.1322341531887725,0.3469387755102041,0.6581152812283279,1.0,4/12,17.69%,IRS1;ABCD2;ABHD5;PRKCD
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6157083823902277,1.132092217029437,0.275,0.6580548976524839,1.0,3/12,19.58%,SPEF1;ARHGEF4;FGD1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.7009460152231952,1.1320513517456332,0.3333333333333333,0.6577369653851429,1.0,4/7,21.89%,CLEC7A;CAMK4;TICAM1;SCIMP
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.4463802964446033,1.131647612240649,0.2857142857142857,0.6582582760216876,1.0,23/84,16.13%,PLAC8;PDGFC;CAMK1D;SYK;OXTR;PPARGC1A;ACADL;EPAS1;STAT6;KDM3A;DIO2;PRKAB2;ZNF516;ACACB;CLEC7A;VEGFA;UCP1;EBF2;KDM6B;ADIPOR2;ACHE;GJA1;ADRB2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.6041829561574261,1.1316003071390361,0.28888888888888886,0.6578742518747152,1.0,3/11,8.57%,CBARP;LILRB1;NOS1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4922102216459513,-1.1315768373482513,0.23529411764705882,0.8659519272954813,1.0,4/44,7.61%,SFRP1;RACK1;IFT81;INTU
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5844001401339018,-1.1314992767636454,0.29411764705882354,0.865201197255584,1.0,3/19,5.48%,TNFRSF21;GAPDH;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.3648605263981104,1.131388672561431,0.09375,0.6579468984036972,1.0,110/686,14.52%,ETV1;TGFB2;PLAC8;NPAS2;PPARG;PDGFB;TP73;BMP6;EGFR;IGF1;PLSCR1;GRHL1;TLR2;MLIP;HNF4G;FOS;FOSL2;CASZ1;HEY1;MACC1;PID1;E2F3;UHRF1;MEF2C;NR4A3;LDB2;BMPR1B;BCL11B;HGF;MET;GCM1;ATF1;KAT2B;NR2F1;MAFF;PPP3CA;KLF15;RHOQ;CIITA;CITED2;PRDM15;MAP2K5;LMO7;RARB;LEF1;PBX1;LILRB1;PLAGL1;MEIS3;PPARGC1A;GRIN1;TP63;SOX9;PER1;TEAD1;EPAS1;NFKBIA;DLX1;WNT5A;MEIS2;STAT6;NOTCH4;TAL1;PTPRN;ZGLP1;LMO2;CLOCK;GLIS3;NOS1;TNFRSF1A;TBL1XR1;BCL9;ARNT;AGRN;IL33;ZBTB18;BMPR2;GRHL2;SATB2;TGFB3;NR1I3;NGFR;CDK12;CX3CL1;PRKD1;POU2F2;ONECUT2;ELK3;ZNF304;NOTCH3;PIK3R1;MRTFB;FHOD1;RFXANK;KAT6B;HES1;CDH13;NR2F2;NCOA1;MED14;WWOX;RPS6KA3;NLRP3;RFX3;NCOA7;ITGB1BP1;HCLS1;VEGFA;GLIS1;CSRNP2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.7598689534333656,1.131335080747236,0.36363636363636365,0.6576299262813237,1.0,3/5,20.38%,ADRA1A;RGS2;CHGA
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.7699513584291491,-1.131236634331434,0.35185185185185186,0.8652181498538677,1.0,2/6,10.26%,SPX;SRI
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.550287956587839,1.1310002952157343,0.23333333333333334,0.6579676606867187,1.0,2/25,5.06%,RHBDF2;STXBP5L
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.7074548402462852,1.1309943845571244,0.3125,0.6575683537937864,1.0,4/6,19.15%,IRGM;FYCO1;ADRB2;CALCOCO2
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.6599735801529834,1.1309129879211468,0.3508771929824561,0.6573846303713089,1.0,3/7,26.07%,B3GALT1;UGCG;B4GALT3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.40580727848274656,1.1306273830134896,0.17073170731707318,0.6577631548884957,1.0,28/220,10.37%,KLRF2;LPL;PTPRC;TLR2;CSF1R;CHI3L1;IL12RB2;IL12A;F3;PLCB1;C1QTNF4;ISG15;SYK;C5;PRKCZ;SULF1;LILRB1;WNT5A;STAT6;TIRAP;NOD1;LAPTM5;CD4;ARNT;IL33;RFTN1;MAPK11;C3
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.597399087206085,-1.1306104159800239,0.32727272727272727,0.8663293532641745,1.0,4/17,13.54%,CHMP2A;SNF8;CHMP3;HGS
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.5553883583644625,1.1305537313819087,0.28846153846153844,0.6575134802262911,1.0,4/25,11.44%,CHST1;B4GALT6;HEXB;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.6038927419703005,1.1305518883732277,0.34615384615384615,0.6570578229288371,1.0,7/13,20.89%,IRGM;FYCO1;UBQLN4;ADRB2;CALCOCO2;RUBCN;TBC1D25
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.675759232363959,-1.1304221744902216,0.3076923076923077,0.8659483708230445,1.0,1/15,1.47%,BUB1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.6574099969528646,-1.130403958771744,0.2916666666666667,0.8650175734244004,1.0,5/15,14.96%,CCT7;CCT2;CCT6A;DKC1;NHP2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.664903026380129,1.1303253790184888,0.3191489361702128,0.6570729003546038,1.0,2/9,6.29%,PTPRC;LILRB1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.6380030796733367,1.1302604984794387,0.3333333333333333,0.6568324634572434,1.0,5/12,8.57%,ADAMTS5;ADAMTS15;ADAM12;JAM2;NOS1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.6513656384789662,-1.130252675960898,0.3220338983050847,0.8644942492502705,1.0,2/14,0.92%,PRELID1;IFNLR1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.5877293999048494,-1.1302084311685219,0.2631578947368421,0.8636444148269546,1.0,8/20,18.80%,TIMM10;SAMM50;TIMM8B;BAX;BAD;TIMM13;TIMM9;TIMM29
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.7163276792103985,1.1300925442508367,0.3469387755102041,0.6568394398546149,1.0,4/7,16.83%,NFKBID;NFKBIZ;CLEC7A;IL12RB1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.6532952566707613,1.1300357859096855,0.40350877192982454,0.6564678112968688,1.0,2/9,8.69%,PLXNA4;PLXNA2
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.7326883829953781,1.1295353820223677,0.3541666666666667,0.6572892701359833,1.0,1/5,13.65%,BCAT2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.7228531902002555,-1.1289289035109118,0.3469387755102041,0.8658838674832007,1.0,1/9,1.53%,TINF2
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.7228531902002555,-1.1289289035109118,0.3469387755102041,0.8658838674832007,1.0,1/9,1.53%,TINF2
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.8106387908129595,-1.1288348661206926,0.32558139534883723,0.8630759366645164,1.0,2/5,13.67%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.8106387908129595,-1.1288348661206926,0.32558139534883723,0.8630759366645164,1.0,2/5,13.67%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.8106387908129595,-1.1288348661206926,0.32558139534883723,0.8630759366645164,1.0,2/5,13.67%,UFC1;UFL1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.6995834607369981,1.1288303209586377,0.3541666666666667,0.6587260181112538,1.0,2/6,21.88%,ATPAF1;ATPAF2
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.7139637790907858,-1.1287805050188127,0.32075471698113206,0.862224047043337,1.0,4/6,26.09%,DKC1;NHP2;MEPCE;NOP10
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.7464944633275574,-1.1287479798557174,0.39215686274509803,0.8613071914653926,1.0,2/5,14.78%,SPHK2;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.6179102327020503,1.1287066548412987,0.2916666666666667,0.6587070294498101,1.0,3/17,8.11%,NCKAP1L;CAMK1D;TIRAP
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6081145878242354,1.1284796714824739,0.2727272727272727,0.6588358045564954,1.0,2/12,8.20%,KLF9;LMO2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5420412422267729,1.1284377002818577,0.3469387755102041,0.6584886867791385,1.0,9/28,20.97%,PTPRC;F2;SOCS3;GHR;HES1;CRLF3;DOT1L;ERBB4;CYP1B1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.5780342920339142,1.1282753198832534,0.36538461538461536,0.6583633481558792,1.0,3/19,7.79%,PRKX;SOX9;TIMELESS
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5056830163168783,1.1282033162982572,0.24,0.6580825584565085,1.0,9/56,13.42%,RHBDF2;EGFR;PTPRJ;SH3GL2;MVB12A;DOK1;TGFA;ARAP1;CDH13
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.5000999603492962,1.1280823890022535,0.3111111111111111,0.6579413010856272,1.0,7/42,8.04%,EPHA3;PLSCR1;TLR2;MCTP1;NRG1;LILRB1;DYSF
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.5807084910603699,-1.1280257519481889,0.3684210526315789,0.862674958093561,1.0,1/16,1.88%,ARPC5
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.6130696368478068,-1.1279748214026548,0.3269230769230769,0.8618550847648584,1.0,2/13,4.53%,NT5C;MBD4
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.5734756847911513,-1.1279320484908124,0.29310344827586204,0.8610180373779588,1.0,4/16,10.65%,BUD23;RIOK2;TRMT112;METTL18
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.4498853972208574,1.1277647517334703,0.2391304347826087,0.6583400820152909,1.0,22/85,14.48%,CLDN5;MCTP1;DACH1;EPHA4;TMIGD3;SRGAP1;CITED2;SULF1;PTPRJ;TPM1;CHRD;FBLN1;PTPRT;ROBO1;DUSP10;NGFR;CX3CL1;DPYSL3;KANK1;ZMYND8;THY1;PTPRK
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.4764144854343576,1.1277351671850893,0.3018867924528302,0.6579209310782306,1.0,10/56,12.73%,TIMP4;HGF;MET;NELL1;RASIP1;GPLD1;BCL2;DAPL1;WDR6;TIMP3
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.5831153474450655,1.1275104042726312,0.37037037037037035,0.6579679447005736,1.0,6/14,15.20%,PYGL;MGAM;AOAH;PHKA2;PGM2L1;AGL
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6134605811324874,1.1274840376611481,0.32075471698113206,0.6575741113195294,1.0,5/13,14.03%,LRRK2;NEDD4L;SCN3B;CAMK2D;FHL1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.5066857760087711,-1.1273657844645664,0.2962962962962963,0.8621149426934506,1.0,1/41,0.07%,CFAP61
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.758917075801525,1.1269243562993014,0.3076923076923077,0.6585267305370418,1.0,3/5,21.03%,TOX;OPHN1;CHD5
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.6986664609440396,1.126744796157955,0.32558139534883723,0.6584591124524443,1.0,2/6,9.98%,CARTPT;UBASH3B
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5288919372478381,1.1264381064519016,0.2,0.6587500060436818,1.0,8/41,12.35%,PPARG;PDGFB;ANGPT1;MEF2C;HSPB1;PRKD1;AKT3;ANGPT2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.5740714253613036,1.1262874885504472,0.26666666666666666,0.6586172052025745,1.0,10/19,17.19%,GRIN2B;SLC8A1;ADRA1A;GRIN1;TRPM1;TRPM2;TRPV4;JPH4;ITPR3;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.43503432402505443,1.1261733445716504,0.2391304347826087,0.658403238162619,1.0,19/119,8.74%,IFNA2;VSIR;SRGN;PTPRC;NCKAP1L;IL12A;PTPN6;ISG15;MAPKBP1;MAP2K5;LEF1;AXL;LILRB1;ZFP36;UBA7;IRAK3;LAPTM5;F2;ABCD2
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.7229453235152226,-1.1261039083107378,0.33962264150943394,0.8647588947719923,1.0,2/8,15.93%,VAMP8;VAMP3
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.4979546529449423,1.126064937939934,0.22641509433962265,0.6582058216465128,1.0,6/53,9.74%,TGFB2;EGFR;PLCB1;LGI1;BCL2;RFTN1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6187894299173009,1.1256321341119526,0.35714285714285715,0.6588291645387758,1.0,5/14,17.13%,PPARG;PRKAB2;PDK4;ADIPOR2;PRKAG2
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.6304849019667667,1.125477280386593,0.34615384615384615,0.6588184437386113,1.0,3/12,10.05%,IGF1;SULF1;ACVR1C
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.5801654588181135,-1.125125669474523,0.2692307692307692,0.8670549541406923,1.0,2/30,2.35%,UXT;UBB
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7425237870661654,-1.1250429986290809,0.37254901960784315,0.8663296078146536,1.0,3/5,18.90%,UBE2D4;RNF6;UBE2S
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.6982385354762145,1.1250125514674767,0.40425531914893614,0.6595459838270311,1.0,2/9,4.48%,ADGRV1;COL11A1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.6070493713789279,1.124404560237407,0.36,0.6606454587943372,1.0,6/12,20.60%,IKZF1;TBX6;MEST;VEGFA;BMX;TIE1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.6258263269520004,1.1241449744836198,0.44,0.6608684695090384,1.0,6/14,10.57%,NTNG1;FLRT2;COL4A1;NTN4;LAMB4;LAMB2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.6726640036705361,-1.1240666521881089,0.36,0.8687891629942465,1.0,4/8,23.00%,HMGA2;RESF1;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5619224594345322,-1.1239529112096078,0.30357142857142855,0.8681581248102067,1.0,9/31,19.54%,TRMT10C;HSD17B10;TRMT112;METTL2A;TRMT10A;METTL6;TRMT1;TRMT13;NSUN2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5602993038161436,1.1232113153163665,0.35555555555555557,0.6626294267891308,1.0,6/27,12.07%,EGFR;PTPRR;SRC;NRG1;ERBIN;PIK3R1
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.618839652852196,1.1231397365904072,0.36585365853658536,0.6618752573367574,1.0,1/8,4.64%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.618839652852196,1.1231397365904072,0.36585365853658536,0.6618752573367574,1.0,1/8,4.64%,SYK
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.6937777818250807,1.1229775323898685,0.4666666666666667,0.6618302026058499,1.0,1/5,17.82%,ATPAF1
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),-0.6820607542460313,-1.1229327304707704,0.3442622950819672,0.8706761613136715,1.0,1/7,0.19%,BMP5
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.44672110502932927,1.1226635851045155,0.23076923076923078,0.6621566173845846,1.0,31/102,21.14%,RND2;ARHGAP10;WTIP;ANK1;PACSIN1;RHOF;TPM1;FMNL3;PCLO;CNTNAP1;DIAPH1;BRWD3;DMTN;SEMA6A;STRIP2;TNIK;WDPCP;RAC3;THY1;CSPG5;PAK5;PALLD;BIN1;SPRYD3;ABI2;ARAP3;FGD1;PPP2R3C;SIPA1;PHIP;SH3D19
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4372835606792687,1.122249720850375,0.2549019607843137,0.6627649917698423,1.0,26/94,12.66%,NPY1R;P2RY12;ADCY8;RXFP1;AKAP12;ADGRE2;GPR161;PTGER3;CNR1;ADGRB1;ADCYAP1R1;ADGRG1;VIPR2;GNAL;ADGRL2;ADCY2;GPHB5;GPR26;RGS1;GPR12;GRM8;ADCY7;GNAO1;HTR1E;ADCY1;GABBR1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6836974555004836,1.1221164086039388,0.43859649122807015,0.6626871735068028,1.0,1/7,9.45%,CORO1C
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7278917729342562,-1.1220899161980917,0.47058823529411764,0.8725747638105588,1.0,1/5,1.71%,SFRP1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6981432868809166,-1.121837370748199,0.3508771929824561,0.8724791353164313,1.0,5/10,18.80%,TIMM10;TIMM8B;TIMM13;TIMM9;TIMM29
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.5192637640288575,1.1218162711686277,0.3469387755102041,0.6628753648932574,1.0,4/33,10.88%,EGFR;PTPRJ;SH3GL2;TGFA
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.42726465764345745,1.1216575863823746,0.23255813953488372,0.6628136817531131,1.0,28/105,14.45%,ADAMTS5;FSTL1;RHOJ;FAP;CSPG4;PCDH18;TNC;POSTN;COL11A1;PDGFRA;TMEM47;OLFML2B;COL12A1;SULF1;CCDC80;COL4A1;COL15A1;COL9A1;BOC;PAMR1;CREB3L2;PRRX1;AEBP1;TIMP3;THY1;COL5A1;VEGFA;PDZRN3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6602658736131476,1.1215932093644572,0.3448275862068966,0.6624704433139789,1.0,1/9,1.34%,RPS6KA6
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.6192585944941108,1.1214214675405427,0.37735849056603776,0.6625377790494138,1.0,2/11,6.29%,IFNA2;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.5987541581087947,-1.120883932229904,0.32653061224489793,0.8749836926825333,1.0,1/12,7.63%,VCPKMT
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6203004327787973,1.1208166219447775,0.325,0.6637059503372316,1.0,4/14,8.84%,IGF1;NRG1;EPAS1;MAPK12
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.528782229292412,-1.1204384572762558,0.33962264150943394,0.875214882189185,1.0,7/25,18.01%,DCTD;AK8;CMPK1;NME3;TYMS;GUK1;DUT
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.5557726347968284,1.1203892000634488,0.2909090909090909,0.66429434728688,1.0,3/21,11.44%,CHST1;B4GALT6;ST3GAL6
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5341124585868032,1.1201787495063205,0.3137254901960784,0.6642800665614151,1.0,10/29,13.81%,CDH9;CDH10;SELL;CDH18;CDH22;PCDHB13;CDH23;CDH6;CDH13;CDH7
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.6630233109737969,-1.1201560431701452,0.3333333333333333,0.87521997589156,1.0,4/7,20.94%,BYSL;PINX1;MCRS1;NVL
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.5714609037477933,-1.120114839102665,0.36,0.874351954746609,1.0,6/26,15.52%,SLC25A1;ELOVL1;HSD17B12;HSD17B8;FASN;ACSF3
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.6226792255907551,1.1199277833167662,0.4074074074074074,0.6639870899415266,1.0,1/9,3.91%,CA12
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.6226792255907551,1.1199277833167662,0.4074074074074074,0.6639870899415266,1.0,1/9,3.91%,CA12
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6874556628248892,1.119752452675813,0.40425531914893614,0.6639169820861122,1.0,5/12,20.51%,CD4;ZFP36L1;FES;IL34;CDK6
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.46919640789127826,1.119347210916826,0.24444444444444444,0.6643511925045715,1.0,18/42,14.29%,SLA;PTPRC;SELL;NCKAP1L;IKZF1;LCP2;TNFRSF1B;CD53;ARHGAP25;LAPTM5;CD4;BCL6;SELPLG;ZAP70;AOAH;SASH3;CD200;HCLS1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.7596676469348336,1.1188009247154884,0.34146341463414637,0.6652807069279315,1.0,1/6,2.60%,RHOJ
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.6609682782125145,-1.118661242085967,0.391304347826087,0.8781934502461384,1.0,2/7,23.94%,B2M;ERAP2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.3797546750785662,1.1186169319970138,0.08333333333333333,0.665385713920524,1.0,45/401,8.67%,ROR1;TGFB2;CX3CR1;PDGFC;PDGFB;EGFR;KITLG;ANGPT1;FLT1;TRIM5;JCAD;PTPRC;IGF1;TLR2;P2RY12;CHI3L1;PIK3AP1;F3;RIT2;BIRC3;HGF;MET;ADGRV1;PTPN6;C1QTNF4;RELN;PDGFRA;SRC;NRG1;IRS1;NTRK2;ADRA1A;CASP10;AXL;PTPRJ;RRAGD;SOX9;NR3C2;WNT5A;C18ORF32;TIRAP;NOD1;ZDHHC13;LAPTM5;TNFRSF1A
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.707248487672298,1.118390416059882,0.4375,0.6655464922261763,1.0,2/5,14.56%,RSAD2;CDH26
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.45506632931368807,-1.1182420901137229,0.25862068965517243,0.8786541486424584,1.0,28/115,17.87%,HELZ2;EDF1;SQLE;PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CERS2;PSME1;OPA3;SC5D;NQO1;IDI1;ADIPOR1;PSMA7;PSMD13;PSMB8;CARM1;FASN;PSMD2;HNF4A;GPAM;PMVK;TM7SF2;PSMC5
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.6551499908448658,-1.1181389721288162,0.3793103448275862,0.8780471723786132,1.0,4/11,19.50%,NOC2L;TAF7;THAP7;SET
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.4247970396233389,-1.1181095984840546,0.19047619047619047,0.8771611856218895,1.0,30/175,15.75%,TPX2;JPT1;BUB1;STMN1;NCL;SQLE;PLK4;H2AX;NDC80;CDK4;TFDP1;NUMA1;HMMR;SNRPD1;KPNA2;H2AZ1;CCNB2;HUS1;KMT5A;HSPA8;MCM3;CDKN2C;DKC1;KIF11;ILF3;CKS1B;CENPF;SAP30;MT2A;KIF4A
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7107812863952021,1.118050138635673,0.2909090909090909,0.6658986253868545,1.0,2/10,4.87%,PTPRC;NRG1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6498454058435257,1.117976774485174,0.39285714285714285,0.6655882163668718,1.0,2/10,12.86%,NRXN1;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.5505489357772704,1.1177535729639028,0.2653061224489796,0.6656528793194328,1.0,3/21,4.32%,CYFIP1;CARMIL2;TWF2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5770880916348776,1.1177024460063023,0.33962264150943394,0.6653032195340385,1.0,4/16,6.85%,KCNC2;GRIN2B;TMEM120B;GRIN1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6715720503267281,1.1172296774262036,0.35714285714285715,0.6655917757995761,1.0,1/6,9.90%,B3GALT1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6715720503267281,1.1172296774262036,0.35714285714285715,0.6655917757995761,1.0,1/6,9.90%,B3GALT1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.723182528654287,1.1170679022642518,0.3877551020408163,0.665568812303727,1.0,1/6,1.81%,CSGALNACT1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.6510435760381525,-1.1170365457514206,0.40425531914893614,0.879357875969501,1.0,5/12,24.84%,CSTF2T;CSTF2;FIP1L1;ERN1;CPSF4
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.46379496228317674,1.117026766917476,0.2553191489361702,0.6652042519998524,1.0,18/71,12.85%,RYR3;TRPC4;SLC8A1;TUSC3;GRIN3A;ITPR1;CACNA1B;NMUR2;CACNG3;ATP2B2;NIPAL2;CACNG8;TRPM2;CDH23;TRPC3;TRPV4;CACNA1E;KCNN4
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5125718859603212,1.1167322051796718,0.2727272727272727,0.6654435818881484,1.0,10/34,16.51%,NCKAP1L;ZFP36;TAL1;MAFB;ARNT;MAPK11;LYN;ACVR2A;ZFP36L1;SPI1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7334196511975077,1.1166351416485631,0.38636363636363635,0.6652938152061073,1.0,2/6,12.70%,PIK3R1;GHR
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.45492478818786114,1.1163609615006536,0.21951219512195122,0.6654614061808884,1.0,7/53,11.51%,FIGN;CAMSAP3;HOOK1;FIGNL1;TUBGCP6;MAPT;TRPV4
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.4127692548643302,-1.1162329635758574,0.22807017543859648,0.8811486585253668,1.0,44/283,12.91%,NGF;CD38;CRYAB;RPS3A;PRELID1;RPS27A;UBC;RPL10;DPEP1;SFRP1;PTMA;MIEN1;UBB;GREM1;PRDX5;GSTP1;GPX4;CFL1;MGMT;TNFAIP8;TPT1;PHB2;EVI2B;ARAF;ANXA5;CDSN;BNIP1;DHCR24;PRDX3;CIAPIN1;TMBIM6;DDAH2;MYDGF;ZNF830;ARHGDIA;PRKAA2;NPM1;TRIAP1;IFI6;GATA1;APIP;KLHL20;UBA52;HMGA2
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.4800671600813425,1.116158994790496,0.22448979591836735,0.665525766301522,1.0,7/35,8.92%,TGFB2;MYO7A;BMPR1B;PBX1;MEIS3;MEIS2;MAFB
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.6017114609905466,1.1161082888148561,0.3469387755102041,0.6652337122959439,1.0,5/13,12.65%,PDGFB;PDGFRA;PRKG1;F2;ALOX12
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.4805703444423581,-1.1159237811809286,0.25862068965517243,0.8811563612622181,1.0,23/70,28.30%,CSTF2T;SRSF7;SRSF9;SRSF3;CSTF2;RBM8A;DHX38;MAGOHB;SSU72;ALYREF;FIP1L1;POLR2D;SLU7;CASC3;SRSF2;PAF1;CDC40;CPSF4;CSTF1;MAGOH;CLP1;DDX39A;THOC5
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.39901355243928405,1.115772501947647,0.18604651162790697,0.6655355326983257,1.0,22/118,16.17%,NRG3;CAMSAP3;RIT2;STON2;GFAP;SPOCK1;PACSIN1;IRAK3;SNCAIP;WNT5A;IRGM;CAMK2D;SLITRK4;KIF14;SETD1A;CDH13;PTPN11;RPTOR;CHPT1;PAK5;SETD5;MAD2L2
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.5022675219024612,1.11561169632059,0.3170731707317073,0.6655759917021477,1.0,6/37,5.23%,ADAMTS5;CD44;MMP16;CAPN1;LAMC1;ADAMTS15
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.4347554936109478,-1.1155130140997425,0.2711864406779661,0.8816850712101004,1.0,32/164,15.58%,RPL5;EIF1;RPS3;RPL10;EIF3D;NCL;GAPDH;ZNF598;EIF5;EIF1B;MIF4GD;RACK1;PASK;METTL5;DHFR;PYM1;RPS4X;RPL13A;EIF3B;METTL18;EIF4G2;NPM1;RPS27L;BTG2;MTRES1;TCOF1;ILF3;CIRBP;TYMS;EIF4B;EPRS1;NAT10
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6412491906806111,-1.1153113177697136,0.375,0.8811438342124698,1.0,6/12,21.07%,GSTP1;ELOVL1;FADS1;ALOX5;CYP2J2;ELOVL2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.5197775719562394,1.1152855227506142,0.3111111111111111,0.6659166976640428,1.0,12/41,28.04%,ADAMTS9;FBXO17;ISG20;DENND3;SIAH2;MANBA;OGA;HNRNPD;DAB2IP;EXOSC7;RAB12;FBXO2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.6569301273278253,1.1152744191287485,0.3488372093023256,0.6655145953833624,1.0,2/9,3.20%,GALNT3;POGLUT2
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.6744242973628333,-1.1150415875254538,0.4489795918367347,0.8808915870580968,1.0,3/11,5.96%,PLPP2;KDSR;SPHK2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.4719407549265225,1.1146625831937946,0.29411764705882354,0.6665494018437321,1.0,23/75,15.16%,KCNIP1;OGDHL;TRPC7;CTNND2;CAMSAP3;NOL4;CDK5R2;NTRK2;NPNT;SH3GL2;GLIS3;SYT7;EPB41L1;CYS1;CPE;ABCC8;PCGF2;SLC7A8;RAB3A;PRR36;VEGFA;PDZRN3;ATN1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.45572581142820284,-1.114293506611876,0.2878787878787879,0.8824110125829853,1.0,25/114,18.51%,BUB1;STMN1;KIF3B;SBDS;PTPA;RPS27;NDC80;DYNLL1;TUBG1;BCCIP;RAN;NEK6;SGO2;MIS12;NUDC;DYNC1H1;KIF11;CENPF;NUP37;DYNC1I2;KIF4A;KNTC1;STIL;EML1;CDC20
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5489874017472165,1.1142013199987528,0.29508196721311475,0.6673935509443465,1.0,4/25,12.83%,FSTL1;BCL9;NREP;SFRP4
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6022584652587912,1.1140934176656745,0.34615384615384615,0.6672198397373056,1.0,1/12,0.42%,DPYS
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.49332240643974135,-1.113643762969927,0.25925925925925924,0.8836769597660955,1.0,12/49,16.69%,RPS3;PRR7;UBXN1;VPS28;PINX1;SVBP;SQSTM1;UFL1;DNAJA1;SH3RF2;SMAD7;PARK7
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.4668869322777016,-1.1132295654824438,0.2631578947368421,0.8841258954066971,1.0,14/81,13.54%,FTL;FTH1;VAMP8;GOPC;CHMP2A;SCAMP2;AP4B1;CCDC22;HSPA8;BLOC1S4;AP1B1;KLHL20;LLGL1;HGS
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7500086484663024,1.1130837572411603,0.38636363636363635,0.6692832887547452,1.0,1/6,9.46%,ARNT
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.47087776753389116,-1.1129031306324206,0.2857142857142857,0.884084013472717,1.0,12/104,9.20%,ARHGEF16;GPRC5C;JUP;PTPRU;BCAM;VWA1;ATP1B1;GNA11;TMEM125;COL18A1;UNC5B;DDR1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.5677259552046632,1.112772754363869,0.37209302325581395,0.6696201933069751,1.0,2/27,5.57%,ZNF366;CITED2
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.7258619037438001,-1.1127655840553534,0.49056603773584906,0.8836360359149725,1.0,1/5,3.87%,SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.7138894161504067,-1.1126624438982764,0.3888888888888889,0.8829585212053159,1.0,1/5,1.82%,WWC2
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.7087942614722144,1.1123589851924034,0.4166666666666667,0.6702319666833004,1.0,2/6,12.73%,TIMP4;TIMP3
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.5944404983938355,1.1123467685263568,0.3076923076923077,0.6698052911827563,1.0,2/13,8.20%,KLF9;LMO2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.770483499432617,-1.1119033123391042,0.37777777777777777,0.8845484340706755,1.0,3/6,19.82%,YBX1;SSB;DDX1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.5900301593293378,-1.111693155545525,0.33962264150943394,0.8844694659796868,1.0,6/17,19.45%,SERPINE1;AJAP1;TFPI;KNG1;CRK;ALOX5
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.7433915736075046,-1.1116523453977492,0.375,0.8835910844364179,1.0,1/6,0.34%,ZDHHC12
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.5634311879348243,1.111294024730848,0.3333333333333333,0.6717673215012051,1.0,6/25,8.59%,PKP2;FGF12;CACNA1G;NEDD4L;SCN3B;SCN1A
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.714725360524623,-1.1112351009759922,0.3541666666666667,0.8840458193043635,1.0,3/6,15.06%,SERPINE1;TFPI;KNG1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5534722210273203,-1.1112008706817043,0.2916666666666667,0.8832156988529501,1.0,2/24,2.08%,IFNLR1;CGAS
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.7367575349663532,-1.11063941775259,0.39622641509433965,0.8830890225148155,1.0,3/6,21.36%,NPHS1;PODXL;JAG1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.7367575349663532,-1.11063941775259,0.39622641509433965,0.8830890225148155,1.0,3/6,21.36%,NPHS1;PODXL;JAG1
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),0.7217411874214148,1.1106175073942317,0.40384615384615385,0.6728239512898,1.0,2/5,13.42%,CLEC7A;CDH13
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.4720856628934083,-1.1105578313763198,0.30158730158730157,0.8823723792288485,1.0,13/81,13.22%,PSMD7;DMAC2;PSMB6;PSME2;PSMD8;FBXO48;PSMB4;PSMD3;PSMB3;PSME1;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.6300479207942307,1.1104711586316642,0.3469387755102041,0.6727259176156312,1.0,3/11,12.85%,KCNK6;KCNK10;KCNN4
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.7305673395565271,-1.1102600671190312,0.3559322033898305,0.882451623258792,1.0,1/5,16.91%,PIP4P1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.645174661455168,-1.1100867358611812,0.3684210526315789,0.8820017346765153,1.0,1/9,7.67%,UBQLN2
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.43028158435757147,1.1100113253717059,0.1891891891891892,0.673404194635094,1.0,17/84,12.21%,PPARG;ADCY8;NR4A3;SORBS1;SRC;KAT2B;IRS1;RHOQ;CYSLTR2;ADCY2;RAB15;GPLD1;PDE3B;PRKAR1B;ADCY7;PIK3R1;ADCY1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.530403878529797,1.109365470271778,0.2549019607843137,0.6744654971402545,1.0,8/21,12.88%,UTRN;FGF12;NEDD4L;SCN3B;NOS1;CAMK2D;YWHAH;SCN4B
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6644747816852438,1.1092610210529712,0.4339622641509434,0.6743352579358121,1.0,4/6,27.11%,RPGRIP1L;BBS4;NRL;RORB
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.557599957296347,-1.10904686501035,0.3673469387755102,0.8843222623202488,1.0,4/21,12.61%,SELENOS;PGP;GCK;MST1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.5820531457500306,-1.108984639077373,0.3888888888888889,0.8836256099166121,1.0,7/24,11.03%,VCPKMT;TRMT112;ANTKMT;CSKMT;SMYD1;METTL18;KMT5A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5792261751992707,1.108411579337928,0.38,0.6759814114315491,1.0,6/14,28.40%,MAD2L2;TNFSF4;PAXIP1;HMCES;TFRC;NECTIN2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.4855980170701048,-1.1083370171984694,0.25,0.8847939348600357,1.0,11/76,13.61%,ZDHHC12;NACA;SRPRA;SRP14;MYO1C;ZDHHC14;NACAD;SEC62;FIS1;YIF1B;SSR2
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7546014969094442,-1.1082830246966893,0.43103448275862066,0.883962089893123,1.0,3/5,22.67%,GSTM4;GSTM3;ACAA1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5777508917658377,-1.1081976554728514,0.35555555555555557,0.8832681152267957,1.0,4/15,9.87%,SOAT2;NPC2;ABCA8;NPC1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.40998320153308315,1.1081085168616718,0.25,0.6761005759683174,1.0,36/166,14.87%,PKP2;DPP10;KCNIP4;RAB3C;NRXN1;ANK1;KCNB2;FGF13;PACSIN1;TESC;RAB34;SCN3B;FYB1;TSPAN14;ZDHHC23;KCNB1;TNFRSF1A;PICK1;RAB15;LIN7A;AGRN;RFTN1;P2RY1;DLG4;HPS6;CPE;KCNIP3;TNIK;CACNB2;ANK3;THY1;RAB3A;RAB29;ITGB1BP1;ZDHHC2;ATP1B3
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6932062281307518,-1.1079831860872078,0.3617021276595745,0.882974306148858,1.0,5/8,18.59%,PHB2;ATG14;SQSTM1;MAP1LC3B;BECN1
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.6410444486103188,-1.1079564022569333,0.3793103448275862,0.8820838144359231,1.0,3/8,6.39%,PDE6A;CNGB1;GNA11
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.4786826219059019,1.1076419570002718,0.32075471698113206,0.676711897359902,1.0,8/54,10.68%,EGFR;AQP1;FOS;MAP3K5;PDGFRA;TPM1;TRPM2;MAPT
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5732084419648008,-1.1076104024688922,0.32075471698113206,0.8821806768970979,1.0,4/25,6.73%,JUP;RBM22;HYAL2;RAN
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.639365575142997,-1.107373447845271,0.38181818181818183,0.881970286150634,1.0,6/11,30.06%,POLD3;XPC;ACTR5;DDB2;DDB1;CUL4B
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5833020795135354,1.1072874350350588,0.3793103448275862,0.6772521326741754,1.0,2/15,6.98%,OGFOD1;IRAK3
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5776395788687949,1.1071194227352223,0.28846153846153844,0.6772219494017924,1.0,3/17,10.09%,FMO5;ACADL;GNB3
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.6429072527608661,-1.106900154841984,0.42857142857142855,0.8827346038326771,1.0,2/10,12.67%,CD81;SAR1B
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5385704939468495,-1.1065182999675216,0.2909090909090909,0.8828754994117531,1.0,4/30,11.86%,PTPA;PPP1R1B;CALM1;PPP1R11
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.493344228760095,1.1063988684971,0.28846153846153844,0.6786346471557793,1.0,2/40,1.17%,CLDN5;CLDN16
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.6196616538242485,1.1063236434700836,0.4166666666666667,0.6783697774316132,1.0,1/8,9.12%,CAMK2D
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.7080434171032285,1.1061260315469672,0.4117647058823529,0.6775383504787708,1.0,4/5,25.85%,SLF1;MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.7080434171032285,1.1061260315469672,0.4117647058823529,0.6775383504787708,1.0,4/5,25.85%,SLF1;MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.7080434171032285,1.1061260315469672,0.4117647058823529,0.6775383504787708,1.0,4/5,25.85%,SLF1;MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.6374662456693105,1.106048926537773,0.3695652173913043,0.6772826616079035,1.0,1/10,2.21%,PIK3AP1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.6362554606260595,1.1056228151734289,0.36363636363636365,0.6777264819535421,1.0,3/12,16.90%,SYK;DYSF;LBP
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.6185007092617928,-1.1055009669065308,0.38596491228070173,0.8852754094191148,1.0,6/13,22.60%,TEFM;TFB2M;EARS2;TFAM;MTERF2;TWNK
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5243235568876998,-1.1053222734600028,0.3269230769230769,0.8849007301226418,1.0,13/41,21.30%,JUP;RBM22;HYAL2;RAN;ANP32B;EMD;TRIM28;NEDD4;ZPR1;TPR;IPO5;FLNA;DMAP1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4111750187808039,1.1051673375831956,0.2391304347826087,0.6784026302716033,1.0,31/206,12.50%,IGFBP3;EGFR;ANGPT1;CSF1R;GRM5;PID1;LRRK2;HGF;TSPYL2;NTRK2;EFNA5;SOX9;BMPER;HSPB1;SH3GL2;KDM4D;VEGFD;F2;KNDC1;CCND1;IRGM;CD4;FBLN1;CORO1C;BST1;C3;P2RY1;CSNK1D;LYN;FGF17;TNIK
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.49281233783292205,-1.1050605138539644,0.3,0.8848591881189296,1.0,11/37,20.10%,MBOAT1;MOCS1;TKT;GPAT2;AGPAT5;FADS1;NFS1;GPAM;PPIP5K1;G6PD;MOCOS
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.6204360238845237,-1.1050419922799646,0.39622641509433965,0.8839743602457066,1.0,1/7,2.89%,SERPINE1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.6704195068087332,-1.1050086616893948,0.32558139534883723,0.8831272930187475,1.0,3/8,19.26%,TSPO;FDXR;STAR
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5109152816779098,1.1050040618875812,0.3018867924528302,0.6783485989710869,1.0,6/36,10.50%,DCX;SPEF1;CFAP74;RSPH9;PLK1;SPAG16
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5527510126375644,1.1045474600024767,0.37777777777777777,0.6788838998517223,1.0,2/15,6.25%,CREB3L1;SULF1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.6753031264446444,1.104499742894912,0.3333333333333333,0.678542934914821,1.0,3/7,23.84%,BCL2L1;SERPINB9;TRIM27
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.451420992066368,1.104272208383492,0.26666666666666666,0.6786205549457813,1.0,21/76,13.58%,RHBDF2;ADCY8;RXFP1;SRC;SYK;ADCYAP1R1;CYSLTR2;GPR176;VIPR2;CYSLTR1;GNG2;ADCY2;GPHB5;ADORA2B;LYN;PRKAR1B;ADCY7;ADCY1;GGT5;HRH2;P2RY11
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6415014022755182,-1.1042005120053267,0.3469387755102041,0.8846366198981236,1.0,3/8,7.07%,SIGIRR;GSTP1;APOD
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.6436377114985015,1.104167191951764,0.3953488372093023,0.6783962791901494,1.0,5/13,17.36%,SYK;PRKCZ;NLRP3;HAVCR2;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.3866403926252907,1.1038874942489747,0.21052631578947367,0.6787677592857114,1.0,37/261,14.61%,CREB3L1;TGFB2;CLDN5;IFNA2;PDGFB;SRGN;IGF1;PARP14;ENC1;MEF2C;KAT2B;ID2;SLC24A3;CITED2;ZFP36;AEBP2;IGF2BP2;SH3GL2;DAPK1;ROBO1;ZNF540;RNF139;PARP9;MAPT;PHF19;CPEB3;HELLS;NANOS3;SYNCRIP;RBMS3;OLFM1;MOV10;ZNF148;SHMT1;SFMBT2;VEGFA;NOS2
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5416173057539778,1.1036407181046686,0.25,0.6789069086151617,1.0,3/20,6.35%,LRRK2;NR4A3;GNG2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.40862470286399016,1.1032274318729984,0.2619047619047619,0.6794088714402547,1.0,31/116,13.29%,PPARG;EGFR;FSTL1;FAP;CSPG4;SLC45A2;TNC;POSTN;LAMC1;LOX;CHST3;COL12A1;CCDC80;COL4A1;TP63;SOX9;TEAD1;EPAS1;TRPM1;HSPB1;PPFIBP1;PXDC1;BNC2;CCND1;ANTXR1;LAMB2;PRRX1;CCN5;PRICKLE2;TIMP3;GPC1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.49717552085759464,1.1030330617960875,0.37777777777777777,0.6795088335569949,1.0,10/29,13.53%,PTPN6;PTPRB;PTPRZ1;PTPRJ;PTPRT;UBASH3B;DUSP10;PTPRO;PTPN11;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.5429600720304631,-1.1028129186107565,0.3442622950819672,0.8883069186085533,1.0,3/24,7.79%,NGF;LRRC59;RASGRF1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.622697465630877,1.102687809207184,0.37037037037037035,0.6795079543235698,1.0,1/11,2.82%,IMPA2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.622697465630877,1.102687809207184,0.37037037037037035,0.6795079543235698,1.0,1/11,2.82%,IMPA2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6172511617122218,1.1024509659401664,0.4,0.6796307682551904,1.0,5/10,12.86%,KCNMB4;SYT1;KCNIP2;KCNMB3;KCNMB2
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.5123893636752659,-1.1023392446845686,0.21052631578947367,0.8886996727614955,1.0,12/38,17.01%,DPEP1;AADAT;GPT;FOLH1B;PYCR3;DDAH2;THAP4;RIMKLA;FOLH1;HNF4A;PYCR1;ASPA
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.5712737794154683,1.1022121274077414,0.4,0.6798381048633544,1.0,3/16,8.08%,DENND1B;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.7238672826007186,-1.1021190182977643,0.42857142857142855,0.8886007708172915,1.0,1/7,10.76%,FIS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.7368158663070892,1.102111286274581,0.4375,0.6795912664829447,1.0,1/6,4.10%,VAPB
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6724055006382698,-1.1019898052009298,0.44,0.88802962557899,1.0,4/12,18.14%,ACTG1;SCRIB;ZDHHC7;FUZ
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.6881200601984716,1.1018172342323154,0.4411764705882353,0.6800136353671474,1.0,3/8,20.49%,ID2;MYT1L;PAX6
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.6090549991695255,1.1016644519168897,0.34146341463414637,0.6799206705221241,1.0,2/14,6.92%,SHMT2;AK4
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.6813128511871275,1.1015469347292095,0.37209302325581395,0.6797433624928421,1.0,2/10,5.20%,AQP1;MT1M
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.7179406053557614,-1.1013509527578131,0.44,0.889115979230967,1.0,4/5,26.97%,B2M;ANXA2;HFE;BDNF
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.7218537890163509,-1.1012735404058323,0.4,0.8883853933923876,1.0,1/5,4.85%,CMPK1
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6866442673785026,1.101030473608088,0.38596491228070173,0.6804640839368651,1.0,1/8,1.99%,NCKAP1L
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4941979450039293,-1.1005855201465917,0.3488372093023256,0.8897444943363987,1.0,3/49,2.10%,ARHGEF16;GPRC5C;GJB1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.6191228574126695,1.100492186701104,0.36,0.6813525857891705,1.0,3/9,14.38%,TENM3;SHROOM2;VEGFA
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6102943632599429,-1.1000858336777946,0.4166666666666667,0.8903550937205611,1.0,1/18,1.47%,BUB1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.544440800712526,-1.0999911860711122,0.29310344827586204,0.8897851251951744,1.0,5/26,19.04%,RNF8;HEXIM1;NELFE;NELFCD;EAF2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.5400725893963084,1.099761678147064,0.3333333333333333,0.6826691078025773,1.0,5/27,18.51%,SORBS1;GPLD1;SCARB1;HSD17B13;MLXIPL
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.5243424621851001,1.0996139722194436,0.24390243902439024,0.6824904883873382,1.0,10/29,18.66%,IFNA2;NCKAP1L;LILRB1;LAPTM5;CR1;SFTPD;LGALS3;HAVCR2;CD80;ARG1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.5882830344059792,1.0995613619652977,0.32608695652173914,0.6821819841907866,1.0,5/13,19.58%,ABCC9;RFC3;TRPC3;KCNJ11;VGF
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.47157768821907026,1.0994346974704228,0.2857142857142857,0.6821339378783059,1.0,5/41,8.78%,ADAMTS5;ZNF423;PGAM5;PLCL2;PLCL1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.5016886821024521,1.0991641451243612,0.32075471698113206,0.6823229160425209,1.0,5/24,11.25%,SYK;ITGAM;DYSF;MAPT;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.7447072751441515,1.0989504137288917,0.4117647058823529,0.682397065899153,1.0,3/5,16.83%,NFKBID;NFKBIZ;IL12RB1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.5091704506971831,-1.0988629531108043,0.28846153846153844,0.8922012421970081,1.0,9/45,18.21%,CRYAB;RAD51AP1;TMEM109;HUS1;HRAS;BLM;XRCC6;ATR;RAD9B
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5160598251839478,-1.098577303741289,0.3,0.8921967758375867,1.0,14/42,16.99%,CRNKL1;SF3A3;SF3A1;SMN1;SRSF9;SNRPD1;SNRPD2;KHDC4;PRPF6;PUF60;SNRPE;SF3A2;SNRPG;SNRNP200
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.6485406251968727,1.0982554314247341,0.3148148148148148,0.6835933424078265,1.0,3/10,9.61%,NRG1;SCIN;GPLD1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.5073754819111002,1.0982525010759445,0.35714285714285715,0.6831630515361237,1.0,8/27,26.34%,EDNRB;DLG4;RIN3;EDN1;SIRT5;SDCBP;PLIN5;AP1AR
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.5053025900667371,-1.0978929521621161,0.2653061224489796,0.8934208444636066,1.0,8/35,19.26%,LIMA1;SOAT2;NPC2;ABCA8;NPC1;STARD5;ABCA5;STAR
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.6832629353282701,-1.097884475602617,0.3333333333333333,0.8924792256670213,1.0,3/6,18.61%,HMGA2;POLE3;EZH1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6992343059271756,-1.0977858896418176,0.40816326530612246,0.8917953744922463,1.0,3/7,13.91%,PRELID1;BAX;ARL6IP5
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.6411659531460018,1.097585986548475,0.43137254901960786,0.6837823062169458,1.0,3/10,10.21%,B3GALNT1;B3GALT1;B3GNT6
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6411659531460018,1.097585986548475,0.43137254901960786,0.6837823062169458,1.0,3/10,10.21%,B3GALNT1;B3GALT1;B3GNT6
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.5390688095599956,-1.0975282066084653,0.2549019607843137,0.89175611729466,1.0,8/34,20.24%,PTPA;CALM1;YWHAB;PPIA;PPP1R16A;PTBP1;SMPD1;DLC1
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5448342256710814,1.0971785319799783,0.3409090909090909,0.6843197787417343,1.0,3/20,6.85%,GRIN2B;GRIN3A;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5646178563495057,1.096776612596837,0.3333333333333333,0.6850848575319145,1.0,4/19,13.97%,EPHA4;LYN;SLC2A13;EFNA3
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5223488903205498,-1.0965165054583828,0.3333333333333333,0.894084364625764,1.0,4/33,11.65%,CENPX;RNF8;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.6987982287011525,1.096328183565475,0.35555555555555557,0.6856436265948089,1.0,2/6,13.48%,RYR3;ANK3
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.7348098110550711,1.0962735768337943,0.3541666666666667,0.6853124756419814,1.0,2/5,6.29%,VSIR;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5356862660471116,-1.0962435971890674,0.3050847457627119,0.8939021018280574,1.0,3/30,4.58%,TAX1BP3;ACTN2;GOPC
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.6459221303403306,1.0961154762165664,0.3902439024390244,0.6852171986330139,1.0,4/10,16.90%,WNT5A;IL33;CLEC7A;LBP
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5928732368453499,-1.0960045212478207,0.375,0.8937114425752417,1.0,1/16,1.71%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6926802862173103,1.09545950367126,0.4406779661016949,0.6862530083125584,1.0,2/6,15.58%,PPARGC1A;NNMT
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4156076341551087,1.0952926559848009,0.225,0.6862255234350966,1.0,31/132,16.38%,PTPRC;PLPPR5;PTPRG;PLPPR3;PLPPR4;PTPRR;PTPN6;PTPRB;HDHD2;PPP3CA;PTPRZ1;PTPRJ;PTPRM;SGPP2;PLPP4;PTPRT;PPM1H;ALPL;PPM1L;DUSP10;PTPRO;TPTE2;PLPP6;PTPN5;PPEF1;DUSP6;PTPRK;PTPN4;ACP6;PPP1CB;PLPPR1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.49194030746726414,1.094906911001434,0.3137254901960784,0.686766626619839,1.0,10/46,9.67%,LPL;PTPRC;TLR2;C1QTNF4;SYK;PTPRJ;HSPB1;WNT5A;TIRAP;IL33
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.7014079919454654,1.094833994319263,0.4090909090909091,0.6865267251930256,1.0,4/9,18.68%,CD4;ZFP36L1;FES;IL34
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.49351948850476424,1.0945937044002119,0.32075471698113206,0.686620255830265,1.0,9/41,13.81%,CDH9;CDH10;CDH18;CDH22;CADM3;CDH6;CDH3;CDH13;CDH7
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.42188677212149706,1.0944910475825356,0.34,0.6863958847446219,1.0,13/68,13.12%,AQP1;CD44;TMCC2;LOX;CSF3R;TAL1;RSAD2;NR1I3;CR1;TUBB1;KCNN4;RBM38;PNPO
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6894853048711094,-1.0944821870751242,0.3448275862068966,0.8966702823453271,1.0,5/9,17.25%,CALM1;SRI;CLIC2;CASQ2;TRDN
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6894853048711094,-1.0944821870751242,0.3448275862068966,0.8966702823453271,1.0,5/9,17.25%,CALM1;SRI;CLIC2;CASQ2;TRDN
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.4641461608218484,1.0942635964213112,0.3111111111111111,0.6864213265907869,1.0,5/48,4.24%,BTBD17;PLSCR1;MX1;VAPB;ISG15
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.6191975689877537,1.0942559880654734,0.375,0.6859933367209194,1.0,1/10,2.97%,ALDH8A1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5692362132003281,-1.0942167713294793,0.34545454545454546,0.8964247799946217,1.0,9/25,21.68%,TINF2;PINX1;DKC1;NHP2;RFC1;PPP6C;GAR1;TELO2;TERF1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.6998964989609443,-1.0940249251540999,0.39622641509433965,0.8961185787766739,1.0,2/6,16.90%,AHR;HMGB1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.43565823242057844,1.0937621549872871,0.25,0.6866835657149183,1.0,19/86,10.07%,COBLL1;ALDH1L1;CLDN16;TRHDE;CMYA5;MACC1;SLC8A1;STON2;PPARGC1A;GDA;SCIN;CLMN;ZBTB7C;NEBL;EMX1;LPP;RSPH3;GRHL2;PDZD2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.7306956524483417,-1.0937360039878978,0.4423076923076923,0.8960401575270902,1.0,1/5,13.71%,CTR9
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.6733757408538754,-1.0931317246383767,0.39622641509433965,0.8970003890089897,1.0,1/5,10.96%,HRAS
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.723459725464088,1.093004338191723,0.4090909090909091,0.6883313990088656,1.0,3/5,23.31%,SLC6A11;SLC6A6;SLC6A1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.47110694262763764,-1.0930037040522784,0.22807017543859648,0.8954575422862687,1.0,12/48,23.91%,CHMP2A;RAN;BANF1;CCNB2;CHMP3;REEP4;NUP37;EMD;CHMP7;SUMO1;CC2D1B;NUP93
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.47110694262763764,-1.0930037040522784,0.22807017543859648,0.8954575422862687,1.0,12/48,23.91%,CHMP2A;RAN;BANF1;CCNB2;CHMP3;REEP4;NUP37;EMD;CHMP7;SUMO1;CC2D1B;NUP93
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5119761502452879,1.0929620106500881,0.29545454545454547,0.6879708933203202,1.0,6/30,9.19%,SLC9C2;SLC4A10;LRRK2;SLC4A4;SLC9A9;SLC9A7
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.41664393265816374,1.0929125527058785,0.25,0.6876560691263665,1.0,25/110,10.57%,EGFR;KITLG;ZNF423;FSTL1;CSPG4;KIAA1217;LRIG3;MET;LAMC1;TMEM47;DDAH1;ADAMTS15;CHST3;COL12A1;DMD;COL4A1;SOX9;TEAD1;LIFR;NTN4;NUAK1;EPB41L1;ANTXR1;BOC;LAMB2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.43998413921736673,-1.0928490682805028,0.2903225806451613,0.8950060708978276,1.0,30/149,20.59%,PARP2;RNF8;H2AX;UBXN1;EME1;PARP1;TONSL;RAD51AP1;DCLRE1B;ZSWIM7;SMARCA5;KPNA2;RFWD3;HUS1;BRCC3;BLM;SFR1;KAT5;ACTR8;ABRAXAS1;HMGB1;XRCC6;MDC1;PARP3;POLM;UBE2N;DDX1;PRKDC;PAXX;EXD2
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.7491215492795507,1.092488439180152,0.4444444444444444,0.6881702466611549,1.0,3/5,16.54%,NRXN1;NLGN1;LRRC4
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.7040106080290922,1.0924693311840534,0.4117647058823529,0.6877503024997758,1.0,1/8,6.88%,ACSM1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.36061057652464273,1.0920820860740807,0.18181818181818182,0.6882412011568119,1.0,79/421,15.19%,TGFB2;CLDN5;CTF1;PDGFC;PDGFB;BMP6;EGFR;KITLG;FLT1;IGF1;TLR2;CSF1R;IL12RB2;IL12A;CAMK1D;CAPN1;EPHA4;BMPR1B;PTPN6;LGI1;PDGFRA;TNFRSF1B;NRG1;PPP3CA;IRS1;TBX6;NTRK2;MERTK;ADGRG1;CITED2;SHANK2;IL13RA1;LEF1;PTPRJ;ZFP36;MEIS3;STX3;GRIN1;TPM1;SOX9;CRLF1;LIFR;DLX1;WNT5A;MEIS2;CHRD;TAL1;VEGFD;CCND1;BST1;BCL2;SPDYA;KIF14;TGFB3;CR1;MAPT;TRPC3;TGFA;CX3CL1;LYN;FGF17;ACER2;CDH3;ACACB;SFTPD;HES1;CLEC7A;RPS6KA3;CDC7;CUL3;ITGB1BP1;HCLS1;VEGFA;PARD3;CIDEB;ACOX2;FGF9;NTRK3;ZFP36L1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.49288563884338166,-1.0917175027562924,0.29411764705882354,0.8979447371590461,1.0,10/84,15.69%,SELENOS;SEC61B;UBXN4;USP19;UBQLN2;TMEM129;ERLIN2;ERLEC1;TOR1A;UBXN8
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.6554637198130768,-1.0917009916417104,0.40384615384615385,0.8970488701519418,1.0,2/10,4.77%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5720040125747048,1.0914984877993237,0.37254901960784315,0.6891901080178509,1.0,5/15,15.91%,BAIAP2;BAIAP2L1;HCLS1;NTRK3;FES
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.49625337093302846,1.0911932632619457,0.35135135135135137,0.6894164976454755,1.0,6/37,5.23%,ADAMTS5;CD44;MMP16;CAPN1;LAMC1;ADAMTS15
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.47224808771963156,-1.0907430986060644,0.29508196721311475,0.8989212672763388,1.0,4/56,6.51%,UXT;TFDP1;FBXO43;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4881373411635497,1.090540921648764,0.28,0.690551192136892,1.0,10/48,9.67%,LPL;PTPRC;TLR2;C1QTNF4;SYK;PTPRJ;HSPB1;WNT5A;TIRAP;IL33
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5102529074577093,-1.0904574387400179,0.3111111111111111,0.8987712711583932,1.0,4/41,3.48%,ARHGEF16;GPRC5C;GJB1;CLDN2
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.680823983103654,-1.0904347872739706,0.3269230769230769,0.8978600368057987,1.0,3/6,22.91%,CTR9;RTF1;PAF1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.7127832068504116,-1.0904345053652866,0.39622641509433965,0.8969247659341261,1.0,3/6,13.91%,PRELID1;BAX;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5694865793775159,1.0903066558585741,0.40540540540540543,0.6907089002972888,1.0,1/9,0.28%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.6633540359757779,1.0902162983974495,0.43859649122807015,0.6905364294588052,1.0,2/5,10.24%,JCAD;ROBO1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.48432728533200076,1.0901653600820553,0.3404255319148936,0.6901992893470215,1.0,10/47,15.91%,EGFR;ACTN1;ARHGAP18;NRG1;DIAPH1;ZSWIM6;LYN;ARAP1;VEGFA;FES
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6369284023184462,-1.0900576736742593,0.38,0.8973559261739513,1.0,3/7,10.39%,AK8;CMPK1;PNKP
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.6784398848970516,-1.0900199043529761,0.3958333333333333,0.8965352747785053,1.0,4/6,27.91%,TEX264;FAM111A;SPRTN;VCP
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.691974382917308,1.0899720357636404,0.425531914893617,0.6902895101823823,1.0,3/6,18.74%,DYSF;BIN1;CAV3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5128577455243178,-1.0898988124376736,0.3392857142857143,0.8959662510022921,1.0,3/24,4.92%,H1-4;RPS3;H1-2
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.6527391271184451,-1.0894876921769423,0.4,0.8962507090095068,1.0,1/10,7.85%,PRPSAP2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.5780960553170842,1.0893436724150884,0.4090909090909091,0.6911805567676135,1.0,4/13,14.75%,ADCY8;RELN;ADCY1;ZDHHC2
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.5594067979131421,1.089275772794539,0.4107142857142857,0.690910973765216,1.0,5/13,15.20%,PYGL;MGAM;PHKA2;PGM2L1;AGL
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.6201177036924935,-1.0892334491653393,0.375,0.8962851721871417,1.0,2/11,2.63%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.5937254473925189,1.0890938640460242,0.3783783783783784,0.6909706738763818,1.0,2/9,1.71%,AQP1;KCNC2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4190257519947932,-1.0890930473674432,0.25,0.895855634937528,1.0,17/152,9.16%,TAX1BP3;DDIT3;TRABD2B;SHISA2;SFRP1;GREM1;PTPRU;PSMD7;PSMB6;PSME2;PSMD8;RACK1;LZTS2;PSMB4;PSMD3;DACT3;PSMB3
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.4431232367069849,1.0890168377222764,0.3191489361702128,0.6906791468174329,1.0,20/73,16.13%,PLAC8;PDGFC;SYK;OXTR;PPARGC1A;ACADL;EPAS1;STAT6;KDM3A;DIO2;PRKAB2;ZNF516;VEGFA;UCP1;EBF2;KDM6B;ADIPOR2;ACHE;GJA1;ADRB2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.5846948510424496,1.088993222988604,0.35185185185185186,0.6902610524202804,1.0,5/11,26.84%,ADRA1A;ADRB2;AKAP13;LMBRD2;DRD2
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6330043871760195,1.0888875241787124,0.4423076923076923,0.6900897267037172,1.0,5/8,27.11%,SOX9;RPGRIP1L;BBS4;NRL;RORB
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6612176743944688,-1.088862936068171,0.35294117647058826,0.8955814691839036,1.0,1/8,1.25%,AMPD1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.6937354961061811,-1.0886436327901623,0.45652173913043476,0.8952992963598596,1.0,1/5,16.95%,XRCC6
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6490552063930822,-1.0884765802340475,0.4375,0.8948121535972037,1.0,2/9,10.97%,SOD1;ZNF830
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.7195499398041064,1.0883293082472958,0.4888888888888889,0.6910297517145741,1.0,2/6,13.60%,HEY1;OLFM1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4657129075263923,-1.0880302358859923,0.26785714285714285,0.8950874860102825,1.0,12/51,23.91%,CHMP2A;RAN;BANF1;CCNB2;CHMP3;REEP4;NUP37;EMD;CHMP7;SUMO1;CC2D1B;NUP93
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.5311129596466084,-1.0880252868827824,0.39622641509433965,0.8941913068558132,1.0,6/29,14.34%,GLYAT;ACSM6;DBI;ACOT1;THEM4;ACOT2
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.635023111004455,-1.0876526597578076,0.3157894736842105,0.8943300995272666,1.0,4/10,19.17%,ABCA8;SMPD2;SMPDL3A;SMPD1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.550941064082665,1.0875281065497706,0.38636363636363635,0.6924306628544127,1.0,1/16,1.54%,MDFIC
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.45203101505984317,1.0874049509666304,0.325,0.6922583017199104,1.0,9/33,13.70%,LRRK2;KYNU;WNT8B;ABCB4;TRPM2;GLDC;ALPL;GGT5;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5411292122062645,1.0874014983147242,0.36363636363636365,0.6918330835886352,1.0,8/23,18.68%,ID2;LEF1;TESC;CD4;HCLS1;ZFP36L1;FES;IL34
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4265234825617799,1.087196258046413,0.275,0.6919514186921332,1.0,30/96,13.77%,MFNG;HNF4G;CAMSAP3;KIAA1217;CKMT1A;LRIG3;EFNB3;NR2F1;DDAH1;CADPS2;NPNT;SOX9;TEAD1;EPAS1;PCLO;MAPK4;SYT7;EPB41L1;NKAIN1;CNTFR;ONECUT2;CPE;SHROOM3;LYPD6;ABCC8;PCGF2;HES1;NR2F2;PRR36;LRP4
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.5311082570210163,1.0869641197307423,0.37254901960784315,0.6919878318988256,1.0,7/20,26.21%,RASIP1;VEGFA;EGFL7;KDR;TGFBR3L;RASA1;PDGFRB
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.6273615077902126,1.0867973756605125,0.3333333333333333,0.6919944821653236,1.0,6/8,31.72%,RGS2;LRP1;FGFR3;SNCA;FGFR1;PDPK1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.6471073203696848,1.0867823661295115,0.44642857142857145,0.6915927631407307,1.0,4/8,19.72%,CBARP;BIN1;FKBP1B;ATP1A2
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7507295072592206,1.0866431641119096,0.42592592592592593,0.6914809293582268,1.0,3/6,18.73%,PCLO;RAB3A;ERC2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.46691919556122197,1.0865502088412082,0.28,0.6912580023580213,1.0,6/53,9.91%,LPL;LRRK2;CARTPT;RRAGD;KCNB1;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.6736405872660377,1.0865119854377676,0.4444444444444444,0.690990887494669,1.0,4/7,26.14%,PUM1;DDX60;USP15;PUM2
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.40512894185569887,1.0864976297489886,0.2553191489361702,0.6906056044490113,1.0,26/118,17.96%,LPL;PPARG;TLR2;PIK3AP1;BIRC3;TNFRSF1B;LRFN5;NFKBIA;WNT5A;TNFRSF1A;FNDC4;BCL6;BST1;IL33;CX3CL1;AOAH;NFKBIZ;NLRP3;CD200;IL17RA;IL16;CCN3;TNFSF4;PRKCD;NLRP12;SEMA7A
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.6459995177668191,-1.0864518490826245,0.35714285714285715,0.8971639198734059,1.0,3/7,16.98%,NOX1;NOXA1;CYBA
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.6291650811405601,1.0860583594926114,0.40816326530612246,0.6912200261534065,1.0,1/12,2.12%,MCTP1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.6131796212383676,-1.0858385885124098,0.37735849056603776,0.8971962181384454,1.0,4/11,25.09%,BLOC1S4;AP3S2;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.6131796212383676,-1.0858385885124098,0.37735849056603776,0.8971962181384454,1.0,4/11,25.09%,BLOC1S4;AP3S2;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.6698674614578871,-1.0856850308555945,0.46153846153846156,0.8958947397670541,1.0,3/6,25.07%,DPH1;DPH2;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.6698674614578871,-1.0856850308555945,0.46153846153846156,0.8958947397670541,1.0,3/6,25.07%,DPH1;DPH2;DPH7
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6207667833189592,1.0854337580736888,0.5,0.6918995373992448,1.0,2/7,1.71%,AQP1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6207667833189592,1.0854337580736888,0.5,0.6918995373992448,1.0,2/7,1.71%,AQP1;KCNC2
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.4736468420104105,1.0853951766757455,0.2631578947368421,0.6915220346103849,1.0,5/38,7.28%,MX1;SYK;ARRB2;LILRB1;DNM1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6007328485108522,-1.085371995282935,0.3620689655172414,0.8958527360396503,1.0,7/17,13.80%,SRPRA;SRP14;SPCS1;SPCS2;ZFAND2A;ZFAND2B;SPCS3
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.6435904479364423,1.0851260047866305,0.4,0.6916987487350688,1.0,4/10,21.23%,DGKB;DGKI;DGKE;DGKA
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.4953696874556081,-1.0848866575122464,0.2833333333333333,0.8964042218981471,1.0,10/46,14.26%,CDKN1C;PKMYT1;CCNB3;CCNG1;BCCIP;CNPPD1;CCNB2;CDKN2C;BLM;CDC37
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.6627421360296686,-1.0848696646165674,0.43137254901960786,0.8955488035387756,1.0,3/10,14.67%,NUMA1;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6006423575961509,1.0848684400209618,0.4,0.6915132057291069,1.0,4/10,11.15%,ADGRV1;GRM2;EDNRB;GABBR2
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6006423575961509,1.0848684400209618,0.4,0.6915132057291069,1.0,4/10,11.15%,ADGRV1;GRM2;EDNRB;GABBR2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.4184462860874623,1.084621790755846,0.3142857142857143,0.6916380099804926,1.0,17/88,17.41%,EGFR;NEDD4L;GFAP;DACT1;ADGRB1;IRAK3;WNT5A;BANP;WWP1;PRKCG;APC2;HECW1;ZDHHC2;MAD2L2;TIPARP;EEF1A2;FAM83D
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated immunity (GO:0002705),0.6930499028189199,1.0842170059331246,0.46153846153846156,0.6920646270645066,1.0,3/5,21.89%,CLEC7A;NOS2;SCIMP
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5643131945528227,1.0840588451337307,0.3333333333333333,0.6920122842020802,1.0,8/23,19.03%,CX3CR1;TNFRSF1B;PRKAB2;C3;PDK4;ADIPOR2;PRKAG2;SIRT5
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5804319962277167,-1.0839269703284518,0.41509433962264153,0.8976983986358728,1.0,3/20,4.74%,VPS25;PTK6;HYAL2
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.6286620102780313,-1.0837529375142994,0.3877551020408163,0.897265969526658,1.0,3/10,14.07%,NDC80;MIS12;CENPF
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7389042291895016,1.0837398954175104,0.38,0.6923130918562348,1.0,1/5,5.48%,CIITA
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.6106314295154285,-1.0836079279274795,0.36,0.8967584359181122,1.0,5/18,14.96%,CCT7;CCT2;CCT6A;DKC1;NHP2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.4965173575945327,-1.083563677046844,0.35,0.895948305503644,1.0,12/44,17.66%,FTL;FTH1;ATP6V1G1;TF;SOD1;SLC22A17;ATP6AP1;CYBRD1;CYB561A3;HMOX2;HEPH;ISCU
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.6034034035627017,1.083558595376044,0.38,0.6923047687289999,1.0,1/11,0.42%,DPYS
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4538328705465408,1.0832845738604822,0.2692307692307692,0.6926491060871904,1.0,8/56,9.78%,TGFB2;PDGFB;EGFR;CITED2;MEIS2;TAL1;CCND1;SPDYA
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5806603613153791,-1.0832189197302464,0.39344262295081966,0.8961677382292679,1.0,1/15,0.25%,CXCR4
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.7202786511740115,-1.0831285898644398,0.49056603773584906,0.8936481805384533,1.0,3/6,16.89%,TMED9;TMED2;GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.7202786511740115,-1.0831285898644398,0.49056603773584906,0.8936481805384533,1.0,3/6,16.89%,TMED9;TMED2;GBF1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.7202786511740115,-1.0831285898644398,0.49056603773584906,0.8936481805384533,1.0,3/6,16.89%,TMED9;TMED2;GBF1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.6303040520924375,-1.0830691201774718,0.375,0.8928872480874018,1.0,1/7,6.52%,NUMA1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5482901313327532,1.082882131243821,0.35294117647058826,0.6931545505614318,1.0,6/22,13.05%,PID1;IRS1;PRKCZ;KANK1;PIP4K2A;GRB14
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5795610655769119,1.0827605917044543,0.36363636363636365,0.692991630013005,1.0,3/14,6.92%,LRRK2;RHOQ;AK4
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.6894285941253853,-1.08261984559674,0.40425531914893614,0.8933936867389708,1.0,1/6,0.19%,BMP5
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.6272342768637592,1.082521829342858,0.39622641509433965,0.6931589089514488,1.0,4/9,14.00%,IGF1;TNFRSF1B;IL33;CD200
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.6151187117399998,1.0824892307926466,0.42857142857142855,0.6927836511870216,1.0,1/12,1.38%,PTPRC
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.4865633864496929,1.0820615531296462,0.2682926829268293,0.6931852294825968,1.0,7/41,11.59%,GRM5;SPRED3;KAT2B;HSPB1;KDM4D;CORO1C;LYN
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.6472882915618974,-1.0817870586217078,0.40425531914893614,0.89461093977494,1.0,2/7,4.85%,AK8;CMPK1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4744538550338904,1.0817069957130534,0.2727272727272727,0.6937400296396841,1.0,1/46,0.01%,MFNG
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.5374954527323985,-1.0816838472417099,0.37254901960784315,0.8940102939931553,1.0,7/28,18.83%,LAMTOR4;CD81;ZFYVE16;GLMP;HGS;NEDD4;LAMTOR5
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.6207824918477869,-1.0814999571729091,0.36363636363636365,0.8936699460335665,1.0,1/11,0.25%,CXCR4
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.5923382018962247,1.0811603401870493,0.47619047619047616,0.6947769573462419,1.0,2/15,7.29%,ADAMTS9;FBXO17
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.6086616856750653,-1.0811319874940186,0.40816326530612246,0.8938896840559102,1.0,7/13,20.10%,PYCR3;MOCS1;HDC;NFS1;PYCR1;ALOX5;MOCOS
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.6813673943351328,1.080853513552711,0.42857142857142855,0.6951400184536994,1.0,1/6,4.61%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.7388504815569983,-1.080807676366458,0.37037037037037035,0.893908799272015,1.0,2/5,15.71%,BAD;DUSP12
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.5817081733215874,-1.0805147163570543,0.3673469387755102,0.893936208609848,1.0,5/24,7.44%,RPS3;PTTG1IP;TPT1;YJU2;DDIAS
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.7111736061725237,-1.0801815828188435,0.48333333333333334,0.8940551285933503,1.0,1/5,21.18%,PODXL
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.4059445964184615,1.080123467358827,0.3617021276595745,0.6965693559188278,1.0,22/97,11.94%,IGFBP3;EGFR;ITGB4;F3;KIAA1217;LRIG3;MET;COL12A1;NPNT;TRIM29;CRLF1;TEAD1;EPAS1;NTN4;PXDC1;FBLN1;EPB41L1;ANTXR1;HOPX;LAMB2;SHROOM3;NOTCH3
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.48876875857058494,-1.0797164550478282,0.3157894736842105,0.8945313899736378,1.0,16/52,18.21%,EME1;MUS81;SDE2;NOP53;RFWD3;HUS1;ZNF830;BRCC3;RPS27L;BLM;HMGA2;TOPBP1;ABRAXAS1;RINT1;MDC1;RAD9B
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.47158762613764516,-1.0796842289733264,0.3090909090909091,0.8937356529547268,1.0,3/42,3.37%,NGF;DPEP1;BEX3
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.6862304937002464,1.0795484534181325,0.39622641509433965,0.6975442269467618,1.0,1/7,2.76%,IL12A
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),-0.7006002371356936,-1.079472463893687,0.40816326530612246,0.8935805439367097,1.0,1/5,0.19%,BMP5
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5350372470585549,1.0792021119213793,0.34146341463414637,0.6979268171118883,1.0,9/30,15.86%,SLCO2B1;SLC26A9;SLC26A4;SLC22A3;SLC13A4;SLC26A7;SLCO1A2;SLC17A5;ABCC11
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.5608729521215028,1.0791281346450723,0.3333333333333333,0.6977838505218037,1.0,3/16,8.95%,PDGFB;GRM6;PLPP4
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.7197660310457659,-1.0790065158999627,0.4897959183673469,0.8943128694992079,1.0,1/5,11.65%,NPM1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.747671615520318,1.078890065197571,0.46938775510204084,0.6974037503738703,1.0,2/5,13.03%,GDPD3;GDPD1
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.747671615520318,1.078890065197571,0.46938775510204084,0.6974037503738703,1.0,2/5,13.03%,GDPD3;GDPD1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7175558357077796,1.0788470725811494,0.4528301886792453,0.6970648186805825,1.0,4/5,28.25%,NTRK3;TMEM108;DOK5;AGT
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.7153614457831325,1.0788374077708727,0.46938775510204084,0.6966972007910015,1.0,5/5,28.48%,SLC32A1;SLC17A8;SLC17A7;SLC17A6;SLC18A2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.5456402215618614,1.0787578414828791,0.425531914893617,0.6964463618407689,1.0,2/10,7.68%,LRCH1;DOCK8
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5646720695062688,-1.0785994620762718,0.35185185185185186,0.8945302114859782,1.0,13/30,26.09%,TINF2;DCLRE1B;PINX1;DKC1;NHP2;RFC1;PPP6C;GAR1;TELO2;TERF1;CTC1;HSP90AA1;NOP10
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.5848435527186733,-1.078169819984004,0.3559322033898305,0.8951442890144758,1.0,1/11,0.28%,LCK
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.6966929095633613,-1.0774609679874914,0.49019607843137253,0.8964018999567908,1.0,1/6,10.96%,HRAS
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.5024668938584637,-1.0773701505020004,0.2982456140350877,0.8957742101275308,1.0,6/31,18.57%,CCT7;CCT2;PNKP;CCT6A;ATR;PKIB
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.6489490415826987,-1.077345264791405,0.3958333333333333,0.8949745249608116,1.0,5/7,33.94%,NCSTN;APH1A;APH1B;ADAM17;PSEN1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6572886564765561,1.0772312476160475,0.41304347826086957,0.6995673429132483,1.0,4/7,29.48%,MVD;IDI2;PDSS1;PHYH
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.720241326785124,1.0769125813945974,0.4634146341463415,0.6999105243614935,1.0,2/5,15.58%,PNPO;NNMT
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.504298897921798,1.0768865555585494,0.3333333333333333,0.6996073844676429,1.0,5/30,13.75%,WTIP;ZFP36;NOTCH4;PUM1;MOV10
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.49922687671210564,1.076882499702208,0.3111111111111111,0.6991885671151534,1.0,6/30,13.32%,CX3CR1;HEY1;BHLHE40;CLOCK;CX3CL1;HES1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.7005982099378277,-1.076848015183517,0.45652173913043476,0.8955197901467307,1.0,1/6,0.19%,BMP5
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.6197807179838515,1.0767739978813429,0.39215686274509803,0.6990384542220972,1.0,3/13,9.50%,TGFB2;SNCAIP;MAOB
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6731597273755947,1.0765757742370075,0.4375,0.6991130908836962,1.0,3/7,29.30%,PICK1;FYN;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.7474790399829151,-1.0761628639150977,0.42857142857142855,0.896582671936872,1.0,2/5,17.25%,CALM1;TRDN
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5274631984566079,1.075696308081287,0.4,0.7008310466565056,1.0,7/26,19.90%,ABHD3;SLC44A5;GPAT4;CHPT1;ACHE;CHKA;CSNK2A1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.5778044817438753,-1.0756373030580961,0.30612244897959184,0.8961301986096964,1.0,1/17,1.04%,CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.5778044817438753,-1.0756373030580961,0.30612244897959184,0.8961301986096964,1.0,1/17,1.04%,CDKN1C
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.6858211021901232,1.075557151393825,0.43636363636363634,0.7007525624244056,1.0,2/7,9.98%,ITGA11;UBASH3B
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6466173229154607,-1.075377896184961,0.46296296296296297,0.89597440873465,1.0,3/10,11.51%,MCM4;ZNF830;MCM3
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.41733835117195084,1.0752918940880252,0.27906976744186046,0.7009706403825466,1.0,7/99,4.85%,CLDN5;CARD18;PDGFB;LRRK2;PRMT8;ADD2;DACT1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5080938441418018,-1.0752611470676263,0.3442622950819672,0.895326880756187,1.0,6/29,11.64%,CRTAM;SELP;ITGAL;ICAM1;PVR;GRID2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.5640762573576176,1.0752436016314368,0.42,0.7006825978470669,1.0,6/16,23.31%,SLC1A2;SLC1A1;SLC25A22;GJA1;SLC6A6;SLC6A1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.46303285090468027,-1.0750583750355533,0.34545454545454546,0.895090264761564,1.0,11/65,10.23%,KLK6;PDE6A;METAP2;FNTA;CNGB1;CALM1;RGS11;DYNLT1;PLCE1;GUCA1C;YWHAB
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.6408969092082184,1.0748420681894053,0.38461538461538464,0.7010954512351713,1.0,3/8,6.09%,IFNA2;PRKCZ;LEF1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.4649725922577229,1.0744111256721676,0.3333333333333333,0.7017820787911834,1.0,7/30,14.75%,SEMA3D;CORO1C;SEMA6A;SEMA5B;SEMA4B;SEMA4G;SEMA3C
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.7085741374789148,-1.0737780089477367,0.46808510638297873,0.898087029065762,1.0,3/5,22.04%,AIF1L;RAC1;INPP5K
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.6863990667036172,-1.073741623505121,0.425531914893617,0.8972676264808574,1.0,1/6,5.38%,MUC4
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.6104815348714654,-1.0736168605645728,0.39215686274509803,0.8967275652129482,1.0,4/12,14.03%,ORC1;HUS1;ZNF830;TOPBP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.6444088963923306,1.073392540031712,0.4146341463414634,0.703795136640309,1.0,3/7,16.90%,WNT5A;IL33;LBP
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5939845508068493,1.07293406857812,0.37209302325581395,0.7044937167646274,1.0,4/13,12.70%,STAT6;LYN;PIK3R1;GHR
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.48871736652534264,-1.0728608053008981,0.3770491803278688,0.8980573086173668,1.0,6/46,10.60%,TINF2;CCT7;CCT2;PINX1;PNKP;CCT6A
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.5753067368576575,-1.0727233394198985,0.35294117647058826,0.8975745996776635,1.0,12/16,35.40%,SPHK2;NAA40;MSL3;DMAP1;EPC1;YEATS4;RUVBL1;TRRAP;MEAF6;MORF4L1;ACTL6A;ING3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5697149890408556,1.0723881887726059,0.3333333333333333,0.705148223742953,1.0,2/19,7.66%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7145862232182392,1.0720266903288906,0.4,0.7055427285964772,1.0,2/5,13.48%,CNTNAP1;ANK3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.40623788260665644,1.0720030124757667,0.3170731707317073,0.7051811823103864,1.0,10/111,7.28%,MX1;STAB1;MRC1;PDLIM7;SYK;ITGAM;FCHSD2;ARRB2;LILRB1;DNM1
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.6823780074448264,-1.0718336742056929,0.4418604651162791,0.8997397783844299,1.0,2/5,20.54%,MFSD2A;FABP5
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),0.6843675343749165,1.0717473648468072,0.48,0.7054241671798855,1.0,1/6,0.57%,TEX15
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.6770678070098275,1.0716201518213413,0.38636363636363635,0.7052859339270208,1.0,2/6,16.13%,BMPR2;ADRB2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.5217562985162969,-1.0716142806350546,0.375,0.8996713252363526,1.0,5/37,7.81%,OOEP;USP51;MGMT;RAD51AP1;OTUB1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.5446736984140353,-1.0711833760739478,0.41818181818181815,0.9001882565689658,1.0,2/18,6.08%,SFRP1;RNH1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6113745937191188,1.0711015388691512,0.38461538461538464,0.7059236234533481,1.0,2/7,29.28%,VEGFA;LRP2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.5104973191076511,-1.070960963279879,0.3269230769230769,0.8999002444041845,1.0,6/29,18.57%,CCT7;CCT2;PNKP;CCT6A;ATR;PKIB
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.35170387869292996,1.0708610053221084,0.21212121212121213,0.7060723996504025,1.0,81/538,14.43%,ZNF366;KANK2;PPARG;PDGFB;BMP6;MLIP;DACH1;ZIM2;HEY1;BHLHE40;DNAJB1;NEDD4L;UHRF1;MEF2C;SCRT1;ZNF20;NR4A3;LDB2;NFATC4;ZEB1;NR2F1;DACT1;ID2;TBX6;BAG3;ZNF608;CIITA;CITED2;MAP2K5;ZNF239;RARB;CRYM;ZFP36;ETS2;SOX9;PER1;PHF21A;SLA2;ATXN1;DLX1;ZBTB16;MEIS2;NOTCH4;ETV6;ZGLP1;CCND1;ZNF343;GLIS3;TBL1XR1;EDNRB;PLK1;BCL6;ZHX2;SMYD2;TENM2;IL33;ZNF764;ZBTB18;GTF2IRD1;ZNF568;NR1I3;PARP9;ZNF550;CBFB;CPEB3;KCNIP3;MYT1L;TGIF1;AEBP1;BACH1;PCGF2;HAMP;HES1;NR2F2;WWOX;ZNF148;MAFK;VEGFA;FOXP2;GLIS1;BCL11A
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.6483276623148915,1.0708272437279773,0.35,0.7057403203685855,1.0,1/8,4.90%,ITGAM
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.4721489103093252,1.070602924690052,0.3125,0.7059105376407327,1.0,5/38,4.55%,PDGFC;PDGFB;AQP1;IGF1;PDGFRA
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.6319111163499371,-1.0705069281467776,0.44642857142857145,0.900407828759763,1.0,1/8,4.34%,GSTP1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.685348956824237,1.0703585448638502,0.48,0.7061020469950066,1.0,4/6,27.80%,DENND3;DENND4A;MADD;DENND1A
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.56413266452801,1.0701285138737116,0.34615384615384615,0.7063291326810237,1.0,2/13,2.20%,ABCC4;SLC25A41
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7097284909793347,-1.070043008681775,0.391304347826087,0.9010440963595447,1.0,4/6,25.85%,DNMT3B;PIH1D1;DNMT1;SMARCB1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.6648626471117779,-1.0700386915351328,0.4,0.9001974159754806,1.0,4/8,20.39%,SNAPC1;SNAPC5;SNAPC3;ZC3H8
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.649939394043605,-1.0700139464632026,0.45652173913043476,0.8993847415012235,1.0,2/5,10.77%,SNRPC;PRPF39
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.6067552474190446,-1.0698551178647568,0.4339622641509434,0.899058508983496,1.0,2/13,6.52%,BUB1;NUMA1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.6029389460246787,-1.069654958962359,0.3684210526315789,0.8987409842874696,1.0,3/13,13.82%,MELTF;PLGRKT;GSN
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4857639551465436,1.0693597591443418,0.3333333333333333,0.7079086233887167,1.0,7/52,13.76%,VSIR;NEDD4L;DACT1;WNT5A;WWP1;APC2;HECW1
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.6957513322836473,1.0693075971151669,0.5714285714285714,0.7075764385049003,1.0,2/5,16.35%,RBM24;ELAVL4
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.6226875513885464,-1.069036239706393,0.5263157894736842,0.8997871094828002,1.0,1/11,3.20%,PPIB
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.5538034639189723,1.0685710211752013,0.36538461538461536,0.7090389094322137,1.0,1/14,0.91%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.4680999239681877,1.0685639759964674,0.2765957446808511,0.7086278594465669,1.0,15/61,14.26%,DACT2;ANGPT1;PTPRC;PLXNA4;SPOCK1;PLXNA2;DMTN;FBLN1;SEMA6A;PDE3B;CX3CL1;PTPRO;ACER2;CDH13;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.6451607240926331,-1.0683886048290279,0.4107142857142857,0.9008795480797327,1.0,2/8,2.63%,SFRP1;GREM1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.707743745415539,1.0683608877835251,0.4883720930232558,0.7086171346611766,1.0,3/5,19.65%,PHF19;ZNF304;OGT
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.4787873881290139,-1.0682839496160697,0.3870967741935484,0.9002955430129672,1.0,13/45,15.81%,DDIT3;HSPE1;DNAJB4;BAK1;TMBIM6;BAX;HSPA8;SERPINH1;HSPB8;DAXX;DNAJA1;HSPA14;HSPA2
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.49714695503921674,1.0681515612023127,0.44,0.7087063209201752,1.0,4/37,8.11%,TLR2;ISG15;LILRB1;TIRAP
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5890786253891716,-1.0679067060695238,0.4,0.9004364350593262,1.0,3/13,15.54%,MYADM;NPC1;ANXA2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.5869881737965148,-1.0677875866664002,0.4482758620689655,0.8999021939588672,1.0,3/18,4.08%,DPEP1;RBM22;CRHBP
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.6977815914927271,-1.0676092123172185,0.44642857142857145,0.8995295118484179,1.0,4/5,28.17%,IDH3B;IDH3G;IDH2;IDH1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.614313578741578,1.0675811573212848,0.4,0.7095441881694957,1.0,4/9,18.98%,GPLD1;GRAMD1B;GRAMD1A;GRAMD1C
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.6782650482890729,1.0675787384040705,0.48214285714285715,0.7091409468091541,1.0,1/6,1.58%,CBLN2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6498850444030715,1.06729637423088,0.4375,0.7093436242738633,1.0,4/9,14.61%,PID1;PPARGC1A;NOS1;NOS2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5388379469199883,-1.0672951900095058,0.4318181818181818,0.8997348838565288,1.0,7/17,22.10%,TALDO1;GCK;TKT;G6PD;PGLS;G6PC3;RPIA
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.37446903490971223,-1.0668110792564083,0.24615384615384617,0.9002362585247762,1.0,70/562,12.91%,NGF;ARHGEF16;TNFRSF8;CD38;CRYAB;RPS3A;PRELID1;PAX8;RPS27A;UBC;RPS3;RPL10;DPEP1;SAP18;PRR7;RPS6;SFRP1;PTMA;MIEN1;USP27X;UBB;GREM1;PTPA;ACTN2;PRDX5;LGALS1;GSTP1;CFL1;TMEM219;MGMT;TNFAIP8;RACK1;TPT1;PHB2;SPHK2;EVI2B;PRMT2;ARAF;SOD1;ANXA5;SEPTIN4;BNIP1;DHCR24;APEX1;NOP53;PRDX3;IKZF3;BAK1;CIAPIN1;TMBIM6;DDAH2;MYDGF;ARHGEF1;BAX;ZNF830;ARHGDIA;PRKAA2;PPIA;GRID2;NPM1;DNAJA3;TRIAP1;IFI6;GATA1;VAV1;APIP;KLHL20;UBA52;RRP1B;HMGA2
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5566020644095184,1.066622881046114,0.38636363636363635,0.7107490901061275,1.0,6/18,16.75%,ACTN1;SORBS1;SRC;THY1;PTPRK;ARHGEF7
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5493072384772623,1.0664153708515072,0.44,0.7107727079589992,1.0,6/19,16.54%,NRXN1;DLG4;LRP4;NLGN4X;NLGN1;LRRC4
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.5960588659000932,-1.0663241150912213,0.4166666666666667,0.9007366662216291,1.0,6/16,15.64%,SLC25A4;SLC25A5;ALKBH7;BAK1;THEM4;BAD
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.6713139713873565,1.0662143033444906,0.4444444444444444,0.710824737710983,1.0,1/7,1.70%,ITGB4
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5694260308201169,1.0660395939769476,0.40425531914893614,0.7108980227228324,1.0,2/11,6.25%,CREB3L1;SULF1
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.7215155958928191,-1.065929795631133,0.48936170212765956,0.9012121236849422,1.0,2/5,4.32%,PRELID1;DBI
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.648303446914811,1.0658266653706152,0.4444444444444444,0.7110564388796616,1.0,2/7,13.72%,ARL13A;RAB29
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5430174033656888,-1.0656742249581173,0.44642857142857145,0.9003328809442593,1.0,3/20,11.65%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5430174033656888,-1.0656742249581173,0.44642857142857145,0.9003328809442593,1.0,3/20,11.65%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.7095061759341239,1.0652955100330548,0.42857142857142855,0.711775353969967,1.0,2/5,18.54%,BAIAP3;GPER1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.46593413937323774,1.0651090762228463,0.37254901960784315,0.711784104082227,1.0,13/43,13.26%,EPHA3;AQP1;BRINP3;WNT8B;TWF2;TESC;SOX9;WNT5A;BRINP1;LYN;ACER2;STRA8;BRINP2
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.6604623117739776,-1.06507431527237,0.4107142857142857,0.9012936670617206,1.0,1/5,10.17%,LAGE3
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5068755152187531,1.0649186195695801,0.40425531914893614,0.7118141103699714,1.0,10/25,16.13%,ADCY8;RXFP1;TMIGD3;ADCY2;ADORA2B;ADCY7;ADCY1;P2RY11;CAP2;ADRB2
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.6938308286957406,1.0648047351878709,0.48,0.7117094726633748,1.0,2/5,18.27%,EDNRB;EDN1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.41499397125428655,-1.0645917257079731,0.32142857142857145,0.9019260580017859,1.0,36/155,19.95%,RAB32;TMEM11;SLC25A4;MSTO1;TIMM10;CHCHD2;ATP5F1B;SAMM50;PARP1;PHB2;SLC25A6;HSD17B10;TIMM8B;AIP;TSPO;PRDX3;CLUH;TFB2M;BAX;FIS1;DNAJA3;TOMM20;PTCD2;TIMM50;TOMM7;IFIT2;PARK7;TIMM13;TFAM;MGME1;TIMM17A;DNAJC19;TIMM9;COX7A2;TIMM23;PINK1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.424421963451954,-1.0642652554168421,0.32727272727272727,0.902000244647487,1.0,16/79,15.59%,SAP18;NCL;SRSF7;DDX5;RBM15B;SRSF9;SRSF3;RBM11;C9ORF78;MBNL3;SF3B4;RBM8A;PUF60;CIRBP;RBM23;JMJD6
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.6552473983992488,-1.0640042664913936,0.4230769230769231,0.901970946947358,1.0,1/6,16.69%,PARK7
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6902871405496268,1.0638399077987015,0.46296296296296297,0.7135308376989059,1.0,2/6,16.90%,TIRAP;LBP
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6269018517788312,1.063659603688345,0.4375,0.7134253042989546,1.0,9/15,23.38%,SLC8A1;CACNA1G;SCN3B;SCN4B;CACNB2;CACNA1C;ATP1A2;SCN1B;CACNA2D1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.5862294281177078,1.0636234661536377,0.43636363636363634,0.7130723753277532,1.0,4/18,9.60%,ST8SIA3;MAN1A1;ST8SIA4;ST8SIA6
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.507075530248106,1.0634873973892047,0.375,0.7130025784189408,1.0,9/28,18.36%,SEMA3D;SLIT1;SEMA6A;ROBO1;SEMA4B;SEMA4G;SEMA3C;SEMA7A;SLIT3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5478112042704382,1.063359411472898,0.45098039215686275,0.7129187370323459,1.0,4/14,20.66%,LAPTM5;SAMSN1;LGALS3;DUSP3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5686092557935496,-1.0630565244612853,0.4,0.9039271540450896,1.0,4/14,23.53%,NPC2;NPC1;STAR;OSBP
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6266807577409135,1.063044641061275,0.33962264150943394,0.7127513522735631,1.0,6/11,14.26%,EFNA5;DMTN;FBLN1;CORO1C;KANK1;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6266807577409135,1.063044641061275,0.33962264150943394,0.7127513522735631,1.0,6/11,14.26%,EFNA5;DMTN;FBLN1;CORO1C;KANK1;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.6200043556031617,-1.0629250536669868,0.39622641509433965,0.9034596890638542,1.0,2/12,2.63%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.49541703909947615,1.0629220316611743,0.35555555555555557,0.7125408889213511,1.0,7/26,19.39%,HEY1;LEF1;NFKBIA;MAD2L2;ILRUN;TNKS;E2F1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.44972437920615216,-1.0628158766633748,0.3275862068965517,0.9028979975514642,1.0,31/92,28.37%,SRSF7;RAN;RBM15B;SRSF9;SRSF3;RBM8A;RAE1;DHX38;MAGOHB;NUP37;ALYREF;FIP1L1;NXT1;SLU7;TPR;CASC3;NUP210;POM121C;SRSF2;UPF2;CDC40;NUP93;NXF1;CPSF4;NUP42;MAGOH;NUP58;MCM3AP;DDX39A;THOC5;NUP85
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.4702790431221525,1.0626740660482692,0.3111111111111111,0.712802818154486,1.0,4/48,4.85%,CLDN5;LRRK2;ADD2;DACT1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5346597554187339,1.062583759826713,0.40425531914893614,0.7125996160397091,1.0,5/13,15.88%,NFATC4;CPEB3;SHANK1;KAT2A;CAMK4
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.48341151521760733,1.0625686616649266,0.43103448275862066,0.7122136508165166,1.0,8/34,11.44%,ST6GAL2;ST8SIA3;ST8SIA4;FUT9;ST8SIA6;B3GALT1;ST6GALNAC5;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.6054400259714804,-1.0622649800619024,0.4090909090909091,0.9038974329385927,1.0,3/7,9.42%,F11;SERPINE1;USF1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5879464842593313,1.062229877551473,0.46808510638297873,0.7126511699742792,1.0,2/13,14.69%,UBA7;UBA3
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.6121938420149332,-1.062184281286174,0.4067796610169492,0.9032810144571233,1.0,3/10,26.03%,HMGB1;PSMC5;PSMC4
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.6965205000041902,-1.0621514490974193,0.4166666666666667,0.9025155945462893,1.0,3/6,16.95%,PLEKHA3;GLTP;CPTP
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.42421383304733085,1.0621122800434022,0.25,0.7125187200267518,1.0,9/75,11.96%,GLRA3;KCNC2;ADCY8;SHMT2;PRMT8;TMEM120B;KCNC3;HOMER1;CARD11
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5404309074890706,-1.0619006490966703,0.37735849056603776,0.902312279595148,1.0,7/16,19.95%,CSTB;SVBP;PSMB8;ECM1;NRDC;CTSH;PINK1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.5750723901218784,1.061667424320944,0.37735849056603776,0.7131522746178491,1.0,1/15,1.43%,NMNAT2
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6581939901055884,1.0616250250949288,0.37777777777777777,0.7128511576862071,1.0,1/8,0.91%,EGFR
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.5968394325945959,1.0614728464732355,0.39622641509433965,0.7128240917913161,1.0,6/11,35.57%,MAD2L2;PAXIP1;HMCES;TFRC;SHLD2;SHLD1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5863166080686435,-1.0613688271163055,0.41935483870967744,0.903032358354745,1.0,2/9,10.26%,CALM1;SRI
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.6130172400401337,1.061304714202163,0.42105263157894735,0.7126918520192734,1.0,5/11,8.34%,CLDN5;ANGPT1;DDAH1;PTPRJ;SH3GL2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3531681993535809,1.061192874560153,0.21621621621621623,0.7125317295590764,1.0,42/363,10.26%,CREB3L1;IFNA2;PPARG;PDGFB;ZNF423;MDFIC;MIDEAS;DACH1;MAEL;HEY1;BHLHE40;PLCB1;IKZF1;ZNF93;ZEB1;PRICKLE1;NRG1;ID2;RUNX1T1;BASP1;LOXL3;CIITA;CITED2;LEF1;TSHZ3;TP63;SOX9;PER1;ATXN1;ZBTB16;WNT5A;TIMELESS;SPINDOC;CLOCK;WWP1;L3MBTL4;BCL6;ZHX2;CDKN2A;ZBTB18;ZNF568;ZNF540
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6354759972416595,1.061190353353262,0.45098039215686275,0.7121195987132648,1.0,2/10,5.88%,MMRN2;MAP2K5
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5628870841939909,1.0611507352935885,0.4,0.7117919686092797,1.0,5/15,18.59%,SULT4A1;SULT2A1;SULT2B1;PAPSS2;TPST2
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.6652551404280129,1.0611421268701897,0.4423076923076923,0.7113947511629987,1.0,2/7,11.99%,PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.4733272849235404,1.0610728988453562,0.34615384615384615,0.7111098902063039,1.0,9/45,13.75%,MEF2C;NR4A3;KAT2B;TESC;SCIN;CBFB;SETD1A;MTURN;MOV10
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.6090000427470472,-1.060955804181836,0.4523809523809524,0.9033097077741401,1.0,1/15,0.78%,ENPP6
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.49460971573823487,-1.060904407964448,0.35555555555555557,0.9025392914787264,1.0,3/35,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6201747321361646,1.0608402576920313,0.3684210526315789,0.7112097597450848,1.0,2/13,4.87%,MEF2C;NRG1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),0.6866385098312251,1.0603048286311287,0.4807692307692308,0.7121337329079785,1.0,1/6,2.76%,IL12A
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.5189231669442325,1.0600686186927641,0.3695652173913043,0.7123096743264172,1.0,5/26,6.29%,VSIR;ISG15;SYK;PRKCZ;LILRB1
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.7319783338637639,-1.0599357390555277,0.4318181818181818,0.9046966800962192,1.0,1/5,4.99%,USH1C
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.681092854827817,1.0598255720131342,0.43137254901960786,0.712562153721211,1.0,2/5,5.32%,CORIN;OXTR
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.6289939180443301,1.0594911536305018,0.4772727272727273,0.7129189272708082,1.0,2/7,3.74%,CAPN1;ADGRV1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.439037537584694,1.0594868838611347,0.32558139534883723,0.7125226773865297,1.0,3/42,3.04%,CX3CR1;HEY1;BHLHE40
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.42983363346954806,-1.0594866292794138,0.32142857142857145,0.9049716655288721,1.0,30/136,16.10%,CDKN1C;PARP2;ATP6V1F;SLC25A4;ATF3;GRPEL1;H2AX;AP2S1;EIF5;BTG3;CYB5R1;HYAL2;CREG1;TARS1;ICAM1;BAK1;TMBIM6;DDX21;CLTB;BTG2;PRPF3;SQSTM1;SELENOW;POLE3;SIGMAR1;CNP;EPCAM;DNAJA1;HSPA2;PRKACA
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.6362720743324187,1.0594606845811156,0.42592592592592593,0.7121686779407577,1.0,4/12,13.71%,DYSF;SYT7;SYTL4;RAB3A
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.409977261037223,1.0593759380839467,0.2926829268292683,0.7118777361361355,1.0,25/121,13.49%,CX3CR1;ROBO2;SLC23A1;GRIN2B;PCDH18;RELN;ADGRG1;CNTN4;CA10;PBX1;MEIS3;GRIN1;COL4A1;ADGRL2;ATXN1;NDRG4;MEIS2;EMX1;GRHL2;CDK5R1;SETD1A;SLC6A4;BBS2;SHROOM2;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.632759990672835,-1.0593138660924835,0.38,0.9037315967286356,1.0,3/9,8.36%,RACK1;SPHK2;SMPD2
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.632759990672835,-1.0593138660924835,0.38,0.9037315967286356,1.0,3/9,8.36%,RACK1;SPHK2;SMPD2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.6660242778242662,-1.0592949845978632,0.43636363636363634,0.9029879299323179,1.0,5/8,22.60%,TEFM;POLG;MGME1;PRIMPOL;TWNK
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.3708734279496786,-1.0584070737541245,0.24561403508771928,0.9046571248728091,1.0,57/356,14.93%,RPS23;RAB32;VPS25;RPS3;EMC6;KIF3B;EXOC7;SQLE;PLK4;FLII;RAB8A;DYNLL1;CNGA4;PTPDC1;ABLIM3;FBF1;GOLGA8M;CNGB1;TMEM107;CHMP2A;NEK6;IFT81;VPS28;INTU;UBQLN2;GABARAPL2;CEP131;CHMP5;TMEM138;MKS1;CFAP70;MIS12;TRAPPC6A;SNF8;SNAP29;NPM1;TTLL3;ATG9A;DHX29;DYNC1H1;ATG14;CFAP43;GORASP2;HAUS6;TTC36;CHMP3;HGS;GOLGA2;GSN;GOLGA8H;WDR90;CENPF;MAP1LC3B;ARL13B;CIRBP;ATG16L1;ATAT1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.5797757449970169,-1.0583120807070745,0.4426229508196721,0.9040234960264227,1.0,3/13,23.13%,EIF2AK1;TPR;PAIP2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.6759847627050178,-1.0582993209174465,0.4489795918367347,0.9031956937957202,1.0,2/8,5.96%,GSTP1;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.6374801718959823,1.05829307439858,0.42,0.7138131700447579,1.0,4/7,22.94%,F2;HES1;DAAM2;NF1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.44113157837089834,1.0580884466355116,0.32558139534883723,0.7138900798750004,1.0,13/59,12.73%,MYO7A;SLC4A10;ADGRV1;COL11A1;PCDH15;TRPM1;ABLIM1;RPGR;DRAM2;CRYBG3;CDH23;GRM8;BBS2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.676835547476681,-1.058041035554985,0.38636363636363635,0.9030408781241698,1.0,1/7,4.85%,CMPK1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.5610471899654418,1.0579874760666503,0.40384615384615385,0.7136889701679945,1.0,3/16,10.82%,TRIM5;AXL;TRIM22
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.5341678301445323,-1.0579485387294363,0.3333333333333333,0.9024339547855917,1.0,3/25,3.20%,RPL13;SBDS;PPIB
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5899455223677201,-1.0578751706094855,0.46938775510204084,0.9017970005962939,1.0,5/16,19.75%,DNMT3B;ZNF335;CTR9;PIH1D1;DNMT1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5252912052081069,1.0578302061274276,0.39622641509433965,0.7136269788592426,1.0,10/27,18.54%,SORBS1;PRKAB2;C3;PDK4;ADIPOR2;ASXL3;PRKAG2;HSD17B13;MLXIPL;GPER1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.6526386635989553,-1.0577817563107945,0.3617021276595745,0.9013325189897301,1.0,2/10,11.62%,EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.6481403339218703,-1.057572977474392,0.47058823529411764,0.9011644737831705,1.0,1/7,1.71%,SFRP1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5251184674381076,1.0574758642581972,0.3783783783783784,0.7139745284547523,1.0,3/25,3.40%,VSIR;PRSS12;TBC1D10A
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6794845806071181,1.057464664772329,0.34545454545454546,0.7135933822287436,1.0,1/7,3.49%,EPHA4
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.6338620377822396,-1.0574294003831282,0.35294117647058826,0.9008024741745292,1.0,3/7,7.61%,SFRP1;GREM1;ATRAID
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.4690617491135833,1.0574118221573103,0.32558139534883723,0.7133235927893038,1.0,12/60,13.49%,PTPRC;BIRC3;PTPN6;SYK;AXL;IRAK3;LIFR;TNFRSF1A;SOCS3;CBFB;PIAS1;PTPN11
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5913507849173661,1.0569302821375168,0.42,0.7141764588652628,1.0,1/13,0.57%,TEX15
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.4612925671027186,-1.0566381085789567,0.3148148148148148,0.9025140048783576,1.0,3/46,0.33%,P2RY10;CXCR4;CD38
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5984089016408541,1.0564265994249662,0.4418604651162791,0.7150006372093205,1.0,4/12,18.98%,GPLD1;GRAMD1B;GRAMD1A;GRAMD1C
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6082173411574932,1.0562786481983608,0.39655172413793105,0.7146335763894095,1.0,2/10,9.66%,CD44;BCL2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6082173411574932,1.0562786481983608,0.39655172413793105,0.7146335763894095,1.0,2/10,9.66%,CD44;BCL2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.39949152598228926,1.0559883936549643,0.23404255319148937,0.714875450523577,1.0,17/138,10.87%,TP73;TRIM5;PTPRC;IGF1;SLC8A1;NELL1;NFKBID;YBX3;KDM6A;IGF2BP2;KIF16B;MKLN1;FUBP1;GNB3;EOLA1;TRIM22;ALPK2
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.679826448129682,1.055958018785588,0.4339622641509434,0.7141363606051928,1.0,1/6,0.72%,PPARG
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.679826448129682,1.055958018785588,0.4339622641509434,0.7141363606051928,1.0,1/6,0.72%,PPARG
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.33567878236583387,1.0557303393676458,0.2903225806451613,0.7143643025319574,1.0,87/744,10.71%,ZNF366;CREB3L1;KANK2;IFNA2;PPARG;PDGFB;BMP6;ZNF423;MLIP;MDFIC;MIDEAS;DACH1;MAEL;ZIM2;HEY1;BHLHE40;DNAJB1;PLCB1;IKZF1;NEDD4L;UHRF1;MEF2C;SCRT1;ZNF20;NR4A3;LDB2;ZNF93;ZEB1;PRICKLE1;NR2F1;DACT1;NRG1;ID2;RUNX1T1;BASP1;TBX6;LOXL3;ZNF608;CIITA;CITED2;MAP2K5;ZNF239;RARB;LEF1;CRYM;ZFP36;TSHZ3;ETS2;TP63;SOX9;PER1;PHF21A;SLA2;ATXN1;DLX1;ZBTB16;WNT5A;MEIS2;TIMELESS;SPINDOC;NOTCH4;ETV6;ZGLP1;CLOCK;WWP1;CCND1;ZNF343;GLIS3;TBL1XR1;EDNRB;L3MBTL4;PLK1;BCL6;ZHX2;CDKN2A;SMYD2;TENM2;IL33;ZNF764;ZBTB18;GTF2IRD1;ZNF568;ZNF540;NR1I3;PARP9;CDK5R1;ZNF550
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.563100466692535,1.0555469876011612,0.46808510638297873,0.7145023332394469,1.0,6/19,13.49%,IGF1;SORBS1;IRS1;RHOQ;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.6650995196177639,-1.0551983652279269,0.4,0.9059519777445909,1.0,2/9,11.62%,EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.4600711256897936,1.0550574886051731,0.4375,0.7153362912607225,1.0,10/41,15.83%,CAMK2B;LILRB1;NOS1;PLPP4;CD4;BCL2;TRPC6;HOMER1;CACNB2;IL16
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.5305354410624931,-1.054667327542139,0.42857142857142855,0.9065396486333348,1.0,4/26,12.18%,GREM1;DDX5;MYBBP1A;TRIAP1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.5058720327316087,1.0543660230300684,0.34782608695652173,0.7165481226922552,1.0,5/22,14.29%,ARHGAP18;PAK3;FCHSD2;ARHGAP28;HCLS1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.6514838300056107,1.0543605990714853,0.44680851063829785,0.7161545849768486,1.0,3/7,22.84%,TCAP;CAMTA2;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.5876569652086152,1.0541547015845725,0.3673469387755102,0.7162362224210731,1.0,1/13,0.45%,IGFBP3
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.4980149142628967,1.054110245846705,0.36363636363636365,0.715967087838423,1.0,9/31,8.02%,EPHA3;AQP1;BRINP3;WNT8B;TWF2;TESC;SOX9;WNT5A;BRINP1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.4011383285044393,1.0537549338839376,0.2894736842105263,0.7163785984637613,1.0,13/112,12.83%,CDS1;PLEKHA2;INPP5D;PIP5K1B;INPP4B;SLA2;PLEKHA4;SOCS3;PIGP;IP6K3;PIK3R1;TPTE2;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),0.6982940888624525,1.0536819133572415,0.5319148936170213,0.7161440327112845,1.0,1/5,7.88%,NOTCH4
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6335859639377652,1.0534239563152938,0.375,0.7163902275058253,1.0,3/7,10.68%,ADCY8;KCNB1;MAPT
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.538388706195863,-1.0518465071054046,0.45454545454545453,0.9136525338419913,1.0,3/21,11.65%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.3949423354296946,1.0516635845605735,0.3488372093023256,0.7197506654068982,1.0,32/123,20.66%,PTPRC;PTPRG;PTPRR;PTPN6;PTPRB;PPP3CA;PTPRZ1;PTPRJ;PTPRM;PTPRT;UBASH3B;PPM1H;PPM1L;DUSP10;PTPRO;TPTE2;PTPN5;PPEF1;PTPN11;DUSP6;PTPRK;PTPN4;PPP1CB;RPRD1B;PPP4R2;SSH2;PTPN13;PTEN;FBXW11;PTPN14;MTM1;DUSP3
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6104755907578314,1.051654311954422,0.4318181818181818,0.7193637261445558,1.0,3/5,17.36%,RSAD2;CDH26;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7006212570424618,1.0515523505048445,0.4716981132075472,0.7192102102398835,1.0,3/6,10.68%,SIAH3;LRRK2;MAPT
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4385881281203841,1.0513389528853838,0.3584905660377358,0.7193650469271551,1.0,16/70,8.61%,EPHA3;KALRN;GRIN2B;EPHA4;PAK3;EFNB3;SRC;SIPA1L1;EPHA6;EFNA5;EPHB1;GRIN1;DNM1;EPHB3;GIT1;NGEF
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.5561916221981986,-1.0510725982073212,0.2857142857142857,0.9149744498069486,1.0,1/19,3.64%,PMM1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.45966888521894184,-1.0509492309530906,0.4166666666666667,0.914431612355488,1.0,17/88,13.22%,TNFRSF8;PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;TMSB4X;TXNDC17;EIF5A;PSMA7;ILK;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.6034860932709561,-1.050943588337677,0.47058823529411764,0.9136118589511515,1.0,5/16,19.26%,TSPO;FDXR;SRD5A1;HSD17B8;STAR
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.5989777826554301,1.0509431408401386,0.46,0.719944059712564,1.0,3/18,6.29%,PTPRC;IL12A;LILRB1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.6362809617511587,-1.050943015102248,0.4528301886792453,0.9127627772978513,1.0,2/6,24.89%,SRI;PDE4D
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.5244952446801732,1.050779011391371,0.45714285714285713,0.7198451989185078,1.0,10/27,19.72%,KCNJ3;KCNJ4;ABCC9;KCNJ6;ATP1B2;ATP1B3;KCNH2;SLC12A5;KCNJ11;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.6184031888560075,1.0503831100816443,0.4406779661016949,0.7204437809906428,1.0,3/7,17.59%,F3;F8;A2M
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.4258063528087434,1.050380444857291,0.3488372093023256,0.7200304454880664,1.0,15/65,11.73%,TGFB2;BMP6;EGFR;ANGPT1;IGF1;UHRF1;NR4A3;LAMC1;ZFP36;SOX9;SGPP2;DUSP10;TGFA;PRKD1;ZNF304
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.4030215058176002,1.0501145736747548,0.3148148148148148,0.720163881777561,1.0,22/105,11.59%,NPY;L1CAM;GPM6A;FRY;CFAP126;CSF1R;CYFIP1;MAP2;LGI1;CARMIL1;CNTN4;STX3;PTPRM;TPM1;GPRIN3;SH3GL2;UNC5A;MAPT;CDK5R1;ATP1B2;ATCAY;LYN
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6112863876615225,1.0500907418921868,0.41025641025641024,0.7198262533114851,1.0,2/12,14.05%,MOV10;GTPBP1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5899822558028488,1.049486829369286,0.37209302325581395,0.7207986244212463,1.0,2/12,8.83%,PARP14;SOCS3
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.4742870287657557,-1.049183683762271,0.35714285714285715,0.9167545317506207,1.0,10/33,21.86%,GABARAPL2;FIS1;CISD2;ATG9A;SQSTM1;MAP1LC3B;WDR45B;BECN1;PINK1;ATG2A
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6436109006764201,-1.0489104597272685,0.4727272727272727,0.9167432660888917,1.0,3/7,15.01%,NOP53;PIK3IP1;STAMBP
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.7424909619290966,-1.0486523937763714,0.532258064516129,0.9166397227841988,1.0,3/6,22.03%,PLCE1;GPAM;MOGAT1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.49616475410546673,1.048294269469487,0.42,0.7232832554111718,1.0,4/27,10.96%,TTC8;ARL13A;CEP89;CSNK1D
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.4396084065375311,-1.0479539971482446,0.38596491228070173,0.9179964113911412,1.0,18/96,16.93%,CRYAB;TRABD2B;SELP;RPS3;RACK1;OPRD1;TFIP11;NOP53;BAK1;BAX;HSPA8;SAR1B;GSN;BRK1;PIH1D1;BBS10;PARK7;CDC42
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.6635460642688087,1.0479337382908858,0.4827586206896552,0.723659796932579,1.0,1/7,0.71%,VSIR
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6316696907854857,-1.0478765059399482,0.41379310344827586,0.9173928750453128,1.0,2/7,19.27%,GTF2H2;MSH3
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3404994346456799,1.0478691030101515,0.23076923076923078,0.7234707442330327,1.0,98/535,14.48%,TGFB2;CLDN5;KANK2;IGFBP3;CTF1;PDGFC;PDGFB;BMP6;EGFR;KITLG;SSTR1;FLT1;IGF1;TRNP1;OSGIN1;CSF1R;MYO16;IL12RB2;CAPN1;UHRF1;NR4A3;PTPN6;TMIGD3;CDKN3;PDGFRA;KAT2B;DDAH1;NRG1;ID2;IRS1;TBX6;ADGRB1;NTRK2;ADGRG1;ADRA1A;TP53I11;SHANK2;IL13RA1;LEF1;PTPRJ;MEIS3;STX3;TESC;SCIN;SOX9;CRLF1;CLMN;TENM1;ZBTB7C;LIFR;P3H2;MEIS2;TIMELESS;GNRH1;STAT6;RERG;VEGFD;BCL6;CDKN2A;NUAK1;SMYD2;GPLD1;BST1;BCL2;SPDYA;BMPR2;KIF14;TGFB3;CR1;UTP20;RNF139;TGFA;WDR6;SMIM22;CX3CL1;LYN;CHRM1;FGF17;TPTE2;SULT2B1;ACER2;GSDME;FABP7;SFRP4;PDS5B;PIAS1;HES1;CLEC7A;CDH13;IFNK;CDC7;CUL3;CD200;ITGB1BP1;HCLS1;WNK2;VEGFA;PTPRK
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.44994344330283753,-1.0477039726819593,0.43103448275862066,0.9170205608278534,1.0,2/70,2.35%,PM20D1;UBB
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5490463997237723,-1.047508686065522,0.42105263157894735,0.9166795867130059,1.0,7/24,13.82%,STMN1;CFL2;CFL1;KATNB1;TWF1;STMN3;GSN
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.5908069771528409,-1.0472995557992384,0.4418604651162791,0.916438770561244,1.0,2/14,9.91%,PARP1;PINX1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.6685812379657545,-1.0472674315000825,0.5,0.9148121737511752,1.0,2/5,11.69%,SLC52A2;FLAD1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.6685812379657545,-1.0472674315000825,0.5,0.9148121737511752,1.0,2/5,11.69%,SLC52A2;FLAD1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6574658998694975,1.04707984968336,0.4909090909090909,0.7250444827622922,1.0,2/8,7.32%,SOX9;ACADL
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.6309773502143758,1.0470303308998294,0.5,0.7247528338573636,1.0,4/5,14.38%,ADGRV1;ADRA1A;WNT5A;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.5956178227950977,1.0469288323410686,0.3958333333333333,0.724549885916844,1.0,1/11,0.45%,IGFBP3
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.41681811023322746,-1.0468233679860612,0.39622641509433965,0.9152532495003834,1.0,20/126,13.22%,LCK;BTN3A1;BTN2A1;TNFRSF21;MOG;PSMD7;PSMB6;PSME2;PSMD8;EIF2B1;PSMB4;PSMD3;PSMB3;CHUK;BTN3A2;PSME1;HLA-DRA;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.39246019625629763,1.0463871019160842,0.35,0.7255224732623758,1.0,25/137,11.59%,TGFB2;ABCC4;PDGFB;SRGN;RAB27B;SYT4;IGF1;ACTN1;SNAP25;HGF;RIMS2;SYT1;SYT13;SCIN;STX1A;PCLO;DNAJC5;VEGFD;SYT7;ARHGAP17;TGFB3;PHACTR2;SYTL4;SYT17;LYN
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5667698483497599,1.0458316029784123,0.4473684210526316,0.7264260537142434,1.0,2/17,3.26%,FAP;NEDD4L
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.6091483354744894,1.0457102724525258,0.4418604651162791,0.7262767866611319,1.0,1/7,4.78%,PEX11A
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5686719770000032,1.045705171533475,0.47058823529411764,0.7258767535157437,1.0,7/14,26.94%,LPCAT4;PLA2G10;PLA2G4A;LPGAT1;LPCAT1;CDS2;PNPLA8
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.3916195838844728,1.0455778527704047,0.32142857142857145,0.7257550817961682,1.0,19/102,10.62%,TGFB2;BMP6;IGF1;CD44;MMP16;VCAN;CHI3L1;KIAA1217;BMPR1B;SULF1;ETS2;SOX9;ZBTB16;WNT5A;CHRD;SOX5;CREB3L2;NCAN;ALPL
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5881989775211981,-1.0455198300485642,0.45652173913043476,0.9184777048169752,1.0,2/14,2.49%,LCK;MYADM
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.4643583300655147,-1.0454121842547461,0.3958333333333333,0.9179010229471442,1.0,22/59,21.93%,JUP;RBM22;HYAL2;CCT7;CCT2;RAN;PYHIN1;PINX1;CCT6A;DKC1;PARK7;TRIM28;EIF2AK3;MCRS1;LAMTOR5;ZPR1;TPR;IPO5;MEPCE;FLNA;DMAP1;TESK1
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.49999090065842544,-1.0453577672950476,0.32653061224489793,0.9172035764470051,1.0,14/35,28.37%,RAN;RAE1;NOL6;TOMM20;NUP37;YBX1;SSB;TPR;NUP210;POM121C;NUP93;NUP42;NUP58;NUP85
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4989828620011836,-1.045286563661992,0.38636363636363635,0.9165074084922377,1.0,7/23,19.95%,UBB;PSME2;PSME1;RHBDF1;PRKACA;TMF1;PINK1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.4290873337861872,-1.0450377262645387,0.3492063492063492,0.9162381143228392,1.0,30/93,28.37%,SRSF7;RBM15B;SRSF9;SRSF3;RBM8A;RAE1;DHX38;MAGOHB;NUP37;ALYREF;FIP1L1;NXT1;SLU7;TPR;CASC3;NUP210;POM121C;SRSF2;UPF2;CDC40;NUP93;NXF1;CPSF4;NUP42;MAGOH;NUP58;MCM3AP;DDX39A;THOC5;NUP85
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),0.7022741992754078,1.044900687343807,0.4523809523809524,0.7269071246267637,1.0,1/5,9.74%,RFTN1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.5332627104481161,1.0448846036443977,0.41304347826086957,0.7265277268631315,1.0,3/17,11.97%,DPYS;NT5C1A;DPYSL3
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.41401904714285426,1.044841606726068,0.3018867924528302,0.7262164266633192,1.0,14/67,11.44%,IGF1;CSGALNACT1;CHST8;BMPR1B;ST8SIA3;B3GALNT1;ST8SIA4;FUT9;ST8SIA6;CHST11;B3GALT1;BMPR2;B3GNT6;ST3GAL6
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.5120378323787396,1.0442187994994208,0.5333333333333333,0.7272580401127493,1.0,4/24,5.54%,XKR4;ITGAM;ADGRB1;ARHGAP25
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.45656792136794094,1.0441467013846113,0.46153846153846156,0.7270142684055283,1.0,5/39,14.65%,PID1;LRRK2;PPARGC1A;MAPT;RHOT1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5836717277729766,-1.043605526936895,0.44,0.9193406157502877,1.0,4/14,12.73%,DDX5;SCNM1;SRSF9;PUF60
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.6904225287098739,1.0435421840226393,0.5,0.7280610027982586,1.0,3/8,15.71%,IGF1;NECAB2;NECAB1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.5648136338732253,-1.0433188666410207,0.375,0.9193043927207044,1.0,5/22,13.46%,CHMP2A;NUMA1;CHMP5;DYNC1H1;CHMP3
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.43647719653101785,1.043006475589969,0.40425531914893614,0.7288162445543634,1.0,4/61,3.81%,RNFT1;ASB4;UHRF1;SH3RF3
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.5225264673483674,1.0426213855716588,0.3695652173913043,0.729341216395104,1.0,8/30,15.91%,CSF1R;BAIAP2;PDGFRA;BAIAP2L1;TRPM2;HCLS1;NTRK3;FES
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.6542859260895006,1.0423506759822228,0.5116279069767442,0.7295418983466593,1.0,1/6,4.94%,PTGER3
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.5517169959804602,-1.0421183515644168,0.47619047619047616,0.9220649443665228,1.0,1/19,0.78%,ENPP6
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.5950271136912993,-1.0419881653281946,0.46808510638297873,0.9215719673013881,1.0,5/9,27.99%,BAX;FIS1;VPS35;ATG3;BNIP3
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.5289981831331044,-1.0418132279624615,0.42592592592592593,0.9212992838084145,1.0,9/27,19.46%,SQLE;ACAA2;DHCR24;SC5D;IDI1;MSMO1;PMVK;TM7SF2;G6PD
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6828413542446585,1.0416512750603735,0.4857142857142857,0.7306994099838948,1.0,2/6,16.35%,RBM24;ELAVL4
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5481643189024038,-1.041537536422162,0.4107142857142857,0.9212689673359657,1.0,1/17,3.34%,GFI1B
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.5620574135084212,1.040903697487359,0.37209302325581395,0.7320172768117612,1.0,2/13,6.92%,SHMT2;AK4
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.49192692094258733,1.0408284910650298,0.3829787234042553,0.7317785115810418,1.0,7/29,17.79%,BMP6;PLSCR1;LY86;PUM1;IFNK;SASH1;SLC15A4
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.4650752690183665,1.0407008526960788,0.3695652173913043,0.7317216833027574,1.0,11/47,16.18%,RAB3C;RIMS2;PTPRN;RAB15;SNX19;OLFM2;TVP23A;WLS;RAB3A;ABCA1;PORCN
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.5988500165926887,1.040695626237893,0.42,0.7309025331476072,1.0,1/9,0.84%,SLCO2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.5988500165926887,1.040695626237893,0.42,0.7309025331476072,1.0,1/9,0.84%,SLCO2B1
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.6422981182475013,-1.040020659585527,0.4583333333333333,0.9239472277258861,1.0,4/11,20.00%,SLC25A11;SLC37A4;SLC25A10;SLC25A3
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.6422981182475013,-1.040020659585527,0.4583333333333333,0.9239472277258861,1.0,4/11,20.00%,SLC25A11;SLC37A4;SLC25A10;SLC25A3
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.5100420327218285,1.0398466690883965,0.3958333333333333,0.7325121181799851,1.0,10/29,15.17%,PDGFB;P2RY12;F3;MET;STX3;HSPB1;PRKD1;CDH13;VEGFA;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.6307956581447909,-1.0397378971537656,0.5319148936170213,0.9238241345935087,1.0,1/6,1.11%,STAC3
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.6478322385812489,1.0397020059192081,0.425531914893617,0.7324012985674715,1.0,2/8,5.57%,LMO3;CITED2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.5617857187131455,-1.0396540526068885,0.4375,0.9231891560169113,1.0,4/19,14.25%,AMPD1;GMPR2;PFAS;IMPDH2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.39482482742202446,1.0394440004939272,0.3333333333333333,0.7325724011463762,1.0,28/144,13.90%,ADAMTS5;EGFR;SRGN;ZNF423;RPS6KA6;PGAM5;PTPRG;HEY1;MEF2C;PTPRR;SPRED3;PLCL2;SOX9;DLX1;PLCL1;CORO1C;BMPR2;GRHL2;ACVR1C;ROBO1;DUSP10;ALPK2;PTPRO;SLC6A4;BBS2;TLE3;LRP4;VASN
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.6081231429439182,1.0393491636270717,0.46,0.7324013212473439,1.0,1/8,3.18%,KYNU
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6321554927628683,-1.0393280269245182,0.39622641509433965,0.9232926989028272,1.0,1/8,1.71%,SFRP1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.5090701291809616,-1.0392721131033853,0.39344262295081966,0.9226067304377604,1.0,10/30,19.33%,BAK1;TMBIM6;BAX;HSPA8;HSPB8;DAXX;HSPA14;HSPA2;PTPN1;DNAJC18
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.6942232273405771,-1.039182041534555,0.4782608695652174,0.9220271514716607,1.0,1/5,1.71%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5896017294612628,-1.039075796024761,0.47368421052631576,0.9206087399940461,1.0,1/13,0.44%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5896017294612628,-1.039075796024761,0.47368421052631576,0.9206087399940461,1.0,1/13,0.44%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.6403539664946445,1.0390558499115177,0.5192307692307693,0.732632548416726,1.0,3/8,21.96%,PHLDB2;RGCC;CLASP1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.5428897286306865,-1.0389098955192297,0.5,0.9202422599866096,1.0,3/22,7.85%,AMPD1;GMPR2;PRPSAP2
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.6755270672139672,-1.0388387451602992,0.574468085106383,0.9196444531208661,1.0,3/7,19.19%,AWAT2;PNPLA3;MGLL
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4616694826687155,1.038749325861569,0.3902439024390244,0.7328434210701479,1.0,2/49,1.05%,DENND1B;SNX31
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.6892170197592582,-1.0385752669641073,0.46153846153846156,0.9194888507402267,1.0,1/6,2.63%,GREM1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.5969130048043836,1.0382209825113609,0.4583333333333333,0.733743577196133,1.0,3/9,22.39%,ABCD2;MLXIPL;LPGAT1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5243284923728445,1.0377380059752679,0.44,0.7343015006322805,1.0,6/23,13.05%,PID1;IRS1;PRKCZ;KANK1;PIP4K2A;GRB14
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.6495649302714641,-1.0375114219502335,0.5208333333333334,0.9216865800804693,1.0,2/9,7.04%,WWC2;SOD1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5245607211970752,-1.0375083846628121,0.37254901960784315,0.9208651885297435,1.0,7/20,23.70%,TSPO;NFE2L1;SUCLA2;PGRMC1;COX10;RSAD1;UROD
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5417783653036818,1.0374719836073178,0.5208333333333334,0.7343840307185561,1.0,4/21,4.57%,IFNA2;EGFR;NCKAP1L;SRC
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.6380102790356431,1.037382859917314,0.4318181818181818,0.7341790946979884,1.0,3/7,14.42%,PDGFB;GRM6;LGALS3
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4302320084587889,-1.037288284557628,0.43103448275862066,0.920634342946048,1.0,16/74,13.82%,PSMD7;PSMB6;AP2S1;PSME2;PSMD8;PFN1;PSMB4;RHOA;PSMD3;PSMB3;PSME1;SAPCD2;PSMA7;PSMD13;PSMB8;RAC1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.47407640096924486,1.0372629755237541,0.4146341463414634,0.7340345027588325,1.0,8/32,17.59%,ISG15;SAMHD1;IRAK3;CR1;TTLL12;SUSD4;NLRC5;A2M
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6580373768176563,1.0371975424220037,0.46153846153846156,0.733756560679703,1.0,3/7,13.97%,EPHA4;LYN;EFNA3
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.5668575142297422,1.0370989081190531,0.4666666666666667,0.7335723362295213,1.0,3/13,12.87%,GPLD1;C3;SCARB1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.6261787592708358,1.0369474261778484,0.44680851063829785,0.7335350170793685,1.0,2/7,3.18%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.6561170247656363,-1.0364067421807734,0.5166666666666667,0.9223334329014837,1.0,4/6,29.94%,BAD;VCP;MTLN;STOML2
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.5606071380350754,-1.0361282742440068,0.54,0.9223621968203591,1.0,9/22,18.30%,CRTAM;RPS3;CD274;AGER;ICOSLG;SCRIB;FADD;HMGB1;TNFSF9
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.5049609591433404,1.0355140483990475,0.42105263157894735,0.7364034202630694,1.0,2/17,6.29%,IGF1;LILRB1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.6717884404138216,1.0354631761164483,0.5111111111111111,0.7360848110143282,1.0,1/6,1.75%,GUCY1A1
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.6691338667555748,1.0353359325758154,0.4782608695652174,0.73590635399799,1.0,2/7,6.65%,PID1;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6404479255203517,1.0350715932160242,0.46938775510204084,0.7360674113893005,1.0,2/8,10.53%,GPLD1;PDE3B
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6673338682107706,1.0349710351176293,0.5217391304347826,0.7358758643284612,1.0,2/8,4.34%,ITGB4;LAMC1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),-0.6733105269048174,-1.034877039758932,0.5434782608695652,0.9251647376194867,1.0,3/5,16.90%,LGALS1;AGER;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5436694159083971,-1.0348519544882064,0.4117647058823529,0.924455357201542,1.0,11/26,27.71%,UBL5;ABLIM3;VPS11;TOMM7;UBE2L3;PINK1;CSNK2A2;HPS4;UBE2J2;BAP1;PDCD5
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.44676876464135484,-1.0348162877537088,0.45,0.9237695155026101,1.0,14/58,20.45%,RNF8;H2AX;DCLRE1B;BRCC3;KAT5;ERCC8;ABRAXAS1;HMGB1;XRCC6;MDC1;POLM;UBE2N;PRKDC;PAXX
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.5439474888676069,-1.0347955712590586,0.5,0.9230255668135176,1.0,6/17,19.10%,BUB1;IK;CENPF;KNTC1;CDC20;TPR
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.41130419616019104,1.0347723366158126,0.35294117647058826,0.7357975098193376,1.0,7/74,8.51%,ABCC4;SLCO2B1;SLC23A1;SLC25A48;SLC43A1;SLC7A9;SLC26A7
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.4295502459029749,1.0345244050808446,0.4,0.7359517163352021,1.0,5/51,6.15%,LPL;PLPPR5;PLPPR3;PLPPR4;LPCAT4
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.45296605790886396,1.034458763480476,0.35,0.7356277860539865,1.0,7/49,10.21%,ADAMTS9;ST8SIA3;MAN1A1;ST8SIA4;FBXO17;ST8SIA6;B3GNT6
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.7167397938047867,1.0343656097419451,0.4666666666666667,0.7354170066469299,1.0,1/5,3.35%,ARL13A
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5842052730792928,-1.0342765124884625,0.44680851063829785,0.923661202564283,1.0,2/13,8.50%,S100A1;DHFR
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.5663142148453373,1.0342459426802768,0.4230769230769231,0.7353390821354222,1.0,4/8,12.27%,DDAH1;SLC2A5;BMPR2;PLCB3
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6068521608151171,1.0340013145745228,0.4807692307692308,0.7356522561537518,1.0,4/9,13.60%,GRIN3A;GRIN1;CDK5R1;GRIA2
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.623532649799664,1.033933908226991,0.5,0.7353689548666319,1.0,3/8,20.53%,PIP4K2A;RUBCNL;ATP13A2
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5829892243533995,1.0338656566413718,0.48717948717948717,0.7351587879936585,1.0,4/11,21.14%,TNFRSF1B;GPLD1;SNX33;SH3D19
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.556113688441474,-1.0336334555932294,0.41818181818181815,0.9245326120439059,1.0,6/26,19.12%,AIMP1;CAPN10;GCK;BAD;MYRIP;HFE
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.6357732764323073,-1.033466164794494,0.4782608695652174,0.9242115882771956,1.0,3/8,16.69%,AGA;MAN2A2;PARK7
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.7028630576838661,1.0334090378068228,0.4222222222222222,0.7357229585986054,1.0,1/5,1.99%,NCKAP1L
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.49718650025664407,-1.0327526067132224,0.31666666666666665,0.9254726354291435,1.0,6/28,15.33%,TPX2;MAP7D3;TUBG1;AKAP9;GOLGA2;TPPP3
prerank,PanglaoDB_Augmented_2021__B Cells,0.3943166251545807,1.032250657378529,0.3055555555555556,0.7381644809502433,1.0,21/91,9.62%,FLI1;DOK3;PTPRC;SELL;NCKAP1L;IKZF1;BIRC3;LCP2;FCRLA;EBF1;CD53;ARHGAP25;FCHSD2;BLNK;LILRB1;WDFY4;BTLA;LY86;LAPTM5;CD70;BST1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.43641269811793,1.032237785446933,0.45454545454545453,0.7378011072326,1.0,12/62,9.49%,CX3CR1;TLR2;MEF2C;TNFRSF1B;AXL;LILRB1;ZFP36;WNT5A;GIT1;TIRAP;IRGM;VIM
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5816319006826323,1.0321386460438253,0.5,0.7376495050519405,1.0,2/9,14.38%,ZSWIM6;VEGFA
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.6298576000309459,1.0314830037112774,0.45454545454545453,0.738838196338751,1.0,2/7,16.52%,PCGF3;PCGF5
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6484582954825324,-1.0310713867882781,0.5111111111111111,0.9293747704785945,1.0,1/8,0.28%,LCK
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.6052768832366019,-1.0309599996928869,0.4444444444444444,0.9287552168327086,1.0,5/10,22.60%,TEFM;TFB2M;TFAM;MTERF2;TWNK
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3842555004328313,1.03080345883206,0.46808510638297873,0.7399991787339869,1.0,18/139,10.88%,KANK2;IGFBP3;TP73;OSGIN1;ACTN1;TNFRSF25;LRRK2;BIRC3;PTPN6;CASP10;TP63;SOX9;LRP8;DAPK1;TP53I3;BCL6;ALPK2;TNFRSF10B
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.4531122193792168,1.030637914666349,0.46511627906976744,0.7399059599199703,1.0,13/38,17.09%,PTPRC;LCP2;TNFRSF1B;ITGAM;CD53;CSF3R;LY86;AOAH;SASH3;CLEC7A;PIK3R5;SPI1;CD80
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.45193933541429404,-1.0306129366636017,0.4166666666666667,0.9289548884151042,1.0,12/63,16.69%,BMP5;SERPINE1;GSTP1;ICAM1;UNC5B;IFI6;GATA1;MAPK7;FAIM;FADD;TMBIM1;PARK7
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.4330987357153125,1.0305171434046967,0.2682926829268293,0.7397667097810344,1.0,10/57,8.83%,PDGFC;CSF2RA;CD44;TLR2;PIM1;TNFRSF1B;CSF3R;IL13RA1;TNFRSF1A;SOCS3
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.43780782875311164,1.030516325468866,0.4186046511627907,0.7393575467778368,1.0,21/64,12.36%,FGL2;TLR2;CSF1R;C1QB;CLEC5A;LCP2;TNFRSF1B;ITGAM;C3AR1;CD53;CSF3R;LILRB1;WDFY4;LY86;LAPTM5;CD4;P2RY13;PILRA;SLC40A1;AOAH;SASH3
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.4914579143825306,-1.0304150970005592,0.4107142857142857,0.928653456812975,1.0,2/37,2.68%,NGF;EDF1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.5841127258696,-1.030041503097205,0.44680851063829785,0.9287277883514047,1.0,1/11,3.71%,ARCN1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.550735287717749,-1.0300349651159473,0.45098039215686275,0.9279272301039901,1.0,2/22,2.68%,NGF;EDF1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.6761176541328555,-1.029989014911756,0.5283018867924528,0.9272088772095869,1.0,1/6,3.64%,PMM1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.48122085750591354,1.029982633178701,0.39215686274509803,0.7401799237802158,1.0,2/28,0.84%,ABCC4;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.42432250633429897,1.0299344426996007,0.39215686274509803,0.7398894195406867,1.0,8/58,6.70%,TGFB2;BMP6;ZNF423;BMPR1B;INHBC;CITED2;SULF1;KIAA0319
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.4240928602600109,1.0297515437104072,0.3023255813953488,0.7398491273896738,1.0,5/54,5.47%,NPAS2;PDGFB;EGFR;HGF;TOX
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6102208787352441,-1.029618192847907,0.5,0.9274603986694587,1.0,3/14,11.87%,CHAMP1;MIS12;IK
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.4860952102186846,1.0294354910206258,0.4782608695652174,0.7401375025500743,1.0,8/30,14.89%,NEDD4L;KNDC1;LZTS1;YWHAH;SARM1;TNIK;HECW1;NSMF
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5119925756756544,-1.0293946943834749,0.3877551020408163,0.9271982758359899,1.0,4/31,7.82%,RAD23A;SERF2;KDM8;PYHIN1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.4148215954607941,-1.0293219268479632,0.39622641509433965,0.9266362924933023,1.0,20/107,15.27%,VPS25;VAMP8;DYNLL1;LIX1;CHMP2A;VPS28;GABARAPL2;MTERF3;PRKAA2;SNF8;SNAP29;ATG14;TOMM20;CHMP3;HGS;SQSTM1;MAP1LC3B;EI24;ATG16L1;TOMM7
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.6573761518453576,1.0291701995953613,0.4444444444444444,0.7403204582856573,1.0,3/5,26.29%,RGS2;SORT1;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.603507829888881,1.0291613702872582,0.4230769230769231,0.7399254737901079,1.0,2/9,3.77%,EPHA4;NELL1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.5084970273183397,-1.028837860869026,0.3793103448275862,0.9271145268863432,1.0,9/27,18.42%,CHMP2A;CEP131;CHMP5;NPM1;CHMP3;CEP120;NAT10;STIL;PKHD1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.6491578858790383,-1.0287261134108738,0.46938775510204084,0.9266413521989124,1.0,1/7,8.19%,RHOA
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.3779399890502973,-1.0286999971053614,0.34782608695652173,0.9259425365814622,1.0,19/195,9.44%,CFAP61;KIF3B;EXOC7;PLK4;RAB8A;DYNLL1;CNGA4;PTPDC1;ABLIM3;FBF1;CNGB1;TMEM107;IFT81;INTU;TTC29;CEP131;TMEM138;MKS1;CFAP70
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.5874701781360404,-1.0286906915389795,0.43636363636363634,0.9251500607595086,1.0,3/10,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5065205335129785,1.0285570249297007,0.4444444444444444,0.7408235584019239,1.0,3/18,8.11%,TLR2;RSAD2;TIRAP
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6140305831759695,1.0283645187488082,0.43636363636363634,0.7408550005738017,1.0,1/10,1.34%,RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),0.6632230051409302,1.0283629137072208,0.5,0.74045381966632,1.0,2/5,15.73%,ACVR1C;GJA1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.5219465117280437,-1.0277989616378969,0.4406779661016949,0.9267655927792814,1.0,5/22,20.67%,RPS6;SYAP1;RPS6KB2;PINK1;MEAK7
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.5318790496168115,1.0274258205851732,0.4,0.7420969189380702,1.0,6/10,18.25%,LRRK2;SRC;BCL2;FZD9;MLLT11;KDR
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.39634842627225986,-1.026937098169562,0.3728813559322034,0.9283637153035438,1.0,18/148,10.82%,TEAD2;POLR2L;TEAD3;POLR2G;TBPL2;POLR1F;POLR1G;POLR2K;GTF2F1;POLR2I;NR2C2AP;POLR2A;SMARCA5;CAVIN1;TAF13;POLR1H;TFB2M;TAF7
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.6796449815028305,-1.026929000062557,0.5535714285714286,0.9275712011032954,1.0,1/5,8.07%,TRMT112
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.6464306955013949,-1.0269141082555329,0.5102040816326531,0.9268018968552124,1.0,3/9,12.73%,NLRP1;NLRP9;APIP
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.6356841899922365,1.0268717033005033,0.5416666666666666,0.743024570715803,1.0,2/5,24.01%,ZNF473;LSM11
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.4712893849634451,1.0267248882959625,0.3333333333333333,0.7429434938000135,1.0,9/36,21.42%,YBX3;ZFP36;TIRAP;RBM24;SYNCRIP;NOCT;ELAVL4;E2F1;DND1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.3720512396723212,1.0267228150806615,0.4489795918367347,0.7425420472310292,1.0,37/127,14.60%,NPY;BCHE;SHISA6;AQP1;CHST1;ITGB4;PLPPR4;DCLK1;CTHRC1;GFAP;SORBS1;LAMC1;ADCYAP1R1;NTRK2;OPCML;BAG3;ASTN1;CADM3;NDRG4;MAPK4;EDNRB;PHYHIP;EPB41L1;GAP43;SPARCL1;NGFR;CNTFR;CPE;PSD2;SCN4B;THY1;GRIA2;LRP4;SCN7A;PRX;PDZRN3;MEGF10
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.5631711257845269,-1.0267119612831122,0.4262295081967213,0.9265571803978345,1.0,3/14,5.10%,SFRP1;GREM1;LMX1B
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.5745205125074746,1.0266050738283188,0.5454545454545454,0.7424809332967737,1.0,5/13,10.72%,ST8SIA3;B4GALT6;ST8SIA4;ST8SIA6;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.587148081839311,1.0265915344225776,0.5217391304347826,0.7420801808877683,1.0,3/9,14.16%,LRRK2;RNF139;PGAP1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.6789837015591571,-1.0264561757654858,0.5,0.9264653704339451,1.0,1/5,8.50%,DHFR
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5716900607731732,-1.026323206920647,0.47058823529411764,0.9259747221465308,1.0,3/12,12.65%,DDIT3;TMSB4X;GATA1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.4162477450968375,-1.0262907249000077,0.41379310344827586,0.9252094997289712,1.0,24/86,20.91%,NDC80;TUBG1;CDC23;CHMP2A;RAN;CHMP5;SGO2;ANKRD53;MIS12;PINX1;NUDC;KMT5A;PHF13;KIFC1;CHMP3;WRAP73;SMC2;BECN1;REC8;CHMP7;SMC1A;SET;CEP55;DCTN2
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.5803663491283003,-1.0262485736940132,0.4807692307692308,0.9245469988683604,1.0,3/12,13.67%,UFC1;TEX264;UFL1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.6306245327507024,1.026017240872856,0.5555555555555556,0.7427808906455143,1.0,4/6,26.17%,IL21R;JAK1;STAT3;STAT4
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.6306245327507024,1.026017240872856,0.5555555555555556,0.7427808906455143,1.0,4/6,26.17%,IL21R;JAK1;STAT3;STAT4
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.6320040628095335,-1.0259332135572776,0.43636363636363634,0.9247177414289953,1.0,1/13,0.16%,P2RY10
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.614358061037521,1.025894136758748,0.5227272727272727,0.742615426736149,1.0,2/11,16.00%,PACSIN1;SNX33
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.5651535174067637,1.025718041066702,0.4418604651162791,0.7425544398901073,1.0,4/7,15.57%,PPARGC1A;ACSM1;ALOX12;ADIPOR2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3751481187928668,-1.025701840904479,0.38333333333333336,0.9245122656794029,1.0,47/347,12.91%,NGF;CD38;CRYAB;RPS3A;PRELID1;RPS27A;UBC;RPL10;DPEP1;SFRP1;PTMA;MIEN1;UBB;GREM1;BEX3;PRDX5;NRBP2;GSTP1;CFL1;MGMT;TNFAIP8;TPT1;PHB2;EVI2B;ARAF;SOD1;ANXA5;BNIP1;DHCR24;UNC5B;PRDX3;CIAPIN1;TMBIM6;DDAH2;MYDGF;MAG;ZNF830;ARHGDIA;PRKAA2;NPM1;TRIAP1;IFI6;GATA1;APIP;KLHL20;UBA52;HMGA2
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.6134085623157002,-1.0255757337888318,0.38596491228070173,0.9240326752874326,1.0,1/5,0.82%,PAX8
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.6663338392482969,-1.0254332749739161,0.5686274509803921,0.9235322689422133,1.0,1/5,4.74%,HYAL2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5443482597834846,1.025231033348079,0.425531914893617,0.7432297068369998,1.0,6/14,22.60%,SLC24A4;GNAL;UBR3;MKKS;BBS4;OR3A2
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.5873548500587269,1.024930764690038,0.46153846153846156,0.7434419282709654,1.0,1/8,6.29%,LILRB1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6638345076335014,1.0240717260061791,0.40384615384615385,0.7448448469368956,1.0,6/8,18.12%,NTNG1;NTN4;LAMB4;LAMB2;LAMB1;PXDN
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4649329434915534,-1.0238179580680928,0.38181818181818183,0.9269191401822966,1.0,8/49,15.73%,EMC6;UBQLN2;GABARAPL2;ATG9A;ATG14;MAP1LC3B;ATG16L1;WDR45B
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.6310039994784293,-1.0235523009056184,0.46153846153846156,0.9268709581558475,1.0,3/6,23.00%,PRDM5;BEND3;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4656863537064752,1.0232325629324397,0.4666666666666667,0.7463893268150696,1.0,6/39,8.43%,EGFR;TLR2;C1QTNF4;NR3C2;NOD1;LAPTM5
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.5039732530678902,-1.023112728260318,0.4444444444444444,0.9274490767778316,1.0,3/22,11.65%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),0.6642819074505696,1.0229991740516862,0.47368421052631576,0.7463849527743047,1.0,1/5,2.67%,DLAT
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.42625291265108767,1.0229804563720946,0.3191489361702128,0.7460037483083715,1.0,17/59,20.50%,OBSCN;SORBS1;SRC;FHDC1;TPM1;MYLK3;EPB41L1;CSRP2;CUL3;PHACTR1;KCTD13;ZYX;CAPN3;CDC42BPA;FHOD3;TCAP;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.6804886376864118,1.0229395228477842,0.4791666666666667,0.745655427630513,1.0,1/7,8.43%,LAPTM5
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.6686167830919505,1.022888560729807,0.5333333333333333,0.7453723873658163,1.0,3/6,9.62%,SYK;FBLN5;BST1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3790403341763632,1.022815506277474,0.3783783783783784,0.7451285746777029,1.0,19/133,13.35%,CERS3;MGST1;CERS6;PAM;ABHD3;VAPB;DMD;SLC44A5;ELOVL4;SGPP2;B3GNT6;GPAT4;PPM1L;PRKD1;ALAS1;PLA2G4A;ACER2;PCSK1;MOCS3
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.5347656638176326,1.0225772547240064,0.40476190476190477,0.7452156610102941,1.0,3/13,13.84%,OGFOD1;P3H2;P3H4
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.5563885224364109,-1.02224620363639,0.4186046511627907,0.9293063089462901,1.0,4/19,11.26%,USP51;ENY2;USP16;BRCC3
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.45429672740683585,-1.022160959743997,0.4,0.9287675757783002,1.0,9/67,5.20%,POLR2L;SFRP1;POLR2G;POLR2K;FRS3;GTF2F1;HYAL2;POLR2I;FGF6
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.4521079754370366,1.0221559940341,0.4594594594594595,0.7458210113046381,1.0,11/37,18.66%,PTPRC;NCKAP1L;TNFRSF1B;LILRB1;CD70;CR1;SFTPD;LGALS3;CD80;TNFSF4;ARG1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5149922980794645,1.02207966673637,0.46,0.7455579245214115,1.0,3/27,10.63%,PPARG;NFKBIA;PLA2G10
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.6563328007128169,-1.0219345835149976,0.52,0.9285815563424341,1.0,4/5,33.94%,NCSTN;APH1A;APH1B;PSEN1
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.6467754682486866,-1.0217120838581957,0.4745762711864407,0.9283599933979289,1.0,6/9,26.98%,ZNF639;HMGA2;JUN;INPP5K;TARDBP;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.42134164071183366,1.0216979816207339,0.40816326530612246,0.7460329819909228,1.0,13/52,17.87%,LPL;TLR2;NFKBIA;WNT5A;TNFRSF1A;IL33;CX3CL1;NFKBIZ;IL17RA;IL16;LBP;TNFSF4;NLRP12
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.3517038500300978,1.020743728698952,0.3125,0.7479695005167332,1.0,52/275,13.86%,TGFB2;RND2;FIGN;MYO7A;CGNL1;ITGB4;KASH5;ACTN1;MYH11;CAMSAP3;GFAP;FGF13;COL11A1;CARMIL1;COL5A3;LOX;LOXL3;ARHGAP25;MYO1B;COL12A1;HOOK1;MYO5C;RHOF;COL4A1;TPM1;COL20A1;TSPAN14;SNCAIP;P3H2;FIGNL1;FBLN5;COL15A1;COL7A1;ARHGAP17;CORO1C;VIM;COL9A1;KIF14;TUBGCP6;MAPT;NEFL;P4HA1;TRPV4;COL27A1;SHROOM3;COL24A1;TLL1;RAC3;SHROOM2;CORO6;P3H4;COL5A1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.6695083922750318,-1.020572215081947,0.62,0.9309410391012739,1.0,1/5,13.71%,CTR9
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.48842737966198985,1.0205222822682998,0.4222222222222222,0.7480289464995848,1.0,2/26,4.77%,CX3CR1;DDAH1
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.6589460093540367,1.0203684731166376,0.45652173913043476,0.7479526279587053,1.0,3/5,32.39%,CHD7;PROX1;GLI3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5808939987379714,1.0202766583078424,0.5,0.7477601409725162,1.0,2/12,8.69%,PLXNA4;PLXNA2
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.6146347449543422,-1.0202281467075711,0.46,0.9309254811072953,1.0,1/9,5.62%,KDM8
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6319607344330309,1.0202173029737387,0.5106382978723404,0.7475291332404708,1.0,4/9,17.38%,EPHA4;LYN;EFNA3;BIN1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.4826415277427889,1.020201377826969,0.5272727272727272,0.7471499934969593,1.0,10/43,10.93%,IGF1;GRM5;EPHA4;SRC;CACNB1;GRIN1;TIMELESS;NOD1;VIM;NGFR
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5886416010097762,-1.019974842929209,0.5,0.9306953160838206,1.0,3/10,17.46%,SERPINE1;PLA2R1;ATR
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5429707075240467,-1.0199466025752482,0.43636363636363634,0.930015204688786,1.0,10/26,21.31%,RPS2;GORASP1;GOLGA2;UBE2L3;CDC20;UBE2S;UBE2N;PINK1;BMI1;SKP1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.4467284832514649,1.0197226145292908,0.39655172413793105,0.7478867529088643,1.0,8/36,14.75%,SEMA3D;NRG1;CORO1C;SEMA6A;SEMA5B;SEMA4B;SEMA4G;SEMA3C
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.5348932862716654,1.0196782780239595,0.39285714285714285,0.7475787186135638,1.0,1/13,1.54%,MDFIC
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.5675894698687832,-1.0196524439220442,0.425531914893617,0.9292793232159663,1.0,1/8,5.90%,ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.5675894698687832,-1.0196524439220442,0.425531914893617,0.9292793232159663,1.0,1/8,5.90%,ABHD17A
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5024947001311953,1.0195107446935527,0.4444444444444444,0.7475544187165826,1.0,2/24,3.14%,CREB3L1;LRRK2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5485982919433111,1.0193864156251544,0.49019607843137253,0.7474335832653313,1.0,6/15,20.20%,RFX3;DNAAF1;ADCY10;ODAD4;CFAP53;AQP4
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.6323019592837038,-1.0192080209206469,0.4716981132075472,0.9297215717073455,1.0,2/6,10.28%,NOX1;CFTR
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.716527819314518,1.0191134749009834,0.55,0.7475573695076111,1.0,1/6,1.52%,TLR2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.4208948005455208,1.018933306608192,0.425531914893617,0.7475717035193092,1.0,9/52,12.39%,CERS3;CERS6;VAPB;ELOVL4;SGPP2;ST8SIA6;PPM1L;PRKD1;ACER2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.46247220836883923,1.01885430252107,0.45098039215686275,0.7473225137172534,1.0,6/35,12.07%,ADCY8;CARTPT;PPARGC1A;KCNB1;NGFR;PIK3R1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.48521415428775133,1.0188295686198712,0.4339622641509434,0.746996509934318,1.0,20/32,24.75%,ABCC9;TRPM3;TRPM1;TRPM2;ASIC2;SLC25A19;ABCC8;SLC25A20;SLC7A8;PKD2L1;KCNJ11;SLC29A4;ATP1A2;PKD2;ATP13A2;SFXN3;SLC7A2;SLC7A1;SLC6A9;SFXN1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.5044870001867583,-1.0186337629659827,0.4230769230769231,0.9304765062353335,1.0,3/26,3.38%,GPC4;VAMP8;GPC2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.600681647146818,1.0186031076542599,0.5652173913043478,0.7471523653877893,1.0,2/11,18.54%,NR3C2;GPER1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.5993247570511087,1.0185381084419713,0.4230769230769231,0.7468781377305714,1.0,1/11,1.38%,PTPRC
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),-0.6703658156595886,-1.0184698045781106,0.5423728813559322,0.9300770871371159,1.0,3/5,16.33%,GPD1;GPAT2;GPAM
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.6237511586063222,1.0184136589014363,0.43478260869565216,0.7467196428173206,1.0,3/5,15.19%,ZFP36;SFRP4;ZFP36L1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.6639906789041807,-1.018362993143347,0.5098039215686274,0.929564567805326,1.0,1/5,1.71%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.3427871628378133,1.0182540843007741,0.42105263157894735,0.7466702840442095,1.0,29/338,7.14%,KLRF2;CLDN5;VSIR;PDGFB;BMP6;EGFR;ANGPT1;PRR16;IGF1;PLSCR1;TLR2;F3;HEY1;PID1;MEF2C;ZNF804A;RIMS2;KAT2B;ID2;SLC26A9;NTRK2;SLC24A3;VSTM2A;CITED2;LEF1;LILRB1;PPARGC1A;TESC;SOX9
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.4097195267257349,1.0182011203514743,0.4146341463414634,0.7463455079366843,1.0,22/76,19.30%,KCNC2;SNAP25;RAPGEF4;IRS1;ITPR1;EFNA5;STX1A;CLOCK;KCNB1;PICK1;SYT7;CACNA2D2;ABCC8;CACNA1E;RFX3;NOS2;ITPR3;CCN3;CACNA1C;EPHA5;GPER1;KCNJ11
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3938925521872797,-1.0179972848174537,0.43478260869565216,0.9296853118927153,1.0,33/154,16.89%,COPE;TRAPPC1;USE1;KDELR1;ARCN1;DYNLL1;NRBP2;GOPC;DCTN3;TMED4;TMED9;F5;TRAPPC3;RANGRF;TRAPPC6A;TMED2;LMAN1;GORASP1;TMED1;DYNC1H1;YIF1B;ERGIC3;SAR1B;COG2;GOLGA2;TRAPPC2L;TMEM115;TMED5;DYNC1I2;DCTN1;LMAN2;TRAPPC4;GBF1
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.6555682504290979,1.0179513693910878,0.5,0.7464628773550227,1.0,4/5,33.73%,GRHL2;PKD1;RCN3;ASCL1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.46305654978349914,-1.0176264146010803,0.41379310344827586,0.9298271475445573,1.0,13/70,15.59%,RPS13;RBM22;POLR2A;SRSF3;RPS26;TMBIM6;C9ORF78;MBNL3;RRP1B;FASTK;RBM23;HNRNPH2;JMJD6
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.656690093218215,-1.0173724678182807,0.49056603773584906,0.9297204748033443,1.0,1/7,7.93%,BRPF1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.4199077071687641,1.0173350368322487,0.41304347826086957,0.7474056438114206,1.0,10/63,11.25%,TRIM5;CD44;TLR2;CIITA;CAMK2B;WNT5A;DAPK1;CAMK2D;TRIM22;CX3CL1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.6415613968749712,-1.0171437753835755,0.5283018867924528,0.929557286212511,1.0,3/7,26.83%,DYNLT1;DDB1;TBC1D20
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.45690781342309617,-1.0167717431777958,0.423728813559322,0.9298263297831645,1.0,3/63,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.532083897894659,1.0167074106198335,0.5128205128205128,0.7484433371433721,1.0,5/14,14.42%,PTPRJ;SLA2;LAPTM5;THY1;LGALS3
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.645317053574364,-1.016539034476662,0.4807692307692308,0.9296067278221813,1.0,1/6,6.45%,CROT
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.47906408767823677,1.0165372696118309,0.4423076923076923,0.7484698960297858,1.0,12/38,18.93%,KAT2B;LEF1;PER1;KAT6B;TAF5L;KAT2A;SPI1;TADA2A;DR1;TAF10;JADE2;SUPT3H
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.4371972490468851,1.016196363272655,0.3617021276595745,0.7488861618232172,1.0,10/44,10.48%,NAGLU;CD44;VCAN;GPC6;CSPG4;HEXB;GPC5;AGRN;LYVE1;NCAN
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.48111792020425787,-1.0161726608148096,0.39655172413793105,0.9298964783760286,1.0,8/56,8.10%,POLR2L;POLR2G;POLR2K;FRS3;GTF2F1;POLR2I;FGF6;POLR2A
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.4408175619789646,-1.016103456766406,0.36065573770491804,0.9292957815801199,1.0,15/71,17.27%,RPL5;EIF3D;RACK1;SPHK2;PASK;METTL5;SMPD2;PYM1;RPS4X;NPM1;RPS27L;CIRBP;NAT10;CHRNA7;PCIF1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.6166189609846517,-1.0157952788432902,0.5,0.9292465619067634,1.0,3/8,12.91%,CGAS;B2M;HMGA2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.49879429882485443,-1.015233396842462,0.48936170212765956,0.9302127880586613,1.0,5/26,9.33%,STMN1;MYADM;PFN1;TUBB4A;TWF1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4174263033920672,1.0151510917504027,0.4090909090909091,0.7508345442233576,1.0,21/75,13.58%,RHBDF2;ADCY8;RXFP1;SRC;SYK;ADCYAP1R1;CYSLTR2;GPR176;VIPR2;CYSLTR1;GNG2;ADCY2;GPHB5;ADORA2B;LYN;PRKAR1B;ADCY7;ADCY1;GGT5;HRH2;P2RY11
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.6561049797636741,-1.0150391043343496,0.5227272727272727,0.9300078804125138,1.0,1/7,12.99%,AURKAIP1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.40496109739339753,1.0148555600891311,0.44,0.7511214514887227,1.0,14/48,11.83%,CX3CR1;P2RY12;GRM5;GRM1;GRPR;GPR35;C3AR1;PTGER3;ADRA1A;NMUR2;HTR2C;P2RY1;CHRM1;HOMER1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5759579605168597,1.0146737338908325,0.4,0.7511401401868284,1.0,5/12,21.66%,B4GALT6;EPHB1;EPHB6;PTEN;B4GALT5
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.49848790261063824,-1.014641391947459,0.4838709677419355,0.9302538269295499,1.0,9/30,9.06%,TGM1;TNS4;CLCA2;KRT10;ENTPD2;LAMB3;DUOXA1;CDSN;ICAM1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.6556557136270464,1.0144824720787917,0.5510204081632653,0.7512161876899234,1.0,1/5,7.83%,HS6ST3
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.48077121830428143,-1.0143467324803752,0.45614035087719296,0.9302813273966613,1.0,2/36,4.80%,UXT;TFDP1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.628595468910151,1.0142754489382013,0.5,0.7514068500433269,1.0,3/6,27.06%,SPI1;KLF7;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.5116187890010856,-1.0139549136575174,0.4461538461538462,0.9304844624030632,1.0,7/25,11.59%,STAC3;ACTN2;CALM1;ANTKMT;P2RY6;EPHB2;TMSB4X
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.45385648729388056,1.0138433199493386,0.45652173913043476,0.7518647898971771,1.0,6/45,10.82%,TRIM5;CD44;CIITA;CAMK2B;CAMK2D;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.5476084662522429,-1.0137439481858246,0.44680851063829785,0.9303010822385236,1.0,2/11,13.46%,CHMP2A;CHMP3
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.5596442551992454,-1.0136970009805986,0.43478260869565216,0.9296269366159851,1.0,1/15,0.78%,ENPP6
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.6484375132621737,1.0136356881845718,0.45454545454545453,0.752029440976592,1.0,2/5,8.11%,TLR2;TIRAP
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.5571439814746458,-1.0135975816222769,0.5348837209302325,0.9290800996533848,1.0,4/12,23.53%,NPC2;NPC1;STAR;OSBP
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.6065339995920795,-1.013416743992833,0.4782608695652174,0.9288633512397955,1.0,1/10,3.43%,SLC31A2
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.49999294591381405,-1.0133783542751549,0.4307692307692308,0.9281501374164353,1.0,5/19,11.39%,PPIL1;PPIB;PPIE;PPWD1;PPIA
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5217508249934987,1.0130980883580436,0.46511627906976744,0.7528300962578226,1.0,3/15,7.12%,KCNB2;TPM1;NMUR2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4180122373638001,1.0127458473548219,0.5,0.7531212242326312,1.0,13/64,10.93%,EGFR;MYH11;F3;TNC;LRIG3;POSTN;COL12A1;COL4A1;TP63;TRIM29;NTN4;LAMB2;NGFR
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.5058187139247073,1.0123805953544134,0.46153846153846156,0.75348194663248,1.0,3/16,7.79%,AQP1;KCNC2;TIMELESS
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.4137486957069763,-1.0122941504988217,0.43103448275862066,0.9302767650008846,1.0,4/87,1.71%,TAX1BP3;TRABD2B;SHISA2;SFRP1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.599651766627646,1.0120180111310773,0.48148148148148145,0.75383593263954,1.0,2/12,2.80%,CARMIL2;FAP
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.6163827575371981,-1.0119273604389047,0.4716981132075472,0.9304926786004666,1.0,3/9,12.91%,CGAS;B2M;HMGA2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.45822101570352314,1.011526101147276,0.4791666666666667,0.754449818959419,1.0,8/31,17.20%,TGFB2;MET;RASIP1;SYNGAP1;KANK1;CUL3;ARHGAP44;KCTD13
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.4551521557035444,-1.0114237967369346,0.38596491228070173,0.9310991069271422,1.0,8/51,15.73%,EMC6;UBQLN2;GABARAPL2;ATG9A;ATG14;MAP1LC3B;ATG16L1;WDR45B
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.5013700631895698,-1.0113702396240007,0.4642857142857143,0.9305537900077894,1.0,8/31,16.10%,CSTF2T;LSM10;CSTF2;SNRPB;SNRPE;SSU72;FIP1L1;SNRPG
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.5520316401126312,1.0112981890412331,0.4222222222222222,0.7545110488334998,1.0,5/13,19.62%,PGAM5;ITPK1;MLKL;TICAM1;LY96
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.4260304459018575,1.011113741178177,0.3695652173913043,0.7546292867828567,1.0,20/63,14.62%,RIMS4;MEX3A;CBARP;EFNB3;NR2F1;CDK5R2;TENM3;MEIS3;TEAD1;DLX1;NKAIN1;NGFR;ONECUT2;TMEM59L;LYPD6;PCGF2;RAC3;NR2F2;CSPG5;SRRM3
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.42370311839206476,1.0108965118339186,0.5121951219512195,0.754728384577377,1.0,12/71,6.40%,ABCC4;SLCO2B1;AQP1;MGST1;SLC23A1;SLC25A41;SLC4A10;CA12;SLC26A9;SLC4A4;SLC22A3;SLCO4A1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.5771922690528969,-1.010783989005832,0.45098039215686275,0.9312148946042611,1.0,3/12,19.75%,DNMT3B;CTR9;DNMT1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.4128255733158085,1.0096990065219096,0.40476190476190477,0.7571712269069268,1.0,9/59,7.78%,CHRM3;CDS1;EGFR;ITGB4;HSD11B2;CAMSAP3;PRKCZ;SLC5A9;EPHB3
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5162857193577873,1.0096464319714045,0.4523809523809524,0.7569206430544031,1.0,6/20,12.15%,SULT4A1;SULT2A1;PPA2;DDO;MTARC2;SULT2B1
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.6182751350993283,-1.0096228755512753,0.46153846153846156,0.9328607371828487,1.0,3/7,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.6182751350993283,-1.0096228755512753,0.46153846153846156,0.9328607371828487,1.0,3/7,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.4687364848395906,-1.0093577125222484,0.3888888888888889,0.9328023230562629,1.0,9/38,16.95%,CRYAB;OPRD1;TFIP11;NOP53;RPL13A;PARK7;HMGB1;CDC42;CPTP
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.6170929615955486,1.0093159525577264,0.5333333333333333,0.7573853892377441,1.0,4/8,18.54%,SOX9;LYN;CD200;GPER1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.47203269601937276,-1.0092420655890686,0.40384615384615385,0.9323203667641308,1.0,7/44,5.50%,OOEP;RPS3;RNF8;H2AX;PCNA;MGMT;PARP1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.5223274533601837,-1.0092044858150762,0.43859649122807015,0.9317212515473632,1.0,9/26,17.95%,BAK1;TMBIM6;BAX;HSPA8;HSPB8;DAXX;HSPA14;HSPA2;PTPN1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.41735617207151354,-1.0091605908753625,0.4166666666666667,0.9310399376024016,1.0,23/125,13.22%,TNFRSF8;RPS3;SFRP1;TNFRSF21;PSMD7;PSMB6;PSME2;CRHBP;PSMD8;HYAL2;PSMB4;PSMD3;PSMB3;CHUK;PSME1;TMSB4X;TXNDC17;ADAMTS12;EIF5A;PSMA7;ILK;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.35576309749415735,1.009111850795293,0.39473684210526316,0.7573816186517515,1.0,23/247,7.14%,PDGFB;EGFR;KITLG;CSF2RA;ANGPT1;IGF1;MAP3K5;GRIN2B;LRRK2;MEF2C;RIT2;HGF;MET;FGF13;GFRA1;PRKG2;PDGFRA;NRG1;IRS1;CAMK2B;ZFP36;GRIN1;SOX9
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.4553004465690764,1.0090571606508687,0.41304347826086957,0.7571250008651159,1.0,11/39,12.57%,CD44;CHI3L1;MEF2C;SULF1;SOX9;ZBTB16;GPLD1;SOX5;CREB3L2;TRPV4;SNX19
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.4286530039278816,-1.008936447192551,0.42105263157894735,0.930830832817444,1.0,15/79,14.07%,ORC1;BUB1;NCL;PLK4;NDC80;PARP1;DNMT3B;MCM4;PFAS;RFWD3;MCM3;NPM1;BLM;KIF11;CENPF
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6268669560795197,1.0087958772981143,0.4888888888888889,0.7572730026557037,1.0,1/8,0.71%,VSIR
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.5328965111612964,-1.0087555274007625,0.4423076923076923,0.9305459376047652,1.0,2/18,5.73%,GREM1;EPHB4
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.5458838427922812,-1.0087410376745138,0.5555555555555556,0.9282855838345878,1.0,6/16,19.10%,BUB1;IK;CENPF;KNTC1;CDC20;TPR
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.5458838427922812,-1.0087410376745138,0.5555555555555556,0.9282855838345878,1.0,6/16,19.10%,BUB1;IK;CENPF;KNTC1;CDC20;TPR
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.5458838427922812,-1.0087410376745138,0.5555555555555556,0.9282855838345878,1.0,6/16,19.10%,BUB1;IK;CENPF;KNTC1;CDC20;TPR
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.3909459378957638,-1.0086769615470352,0.45652173913043476,0.9276243213465917,1.0,22/103,19.95%,GAPDH;EXOC7;ATP6V1G1;NRBP2;ATP6V1G2;LAMTOR4;RRAGA;UBQLN2;CAPNS1;ATP6V1E2;PRKAA2;SLC38A9;SCOC;ATP6V0E1;LAMTOR2;PRKACA;SUPT5H;NEDD4;LAMTOR5;IKBKG;VPS35;PINK1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.38045351563233687,1.0085693826050295,0.3111111111111111,0.7573829600382013,1.0,16/114,11.96%,ROR1;CX3CR1;TRIM5;TLR2;PRKCZ;IRAK3;NFKBIA;WNT5A;TIRAP;NOD1;CLOCK;IL1RAP;TRIM22;CX3CL1;PRKD1;CARD11
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.6585691864610852,-1.0079741751319116,0.5344827586206896,0.9287494450914872,1.0,1/6,0.44%,CRTAM
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.4877205077985752,1.007600291392561,0.5116279069767442,0.7594682159797571,1.0,7/32,10.05%,PDGFB;BMPR1B;TWF2;MAP2K5;NOS1;BMPR2;ACVR1C
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4409047652978662,1.0074824722367384,0.4489795918367347,0.7593182707738266,1.0,8/43,16.28%,TP73;TNFRSF1B;BCL2;DYRK2;BCL2L1;CIDEB;DDIT4;AEN
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.5508769567090185,-1.0072732967619142,0.46,0.9297900540184808,1.0,2/12,20.20%,RAN;DGKQ
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.3715759097326936,-1.0070622175160353,0.43548387096774194,0.929665951580078,1.0,57/357,16.93%,CFAP61;RAB32;CNN2;TMEM11;MSTO1;CFL1;CHCHD2;ATP5F1B;PARP1;PHB2;GOLGA8M;HSD17B10;TMED4;MCOLN1;CHMP2A;NUMA1;TMED9;TTC29;BNIP1;CHMP5;PRDX3;PLCE1;CLUH;ZFYVE16;TFB2M;ZNF135;TMED2;LMAN1;GORASP1;PPIA;ZMYM6;RAB31;USP6NL;DNAJA3;TMED1;SAR1B;KLHL20;GORASP2;CHMP3;SYNE3;COG2;GOLGA2;GOLGA8H;VPS11;TOR1A;PTCD2;TMED5;PNPLA3;KIF4A;LMAN2;FBXW8;SURF4;PARK7;GBF1;WASF3;BLZF1;CDC42
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.5579216216586703,1.0067673502772443,0.4523809523809524,0.760542875846647,1.0,2/12,11.59%,CAMK1D;LYN
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.518703310114254,1.0066647918622058,0.44680851063829785,0.7603862194972592,1.0,3/18,9.61%,LPL;SLC2A5;GPLD1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.5103068331792336,-1.006500818735835,0.44642857142857145,0.9304427938128434,1.0,8/26,19.46%,SQLE;ACAA2;DHCR24;IDI1;MSMO1;PMVK;TM7SF2;G6PD
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.4100907503847019,1.0064157955059332,0.44,0.7605509207302917,1.0,12/64,13.77%,CERS3;CERS6;ST8SIA3;VAPB;B4GALT6;ELOVL4;SGPP2;ST6GALNAC5;PPM1L;PRKD1;ACER2;PNPLA1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.6009395309966741,1.0063001945815713,0.5319148936170213,0.7603881311759015,1.0,3/6,2.76%,VSIR;NCKAP1L;IL12A
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.6207910255429777,1.0059001769005222,0.48148148148148145,0.7607539766348201,1.0,1/5,5.30%,MAPKBP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.644181739368473,-1.0058121225597265,0.5714285714285714,0.9315000272030143,1.0,2/8,18.50%,ENTPD2;NUDT5
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.4804272181557075,1.0056490371193616,0.41304347826086957,0.7608804953911293,1.0,5/28,12.07%,CYFIP1;CARMIL2;TWF2;DMTN;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.6847749592862984,-1.0056104959036984,0.575,0.9312581219090962,1.0,2/5,13.82%,HYAL2;RAC1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.556920408671012,1.0055723430785788,0.5306122448979592,0.7606800821132167,1.0,4/14,18.27%,RIMS2;PTPRN;SNX19;EDN1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.6381186324921864,-1.005471705664991,0.42857142857142855,0.9308382870640031,1.0,1/6,4.99%,USH1C
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.5020326383459127,1.0051045171466344,0.40816326530612246,0.7613341332313898,1.0,7/28,17.13%,PPARG;ABCD2;PRKAB2;ACACB;SLC25A20;SLC27A2;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6161593899746649,1.0048205195993134,0.5116279069767442,0.7615794273324784,1.0,3/11,14.36%,ADCY8;GPLD1;BAIAP3
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.4639577821367235,-1.0047697855784468,0.4074074074074074,0.9319062811130717,1.0,1/25,0.16%,P2RY10
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.38428709402362676,1.004287084063232,0.3888888888888889,0.7623138859029058,1.0,20/75,14.47%,TGFB2;ITGB4;COL11A1;COL5A3;LOX;LOXL3;COL12A1;COL4A1;COL20A1;P3H2;COL15A1;COL7A1;COL9A1;P4HA1;COL27A1;COL24A1;TLL1;P3H4;COL5A1;COL22A1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.4302801681745841,1.0041521524468977,0.4482758620689655,0.7621633107482351,1.0,13/42,20.99%,SEMA3D;CORO1C;SEMA6A;AMOTL1;SEMA5B;SEMA4B;SEMA4G;SEMA3C;CCN3;SEMA7A;ERBB4;AMOTL2;AMOT
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.5418906883481961,1.0038861304347413,0.4807692307692308,0.7619190184483855,1.0,1/16,3.75%,CBLIF
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.5418906883481961,1.0038861304347413,0.4807692307692308,0.7619190184483855,1.0,1/16,3.75%,CBLIF
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.6297883383708227,1.0037867157145834,0.5357142857142857,0.7616874894562196,1.0,3/6,28.25%,RGCC;TIE1;AGT
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.6215149309924921,-1.003768293945984,0.5471698113207547,0.9338626884042621,1.0,2/9,10.26%,SPX;SRI
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.6250929741388622,1.0037575633967588,0.5111111111111111,0.761356073123597,1.0,2/7,7.95%,SOX9;CHRD
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6059556742545347,-1.0037146978953064,0.5094339622641509,0.9332296470399296,1.0,2/7,10.39%,TINF2;PNKP
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.4112945097061259,1.003678525519332,0.47619047619047616,0.7611125732385475,1.0,12/52,13.12%,SLCO2B1;CSF1R;C1QB;MRC1;SCEL;CRLF1;TMEM176B;C3;ADGRF5;CEBPD;SOAT1;SFTPD
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.4623377006431282,1.0036605409533204,0.41304347826086957,0.7607442970627781,1.0,10/32,21.48%,NRXN1;DMKN;RFTN1;ANK3;LRP4;NLGN4X;NLGN1;PTEN;UGCG;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.646165875327576,1.0035634291317457,0.5254237288135594,0.760513870293778,1.0,1/7,2.76%,IL12A
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.4599832860450169,1.0033604016719826,0.38095238095238093,0.7605209967168923,1.0,7/33,12.96%,TLR2;KYNU;CIITA;WNT5A;DAPK1;CX3CL1;SYNCRIP
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.46159189867350336,-1.0031943213253345,0.40816326530612246,0.9338144964108558,1.0,2/39,1.25%,PANK1;AMPD1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.47363864350021145,-1.0030905279415225,0.423728813559322,0.9332918263103074,1.0,6/34,12.61%,PTGIS;GLA;PGP;ERLIN2;GCK;MST1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6648653749605257,1.003029234277502,0.5283018867924528,0.760865171094855,1.0,2/5,29.41%,VPS41;VPS39
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.5888098452973192,1.0029784898267542,0.5098039215686274,0.7605102731748248,1.0,2/8,8.45%,NR4A3;CCND1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.5489107858411677,1.0029211260860027,0.425531914893617,0.7601931582631283,1.0,2/13,7.66%,NFKBIE;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.46359028878625425,1.0029166932711964,0.4318181818181818,0.759801591613948,1.0,13/28,19.82%,TRIM46;MAP2;FGF13;KIAA0319;DUSP10;SLC6A4;BBS2;DIP2B;CDKN1A;OSTN;WWC1;PTEN;ULK1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.35944528935685827,1.0027731982292893,0.5,0.7596782690419226,1.0,29/140,12.01%,ETV1;IGFBP3;CSF2RA;GUCY1A1;LAT2;SNAP25;AKAP12;GALNT3;IKZF1;BIRC3;PTPRR;PRKG2;RELN;TNFRSF1B;ID2;C3AR1;ITGBL1;SPON1;SOX9;LAPTM5;MAFB;TMEM176B;IL33;SPARCL1;NAP1L2;PRRX1;CPE;TSPAN13;ST6GAL1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.42025291789487296,1.0027002689336968,0.4523809523809524,0.7594554681522135,1.0,15/59,17.33%,RYR3;SHMT2;GRIN2B;HCN1;SAMHD1;GRIN1;KCNC3;TRPM2;HOMER1;ACACB;PKD2L1;SHMT1;CBR4;TDO2;SYCP1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5151670856198212,1.0021079636624206,0.4473684210526316,0.7602097855464505,1.0,5/17,14.42%,PTPRJ;SLA2;LAPTM5;THY1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.6417153610237081,1.0021010531280665,0.58,0.7598128091571312,1.0,4/8,28.78%,ATP9A;IL1RAPL1;SNCA;RAB33B
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.48543916037707047,-1.0020533465750885,0.43636363636363634,0.9354385830424253,1.0,5/31,7.07%,JUP;RBM22;HYAL2;RAN;APOD
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.5830474863088222,1.0018901865508532,0.4782608695652174,0.7599880920513715,1.0,2/8,4.90%,SYK;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.6603845619287457,-1.0018215864465607,0.5714285714285714,0.9345157986783255,1.0,1/5,0.44%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.6603845619287457,-1.0018215864465607,0.5714285714285714,0.9345157986783255,1.0,1/5,0.44%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.6301411636395922,-1.001640939172052,0.5636363636363636,0.9342325547686756,1.0,2/7,4.77%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.44518091171828394,-1.000763025281871,0.47540983606557374,0.9357864780062823,1.0,9/59,7.41%,AMPD1;PTH;GLYAT;ACSM6;DBI;ACOT1;CROT;RAN;GMPR2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5412051441920371,1.0001398387742308,0.4489795918367347,0.7636732337005274,1.0,2/15,1.41%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.529653419962688,1.000023319932809,0.46296296296296297,0.7635482783304548,1.0,5/14,10.38%,CX3CR1;SELL;ADD2;JAM2;SELPLG
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5055946944316004,-0.9999913392249444,0.48148148148148145,0.9371135538698516,1.0,9/29,19.46%,SQLE;ACAA2;DHCR24;SC5D;IDI1;MSMO1;PMVK;TM7SF2;G6PD
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.5073273269193276,-0.9998801208568777,0.4807692307692308,0.936652301293285,1.0,5/24,11.84%,DDIT3;SELENOK;BAK1;BAX;ATP2A3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5157837487181978,0.9998736507852921,0.46511627906976744,0.7634482771435289,1.0,1/22,0.07%,CREB3L1
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.6739595730506223,0.9998262458515327,0.5454545454545454,0.7631436891737634,1.0,1/5,9.91%,BMPR2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.47851513696576664,-0.9993868957652986,0.42,0.9372029045470524,1.0,5/42,15.78%,LSM2;DDX5;RNH1;NUDT12;NUDT16L1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.41207857779519086,-0.999078517725124,0.4696969696969697,0.9372915428071081,1.0,21/75,24.65%,KIF3B;AP2S1;DYNLL1;DCTN3;DYNC1H1;AP1B1;SAR1B;HLA-DRA;KIF11;DYNC1I2;DCTN1;KIF4A;HLA-DPA1;AP2A1;DCTN2;AP1S1;CLTA;AP2B1;CTSL;DCTN6;KIF18A
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.622861258460443,0.9990576017444507,0.5531914893617021,0.7644140982172997,1.0,3/5,17.28%,WNT5A;PTPN11;CHD7
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.5055985128625748,0.9988922882455864,0.3958333333333333,0.7643943545618558,1.0,4/16,13.09%,SRC;BCL2;ZNF304;PDK4
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.6364258010753319,0.9987987417791672,0.5,0.7642445767733074,1.0,1/5,13.71%,RAB3A
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.4723354990880315,-0.9986933571672351,0.41379310344827586,0.9373868111889219,1.0,11/44,12.80%,FTH1;ATP6V1F;ATP6V1G1;ATP6V1G2;TF;MCOLN1;MELTF;TTYH1;ATP6V1E2;ATP6AP1;ATP6V0E1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.4790880686212511,-0.9986819854675809,0.4117647058823529,0.9366425295542005,1.0,2/35,1.92%,TNFRSF8;CNN2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.6512481459274293,-0.9986442061686897,0.5192307692307693,0.9359806266247364,1.0,1/6,1.71%,SFRP1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.5071670041554701,-0.9983487961039029,0.45454545454545453,0.9360699715011459,1.0,8/25,20.11%,RPS2;FEM1A;SMAD7;UBE2L3;PARK7;UBE2N;PINK1;BMI1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.4626113770601662,-0.9982635270505018,0.5490196078431373,0.9356324535685379,1.0,3/38,4.38%,CDKN1C;BUB1;BTG3
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.4441689312970433,0.9981947041647122,0.44,0.765233889018345,1.0,5/41,10.57%,TM4SF20;TBC1D10A;F2;PLK1;RNF139
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.5372177191893204,-0.9980393048226993,0.46153846153846156,0.9353913186687716,1.0,2/16,5.73%,GREM1;EPHB4
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.6300207528672968,-0.997514057989558,0.5370370370370371,0.9359798189254918,1.0,2/8,4.77%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.47210486819014474,-0.9965922556349224,0.4915254237288136,0.9376653878788515,1.0,15/40,27.75%,RNF8;CHD4;SMARCA5;ACTR8;DMAP1;RBBP4;NASP;ACTR5;ZNHIT1;SMARCB1;SMARCA4;ACTB;HDAC1;MTA2;VPS72
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.6359062401360671,0.9964174707605353,0.5909090909090909,0.7684308056816265,1.0,1/7,2.19%,ADCY8
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.47864618921948454,0.9962627177353299,0.3902439024390244,0.7683471831842106,1.0,3/27,4.85%,KANK2;MYO16;DACT1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4642474840056727,0.9960788089351515,0.5238095238095238,0.768300728821238,1.0,3/30,4.85%,KANK2;MYO16;DACT1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.6656036787938797,0.9959302957550948,0.5238095238095238,0.7682234375549085,1.0,3/5,20.89%,DMTN;ANK3;JAK1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.6816075170064848,0.9957959033053358,0.5,0.768096835894124,1.0,3/5,29.47%,IL12RB1;IL1R1;IL18
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.4943031508985938,0.9955341160086917,0.49122807017543857,0.7681863370375399,1.0,9/25,18.42%,LRRK2;EPHA4;SIPA1L1;WNT5A;CDK5R1;HOMER1;ARHGAP44;ABHD17C;ABI2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.5911018492819963,0.9952996791167547,0.4909090909090909,0.7683374197006392,1.0,3/6,28.31%,ADARB2;NUDT16;ADARB1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.548220166108203,0.9946996387020999,0.46153846153846156,0.769363666573456,1.0,4/12,19.12%,LYN;PRKCE;LBP;TICAM1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.6002362953664336,0.9946740006541225,0.525,0.7686542574474825,1.0,4/8,20.78%,SLC1A2;MLKL;DISP1;STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.6002362953664336,0.9946740006541225,0.525,0.7686542574474825,1.0,4/8,20.78%,SLC1A2;MLKL;DISP1;STEAP4
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.5305143040782734,0.9943995856955625,0.5,0.7688601780299896,1.0,6/15,19.58%,ABCC9;TRPM2;P2RY1;TRPC3;KCNJ11;VGF
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.4536489003635196,0.9942919349337694,0.44680851063829785,0.7687029477600897,1.0,6/21,8.13%,MYH11;POSTN;SCEL;TP63;TRIM29;MUCL1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4685380038562183,0.9942421633190887,0.484375,0.7684044685236999,1.0,2/23,13.96%,KLHL15;CUL3
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.5463532007632569,0.994121157216837,0.4523809523809524,0.7682845065304374,1.0,1/13,4.97%,PPP3CA
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.39999094182117045,0.9938196017106494,0.3870967741935484,0.7685331868397851,1.0,25/114,13.62%,PLSCR1;MX1;CSF1R;CHI3L1;SHMT2;PID1;KYNU;TIMP4;PTPN6;ISG15;SRC;CIITA;LEF1;XAF1;IRAK3;MAPKAPK3;LIFR;BCL2;DPYSL3;GGT5;TIMP3;PTPN5;PTPN20;PTPN11;BCL2L1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.40468102822308916,0.9936868514665423,0.48,0.768401004548745,1.0,13/72,9.50%,CORIN;CGNL1;NPY1R;KALRN;SORBS2;SORBS1;ADAMTS6;COL12A1;PPARGC1A;SLC7A9;CHRD;F2;MAOB
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.5898599780876764,-0.9934113499686884,0.5,0.9448675447594839,1.0,2/13,6.50%,CBR1;PTGIS
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5019023089852153,-0.9933970150727476,0.42857142857142855,0.9441287515325264,1.0,6/27,20.24%,PTPA;CALM1;PPIA;PTBP1;SMPD1;DLC1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.46898248316100444,0.9933862161271998,0.43902439024390244,0.7686677755414529,1.0,13/32,22.88%,RAB27B;CADPS;CADPS2;RAB15;SYTL4;RAB3A;EXPH5;ATP13A2;TSG101;RAB27A;CLASP1;SDCBP;STXBP5
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5214140744930184,0.9931686492747841,0.4375,0.7687932245719485,1.0,6/18,20.97%,F2;GHR;HES1;CRLF3;ERBB4;CYP1B1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.41855687133151,0.9929433241986249,0.5116279069767442,0.7688756391506595,1.0,6/51,8.70%,KCND2;AQP1;SCN2A;AK4;EPAS1;PICK1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.4318140579151318,-0.9928635852891089,0.4528301886792453,0.9448426704771643,1.0,12/59,13.22%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;GATA1;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.5605981139900984,0.9927357452712677,0.48,0.7689150856887765,1.0,2/9,14.01%,SHMT2;SHMT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.5185343635281169,0.9925005036534195,0.52,0.7691259364808534,1.0,3/16,5.86%,ISG15;SYK;PRKCZ
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.45289124434780537,0.9919597688406043,0.44680851063829785,0.7699057196596808,1.0,5/28,7.75%,TGFB2;KITLG;BASP1;SOX9;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5691075701271349,0.9918655660487601,0.5098039215686274,0.7697977746105182,1.0,3/11,7.07%,CYFIP1;FCHSD2;SCIN
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.6309735606519837,0.9917015888883541,0.5652173913043478,0.7696777131890452,1.0,2/5,29.58%,SNCA;PLAA
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.47432828975849695,-0.9912662747756976,0.4166666666666667,0.9482546806700548,1.0,9/32,17.95%,CRYAB;NUMA1;ANTKMT;CAPN10;DYNC1H1;DNAJC30;GAS1;RINT1;PTPN1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.627416776202003,0.9912512868231014,0.5925925925925926,0.7703215828003019,1.0,1/6,3.86%,MAP2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5714131356306382,0.9912485386525299,0.5365853658536586,0.7699326534202401,1.0,2/12,4.64%,IL12A;SYK
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),0.647135931699903,0.9907134188738906,0.5,0.7706550869025274,1.0,2/5,3.15%,PID1;E2F3
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.40602808243193517,0.9905359552377964,0.41509433962264153,0.770632449456601,1.0,6/61,6.20%,CARD18;PDGFB;LRRK2;MAP2;DACT1;ARRB2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4125878151649583,0.9904264443462358,0.49019607843137253,0.7704512885550797,1.0,10/61,12.07%,NCKAP1L;CYFIP1;BAIAP2;NR4A3;SRC;SYK;WIPF3;PLPP4;LYN;PIK3R1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.39841725363187785,-0.990184193028327,0.47540983606557374,0.950574297589311,1.0,20/104,15.45%,SFRP1;PSMD7;PSMB6;AP2S1;PSME2;PDE6A;PSMD8;PFN1;CALM1;PSMB4;RHOA;PSMD3;PSMB3;PSME1;PSMA7;PSMD13;PSMB8;RAC1;NFATC1;PSMD2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.6184285878275959,0.9900960212450257,0.5,0.7707761837084242,1.0,2/6,14.38%,HES1;VEGFA
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.5333973939622244,0.9900131379237725,0.5306122448979592,0.7704915755583086,1.0,3/12,13.20%,SOCS3;PARP9;PIAS1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.5838204969139382,0.9898382165098729,0.5,0.7705664855193358,1.0,4/8,18.54%,KCNMA1;NOS1;ADRB2;GPER1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5280934813809063,0.9897742562904335,0.5294117647058824,0.7699071199188418,1.0,6/14,19.48%,SRC;DMTN;CORO1C;ITGB1BP1;PHLDB2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5280934813809063,0.9897742562904335,0.5294117647058824,0.7699071199188418,1.0,6/14,19.48%,SRC;DMTN;CORO1C;ITGB1BP1;PHLDB2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6505999789883941,0.9895260661403732,0.5714285714285714,0.7696926603158022,1.0,2/5,21.96%,PHLDB2;CLASP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6505999789883941,0.9895260661403732,0.5714285714285714,0.7696926603158022,1.0,2/5,21.96%,PHLDB2;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5996683377747819,-0.9892882273983771,0.5925925925925926,0.9520522051442531,1.0,5/9,34.12%,GPATCH3;C1QBP;TKFC;RIOK3;NPLOC4
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.5913197132846437,0.9892291096402293,0.5178571428571429,0.7699985633667129,1.0,1/7,2.10%,C1QB
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.4890857721691615,-0.9890990342026552,0.5,0.9517861728362347,1.0,4/29,12.36%,GREM1;CCT2;PNKP;DKC1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4474691163374992,-0.9890362821891207,0.5081967213114754,0.9511725396649872,1.0,10/36,17.24%,GAPDH;SERPINE1;UBXN1;CSTB;SERPINB8;SERPINH1;KNG1;TIMP2;PARK7;ECM1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.43429000360600695,0.9889984176696859,0.37209302325581395,0.7700977754272018,1.0,8/36,9.66%,PTPRC;NCKAP1L;TNFSF13B;MEF2C;SYK;TIRAP;BST1;BCL2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.6248089458653227,-0.9887860905788879,0.5490196078431373,0.9510748321933358,1.0,3/5,20.76%,NOP53;MAF1;FLNA
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.5193296730968083,-0.9887600571840867,0.5185185185185185,0.9503558462010016,1.0,5/13,18.34%,UQCRFS1;ETFRF1;ETFB;NDUFA5;ETFA
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.6026001578538986,0.9882669120807749,0.574468085106383,0.771489132522652,1.0,2/8,4.87%,CBARP;GPR35
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6524024187837544,0.9882569176723073,0.5531914893617021,0.771120572458597,1.0,2/5,20.38%,CAMK2D;CHGA
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.6614113193453177,-0.987976097922855,0.5357142857142857,0.9507893236572671,1.0,1/5,4.99%,USH1C
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.6614113193453177,-0.987976097922855,0.5357142857142857,0.9507893236572671,1.0,1/5,4.99%,USH1C
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5784923414158345,-0.9878064561168839,0.4782608695652174,0.9504855917679588,1.0,1/10,2.82%,AWAT2
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.5982679544059346,0.9877171378986974,0.5882352941176471,0.7718372542931538,1.0,2/7,1.89%,CBLN2;CSF1R
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.6565294163486108,-0.9875867488200647,0.5384615384615384,0.9503088998478111,1.0,3/5,20.43%,DDX21;PRIMPOL;DDX23
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.39459737351013946,0.9874194739112132,0.4418604651162791,0.7719777326316635,1.0,11/67,8.52%,AQP1;TLR2;STAB1;IL12A;ISG15;H2BC11;SYK;ADGRB1;TIRAP;NOD1;IRGM
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.3814227067880402,0.9873131759161974,0.4230769230769231,0.7718456135719738,1.0,18/91,18.90%,PTPRC;LCP2;RELN;TSPYL2;HSPB1;CD4;SPDYA;CAMKK1;UBASH3B;THY1;ITGB1BP1;CDKN1A;GAS6;PRKAG2;WWTR1;CAMK2N2;CAV3;YWHAG
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.6342394483889954,-0.9870849868916522,0.5925925925925926,0.9508645757768381,1.0,2/6,25.95%,GPATCH3;C1QBP
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.45498962874331844,-0.9870460534764622,0.4107142857142857,0.9502090647471894,1.0,3/44,2.97%,ARHGEF16;TEAD3;PTPRU
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.6444878507504533,-0.986584308387079,0.5303030303030303,0.9507971540962402,1.0,2/6,26.34%,MSH3;RMI2
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.6353385752779379,0.9863434090210361,0.5777777777777777,0.7734564519522422,1.0,2/6,6.28%,FAP;PTPRJ
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.48351516105320613,0.986318241848455,0.46,0.7731120222323259,1.0,6/32,7.38%,AQP1;ADCY8;KLF9;SRC;GNG2;ADCY2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.6088781227600892,0.9862829112044694,0.5531914893617021,0.7727618968615262,1.0,2/6,13.34%,NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.5842665491025868,-0.9862351515655362,0.4897959183673469,0.9509527453673128,1.0,5/7,35.64%,GLYATL2;ADO;TST;TXN2;CTH
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.594178540400359,-0.9857774761213637,0.509090909090909,0.9514464235902672,1.0,4/9,11.17%,CYB5A;GSTO2;CYB5R3;RGN
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.552452228196824,-0.9855446347917785,0.5789473684210527,0.9513294696100234,1.0,2/12,4.77%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.4905092955548171,0.9854874434013678,0.5510204081632653,0.7741522972413406,1.0,4/22,12.16%,CAMSAP3;MAP2;MAPT;AEBP1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6171915684655083,-0.985481372434208,0.5348837209302325,0.9507358143204996,1.0,4/6,29.12%,SAT2;AMD1;SRM;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.36296203857668424,0.9853345798369364,0.44,0.7741099983671896,1.0,35/130,20.39%,IGFBP3;PTPRC;PID1;LRRK2;PTPN6;SPRED3;PRKCZ;DMD;HSPB1;SH3GL2;DMTN;FBLN1;CORO1C;UBASH3B;LYN;SAMSN1;THY1;ITGB1BP1;PARD3;NTRK3;DDIT4;PRKAG2;PRKCD;WWTR1;NLRP12;CAMK2N2;SNX25;MLXIPL;CAV3;YWHAG;PTPN13;PTEN;TERF2IP;PAK2;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.5224757644590733,0.9851833378346804,0.5,0.7740737785044061,1.0,1/14,4.57%,SRC
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.6398165197736564,-0.9851344040916212,0.5777777777777777,0.9508512492284545,1.0,4/6,33.88%,PIH1D1;ZNHIT6;NOP58;ZNHIT3
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.4155038428105044,0.9848905262087284,0.46808510638297873,0.7742970175990426,1.0,8/54,9.62%,PIK3AP1;BIRC3;SAMHD1;LRP8;WNT5A;TIRAP;BCL6;BST1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.455550722917193,0.9846737283087006,0.3953488372093023,0.7743572200589764,1.0,11/29,15.32%,AQP1;RIMS2;IRAG1;PDE7A;NUDT4;SOX9;ADCY2;HTR2C;ADCY1;CAP2;PDE9A
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6787262298989101,0.9846700074474949,0.5849056603773585,0.7739773928136828,1.0,4/5,30.98%,SH3GL2;TMEM108;AUTS2;LLPH
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.5824462937080748,0.9842284651844216,0.5306122448979592,0.7747003273447445,1.0,2/10,2.07%,MX1;ZDHHC11
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.3611738554286554,-0.9842259293878987,0.417910447761194,0.9522163361941528,1.0,58/280,19.04%,TEAD2;POLR2L;TEAD3;POLR2G;DRAP1;BTF3;ADRM1;POLR2K;GTF2F1;CSTF2T;DDX5;TFDP1;POLR2I;PHAX;PARP1;ELOC;ELOB;LSM10;NR2C2AP;NFIC;INTS14;POLR2A;SNAPC1;CSTF2;TAF13;IRF9;ABT1;DDX21;TAF7;POLR2E;SNRPB;ELOF1;SNRPE;NELFE;CTR9;SSU72;TAF11;NR5A2;POLR2C;FIP1L1;POLR2D;SNRPG;SNAPC5;HNF4A;NELFCD;SUPT5H;SNAPC3;GTF2H2;CCNT1;TAF9B;RXRB;ATF4;POLR2J;SNAPC2;RTF1;CTDP1;CCNK;EAF2
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.4989202274475696,0.9841260847303261,0.5116279069767442,0.7745856292102227,1.0,3/15,9.81%,MEF2C;BASP1;ZBTB18
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.6343638031299187,0.9840435871956538,0.5185185185185185,0.7744349399924221,1.0,2/5,10.68%,LRRK2;MAPT
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4073482418016563,0.9839167921617081,0.45098039215686275,0.7742844029859529,1.0,6/50,9.03%,PPARG;CSF1R;LEF1;PDE1B;PIR;CD4
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.37792697335009834,0.9838161599134988,0.358974358974359,0.7741159826876987,1.0,18/136,7.95%,PKP2;PPARG;EGFR;HEY1;ADAMTS7;ADGRV1;SPRED3;ID2;DTX1;RUNX1T1;CNTN4;SOX9;NFKBIA;ZBTB16;WNT5A;MEIS2;NOTCH4;CHRD
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5924425931231955,0.9837789829060246,0.5853658536585366,0.7738395753008289,1.0,3/6,18.25%,VEGFA;ADIPOR2;KDR
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.5362724106592371,-0.9836167578910239,0.5370370370370371,0.9530572471629283,1.0,2/14,2.87%,DSCAM;ROBO3
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5741393521464591,-0.9835835491529764,0.48333333333333334,0.9524575040992848,1.0,2/12,2.01%,SFRP1;TNFRSF21
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4930062699687893,-0.9835585806596295,0.425531914893617,0.951779549094501,1.0,4/18,20.53%,BACE2;NCSTN;BACE1;RBMX
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.4152469506017488,0.9833903719739286,0.47619047619047616,0.7742721186113694,1.0,10/39,14.38%,NCKAP1L;IKZF1;ID2;TAL1;DMTN;ALAS1;LYN;DYRK3;HCLS1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.44980577777114583,-0.9833168319186566,0.47368421052631576,0.9516102457472756,1.0,7/41,10.96%,RBM22;BUD23;DDX5;RIOK2;TRMT112;POLR2A;HRAS
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.5859238200466305,0.9831923662553926,0.46,0.7742600285192334,1.0,2/12,8.74%,IRS1;ABCD2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.45419533746002116,-0.9830540922559985,0.4915254237288136,0.9515861173774393,1.0,6/26,18.42%,NDC80;NUMA1;DYNLT1;SAPCD2;DCTN1;PKHD1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.581024989237914,0.9830262549223837,0.5434782608695652,0.774337945256003,1.0,5/9,19.68%,ADGRE2;SYK;LYN;FES;FER
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.35113428272411695,-0.9828491701828113,0.4117647058823529,0.951351421707991,1.0,40/316,15.50%,DDIT3;RAD23A;RNF8;ANAPC15;PSMD7;PSMB6;UBXN1;PSME2;ADRM1;PSMD8;UBE2D4;HECTD3;ELOC;CDC26;RNF167;CDC23;PSMB4;VPS28;UBQLN2;PSMD3;PSMB3;PSME1;PPP1R11;ZFAND2A;SPSB3;ZFAND2B;KLHL20;PSMA7;MYLIP;PSMD13;PSMB8;KAT5;SQSTM1;ERCC8;RNF6;KEAP1;FEM1A;RNF126;PSMD2;UBE2A
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4104734683276231,0.9822429246353851,0.5675675675675675,0.775537151877268,1.0,15/88,19.90%,NEDD4L;UHRF1;DACT1;MAP2K5;NFKBIA;WNT5A;WWP1;PLA2G10;APC2;HECW1;TIPARP;CD80;TRIM32;TFR2;CSNK2A1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.587231505663843,0.9822075687040805,0.5,0.7752247631706537,1.0,3/8,17.36%,NCKAP1L;CBFB;TNFSF4
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.45538249335270237,0.9821146223753683,0.38095238095238093,0.7751103781878015,1.0,10/40,22.58%,SRGN;HOOK1;DNM1;ALS2CL;SNX33;SAR1A;SNX10;SORT1;WASL;ARFGEF2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.45043463209590556,0.9818131131898983,0.5166666666666667,0.775325424985916,1.0,5/30,13.71%,NR4A3;RAB34;SYTL4;HPS6;RAB3A
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4712008184043629,-0.9817125299652331,0.45454545454545453,0.9535502952861794,1.0,8/27,19.62%,NDC80;NUMA1;DYNLT1;SAPCD2;LLGL1;DCTN1;PKHD1;MAP4
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.46641139815006166,-0.9815417873207443,0.4375,0.9532289930685723,1.0,7/34,20.57%,TSN;BLM;HMGB1;EXO1;MSH3;ENDOG;THAP9
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.42677249706900966,0.9815208640310796,0.4444444444444444,0.7754205642829312,1.0,7/50,14.24%,LPL;ACSM1;PLA2G10;GRAMD1B;SOAT1;SCARB1;ABCA1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.4899110336300173,0.9814424006897693,0.5,0.7751626958010968,1.0,7/19,15.36%,KCNT2;SLC4A4;KCNIP2;ATP1B2;SLC40A1;ATP1B3;KCNH2
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.5884840313404603,0.9813868692799395,0.5454545454545454,0.7749230219036011,1.0,2/7,3.26%,AQP1;NEDD4L
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.429942608632381,-0.9810191176675571,0.45454545454545453,0.9538208459324884,1.0,26/94,22.85%,ORC1;KIN;GRWD1;POLD4;MCM4;PNKP;HUS1;MCM3;BLM;POLG;KAT5;TOPBP1;POLE3;RFC1;ATR;DUT;RAD9B;EXO1;SET;ORC6;WDHD1;ATRIP;FAM111A;MCMBP;MCM6;CLSPN
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5410443052824445,0.9810086087588296,0.44642857142857145,0.7752930956724936,1.0,4/11,19.15%,IRGM;FYCO1;ADRB2;CALCOCO2
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.5285285320624382,-0.9809605630660453,0.5636363636363636,0.9531980496222404,1.0,5/16,9.46%,SEPHS2;GLYAT;DAO;SARS1;THNSL2
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.670373698288399,-0.9808591595749475,0.5957446808510638,0.9526876795197886,1.0,1/5,2.82%,AWAT2
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.4674402178918774,-0.9808509185548746,0.4,0.951191562655935,1.0,12/33,28.37%,RAN;RAE1;NOL6;NUP37;SSB;TPR;NUP210;POM121C;NUP93;NUP42;NUP58;NUP85
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4674402178918774,-0.9808509185548746,0.4,0.951191562655935,1.0,12/33,28.37%,RAN;RAE1;NOL6;NUP37;SSB;TPR;NUP210;POM121C;NUP93;NUP42;NUP58;NUP85
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.37428377179715544,0.9806119388091603,0.425,0.7757523867070109,1.0,30/91,19.68%,CX3CR1;IL12A;MEF2C;TNFRSF1B;AXL;LILRB1;ZFP36;IRAK3;MAPKAPK3;WNT5A;GIT1;TIRAP;IRGM;NOS1;VIM;ERBIN;GGT5;SCARB1;RPS6KA3;NLRP3;NOS2;NOCT;LBP;CD80;TNFSF4;NLRP7;TICAM1;LDOC1;LY96;FER
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.5768668671744599,0.9804642318202437,0.4634146341463415,0.7756978342996673,1.0,1/9,4.89%,ID2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.5496579321648488,0.979907471704917,0.5576923076923077,0.7764070586657709,1.0,4/13,10.51%,IGF1;SORBS1;IRS1;DYRK2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.572784784797713,0.9792918799287954,0.5094339622641509,0.7772288809753797,1.0,2/9,15.55%,PLA2G4A;CHPT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.40696003069978653,-0.9791938647041164,0.5396825396825397,0.9547714387262047,1.0,21/79,24.65%,KIF3B;AP2S1;DYNLL1;DCTN3;DYNC1H1;AP1B1;SAR1B;HLA-DRA;KIF11;DYNC1I2;DCTN1;KIF4A;HLA-DPA1;AP2A1;DCTN2;AP1S1;CLTA;AP2B1;CTSL;DCTN6;KIF18A
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.440075342134869,-0.9788650549731832,0.4827586206896552,0.9548691721111048,1.0,6/38,11.96%,ABCA13;SERPINE1;TF;VPS28;RAB31;B2M
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.5501676959269636,-0.9786020225774049,0.5319148936170213,0.9546925067194079,1.0,1/9,5.90%,ABHD17A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5455085032711975,0.9785559028956452,0.5416666666666666,0.7785028867299479,1.0,7/13,23.69%,FAP;AEBP1;LRP1;RIC1;TIE1;DDR2;ANGPTL7
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.5625287024998118,0.9785120799958504,0.58,0.7782266354318899,1.0,4/12,10.51%,IGF1;SORBS1;IRS1;DYRK2
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.36827787672835927,-0.9783901213395447,0.5217391304347826,0.9545095945943066,1.0,64/308,21.33%,DDIT3;RPS3;PARP2;RNF8;ZDHHC16;CGAS;KIN;H2AX;MBD4;ENDOV;MGMT;PARP1;MUS81;MACROD2;RAD51AP1;USP16;OTUB1;ALKBH7;APEX1;NOP53;BAK1;RFWD3;PNKP;BAX;HUS1;NPM1;BTG2;CDKN2AIP;BLM;UFL1;NUDT1;ERCC8;TOPBP1;POLE3;UBE2A;CBX5;MEN1;REXO4;CHCHD6;PARK7;ADPRS;BCL2A1;PLK3;TRIM28;ATR;DDX11;RAD9B;PARP3;EXO1;CCNK;CASP9;MSH3;NSMCE4A;IKBKG;SMC1A;PRKDC;PAXX;FANCF;CHRNA4;OGG1;XPC;WDHD1;ATRIP;FAM111A
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.5607138210619184,0.9783549254726307,0.5116279069767442,0.7778297045956226,1.0,3/13,11.51%,SLC8A1;TRPM2;TRPV4
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.5607138210619184,0.9783549254726307,0.5116279069767442,0.7778297045956226,1.0,3/13,11.51%,SLC8A1;TRPM2;TRPV4
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.5274924891297946,-0.978295803557443,0.5,0.9540596751020712,1.0,4/13,22.65%,EXOG;HMGB1;ENDOG;DICER1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.4650600618156034,-0.9782325955148725,0.4883720930232558,0.9534801765874779,1.0,5/27,16.05%,RAD23A;PPIE;PPIA;NR5A2;FKBP6
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.3592521958358066,0.9780004322142251,0.4782608695652174,0.778262098475336,1.0,20/99,9.12%,PLAC8;CX3CR1;SLA;FGL2;PTPRC;VCAN;NR4A3;SEPTIN6;LCP2;TNFRSF1B;ITGAM;CD53;AXL;LILRB1;WDFY4;BTLA;LY86;ETV6;LAPTM5;CAMK2D
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.6379095067281451,-0.9779854658127486,0.6140350877192983,0.9533181731631826,1.0,1/8,6.06%,GLYATL1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.47761174593849554,-0.9779501499961303,0.4727272727272727,0.9526686194499682,1.0,6/22,18.42%,NDC80;NUMA1;DYNLT1;SAPCD2;DCTN1;PKHD1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.4318490495804928,0.9779444688232538,0.4583333333333333,0.7779865190661681,1.0,8/52,10.94%,LRRK2;HGF;MET;RASIP1;BCL2;LZTS1;DAPL1;WDR6
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.5084698667024757,-0.9778237024932791,0.5272727272727272,0.9523125363810235,1.0,3/10,11.05%,NT5C;DNPH1;ITPA
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.4267479259869326,0.9777729390916581,0.4339622641509434,0.7779489250991167,1.0,7/51,14.24%,LPL;ACSM1;PLA2G10;GRAMD1B;SOAT1;SCARB1;ABCA1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.41918226461947006,0.9777690357281721,0.4888888888888889,0.7775609206476957,1.0,4/50,8.17%,LPL;ACSM1;OSBPL3;ELOVL4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5163505302519233,-0.977682147687087,0.49122807017543857,0.9518725901527538,1.0,3/22,9.91%,TINF2;PARP1;PINX1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.6307370601044213,0.9771949554631648,0.5357142857142857,0.7783784806129533,1.0,3/7,6.98%,PTPRC;MAP2K5;IRAK3
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5936233808589741,0.9770851483450718,0.5531914893617021,0.7782992104020542,1.0,4/12,15.73%,PTPRC;FBLN1;ZFP36L1;GJA1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.6266915917277274,0.9769318920259722,0.5909090909090909,0.7781547790018851,1.0,1/7,4.57%,SRC
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.5780798967133955,0.9769052133408755,0.5471698113207547,0.7778622921367141,1.0,3/9,10.90%,RTN4RL2;GAP43;NREP
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.6500651023792166,0.9767986269611798,0.5333333333333333,0.7777063717801801,1.0,1/5,14.04%,ACSL5
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.4607170293743287,0.9767902021164564,0.5217391304347826,0.7773433338860668,1.0,4/30,11.41%,CYFIP1;SH3GL2;FLRT1;SEMA5B
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4315574093884156,0.9764816785675281,0.41818181818181815,0.777667276066814,1.0,11/40,12.43%,CORIN;RYR3;SLC8A1;ITPR1;ABCC9;ATP2B3;ATP2B2;NOS1;TMEM65;ATP1B2;DMPK
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4925871906444334,0.9763927940608589,0.4528301886792453,0.7773992773373182,1.0,4/15,20.00%,DDAH1;CLEC7A;EDN1;PKD2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.4583627588469335,0.9762814566859268,0.47619047619047616,0.7772320700457624,1.0,3/29,4.77%,EGFR;NOSTRIN;DDAH1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.4229314691574404,0.9762642701033776,0.47368421052631576,0.776869988207883,1.0,11/42,17.33%,RYR3;SHMT2;HCN1;SAMHD1;TRPM2;ACACB;PKD2L1;SHMT1;CBR4;TDO2;SYCP1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.41513254859789595,0.9762433104743198,0.42857142857142855,0.7765259877384132,1.0,5/50,5.78%,PPARG;SLC4A10;NEDD4L;SLC4A4;ABCB4
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5515167564804675,0.9755772785597999,0.5217391304347826,0.7777588186419662,1.0,3/10,12.70%,STAT6;LYN;GHR
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.5121383627479792,0.9754079576369454,0.5686274509803921,0.7777215983200897,1.0,5/13,10.72%,ST8SIA3;B4GALT6;ST8SIA4;ST8SIA6;ST6GALNAC5
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.6013146553434406,0.9753843943441856,0.5294117647058824,0.7773835858065267,1.0,1/6,6.09%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.5129733159156095,0.9753817751412163,0.46551724137931033,0.7770046381361669,1.0,1/15,2.58%,CARMIL2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.5512490363417419,-0.975254413344059,0.48,0.9572992074125696,1.0,2/14,8.50%,SPHK2;DHFR
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.4318416968955954,-0.9748382256546508,0.48148148148148145,0.9576665191378992,1.0,3/52,0.31%,P2RY10;CXCR4;TNFRSF8
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.611280971678688,0.9748252996138767,0.6153846153846154,0.7778222981383925,1.0,2/5,19.82%,IRGM;ULK1
prerank,MSigDB_Hallmark_2020__Complement,0.37296056471913674,0.9745383363347616,0.43243243243243246,0.7780501636361856,1.0,31/151,13.53%,CD59;PDGFB;PLSCR1;F3;KYNU;PIM1;ZEB1;LCP2;SRC;MAFF;ITGAM;CASP10;KCNIP2;GNG2;PCLO;NOTCH4;CASP7;F2;L3MBTL4;XPNPEP1;CR1;C3;DYRK2;CDK5R1;OLR1;LYN;KCNIP3;PLA2G4A;CTSO;CDH13;DUSP6
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.6794064247342225,-0.9745347033043802,0.5689655172413793,0.9568587029000759,1.0,1/5,4.08%,CRHBP
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.6794064247342225,-0.9745347033043802,0.5689655172413793,0.9568587029000759,1.0,1/5,4.08%,CRHBP
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.3709217212991083,0.9744246028239751,0.4186046511627907,0.7778186220741652,1.0,20/99,16.55%,L1CAM;PPARG;AQP1;SLC23A1;SLC35F1;SLC2A5;COL20A1;GIPC2;VIL1;NR1I3;SLC40A1;SLC11A2;RGMB;DAB1;ACSL5;LGALS2;DGAT1;ASPN;GFRA2;FERMT1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.5156455249581973,0.9742821216058772,0.5660377358490566,0.7777344102429323,1.0,6/15,11.97%,P2RY12;RTN4RL2;GAP43;NREP;SARM1;DPYSL3
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.4132111503536921,-0.9741701856756487,0.46938775510204084,0.9570379105527681,1.0,7/83,6.80%,RPS27A;UBC;FAM89B;UBB;GREM1;BAMBI;IL17RD
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.53272154421592,-0.9739680398296338,0.5254237288135594,0.9567902459237208,1.0,2/14,3.31%,WNT9A;HOXD3
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.5801793149694139,-0.9738904334974249,0.46296296296296297,0.9562587926562504,1.0,3/10,15.36%,CARNS1;RGN;FADS1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.5635494912950726,-0.9736602006002917,0.5294117647058824,0.9559863051224292,1.0,1/13,1.53%,TINF2
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5213650266473053,-0.9734731384192641,0.5098039215686274,0.9557916226260199,1.0,4/17,16.97%,SUN3;TOR1A;REEP4;EMD
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.5297617961973109,0.9733543069707928,0.48148148148148145,0.7791617324291383,1.0,5/13,10.38%,CX3CR1;SELL;ADD2;JAM2;SELPLG
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5554735679986561,0.9732285763735923,0.4716981132075472,0.779029914961119,1.0,1/11,0.07%,CREB3L1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.4086448874657002,0.9732060028860461,0.5454545454545454,0.7786690897276496,1.0,6/59,8.17%,LPL;PAM;OLAH;LSS;ACSM1;ELOVL4
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5236148319685139,-0.973197451712593,0.48148148148148145,0.955790546212838,1.0,3/17,10.23%,STMN1;APLP1;YWHAB
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.48591414127478477,0.9731855829334309,0.4222222222222222,0.7783262376329894,1.0,5/26,6.98%,VSIR;IGF1;PTPN6;LILRB1;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.6017751335407675,0.9731749418642626,0.5769230769230769,0.7779719844150322,1.0,3/8,13.97%,EPHA4;LYN;EFNA3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.45968529723564977,-0.9730919274299569,0.4444444444444444,0.9554289176779434,1.0,6/32,20.49%,GAPDH;PGAM1;GCK;NEU4;ENOSF1;PFKL
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.6069979469157597,0.9726900828701606,0.5576923076923077,0.7785684768909311,1.0,1/8,3.86%,MAP2
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.4112000531797463,-0.9725147256500817,0.4339622641509434,0.9561937069724481,1.0,15/67,18.83%,ATP6V1F;ATP6V1G1;ATP6V1G2;LAMTOR4;RRAGA;ATP6V1E2;SLC38A9;CASTOR2;ATP6V0E1;MIOS;LAMTOR2;DAP;EIF2AK3;ATF4;LAMTOR5
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.694018361708554,0.9724297518027205,0.6326530612244898,0.7787128726438957,1.0,1/5,4.63%,LZTFL1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.5049233462645559,0.9722949288772456,0.5128205128205128,0.778569943552468,1.0,2/17,4.05%,PKP2;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.3522456471129199,0.9721923757745623,0.6046511627906976,0.7783217112677056,1.0,31/148,16.75%,PDGFB;PLCB1;NRXN1;BMPR1B;RELN;SRC;GRIP1;BASP1;PACSIN1;CAMK2B;SOX9;LRP8;DLX1;ZBTB16;WNT5A;CORO1C;SOX5;BMPR2;VIL1;DLG4;CPEB3;TMEM79;SHANK1;RPS6KA3;ZDHHC6;VEGFA;GJA1;NLGN1;MAD2L2;PHLDB2;ARHGEF7
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.5984606199112982,0.972192284189963,0.5348837209302325,0.7775567759249363,1.0,3/9,12.21%,ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.5984606199112982,0.972192284189963,0.5348837209302325,0.7775567759249363,1.0,3/9,12.21%,ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.45542382854578234,-0.9721895072340953,0.5,0.9562308925259072,1.0,7/29,14.79%,FUCA1;DCXR;PMM1;APOD;GALT;GALK1;SLC37A4
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4192910678757066,0.9721439569415802,0.5531914893617021,0.7772567628147148,1.0,14/58,16.53%,RPS6KA6;HEY1;GRIN3A;KIAA0319;SOX9;NOTCH4;HOPX;MAPT;ALPK2;KANK1;THY1;BCL11A;SPI1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.6375783297070329,0.9721275629674266,0.56,0.7768985794096601,1.0,1/6,3.49%,EPHA4
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5545468117218615,-0.9719481220116496,0.532258064516129,0.9560881622202612,1.0,2/14,4.08%,SFRP1;CRHBP
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5770135920643868,0.9717793683206293,0.47058823529411764,0.7773004177343186,1.0,2/8,5.58%,CYFIP1;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.5784919534089009,0.9717670767760141,0.5952380952380952,0.776930882749338,1.0,1/8,4.64%,SYK
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6069911945763249,0.9717487379350702,0.5102040816326531,0.7765967373820278,1.0,3/7,19.29%,IRAK3;UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.583894826402735,0.9717280309214466,0.43478260869565216,0.7762337443088563,1.0,3/9,6.73%,GRIP2;GRIP1;STX3
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.584853562386745,-0.9717273649610654,0.4528301886792453,0.955798026207053,1.0,1/5,19.19%,MGLL
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.38752420068321675,0.9713220248704528,0.5178571428571429,0.7766467854078346,1.0,24/92,15.49%,PDGFB;ROBO2;CSF1R;PID1;LRRK2;BMPR1B;PTPN6;TWF2;MAP2K5;LEF1;NOS1;BMPR2;ACVR1C;DPYSL3;GHR;PTPN5;PTPN20;PTPN11;NCOA1;SLC1A1;HCLS1;UCP1;ACVR2A;PTPN4
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.40078868082599123,0.9713212345622378,0.4716981132075472,0.7762666352436605,1.0,12/60,13.03%,CSF1R;PLCB1;ABHD3;PLAAT1;PIGP;GDPD3;GPLD1;PLA2G10;IP6K3;PLA2G4A;PLCB3;GDPD1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.4593717507225016,-0.971192397483239,0.47368421052631576,0.9562972092663806,1.0,2/32,2.97%,LCK;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4994252953427517,0.9711415546287948,0.43859649122807015,0.7762597507193207,1.0,9/21,26.78%,CCP110;KANK1;ARHGAP44;PRKCD;LIMK2;YAP1;SRGAP2C;CEP97;ARHGAP24
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.5400798147694681,0.9710226590435062,0.5660377358490566,0.7761305770232338,1.0,1/10,11.68%,CPEB3
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.48736276333343154,0.9709487661998525,0.5,0.7759840672921293,1.0,2/17,2.03%,KASH5;SGO1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.5272585063274514,0.9709164727974081,0.425,0.775680616742321,1.0,5/13,26.74%,REEP1;ATL2;TMEM33;RAB18;REEP2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.5868300785980343,-0.9709071266910103,0.543859649122807,0.9563406086662997,1.0,1/8,6.52%,NUMA1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.626454720221876,0.9706736928756312,0.5660377358490566,0.7757728882312387,1.0,3/7,29.47%,RFTN1;PRKCQ;IL18
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.38920704288129987,0.9706636682368383,0.55,0.7754291512189626,1.0,23/85,15.38%,PDGFB;BMP6;EGFR;IGF1;F3;NR4A3;LAMC1;SOX9;WNT5A;PTPRN;VEGFD;ARNT;BMPR2;TGFA;PRKD1;AKT3;ZNF304;VASH2;CDH3;CDH13;VEGFA;FGF9;LAMB1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.5602923208896847,-0.9704677544560668,0.5319148936170213,0.9567105290234307,1.0,2/7,4.85%,AK8;CMPK1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4928781048240618,0.9704081714963665,0.5714285714285714,0.7756957376702867,1.0,6/20,14.38%,CX3CR1;TOX;FZD3;CX3CL1;FZD9;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.5556963913835383,0.9703678983753148,0.5454545454545454,0.7754104392447395,1.0,3/11,21.08%,TRPC6;RXRA;SGK1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.4848340375486134,-0.9703280497782318,0.5,0.9562928329977168,1.0,5/42,6.89%,OOEP;CGAS;USP51;PARP1;RAD51AP1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.4817577257111712,-0.9702109556060607,0.5,0.9558885682072872,1.0,5/32,8.80%,DDIT3;HYAL2;RACK1;NOP53;OTUD3
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5226870163125478,0.9699690705744001,0.48717948717948717,0.7758450836871842,1.0,4/13,9.30%,CYB561;ENOX2;PPARGC1A;PDIA5
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.4599144024252275,0.9699077337233896,0.56,0.7755715922924182,1.0,8/29,12.07%,CYFIP1;CARMIL2;TWF2;CARMIL1;SRC;CORO1C;VIL1;PIK3R1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.6378374478323225,-0.9696444584056111,0.631578947368421,0.9564113157357425,1.0,3/5,18.33%,PARP1;MGME1;PRIMPOL
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4736143411997997,0.9692164506640822,0.5094339622641509,0.7768928439330335,1.0,3/19,10.09%,FMO5;ACADL;GNB3
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.6493686607503777,0.9691163425285568,0.6444444444444445,0.7766944474357752,1.0,3/6,20.53%,UNC80;SLC7A8;ATP13A2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.543877275672954,-0.9688814946528402,0.4666666666666667,0.9574439775402129,1.0,4/16,21.07%,ELOVL1;HSD17B12;ACSF3;ELOVL2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.41497992116037874,-0.96880297494779,0.5098039215686274,0.9568802832786013,1.0,2/46,2.35%,NGF;UBB
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.36399947983430486,-0.9686236505086491,0.543859649122807,0.956610666950555,1.0,21/115,18.06%,DAD1;DPM3;B3GALT4;B3GALT9;PMM1;C1GALT1C1;MOGS;B4GALT7;NPC1;DDOST;GALNT1;ST3GAL1;GOLGA2;DPAGT1;MAGT1;B3GNT9;ALG5;MGAT4B;GALNT10;ALG3;ALG12
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.5515818823205112,0.9684929583589791,0.5116279069767442,0.777591018312269,1.0,2/10,6.29%,ARRB2;LILRB1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.574492345372476,0.9682670361223349,0.5333333333333333,0.7776935366356006,1.0,4/10,14.87%,SLC8A1;NEDD4L;ATP1B2;ATP1B3
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.42691036952386696,0.9679476602632612,0.5625,0.7779869206483292,1.0,6/37,9.57%,LPL;GPC6;BCO1;LRP8;GPC5;AGRN
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.41167206657939326,-0.9673229392882557,0.4230769230769231,0.9593541352934225,1.0,15/66,18.83%,ATP6V1F;ATP6V1G1;ATP6V1G2;LAMTOR4;RRAGA;ATP6V1E2;SLC38A9;CASTOR2;ATP6V0E1;MIOS;LAMTOR2;DAP;EIF2AK3;ATF4;LAMTOR5
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.5810104008812592,0.9673143441218418,0.5777777777777777,0.7789278296246748,1.0,1/11,3.12%,PID1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.5950930241316361,0.9668064340935724,0.52,0.7797117324392236,1.0,2/7,8.70%,WNT5A;PICK1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.590677545905644,-0.9667859276491491,0.5510204081632653,0.9601204323207556,1.0,2/6,19.62%,WRAP73;MAP4
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),0.6133501579893391,0.9667021985834064,0.5555555555555556,0.7795414378094448,1.0,1/5,8.43%,LAPTM5
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.599379835785112,-0.9663880280711594,0.6122448979591837,0.9603449956114615,1.0,1/6,2.32%,KIF3B
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.4380730032022083,-0.9663668056269996,0.4883720930232558,0.9596287264930917,1.0,12/44,18.25%,SQLE;SOAT2;FDXR;LIPA;SC5D;CYP4V2;MSMO1;CYP7B1;PIP4P1;PMVK;TM7SF2;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.6122869693165497,-0.966212884289754,0.6166666666666667,0.9593453391528639,1.0,2/7,23.87%,VPS11;MSN
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.4582682224258714,0.9657826791371208,0.5111111111111111,0.7812021742425592,1.0,3/25,4.23%,EGFR;SSTR1;WNT8B
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5278695567074771,0.9656774388737644,0.5,0.7810601862564323,1.0,3/13,8.27%,RYR3;SLC8A1;CASP7
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.48540581839530395,0.9655898758532057,0.46153846153846156,0.7808894858272698,1.0,4/16,20.00%,DDAH1;CLEC7A;EDN1;PKD2
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),-0.6111811493166146,-0.9654998200411785,0.5957446808510638,0.9604963405564292,1.0,3/5,13.94%,FOLH1B;AGBL1;FOLH1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.5725564730336953,0.9653244556559639,0.58,0.7810419145675573,1.0,4/8,14.01%,CBS;SHMT2;GLDC;SHMT1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.6353879648780768,-0.9650504445898714,0.543859649122807,0.961017914615091,1.0,3/6,17.95%,BAK1;BAX;PTPN1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.46127421374703675,-0.964985293349897,0.45901639344262296,0.9604363591200892,1.0,5/34,12.16%,H1-4;H1-2;BANF1;KMT5A;PHF13
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.3582600171275917,0.9648325237161459,0.5142857142857142,0.7816726426069371,1.0,37/169,10.48%,SHISA6;ITGB4;HTR5A;GRM5;ADCY8;SYNPR;C1QL2;RAPGEF4;NRXN1;ST8SIA3;GFAP;SORBS1;SLC1A2;EFNB3;MPPED1;RGS7BP;ADCYAP1R1;NTRK2;TNR;OPCML;CA10;PRKCZ;ASTN1;SNCB;CDH22;EPHB1;CADM3;MAPK4;ARRDC2;ATP2B2;IGSF21;PHYHIP;PTPRT;IL33;GABRG1;SPARCL1;NCAN
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5542559441917931,0.9647406572917798,0.4888888888888889,0.7814615622083406,1.0,4/7,32.53%,SLC27A2;ALDH3A2;PHYH;HACL1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.39248315198496553,0.9647222007467459,0.5365853658536586,0.7811527855825894,1.0,15/55,21.61%,E2F3;CDKN3;CCND1;CDKN2A;SPDYA;CDC7;CUL3;DBF4;RCC1;CRLF3;CDKN1A;CUL4A;E2F1;CDK6;POLE
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5773994403877838,-0.9644470020856969,0.5740740740740741,0.9610521394857078,1.0,2/10,12.67%,CD81;SAR1B
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.3705554664429384,0.9644275262832335,0.5454545454545454,0.7813853772367474,1.0,38/162,18.82%,EGFR;ANGPT1;CSF1R;LRRK2;HGF;NTRK2;EFNA5;SOX9;VEGFD;F2;KNDC1;CCND1;IRGM;CD4;C3;P2RY1;CSNK1D;LYN;FGF17;TNIK;VEGFA;NSMF;FGF9;ACVR2A;NTRK3;NNMT;FGF22;GAS6;RAMP1;LEPR;SPPL3;PRKCD;PROM2;KDR;TRABD2A;GPER1;IL34;LIMK2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.44332228379351496,0.9641485913064972,0.4888888888888889,0.7815832244786416,1.0,2/36,2.19%,LPL;ADCY8
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4100643774179106,0.963539867666301,0.48,0.7824191864872908,1.0,6/68,6.20%,TGFB2;CLDN5;FOS;SRC;PRKCZ;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.670557081031912,0.9633806336812988,0.6153846153846154,0.7823519483426045,1.0,4/7,18.54%,LRFN5;CD200;HAVCR2;GPER1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.42481742192988425,-0.9632060745110002,0.5084745762711864,0.9637227983064652,1.0,12/64,13.22%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.6203352602579,-0.9631829162787414,0.5272727272727272,0.9630583414398252,1.0,3/8,19.62%,METAP2;NAA20;METAP1D
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.6349216146359647,0.9631164580661292,0.6274509803921569,0.7824973384026619,1.0,1/5,5.88%,MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5209329412398255,0.9631101051666747,0.5681818181818182,0.7821372759805965,1.0,2/11,17.91%,CDK12;CDK13
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.5097816799274549,0.9630473763521046,0.5405405405405406,0.7815214515337509,1.0,7/11,31.67%,IRS1;JAK1;STAT3;STAT5B;STAT5A;IRS2;BRWD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.5097816799274549,0.9630473763521046,0.5405405405405406,0.7815214515337509,1.0,7/11,31.67%,IRS1;JAK1;STAT3;STAT5B;STAT5A;IRS2;BRWD1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5114759876268699,-0.9627458056601237,0.5531914893617021,0.9633675542592169,1.0,4/19,11.05%,NT5C;PRPSAP2;DNPH1;ITPA
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.4324959158172918,-0.9626675092039636,0.5208333333333334,0.9628306013250859,1.0,4/43,2.01%,TEAD2;TEAD3;RPL10;NES
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.43507580323467626,-0.9624396267419955,0.4909090909090909,0.9626728462984593,1.0,3/38,3.37%,NGF;DPEP1;BEX3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.41273449746681046,-0.9622414734831677,0.5272727272727272,0.9625468387193807,1.0,17/78,13.62%,GFI1B;PSMD7;PSMB6;PSME2;PSMD8;CDK4;PRMT2;PSMB4;PSMD3;PSMB3;PINX1;PSME1;CDKN2C;PSMA7;PSMD13;PSMB8;BRD7
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5198757463022882,0.9621842575728428,0.5227272727272727,0.782916949693335,1.0,5/16,10.72%,ST8SIA3;HEXB;ST8SIA4;ST8SIA6;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.4548669933766051,-0.9620458628023608,0.49122807017543857,0.9622384152985932,1.0,2/38,4.80%,UXT;TFDP1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.45380529514355084,0.962042056029844,0.43137254901960786,0.782866859547061,1.0,11/32,14.26%,SPOCK1;EFNA5;DMTN;FBLN1;CDKN2A;CORO1C;CX3CL1;PTPRO;ACER2;KANK1;ITGB1BP1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.4455868869606722,-0.9615420263849017,0.5614035087719298,0.962874262687404,1.0,4/35,4.99%,ARHGEF16;EFNA2;DPEP1;USH1C
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.5064891956521684,-0.9612335791299443,0.5185185185185185,0.9629244320213594,1.0,5/15,19.17%,GLA;SMPD2;SGPL1;SMPDL3A;SMPD1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6263979858974611,0.9610378044331885,0.6101694915254238,0.784592613845694,1.0,2/6,22.85%,PARD6A;GSK3B
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.4934177951323999,0.9608911154437386,0.5,0.7845188637712576,1.0,6/16,12.79%,B4GALT6;PICK1;C3;CX3CL1;SRRM4;ACTL6B
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5362754489968996,0.9606858844422873,0.6304347826086957,0.7845024132724793,1.0,4/19,16.28%,TP73;DYRK2;DDIT4;AEN
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.550664808063779,-0.9606668551326091,0.5087719298245614,0.9634896899749633,1.0,3/14,8.47%,GREM1;SERPINE1;CREB3
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.5679778287230915,0.9605913643645851,0.5365853658536586,0.7843143749497864,1.0,3/10,16.54%,F2;PIK3R1;EEF1A2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.6518586346859717,0.9603159285250117,0.6111111111111112,0.7844581249103681,1.0,2/6,5.65%,OXTR;ADRA1A
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.5597932777725619,0.9603054504799751,0.5813953488372093,0.7841274225152274,1.0,1/8,0.97%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.4794390117389725,0.9601720057071004,0.48,0.7840654961938179,1.0,2/26,4.24%,TLR2;ISG15
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.4733662015847174,0.9600633521405485,0.4528301886792453,0.7839122828090193,1.0,9/26,14.75%,ROBO2;SEMA3D;SEMA6A;ROBO1;SEMA5B;SEMA4B;ANGPT2;SEMA4G;SEMA3C
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.42166109850517874,0.9600148769443193,0.5111111111111111,0.7836336750829742,1.0,12/55,13.59%,EPHA3;UTRN;PLEKHA2;CAMSAP3;EFNA5;CDKN2A;CORO1C;BST1;CX3CL1;ACER2;CDH13;THY1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.5712902314088085,0.9599828656060544,0.5714285714285714,0.7833325194875486,1.0,1/8,7.75%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.6825789289905049,0.9597433322375776,0.6052631578947368,0.7835561399312386,1.0,2/5,5.57%,LMO3;CITED2
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.6276840828669363,0.959599955780137,0.5909090909090909,0.7834946350998727,1.0,3/5,16.75%,ALOX12;PTGR1;LTC4S
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.38017234452669807,-0.9590259751220799,0.5423728813559322,0.9666844669083485,1.0,25/178,16.47%,RPS27A;UBC;RNF8;UBB;ANAPC15;ADRM1;UBE2D4;ELOC;CDC26;RNF167;CDC23;UBQLN2;PSMD3;PPP1R11;UBA52;MYLIP;PSMD13;SQSTM1;RNF6;KEAP1;FEM1A;RNF126;UBE2A;UBE2L3;WDR91
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.544333927618579,0.9589769308175574,0.4444444444444444,0.7844583791981994,1.0,5/11,15.45%,BMP6;BCL2;SLC11A2;HAMP;ACO1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.503763210267518,0.9589730318656171,0.5208333333333334,0.7841004774275687,1.0,7/15,24.96%,LRRK2;RNF139;NLRP7;SERPINE2;BAG2;SNX12;CCBE1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.479946667636035,0.958966291426782,0.5818181818181818,0.7837372275976269,1.0,8/18,23.34%,PPARGC1A;NOS1;DIP2B;TADA2A;ARRB1;PAXIP1;RPS6KA4;RUVBL2
prerank,MSigDB_Hallmark_2020__Glycolysis,0.3531141637310872,0.9584360719943862,0.5306122448979592,0.7844833561713036,1.0,16/170,7.14%,PKP2;IGFBP3;EGFR;CHST1;CD44;VCAN;PAM;NDST3;PYGL;MET;MERTK;CITED2;IL13RA1;RRAGD;AK4;SOX9
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.5796796817382045,0.9582983016965632,0.6041666666666666,0.7844442940485944,1.0,3/10,16.53%,AXL;WNT5A;GAS6
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.6446373787813695,0.9579078463116074,0.5686274509803921,0.7850132339936141,1.0,2/5,24.92%,PLA2G10;ABCG5
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.47624257086796185,-0.9572829488976814,0.5,0.9701817911237689,1.0,2/33,3.31%,NGF;HOXD3
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4975961506666964,-0.9572119957822482,0.4883720930232558,0.9696934875438149,1.0,5/18,13.22%,PSMB6;PSMB4;PSMB3;PSMA7;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.46339165135905835,0.9569231684712685,0.574468085106383,0.7866038881124222,1.0,8/25,13.59%,PTPRC;PARP14;PTPN6;PRKCZ;SOCS3;DMTN;SAMSN1;THY1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.3461474379409858,0.9568401531050983,0.5208333333333334,0.786359517197512,1.0,26/193,13.82%,SRGN;ADAMTS9;PCSK4;PCSK2;TRHDE;MMP16;FAP;F3;CAPN1;HGF;ADAMTS7;ADGRV1;LRP8;TASP1;CASP7;THOP1;XPNPEP1;OLR1;TMPRSS11D;CPE;AEBP1;VASH2;GGT5;CTSO;PCSK1;MMP24
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.6106460374136082,-0.9565630430335582,0.5849056603773585,0.9705149985471909,1.0,3/7,17.19%,GOLGA2;GBF1;PLK3
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.4308840677948359,-0.9565391259730706,0.4883720930232558,0.969839416030233,1.0,5/49,8.80%,USE1;ENPEP;BCKDK;SMPD2;NPL
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.3922717213853609,0.9561698420150144,0.6041666666666666,0.7873068756749507,1.0,8/72,10.96%,RNFT1;LRRK2;PRICKLE1;RNF217;RNF144B;PLK1;ARIH2;CSNK1D
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.41363939781503767,0.9559658700887514,0.5555555555555556,0.7873799838497184,1.0,3/29,3.17%,FSTL1;FAP;PRKX
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.4718750976809044,-0.9559050809824412,0.5283018867924528,0.9708534556661517,1.0,1/24,0.23%,ABCA13
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.5357852348536841,-0.9556951214678715,0.5208333333333334,0.9707473292442237,1.0,4/14,10.72%,GAPDH;RPL30;RPS19;H2BC21
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.43401068283002064,-0.9556038478593937,0.5957446808510638,0.9702042351441179,1.0,1/30,0.19%,BMP5
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.5316468984047372,0.9555514260343422,0.58,0.7877761207771686,1.0,1/11,0.76%,RNFT1
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.5996402594605501,-0.955293003532619,0.6140350877192983,0.9702235560807123,1.0,1/6,2.01%,TNFRSF21
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.5572668111362636,0.9546457742815172,0.625,0.7894636593359646,1.0,1/10,8.70%,PICK1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.5329223069388291,0.9543115281330253,0.5,0.7896828756778668,1.0,4/11,26.35%,ID2;IL34;C1QC;CASP8
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.5737016111974885,0.954193415370389,0.5660377358490566,0.7896018872233327,1.0,1/9,1.40%,CHST1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.6016923994599991,0.9539317125754249,0.5641025641025641,0.7898095143757189,1.0,4/8,24.51%,CDK12;CDK13;CCNH;CDK7
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.47532279133298855,-0.9534636304132104,0.5714285714285714,0.9739528476287519,1.0,2/23,0.33%,LCK;CD38
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.5559630859987407,0.9533886683760577,0.5098039215686274,0.7906616068638923,1.0,3/8,19.52%,PKIA;PRKAR1B;PKIG
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.5569317136370326,0.9533799449471104,0.6,0.7902976566866238,1.0,3/5,14.47%,MET;COL15A1;COL22A1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.6300208670387891,-0.9533215471544128,0.673469387755102,0.9735082599661018,1.0,3/7,27.73%,GSN;ASAP1;IL5
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.47882314854197394,-0.9533046144411854,0.5555555555555556,0.9728402055750807,1.0,4/28,9.33%,MYADM;PFN1;LIMA1;TWF1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.41651368949152134,0.9531468207718343,0.5531914893617021,0.7903747182035497,1.0,7/32,7.27%,CX3CR1;GRIK2;NRG3;GRIK1;RELN;CACNA1B;LRP8
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.6271222017531441,0.953113792303993,0.5957446808510638,0.79006771810016,1.0,1/6,10.82%,DUSP10
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.45672812421535147,0.9530181047212604,0.575,0.7898513164171875,1.0,2/23,8.74%,PEX11A;ABCD2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3443371581079643,0.9530111624028117,0.5853658536585366,0.7894884397080174,1.0,36/206,14.31%,BICC1;EGFR;SHISA6;CTNND2;IGFBP4;LRRK2;PRICKLE1;DACT1;PRDM15;SCEL;SOX9;GPC5;WNT5A;AMER1;PLEKHA4;TBL1XR1;TMEM170B;ANKRD6;CSNK1D;FZD6;PTPRO;LYPD6;KANK1;SFRP4;CDH3;RBMS3;TLE3;APC2;WLS;DRAXIN;LRRK1;HECW1;LRP4;FZD9;CUL3;WNK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4951457211068425,-0.9529254543352185,0.54,0.9730005818237532,1.0,1/20,0.28%,LCK
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4031030842233243,-0.9527768233424793,0.5166666666666667,0.9726260892631262,1.0,21/88,23.33%,PARP1;TONSL;MUS81;RAD51AP1;ZSWIM7;MCM4;RFWD3;HUS1;MCM3;BLM;SFR1;REC8;UBE2N;EXD2;SMC6;AP5S1;YY1;MCM6;AP5Z1;GINS4;GINS2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.47281861464309366,-0.952718385617504,0.5192307692307693,0.9720657985849229,1.0,7/24,18.23%,CGAS;NEK6;B2M;HMGA2;RSL1D1;YBX1;ING2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.4573122046692075,0.9526878174015698,0.5510204081632653,0.7897179878945738,1.0,4/30,8.41%,CSF1R;IL12A;ANO6;VEGFD
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.35152480389005714,0.9525423441210529,0.6,0.7896035105776622,1.0,31/171,16.96%,TGFB2;EGFR;OSGIN1;NRG3;LGI1;SPOCK1;TSPYL2;PTPRJ;RERG;CAMK2D;BCL6;CDKN2A;BCL2;BMPR2;KIF14;RPS6KA3;OSGIN2;GNG4;FHL1;APBB2;RPTOR;CHPT1;SMARCA2;GJA1;PAK5;CRLF3;MAD2L2;FRZB;CDKN1A;SESN2;CCN3
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.39931036238356127,0.9519566576794742,0.4883720930232558,0.7904750100812616,1.0,14/58,11.17%,EPSTI1;SLA;PTPRC;SELL;IKZF1;LCP2;CD53;ARHGAP25;LEF1;APBB1IP;CD4;BCL2;SELPLG;ZAP70
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.3673996586708196,0.9517769345021514,0.6222222222222222,0.7904897931147415,1.0,17/137,7.99%,ROR1;CD59;KITLG;PTPRG;FSTL1;PROM1;LRIG3;LAMC1;MYO1B;LEF1;TENM3;ANO6;COL4A1;ADGRL2;TEAD1;LIFR;PAWR
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.589657887320987,-0.9516572748305467,0.56,0.9736478685564567,1.0,2/7,11.65%,RAN;NPM1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.46170661803473323,-0.9516260180978992,0.5185185185185185,0.9729946116353243,1.0,11/35,16.69%,PRELID1;UBB;OPRD1;SOD1;PRDX3;BAK1;BAX;ARL6IP5;BAD;PYCR1;PARK7
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.4945700561216299,-0.9513648648920412,0.5,0.9729001540603112,1.0,1/20,0.70%,TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4684858324867368,0.9510186023823288,0.5490196078431373,0.791138127904683,1.0,9/22,19.94%,TP73;TP63;BCL2;YWHAH;BBC3;NMT1;YWHAG;E2F1;TFDP2
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4684858324867368,0.9510186023823288,0.5490196078431373,0.791138127904683,1.0,9/22,19.94%,TP73;TP63;BCL2;YWHAH;BBC3;NMT1;YWHAG;E2F1;TFDP2
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.5389028721589866,-0.9509221142103923,0.5294117647058824,0.9732517633238342,1.0,5/11,28.58%,RAG2;HMGB1;PRKDC;RAG1;LIG1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.49317596883275816,0.9505133435683435,0.5476190476190477,0.7917373579956474,1.0,1/19,1.20%,TRIM5
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.5291227281222217,-0.9504605169192533,0.5,0.973491449857567,1.0,3/17,9.06%,SELP;ITGAL;ICAM1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.49391318089534936,-0.9504302427690337,0.5,0.9728526249764721,1.0,3/19,13.29%,SMDT1;PHB2;SLC8A3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.44208892132747435,-0.9504081335587072,0.5789473684210527,0.9721900331162769,1.0,5/38,10.39%,OOEP;MGMT;PARP1;RAD51AP1;PNKP
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.5773470518757022,0.950338342223852,0.5581395348837209,0.7912994034326216,1.0,1/7,7.75%,WNT5A
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.5773470518757022,0.950338342223852,0.5581395348837209,0.7912994034326216,1.0,1/7,7.75%,WNT5A
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.4851430025362312,-0.9499444033360116,0.6046511627906976,0.9724978994141573,1.0,1/25,0.69%,PLAAT5
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.3998671891429577,0.949910798593341,0.48717948717948717,0.7917573363723411,1.0,8/66,6.73%,EPHA3;DPP10;EGFR;PID1;SORBS1;STAC2;RHOQ;STX3
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4326527095200978,0.9494604111209857,0.5769230769230769,0.792220450002824,1.0,9/43,8.16%,PTPRC;TLR2;CHI3L1;F3;SYK;MAPKBP1;MAP2K5;TIRAP;NOD1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.43268074242157495,0.9493236945887256,0.47619047619047616,0.7921221621282581,1.0,9/32,15.91%,NCKAP1L;TESC;SCIN;TAL1;ARNT;MAPK11;MTURN;ACVR2A;FES
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.35547986124220293,0.948856688849885,0.5,0.7927977343419836,1.0,16/148,5.48%,CX3CR1;SLA;PPARG;TRIM5;TLR2;MX1;ZDHHC11;SHMT2;KYNU;CLEC5A;ISG15;H2BC11;SRC;TNK2;SYK;CIITA
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.4607225858786387,0.9487839843754081,0.45652173913043476,0.7925983886044424,1.0,5/28,13.24%,PTCHD1;CC2D2A;DYRK2;TTBK2;PKD2L1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.5836499133386468,-0.9486360500090875,0.5714285714285714,0.9748477072847647,1.0,1/10,3.59%,PNRC2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5271198613006287,0.9482220745348868,0.5,0.7933347203842882,1.0,2/10,12.87%,GPLD1;SCARB1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.487616527556822,-0.947982166526635,0.5254237288135594,0.9756525719651008,1.0,4/26,6.08%,PARP2;PARP12;PARP1;ART3
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.5978494402355893,0.9479101966691839,0.6037735849056604,0.7937456118345736,1.0,1/6,6.09%,LEF1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5427963826193217,0.9478546974495721,0.5609756097560976,0.7935293122834427,1.0,4/14,14.87%,SLC8A1;NEDD4L;ATP1B2;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5350432434185761,0.9475103923026363,0.5490196078431373,0.7938670063797428,1.0,2/14,20.66%,LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.45152199695107725,-0.9472657988198666,0.58,0.976807431659562,1.0,9/40,21.72%,PLK4;NUMA1;SAXO1;DYNC1H1;CEP120;CROCC;FUZ;G3BP2;ASAP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.48947238436637963,-0.9466198471556521,0.4838709677419355,0.9769341730302705,1.0,5/18,26.60%,PARP1;GTF2H2;DDB2;GTF2H5;DDB1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.48947238436637963,-0.9466198471556521,0.4838709677419355,0.9769341730302705,1.0,5/18,26.60%,PARP1;GTF2H2;DDB2;GTF2H5;DDB1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.5800815695274546,0.9460669357632632,0.6153846153846154,0.7965415119942927,1.0,2/10,15.27%,TJP2;TJP3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.4015232617564235,-0.9460498370197654,0.5384615384615384,0.9763378612353842,1.0,14/84,13.22%,PSMD7;PSMB6;PSME2;PSMD8;MUC4;PSMB4;PSMD3;PSMB3;CHUK;PSME1;HRAS;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.4015232617564235,-0.9460498370197654,0.5384615384615384,0.9763378612353842,1.0,14/84,13.22%,PSMD7;PSMB6;PSME2;PSMD8;MUC4;PSMB4;PSMD3;PSMB3;CHUK;PSME1;HRAS;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.4015232617564235,-0.9460498370197654,0.5384615384615384,0.9763378612353842,1.0,14/84,13.22%,PSMD7;PSMB6;PSME2;PSMD8;MUC4;PSMB4;PSMD3;PSMB3;CHUK;PSME1;HRAS;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.40256933470521505,0.9458561397460682,0.5476190476190477,0.7966315775491544,1.0,13/58,18.54%,PPARG;MAPKBP1;LRFN5;IRAK3;TNFRSF1A;FNDC4;AOAH;NLRP3;CCN3;ILRUN;PRKCD;NLRP12;GPER1
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5863104220206492,-0.9453951533748924,0.6222222222222222,0.977223335119501,1.0,5/7,33.94%,NCSTN;BACE1;APH1A;APH1B;PSEN1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.4105725357371128,0.9453808557441766,0.575,0.7972354680118079,1.0,7/57,8.43%,EGFR;TLR2;C1QTNF4;NR3C2;NFKBIA;NOD1;LAPTM5
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.5685592465942884,0.945264062683502,0.5777777777777777,0.7971129563650987,1.0,2/7,6.25%,KCNT2;KCNIP2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.5619835619443945,0.945072894687541,0.5862068965517241,0.797219369733458,1.0,3/7,28.31%,ADARB2;NUDT16;ADARB1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.400326249957525,-0.9448948182771332,0.5892857142857143,0.9777274797277519,1.0,8/75,7.82%,NGF;RPL11;STMN1;EDF1;BAMBI;ZNF618;RAN;PYHIN1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5225139371903982,-0.944672104788293,0.5111111111111111,0.9775203972752374,1.0,1/9,6.50%,DNMT3B
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.562532671899701,0.9445110645334904,0.5740740740740741,0.7980006362477152,1.0,1/6,0.60%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.43154982504424866,0.9444614403071075,0.4888888888888889,0.7977218241326895,1.0,10/33,17.09%,PTPRC;ZFP36;LAPTM5;CD4;CR1;CARD11;SFTPD;CLEC7A;HAVCR2;CD80
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.5610568423621545,0.9444487699323839,0.5769230769230769,0.7970034437819564,1.0,1/8,7.96%,GIT1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.5610568423621545,0.9444487699323839,0.5769230769230769,0.7970034437819564,1.0,1/8,7.96%,GIT1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.48368771912974856,-0.9442448824367699,0.56,0.9770521055563937,1.0,1/22,0.34%,ZDHHC12
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.48368771912974856,-0.9442448824367699,0.56,0.9770521055563937,1.0,1/22,0.34%,ZDHHC12
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.5130838797490481,0.9438906110763609,0.5652173913043478,0.7976107518192748,1.0,4/11,8.43%,TNFRSF1B;LILRB1;WNT5A;LAPTM5
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.6075624730295276,0.9438140666951964,0.6274509803921569,0.7973938590226435,1.0,2/7,8.31%,B4GALT6;CNTNAP1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.37776251128960003,-0.9438079301540032,0.5849056603773585,0.9773776629456459,1.0,16/142,9.70%,LCK;CD38;BTN3A1;BTN2A1;TNFRSF21;MOG;PSMD7;PSMB6;PSME2;PSMD8;EIF2B1;PSMB4;PSMD3;PSMB3;CHUK;BTN3A2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.35661124375200415,0.9436308319866684,0.5777777777777777,0.7973718559945214,1.0,22/104,13.82%,TRPC4;ADCY8;TRPC7;SLC8A1;VAPB;SLC24A4;SLC24A3;ATP2B3;F2;ATP2B2;CAMK2D;BCL2;MAIP1;HTR2C;TRPC6;CDH23;TRPC3;TRPV4;DMPK;MICU3;HCRTR2;FZD9
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5305223143013077,0.9435960766723367,0.47058823529411764,0.7970329595865302,1.0,2/11,6.30%,PRKG2;FTCD
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.5286109061169615,-0.9433635708501753,0.5098039215686274,0.9777210616978428,1.0,1/12,4.83%,BHLHE41
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.4253988662697173,0.9432496756325401,0.6470588235294118,0.7974390575219267,1.0,9/44,9.99%,FOSL2;SMAGP;BHLHE40;GCM1;MAFF;SCEL;TRIM29;CD4;HOPX
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.5821736716591943,-0.9432207411330545,0.5517241379310345,0.9774659266165819,1.0,4/8,23.31%,PARK7;PINK1;P4HB;LANCL1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.30034574357864724,0.9431856976567276,0.75,0.7972004306295704,1.0,135/852,15.96%,CHRM3;TGFB2;IGFBP3;PDGFB;PTPRC;MAP3K21;VCAN;ASB4;PTPRG;FSTL1;MAP3K5;PARP14;IGFBP4;LRRK2;PEAK3;TNC;DCLK1;PIM1;BMPR1B;PTPRR;CDKL4;ST8SIA3;B3GALNT1;PTPN6;ISG15;STK17B;PAK3;HUNK;LAMC1;PRKG2;PTPRB;SYK;PPP3CA;PTPRZ1;MERTK;LOX;PRKG1;GAD1;PRKCZ;HIPK3;LMO7;MACROD1;OGFOD1;CAMK2B;PTPRJ;CCNF;UBA7;PTPRM;IRAK3;ST8SIA4;FBXO17;MYLK3;EPAS1;FBXO41;FBXL16;ZBTB16;AURKC;FBXW9;PRKCG;PICK1;DAPK1;FUT9;SOCS3;PLK1;CAMK2D;NUAK1;PTPRT;ST8SIA6;B3GALT1;BMPR2;ACVR1C;B3GNT6;TEC;C3;SPARCL1;MKNK1;DYRK2;PPM1H;LAMB2;PARP9;PPM1L;DUSP10;GAN;FEM1B;CSNK1D;CDK12;ZAP70;PRKD1;ST3GAL6;CPE;LYN;AKT3;PRKAR1B;IP6K3;PTPRO;TPTE2;DMPK;PHKA2;TNIK;UST;PARP8;PTPN5;PPEF1;PDK4;LTBP1;DUSP6;RAB3A;CUL3;ZDHHC6;DYRK3;MAK;CHRDL1;PGAP1;FBXL5;STK17A;WNK2;CDK19;PTPRK;UBA3;PTP4A2;FBXO31;DYRK1B;PRKCE;HIF3A;ACVR2A;LAMB1;PTPN4;TSSK3;ENGASE;GLRX;LMTK3;CAMK4;PPP1CB;KLHL11;PAK5
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4395751040181633,-0.9430479835212141,0.56,0.9771989707556114,1.0,7/25,15.69%,RPS3;KATNB1;NUMA1;ANKRD53;AKAP9;RAC1;DCTN1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.5283333151693632,-0.9428758554527465,0.5897435897435898,0.9767983526676995,1.0,6/11,36.88%,TOR1A;VCP;AUP1;UGGT2;BAG6;RNF5
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5238701650017319,0.9427914955313298,0.5777777777777777,0.7975561027877965,1.0,6/12,22.59%,MYO7A;THY1;VEGFA;RPGRIP1L;BBS4;NRL
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5488976397131305,0.9427665716449809,0.5434782608695652,0.7972011036136358,1.0,5/11,21.66%,B4GALT6;CNTNAP1;TENM4;PTEN;B4GALT5
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.5974538437398911,0.942440114484551,0.6153846153846154,0.797506521630075,1.0,1/7,5.72%,ME3
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.33397563214342363,-0.9423229381205678,0.6060606060606061,0.9772812134564033,1.0,64/353,15.54%,ABCA13;FTL;CKAP4;JUP;FUCA1;TRAPPC1;EEF1A1;ARPC5;FTH1;CNN2;DEGS1;VAMP8;PSMD7;PPIE;CSTB;TMEM179B;DYNLL1;SRP14;GSTP1;TUBB4B;RHOG;ADGRE5;C6ORF120;CCT2;CREG1;ITGAL;CD63;NPC2;LILRB3;GLA;PGAM1;AGA;RHOA;DYNLT1;HLA-C;CYB5R3;PSMD3;HLA-B;COMMD9;ILF2;DDOST;HSPA8;SNAP29;PPIA;EPX;RAB31;B2M;BRI3;DYNC1H1;CAP1;TUBB;PSMD13;ARL8A;GSN;RAC1;PADI2;IMPDH2;LAMTOR2;GALNS;MAGT1;NCSTN;TIMP2;PSMD2;ANXA2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.5828454563837132,-0.941887748416283,0.5535714285714286,0.9776112552470029,1.0,1/6,1.12%,SELENOS
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.5902699262582742,0.9418812432229505,0.5471698113207547,0.7983494584811912,1.0,3/6,20.39%,PHF19;OGT;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.3841480057761777,-0.9415702350220696,0.5227272727272727,0.9776672142618614,1.0,12/58,20.56%,LAMTOR4;ARAF;RRAGA;PRKAA2;SLC38A9;MIOS;LAMTOR2;PIH1D1;PKHD1;LAMTOR5;DGKQ;TELO2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.3911394658672157,0.9414076814154427,0.5918367346938775,0.7989754813028958,1.0,13/52,13.86%,PLSCR4;PLSCR1;DMKN;PACSIN1;ANO6;DYSF;ABCD2;SYT7;CR1;SYTL4;ANK3;RAB3A;COL5A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6441166221164109,0.9413794148437823,0.7,0.7982990333891575,1.0,3/5,33.35%,SLC11A2;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6441166221164109,0.9413794148437823,0.7,0.7982990333891575,1.0,3/5,33.35%,SLC11A2;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.5066965769461389,-0.9413308807704213,0.5555555555555556,0.97755905200204,1.0,6/16,22.55%,DOLK;DPAGT1;ALG3;ALG12;ALG1;DOLPP1
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.6217506336314836,-0.9412751067539018,0.6078431372549019,0.9769896453920626,1.0,2/6,5.96%,VAMP8;SPHK2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.5628579718949989,-0.940627208589022,0.6078431372549019,0.9777739339490448,1.0,3/11,11.03%,CSKMT;METTL18;KMT5A
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.334218640051117,-0.9403498421144386,0.6060606060606061,0.9776598685419762,1.0,64/350,15.54%,ABCA13;FTL;CKAP4;JUP;FUCA1;TRAPPC1;EEF1A1;ARPC5;FTH1;CNN2;DEGS1;VAMP8;PSMD7;PPIE;CSTB;TMEM179B;DYNLL1;SRP14;GSTP1;TUBB4B;RHOG;ADGRE5;C6ORF120;CCT2;CREG1;ITGAL;CD63;NPC2;LILRB3;GLA;PGAM1;AGA;RHOA;DYNLT1;HLA-C;CYB5R3;PSMD3;HLA-B;COMMD9;ILF2;DDOST;HSPA8;SNAP29;PPIA;EPX;RAB31;B2M;BRI3;DYNC1H1;CAP1;TUBB;PSMD13;ARL8A;GSN;RAC1;PADI2;IMPDH2;LAMTOR2;GALNS;MAGT1;NCSTN;TIMP2;PSMD2;ANXA2
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),0.6499259758245952,0.9400832364514741,0.6666666666666666,0.8004350046240368,1.0,1/5,1.70%,ITGB4
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4803973632771549,-0.9398439698301828,0.5471698113207547,0.9782123268246115,1.0,4/21,10.75%,STMN1;MAP7D3;KATNB1;STMN3
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.5524092365274422,0.9395399016987809,0.5434782608695652,0.8011584624725887,1.0,4/8,26.36%,ZFP36;ZFP36L1;YAP1;TEK
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.516111253522217,0.9394873763654237,0.5714285714285714,0.8009081588302852,1.0,3/14,9.61%,CD44;HEXB;LYVE1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.5064398696750725,-0.9387391616824262,0.5961538461538461,0.9800896680802021,1.0,11/21,21.26%,PYCR3;FDXR;MOCS1;HDC;SRD5A1;NFS1;PYCR1;STAR;ALOX5;MOCOS;PRLR
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5288586186939421,0.9386861817312253,0.5454545454545454,0.8021446765657504,1.0,2/12,3.20%,OLAH;ABHD3
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.6136799408738058,-0.9386376075725205,0.5555555555555556,0.9788977442019094,1.0,3/5,37.20%,BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.6136799408738058,-0.9386376075725205,0.5555555555555556,0.9788977442019094,1.0,3/5,37.20%,BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.5962986774592928,-0.9384140174800784,0.5416666666666666,0.9786745531432111,1.0,3/5,34.33%,PINK1;HAX1;ATP5IF1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.4941792845701345,-0.9381649881239019,0.5416666666666666,0.9785965450650798,1.0,3/15,15.33%,SLC25A1;HSD17B8;FASN
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.5420210256217913,0.938040184761086,0.5918367346938775,0.8029436678271162,1.0,1/6,5.97%,HOOK1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6275612033127093,0.9376771004496627,0.6792452830188679,0.8032229226951567,1.0,1/5,6.48%,DMD
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.5798492242808437,-0.9376736566745327,0.5833333333333334,0.9790433802280439,1.0,3/7,36.20%,AP2A1;ABCA2;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.550201596255832,0.9376168459630796,0.5416666666666666,0.8029942010366645,1.0,1/9,0.91%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.30661492798267714,0.9375847524658066,0.7567567567567568,0.8026829495347834,1.0,49/431,10.70%,CREB3L1;IFNA2;PPARG;PDGFB;ZNF423;MDFIC;MIDEAS;DACH1;MAEL;ENC1;HEY1;BHLHE40;PLCB1;IKZF1;ZNF93;ZEB1;PRICKLE1;NRG1;ID2;RUNX1T1;BASP1;TSPYL2;LOXL3;CIITA;CITED2;LEF1;TSHZ3;TP63;SOX9;IGF2BP2;PER1;ATXN1;ZBTB16;WNT5A;TIMELESS;SPINDOC;CLOCK;WWP1;DAPK1;L3MBTL4;BCL6;ZHX2;CDKN2A;ZBTB18;BMPR2;ZNF568;ZNF540;RNF139;CDK5R1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.5671432950228775,-0.9373793734929281,0.5957446808510638,0.9790737035596394,1.0,1/10,6.91%,RBM15B
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.5878681748199214,-0.9370560568044305,0.6545454545454545,0.9792123901100006,1.0,2/8,11.51%,MCM4;MCM3
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.62857316975312,0.9370237134684065,0.6470588235294118,0.803331345836259,1.0,2/5,26.84%,CHD7;DRD2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.44065619200379197,0.936867375287741,0.5384615384615384,0.8032627108045794,1.0,3/23,11.41%,CYFIP1;SLIT1;SEMA5B
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.5775367858061289,-0.9367197930959855,0.5476190476190477,0.9792906929548976,1.0,1/7,8.80%,NPL
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.28936411479857355,0.9366412899324584,0.88,0.8033759184627656,1.0,234/1642,14.68%,ZNF366;CREB3L1;ETV1;FLI1;KANK2;PLAC8;NPAS2;PPARG;TP73;BMP6;EGFR;MYT1;IGF1;IKZF2;PLSCR1;GRHL1;TLR2;MLIP;HNF4G;FOS;CSF1R;FOSL2;KLF9;MIDEAS;DACH1;CASZ1;ZIM2;ZNF157;HEY1;BHLHE40;MACC1;DNAJB1;PID1;E2F3;IKZF1;NEDD4L;UHRF1;MEF2C;SCRT1;ZNF20;NR4A3;LDB2;BMPR1B;BCL11B;HGF;MET;ZNF93;ZSCAN22;NFATC4;ZEB1;GCM1;ATF1;KAT2B;NR2F1;PURG;ZNF652;MAFF;DACT1;EBF1;ID2;TBX19;PPP3CA;TBX6;KLF15;RHOQ;ZNF608;HIVEP2;TOX;CIITA;CITED2;PRDM15;MAP2K5;LMO7;ZNF239;RARB;LEF1;ZNF215;CRYM;PBX1;LILRB1;PLAGL1;ZFP36;HIRA;TSHZ3;MEIS3;PPARGC1A;AEBP2;ETS2;GRIN1;TP63;SOX9;PER1;NR3C2;TEAD1;PHF21A;EPAS1;SLA2;ATXN1;ZBTB7C;NFKBIA;DLX1;ZBTB16;WNT5A;MEIS2;STAT6;NOTCH4;TAL1;PTPRN;ETV6;KDM3A;ZGLP1;LMO2;CLOCK;HES4;EMX1;CCND1;ZNF343;BRWD3;GLIS3;ZNF442;NOS1;TNFRSF1A;TBL1XR1;EDNRB;ZNF768;MAFB;PLK1;BCL9;ZNF697;CAMK2D;BCL6;ZHX2;CDKN2A;ZSCAN1;NEUROD6;ARNT;SMYD2;AGRN;TENM2;IL33;SOX5;ZNF764;ZBTB18;BMPR2;ZNF600;HOPX;GRHL2;SATB2;GTF2IRD1;TGFB3;ZNF568;ZNF540;NR1I3;CREB3L2;ZNF615;ZNF644;PARP9;ZNF550;ZNF467;TGFA;ZNF473;CDK12;PRRX1;ZNF616;ZNF433;CX3CL1;PRKD1;ZNF587;PROX2;POU2F2;ONECUT2;CBFB;NPAS1;CPEB3;KCNIP3;ELK3;ZNF304;MYT1L;MED12L;TGIF1;KLF3;PIK3R1;MRTFB;AEBP1;CEBPD;ZXDA;FHOD1;BACH1;ZNF571;STRA8;ARID3A;ZNF384;ZNF584;ACTL6B;PCGF2;ZFP30;RFXANK;KAT6B;ZNF549;HAMP;SRA1;PIAS1;CCNQ;HES1;ZNF493;CDH13;NR2F2;NCOA1;MED14;WWOX;RPS6KA3;NLRP3;MOV10;ZNF33B;RFX3;ZNF148;NCOA7;ZBTB34;MAFK;ITGB1BP1;HCLS1;ZNF438;PCGF3;POU6F2;VEGFA;FOXP2;GLIS1;ZNF775;BCL11A;CSRNP2;ZNF415;ZKSCAN7;ZNF536;ZNF577
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.4898199755819195,-0.9366044304002894,0.6470588235294118,0.9788336456254266,1.0,5/18,23.70%,TSPO;NFE2L1;PGRMC1;COX10;UROD
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.35221172772701087,-0.9363626180488324,0.6440677966101694,0.9786116322901076,1.0,25/187,15.50%,DDIT3;RAD23A;PSMD7;PSMB6;UBXN1;PSME2;PSMD8;HECTD3;PSMB4;PSMD3;PSMB3;PSME1;ERLEC1;ZFAND2A;SPSB3;ZFAND2B;KLHL20;PSMA7;PSMD13;PSMB8;KAT5;ERCC8;RNF126;PSMD2;UBE2A
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3837981571330986,-0.9362879534563633,0.5735294117647058,0.9780356339055389,1.0,21/77,24.65%,KIF3B;AP2S1;DYNLL1;DCTN3;DYNC1H1;AP1B1;SAR1B;HLA-DRA;KIF11;DYNC1I2;DCTN1;KIF4A;HLA-DPA1;AP2A1;DCTN2;AP1S1;CLTA;AP2B1;CTSL;DCTN6;KIF18A
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5661690989604728,-0.9362685267221733,0.6,0.9774004599895417,1.0,1/9,4.83%,BHLHE41
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.6181744998667377,0.935890274056603,0.5909090909090909,0.8045241332501447,1.0,2/7,15.31%,ABCD2;SLC27A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.493274638469224,0.9358827506163546,0.6382978723404256,0.8041743703266088,1.0,1/15,0.42%,DPYS
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.5737851234497243,0.9356818133280113,0.5384615384615384,0.804198986784162,1.0,2/5,24.18%,SLC7A8;SLC6A9
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.41495246120805696,0.9354864733863295,0.5576923076923077,0.8042290787997785,1.0,17/42,26.35%,TBC1D10A;TNFRSF1B;MAPK12;PLK1;GPLD1;WDR48;SNX33;CAPN3;TRIM32;OGT;FBXW11;SH3D19;BAG2;CCBE1;TANK;FURIN;CASP8
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.5950311512830276,-0.9354701618126962,0.6037735849056604,0.977936511378635,1.0,2/8,24.95%,ERLIN2;ARHGEF10L
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.5950311512830276,-0.9354701618126962,0.6037735849056604,0.977936511378635,1.0,2/8,24.95%,ERLIN2;ARHGEF10L
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5247771157912351,-0.9354474503017228,0.5740740740740741,0.9772967959536923,1.0,3/8,12.42%,ACTN2;ATP1B1;AKAP9
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.46815398282445225,0.9354274948346559,0.4482758620689655,0.8039458852548195,1.0,11/20,31.93%,DLX1;BCL9;NREP;DKK3;TGFBR3L;ZNF703;SMURF2;ITGA3;EID2;TRIM33;SMAD4
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.4244489715813473,0.935355733341627,0.5416666666666666,0.8037508444100278,1.0,12/36,12.36%,SLA;PTPRC;SELL;IKZF1;LCP2;CD53;ARHGAP25;CD4;SELPLG;ZAP70;AOAH;SASH3
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.574619141268241,0.9347257655062515,0.6153846153846154,0.804621175933852,1.0,1/5,7.61%,SLF1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5443165998646988,-0.9342674238057922,0.6037735849056604,0.9793146965560492,1.0,2/12,2.35%,UXT;UBB
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.5333246549121282,-0.933927652990965,0.5531914893617021,0.9794342725981103,1.0,1/13,5.80%,ENY2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.47433271838024627,0.9338505216587478,0.5227272727272727,0.8060230561350363,1.0,5/18,6.48%,CBARP;STAC2;GPR35;CACNB1;DMD
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4217370555508552,-0.9335972157252213,0.509090909090909,0.9794879522510482,1.0,2/41,5.10%,BMP5;LMX1B
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.5092364290562501,0.9332375356416854,0.5609756097560976,0.8068476542603303,1.0,5/11,20.69%,LAPTM5;AP1G1;CCDC91;SORT1;EHD3
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6081074626755858,-0.9332355722322099,0.5681818181818182,0.9797206735665027,1.0,2/8,16.95%,DHX33;CPTP
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.5513718380026762,-0.9331269872639674,0.603448275862069,0.9792788641172328,1.0,2/10,23.87%,VPS11;MSN
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5590707265486765,0.9331184555907346,0.4888888888888889,0.806728400007568,1.0,3/13,2.76%,VSIR;NCKAP1L;IL12A
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.42323485145986756,-0.9328039138123511,0.5306122448979592,0.9793742740857141,1.0,14/54,19.46%,SQLE;ACAA2;SOAT2;SCARF1;DHCR24;AKR1D1;SNX17;IDI1;MSMO1;PIP4P1;PMVK;TM7SF2;ABCA5;G6PD
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4425722608073642,-0.9324389640302596,0.5555555555555556,0.9795946602704232,1.0,10/32,24.79%,UFC1;TEX264;GOLGA2;UFL1;GBF1;PLK3;MTIF2;ATG2A;ZFAND1;ULK2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.5415647581616825,-0.932298598495795,0.5510204081632653,0.9792074735060206,1.0,4/16,14.41%,POLD3;POLD4;PPIA;TYMS
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5278573733760816,0.932251782712802,0.5609756097560976,0.8080944916147557,1.0,3/11,18.54%,ZFP36;ZFP36L1;GPER1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.4596954705815224,0.9320303766950041,0.5384615384615384,0.808133637145737,1.0,3/19,9.12%,PKP2;FGF13;CAMK2D
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.47350923264598277,0.9318800051854486,0.6153846153846154,0.8081179913167841,1.0,8/29,14.38%,ANGPT1;ARRB2;MKLN1;PICK1;DLG4;RIN3;SFRP4;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3537354977760384,0.9315931121632972,0.5813953488372093,0.8084799982532483,1.0,19/92,15.55%,TGFB2;NEDD4L;NRXN1;RELN;SYK;NRG1;ABCB4;CAMK2B;SLF1;TAL1;TIRAP;FRMPD4;TGFB3;CLEC7A;LRP4;VEGFA;LGALS3;ADD1;ATP10A
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4191318710703441,0.9311186663777673,0.5454545454545454,0.8091589619667192,1.0,9/36,11.51%,PTPRC;RYR3;GRIN2B;SLC8A1;ITPR1;GRIN1;TRPM2;HTR2C;TRPV4
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.4742807688090465,0.9311075352676315,0.5454545454545454,0.8088038512748332,1.0,3/18,10.20%,BMP6;KIAA0319;TGFB3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3302905251365101,-0.93108951763001,0.6567164179104478,0.981367112233925,1.0,64/352,15.54%,ABCA13;FTL;CKAP4;JUP;FUCA1;TRAPPC1;EEF1A1;ARPC5;FTH1;CNN2;DEGS1;VAMP8;PSMD7;PPIE;CSTB;TMEM179B;DYNLL1;SRP14;GSTP1;TUBB4B;RHOG;ADGRE5;C6ORF120;CCT2;CREG1;ITGAL;CD63;NPC2;LILRB3;GLA;PGAM1;AGA;RHOA;DYNLT1;HLA-C;CYB5R3;PSMD3;HLA-B;COMMD9;ILF2;DDOST;HSPA8;SNAP29;PPIA;EPX;RAB31;B2M;BRI3;DYNC1H1;CAP1;TUBB;PSMD13;ARL8A;GSN;RAC1;PADI2;IMPDH2;LAMTOR2;GALNS;MAGT1;NCSTN;TIMP2;PSMD2;ANXA2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5809316554325465,0.9308888214081306,0.5434782608695652,0.8087988575581084,1.0,1/5,4.77%,DDAH1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.4771572544649244,-0.9307547149501118,0.6481481481481481,0.9813775233862034,1.0,4/22,5.83%,DDIT3;HOXD3;BHLHE41;HES6
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.599707895316853,0.9307270799925287,0.6304347826086957,0.8087447016222633,1.0,1/5,0.91%,BMP6
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.577720075068926,0.9303595023742641,0.5681818181818182,0.8090127632567834,1.0,1/6,4.77%,DDAH1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.43341450620947763,0.9301812671400854,0.5576923076923077,0.8090568023972011,1.0,2/21,4.32%,L1CAM;TWF2
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.6067027080005309,0.9301362248225528,0.5636363636363636,0.8087625620312445,1.0,2/6,25.95%,PRKCD;RELA
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.4605665424133104,-0.9298774115136309,0.4897959183673469,0.9828196313996117,1.0,7/26,25.59%,NUTF2;RAN;RANBP17;TPR;CALR;CSE1L;NUP42
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5866512592331781,-0.9297733761564287,0.574468085106383,0.9823184528169924,1.0,2/7,29.12%,DNAJC18;HDAC6
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.5562903172770793,-0.9297632286087026,0.6140350877192983,0.9816518885576812,1.0,2/10,8.02%,JUP;SERPINB8
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.32793538797404864,0.9297251149440963,0.717948717948718,0.8092538191390021,1.0,39/215,14.52%,PKP2;DCX;NCKAP1L;CYFIP1;RHOJ;BAIAP2;ADD2;LAMC1;SPEF1;RHOQ;MYO1B;CFAP74;RSPH9;PPARGC1A;BAIAP2L1;SCIN;SOX9;SLC7A9;TEAD1;PCLO;WNT5A;PAWR;IL1RAP;DMTN;LIN7A;GRHL2;VIL1;SPAG16;DLG4;DPYSL3;SHANK1;RAC3;FANCC;HES1;SHROOM2;ANK3;P3H4;NLGN4X;PARD3
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.45224456881754743,0.9295943123494717,0.5434782608695652,0.8091668760489328,1.0,5/22,15.73%,SLC1A2;SLC26A7;SLC1A1;SLC25A22;GJA1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.45957245299800753,0.9295744145275662,0.5641025641025641,0.80886754115222,1.0,3/23,7.95%,PPARG;SOX9;CHRD
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5292215683905703,0.9295352930193649,0.5849056603773585,0.8085303615495337,1.0,1/10,1.99%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.6328977303527297,-0.9295130028303457,0.6458333333333334,0.9817272743610134,1.0,3/6,26.15%,OAS3;MUL1;SIRPA
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3474076766953348,0.9294095528023111,0.6666666666666666,0.8084166532987982,1.0,15/97,16.75%,LPL;PPARG;PPARGC1A;ACSM1;ELOVL4;ABCD2;AOAH;GGT5;ALOX12;ACSL5;ACOX2;SLC27A2;ADIPOR2;CBR4;LTC4S
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5290197448529088,0.9292811666979368,0.6,0.8083356920405611,1.0,5/10,18.66%,DDAH1;GAD1;NOS1;NOS2;ARG1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.4221795544931555,-0.9292434719170386,0.5102040816326531,0.9817788575417187,1.0,3/31,8.65%,LCK;GPR89A;RAG2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5366435264249312,0.9292186446058077,0.6274509803921569,0.808091663737634,1.0,5/11,7.76%,IGFBP3;MEF2C;PRKG1;TPM1;NDRG4
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.5831371373699961,-0.9291669444322687,0.5681818181818182,0.9804976214749942,1.0,2/9,8.99%,CHMP2A;CHMP5
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.5831371373699961,-0.9291669444322687,0.5681818181818182,0.9804976214749942,1.0,2/9,8.99%,CHMP2A;CHMP5
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.5133328113436122,-0.9291558848589635,0.5357142857142857,0.979816994627092,1.0,6/14,26.11%,INTS14;TOE1;SSB;ERI1;INTS5;INTS8
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.5794370493925518,0.9291298008544191,0.6,0.807869600392865,1.0,6/7,34.03%,TFR2;BAG2;CCBE1;RHBDD1;ADAM8;SOX4
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.39476051668294765,0.929071207995615,0.5675675675675675,0.8076205743055282,1.0,6/54,9.66%,CREB3L1;LRRK2;SRC;YBX3;HSPB1;BCL2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.3624383883365388,0.9289371195520177,0.5,0.8075509849156838,1.0,20/92,17.15%,TM4SF20;ITGB4;SLC25A48;PROM1;FMO5;SCEL;BAIAP2L1;TP63;TRIM29;CDKN2A;GRHL2;FZD6;PLA2G4A;ST6GAL1;CDH3;MUC16;CKAP2;MAL2;FERMT1;CDKL1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.4943744701539538,0.9288837225368862,0.5555555555555556,0.8072751904642879,1.0,4/13,15.20%,PYGL;PHKA2;PGM2L1;AGL
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6004505108080547,0.9288706073942028,0.6326530612244898,0.8069345395612963,1.0,3/5,10.24%,ROBO2;GAP43;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5837943217490698,-0.9287490905881133,0.6451612903225806,0.9799938352000773,1.0,1/8,3.23%,VAMP8
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.31652854334921154,0.9287053113697982,0.6538461538461539,0.8068870503397726,1.0,37/239,14.12%,ABCC4;TTC8;P2RY12;CYFIP1;CC2D2A;SEPTIN6;CARMIL1;LZTFL1;SPEF1;FHDC1;ANO6;DYNLL2;SSX2IP;ARHGEF6;ABLIM1;RPGR;DMTN;CEP89;TTC39C;DNAI2;CYS1;EXOC6;DZIP1;RAB3IP;SPAG16;TEKT3;PTPRO;TTBK2;TNIK;BBS2;WDPCP;TEKT5;ARL6;CDH13;RFX3;DNAAF1;MAK
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.571457217193691,-0.9286500167976879,0.5714285714285714,0.9787836623326126,1.0,1/8,1.12%,PDZD11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.571457217193691,-0.9286500167976879,0.5714285714285714,0.9787836623326126,1.0,1/8,1.12%,PDZD11
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3862744363695173,0.9285918354328574,0.5,0.8067528730488678,1.0,10/61,13.09%,PPARG;ADCY8;PYGL;CARTPT;IRS1;PPARGC1A;KCNB1;NGFR;PIK3R1;PDK4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.5817336441310063,-0.9284632420758918,0.6724137931034483,0.9785187874475484,1.0,1/7,3.69%,NOC2L
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.5963070506671805,-0.9284572851238999,0.625,0.9778302000722652,1.0,2/6,23.41%,SKP1;CAND2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.46345340631517107,-0.9276271315400086,0.5873015873015873,0.979037862159112,1.0,2/22,12.36%,KIF3B;DYNC1H1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.4483000605044848,-0.9272632813322187,0.5789473684210527,0.979167448787124,1.0,13/47,17.66%,FTL;FTH1;ATP6V1G1;TF;SOD1;SLC22A17;ATP6AP1;B2M;CYBRD1;CYB561A3;HMOX2;HEPH;ISCU
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.45338944099141487,-0.9270805506256828,0.5882352941176471,0.9788971748492358,1.0,3/32,4.77%,CCDC78;STAC3;ATP1B1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5786000040784233,0.9270554793835961,0.6666666666666666,0.8093604473250462,1.0,1/8,8.82%,FZD3
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.43808902336156746,-0.9270335330248918,0.5,0.9782924971848709,1.0,2/35,1.21%,CRTAM;BTN3A1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6203366932251819,-0.9267783561472683,0.6470588235294118,0.9781993029992327,1.0,3/7,29.12%,TOMM7;PINK1;HDAC6
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.4688794992455605,0.9267338304205543,0.5625,0.8096422820472946,1.0,3/17,9.31%,COL11A1;COL12A1;COL7A1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.4421554566203183,0.9265916498122145,0.48936170212765956,0.8095503418625724,1.0,5/27,5.31%,IGF1;PID1;SORBS1;IRS1;RHOQ
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.4876593179700415,-0.9265016100446568,0.58,0.978188352522287,1.0,1/17,1.34%,RPS3
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.44767626372551095,0.9263730907840623,0.5681818181818182,0.8096154000145506,1.0,1/23,0.27%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.5942856335287907,-0.9262111122733502,0.6190476190476191,0.9782653325086572,1.0,1/5,16.64%,TMBIM1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.3479588319537569,-0.9262033899928926,0.532258064516129,0.977592525306478,1.0,36/283,13.32%,RAB32;VPS25;RPL11;SRPRA;ARCN1;NUTF2;PTTG1IP;KATNB1;PHB2;TMED4;STX10;TMED9;ERP29;RAN;TBC1D16;ARL17A;VPS28;MYO1C;TRARG1;ARFIP2;RANGRF;AP4B1;NXT2;SNX17;DNAJC27;TMED2;LMAN1;VPS29;SNF8;RAB31;NPM1;USP6NL;TMED1;SAR1B;STX6;RANBP17
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.5681303086681093,-0.9260629765695811,0.6140350877192983,0.9772133037164826,1.0,2/7,4.34%,GREM1;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.31375613162470795,0.9259090567412116,0.7560975609756098,0.8103618571834781,1.0,76/426,14.54%,DACT2;TGFB2;KANK2;IGFBP3;TEX15;NPAS2;ANGPT1;SSTR1;PLSCR1;TLR2;OSGIN1;ACTN1;MYO16;PTPN6;TMIGD3;CDKN3;KAT2B;TNFRSF1B;DDAH1;PLXNA4;SPEF1;TSPYL2;ADGRB1;ADGRG1;ADRA1A;TP53I11;PTPRJ;LILRB1;TESC;SCIN;CLMN;TENM1;ZBTB7C;P3H2;GNRH1;NOTCH4;RERG;BRINP1;DYSF;JAM2;NOS1;PLXNA2;FBLN1;BCL6;CDKN2A;SMYD2;GPLD1;BCL2;BMPR2;HOPX;TGFB3;CR1;UTP20;PDE3B;RNF139;WDR6;PRKD1;LYN;CCN5;TPTE2;SULT2B1;GSDME;FABP7;SFRP4;PDS5B;CDH13;IFNK;OSGIN2;CD200;GNG4;FHL1;ITGB1BP1;WNK2;CHMP1A;PTPRK;APBB2
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4870116676426075,-0.9258979285122299,0.5538461538461539,0.9768872540956496,1.0,7/28,19.12%,FTL;TF;B2M;CYBRD1;HMOX2;HEPH;HFE
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.44856008450318086,0.9257462413598881,0.5,0.8102534977388283,1.0,3/19,9.12%,PKP2;FGF13;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.5694596132018568,0.9256811555006526,0.5531914893617021,0.8100263598467821,1.0,1/8,3.14%,LRRK2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4236949846009078,-0.9256379949340638,0.5294117647058824,0.9768071322758917,1.0,8/34,13.90%,DPM3;PGAP2;PIGO;PIGF;PGAP4;SCCPDH;PIGW;DPM2
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.4040097871495622,0.9255719962579563,0.6444444444444445,0.8098534383686042,1.0,14/61,10.90%,NRCAM;BRINP3;CASZ1;HEY1;LRRK2;MEF2C;ZEB1;ID2;DTX1;CNTN4;BRINP1;CDK5R1;YWHAH;NREP
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.33918671900002056,0.9254916202425266,0.6530612244897959,0.8096320863454765,1.0,38/184,16.49%,IFNA2;PLSCR1;TLR2;MX1;TNFRSF25;FAP;SCN2A;ADRA1A;EFNA5;CASP10;PLAGL1;PDE1B;TP63;NFKBIA;ARHGEF6;ZBTB16;PAWR;CASP7;DAPK1;BCL2;SEMA6A;TNFRSF10B;NGFR;FEM1B;ATCAY;BBC3;DMPK;BCL2L1;NLRP3;PRUNE2;CIDEB;PRKCE;ATN1;TNFRSF10A;PAK5;DDIT4;NSG1;TNFRSF19
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.5933533942975165,0.9254163999861764,0.6206896551724138,0.8094217272029132,1.0,4/6,35.94%,EID2;SMAD4;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.4800082192904678,-0.9251378748324729,0.5957446808510638,0.9772877994134112,1.0,7/26,16.69%,CDKN1C;PHPT1;PRDX3;PINX1;MEN1;SMAD7;PARK7
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.3889049547285623,-0.9250027269304371,0.6226415094339622,0.9769565490031915,1.0,12/72,7.80%,F11;CYP2E1;GJB1;CLDN2;GLYAT;ENPEP;SLC28A1;DAO;GBA3;SOD3;HSD11B1;SLC22A6
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5815712111783736,-0.924971156466772,0.5952380952380952,0.9763283235694116,1.0,1/7,16.10%,PRKACA
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.5632009918443696,0.9248955402596178,0.5945945945945946,0.8097024439894024,1.0,4/6,29.35%,JAK1;STAT3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.5632009918443696,0.9248955402596178,0.5945945945945946,0.8097024439894024,1.0,4/6,29.35%,JAK1;STAT3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5748090611279051,0.9245909410417692,0.6296296296296297,0.8099665547054753,1.0,1/8,0.65%,CDS1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.5536860690349709,0.9245451355686488,0.5769230769230769,0.809681015501716,1.0,2/8,15.37%,CARD11;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.5375972070962689,-0.924513502668852,0.5740740740740741,0.976662612487449,1.0,2/5,22.19%,CD81;RNF128
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.4609525432869826,-0.9243094965746057,0.5660377358490566,0.97643150588397,1.0,7/30,15.81%,CCT2;HSPE1;SDF2L1;DNAJB4;HSPA8;HSPA14;HSPA2
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6168173044767464,-0.9242499156570749,0.6739130434782609,0.97585152948582,1.0,2/5,19.59%,BRK1;EPS8
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.4826601211067518,0.9234760289939555,0.5614035087719298,0.8115439294889873,1.0,3/19,1.89%,FLT1;PTPRC;CSF1R
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.5099010661236725,0.9234628831672782,0.58,0.8112041204193573,1.0,2/13,14.25%,PID1;CSPG5
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4755612505065979,-0.9232738119870075,0.5666666666666667,0.9774125878463445,1.0,7/29,16.42%,AADAT;GLYATL1;PYCR3;DDAH2;RIMKLA;ART4;PYCR1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4872254807976292,-0.9230644532973035,0.6,0.9772105003064638,1.0,2/25,0.75%,CRTAM;PRELID1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5479393403656913,0.9228957423123806,0.5897435897435898,0.8118974024159508,1.0,3/14,3.26%,KCNMA1;SLC8A1;NEDD4L
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3731100955869109,0.9227923198492164,0.6428571428571429,0.8117459235287124,1.0,19/72,17.17%,CBS;SHMT2;KYNU;DDAH1;ABAT;GAD1;CRYM;FTCD;NOS1;DDO;GLDC;BCAT2;SHMT1;NOS2;KMO;MCCC1;ALDH5A1;SLC25A21;TDO2
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5068472195881559,0.9227572148096321,0.5614035087719298,0.8114548513987418,1.0,5/17,17.13%,ABCD2;PRKAB2;ACACB;SLC25A20;PRKAG2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.5380955274213493,-0.9218990067146463,0.54,0.9789716916698079,1.0,2/10,5.51%,CD9;PMP22
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.445378239972619,0.9218511554182272,0.5952380952380952,0.8128507886199883,1.0,7/26,12.95%,PKP2;KCNJ3;CACNA1G;SCN3B;CAMK2D;SCN4B;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.38568510171253634,0.9216599935305453,0.5526315789473685,0.81282794997205,1.0,6/75,7.66%,CARD18;PDGFB;LRRK2;DACT1;LEF1;NFKBIA
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.5285615004678057,-0.9210737300101483,0.5932203389830508,0.980300951996395,1.0,1/11,1.52%,DPEP1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5216321042604851,-0.9208456272608265,0.6226415094339622,0.9801668644610924,1.0,2/12,4.99%,PAX8;USH1C
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.36358132869963744,0.9206957979103254,0.6341463414634146,0.8145064592915396,1.0,8/90,3.71%,TGFB2;ABCC4;PDGFB;SRGN;RAB27B;IGF1;ACTN1;HGF
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.40224080541060625,0.91991885018413,0.5365853658536586,0.8158293964175648,1.0,8/33,16.48%,TRPM1;FIGNL1;CLOCK;KDM4D;OPN3;RRH;RAD9A;CDKN1A
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.4318365648295276,-0.9199049324013955,0.5769230769230769,0.9816209349632182,1.0,13/40,18.95%,F11;GLOD5;TPH2;GBA3;ADH4;TFPI;ANXA13;HNF4A;ADH6;ESM1;CYP3A4;SLC3A1;SCTR
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.5958153535909128,0.9196715609737204,0.6744186046511628,0.8160733540290257,1.0,2/5,2.03%,HORMAD2;SGO1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.4615656049127008,-0.9195466166137173,0.5434782608695652,0.9818973077663101,1.0,5/26,13.71%,VCPKMT;ANTKMT;ZNF335;CSKMT;CTR9
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.34122771690606873,0.9191896856303248,0.6444444444444445,0.8166493945247847,1.0,17/134,13.39%,ROR1;TRIM5;BIRC3;CASP10;C18ORF32;TIRAP;NOD1;ZDHHC13;TNFRSF1A;CD4;TRIM22;TNFRSF10B;CX3CL1;PRKD1;CARD11;WLS;CLEC7A
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.4197007230010737,-0.9190837633722707,0.543859649122807,0.9822716814347034,1.0,20/61,24.41%,AARS1;URM1;TRMT112;PUSL1;METTL2A;QTRT2;TRMT10A;METTL6;TRMT1;PUS1;TRMT6;SSB;TRMT13;CTU2;NSUN2;AARS2;ELP5;TRDMT1;FTSJ1;ALKBH8
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.33787546140291036,0.9190618510746724,0.6111111111111112,0.8165820400216501,1.0,29/183,14.74%,ROR1;CX3CR1;PPARG;TRIM5;TLR2;ADCY8;CAMK1D;RELN;PRKCZ;PPARGC1A;IRAK3;LRP8;NFKBIA;WNT5A;TIRAP;NOD1;CLOCK;IL1RAP;TRIM22;CX3CL1;PRKD1;CARD11;ADCY1;CLEC7A;NLRP3;CD200;HCLS1;VEGFA;EDA
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3711390590261957,-0.9190576110075132,0.5892857142857143,0.9816392221313074,1.0,7/142,7.79%,ARHGEF16;TAX1BP3;SFRP1;RHOG;RACK1;TBC1D16;RASGRF1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.6058723262615822,-0.9185036183663928,0.6538461538461539,0.9820710478157402,1.0,3/7,18.33%,PARP1;MGME1;PRIMPOL
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5577982026369217,0.9184576998528694,0.6111111111111112,0.8175857255566998,1.0,2/8,11.99%,PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4066923948226635,0.9184559350702876,0.5365853658536586,0.817223623788665,1.0,7/42,12.52%,GRM5;CYFIP1;UHRF1;NFKBIA;EDNRB;PLA2G10;NANOS3
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4891064349767009,-0.9183870603190316,0.5961538461538461,0.9816532962730563,1.0,2/18,7.72%,CDK4;DBF4B
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.37291187699883,0.9183860935306857,0.6041666666666666,0.8170169998563195,1.0,25/100,17.34%,TGFB2;OSGIN1;TRIM46;MAP2;FGF13;TSPYL2;PTPRJ;KIAA0319;RERG;BCL6;CDKN2A;BMPR2;OSGIN2;GNG4;FHL1;APBB2;DIP2B;SMARCA2;GJA1;CRLF3;FRZB;CDKN1A;SESN2;CCN3;OSTN
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.605938510710085,0.9180746102583262,0.6206896551724138,0.8172811576553021,1.0,3/5,16.13%,KCNMA1;DOCK5;ADRB2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.4855209665285433,0.9178930042185822,0.6222222222222222,0.8172190160341533,1.0,6/17,19.72%,KCNMA1;ATP1B2;ATP1B3;KCNH2;SLC12A5;ATP1A2
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.5757563004139952,-0.9178451423109597,0.6363636363636364,0.9822287948826116,1.0,1/5,1.12%,SELENOS
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.37270429908293956,0.9175994471990104,0.5909090909090909,0.8173973600158864,1.0,15/86,12.07%,EPHA3;DPP10;TP73;EGFR;SORBS1;STAC2;ITGAM;STX3;TP63;KCNB1;BCL2;YWHAH;NECAB2;BBC3;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.5589196017663283,0.9170002756113773,0.5769230769230769,0.8181629978975251,1.0,1/5,13.32%,HES1
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5896564031846674,-0.9169709715235628,0.62,0.9827088494838203,1.0,1/8,3.86%,EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5896564031846674,-0.9169709715235628,0.62,0.9827088494838203,1.0,1/8,3.86%,EXOSC8
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.2897918577398094,0.9169029920725802,0.8666666666666667,0.8179617540804788,1.0,95/905,10.29%,ETV1;FLI1;PLAC8;IFNA2;NPAS2;PPARG;PDGFB;TP73;BMP6;EGFR;ZNF423;IGF1;PLSCR1;GRHL1;TLR2;MLIP;HNF4G;MDFIC;FOS;FOSL2;MAP3K5;CASZ1;HEY1;MACC1;PID1;PLCB1;E2F3;UHRF1;MEF2C;NR4A3;LDB2;BMPR1B;BCL11B;HGF;MET;GCM1;ATF1;KAT2B;NR2F1;MAFF;ID2;PPP3CA;KLF15;RHOQ;CIITA;CITED2;PRDM15;MAP2K5;LMO7;RARB;LEF1;PBX1;LILRB1;PLAGL1;MEIS3;PPARGC1A;ETS2;GRIN1;TESC;TP63;SOX9;PER1;TEAD1;EPAS1;TASP1;NFKBIA;DLX1;ZBTB16;WNT5A;MEIS2;STAT6;NOTCH4;TAL1;PTPRN;KDM3A;ZGLP1;LMO2;CLOCK;GLIS3;NOS1;TNFRSF1A;TBL1XR1;MAFB;BCL9;CD4;ARNT;AGRN;IL33;ZBTB18;BMPR2;GRHL2;SATB2;TGFB3;NR1I3;CREB3L2
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.5559255581212881,-0.9168226714467158,0.6274509803921569,0.9823494081154858,1.0,6/11,23.33%,MUS81;MCM4;MCM3;MCM6;GINS4;GINS2
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.4036675240791148,0.9167357621120626,0.5581395348837209,0.8179154260100013,1.0,8/45,11.25%,CHI3L1;ADAMTS7;SRC;IRAK3;SOX9;MYLK3;MAPK11;CX3CL1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.3563734626367103,0.9166135147982587,0.5833333333333334,0.8177678064546285,1.0,10/102,9.60%,IFNA2;EGFR;NCKAP1L;GRM5;LDB2;HSPB1;KDM4D;CDKN2A;CORO1C;NUP43
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.495676789621343,0.9165383990336095,0.6491228070175439,0.8175296932916274,1.0,6/13,33.10%,SYT7;LEPR;DDR2;IL18;GPNMB;CST3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.39552750833617034,-0.9159052037927169,0.55,0.9838494345871392,1.0,8/78,6.12%,PRELID1;PAX8;IFNLR1;DCXR;CBR1;GREM1;CHCHD2;CD63
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.47734377323190014,0.9156175703791942,0.6470588235294118,0.8191194831587925,1.0,7/21,15.36%,SLC8A1;DMD;TPM1;SCN3B;CAMK2D;SCN4B;KCNH2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.48827136289405615,-0.9151012026427133,0.5185185185185185,0.9850943233023304,1.0,3/10,11.05%,NT5C;DNPH1;ITPA
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5739531698306617,0.9150719059024582,0.5652173913043478,0.8198237086258928,1.0,2/6,23.84%,SERPINB9;TRIM27
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.38639256601448074,-0.9149487527684008,0.5892857142857143,0.9847224820025134,1.0,17/104,11.39%,SELENOS;RPS3;PRDX1;PRDX5;GSTP1;CHCHD2;PARP1;SOD1;SOD3;ETV5;VKORC1L1;RBM11;PRDX3;CHUK;PLA2R1;PRKAA2;PPIA
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.5406286559176207,-0.9147953409903764,0.56,0.9844775095936414,1.0,1/7,0.92%,IFNLR1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.4193809554931122,-0.9144735822781779,0.5178571428571429,0.9845772401482726,1.0,5/44,9.39%,NGF;PIK3C2G;GPR143;RHOA;PLCE1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.5236547158650904,-0.9143419108472914,0.6226415094339622,0.9841950562470089,1.0,1/10,2.69%,SMDT1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.43310841958765717,-0.9142465161638843,0.5660377358490566,0.9836758448261592,1.0,3/26,6.18%,F11;DAO;CDHR2
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.6177633039049037,-0.914099868792763,0.625,0.9826796354315215,1.0,2/5,29.81%,HSBP1L1;HSBP1
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.6177633039049037,-0.914099868792763,0.625,0.9826796354315215,1.0,2/5,29.81%,HSBP1L1;HSBP1
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.5721774085758886,-0.9140890234816933,0.55,0.9820252709017229,1.0,2/5,6.09%,PDE6A;CNGB1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.5672919297635004,0.9139958822314737,0.6041666666666666,0.8216293265501854,1.0,2/5,8.35%,DOCK8;JAM2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.504626325627396,0.9135880549343555,0.5833333333333334,0.8220923382461032,1.0,4/16,13.74%,C3AR1;ANO6;C3;NLRP3
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.4530993636683505,0.9135086549945152,0.5135135135135135,0.8218581443889094,1.0,4/25,10.10%,NCKAP1L;TAL1;ARNT;MAPK11
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5589970125043477,0.9132049830237672,0.6037735849056604,0.8220973413117145,1.0,3/7,29.58%,SASH1;PARP10;PLAA
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.45365478922300667,0.9130960234682908,0.6,0.8219696397428923,1.0,7/33,11.12%,PLSCR1;DNAJB1;UHRF1;TPM1;DYNLL2;SETMAR;ATP1B2
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.5423128016653085,0.912869146261339,0.5925925925925926,0.8220917116406523,1.0,2/8,22.12%,MAPK12;CRY1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5498764617182595,-0.9122134536497748,0.6491228070175439,0.9856014151373633,1.0,3/9,34.28%,DICER1;CLP1;AGO4
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.5852604582778212,-0.9119898722243898,0.6229508196721312,0.9855171156569106,1.0,2/5,12.91%,MST1;HMGA2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.45863010925815095,0.9119650942475644,0.5909090909090909,0.8234667254432655,1.0,5/27,6.98%,VSIR;IGF1;PTPN6;LILRB1;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.4190110521911608,-0.9119624332652829,0.5849056603773585,0.9849078123504627,1.0,5/38,9.14%,CRYAB;PFDN2;EIF2AK1;VBP1;PFDN1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.4516162442718408,-0.9115461786847595,0.6,0.9852062668025661,1.0,13/38,16.93%,DYNLL1;CALM1;S100A1;RHOA;COX6B1;YWHAQ;ATP5PF;MBP;PADI2;CNP;PLP1;ATP5PB;CDC42
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.4974283646587407,-0.9112072262587528,0.631578947368421,0.9853447117575809,1.0,1/11,1.33%,SEPHS2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4920677367431865,0.9110944117343661,0.6666666666666666,0.8247874420335788,1.0,3/21,8.45%,EGFR;PLCB1;CCND1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.49998111959539604,-0.9108714238872417,0.6153846153846154,0.9853861334618349,1.0,3/11,17.19%,GOLGA2;GBF1;PLK3
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.38229694609625947,-0.9107585515476352,0.6666666666666666,0.9849265878803048,1.0,16/83,19.90%,RPS3;NCL;GAPDH;RACK1;DHFR;RPL13A;MEX3D;BTG2;ILF3;TYMS;EPRS1;PCIF1;YBX1;EIF2AK3;TPR;EIF4ENIF1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.5795015178172522,0.9107522182768223,0.6666666666666666,0.825072544677033,1.0,1/7,8.82%,FZD3
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3859133851838107,0.9106276965074547,0.6136363636363636,0.8249331978371152,1.0,7/64,11.63%,CD59;VAPB;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.473393877306121,0.9106205251451582,0.5625,0.8245872716995456,1.0,3/16,3.74%,AKAP12;LRRK2;ADGRV1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.5677431810647914,-0.9103396000283055,0.6122448979591837,0.985269717323532,1.0,1/6,6.18%,CDHR2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4180732397406198,0.9100365194621973,0.6346153846153846,0.825449535221771,1.0,9/36,23.25%,ZFP36;CPEB3;PUM1;RBM24;MOV10;ZFP36L1;FTO;DND1;GIGYF2
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.45965006193902325,0.9097239280038035,0.6666666666666666,0.8257232456521878,1.0,2/18,2.58%,P2RY12;CARMIL2
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.5823838651487281,-0.909667451377337,0.6333333333333333,0.9861751290494891,1.0,1/6,3.69%,NOC2L
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.4969947364492596,0.9094693174108132,0.631578947368421,0.8259173175065803,1.0,3/9,14.29%,LEF1;TESC;HCLS1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.3971380790998804,0.9093467176805659,0.6190476190476191,0.825809648903645,1.0,13/42,19.68%,IL12A;IRAK3;MAPKAPK3;TIRAP;NOS1;ERBIN;GGT5;RPS6KA3;NOS2;NOCT;LBP;LY96;FER
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.4363868501850429,-0.9093244057534003,0.5892857142857143,0.9862272299099635,1.0,8/33,19.10%,ACTN2;NUMA1;CEP131;CAPN10;DYNC1H1;PLK3;NEDD4;TPR
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.63858897477333,-0.9092742117480239,0.7,0.9849981309552966,1.0,3/6,22.55%,DOLK;DPAGT1;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.63858897477333,-0.9092742117480239,0.7,0.9849981309552966,1.0,3/6,22.55%,DOLK;DPAGT1;DOLPP1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.3865157183818135,0.9091148561721496,0.5897435897435898,0.8259559151754104,1.0,11/47,19.68%,THSD7A;SIPA1L1;MKLN1;DMTN;ANTXR1;TRPV4;TNIK;PHACTR1;CASS4;CDC42BPA;FER
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.4079906669165882,0.9086747991878563,0.6222222222222222,0.826450925663025,1.0,9/42,9.66%,PTPRC;NCKAP1L;IL12A;TNFSF13B;MEF2C;TIRAP;CD70;BST1;BCL2
prerank,PanglaoDB_Augmented_2021__Platelets,0.35235668629192607,0.9085492167792004,0.5853658536585366,0.8263061782472662,1.0,31/110,14.38%,ABCC4;SRGN;FGL2;ANGPT1;P2RY12;SELL;ARHGAP10;LCP2;TNFRSF1B;ITGAM;C3AR1;CSF3R;SLC26A4;NRGN;LY86;MAP3K7CL;LAPTM5;MFSD2B;P2RY13;IL33;SELPLG;SH3BGRL2;AOAH;SASH3;TUBB1;ALOX12;SCARB1;FHL1;LGALS8;HCLS1;VEGFA
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.41094465565066096,0.9081861201716261,0.6363636363636364,0.826621030774281,1.0,7/52,6.38%,PKP2;CLDN5;CDH9;CDH10;CTNND2;CDH18;CDH22
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.6340636063281108,-0.9080889276658969,0.6862745098039216,0.9869669955269328,1.0,4/5,23.18%,GPD1;GPAT2;GPAM;GK5
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.32987899074535637,-0.9080321416308356,0.6666666666666666,0.9864462520099747,1.0,17/260,6.79%,POU3F1;NGF;RPL5;RPL11;RPL23;RPS3;RPS7;GREM1;HOXD3;PDCL3;SLC22A2;FGF6;CD63;DNMT3B;ERP29;ACTG1;FAM98A
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.5240709994992423,-0.907890059949289,0.5769230769230769,0.986096051983629,1.0,1/13,1.39%,PARP2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.5844093894999084,0.9078553682620136,0.6923076923076923,0.8268722568805471,1.0,1/7,2.58%,CARMIL2
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5665316137517116,0.9076377550045982,0.5333333333333333,0.8270071751139009,1.0,1/9,3.14%,LRRK2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.5892589264380508,-0.9072287776505973,0.6458333333333334,0.987109724988882,1.0,1/6,4.32%,NUTF2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.5977026411009,0.9071286539545387,0.6785714285714286,0.827643029074931,1.0,2/6,14.60%,ITGB1BP1;MEGF10
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.5384928567312437,-0.9069577787839486,0.5777777777777777,0.9870252594201155,1.0,2/6,11.65%,RAN;NPM1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.48271790665673264,0.9068868587773126,0.6304347826086957,0.8278565656201629,1.0,2/16,1.14%,EGFR;SSTR1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.4854529764661877,0.9067603821777744,0.5102040816326531,0.8276957717307308,1.0,3/11,5.50%,AQP1;KCNC2;IRAG1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.4707606688561594,0.9067211320099684,0.5227272727272727,0.8274139729227443,1.0,1/17,2.72%,CAMSAP3
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.4843189503885016,-0.9066561123394627,0.5681818181818182,0.9870369510450766,1.0,2/16,7.96%,PPM1G;DUSP7
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.5753192082780032,0.9063348941546181,0.5957446808510638,0.8277958055688882,1.0,2/6,19.86%,NT5C1A;AMPD3
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4693300833674258,0.9063034346233707,0.5454545454545454,0.827466848094822,1.0,5/15,9.10%,PTPRC;GRM5;PTPRJ;TRPM2;DMTN
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.44649184589661184,0.9059920235880919,0.5769230769230769,0.8277168128821081,1.0,6/19,20.11%,PTPRR;TGFB3;ZNF568;VEGFA;CHD7;MBNL1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.45029771613963593,-0.9058546693415866,0.5625,0.9880422695647854,1.0,5/18,20.86%,NELFE;CTR9;SUPT5H;CCNT1;VIRMA
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.44148004889854225,0.9058436933039808,0.6041666666666666,0.8276510790246484,1.0,4/34,4.64%,PTPRC;IGF1;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.39928060242180025,0.9044940168148864,0.5365853658536586,0.8299346765213312,1.0,2/40,5.13%,EGFR;TSPYL2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.39394904698554567,-0.9043747569527865,0.6071428571428571,0.9908290489109877,1.0,4/83,2.41%,P2RY10;CXCR4;CCR3;JPH1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.39660514893242704,0.9039731610926178,0.5952380952380952,0.8304879148836626,1.0,6/45,6.73%,EPHA3;DPP10;EGFR;SORBS1;STAC2;STX3
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.5999669604974479,-0.9035862304109631,0.5555555555555556,0.9919037197057298,1.0,2/5,11.25%,BEX4;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.5839167749615923,-0.902608359866547,0.6792452830188679,0.9935685222751656,1.0,2/7,26.03%,PSMC5;PSMC4
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.44505009608872803,-0.9025564815711484,0.66,0.9930126974222938,1.0,2/21,2.63%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5625143256376798,-0.9025564777848498,0.5961538461538461,0.9923394684748889,1.0,1/8,1.12%,SELENOS
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.5946700286324723,-0.9025234107822511,0.6037735849056604,0.9910744106024981,1.0,3/5,13.94%,MYADM;MAPK7;MBP
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.5946700286324723,-0.9025234107822511,0.6037735849056604,0.9910744106024981,1.0,3/5,13.94%,MYADM;MAPK7;MBP
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.4405207079964446,0.9025084772956983,0.6086956521739131,0.8328260089313253,1.0,4/24,7.75%,TGFB2;KITLG;SOX9;WNT5A
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.578281488663648,0.9021207112826987,0.6666666666666666,0.8332147757858551,1.0,1/7,4.57%,SRC
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.47220836123902327,-0.9021162273722296,0.49056603773584906,0.9912798212888693,1.0,2/16,4.51%,JAGN1;CDK4
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.6133924992473476,0.9020012075209073,0.627906976744186,0.8330733153305405,1.0,1/5,6.55%,HEXB
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.4872471451261061,0.9019705084011315,0.5869565217391305,0.8327589250185482,1.0,5/11,16.76%,PARP14;PARP9;PARP8;TIPARP;PARP16
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.625591442752486,-0.9008932958054728,0.6458333333333334,0.9934489241079902,1.0,1/5,11.39%,PPIA
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.42842968230328277,-0.900716165914741,0.6271186440677966,0.9931253430050486,1.0,3/34,1.91%,JUP;SFRP1;CCL28
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.5421141754423481,-0.9006824115048321,0.6086956521739131,0.9925276144032593,1.0,2/8,11.59%,ATP6V1G1;ATP6AP1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.41942685795509416,-0.9005829634984639,0.5471698113207547,0.9920762920259729,1.0,8/30,14.42%,NDC80;CHAMP1;TUBG1;RAN;SGO2;MIS12;KIFC1;WRAP73
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3785331531463428,-0.900159348891361,0.6964285714285714,0.9923754701105862,1.0,19/93,16.43%,PARP2;BUB1;GSG1;LDHC;DDX4;ART3;MLF1;SEPTIN4;TSN;TALDO1;CCNB2;CFTR;RPL39L;PEBP1;GSTM3;TOPBP1;PCSK1N;HSPA2;NAA11
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.47353076319425813,0.9001413235998468,0.627906976744186,0.8358886515261452,1.0,3/16,9.61%,CD44;HEXB;LYVE1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.6126264380786945,0.9000802437632305,0.6818181818181818,0.8352791729409463,1.0,1/5,24.60%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.6126264380786945,0.9000802437632305,0.6818181818181818,0.8352791729409463,1.0,1/5,24.60%,CPSF6
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3800485020723086,0.9000588038879503,0.7346938775510204,0.8345661144263753,1.0,9/60,12.07%,NCKAP1L;CYFIP1;BAIAP2;SRC;SYK;WIPF3;PLPP4;LYN;PIK3R1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.3800485020723086,0.9000588038879503,0.7346938775510204,0.8345661144263753,1.0,9/60,12.07%,NCKAP1L;CYFIP1;BAIAP2;SRC;SYK;WIPF3;PLPP4;LYN;PIK3R1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.39774110761457865,0.9000026749868125,0.64,0.8342728179701117,1.0,12/48,12.36%,SLA;PTPRC;IKZF2;SELL;LCP2;TNFRSF1B;CD53;CD4;SELPLG;ZAP70;AOAH;SASH3
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.5058131626248243,0.8998427775096941,0.5576923076923077,0.8341941253557161,1.0,4/9,9.10%,F3;ANO6;F2;DMTN
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4297176307646158,-0.8994732500720973,0.5957446808510638,0.9934236314728779,1.0,6/20,22.91%,NCL;SF3B4;CIRBP;RBMX;PRDX6;PAF1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3558542028326302,-0.8994316041156126,0.6415094339622641,0.9928440780582666,1.0,25/189,16.93%,TPX2;BUB1;UXT;KIF3B;NDC80;KATNB1;NUMA1;CDC42EP1;CEP131;ARFIP2;CCNB2;WASF2;ARHGDIA;DYNC1H1;SHROOM1;KIF11;LLGL1;ARL8A;GSN;CENPF;LRPPRC;KIF4A;RFC1;KNTC1;CDC42
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.4618145270040882,0.8991924463798947,0.6274509803921569,0.8350299932631086,1.0,6/16,15.19%,KLF9;ZFP36;PRKD1;CDH3;PTPRK;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.36918377733833063,0.8990909989044272,0.6666666666666666,0.834825676617847,1.0,17/53,16.75%,PDGFB;UTRN;PLEKHA2;CARMIL1;NPNT;VIT;DMTN;FBLN2;CX3CL1;RAC3;CDH13;DOCK5;CSPG5;ECM2;CASS4;DOCK1;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.4873334910535483,0.8987476424342582,0.6538461538461539,0.8350862155590709,1.0,5/16,21.12%,LDB2;FEM1B;NLRC5;HMBOX1;SPTSSB
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.44268027898959417,-0.8983924886383114,0.6122448979591837,0.9944769288654037,1.0,12/41,26.79%,LACC1;PGAM1;GCK;RAE1;NUP37;TPR;NUP210;POM121C;SLC2A6;NUP93;NUP42;NUP58
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4636686185263294,0.8980630901507257,0.6122448979591837,0.8360980327316606,1.0,2/19,3.14%,CREB3L1;LRRK2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.525217026951228,0.8977976725861085,0.6166666666666667,0.8362534559183563,1.0,2/9,15.22%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.4725204620774068,0.8976119894039796,0.6170212765957447,0.8362053882023038,1.0,3/22,14.25%,TLR2;PICK1;CSPG5
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.5590492712014904,-0.8975173706463532,0.6956521739130435,0.9957169027399543,1.0,3/8,13.94%,FOLH1B;AGBL1;FOLH1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3086990022092848,0.8974246129614739,0.8484848484848485,0.8361625745024927,1.0,38/393,9.03%,FLI1;IFNA2;NPAS2;PPARG;PDGFB;TP73;EGFR;ZNF423;IGF1;MDFIC;FOS;MAP3K5;CASZ1;HEY1;PLCB1;MEF2C;GCM1;ID2;CIITA;CITED2;LEF1;PPARGC1A;ETS2;TESC;TP63;SOX9;TEAD1;TASP1;ZBTB16;WNT5A;NOTCH4;TAL1;KDM3A;CLOCK;NOS1;TBL1XR1;MAFB;CD4
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.37194786743250646,-0.8970079224196709,0.576271186440678,0.9961576413530442,1.0,18/73,19.38%,LCK;SLC39A6;ATP1B1;TPT1;RMDN3;ATP2C2;RGN;ATP2A3;SLC8A3;MT1E;MT2A;CHRNA7;SLC39A7;SLC41A1;TRDN;PKHD1;TMCO1;MT1G
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.35470464313351235,-0.8967288339102624,0.6037735849056604,0.9961853373354681,1.0,21/129,15.73%,SFRP1;ATP6V1F;ATP6V1G1;ATP6V1G2;MYBBP1A;LAMTOR4;RRAGA;GABARAPL2;ATP6V1E2;PRKAA2;HSPA8;SLC38A9;CASTOR2;ATG14;ATP6V0E1;MIOS;MAP1LC3B;LAMTOR2;DAP;FADS1;WDR45B
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.3708017799601717,-0.8964646253564464,0.6470588235294118,0.9960960278943298,1.0,8/71,11.64%,NGF;DDIT3;NRBP2;SOD1;UNC5B;BAX;MAG;GRID2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5231633788695036,0.8962978965889035,0.5882352941176471,0.8379796482729392,1.0,2/8,6.85%,ADGRB1;GRIN1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4066841339824934,-0.8962725604597573,0.5892857142857143,0.9958398528252094,1.0,6/60,8.37%,OOEP;PLK4;RACK1;EVI2B;CALM1;TXNIP
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.33125073419695894,-0.8960430177747832,0.7358490566037735,0.9957175199587036,1.0,43/274,16.23%,TUBA1A;DYNLRB1;KIF3B;EXOC7;SSNA1;PLK4;RAB8A;DYNLL1;TUBB4B;CNGA4;TUBB4A;PTPDC1;TUBG1;ABLIM3;FBF1;DCTN3;CNGB1;TMEM107;IFT81;RSPH4A;INTU;CEP131;TMEM138;MKS1;CFAP70;SNAP29;TTLL3;DYNC1H1;AKAP9;CFAP43;HAUS6;TUBB;TTC36;GSN;WDR90;ARL13B;ATAT1;DYNC1I2;DCTN1;BBS10;HAUS1;PRKACA;TCTN3
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.32354268735898617,0.895780180667654,0.7027027027027027,0.8387172041049453,1.0,14/149,6.82%,SCN9A;FGL2;IKZF2;PLSCR1;CD44;SELL;CYFIP1;BHLHE40;PIM1;TNFRSF1B;MAFF;AHCY;PLAGL1;RRAGD
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.40293719400041866,-0.8955378144356397,0.6060606060606061,0.9961623408660931,1.0,8/36,18.74%,GAPDH;SLC25A11;SLC25A1;PGAM1;CRTC2;SLC37A4;SLC25A10;ATF4
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.40570170332399236,0.8954764372053539,0.6037735849056604,0.8389804502103316,1.0,12/44,12.70%,L1CAM;SYT4;PLCB1;NEDD4L;RIMS2;TWF2;SYT1;AGRN;CPNE5;MAPT;SYT17;GHR
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.5423093136273113,0.8951193189243534,0.6808510638297872,0.839300697502378,1.0,1/9,2.67%,DLAT
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.48954322878452844,0.8950814945811874,0.5714285714285714,0.8389965974162001,1.0,1/8,10.09%,ZFAND6
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.45529460529917404,-0.8949428828007041,0.62,0.9967398863881733,1.0,4/19,13.46%,LGALS1;CHMP2A;KPNA2;CHMP3
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.48422938669308957,0.8949369127279666,0.5818181818181818,0.8388799013896631,1.0,5/11,19.72%,SNAP25;SLC22A3;SLC29A2;SLC29A4;ATP1A2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5012827882640237,0.8948739017741083,0.55,0.8386593866713553,1.0,3/11,11.26%,MET;HSPB1;PRKD1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.32437056150249527,-0.8948322228768869,0.6833333333333333,0.9963340812846714,1.0,59/341,19.95%,RPS27A;SELENOS;UBC;RNF8;UBB;RNF212;ZNF598;PCNA;MARCHF2;UBE2D4;UFC1;RACK1;RNF113A;ELOC;CDC23;TRIM60;RRAGA;ELOB;URM1;SDE2;RNF181;TMEM129;TRIM52;CCDC22;RFWD3;KIAA1586;TRIM61;RAE1;KLHL20;UBA52;DCAF15;MYLIP;ASB5;UBE2Q2;UFL1;CTR9;RNF6;VPS11;KEAP1;NUP37;UBE2M;UBE2A;FBXW8;UBE2L3;FBXL15;TRIM14;TRAF7;TRIM28;RNF41;NEDD4;RTF1;UBE2S;TPR;UBE2N;TRIM7;PEX10;PJA2;PRKDC;PINK1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.48963842645150646,-0.8946660957595792,0.640625,0.9961451742169124,1.0,2/15,9.30%,INTS14;TOE1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.5273515331563456,-0.8946226068774785,0.5666666666666667,0.9955795362662814,1.0,3/10,13.82%,CORO1B;ARFIP2;GSN
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.526287987648734,0.8946048144125606,0.5625,0.8388182087703374,1.0,1/8,9.91%,BMPR2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.6123197899813126,-0.8945987684520532,0.7115384615384616,0.9949703321410932,1.0,1/7,3.11%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.42799242784433283,0.8945038176668357,0.5681818181818182,0.8386757856375787,1.0,9/29,18.40%,TGFB2;WNT5A;RSAD2;CDKN2A;HOMER1;ACOX2;CD80;PRKCD;HMGA1
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.620302596640622,0.8944909848893138,0.6964285714285714,0.8383103495654055,1.0,1/5,3.85%,ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.45150730557187946,-0.8943249312515665,0.6041666666666666,0.9949654165793856,1.0,8/28,20.85%,NCL;RBM22;POLR2A;SF3B4;CIRBP;ZPR1;RBMX;PRDX6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.41758546990124185,0.894138301822716,0.5531914893617021,0.8387077169553587,1.0,3/27,8.45%,EGFR;PLCB1;CCND1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.5716787866386541,-0.8939511300231313,0.6415094339622641,0.9951873517068347,1.0,2/7,8.47%,SERPINE1;CREB3
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3421976422157954,0.8935734692192367,0.6585365853658537,0.8394313754384916,1.0,21/116,13.29%,FKBP5;EGFR;PPP1R3C;GPC6;KIAA1217;LRIG3;TMEM47;DDAH1;CHST3;MYO1B;ADGRL2;TEAD1;KCTD3;FNDC4;SYT7;EPB41L1;LAMB2;CPE;CDC42EP4;SFRP4;GPC1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.4745326646579391,0.8934543617421844,0.6382978723404256,0.8392733860093119,1.0,4/15,18.98%,GPLD1;GRAMD1B;GRAMD1A;GRAMD1C
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.43722539189523235,0.893355356785759,0.64,0.839068912175496,1.0,4/24,7.75%,TGFB2;KITLG;SOX9;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.5650612127833365,-0.8933347918807855,0.6181818181818182,0.9958236734467116,1.0,1/7,8.19%,RHOA
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),0.48471796128844985,0.8932761857051014,0.6444444444444445,0.8388076586630683,1.0,3/13,4.89%,NCKAP1L;SYK;ID2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.5129507086253808,-0.8929521930659363,0.6086956521739131,0.9960005383128359,1.0,7/12,33.94%,NCSTN;BACE1;CLN3;APH1A;APH1B;ADAM17;PSEN1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.5427563119732379,-0.8929403999090219,0.6666666666666666,0.9953544285248836,1.0,5/9,33.62%,GGCT;OPLAH;HAGH;CNDP2;MGST2
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3826152085801676,-0.8922182559141653,0.639344262295082,0.9963425263292974,1.0,4/82,2.01%,NGF;CRYAB;TEAD3;NES
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.5920549917574413,0.8921977849400983,0.6875,0.8403736552462147,1.0,1/5,6.36%,SLC2A5
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.5569304995830486,0.8915104610884922,0.6052631578947368,0.8413381705834889,1.0,1/6,1.46%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.5691617221561565,-0.8910749896768808,0.75,0.9980572121691184,1.0,2/9,30.13%,HDAC6;ABL1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.47403491103073403,-0.8910255669959863,0.7166666666666667,0.997493684911451,1.0,1/18,1.04%,CDKN1C
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.3875801517977917,0.8904208199327193,0.673469387755102,0.8431861248467439,1.0,6/65,9.60%,IGF1;SLC4A4;GIT1;PFKFB3;ARNT;NUP43
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.39132553381763896,-0.8896424425452537,0.5818181818181818,1.0,1.0,5/48,12.41%,PRELID1;NPC2;PRELID2;TRIAP1;ABCC1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.38880241502581553,0.8895632315858103,0.6086956521739131,0.844298482179866,1.0,6/45,6.73%,EPHA3;DPP10;EGFR;SORBS1;STAC2;STX3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.4258055720961292,-0.8893877680607083,0.6111111111111112,1.0,1.0,4/51,7.29%,LSM7;LSM2;EXOSC8;NT5C3B
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.4520653489786338,-0.8893296826024463,0.6052631578947368,0.9995364387472598,1.0,8/26,15.35%,SF3A3;SF3A1;SNRPC;SRSF9;PRPF39;KHDC4;PUF60;SF3A2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.4649115657339169,0.88903016979689,0.5869565217391305,0.8450120368344655,1.0,1/13,1.20%,TRIM5
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.3942514529985408,-0.8889815554171555,0.6984126984126984,0.9996439540820523,1.0,2/50,1.71%,WNT9A;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.4658005746662497,0.8888270796736971,0.5714285714285714,0.8450226032940382,1.0,3/13,14.46%,GPLD1;SCARB1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3887478071688666,0.8885590328396035,0.6086956521739131,0.8451518921531389,1.0,6/55,12.91%,MAP3K5;PLCB1;SH3RF3;TIRAP;ANKRD6;MTURN
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.48731627998456256,0.888319754424337,0.5348837209302325,0.8452139889110472,1.0,5/12,18.25%,MET;HSPB1;PRKD1;VEGFA;KDR
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.5053728420731579,-0.8883162438991989,0.6530612244897959,1.0,1.0,1/8,4.58%,GPX4
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.5044424841708404,-0.8882113646246835,0.6538461538461539,1.0,1.0,6/19,21.71%,SURF1;NDUFS8;UQCR10;UQCRB;UQCRH;NDUFS7
prerank,MSigDB_Hallmark_2020__Coagulation,-0.3753854288460989,-0.8879502939817479,0.5932203389830508,0.9998833686792128,1.0,13/86,13.82%,MMP11;F11;SERPINE1;MSRB2;CD9;TF;S100A1;SPARC;CFH;RGN;MST1;GSN;RAC1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.37621293447840226,-0.8879171873106813,0.59375,0.9993216129285145,1.0,8/70,12.66%,PARP1;TONSL;RAD51AP1;ZSWIM7;RFWD3;HUS1;BLM;SFR1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.4430302743531782,-0.8878812559663058,0.6415094339622641,0.9987551207658216,1.0,12/37,18.88%,SURF1;UQCRFS1;ETFRF1;NDUFS8;ETFB;UQCR10;LYRM7;NDUFA5;UQCRB;ETFA;COQ10B;UQCRH
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.5232315230850035,0.8876648389161315,0.627906976744186,0.8460858018232117,1.0,4/8,18.66%,DDAH1;NOS1;NOS2;ARG1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.5251557385285612,0.8876472320797334,0.56,0.8457607752135204,1.0,2/7,16.58%,ARNT;SESN2
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.445985229412057,0.8871208027367694,0.723404255319149,0.8464409246880947,1.0,7/20,9.66%,PTPRC;NCKAP1L;TNFSF13B;MEF2C;TIRAP;BST1;BCL2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.4372783967851892,0.88688654424373,0.6415094339622641,0.8465538672493026,1.0,5/20,23.32%,ACADL;AOAH;PLBD2;CYP1B1;CEL
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.5826531621159887,0.8867613465385126,0.6326530612244898,0.8464195673177556,1.0,2/7,13.59%,EPHA4;THY1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3288925105595112,-0.8864532321516939,0.7377049180327869,1.0,1.0,48/346,16.54%,TEAD2;DDIT3;WWC2;THAP1;EDF1;DRAP1;PPIE;SPIN2B;ZNF664;ZNF22;LMX1B;MLX;NKX6-2;MYBBP1A;HES6;ZNF676;ZNF492;MLF1;RPL6;POLR2A;ZSCAN21;PATZ1;ACVR1B;PCGF1;CDK11A;AHR;CDK11B;ZFHX3;SLC2A4RG;HMGA2;CARM1;ZNF117;ZNF221;CTR9;SBNO1;RNF6;DAXX;ACTR8;SOX15;THAP7;SAP30;FADS1;NR5A2;TCF7L1;SPIN2A;REXO4;UBE2L3;GON4L
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5344094436683968,-0.8860769801184093,0.6349206349206349,1.0,1.0,2/11,12.36%,EXOSC5;DKC1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.40254404209357364,0.8860689495418376,0.5957446808510638,0.8473558815907096,1.0,2/39,1.41%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5635732333885939,-0.8857816944567886,0.6744186046511628,1.0,1.0,2/5,14.78%,TAF7;PIH1D1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.392885989155169,-0.8857769576700629,0.5892857142857143,1.0,1.0,3/53,1.21%,CRTAM;DDIT3;BTN3A1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.43637524066004785,0.885690229168337,0.6097560975609756,0.8476894918657991,1.0,8/32,10.68%,PDGFB;PID1;SYK;ITGAM;ADGRB1;GRIN1;F2;MAPT
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.49410757767172636,0.8854802989311975,0.6170212765957447,0.8476988566329595,1.0,5/11,14.26%,LOXL3;DMTN;BST1;PRKD1;ITGB1BP1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.3789386566075132,-0.885211382097146,0.6153846153846154,1.0,1.0,21/67,21.46%,NUTF2;GEMIN6;PTTG1IP;PHB2;SNUPN;RAN;SMN1;SNRPD1;NXT2;SNRPD2;SNRPB;SNRPE;RANBP17;SNRPG;APPL2;NXT1;TPR;EIF4ENIF1;IPO5;POM121C;IPO7
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.4521057265214595,-0.8850795158699499,0.5384615384615384,1.0,1.0,1/16,3.23%,VAMP8
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.5318928997765384,-0.8848559485713697,0.6666666666666666,1.0,1.0,2/9,16.71%,TRARG1;ZDHHC7
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5921455703989992,0.8848332063486037,0.6444444444444445,0.8485820068364575,1.0,2/5,25.94%,AFG1L;BNIP3L
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.3716369681226496,0.8844697017639391,0.6829268292682927,0.8488221769880337,1.0,14/66,8.43%,ADAM28;PTPRC;SELL;NCKAP1L;IKZF1;CD53;ARHGAP25;PNOC;NPIPB15;LILRB1;WDFY4;BTLA;LY86;LAPTM5
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.5442236307811228,0.8843876350518688,0.675,0.8486358911026509,1.0,6/12,20.89%,CGNL1;TJP2;TJP3;MPP7;PAK2;JAK1
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.49946027656973185,-0.8841921773295813,0.6551724137931034,1.0,1.0,2/9,4.70%,SLC22A2;DAGLA
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.33707251744644345,-0.8839956863914702,0.7037037037037037,1.0,1.0,34/180,13.31%,UBC;JAGN1;CYC1;GRPEL1;ACAA2;ECHS1;GPX4;SOWAHC;CMPK1;SAMM50;COX7B;SLC25A1;ARAF;SOD1;NDUFAB1;COX6A1;RMDN3;ECH1;CAVIN1;UCP2;UQCRQ;PRDX3;CHUK;ETFB;TALDO1;UCK1;ABCB8;MRPL15;CDKN2C;TKT;SSPN;MGST3;HSPB8;UQCR10
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3224827909049637,0.8839437260799538,0.75,0.8491222301232145,1.0,22/176,13.39%,ROR1;TRIM5;BIRC3;MAPKBP1;CASP10;PER1;HSPB1;WNT5A;C18ORF32;TIRAP;NOD1;ZDHHC13;TNFRSF1A;CD4;ZFAND6;TRIM22;TNFRSF10B;CX3CL1;PRKD1;CARD11;WLS;CLEC7A
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.4254256934474963,-0.8825709505691858,0.6122448979591837,1.0,1.0,3/20,4.85%,DCTD;AK8;CMPK1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.3225808367006815,-0.8824999071723805,0.7704918032786885,1.0,1.0,42/280,15.95%,CKAP4;COPS6;ASB6;PSMD7;RAB8A;PSMB6;PSME2;LGALS1;DCAF13;FBXW10;PSMD8;VWA1;BTBD6;ELOC;TF;F5;ELOB;PSMB4;AFP;MELTF;PSMD3;PSMB3;CCDC22;PSME1;SPSB3;GPS1;KLHL20;PSMA7;ASB5;PSMD13;KBTBD8;PSMB8;ERCC8;COPS5;KEAP1;FEM1A;KNG1;APLP2;UBE2M;PSMD2;FBXW8;MEN1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.5496923063799808,-0.8824785435091173,0.6511627906976745,1.0,1.0,2/6,18.61%,DPY30;EZH1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.5325162593781595,0.8820949845461805,0.6,0.8522250129518539,1.0,3/9,14.87%,KCNMA1;ATP1B2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.5290484921171522,0.8818586591409682,0.6590909090909091,0.8523965248439314,1.0,3/11,6.09%,IFNA2;PRKCZ;LEF1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.47643977186929864,-0.8814625273404683,0.6226415094339622,1.0,1.0,1/11,1.25%,AMPD1
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),0.572183524454963,0.88142527715126,0.723404255319149,0.8528908702926293,1.0,4/6,33.07%,PAH;SDS;CPS1;ALDH18A1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.5020083264246477,0.8813801076148362,0.6,0.852580246944171,1.0,6/12,15.27%,BMP6;ANGPT1;TJP2;TRPV4;VEGFA;TJP3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.4279727490641728,-0.8813588509037056,0.56,1.0,1.0,8/33,20.46%,VAMP5;TRARG1;GORASP1;RAB31;GORASP2;BLZF1;NECTIN3;GOLGA7
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.5120834263904799,-0.8812873303762558,0.6304347826086957,1.0,1.0,2/12,12.95%,B2M;HLA-DRA
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.5356176302821868,0.8809730954249898,0.58,0.8531919004770119,1.0,5/7,27.06%,NR4A3;LEPR;UGCG;STAT3;SIRT1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.5376074986860927,-0.8807214240270175,0.660377358490566,1.0,1.0,1/8,3.11%,RAB7B
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.45805121411460753,0.880418456311708,0.7090909090909091,0.8538132682300996,1.0,3/13,8.92%,CARTPT;LILRB1;MAFB
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.5113787597678372,0.8804073021680777,0.62,0.8534565880904902,1.0,4/7,19.68%,ADGRE2;LYN;FES;FER
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3930156123860973,-0.8798460643328639,0.5882352941176471,1.0,1.0,5/45,6.42%,FUCA1;GPC4;GPC2;HYAL2;B4GALT7
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.44035440576662577,-0.8798074013407715,0.6458333333333334,1.0,1.0,5/15,20.85%,NCL;SF3B4;CIRBP;RBMX;PRDX6
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3455842588815328,0.8797447117876116,0.6666666666666666,0.85432286073082,1.0,26/91,14.03%,FIGN;EGFR;FSTL1;CSPG4;LAMC1;DDAH1;LOX;ADAMTS15;CHST3;COL12A1;GPR176;TENM3;MEIS3;COL4A1;TEAD1;NUAK1;ANTXR1;AMOTL1;LAMB2;PCGF2;GPC1;NR2F2;LRP4;P3H4;CAP2;FHL1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.35301543238767674,-0.8797340022985932,0.6491228070175439,1.0,1.0,17/115,13.71%,JUP;SFRP1;PSMD7;PSMB6;PSME2;PSMD8;BAMBI;SEMA5A;PSMB4;PSMD3;PSMB3;PSME1;PSMA7;ILK;PSMD13;PSMB8;TMEM198
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.562693387352868,-0.8796804547260063,0.6382978723404256,1.0,1.0,1/6,14.16%,BRK1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4068376328523766,-0.8792499007852387,0.6666666666666666,1.0,1.0,1/36,0.19%,BMP5
prerank,GO_Biological_Process_2021__regulation of dendritic cell cytokine production (GO:0002730),0.5594506198522524,0.8791553281806632,0.6666666666666666,0.8550810064194317,1.0,2/5,21.89%,CLEC7A;SCIMP
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.4342878499786141,-0.8789807664495232,0.6545454545454545,1.0,1.0,9/30,15.66%,BAK1;BAX;FIS1;IFI6;THEM4;TIMM50;GGCT;BAD;IFIT2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.535365354114929,-0.878921303025615,0.6538461538461539,1.0,1.0,1/11,1.19%,MBOAT1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.3710434919430936,-0.878627450186327,0.66,1.0,1.0,16/79,17.99%,RPS3;NCL;GAPDH;ORMDL2;ORMDL1;RACK1;DHFR;RPL13A;BTG2;ILF3;TYMS;EPRS1;CHRNA7;PCIF1;YBX1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.598718021502816,0.878623887191878,0.6938775510204082,0.8557260530915936,1.0,1/5,1.46%,PLSCR1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4635930650035629,0.8784171456544676,0.6486486486486487,0.8556450553571298,1.0,7/21,14.77%,SLC43A1;SLC7A9;SLC6A15;SLC7A8;SLC1A1;SLC6A7;SLC38A6
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.3761389684947087,-0.8777670392978393,0.5517241379310345,1.0,1.0,11/63,13.47%,ZDHHC12;NACA;MYO1C;ZDHHC14;NACAD;GRIN3B;NPC1;GORASP1;YIF1B;GORASP2;SYNE3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.43064061086939837,-0.8777187574731321,0.6440677966101694,1.0,1.0,8/32,12.80%,ATP6V1F;ATP6V1G1;ATP6V1G2;TF;MCOLN1;ATP6V1E2;ATP6AP1;ATP6V0E1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.418668424277653,0.8776031231137689,0.6170212765957447,0.8566978589727241,1.0,6/29,14.25%,VCAN;CSPG4;HEXB;NCAN;GGT5;CSPG5
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.4313218595928371,0.877561120450463,0.6428571428571429,0.8564480586511029,1.0,9/37,22.58%,HOOK1;DNM1;CORO1C;ALS2CL;CLCN3;SNX33;SNX10;RAB27A;ARFGEF2
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.5378382928764127,-0.8775550807462844,0.68,1.0,1.0,3/11,20.06%,FNTA;ING2;AKAP8
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.5488545538192956,0.8774404310523345,0.6530612244897959,0.856351548111414,1.0,3/7,13.59%,FUT9;BST1;THY1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3211554809850178,-0.8772748716011075,0.7903225806451613,1.0,1.0,53/383,16.54%,TEAD2;DDIT3;RPL10;WWC2;THAP1;EDF1;DRAP1;PPIE;SPIN2B;ZNF664;ZNF22;LMX1B;MLX;NKX6-2;MYBBP1A;HES6;ZNF676;ZNF492;MLF1;RPL6;POLR2A;ZSCAN21;PATZ1;ACVR1B;PCGF1;CDK11A;PDGFA;METTL18;AHR;CDK11B;ZFHX3;SLC2A4RG;GATA1;HMGA2;TCOF1;CARM1;ZNF117;ZNF221;CTR9;SBNO1;RNF6;DAXX;ACTR8;SOX15;THAP7;SAP30;FADS1;NR5A2;TCF7L1;SPIN2A;REXO4;UBE2L3;GON4L
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.35723897386354286,0.8772095294321661,0.723404255319149,0.8564744348151093,1.0,11/65,15.25%,ANGPT1;LRRK2;BIRC3;PRICKLE1;AMER1;LAPTM5;DCUN1D4;FANCI;PIAS1;CUL3;WDR48
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.4679128119554235,0.8769742157128045,0.6363636363636364,0.8565411365950532,1.0,5/11,24.72%,NOS1;NOS2;CACNA1C;NF1;STIM1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.45807565640306896,0.8769166978062136,0.6046511627906976,0.8562765429694634,1.0,1/11,3.26%,NEDD4L
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.5539592578553432,-0.8768916541631182,0.7291666666666666,1.0,1.0,1/8,0.19%,BMP5
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.562636839758558,-0.8764010904946741,0.6792452830188679,1.0,1.0,3/5,18.59%,ATG14;SQSTM1;BECN1
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.5487852863607188,0.8763548510350476,0.6744186046511628,0.8571226228996474,1.0,2/5,28.24%,OTUD7B;USP9X
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.42561565029338355,-0.8762589749396184,0.6,1.0,1.0,5/41,4.80%,RPS3;RNF8;H2AX;PCNA;USP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.38686986555701075,-0.8754386770256357,0.7017543859649122,1.0,1.0,5/78,7.28%,NGF;RACK1;OPRD1;ARAF;CNKSR3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.5933169205060367,-0.8753562233708823,0.6274509803921569,1.0,1.0,1/7,3.71%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.5933169205060367,-0.8753562233708823,0.6274509803921569,1.0,1.0,1/7,3.71%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.5338982484180338,-0.8749774930821945,0.6349206349206349,1.0,1.0,1/8,3.74%,PCNA
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.5338982484180338,-0.8749774930821945,0.6349206349206349,1.0,1.0,1/8,3.74%,PCNA
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.3936746047682855,-0.8747446727743535,0.6226415094339622,1.0,1.0,9/29,21.35%,CLDN2;LAMB3;EHF;TSPAN8;HNF4A;PTPRH;KRT8;B3GNT3;LIPH
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.3556071385222187,0.8746571417754343,0.6829268292682927,0.8599944428591653,1.0,19/75,14.93%,NCKAP1L;SYNPO2;BAIAP2;MET;CARMIL1;FCHSD2;BAIAP2L1;MYLK3;TENM1;VIL1;MAPT;CDK5R1;CX3CL1;TRPV4;CDC42EP4;CDC42EP3;SYNPO;STMN2;PRKCE
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.5542757770125287,-0.8744973970800682,0.6491228070175439,1.0,1.0,1/5,6.73%,RAN
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.37426743345721597,-0.8744259358906895,0.6415094339622641,1.0,1.0,15/96,13.67%,DDIT3;SELENOK;SELENOS;ATF3;UFC1;FICD;USP19;RASGRF1;BAK1;CFTR;BAX;ERLEC1;ATP2A3;GORASP2;UFL1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.5534523052061762,-0.8740343451340609,0.75,1.0,1.0,2/7,20.64%,PNKD;SYT11
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.5057876275624332,0.8740280491744277,0.6274509803921569,0.860721153657563,1.0,6/10,34.03%,FZD3;NF1;NRP2;GDNF;ASCL1;SOX4
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.37749090181514444,-0.8740218484419268,0.6923076923076923,1.0,1.0,7/89,9.50%,ABCA13;PRELID1;SLC10A3;NPC2;ABCA8;PLEKHA3;PRELID2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.3595813031553579,-0.873978461956917,0.8,1.0,1.0,6/99,3.23%,CXCR4;CRYAB;TXLNB;SRL;SLC25A4;ACTN2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5169996781091781,0.873947992661538,0.5952380952380952,0.8604908374344494,1.0,2/7,23.84%,SERPINB9;TRIM27
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.49480465776272,-0.8739293628376398,0.6785714285714286,1.0,1.0,3/11,13.82%,STMN1;MST1;RAC1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.39700059058920734,0.8738041992811444,0.6170212765957447,0.8604285260182838,1.0,5/33,12.83%,SLA2;SOCS3;IP6K3;PIK3R1;PIP4K2A
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.4002719491928375,-0.8735568016394951,0.6222222222222222,1.0,1.0,3/56,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.522896140523586,-0.8732826199436919,0.6862745098039216,1.0,1.0,1/7,2.56%,PTH
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.4686860440603955,-0.8732490681396782,0.6862745098039216,1.0,1.0,3/12,11.05%,AK8;CMPK1;ITPA
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.5467523288702253,0.8729153317426517,0.7,0.8617081598117815,1.0,2/6,11.34%,CX3CL1;NECAB2
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.5977972781544312,0.8727273806748007,0.6923076923076923,0.8616707860060481,1.0,2/6,12.01%,ST8SIA3;ST6GAL1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.5115911481892008,0.8726182815471674,0.6046511627906976,0.8615267937023787,1.0,1/7,1.07%,AQP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5205702680782524,0.8725379583481789,0.6875,0.8613220070613063,1.0,1/10,2.60%,MAP3K5
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.4182126457336484,0.872365327086786,0.6792452830188679,0.861254399989314,1.0,9/30,16.58%,GLRA3;RRAGD;GRIN1;GLRB;CPEB3;GLRA2;NSMF;RPTOR;SESN2
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4290541358735134,0.8719731917390553,0.6382978723404256,0.8619273771589581,1.0,5/26,10.20%,TGFB2;BMP6;INHBC;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4189214293211345,-0.8719029906137776,0.6666666666666666,1.0,1.0,6/27,15.54%,SERPINE1;ACTG1;AJAP1;HRAS;EPHB2;CRK
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.44230665577354394,-0.8718814271320727,0.5961538461538461,1.0,1.0,3/27,5.68%,PRELID1;ACAA2;SLC25A5
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.3387211333177083,0.8718211095629564,0.7906976744186046,0.861844360112086,1.0,19/144,8.83%,EPSTI1;FGL2;PLSCR1;MX1;PARP14;PIM1;PTPN6;ISG15;LCP2;CIITA;SAMHD1;XAF1;ST8SIA4;NFKBIA;MARCHF1;RSAD2;NOD1;CASP7;SOCS3
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.3311517801218322,0.8716571625875386,0.6842105263157895,0.8617715492854066,1.0,17/107,14.33%,AQP1;SLC23A1;SLC25A48;CBLIF;SLC22A3;SLC43A1;SLC7A9;ARRDC2;PICK1;SLC15A2;SLC6A8;SLC6A15;SLC35F3;SLC6A4;SLC7A8;ARRDC5;CHMP1A
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.5214264046865247,-0.8715502644485966,0.6444444444444445,1.0,1.0,2/10,11.73%,NPL;ST3GAL1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.42891896193565493,0.8711209246384264,0.717391304347826,0.8624738414994031,1.0,7/32,20.49%,LRRK2;KAT2B;CCP110;KAT2A;CAV3;LIMK2;MTM1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.4805788017184156,-0.8711043951019856,0.6976744186046512,1.0,1.0,1/12,0.19%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.43426425003560953,-0.8710228172731765,0.7647058823529411,1.0,1.0,4/31,5.40%,TPX2;STMN1;TUBB4A;KATNB1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.45874172488905246,0.8708549253415971,0.6,0.862664125616433,1.0,3/19,9.74%,IFNA2;IRAK3;RFTN1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.3809932156948039,-0.8707972834465283,0.6785714285714286,1.0,1.0,7/72,8.72%,ORC1;PCNA;CDK4;TFDP1;DHFR;CDK15;ACVR1B
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.47723745520334293,0.870467103994999,0.7083333333333334,0.8630668235380987,1.0,4/12,12.21%,ADCY8;ADCY2;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.5426599364400588,0.8703546027516683,0.65,0.8629582029145305,1.0,1/6,11.23%,P4HA1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.3752589036741578,-0.8702096579573532,0.7090909090909091,1.0,1.0,2/47,2.18%,TLN1;SRPRA
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.5567061979980672,-0.8695866366587716,0.6744186046511628,1.0,1.0,1/5,14.42%,WRAP73
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.37032413258649394,-0.8688304533486281,0.6666666666666666,1.0,1.0,17/80,21.04%,RAB7B;STX10;TMED9;WASHC2A;LMAN1;VPS29;STX6;RNF126;DCTN1;VAMP3;SURF4;GBF1;SNX3;CLTCL1;VPS35;ARL1;ANKFY1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4135057292039742,-0.8686016331790093,0.6666666666666666,1.0,1.0,9/36,17.99%,PRMT2;FAM98A;VCPKMT;TRMT112;CSKMT;SNRPB;CARM1;FAM98B;ETF1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5997230617096361,-0.8685110751624836,0.7254901960784313,1.0,1.0,1/5,5.52%,HMGCL
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.5433859542761577,-0.8683832490211418,0.5918367346938775,1.0,1.0,1/7,4.09%,LGALS1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.5433859542761577,-0.8683832490211418,0.5918367346938775,1.0,1.0,1/7,4.09%,LGALS1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.5010383524663466,-0.8683601728553085,0.6981132075471698,1.0,1.0,2/11,5.34%,STMN1;TUBB4A
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.5554549707742542,-0.8682875319545105,0.7142857142857143,1.0,1.0,3/6,26.62%,TPR;NSUN2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.5554549707742542,-0.8682875319545105,0.7142857142857143,1.0,1.0,3/6,26.62%,TPR;NSUN2;SUPT6H
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.4461395551464278,0.8681606254202064,0.6382978723404256,0.86663738556453,1.0,3/21,8.30%,ADCY8;SLC2A5;KCNB1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.4126466903983601,0.8681115740228567,0.6818181818181818,0.8663251465250184,1.0,11/28,20.00%,CITED2;ODAD3;DNAI2;DNAH11;ARL6;RFX3;DNAAF1;MKKS;ODAD4;CFAP53;PKD2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.39151111150637946,0.8680280826500187,0.6666666666666666,0.8661091743586469,1.0,6/34,14.24%,RAB3C;RAB15;OLFM2;TVP23A;RAB3A;ABCA1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5032952170631868,0.867899025895106,0.6808510638297872,0.8659337900963336,1.0,3/12,8.51%,SLC26A4;SLC13A4;SLC26A7
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.4083581139361949,0.8678687995194088,0.7222222222222222,0.8656272948483721,1.0,6/23,17.62%,KASH5;TERB1;P3H4;IHO1;SYCP1;SYCP2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.5310640777556959,-0.8673236656783712,0.673469387755102,1.0,1.0,3/8,23.82%,TAF7;TAF11;GTF2A2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.33819462288043844,0.8664259562740005,0.7380952380952381,0.8680309278302535,1.0,12/82,14.09%,GALNT8;GALNT3;GALNT14;POGLUT2;GALNTL6;GCNT4;MUCL1;ST8SIA6;B3GNT6;ST6GAL1;FKRP;MUC16
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.4774772556110986,-0.8662508856568736,0.6551724137931034,1.0,1.0,1/13,1.11%,STAC3
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.5567540198992228,0.865812147809868,0.5869565217391305,0.8687931685792563,1.0,3/6,16.51%,TNFRSF10B;TNFRSF10A;SPI1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.442394184375921,-0.8658110931323111,0.631578947368421,1.0,1.0,3/26,4.66%,CA6;CA5A;CYB5R1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.5448963983223388,-0.865650627029629,0.6274509803921569,1.0,1.0,2/7,12.07%,NUMA1;SAPCD2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.3581048733879605,0.8655890898478387,0.5961538461538461,0.8688740888971662,1.0,9/41,13.29%,GPC6;B3GALNT1;HS3ST1;GPC5;AGRN;B3GALT1;B3GNT6;HS3ST3A1;GPC1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.36390012161550145,-0.8654627493936743,0.625,1.0,1.0,3/62,3.37%,NGF;DPEP1;BEX3
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.3965441738427169,-0.8653173752138524,0.6724137931034483,1.0,1.0,11/66,15.95%,RNF8;H2AX;RAD51AP1;RFWD3;HUS1;BRCC3;BLM;KAT5;TOPBP1;ABRAXAS1;MEN1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.5062555517918349,0.8651134928530129,0.65,0.8694992502903021,1.0,1/9,2.73%,NHEJ1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.5131852390455757,0.8651114918992595,0.6923076923076923,0.8691314418087919,1.0,6/11,27.32%,CX3CL1;MSMP;GAS6;CXCL13;CXCL16;HSD3B7
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.5544929395282241,-0.8649581986453743,0.6296296296296297,1.0,1.0,1/5,11.62%,EXOSC5
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.5420343414934774,0.8649207666179074,0.6785714285714286,0.8691315461854515,1.0,1/7,3.14%,LRRK2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.4883940932111759,0.864795493785424,0.7115384615384616,0.8690058126497094,1.0,5/13,29.58%,SEMA6A;NSMF;SRGAP2C;DAB2IP;PLAA
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.5757646777196334,-0.8647474479422987,0.7368421052631579,1.0,1.0,4/5,37.04%,MSN;SPP1;NCOA4;ROCK2
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.5757646777196334,-0.8647474479422987,0.7368421052631579,1.0,1.0,4/5,37.04%,MSN;SPP1;NCOA4;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.45699181106984715,-0.8645513369244208,0.5882352941176471,1.0,1.0,7/19,27.99%,FIS1;VPS35;PINK1;RALA;DCN;MUL1;BNIP3
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.47945137882266076,-0.8645427084022675,0.7083333333333334,1.0,1.0,2/10,15.73%,ATG9A;WDR45B
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.45487777400365426,-0.8643823705018984,0.75,1.0,1.0,1/20,1.04%,CDKN1C
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.42267466728191333,0.8642918445925261,0.5476190476190477,0.869670113022191,1.0,6/20,21.06%,ITGAM;ARHGAP25;SNX33;DOCK1;ELMO1;SPIRE1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.4332697697103579,-0.8639184124665608,0.6037735849056604,1.0,1.0,1/23,0.25%,CXCR4
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.43295095092601543,-0.8637660741423844,0.6666666666666666,1.0,1.0,3/50,2.35%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.5049754425129348,0.8634780759744668,0.6818181818181818,0.8709625100412953,1.0,3/6,18.74%,DMD;DMPK;CAV3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5387073944204549,0.8633830930067135,0.6875,0.8707959457344747,1.0,3/10,17.36%,NCKAP1L;CBFB;TNFSF4
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.3646127191832412,0.8632243326274194,0.7142857142857143,0.8707450973927359,1.0,20/64,19.62%,CX3CR1;MEF2C;TNFRSF1B;AXL;LILRB1;ZFP36;WNT5A;GIT1;IRGM;VIM;LYN;NLRP3;PRKCE;LBP;CD80;TNFSF4;NLRP7;TICAM1;LDOC1;LY96
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.4647814513822612,-0.8630763933610021,0.7115384615384616,1.0,1.0,1/16,1.71%,SFRP1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3373494539613922,-0.8627980277347236,0.8,1.0,1.0,11/124,11.23%,TAX1BP3;ERAS;RHOG;CFL1;CDC42EP1;RHOA;PLCE1;ARHGEF1;CDC42EP5;HRAS;ARHGDIA
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.36683920354953553,0.8627948388250276,0.5952380952380952,0.8711764901720105,1.0,10/62,12.43%,SLC8A1;VAPB;SLC24A4;SLC24A3;GRIN1;ATP2B3;ATP2B2;HTR2C;TRPV4;DMPK
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5234018286143732,-0.8627779717138833,0.6415094339622641,1.0,1.0,4/8,38.06%,CDC42;ECT2;CCNB1;SIRT2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.44991608556870416,-0.8626576429885052,0.6481481481481481,1.0,1.0,2/19,4.51%,DPEP1;ENPEP
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.5441600475102754,-0.8624653796859322,0.6111111111111112,1.0,1.0,2/5,15.26%,CHMP2A;CEP120
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.3799194057607217,0.8623373611820511,0.6888888888888889,0.8717129556071506,1.0,5/38,10.03%,AQP1;TRIM29;ZBTB7C;IL33;GRHL2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.4220523353904747,0.8623016228477728,0.6833333333333333,0.8714158705367363,1.0,2/19,13.96%,KLHL15;CUL3
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.5612116840213541,-0.8621726429422122,0.68,1.0,1.0,1/5,8.19%,RHOA
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.3911599653684712,-0.8619566995548441,0.75,1.0,1.0,10/46,17.38%,FUCA1;GLA;GBA3;SMPD2;SCCPDH;PIGW;GLTP;NEU4;CPTP;ESYT1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.29002676813916567,0.861901998631717,0.8648648648648649,0.8718765349245181,1.0,77/377,17.87%,ARHGAP31;TP73;EGFR;ARHGAP10;KALRN;RHOJ;AKAP12;ARHGAP18;LRRK2;RIT2;BIRC3;OBSCN;PAK3;PIP5K1B;FAM13B;SRGAP1;NTRK2;RHOQ;ARHGAP25;TIAM2;RHOF;TP63;NFKBIA;ARHGEF6;HSPB1;WNT5A;BANP;GRM2;NGEF;FAM13A;ARHGAP17;NUAK1;SMYD2;RFC3;BST1;PRKAB2;MCF2;ZFAND6;MAPK11;DYRK2;SLC15A2;MAPT;CDK5R1;LYN;PRKAR1B;TPTE2;ARAP1;ARHGAP28;TNIK;PIP4K2A;RAC3;CLEC7A;ARAP2;VEGFA;RHOT1;CHN1;NTRK3;TRIP10;ARHGEF4;ARHGEF26;NLGN1;PAK5;RAD9A;DDIT4;MBD3;RBBP8;ARHGAP44;ARHGEF7;TP53INP1;PRKAG2;FAM83D;A2M;TAF10;SLC15A4;WWC1;ARHGEF9;NLRP12
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.4533323413760674,-0.861841356668551,0.673469387755102,1.0,1.0,3/18,15.33%,SLC25A1;HSD17B8;FASN
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.4975972447426147,0.8611710393290019,0.72,0.8729535873324314,1.0,3/10,14.38%,CSF1R;CD4;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.529652238529848,0.8610936580183329,0.66,0.8727766510935809,1.0,1/5,23.15%,SLC6A6
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5306353582073464,0.8610664956923401,0.6,0.8724395367052696,1.0,4/7,27.39%,WNT5A;SLC16A2;NF1;KDM2B
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.5291827849253479,0.8608562810735038,0.6666666666666666,0.8720865426297074,1.0,4/7,28.66%,SLIT1;SLIT3;NRP2;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.5291827849253479,0.8608562810735038,0.6666666666666666,0.8720865426297074,1.0,4/7,28.66%,SLIT1;SLIT3;NRP2;ALCAM
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.47088228290583334,-0.8607524257713338,0.6491228070175439,1.0,1.0,2/17,5.96%,PLPP2;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.5744780886067377,-0.8607095020183715,0.639344262295082,1.0,1.0,1/6,7.81%,OTUB1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5796699292006923,0.8605210672048386,0.7291666666666666,0.8723956467616879,1.0,4/5,41.72%,GOLPH3;SORL1;VPS13A;VPS13C
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.5389454066403544,0.8601556190354009,0.717948717948718,0.8727545092760841,1.0,2/12,7.32%,SOX9;ACADL
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3224438605630948,0.860151997395638,0.8372093023255814,0.8723881135962872,1.0,30/121,17.66%,EPHA3;ST7;CASZ1;HEY1;BMPR1B;GCM1;ID2;SCIN;DLX1;NOTCH4;MAFB;BCL6;HOPX;GNB3;CDK5R1;YWHAH;NREP;CBFB;CEBPD;APC2;RPS6KA3;LGALS3;MEGF10;ZFP36L1;NLGN1;FES;PHLDB2;MBOAT2;BIN1;RUNX2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.375478768573114,-0.8601249670387558,0.7090909090909091,1.0,1.0,7/49,8.73%,CDK4;TFDP1;PHB2;CDC23;LSM10;DBF4B;ADAMTS1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.3765798936114498,0.8600406115383529,0.7142857142857143,0.8722219296070245,1.0,5/41,10.72%,ST8SIA3;B3GALNT1;B4GALT6;HEXB;ST6GALNAC5
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.4977156233571738,0.8597585887908252,0.6031746031746031,0.8723506200208967,1.0,4/9,17.13%,PRKAB2;ACACB;SLC25A20;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.3629409907583626,0.8594939258021052,0.6938775510204082,0.8723993078990451,1.0,17/60,22.85%,CAMK1D;NEDD4L;MERTK;SCIN;GPLD1;CHRM1;CDH3;SFTPD;CLEC7A;GAS6;RXRA;LRP1;TFR2;SGK1;RAB27A;CALY;GSK3B
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.30954195206902185,0.8594392920246899,0.7555555555555555,0.8721834149579254,1.0,35/230,14.52%,CD59;NCKAP1L;ADCY8;LRRK2;ADD2;LAMC1;RSPH9;LEF1;DMD;GRIA1;PPARGC1A;ANO6;SOX9;SLC7A9;TEAD1;AMER1;TNFRSF1A;BCL9;IL1RAP;DMTN;LIN7A;COL7A1;VIL1;DLG4;TGFA;CSNK1D;CX3CL1;ANKRD28;SHANK1;TLE3;FANCC;HES1;CUL3;ITGB1BP1;PARD3
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.36725277937083134,0.8590066372390918,0.6956521739130435,0.8726212920192802,1.0,12/59,12.73%,MYO7A;SLC4A10;ADGRV1;COL11A1;TRPM1;ABLIM1;GRM6;RPGR;DRAM2;CRYBG3;GRM8;BBS2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.44564847158000376,-0.858791985623545,0.6538461538461539,1.0,1.0,5/19,19.36%,CHMP2A;TOR1A;DCTN1;EMD;CHMP7
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.505805419305941,0.8584284666391316,0.6444444444444445,0.8733031722373256,1.0,4/7,19.48%,WNT5A;NLGN1;LRRC4;PTEN
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.5522973618010487,-0.8583921338394379,0.6538461538461539,1.0,1.0,1/6,2.01%,TNFRSF21
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.4577998219301477,0.8583269606490334,0.7045454545454546,0.8731320375379813,1.0,1/14,3.14%,LRRK2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.3323056260587048,0.8579881232539869,0.6285714285714286,0.8732650070486172,1.0,17/116,9.37%,TGFB2;EGFR;SRGN;PTPRC;TLR2;STAB1;IL12A;PTPN6;LCP2;CARTPT;FYB1;ST8SIA4;LY86;F2;PRKCG;CD4;CDKN2A
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.4134835534093707,-0.8574920473157217,0.6206896551724138,1.0,1.0,11/38,16.93%,CNN2;PSME2;CFL1;AIP;SOD1;RPLP0;TALDO1;PPIA;HNRNPDL;ANXA2;CDC42
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.4711858808455188,-0.8574405339269998,0.5818181818181818,1.0,1.0,1/21,0.28%,LCK
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.43156238001380753,0.8574063905705286,0.6382978723404256,0.873945762483859,1.0,5/25,7.24%,SLC8A1;DMD;TPM1;SCN3B;SGCZ
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3793663428633728,-0.8573009748119425,0.660377358490566,1.0,1.0,2/51,1.96%,USE1;CELA2A
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.48986341660778,0.856972043500598,0.6363636363636364,0.8743023266690827,1.0,1/7,10.09%,ZFAND6
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.5157924821000184,-0.8568246844467773,0.6296296296296297,1.0,1.0,2/8,6.18%,USH1C;CDHR2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.48432003710477445,0.8568042310045918,0.6956521739130435,0.8742057113009373,1.0,2/11,7.75%,DOCK8;WNT5A
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.5796551035825858,0.8564877218917508,0.6724137931034483,0.8744723254747073,1.0,1/5,0.60%,PDE10A
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.34559115101053317,-0.8563991803410022,0.7222222222222222,1.0,1.0,1/64,0.10%,NGF
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.41590337548080575,-0.8552610251073097,0.6491228070175439,1.0,1.0,8/49,13.48%,ACAA2;DECR2;ECHS1;HSD17B10;CROT;ETFB;EHHADH;HADHA
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.42970362528198086,-0.8551231473293178,0.7073170731707317,1.0,1.0,5/31,14.07%,CENPX;SMARCA5;MIS12;NPM1;CENPF
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.44515675619638717,0.8550882655636898,0.7368421052631579,0.8766979073701503,1.0,4/17,10.37%,C5;SULF1;ARNT;C3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.4798943443484705,-0.8547077097893998,0.65,1.0,1.0,3/17,15.58%,TINF2;PINX1;NAT10
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4610535468962435,0.8546187028733478,0.5849056603773585,0.8772763996538523,1.0,4/16,16.17%,BMP6;NOTCH4;VEGFA;MAD2L2
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.4618218025364296,0.8545369496366714,0.660377358490566,0.8771041785340565,1.0,3/16,7.96%,SIGLEC10;EPHA4;GIT1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4125165353344602,0.8545303786291634,0.7192982456140351,0.8767483463425743,1.0,2/29,2.60%,AQP1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.5684320789676202,0.8543568903610574,0.7017543859649122,0.876735345660168,1.0,2/5,13.39%,CAMK1D;CLEC7A
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.5259171676153158,0.8541984743088398,0.6888888888888889,0.876583414075402,1.0,2/6,14.46%,GPLD1;ABHD5
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.5143214454825368,-0.8540787274698394,0.6851851851851852,1.0,1.0,5/10,23.73%,TPH2;HDC;SAT2;MOXD1;SRM
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.5806623155007952,0.8537909594659207,0.7446808510638298,0.8769177025855,1.0,2/5,14.26%,DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.5498704539583571,-0.853706262018067,0.6382978723404256,1.0,1.0,1/8,4.34%,GSTP1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.4152087482763686,0.8535986423091309,0.6666666666666666,0.8769046476340696,1.0,9/26,19.12%,PER1;F2;ABCD2;ADCY7;CLEC7A;NOS2;IL17RA;NLRP7;TICAM1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.3847486298662485,0.8533334374840345,0.66,0.8770303718241006,1.0,8/42,14.38%,ANGPT1;BMPER;VEGFD;GPLD1;ROBO1;CDH13;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.5475123876001369,0.8533016682876846,0.6666666666666666,0.8767547216071322,1.0,1/6,8.43%,LAPTM5
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4507822015063105,-0.8530549638210704,0.6792452830188679,1.0,1.0,6/26,18.71%,LSM10;SNRPB;SNRPE;SNRPG;SSB;LSM1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.4725777355583496,0.8529903602287162,0.6481481481481481,0.8770190564602298,1.0,1/16,0.65%,CDS1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.38584212053141004,0.8529452522526804,0.7090909090909091,0.8767535397424956,1.0,9/35,12.65%,PLPPR5;PLPPR3;PLPPR4;DGKB;SGPP2;PLPP4;DGKI;PLPP6;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.580024946493475,0.8528294203699278,0.7307692307692307,0.8766366768609983,1.0,2/5,17.79%,RSAD2;SLC15A4
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.4360555848457486,0.8525674045383593,0.6170212765957447,0.8766633368966403,1.0,6/19,26.35%,BIRC3;MLKL;OGT;SDCBP;PELI1;CASP8
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.4302615533023898,-0.8524958132847847,0.6304347826086957,1.0,1.0,3/18,16.69%,S100A1;DHFR;PARK7
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.4804140494442195,-0.852235003602984,0.6181818181818182,1.0,1.0,1/9,11.71%,ERLEC1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.34224004935029645,-0.852141857843631,0.7735849056603774,1.0,1.0,10/119,9.15%,TEAD2;POLR2L;TEAD3;POLR2G;POLR2K;GTF2F1;POLR2I;NR2C2AP;POLR2A;TAF13
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.3963877225200922,-0.8518247219503566,0.6491228070175439,1.0,1.0,6/33,11.02%,FTH1;SLC31A2;TF;MELTF;ATP2C2;TTYH1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.5591469455815837,0.8516181134361115,0.7906976744186046,0.8779951026538836,1.0,1/7,7.96%,GIT1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4796439931403843,-0.8514378597772211,0.6727272727272727,1.0,1.0,2/11,4.77%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.4428731546654731,-0.8507623090326497,0.72,1.0,1.0,6/18,16.46%,PARP1;TTLL9;VKORC1L1;TTLL3;NAA11;TPGS1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.3808928253489309,0.8504357404004556,0.7659574468085106,0.8798891072990759,1.0,9/49,10.20%,TGFB2;BMP6;BMPR1B;ADAMTS7;VSTM2A;SOX9;DLX1;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.549688316039686,-0.8503694993239241,0.7068965517241379,1.0,1.0,1/5,2.25%,STMN1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.38080483221731115,0.8501631319062258,0.6595744680851063,0.8800378742950847,1.0,10/42,10.93%,L1CAM;ROBO2;TWF2;PLXNA4;NTRK2;TIAM2;PLXNA2;ROBO1;MAPT;NGFR
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.3397353664918835,-0.8500478140414635,0.7704918032786885,1.0,1.0,20/119,15.99%,CD38;DDIT3;ATF3;BTG3;GPX4;MGMT;FEZ1;SOD1;TSPO;TXNIP;FDXR;BAX;SC5D;BTG2;SQSTM1;GSN;DAP;TIMP2;DNAJA1;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.5342739678433799,0.8500394787214841,0.72,0.8798606417948894,1.0,1/5,6.83%,SLC43A1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.4443000288386503,0.8500284954683497,0.7441860465116279,0.879520685647605,1.0,3/14,12.36%,PTPRC;CR1;SASH3
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.49387809170732855,-0.8498111369096053,0.6666666666666666,1.0,1.0,2/10,4.77%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3930775644356476,-0.8492712340998301,0.6181818181818182,1.0,1.0,2/33,2.63%,BMP5;GREM1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.43400423158266693,-0.8491230091357096,0.6481481481481481,1.0,1.0,8/24,25.51%,TCEA2;ALYREF;SUPT5H;CCNT1;CCNK;EAF2;HTATSF1;HMGN1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.3974294523571159,0.8489031154623141,0.75,0.8811099809332164,1.0,4/29,9.79%,CERS3;SCEL;WNT5A;OPN3
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.4922200927899296,-0.8486763937975549,0.711864406779661,1.0,1.0,3/8,20.70%,SLC66A1;SLC3A1;SLC38A3
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5570059800444049,0.8483046829463289,0.6785714285714286,0.8814798286495573,1.0,2/5,29.47%,CD80;IL18
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5570059800444049,0.8483046829463289,0.6785714285714286,0.8814798286495573,1.0,2/5,29.47%,CD80;IL18
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.347594512129568,-0.8482997193229245,0.7,1.0,1.0,12/118,7.32%,CRYAB;GPRC5C;FSHR;S100A16;BCAM;VWA1;ABLIM3;TNS2;TF;COL18A1;SOD3;CDC42EP1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.41602201941699796,0.8480839991466083,0.6590909090909091,0.8815487313550406,1.0,4/15,16.20%,SPRED3;DMTN;PARD3;DDIT4
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.5579284594510147,0.8480445079513694,0.74,0.8812186305735693,1.0,1/5,2.11%,GRM5
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.4208664135470075,-0.8480238520047425,0.6739130434782609,1.0,1.0,2/26,4.34%,RPS3;GSTP1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.46547656097654755,-0.8479114841635693,0.6538461538461539,1.0,1.0,3/12,16.93%,ACTG1;RAC1;CDC42
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.5067610676310905,0.8478246372836322,0.7169811320754716,0.8811989661614141,1.0,2/11,2.58%,P2RY12;CARMIL2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.4822773512757658,-0.8475140948872532,0.6538461538461539,1.0,1.0,1/12,0.34%,ZDHHC12
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.32368967686977856,-0.8474256877851993,0.6938775510204082,1.0,1.0,15/102,16.69%,PARP2;USP51;ENY2;PRMT2;USP16;PRDM5;RCOR2;ZNF541;KAT5;CARM1;UFL1;PADI2;MRGBP;UBE2A;PARK7
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.5900798404285981,0.8473344775697181,0.7333333333333333,0.8818239945339077,1.0,2/5,17.77%,PGAP1;PIGK
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.544258508586287,-0.8471802424793997,0.6976744186046512,1.0,1.0,3/6,23.73%,SAT2;AMD1;SRM
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.3532794734638883,-0.8470128055636764,0.6507936507936508,1.0,1.0,11/88,10.12%,LCK;AQP9;PRDX5;SOAT2;CROT;ABCA8;SOD1;DHCR24;NPC1;FDXR;AKR1D1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.4365355198599224,-0.8467233833764564,0.65,1.0,1.0,3/25,11.65%,CENPX;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.4365355198599224,-0.8467233833764564,0.65,1.0,1.0,3/25,11.65%,CENPX;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.5290924373999427,0.8463207077579952,0.75,0.8832946024653199,1.0,3/10,13.62%,FAP;FZD3;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.33708175298883164,0.8459953951331587,0.7454545454545455,0.8836084701983158,1.0,10/77,11.59%,IGFBP3;PID1;LRRK2;GIT1;SH3GL2;FBLN1;CDKN2A;CORO1C;MAPT;LYN
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.40916912437146413,-0.8459897637938875,0.6896551724137931,1.0,1.0,11/40,16.93%,CNN2;PSME2;CFL1;AIP;SOD1;RPLP0;TALDO1;PPIA;HNRNPDL;ANXA2;CDC42
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3283528503824965,0.8459601374913444,0.7608695652173914,0.8833224364371418,1.0,25/106,16.53%,NFKBIE;BHLHE40;PIM1;TMIGD3;ID2;TBX6;MAP2K5;ARRB2;IRAK3;NFKBIA;CDKN2A;ERBIN;PLA2G10;FZD6;SFRP4;MTURN;HES1;NLRP3;CD200;HAVCR2;NLRC5;GLIS2;MAD2L2;SPI1;GAS6
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.5181147943065902,0.8459366213065398,0.6744186046511628,0.883021899455045,1.0,1/8,6.26%,OGFOD1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.5202652520058797,-0.8458435963789954,0.7111111111111111,1.0,1.0,1/5,2.63%,GREM1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.46204707271759093,-0.845814638541316,0.7446808510638298,1.0,1.0,5/22,12.42%,ACTN2;WNK4;ATP1B1;CFTR;AKAP9
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.34575711543594945,0.8458088149954566,0.6976744186046512,0.8828296533970368,1.0,12/43,17.94%,SLC23A1;SLC6A11;SLC16A14;SLC6A15;SLC7A8;SLC1A1;SLC6A7;SLC38A6;SLC17A5;SLC16A2;SLC15A4;SLC16A7
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.44413020974439377,0.8457020220697473,0.6428571428571429,0.8825933846131423,1.0,2/18,4.90%,TGFB2;ITGAM
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.45026326647460385,-0.8455541607032883,0.7142857142857143,1.0,1.0,6/20,22.65%,MUS81;EXOG;REXO4;HMGB1;ENDOG;DICER1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.31757545424001743,-0.845209640727082,0.9047619047619048,1.0,1.0,19/280,7.61%,NGF;BMP5;TNFRSF8;WNT9A;IFNLR1;CDKN1C;TINF2;SFRP1;FTH1;GREM1;PTPRU;GSTP1;BTG3;TFDP1;TNS2;B4GALT7;COL18A1;APOD;ATRAID
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3845115259100108,0.8449691448835968,0.6730769230769231,0.8835153627900835,1.0,5/29,11.70%,TP73;TP63;BCL2;YWHAH;BBC3
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.481790514864992,0.8441302895562797,0.7777777777777778,0.8845444910743546,1.0,3/9,16.10%,KLF15;DIP2B;SETD5
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.4404271962806626,-0.84412540539135,0.6984126984126984,1.0,1.0,5/18,14.11%,PCNA;POLD3;MCM4;MCM3;POLE3
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.40885470689833847,-0.8440605870803889,0.6896551724137931,1.0,1.0,7/28,17.13%,NOP53;BRCC3;BLM;HMGA2;TOPBP1;ABRAXAS1;RINT1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.3970022455260288,-0.8435452943668258,0.6875,1.0,1.0,9/39,21.68%,GREM1;CCT2;PINX1;PNKP;DKC1;MEN1;PKIB;NVL;TERF1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.5135257557320326,-0.8433932384270407,0.6538461538461539,1.0,1.0,1/7,7.11%,MDGA2
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.5618404880090401,0.843269785007775,0.7272727272727273,0.8857247637742284,1.0,1/5,1.38%,PTPRC
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.40401435295951227,0.8427984141506024,0.6304347826086957,0.8860758056760573,1.0,3/21,9.31%,COL11A1;COL12A1;COL7A1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.4306149953382969,0.842798205169311,0.6666666666666666,0.8857113154227969,1.0,6/19,18.76%,XKR4;ADGRB1;SCARB1;MEGF10;GAS6;LRP1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.36841209891491633,-0.8427102647506037,0.7142857142857143,1.0,1.0,8/38,15.69%,RPS3;STMN1;TUBB4A;NUMA1;ANKRD53;AKAP9;RAC1;DCTN1
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.5362548991842929,0.8426654597459272,0.7254901960784313,0.8855968674623675,1.0,1/6,8.85%,EDNRB
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.32876129758421935,0.842633118066467,0.8,0.8852818226819865,1.0,7/114,8.06%,LAMP5;ZNF423;LRRK2;OBSCN;ISG15;STX1A;BANP
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.41582019727895964,-0.8425397557680379,0.7272727272727273,1.0,1.0,2/29,5.71%,SELENOS;BCKDK
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3649144716068838,-0.8422711380226428,0.6785714285714286,1.0,1.0,8/84,6.88%,CRYAB;GJC1;TLN1;ACTN2;MYL12B;MYL12A;MYL6;CALM1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.40377024250439253,0.8421598686363198,0.68,0.8857498990019729,1.0,7/33,9.98%,P2RY12;ACTN1;MEGF11;PDGFRA;TJP2;HSPB1;UBASH3B
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.36136870164711377,-0.8420529101593064,0.75,1.0,1.0,13/90,9.50%,PLAAT5;TSKS;COX7B2;GSG1;LDHC;SPAG6;DDX4;SPATA16;MLF1;MRPL14;DYNLT1;CREB3L4;SPATA33
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5683299170784206,-0.842007077325176,0.7307692307692307,1.0,1.0,1/7,2.89%,SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.5469335699722216,0.8419780991488838,0.75,0.8857187211519562,1.0,3/6,22.94%,HES1;DAAM2;NF1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.4053677040034046,-0.8419050257823042,0.7674418604651163,1.0,1.0,2/22,6.59%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5005490287888671,-0.8418610666579084,0.7450980392156863,1.0,1.0,1/8,2.63%,GREM1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.44938574744958754,-0.8418292818130617,0.6862745098039216,1.0,1.0,1/22,1.75%,USE1
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.5260168644834045,-0.8412005617557551,0.7777777777777778,1.0,1.0,2/8,3.93%,CYP2E1;AADAT
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.4122561099819797,0.8410334713277441,0.64,0.886939120077667,1.0,8/32,11.79%,CD44;CHI3L1;SULF1;SOX9;ZBTB16;SOX5;CREB3L2;ZNF516
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.36139581737029514,-0.8408149246241592,0.7166666666666667,1.0,1.0,3/69,0.94%,ARHGEF16;GPRC5C;FXYD4
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.36705439420518393,0.8407257651587721,0.7906976744186046,0.8863852884764044,1.0,6/57,11.63%,CD59;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.36705439420518393,0.8407257651587721,0.7906976744186046,0.8863852884764044,1.0,6/57,11.63%,CD59;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.36705439420518393,0.8407257651587721,0.7906976744186046,0.8863852884764044,1.0,6/57,11.63%,CD59;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.48802408220817095,0.8404696849486135,0.717391304347826,0.8864466503975712,1.0,3/8,12.31%,TWF2;SCIN;TMSB15B
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.3214710566237796,0.8401733167108898,0.8205128205128205,0.8865665083352529,1.0,24/129,12.86%,TLR2;STAB1;SELL;F3;CLEC5A;MET;SLC1A2;LCP2;TNFRSF1B;C3AR1;CSF3R;SLC4A4;AXL;RNF144B;NFKBIA;CD70;RGS1;ADORA2B;CX3CL1;OLR1;LYN;SLC11A2;GABBR1;KCNMB2
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5519884856577031,0.8398999594027786,0.7796610169491526,0.8866716375297263,1.0,3/5,25.10%,WDR48;OTUD4;TANK
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3244081057227559,0.8398424592087624,0.7105263157894737,0.8864159407550317,1.0,10/72,10.70%,PDGFB;EGFR;CDKN3;CDK5R2;CCNF;CCND1;PLK1;CDKN2A;SPDYA;CDK5R1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.4677724430220301,-0.839720354494715,0.6909090909090909,1.0,1.0,3/19,13.29%,SMDT1;FIS1;SLC8A3
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3081451236188624,-0.839711165852835,0.9074074074074074,1.0,1.0,34/283,16.53%,RPS27A;UBC;RNF8;UBB;PSMD7;PSMB6;PSME2;FBXW10;PSMD8;UBE2D4;CDC26;RNF167;CDC23;PSMB4;PSMD3;PSMB3;TMEM129;PSME1;KLHL20;UBA52;DCAF15;PSMA7;MYLIP;PSMD13;PSMB8;UBE2Q2;ERCC8;RNF6;RNF126;PSMD2;UBE2A;FBXW8;UBE2L3;FBXL15
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.5032149708632082,0.8394733918974447,0.6923076923076923,0.8867062145456653,1.0,1/6,1.07%,AQP1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.519780159110272,-0.83861754884746,0.6491228070175439,1.0,1.0,2/8,6.75%,GLA;GBA3
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.5281095995863833,0.8381905032222141,0.6530612244897959,0.8884964806838364,1.0,3/5,24.96%,BMPR2;ACVR2B;CCBE1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.5457388655792712,-0.838005431699106,0.6458333333333334,1.0,1.0,5/7,29.79%,GLYCTK;TKT;KHK;TKFC;TPI1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.45374465855537116,-0.8379174409350042,0.6304347826086957,1.0,1.0,2/17,6.50%,GSTP1;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.47125931551851197,-0.8377589726428518,0.625,1.0,1.0,1/10,11.71%,ERLEC1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.5479777393755878,0.837721442874868,0.7586206896551724,0.8889658152694963,1.0,3/5,23.65%,WNT5A;NLRC5;UBE2K
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5301488454372899,0.8372218222346955,0.6724137931034483,0.8895759062056001,1.0,1/7,2.80%,FAP
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.5291464416179157,-0.8367318905895282,0.6909090909090909,1.0,1.0,1/5,1.78%,KCND3
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.37952578691094613,-0.8365565706515088,0.723404255319149,1.0,1.0,5/39,13.07%,TNFAIP2;VAMP8;LAMB3;ADIPOR1;EHF
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.4872110612651483,-0.8363792748377258,0.6818181818181818,1.0,1.0,5/10,29.41%,SAT2;AMD1;SRM;HDAC6;ODC1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.38453658150596076,0.8362015144728645,0.78,0.8910417222862032,1.0,5/45,8.67%,BIRC3;H2BC11;SYK;LAPTM5;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.5177256762174973,0.8357474765999946,0.7368421052631579,0.8914413617600323,1.0,3/5,17.87%,CIITA;NLRC5;NLRP12
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.43911130334524817,-0.8355211984019959,0.6415094339622641,1.0,1.0,1/11,3.57%,BACE2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.5075485208642743,-0.8353656329144032,0.6363636363636364,1.0,1.0,1/9,0.65%,GJC1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.5556314260907408,-0.8346357168741552,0.75,1.0,1.0,1/5,11.49%,PTPN12
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.46100352914292486,-0.8346052711964966,0.7380952380952381,1.0,1.0,3/12,24.22%,SQSTM1;MAP1LC3B;ACBD5
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.4738896431286612,-0.8345863278588579,0.8125,1.0,1.0,1/12,6.50%,DNMT3B
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.32762628342566913,-0.8344788363385646,0.796875,1.0,1.0,23/127,17.31%,JUP;RBM22;UBL5;HYAL2;TFDP1;ABLIM3;RAN;MYO1C;CEP131;CD81;YWHAB;FIS1;HRAS;SAR1B;YWHAQ;VPS11;TOMM7;BAD;UBE2L3;ANP32B;EMD;PLK3;TRIM28
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.3517832545112284,0.8335969858484509,0.8260869565217391,0.8949711173819027,1.0,18/47,17.28%,KCNC2;SNAP25;RAPGEF4;ITPR1;STX1A;CLOCK;KCNB1;PICK1;SYT7;HTR2C;CACNA2D2;ABCC8;CACNA1E;RFX3;NOS2;ITPR3;CACNA1C;CHD7
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.5530152220481853,0.8335820694453577,0.7450980392156863,0.8946448437042425,1.0,1/6,14.06%,SLC25A22
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.4898755966976671,-0.833368167164949,0.6530612244897959,1.0,1.0,3/10,20.26%,PHB2;DNAJC19;MFSD2A
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.32533410830493065,-0.833148986814422,0.7619047619047619,1.0,1.0,27/203,14.79%,RPS27A;UBC;ARPC5;UBB;MYADM;VAMP8;AP2S1;SUN3;TF;CHMP2A;ACTG1;PLEKHA3;GRIN3B;CHMP5;NPC1;CFTR;HSPA8;SNAP29;CLTB;SAR1B;UBA52;CHMP3;HGS;MTCH1;TOR1A;REEP4;TIMM50
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.34493134088362987,-0.8325560666464495,0.8181818181818182,1.0,1.0,2/75,3.20%,CFAP61;RGS22
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.33650886436396577,0.832531178337819,0.7727272727272727,0.8960624885666819,1.0,13/57,15.91%,NCKAP1L;BAIAP2;MET;CARMIL1;FCHSD2;BAIAP2L1;TENM1;MAPT;CDK5R1;CDC42EP4;CDC42EP3;PRKCE;FES
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.42956965615273535,-0.831870760234895,0.7083333333333334,1.0,1.0,3/15,13.73%,SOD1;PPIA;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.4325064998771282,-0.8317422730083498,0.7083333333333334,1.0,1.0,3/24,5.40%,TPX2;LIMA1;KATNB1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.42978115183600096,-0.8316893656671456,0.6612903225806451,1.0,1.0,7/19,17.25%,JPH1;CALM1;SRI;CLIC2;CASQ2;PRKACA;TRDN
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.43952274898828614,-0.831482262486824,0.6538461538461539,1.0,1.0,1/26,0.25%,CXCR4
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.3493847373223351,-0.8313993318594352,0.7192982456140351,1.0,1.0,14/91,16.89%,COPE;ARCN1;AP2S1;CD63;GLA;SOD1;TMED2;LMAN1;ERGIC3;SSPN;COG2;TSPAN8;VAMP3;GBF1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.56531642099271,0.8310237669620167,0.7454545454545455,0.8987218551495643,1.0,1/5,14.24%,ABCA1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.5230506523365503,-0.8309122284606144,0.7192982456140351,1.0,1.0,2/8,4.34%,SELENOS;GSTP1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.36827681309729504,-0.8309102059507254,0.7441860465116279,1.0,1.0,6/53,15.50%,RNF8;UBE2D4;UBE2Q2;RNF6;RNF126;UBE2A
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.6031726804733966,0.8309099482265008,0.75,0.8985885724052572,1.0,3/5,37.44%,CAV3;CAV1;PACSIN2
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.3766772100072781,-0.8308895563571099,0.7454545454545455,1.0,1.0,2/53,2.25%,P2RY10;STMN1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.36727563899572147,0.8308559731511038,0.675,0.8983147182176837,1.0,9/32,23.96%,SNAP25;SLC11A2;SLC7A8;SLC29A2;SLC16A2;ATP1A2;SLC6A6;SLC7A1;NEURL1B
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.4655719676261908,0.8308024108049773,0.6410256410256411,0.8980216907978855,1.0,1/11,1.81%,CSGALNACT1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.5035458650217793,-0.8307903313350412,0.7288135593220338,1.0,1.0,4/11,13.82%,CFL2;CFL1;TWF1;GSN
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.5144514104455529,0.8305872388034682,0.7068965517241379,0.8980633508753324,1.0,2/9,22.85%,PARD6A;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.5477312383855114,-0.829983863580299,0.7321428571428571,1.0,1.0,2/7,22.04%,CTTNBP2NL;INPP5K
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.527289148938251,-0.8296120694675905,0.6730769230769231,1.0,1.0,2/6,19.95%,TOMM7;PINK1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.3865569245612296,-0.8295936384697801,0.6785714285714286,1.0,1.0,3/34,5.28%,CXCR4;DAGLA;BTBD6
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.434395182203629,0.8294217204725819,0.6976744186046512,0.8999606559459135,1.0,1/12,1.38%,PTPRC
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.38158450714060504,0.8293306535557158,0.6875,0.899788395275412,1.0,1/21,1.10%,PRR16
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.49057810842453603,-0.8286841507003575,0.64,1.0,1.0,1/8,4.74%,HYAL2
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.3708172118304533,-0.8282295407064443,0.7796610169491526,1.0,1.0,4/83,3.23%,CXCR4;CRYAB;SRL;ACTN2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.39675023329123005,-0.8280340646055229,0.6595744680851063,1.0,1.0,6/27,15.69%,RPS3;NUMA1;ANKRD53;AKAP9;RAC1;DCTN1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.45548773374641993,-0.8277771464295767,0.72,1.0,1.0,1/10,3.31%,HOXD3
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.528201023562765,0.827440807827768,0.7291666666666666,0.9027630387159136,1.0,1/5,3.20%,ABHD3
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.38388494679609875,0.8274397878195705,0.7435897435897436,0.9023962109878698,1.0,3/36,3.85%,TDRD1;MAEL;EXD1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.4362760477717726,0.8272581372822101,0.6410256410256411,0.9023392647882374,1.0,6/17,17.19%,ADGRV1;GRM2;EDNRB;GABBR2;CAP2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.47927659484856344,-0.8270768125499747,0.6428571428571429,1.0,1.0,3/10,18.23%,NEK6;RSL1D1;ING2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.4736107378001531,-0.826943559605381,0.7288135593220338,1.0,1.0,4/10,15.69%,SYNE2;DYNC1H1;SYNE3;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.4965056095672756,-0.8264932621462036,0.6666666666666666,1.0,1.0,2/6,13.97%,RNF113A;PADI2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.5147779869108954,-0.8263025557284107,0.7843137254901961,1.0,1.0,5/8,29.79%,PGP;COQ3;GK5;TKFC;TPI1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3924169139805763,-0.8258276589565788,0.7037037037037037,1.0,1.0,7/28,19.91%,USP51;TFIP11;PNKP;HMGA2;NUDT16L1;PARP3;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.3577652625134762,-0.8256485084188837,0.7068965517241379,1.0,1.0,11/72,14.78%,TRABD2B;RPS3;PFN1;RACK1;CHMP2A;BAK1;BAX;SNF8;HGS;BRK1;PIH1D1
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.4950655819900215,-0.8256337128502216,0.6792452830188679,1.0,1.0,2/7,14.07%,MIS12;CENPF
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.36982698186071206,0.8252805236939862,0.7346938775510204,0.9055848602489995,1.0,6/44,10.20%,TGFB2;BMP6;BMPR1B;CHRD;BMPR2;TGFB3
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.41611176411128,0.8251414062537327,0.6956521739130435,0.9055073329115505,1.0,11/23,27.06%,ID2;CDKN2A;CDKN1A;SPI1;PRKCD;HMGA1;MAPKAPK5;SMC5;NSMCE2;PML;SIRT1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.40124463887323775,0.8249986602677081,0.7317073170731707,0.9053718922087952,1.0,4/21,9.79%,CERS3;SCEL;WNT5A;OPN3
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.45347986330212176,0.8248455367720371,0.7254901960784313,0.9052075849737319,1.0,7/16,19.92%,OBSCN;TPM1;MYLK3;CSRP2;CAPN3;FHOD3;TCAP
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.2563707001920307,0.8248182006961301,1.0,0.9048744505824805,1.0,249/1673,16.53%,ZNF366;CREB3L1;ETV1;FLI1;IFNA2;NPAS2;PPARG;PDGFB;TP73;EGFR;ZNF423;MYT1;IGF1;IKZF2;GRHL1;HNF4G;MDFIC;FOS;FOSL2;KLF9;WTIP;MIDEAS;DACH1;MAP3K5;CASZ1;MAEL;ZIM2;ZNF157;HEY1;BHLHE40;PLCB1;E2F3;IKZF1;MEF2C;SCRT1;ZNF20;NR4A3;ELAVL2;BCL11B;ZNF93;ZSCAN22;NFATC4;ZEB1;PRICKLE1;GCM1;ATF1;NR2F1;PURG;ZNF652;MAFF;NRG1;EBF1;ID2;TBX19;RUNX1T1;BASP1;TBX6;KLF15;LOXL3;ZNF608;HIVEP2;TOX;CIITA;CITED2;PRDM15;ZNF239;LEF1;ZNF215;PBX1;PLAGL1;HIRA;TSHZ3;MEIS3;PPARGC1A;AEBP2;ETS2;TESC;TP63;SOX9;PER1;NR3C2;TEAD1;EPAS1;ATXN1;TENM1;ZBTB7C;TASP1;DLX1;ZBTB16;WNT5A;MEIS2;TIMELESS;SPINDOC;STAT6;NOTCH4;TAL1;ETV6;KDM3A;ZGLP1;BNC2;CLOCK;HES4;WWP1;EMX1;ZNF343;BRWD3;GLIS3;ZNF442;NOS1;TBL1XR1;ZNF768;L3MBTL4;MAFB;CD4;ZNF697;CAMK2D;BCL6;ZHX2;CDKN2A;ZSCAN1;NEUROD6;ARNT;SOX5;ZNF764;ZBTB18;ZNF600;HOPX;GRHL2;SATB2;GTF2IRD1;TGFB3;ZNF568;ZNF540;CREB3L2;ZNF615;ZNF644;PARP9;CDK5R1;ZNF550;PHF19;ZNF730;YWHAH;TRIM22;ZNF467;TGFA;ZNF473;PRRX1;ZNF616;ZNF433;ZNF587;PROX2;POU2F2;ONECUT2;CBFB;NPAS1;ELK3;ZNF304;MYT1L;ZNF516;MED12L;TGIF1;KLF3;CEBPD;ZXDA;BACH1;ZNF486;ZNF571;STRA8;ARID3A;ZNF384;ZNF584;ACTL6B;ZFP30;RFXANK;RGMB;KAT6B;ZNF549;SRA1;PIAS1;CCNQ;HES1;ZNF493;NR2F2;NCOA1;MED14;TAF5L;IFNK;RPS6KA3;ZNF33B;RFX3;ZNF148;SFMBT2;NCOA7;ZBTB34;MAFK;HCLS1;CHMP1A;ZNF438;PCGF3;POU6F2;VEGFA;FOXP2;GLIS1;ZNF775;BCL11A;PTPRK;CSRNP2;APBB2;ZNF415;ZKSCAN7;ZNF536;ZNF577;DYRK1B;TULP3;ZNF654;CREB5;ZNF98;EBF2;HIF3A;ZFAT;ZNF235;KAT2A;SAMD13;KCNH2;ZNF439;NFIA;SMARCA2;FOXN2;ZNF248;ALX3;TOX2;CAMK4;ZNF383;ZBTB1;SETD5;GLIS2;CRLF3;SMARCA1;MAD2L2;ZNF483;MYNN;FOXN3;JUNB;ETV3;CDKN1A;RBBP8;SPI1;PCGF5;GAS6
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.3720505965220625,-0.8243304940839171,0.6721311475409836,1.0,1.0,1/59,0.10%,NGF
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.3838367357262674,0.824206046071276,0.8222222222222222,0.905497031759033,1.0,5/36,10.94%,NPAS2;RADX;SMYD2;MAPT;FEM1B
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.35664283997838053,-0.8241649514124937,0.8382352941176471,1.0,1.0,19/68,15.75%,TAX1BP3;S100A16;CLCA2;BACE2;CD9;LAMB3;DUOXA1;METTL5;MYO1C;ALKBH7;DNPH1;CDC42EP5;EHF;ILK;DUSP23;MT1E;TMEM54;ANXA2;SH3RF2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.5140341929058655,-0.8236493959958838,0.7547169811320755,1.0,1.0,2/8,31.17%,PMVK;ABCA2
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.488789705055671,0.8227818193785682,0.7391304347826086,0.9074696965758969,1.0,1/9,2.72%,CAMSAP3
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.38653107586008806,-0.8223532114874507,0.7843137254901961,1.0,1.0,15/57,19.17%,NOC2L;PCNA;HYAL2;PARP1;SDE2;BAK1;NPM1;TRIAP1;ATR;COPS9;TMEM161A;NEDD4;ATF4;CASP9;SMPD1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.36941254319035205,-0.8222164193937925,0.7586206896551724,1.0,1.0,5/57,6.80%,BMP5;SFRP1;GREM1;BAMBI;IL17RD
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.4401172574776773,0.8221692164751531,0.6530612244897959,0.9081678681405166,1.0,2/11,5.04%,ROBO2;BASP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.49003291491483975,0.8221185412298424,0.6470588235294118,0.9078629927555284,1.0,5/9,20.50%,MAPKBP1;MAP2K5;OTUD7B;ANXA4;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.44718195570219704,0.8219655332880086,0.7209302325581395,0.9078137007887391,1.0,4/12,11.15%,ADGRV1;GRM2;EDNRB;GABBR2
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.5397643197109189,-0.8211314291255614,0.7346938775510204,1.0,1.0,2/6,19.95%,SYAP1;PINK1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.5652565258902191,-0.8208826282524329,0.75,1.0,1.0,1/5,12.65%,ORAI1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.422197370751589,-0.8208017091756895,0.6727272727272727,1.0,1.0,4/26,12.95%,CRTAM;HLA-B;PVR;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.47401698830878114,0.8207470886105339,0.74,0.9095992404895004,1.0,4/15,16.17%,KDM4D;SETMAR;PARP9;MAD2L2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.3486224165746974,-0.8207147918366802,0.7543859649122807,1.0,1.0,6/78,8.96%,CRYAB;PRR7;UBB;CHMP2A;DHCR24;TMEM109
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.5231095532913999,-0.8206390097779007,0.6785714285714286,1.0,1.0,3/6,29.76%,GRN;CLN3;ATP6AP2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.41778454391088177,-0.8199266943439392,0.7241379310344828,1.0,1.0,5/23,8.62%,SELP;SERPINE1;RPL30;RPS19;PRB3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5104221567621687,-0.8195349579629455,0.6615384615384615,1.0,1.0,3/7,17.25%,CALM1;SRI;TRDN
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),-0.5522093001836179,-0.819505443881483,0.6739130434782609,1.0,1.0,2/5,12.59%,ICAM1;AGER
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.4377257048410379,0.8193816907187567,0.6981132075471698,0.911725115125528,1.0,3/17,12.13%,SLC22A16;SLC22A3;SLC25A19
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.41279121571388466,-0.8193414125712349,0.6923076923076923,1.0,1.0,7/25,19.33%,HSPE1;SDF2L1;DNAJB4;HSPA8;HSPA14;HSPA2;DNAJC18
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.4476963893843121,0.8193188412942727,0.7111111111111111,0.9114962845572786,1.0,4/17,12.33%,ADAMTS9;SAMHD1;FBXO17;AOAH
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.5139607843062428,-0.8192657921662038,0.7619047619047619,1.0,1.0,1/5,8.32%,ALKBH2
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.509393882148187,0.8191667601060993,0.7547169811320755,0.9113445970940408,1.0,2/5,23.78%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.5296325576422851,0.8188993328847602,0.6875,0.9115728601425568,1.0,1/5,7.37%,CHDH
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.40250875014068954,0.8182336330776978,0.8043478260869565,0.9122142557812045,1.0,2/18,9.81%,MEF2C;ZBTB18
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.5319809606672081,0.8181526161799019,0.717391304347826,0.912004813413171,1.0,2/7,13.89%,CLOCK;RFX3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.3858297621728095,0.8181290052097285,0.7777777777777778,0.9116658823392453,1.0,2/25,10.68%,LRRK2;MAPT
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.3784760700282489,-0.8181239574961947,0.7358490566037735,1.0,1.0,17/49,19.17%,NOC2L;PCNA;PDE6A;PARP1;CNGB1;SDE2;BAK1;NPM1;TRIAP1;ATR;OPN4;COPS9;TMEM161A;NEDD4;ATF4;CASP9;SMPD1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.41808712796479686,0.8180152061783604,0.813953488372093,0.9114520296392886,1.0,4/17,14.42%,NCKAP1L;THY1;VEGFA;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.33135378003424754,0.817973812810086,0.86,0.9111615770354343,1.0,20/96,16.96%,TGFB2;OSGIN1;TSPYL2;MT1M;PTPRJ;RERG;BCL6;CDKN2A;BMPR2;OSGIN2;GNG4;FHL1;APBB2;SMARCA2;GJA1;CRLF3;FRZB;CDKN1A;SESN2;CCN3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.4426905355317428,0.8177639136528138,0.7346938775510204,0.9111879162785637,1.0,7/13,11.99%,PDGFB;PDGFRA;SYK;F2;TEC;LYN;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.40325109040917384,0.8175583410257665,0.7083333333333334,0.9111039630953174,1.0,6/23,11.59%,VSIR;GRIN2B;EPHA4;GRIN1;CR1;LYN
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.5465134441752832,-0.8170634677707946,0.75,1.0,1.0,4/5,31.36%,BAX;CASP9;CYCS;BOK
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.36915072951947564,-0.8169912447315242,0.72,1.0,1.0,5/62,4.74%,RPS3;SFRP1;TNFRSF21;CRHBP;HYAL2
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.5069853204046814,0.8169288949853458,0.76,0.9118635524641728,1.0,2/9,4.61%,IL12A;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.43393629901301267,0.8167129526536284,0.6470588235294118,0.9118368815698792,1.0,3/10,13.82%,BIRC3;YBX3;FZD9
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.2999661628164981,-0.8166661949616925,0.9571428571428572,1.0,1.0,40/303,15.36%,RAB32;KIF3B;ATP6V1F;VAMP5;RAB8A;ARCN1;ATP6V1G1;ATP6V1G2;TF;TMED4;STX10;MCOLN1;CHMP2A;TMED9;ERP29;TBC1D16;ARL17A;SCAMP2;TXNIP;ARFIP2;SNX17;DNAJC27;TMED2;VPS29;ATP6V1E2;RAB31;ATP6AP1;NPM1;USP6NL;TMED1;SAR1B;SVBP;ATP6V0E1;STX6;CHMP3;ARL6IP5;CENPF;UNC93B1;TMED5;STX19
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.4749474968802657,-0.8164599190869369,0.7346938775510204,1.0,1.0,5/11,30.50%,ELOF1;PADI2;ZMIZ2;SMARCD1;CHEK1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4287137550911756,0.8163628615245732,0.6923076923076923,0.9119778337357277,1.0,4/13,19.52%,PKIA;PRKAR1B;ADRB2;PKIG
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.36914125284787735,0.8160842044970983,0.7727272727272727,0.9120516588968153,1.0,1/25,0.90%,TP73
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.4396669043993501,0.8159538847373642,0.7555555555555555,0.9119292491807693,1.0,3/19,6.29%,PTPRC;PTPRJ;LILRB1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5026882709479227,-0.8157734774336729,0.7777777777777778,1.0,1.0,3/11,20.53%,UCKL1;UCK1;TK2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3481304478988357,0.8155779379532206,0.84,0.9121178229099461,1.0,9/61,13.09%,BAIAP2;SORBS1;IRS1;RHOQ;ATP6V0D2;GPLD1;PIK3R1;GRB14;PDK4
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.5403414503827776,-0.8155323772526544,0.7321428571428571,1.0,1.0,1/5,5.05%,LACC1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.38803806362275783,-0.8154999025086767,0.8113207547169812,1.0,1.0,5/35,12.32%,SLC22A2;SLC3A2;SLC38A7;SLC38A9;SLC7A11
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3562424516368193,-0.8149585684003223,0.6730769230769231,1.0,1.0,13/87,16.69%,RPL11;RAD23A;UBXN1;RACK1;ARAF;ELOB;NOP53;UFL1;KEAP1;MAP1A;SH3RF2;SMAD7;PARK7
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3910846876263166,-0.8147592548088564,0.7391304347826086,1.0,1.0,6/31,20.53%,BACE2;NCSTN;BACE1;CTSH;AFG3L2;RBMX
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3870894546159937,-0.8146186612279253,0.7959183673469388,1.0,1.0,15/47,19.64%,RPS3;RNF8;H2AX;PCNA;DDX5;PLA2R1;BRCC3;HMGA2;ERCC8;ABRAXAS1;TRIM28;ATR;TMEM161A;NSMCE4A;UBE2N
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.5179948600039999,0.8145437163138138,0.6938775510204082,0.9134584488861405,1.0,4/6,29.52%,LRP1;ATP13A2;LRP2;MGAT3
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5151655366765947,0.8141693945239532,0.72,0.9137275007900321,1.0,1/6,23.15%,SLC6A6
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.4442662119180577,-0.8141317726089707,0.7454545454545455,1.0,1.0,1/19,6.73%,RAN
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.4848787843582877,0.8138888275697026,0.7391304347826086,0.9138769095347589,1.0,2/12,7.66%,NFKBIE;NFKBIA
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.3423696244402742,-0.8138621384604738,0.8888888888888888,1.0,1.0,18/98,16.69%,RPS3;PRR7;CENPX;UBB;UBXN1;PTTG1IP;VPS28;SEPTIN4;PINX1;SVBP;SQSTM1;UFL1;DAXX;DNAJA1;SH3RF2;SMAD7;UBE2L3;PARK7
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.4059889438895772,-0.8137815885364741,0.74,1.0,1.0,4/25,4.74%,FUCA1;GPC4;GPC2;HYAL2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.5443571367598049,-0.8135971110443808,0.7058823529411765,1.0,1.0,3/5,23.31%,ATF4;PINK1;LANCL1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.5209446393227731,-0.8134382524674203,0.7777777777777778,1.0,1.0,3/7,39.53%,DICER1;AGO4;ADAR
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.4631805053617797,-0.8134149831748226,0.7692307692307693,1.0,1.0,7/17,15.64%,BAK1;BAX;FIS1;IFI6;TIMM50;GGCT;BAD
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.45830953272077074,-0.8129822716628443,0.7213114754098361,1.0,1.0,6/13,19.94%,SYNE2;DYNC1H1;SYNE3;CEP120;DCTN1;TMEM201
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.4437919719086,-0.8128516052389126,0.7843137254901961,1.0,1.0,2/19,4.08%,VPS25;CRHBP
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.47162946458056537,-0.8128158034044884,0.7291666666666666,1.0,1.0,2/10,6.83%,ERH;MACROD2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5041259242718075,0.8126066370835172,0.7735849056603774,0.9156258827923848,1.0,2/7,17.69%,HEXB;OGN
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.44449296492016505,0.8125921352924504,0.7450980392156863,0.915292311313012,1.0,3/18,10.65%,ZDHHC11;LILRB1;PARP9
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.3267174565838867,-0.8124890942671786,0.7894736842105263,1.0,1.0,12/85,11.87%,CXCR4;PDE6A;LACC1;METAP2;NLRP1;FNTA;CNGB1;CALM1;GUCA1C;EPHB2;TMSB4X;ADAMTS12
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.39846980102427965,-0.8122201207984282,0.7254901960784313,1.0,1.0,4/33,11.65%,CENPX;SMARCA5;ASF1B;NPM1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.4350642619138935,0.8122144191900937,0.7291666666666666,0.9154743130084599,1.0,3/15,7.14%,SRGN;MEF2C;SOX9
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.4106963523357514,-0.8121478342715439,0.75,1.0,1.0,2/20,6.37%,LCK;ITPR2
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.45435476344542525,-0.8119880892542158,0.5789473684210527,1.0,1.0,7/14,33.57%,SSB;LSM1;ERI1;TUT4;EXOSC4;EXOSC10;ATM
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.35099193918915106,-0.8118409740546516,0.7551020408163265,1.0,1.0,12/76,13.22%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;GATA1;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.4523041029683491,-0.8118176346479486,0.7391304347826086,1.0,1.0,2/14,5.46%,B3GALT4;B4GALNT2
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.5430421282599733,0.8116483779965915,0.7906976744186046,0.9160997268476045,1.0,2/5,24.83%,RPS6KA4;FMR1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5256754697981976,0.8115900983691814,0.7906976744186046,0.9158426467762607,1.0,3/7,20.50%,ARRB2;ADRB2;ARRB1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.40164359890575196,0.8110702058445064,0.8085106382978723,0.9163768658561583,1.0,2/19,8.18%,HOOK1;KIF16B
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.4444662491102257,0.8109443799116798,0.7333333333333333,0.9162580283767511,1.0,2/12,16.10%,SETD1A;SETD5
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.40062449055755855,-0.8105943401619796,0.7608695652173914,1.0,1.0,3/29,6.38%,SQLE;SOAT2;IDH3B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.43979526861361545,-0.809595698427332,0.7368421052631579,1.0,1.0,3/11,15.11%,RIC3;RANGRF;MAP1A
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3371221098898507,0.8095798952125367,0.75,0.9181916268784942,1.0,11/73,16.22%,NEDD4L;TNFRSF1B;DACT1;WNT5A;AMER1;WWP1;GPLD1;APC2;HECW1;SNX33;TIPARP
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.27937029029218835,-0.8090821976106328,1.0,1.0,1.0,71/791,11.58%,POU3F1;NGF;TEAD2;DDIT3;RPL5;BTN3A1;RPL11;RPL23;RPS3;SFRP1;WWC2;RPS7;BTN2A1;THAP1;MYADM;PTH;EDF1;MOG;DRAP1;HOXD3;PPIE;PDCL3;SLC22A2;SPIN2B;ZNF664;CDK4;ATP1B1;ZNF22;LMX1B;MLX;FGF6;RACK1;NKX6-2;MYBBP1A;HES6;NKAPL;ZNF676;ZNF492;OPRD1;DNMT3B;ERP29;MLF1;ACTG1;FAM98A;TRIM60;APLN;RPL6;PCBP3;ATRAID;POLR2A;NKAP;ZSCAN21;PATZ1;RAG2;ACVR1B;PCGF1;PRDM5;CDK11A;BTN3A2;ZNF335;METTL18;HRAS;AHR;COQ7;TRIM61;PRKAA2;SNF8;MBNL3;CDK11B;ZFHX3;EPHB2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.38358906883680494,-0.8080978361978216,0.7454545454545455,1.0,1.0,9/36,16.85%,H2AX;CHAF1B;GRWD1;SMARCA5;ASF1B;H2BC21;NPM1;DAXX;ANP32B
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.28861149478744746,0.8080118886117715,1.0,0.9203902346276607,1.0,32/271,13.72%,EGFR;ANGPT1;SNX31;MYO7A;LRRK2;TBC1D10A;SEPTIN6;REEP1;TBC1D8B;PACSIN1;DMD;STX3;RRAGD;STX1A;WNT5A;CNTNAP1;FBLN5;LAPTM5;PICK1;RPGR;TBC1D9;YWHAH;NGFR;HPS6;SEPTIN12;CPE;BBS2;WLS;STX17;SEPTIN3;ARL6;RAB29
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.4900570173342457,-0.8079629798270125,0.7090909090909091,1.0,1.0,2/8,11.73%,PARP1;ST3GAL1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.3653136504698952,-0.8078893064140376,0.7735849056603774,1.0,1.0,4/37,15.60%,USP1;KPNA2;PDGFA;ALYREF
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.32966781486847446,-0.8077667551263154,0.8153846153846154,1.0,1.0,21/111,17.19%,GOLGA8M;TMED4;TMED9;TMED2;LMAN1;GORASP1;USP6NL;TMED1;STX6;GORASP2;COG2;GOLGA2;GOLGA8H;TMED5;LMAN2;FBXW8;SURF4;GBF1;BLZF1;CDC42;PLK3
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.338192217932777,-0.8077233103125325,0.7543859649122807,1.0,1.0,15/107,12.80%,SELENOS;ATP6V1F;RAB8A;ATP6V1G1;ATP6V1G2;PARP1;TRARG1;SYAP1;USF1;CAPN10;ATP6V1E2;RAB31;ATP6AP1;GCK;ATP6V0E1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.4887213733625949,-0.8075385152852899,0.74,1.0,1.0,2/11,10.09%,NEK6;CCNB2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.3900354138126101,-0.8071994518495198,0.6896551724137931,1.0,1.0,6/31,15.75%,KIF3B;SOD1;BLOC1S4;DYNC1H1;DCTN1;KIF4A
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.5117658569772158,-0.8071023805304595,0.711864406779661,1.0,1.0,1/8,1.66%,EEF1A1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.4235958315426245,0.8070735742571112,0.7692307692307693,0.9212388822554739,1.0,4/17,10.25%,ADD2;TWF2;SCIN;VIL1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.4235958315426245,0.8070735742571112,0.7692307692307693,0.9212388822554739,1.0,4/17,10.25%,ADD2;TWF2;SCIN;VIL1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.47368766072177354,0.8070333221463915,0.7619047619047619,0.9209424353464674,1.0,4/9,21.67%,SLC24A4;UBR3;MKKS;BBS4
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.41199232947725345,-0.80659471697892,0.7627118644067796,1.0,1.0,5/24,11.39%,PPIL1;PPIB;PPIE;PPWD1;PPIA
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.421983060734449,0.8063049281592514,0.717391304347826,0.9217392565859527,1.0,2/18,3.18%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.3504714633959908,0.8057714591677219,0.7580645161290323,0.9221554089076696,1.0,2/39,2.60%,AQP1;MAP3K5
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.33296248672682616,0.8056983974505969,0.8297872340425532,0.9219254304586266,1.0,10/75,10.25%,KANK2;PPARG;BDH2;DACT1;LOXL3;SOX9;NDRG4;TIMELESS;GRHL2;VIL1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.3345783828270069,-0.8056333025581762,0.7936507936507936,1.0,1.0,9/71,8.39%,OOEP;PLK4;NDC80;RANBP1;NUMA1;USP19;DBF4B;RHOA;MAP10
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.5264440151016192,0.8054799404356111,0.6949152542372882,0.9218665139694733,1.0,3/6,14.29%,LEF1;TESC;HCLS1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.36856555025252263,-0.8054484403349474,0.8135593220338984,1.0,1.0,10/59,13.34%,PCNA;TFDP1;SDE2;RFWD3;BAX;RPS27L;BTG2;TRIAP1;GML;CARM1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.5167154335005804,-0.805362423482033,0.74,1.0,1.0,3/6,20.10%,MOCS1;NFS1;MOCOS
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.5106295442668234,-0.8052552643151331,0.7083333333333334,1.0,1.0,3/8,24.37%,PINK1;MAP2K2;ERN1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.3263483856532362,-0.8048520001107254,0.8888888888888888,1.0,1.0,14/140,11.68%,TYRP1;RPL5;EIF3D;PTH;PCNA;PASK;DUOXA1;METTL5;PYM1;RPS4X;DDAH2;NPM1;GCK;RPS27L
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.33736025133991066,-0.8046015538209655,0.7868852459016393,1.0,1.0,18/61,19.61%,DPEP1;BACE2;GSTP1;ENPEP;SOD1;SPCS1;GSTM4;SEC11C;SPCS2;GSTM3;SPCS3;CPXM2;CTNS;BACE1;GSTZ1;ETHE1;G6PD;ADAMTS13
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.4080847775809226,-0.8044368095819734,0.7924528301886793,1.0,1.0,1/20,1.69%,RNF8
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.5378063807865798,-0.8043530635735392,0.7419354838709677,1.0,1.0,4/6,25.80%,ADH4;CYP3A4;LDHD;CYP4F12
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.4206140210581194,-0.8041968526478701,0.782608695652174,1.0,1.0,3/17,10.96%,SCARF1;ACTG1;HRAS
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.45343488030202184,0.8039628400436826,0.8,0.923698132356854,1.0,3/11,17.62%,P3H4;SYCP1;SYCP2
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.45343488030202184,0.8039628400436826,0.8,0.923698132356854,1.0,3/11,17.62%,P3H4;SYCP1;SYCP2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.35070319568472835,-0.8036770801811604,0.7413793103448276,1.0,1.0,17/64,23.38%,SRSF7;SRSF9;SRSF3;RBM8A;RAE1;DHX38;MAGOHB;ALYREF;YBX1;SLU7;TPR;RTRAF;CASC3;POM121C;SIDT2;SRSF2;CDC40
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.4068771084205576,0.8035520161922731,0.8301886792452831,0.9240083754212739,1.0,2/21,4.01%,SGO1;SYCP3
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.3635238411403414,-0.8033001101261829,0.8571428571428571,1.0,1.0,6/62,7.82%,P2RY10;CXCR4;ITGAL;EVI2B;HSD11B1;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),-0.5209331815948627,-0.8027618667400362,0.6875,1.0,1.0,1/5,8.72%,ACVR1B
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.4070503367627912,-0.8025392493376047,0.8461538461538461,1.0,1.0,9/31,25.00%,PHAX;DKC1;CIRBP;YBX1;VIP;NSUN2;EIF4ENIF1;TRDMT1;MEIOC
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.43863842302664247,0.8020968900709815,0.7380952380952381,0.9259960035905256,1.0,3/14,13.24%,PKD1L3;GPLD1;PKD2L1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.4667445714021695,-0.8020963264634933,0.7169811320754716,1.0,1.0,1/17,0.44%,CRTAM
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.3976059192778132,0.8019996332963956,0.7391304347826086,0.9257697835216301,1.0,6/23,13.91%,SYNPO2;VIL1;CX3CL1;FHOD1;SHANK1;SYNPO
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3828503204698195,-0.8012048473693579,0.8076923076923077,1.0,1.0,5/23,13.82%,MYADM;PFN1;TWF1;TMSB4X;GSN
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.5192344875038662,-0.8008693478159904,0.6470588235294118,1.0,1.0,3/5,21.93%,IKBKG;SYT11;TESK1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3448345147838775,-0.800867257305024,0.75,1.0,1.0,12/63,13.22%,PSMD7;PSMB6;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;GATA1;PSMA7;PSMD13;PSMB8
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.45815564126357466,-0.8008234043930146,0.7659574468085106,1.0,1.0,1/13,1.29%,SELP
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.40596082360316144,0.8007595546808645,0.75,0.9272768649218655,1.0,7/25,14.19%,IL12A;IRGM;MAPK11;POU2F2;GSDME;VWCE;LGALS8
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.4640724458781052,0.8006085064572598,0.6808510638297872,0.9271449840470868,1.0,6/10,30.31%,FBLN1;SPINT2;DUSP3;CCDC125;WAS;FRMD5
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.4957751462306707,0.8005199139605207,0.7704918032786885,0.9268854563254275,1.0,2/7,14.24%,MAP2K5;ABCA1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.4016308266525965,0.8003787386118943,0.75,0.9266781610358247,1.0,2/23,8.41%,ANGPT1;FBLN5
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.4263261429775263,-0.7999187698660076,0.7636363636363637,1.0,1.0,5/20,16.33%,AWAT2;PLCE1;GPAT2;PNPLA3;GPAM
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4478901376245254,-0.7997026906984299,0.7111111111111111,1.0,1.0,1/14,1.19%,MBOAT1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.3952035225633337,0.7996607773676311,0.8,0.9274922320000402,1.0,5/23,14.06%,SLC1A2;SLC7A9;SLC7A8;SLC1A1;SLC25A22
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.3960765632084386,0.7993870469995202,0.7555555555555555,0.9275117040975502,1.0,5/25,14.26%,ITGAM;KCNB1;DMTN;ANK3;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.38766623901804553,0.7993107199053705,0.74,0.9273280272516184,1.0,6/24,12.86%,CGNL1;MET;PIK3R1;ARAP1;ARHGAP28;SHANK1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.4763754798664823,-0.7989606554466891,0.6779661016949152,1.0,1.0,1/8,8.80%,OTUD3
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5365083250351463,0.7989368374674649,0.8,0.9275694906137969,1.0,1/5,3.57%,NR4A3
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4037615002108301,-0.7988585308412619,0.813953488372093,1.0,1.0,3/27,11.65%,CENPX;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.4607545654579158,-0.798844591192574,0.7391304347826086,1.0,1.0,4/17,19.10%,CHMP2A;CHMP5;CHMP3;TPR
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.3718209581673021,-0.798688950729175,0.8490566037735849,1.0,1.0,7/39,22.26%,LSM2;RNH1;NUDT12;NUDT16L1;ZPR1;DXO;SIDT2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.3974141994264396,-0.7984649342920633,0.7857142857142857,1.0,1.0,11/30,19.46%,DPEP1;GSTP1;SOD1;GSTM4;GSTM3;GGCT;CTNS;PARK7;GSTZ1;ETHE1;G6PD
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.4240265745476941,0.7983829503436114,0.7924528301886793,0.9281600640265361,1.0,2/17,5.33%,LRRK2;LRCH1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.4708695073656251,-0.7983326361794736,0.7254901960784313,1.0,1.0,2/8,4.91%,AADAT;AFMID
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.4515594051328235,-0.7979560269032577,0.7222222222222222,1.0,1.0,3/11,18.26%,APLN;HMGB1;SIRT6
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.4908637611270987,0.7976267833850715,0.74,0.9288822852285789,1.0,1/8,0.60%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.4730754662482606,-0.7975378554367244,0.7906976744186046,1.0,1.0,2/14,13.82%,RACK1;GSN
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4491823189141946,-0.797533920320016,0.6909090909090909,1.0,1.0,5/11,19.91%,SDE2;RFWD3;RPS27L;PLK3;PRKDC
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.4753279773289343,-0.7974723447270947,0.8113207547169812,1.0,1.0,1/8,7.14%,XG
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.37274571892086605,-0.7971702454719536,0.8135593220338984,1.0,1.0,11/46,15.23%,PRELID1;GAPDH;SERPINE1;PSME2;SERPINB8;PSME1;SERPINH1;PSMB8;KNG1;NCSTN;TIMP2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.5414953327067624,0.7970681649911346,0.7413793103448276,0.9294718709417377,1.0,2/5,14.60%,MEF2C;MEGF10
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4004985395655096,0.7967923499709114,0.7954545454545454,0.9295329452378184,1.0,8/23,15.91%,NRXN1;PICK1;AGRN;DLG4;THY1;LRP4;ITGB1BP1;NLGN1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.5621124881736581,0.7967344829397486,0.82,0.9292263713741842,1.0,2/5,14.21%,SLC6A15;SLC6A7
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.44022921224010453,0.7964995491127204,0.8135593220338984,0.9291650096604971,1.0,4/13,22.33%,TOP2A;MTERF1;TOP1MT;HMGB2
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.48857903311442347,-0.796472684600713,0.673469387755102,1.0,1.0,3/11,10.80%,DDX5;PYHIN1;PLA2R1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.48334478489034405,-0.7964597534137726,0.7192982456140351,1.0,1.0,2/8,17.20%,PDPR;GSTZ1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.48334478489034405,-0.7964597534137726,0.7192982456140351,1.0,1.0,2/8,17.20%,PDPR;GSTZ1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.3452476661885286,0.7961676321146758,0.82,0.9293768237636714,1.0,13/51,10.93%,ROBO2;EPHA4;PAK3;EFNB3;PLXNA4;SIPA1L1;NTRK2;TIAM2;EPHB3;PLXNA2;MCF2;ROBO1;NGFR
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.4078669677889708,-0.7957073053689739,0.8392857142857143,1.0,1.0,2/21,6.37%,LCK;ITPR2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.47091427070853137,0.7953375628991197,0.75,0.9302521898425824,1.0,4/8,18.25%,HSPB1;PRKD1;VEGFA;KDR
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.45382724723735857,-0.795240532266363,0.813953488372093,1.0,1.0,2/16,13.09%,RACK1;LLGL1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.5337632066484699,-0.7946579275520905,0.7708333333333334,1.0,1.0,1/7,1.07%,CORO1B
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.5171295931647624,-0.7945022154643642,0.78,1.0,1.0,2/5,17.47%,ADIPOR1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4237580090454118,0.7943583878294423,0.7543859649122807,0.9313997756707064,1.0,1/15,1.47%,CD44
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.34037318206855494,0.7943135355909917,0.8541666666666666,0.9310977734226193,1.0,10/47,12.42%,SLC23A1;FMO5;SULT2A1;SLC5A9;SLC7A9;SLC26A7;TPO;ABCC6;KCNIP3;SLC6A4
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.3961684365497314,0.7940772271599532,0.7272727272727273,0.9310640039539368,1.0,6/25,15.19%,EGFR;ZFP36;SOX9;VIL1;PTPN11;ZFP36L1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.5535016005703489,-0.7935603092683996,0.7894736842105263,1.0,1.0,2/5,8.54%,DSCAM;SDK2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.32178378838597654,0.7934867013242796,0.8536585365853658,0.9315237400753464,1.0,3/70,1.41%,TGFB2;KANK2;IGF1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.41218359955274547,-0.7934498645622265,0.7719298245614035,1.0,1.0,1/18,2.01%,NES
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.505981316035165,-0.7934174072265346,0.7049180327868853,1.0,1.0,1/9,4.58%,GOPC
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.35982535361193646,-0.7934105500149883,0.7647058823529411,1.0,1.0,5/53,10.71%,NGF;NRBP2;SOD1;UNC5B;MAG
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),-0.49456303095558196,-0.7934039715945487,0.75,1.0,1.0,2/7,28.30%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),-0.49456303095558196,-0.7934039715945487,0.75,1.0,1.0,2/7,28.30%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.33682109170273083,0.7933895743879411,0.8604651162790697,0.9313019113976312,1.0,7/55,10.82%,TGFB2;KLF9;SULF1;PTPRM;SOX9;ROBO1;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.46853491599193464,0.793334747589865,0.7843137254901961,0.9310098162696641,1.0,2/10,6.29%,VSIR;LILRB1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.38543702019257825,-0.7931523019765068,0.7692307692307693,1.0,1.0,13/39,24.01%,SQLE;HSD17B10;AKR1D1;SC5D;MSMO1;CYP7B1;PARK7;PMVK;TM7SF2;PSAT1;OSBPL7;OSBP;SLC27A5
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.3590190047083266,0.7931507712754283,0.7346938775510204,0.9308634729084779,1.0,2/32,6.25%,TGFB2;SULF1
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.4932998492509425,-0.7929182343034067,0.7857142857142857,1.0,1.0,1/11,6.01%,CDC23
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.4932998492509425,-0.7929182343034067,0.7857142857142857,1.0,1.0,1/11,6.01%,CDC23
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.4932998492509425,-0.7929182343034067,0.7857142857142857,1.0,1.0,1/11,6.01%,CDC23
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.502705085515848,-0.7920861397620662,0.8431372549019608,1.0,1.0,3/10,20.53%,UCKL1;UCK1;TK2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.502705085515848,-0.7920861397620662,0.8431372549019608,1.0,1.0,3/10,20.53%,UCKL1;UCK1;TK2
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.4254864898159,0.7919956159890716,0.7962962962962963,0.9322891962925168,1.0,2/16,4.57%,CSF1R;SRC
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3240585666462414,-0.7919524304639908,0.8490566037735849,1.0,1.0,25/89,23.91%,RPL11;NUTF2;PTTG1IP;PHB2;RAN;NOP53;NXT2;PINX1;RPF2;RANBP17;TOR1A;NOL8;MORC3;APPL2;NXT1;TPR;EIF4ENIF1;IPO5;POM121C;SKP1;IPO7;CALR;PAF1;CSE1L;NUP93
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.3897719425649299,0.7918221118603463,0.7708333333333334,0.9321471548605856,1.0,5/18,14.38%,ANGPT1;ARRB2;PICK1;SFRP4;VEGFA
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3303989244968484,-0.791607097926377,0.8596491228070176,1.0,1.0,13/106,14.07%,ABCA13;AQP9;SLC22A2;CHMP2A;ABCA8;SLC22A6;SCAMP2;TXNIP;SLC22A25;SLC22A24;CHMP3;ARL6IP5;CENPF
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.3681326370804483,-0.7915859332558888,0.8545454545454545,1.0,1.0,6/27,11.58%,CD38;TNFRSF21;CD81;IKZF3;AHR;EPHB2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.4119443969104149,0.7915752231162096,0.8297872340425532,0.9322021505677911,1.0,4/21,5.07%,IGF1;PPP1R3C;SORBS1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.3872687393295788,0.7914324382590504,0.8163265306122449,0.9320415077827984,1.0,1/22,1.38%,PTPRC
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.4014290289772585,0.7914113871275683,0.8367346938775511,0.9317076460731109,1.0,2/18,14.14%,RGPD3;RGPD2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4322472177815685,-0.7912435370761469,0.7083333333333334,1.0,1.0,3/21,11.65%,CDK4;DBF4B;NPM1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.2771376005876724,-0.7911177070115905,1.0,1.0,1.0,48/447,14.31%,RPS27A;SELENOS;UBC;RNF8;UBB;ZNF598;PSMD7;PSMB6;PCNA;MARCHF2;PSME2;FBXW10;PSMD8;UBE2D4;RACK1;RNF113A;ELOC;RNF167;CDC23;TRIM60;RRAGA;ELOB;PSMB4;SDE2;RNF181;PSMD3;PSMB3;TMEM129;TRIM52;CCDC22;RFWD3;PSME1;TRIM61;KLHL20;UBA52;DCAF15;PSMA7;MYLIP;ASB5;PSMD13;KBTBD8;PSMB8;UBE2Q2;CTR9;ERCC8;RNF6;VPS11;KEAP1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.41563471560928644,-0.7907004634052848,0.7647058823529411,1.0,1.0,4/21,13.46%,CHMP2A;CHMP5;TMEM50A;CHMP3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.32805523736077175,-0.7905118858665333,0.9344262295081968,1.0,1.0,16/89,16.19%,RPL5;EIF3D;PTTG1IP;PASK;METTL5;PYM1;BAK1;RPS4X;NPM1;RPS27L;AURKAIP1;VPS11;CIRBP;NAT10;BAD;FADD
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3492822648931285,-0.790491154475875,0.7833333333333333,1.0,1.0,1/62,0.10%,NGF
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.33861608006913596,-0.7903696888396061,0.8103448275862069,1.0,1.0,10/62,15.87%,POLR2L;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;RAE1;NUP37;POLR2C;POLR2D
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3371178097966951,0.7899931963619048,0.8297872340425532,0.9334908380647954,1.0,10/87,7.75%,TGFB2;CLDN5;FOS;MEF2C;SRC;PRKCZ;ARRB2;SOX9;DLX1;WNT5A
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.343378988416489,-0.7896445402035529,0.8524590163934426,1.0,1.0,10/69,11.65%,SELENOS;CELA2A;RAB8A;PARP1;TRARG1;SYAP1;USF1;CAPN10;RAB31;GCK
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.32751566302126445,0.789635993457702,0.85,0.9336809775584294,1.0,6/60,9.76%,TBC1D10A;TWF2;ODAD3;TRPM2;DMTN;GAP43
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.503626108789008,-0.7890928870623054,0.7111111111111111,1.0,1.0,1/5,3.87%,SLC22A2
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.3414803382440987,0.7889269688046072,0.8372093023255814,0.9344465443988614,1.0,2/43,2.39%,CERS3;CERS6
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.30624263343807034,-0.7887831356558144,0.8771929824561403,1.0,1.0,21/160,14.27%,PDE3A;DDIT3;WWC2;MYADM;NOC2L;GSTP1;HYAL2;RACK1;NOP53;OTUD3;SPRY3;CCDC22;TRIM59;PRKAA2;TMSB4X;ADIPOR1;NLRX1;PEBP1;PIK3IP1;UACA;THEM4
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.5317806986312623,0.7887270554684096,0.7291666666666666,0.9343788885163377,1.0,1/5,13.48%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.43379922738767296,-0.788714021038426,0.74,1.0,1.0,6/13,23.00%,RESF1;TRIM28;SIRT6;TPR;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.4783502175087946,0.7883397733699633,0.7674418604651163,0.9345263730849428,1.0,1/11,1.32%,NTNG1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.3991433161313938,-0.7881885352842979,0.8,1.0,1.0,2/25,2.39%,CYB5A;SEC61B
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.502910955576941,-0.7879644199334173,0.7068965517241379,1.0,1.0,1/6,3.23%,ACTN2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.33613743785507144,-0.7878783799666891,0.8333333333333334,1.0,1.0,11/97,9.79%,BMP5;RPS27A;UBC;UBB;DDX5;FNTA;BAMBI;RHOA;ACVR1B;DUSP15;ZFYVE16
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.35466962048064254,-0.7877804550532,0.7818181818181819,1.0,1.0,2/52,0.44%,LCK;CRTAM
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.42391549395128914,0.7874926764113018,0.7659574468085106,0.9354122301481461,1.0,1/11,2.19%,ADCY8
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.3137074496024565,0.7874297889536983,0.9148936170212766,0.9351200121947234,1.0,12/71,14.43%,DOK3;CD44;ADGRE2;PIM1;LRP8;TAL1;LMO2;MFSD2B;ADCY7;TUBB1;FAM117A;BCL11A
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.28055364329173615,0.7871850181927722,1.0,0.9351315936119198,1.0,26/248,11.04%,TGFB2;TP73;PTPRC;TRNP1;IL12A;FAP;BIRC3;CDKN3;KAT2B;ID2;TSPYL2;CITED2;LILRB1;PLAGL1;SOX9;FIGNL1;BRINP1;UHRF2;CCND1;MAPK12;PLK1;CDKN2A;PCLAF;SETMAR;WDR6;SMIM22
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.46939246380854666,0.7866463709444189,0.7058823529411765,0.935670704153757,1.0,3/6,31.29%,PAH;KYAT1;PCBD1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.43172122969510923,-0.7865272820487546,0.7307692307692307,1.0,1.0,3/13,14.78%,ZNF335;CTR9;PIH1D1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.43176943095966736,0.7865251886237786,0.7906976744186046,0.9355000613427806,1.0,1/12,2.72%,CAMSAP3
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.4578461910639947,-0.7857101083042961,0.7741935483870968,1.0,1.0,2/7,10.18%,MEOX1;MEOX2
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.36989287604591414,0.7854069319634004,0.7954545454545454,0.9368316250364837,1.0,4/25,10.39%,IRS1;CACNA1B;STAT6;ERBIN
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.409389570678915,-0.7852672754473352,0.7755102040816326,1.0,1.0,2/13,10.75%,RASGRF1;STMN3
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.3905429143821718,0.7848656593580914,0.7678571428571429,0.9372295468103343,1.0,6/19,20.96%,CARTPT;MAFB;UBASH3B;CAMK4;FBN1;GPR137
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.4260936952784463,0.7847689593143219,0.782608695652174,0.9366779049018378,1.0,4/11,12.65%,MET;TP63;TMEM79;ALOX12
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.4260936952784463,0.7847689593143219,0.782608695652174,0.9366779049018378,1.0,4/11,12.65%,MET;TP63;TMEM79;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.5125199091681619,-0.784654282515957,0.6875,1.0,1.0,3/5,8.20%,TAC3;SPX;TBXA2R
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.4153139747820026,0.7840625156296013,0.7058823529411765,0.9374061042134527,1.0,2/13,9.18%,ACTN1;FBLN1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.47385834853095754,0.7839737028133194,0.75,0.9371606919692993,1.0,1/9,6.23%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.5144045144401497,-0.7839159470400632,0.7777777777777778,1.0,1.0,1/6,3.69%,NOC2L
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.447413987223224,0.7836904565149813,0.8620689655172413,0.9372598590173603,1.0,2/11,20.28%,ZFP36L1;PAPOLA
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.5339899019024317,-0.783462021523762,0.8,1.0,1.0,1/5,2.89%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.5339899019024317,-0.783462021523762,0.8,1.0,1.0,1/5,2.89%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.34922424981649586,0.7833036947121345,0.803921568627451,0.9375264230054094,1.0,12/53,20.97%,IGF1;SRC;TNFRSF10B;FEM1B;WWOX;LGALS3;TNFRSF10A;GPER1;SIAH2;TMC8;PAK2;PHIP
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.411793949364164,-0.7830969102277403,0.7931034482758621,1.0,1.0,2/15,4.30%,CELA2A;CD9
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.360541446039135,-0.7830588211911701,0.8103448275862069,1.0,1.0,9/51,17.32%,PCNA;TFDP1;BAX;BTG2;TRIAP1;GML;CARM1;PLK3;CNOT3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.49645113977623345,0.7830335973231107,0.8,0.9375091135376088,1.0,2/9,14.24%,SCARB1;ABCA1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3415099455267272,-0.7830023509735854,0.8214285714285714,1.0,1.0,5/62,9.39%,NGF;PIK3C2G;GPR143;RHOA;PLCE1
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),0.5137686012614483,0.7828728420550402,0.7678571428571429,0.9373709582599983,1.0,3/5,15.42%,LILRB1;LGALS3;HAVCR2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.37313905929192664,0.7825203560660244,0.75,0.9375581743160304,1.0,5/28,11.87%,OBSCN;PDGFRA;TPM1;MYLK3;CSRP2
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.4775599040391174,-0.782436985980279,0.7021276595744681,1.0,1.0,2/8,17.20%,THAP4;GSTZ1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.46517088140185736,0.7823516353842653,0.7346938775510204,0.9374526213362098,1.0,3/9,14.01%,SHMT2;GLDC;SHMT1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.34003623891304846,-0.7823348336306393,0.7903225806451613,1.0,1.0,4/34,6.12%,GREM1;SERPINE1;TF;CD63
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.41302923136100816,-0.7822895476412173,0.6170212765957447,1.0,1.0,3/19,9.26%,ACTN2;MYL6;TPM4
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.41302923136100816,-0.7822895476412173,0.6170212765957447,1.0,1.0,3/19,9.26%,ACTN2;MYL6;TPM4
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.42234253967975177,-0.7813844638467979,0.7833333333333333,1.0,1.0,2/13,12.00%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.4411372012856978,-0.7810331531199429,0.75,1.0,1.0,1/14,1.71%,SFRP1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.5182633531588886,-0.7806991962743163,0.75,1.0,1.0,2/5,18.94%,SSU72;CTDP1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.3583747958243583,0.7805824276420871,0.8103448275862069,0.9397243659961181,1.0,8/29,24.83%,PPARGC1A;NOS1;TADA2A;ARRB1;PAXIP1;RPS6KA4;RUVBL2;FMR1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3094643738157699,-0.7803492828483068,0.9107142857142857,1.0,1.0,13/129,9.16%,DDIT3;SFRP1;GREM1;PTPRU;PSMD7;PSMB6;PSME2;PSMD8;LZTS2;PSMB4;PSMD3;DACT3;PSMB3
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.31413810710734713,-0.7803352271005848,0.8928571428571429,1.0,1.0,13/88,12.42%,PDE3A;JUP;SFRP1;AQP9;CRHBP;LAMTOR4;RRAGA;P2RY6;CFTR;HCN2;AHR;SLC38A9;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3103394039413871,-0.7802390532639205,0.9215686274509803,1.0,1.0,17/82,17.99%,RPS3;NCL;GAPDH;CSTB;RACK1;ATRAID;DHFR;RPL13A;BTG2;ILF3;TYMS;KNG1;EPRS1;PCIF1;YBX1;DNAJC1;EIF2AK3
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.5168528686190142,-0.7799975154010214,0.625,1.0,1.0,3/5,26.36%,GLYCTK;KHK;TKFC
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.5168528686190142,-0.7799975154010214,0.625,1.0,1.0,3/5,26.36%,GLYCTK;KHK;TKFC
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.5047181397763053,0.7796690765676093,0.7916666666666666,0.9407365777119555,1.0,1/6,18.76%,JADE2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.3668162115073244,-0.7787215006673085,0.8444444444444444,1.0,1.0,4/33,5.17%,DDIT3;SERPINE1;HYAL2;TLR1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.312548741463618,0.7785859206593965,0.926829268292683,0.941919657900217,1.0,12/79,12.18%,AQP1;FLT1;CHI3L1;F3;ADAM12;BMPER;HSPB1;WNT5A;VEGFD;PRKD1;ZNF304;VASH2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.3998432693649373,-0.7783796176409817,0.7413793103448276,1.0,1.0,1/20,0.58%,PDE3A
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.3857896635267875,0.7783674842857081,0.8048780487804879,0.9418960472796519,1.0,4/29,10.82%,DACT1;HIPK3;PER1;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.39048393638388545,-0.7782988227111378,0.875,1.0,1.0,4/27,8.82%,SERPINE1;ADAM15;APOD;AJAP1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.46718212084860944,-0.777915755528932,0.7307692307692307,1.0,1.0,2/10,4.91%,AADAT;AFMID
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.3648605248741941,0.7777161447989075,0.8780487804878049,0.9425260985306562,1.0,4/36,13.49%,GFAP;SNCAIP;IRGM;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.3810436579971429,-0.7777128663204232,0.8269230769230769,1.0,1.0,1/20,3.84%,PTK6
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.30248212063278157,-0.7775679795197769,0.90625,1.0,1.0,17/135,13.71%,JUP;SFRP1;PSMD7;PSMB6;PSME2;PSMD8;BAMBI;SEMA5A;PSMB4;PSMD3;PSMB3;PSME1;PSMA7;ILK;PSMD13;PSMB8;TMEM198
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.4716311946840086,-0.7774496215896496,0.8297872340425532,1.0,1.0,3/13,15.69%,NEK6;CCNB2;DCTN1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.3595875219244431,0.777406708506212,0.7659574468085106,0.9425810477307771,1.0,6/41,12.52%,GRM5;CYFIP1;PER1;PARP9;PUM1;NANOS3
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.46300494621196386,0.7773729332393194,0.8367346938775511,0.9422653811266327,1.0,1/10,3.30%,DGKB
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.4565298774379643,-0.7773654534626477,0.7916666666666666,1.0,1.0,2/9,12.91%,MEOX1;HMGA2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.31482699622061705,-0.7772006843667719,0.8,1.0,1.0,23/112,20.97%,CRYAB;ATF3;CRHBP;USP51;CHCHD2;NEK6;USP19;HSPA8;NPM1;RAE1;HSPB8;RSL1D1;NUP37;ATR;ING2;ATF4;TPR;CASP9;ALOX5;PINK1;NUP210;POM121C;FKBP4
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.5024854239150458,0.7770249422715108,0.7924528301886793,0.9424129962103445,1.0,1/7,5.48%,CIITA
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.2907998589307159,-0.7768410828018145,0.9655172413793104,1.0,1.0,17/168,12.94%,H4C3;RAD23A;UBAC1;MARCHF2;BCAM;SLC10A3;EIF2AK1;BLVRA;UCP2;CLIC2;NFE2L1;ADIPOR1;BTG2;SLC7A11;CROCCP2;GATA1;MGST3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.4831856428872159,0.776794678665273,0.6818181818181818,0.9423892397346656,1.0,2/7,9.12%,FGF13;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.4143782581102625,0.7765877852262241,0.6486486486486487,0.9422961002511226,1.0,5/12,20.48%,ANO6;SFRP4;GPER1;RGCC;PLCG1
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),-0.5075506275587428,-0.7765388633534044,0.7777777777777778,1.0,1.0,2/5,17.14%,IDI1;PMVK
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.43066505257669074,-0.7763550616680076,0.8035714285714286,1.0,1.0,1/16,9.45%,CHUK
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.5027764138268916,-0.7762936810962346,0.7457627118644068,1.0,1.0,3/5,19.42%,SOD1;CYBA;ACOX1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.464766389187019,0.7759895482021868,0.7959183673469388,0.942767279161318,1.0,1/11,1.47%,CD44
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.37508571230333304,0.7755578788392165,0.8431372549019608,0.9429745714319336,1.0,5/21,12.45%,CGNL1;MET;PIK3R1;ARAP1;ARHGAP28
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.4191514728347363,0.7755363754175021,0.7446808510638298,0.9426225160588669,1.0,2/15,10.03%,DACT1;GRHL2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.5490743064265967,0.7748638764453819,0.7551020408163265,0.9433655755961207,1.0,1/5,12.70%,GHR
prerank,GO_Biological_Process_2021__water transport (GO:0006833),0.4718409342084639,0.774422686550857,0.7619047619047619,0.9436093371029481,1.0,1/7,1.07%,AQP1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.438308181823428,-0.7742956483589558,0.7692307692307693,1.0,1.0,1/17,0.63%,DDIT3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.3525912149018552,-0.7740838922082659,0.8846153846153846,1.0,1.0,7/66,9.45%,RPS27A;UBC;UBB;TLR1;CNPY3;S100A1;CHUK
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.3856505977837054,0.7740600792012895,0.7735849056603774,0.9437328935296662,1.0,5/26,7.88%,MET;COL4A1;NPNT;RASIP1;NOTCH4
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.4701002754383772,-0.7735199684759326,0.7916666666666666,1.0,1.0,1/8,5.15%,CHAMP1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.37552765323178006,-0.7733106043578967,0.8,1.0,1.0,12/41,28.37%,PGAM1;GCK;RAE1;NUP37;TPR;NUP210;POM121C;SLC2A6;NUP93;NUP42;NUP58;NUP85
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.35977820337009137,-0.7732948005279159,0.8070175438596491,1.0,1.0,8/50,9.45%,RPS3;PRDX5;GSTP1;HYAL2;SOD1;APOD;PRDX3;CHUK
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.4012297234961658,0.7731888411306865,0.75,0.9445992430007695,1.0,5/18,10.36%,VSIR;AXL;LILRB1;LAPTM5;CR1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.5352879900011187,-0.7729830400087729,0.8214285714285714,1.0,1.0,2/6,15.23%,SVBP;TIMP2
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.4824954952830975,0.7728287407990841,0.7692307692307693,0.9447269327632459,1.0,2/8,9.49%,NOD1;VIM
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.44005601069360656,-0.7720534990735038,0.7708333333333334,1.0,1.0,2/14,6.88%,PTPA;CALM1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3441699635419357,-0.7720042564998872,0.723404255319149,1.0,1.0,11/59,15.15%,DDIT3;PTGIS;PRMT2;COMMD6;TCEAL7;CHUK;CCDC22;TMSB4X;UFL1;NLRP2;DAP
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3770552565337203,0.7709140885110595,0.8235294117647058,0.9473995987655996,1.0,6/17,30.23%,MED14;PAXIP1;MED30;MITF;MED13;BCLAF1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.415076744822145,-0.7708569832901013,0.8181818181818182,1.0,1.0,4/17,11.51%,POLD3;DCLRE1B;MCM4;MCM3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4469928746226027,-0.7706633851923019,0.7818181818181819,1.0,1.0,4/13,25.64%,UCKL1;UCK1;TK2;DHODH
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.36631278817899454,0.7704430938816453,0.8048780487804879,0.9477611577774446,1.0,6/27,16.97%,TAL1;AURKC;KIF14;CUL3;PRKCE;PKP4
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.4306164273057847,-0.7701739824296737,0.72,1.0,1.0,4/14,23.00%,HMGA2;POLE3;EZH1;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.41345271841884557,-0.7701637438033593,0.796875,1.0,1.0,2/19,7.52%,TNFRSF21;CD274
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.37196678729379773,0.7696647497439059,0.7659574468085106,0.9485094314442457,1.0,4/23,9.96%,SLC8A1;ADRA1A;NOS1;RNF207
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.4191434097900193,-0.7695688488920241,0.723404255319149,1.0,1.0,3/8,21.83%,SOAT2;MFSD2A;P4HB
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.44273192184957066,0.7693815115768973,0.782608695652174,0.9485294898625136,1.0,2/12,5.94%,WTIP;SHANK2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.3765163810239913,0.7693691984174168,0.7450980392156863,0.9481950621670726,1.0,4/22,8.44%,PDGFB;F3;PDGFRA;F2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.36364226262023125,-0.7692411113206569,0.8431372549019608,1.0,1.0,5/22,19.10%,RBM22;PARK7;ANP32B;EMD;TPR
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.4340994984266697,0.7691823624368216,0.78,0.9480725727531819,1.0,1/12,3.14%,LRRK2
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3503334384536925,0.7691710688651311,0.7959183673469388,0.9477385798868257,1.0,15/42,19.68%,CARMIL1;EFNA5;DMTN;FBLN1;CORO1C;KANK1;RAC3;DOCK5;CSPG5;ITGB1BP1;CASS4;DOCK1;ARHGEF7;SPRY4;TRIOBP
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.352990465780826,-0.7691310362862477,0.7931034482758621,1.0,1.0,3/41,8.70%,LCK;CD274;CD81
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.4928629866903096,-0.7684489940677667,0.8076923076923077,1.0,1.0,1/5,18.59%,BECN1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.5207171522013363,-0.7681953430988449,0.7924528301886793,1.0,1.0,2/9,5.50%,PARP2;PARP1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.41435340305226753,-0.7679771616503226,0.7894736842105263,1.0,1.0,6/22,20.24%,PTPA;CALM1;PPIA;PTBP1;SMPD1;DLC1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.4390298782803762,-0.7677445752191174,0.7454545454545455,1.0,1.0,1/9,3.15%,NOX1
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.44568637026925095,0.7674490243354564,0.7916666666666666,0.9492835748621719,1.0,2/8,15.66%,CR1;SUSD4
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.44568637026925095,0.7674490243354564,0.7916666666666666,0.9492835748621719,1.0,2/8,15.66%,CR1;SUSD4
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.44568637026925095,0.7674490243354564,0.7916666666666666,0.9492835748621719,1.0,2/8,15.66%,CR1;SUSD4
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.3244719140752458,0.7674194728433235,0.9464285714285714,0.9489817802260947,1.0,12/54,15.27%,RHBDF2;CAPN1;GDPD3;ANXA11;NBEAL2;SLC14A1;SULT2B1;TMEM79;AP1G2;DTX2;PRICKLE3;TJP3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.47778483876904154,-0.7671961725969865,0.7358490566037735,1.0,1.0,4/9,19.50%,NOC2L;TAF7;THAP7;SET
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.45380412101453454,0.7670666116406932,0.7441860465116279,0.9490750521566005,1.0,2/8,9.52%,SOCS3;PTPRT
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.44436436701331494,-0.7669663035290913,0.84,1.0,1.0,2/12,13.33%,PRKAA2;KAT5
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.3169988271685556,0.7669582331506579,0.8648648648648649,0.9488653569215134,1.0,11/69,12.18%,AQP1;FLT1;CHI3L1;F3;ADAM12;HSPB1;WNT5A;VEGFD;PRKD1;ZNF304;VASH2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.3941073931043554,-0.7669218599753258,0.8627450980392157,1.0,1.0,1/21,1.71%,SFRP1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.40667017725309357,-0.7664919303799956,0.7358490566037735,1.0,1.0,1/18,1.13%,JUP
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.4591697306499374,0.7664188362077153,0.8043478260869565,0.9491696293515199,1.0,3/7,14.38%,OXTR;GPAT4;VEGFA
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.4378287176347594,-0.766367916177402,0.8444444444444444,1.0,1.0,3/16,6.88%,PLPP2;SPHK2;CALM1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.46447014195239156,0.7663173788941479,0.85,0.9489508876127425,1.0,2/11,5.14%,XKR4;ADGRB1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.41477726534265746,0.7662923580313503,0.7843137254901961,0.9486222977150612,1.0,7/16,17.87%,NCKAP1L;PTPN6;IRAK3;CX3CL1;CD200;GAS6;NLRP12
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.4073018774974313,-0.766267846259475,0.7222222222222222,1.0,1.0,1/18,3.87%,SLC22A2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.3708586585848673,0.766083043107195,0.673469387755102,0.9485734784877337,1.0,4/24,13.09%,FMO5;ACADL;GNB3;PDK4
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.3359484750977941,-0.7657764118455705,0.8823529411764706,1.0,1.0,4/67,4.39%,RPS2;CENPX;UBB;PTTG1IP
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.33170551333778014,0.7657558837641236,0.7872340425531915,0.948694175195252,1.0,2/35,5.88%,NEDD4L;MAP2K5
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.33639608507817775,-0.7655240206314251,0.84,1.0,1.0,8/62,9.98%,TAGLN2;CBR1;EDF1;PCNA;ACTL8;CDHR2;DNPH1;TAGLN
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.339046720827249,0.7651775184913642,0.8571428571428571,0.9490620308252162,1.0,5/49,8.30%,PPARG;ADCY8;PYGL;IRS1;KCNB1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.480693704979442,0.7646235488989629,0.7627118644067796,0.9494799504433497,1.0,1/6,8.67%,TNFRSF1A
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.4513159472313293,-0.7640874140146156,0.8113207547169812,1.0,1.0,1/11,5.96%,SPHK2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.4513159472313293,-0.7640874140146156,0.8113207547169812,1.0,1.0,1/11,5.96%,SPHK2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.32320898780315227,-0.7637737295960866,0.8392857142857143,1.0,1.0,11/50,23.91%,RNF212;KIAA1586;RAE1;NUP37;TRIM28;TPR;NUP210;POM121C;PIAS3;SUMO1;NUP93
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.32274098310652094,-0.7636224115553243,0.9272727272727272,1.0,1.0,16/61,22.83%,NDC80;NUMA1;VPS28;PYHIN1;RIC3;RANGRF;PRKAA2;MAP1A;PARK7;CROCC;EIF2AK3;LAMTOR5;SYT11;MEAK7;TESK1;GPR137B
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.42142374504752467,-0.7633022273290906,0.723404255319149,1.0,1.0,6/11,19.23%,PYHIN1;KLHL20;RO60;IFNAR1;TPR;PDE12
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.506635422660783,0.7632907762021414,0.82,0.9509178225030157,1.0,1/5,18.76%,LRP1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.46487070755560944,0.7632540737055444,0.8409090909090909,0.9506303955199318,1.0,5/10,12.75%,CD44;SRC;CORO1C;VIL1;KANK1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.36875007311108443,0.7628651511041477,0.8837209302325582,0.9508277899464456,1.0,4/35,10.88%,EGFR;PTPRJ;SH3GL2;TGFA
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4365053232086075,-0.7628043635632712,0.8163265306122449,1.0,1.0,4/14,19.10%,RBM22;ANP32B;EMD;TPR
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4459103541854882,0.7627619101345343,0.8214285714285714,0.9506091673615646,1.0,2/13,3.07%,PKP2;SLC8A1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.4942303171720551,-0.762396016689715,0.78,1.0,1.0,2/6,14.38%,GALT;GALK1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.39034328448409195,-0.7623480339427116,0.6818181818181818,1.0,1.0,3/23,10.96%,SERPINE1;ACTG1;HRAS
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.4581998297340568,0.7621599283284543,0.717391304347826,0.9511536015299092,1.0,3/7,16.70%,DNAH11;DNAAF1;DRC1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.4260566510441192,-0.7618856600244026,0.723404255319149,1.0,1.0,3/15,10.62%,DDIT3;BAK1;BAX
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3466214440903319,0.761301904666566,0.7954545454545454,0.951994437190139,1.0,9/40,14.26%,SYNPO2;CARMIL1;TPM1;TGFB3;VIL1;CX3CL1;FHOD1;SYNPO;ITGB1BP1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.38127687864797477,0.761280470198225,0.8148148148148148,0.9516478073432736,1.0,3/27,8.30%,ADCY8;PTPRN;KCNB1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3780537428778677,0.7604592082455873,0.8043478260869565,0.9524741204930922,1.0,3/27,9.12%,SLC8A1;TSPYL2;CAMK2D
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.4690654127266643,-0.7598816835590607,0.8235294117647058,1.0,1.0,3/7,21.96%,ADH4;ADH6;ADH5
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.4373044313754565,0.7597444440972169,0.8043478260869565,0.9531675259121537,1.0,2/11,14.74%,ZNF516;DYRK1B
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.4728430257673057,0.7596700155553225,0.7777777777777778,0.9524926604120887,1.0,2/6,14.38%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.4728430257673057,0.7596700155553225,0.7777777777777778,0.9524926604120887,1.0,2/6,14.38%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.4046150834777903,0.7593658056476404,0.7547169811320755,0.9526203233198862,1.0,2/15,12.32%,BIRC3;PUM1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.451741642998863,0.7592661603715353,0.8,0.9523744423487005,1.0,1/11,4.64%,SYK
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4067085178234915,-0.7592262078432235,0.8043478260869565,1.0,1.0,4/21,21.07%,ELOVL1;HSD17B12;ACSF3;ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.4635430220579822,0.7589465781224125,0.782608695652174,0.9524565280299886,1.0,2/6,23.78%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.4884024320960918,-0.7584567932199575,0.74,1.0,1.0,2/5,26.39%,CALR;SEC22B
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.405180055479101,0.7583267916792135,0.7758620689655172,0.9528980595925624,1.0,2/12,6.85%,GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.3605160074208721,0.7582125878891506,0.8611111111111112,0.9526841973182435,1.0,1/24,3.36%,UHRF1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.32956994650639626,-0.757938118893872,0.8775510204081632,1.0,1.0,7/68,9.74%,RPL23;NUTF2;PTTG1IP;PHB2;RAN;KPNA2;NXT2
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.41748445250752353,-0.7579068433214273,0.8135593220338984,1.0,1.0,2/15,12.00%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.4057252065275888,-0.7576807024591722,0.7708333333333334,1.0,1.0,2/15,5.46%,B3GALT4;B4GALNT2
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.4816296721957305,0.7576348963007529,0.7916666666666666,0.9531253047752757,1.0,3/5,21.75%,LILRB1;FBN1;NOTCH2
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.41035899172843815,0.7574989064175977,0.7446808510638298,0.9529569743315532,1.0,1/11,2.57%,SHMT2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.3535879906765807,0.7574208148331313,0.8409090909090909,0.9527342467725051,1.0,11/38,21.85%,DGKB;LPCAT4;GPAT4;PLA2G10;PLA2G4A;ABHD5;ACP6;ABHD8;DGKE;DGKA;GPAT3
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.4831512115231458,0.7573370210189878,0.7804878048780488,0.9525071470408556,1.0,3/5,20.31%,TIMP3;LRP1;RECK
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.406266365228526,0.757248985456479,0.7551020408163265,0.9522711398048616,1.0,2/14,5.88%,PDGFB;MAP2K5
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.4384919428300279,-0.7569109594524338,0.76,1.0,1.0,6/11,30.12%,PFAS;IMPDH2;ATIC;GART;LHPP;ADSS1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.4811220952557397,-0.7567665251624356,0.82,1.0,1.0,1/6,14.13%,TOR1A
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.4770881116327421,-0.7566833160364719,0.8297872340425532,1.0,1.0,2/5,27.75%,TRPV1;RYR1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.3981778478174528,-0.7566724318400846,0.8387096774193549,1.0,1.0,4/20,18.45%,ZFYVE16;HSPA8;HGS;NEDD4
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3215176503608909,-0.7565461548513096,0.9259259259259259,1.0,1.0,7/47,12.73%,SAP18;DDX5;RBM15B;RBM11;MBNL3;RBM8A;PUF60
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.3979713033318799,0.756532743359267,0.7843137254901961,0.9528885696306939,1.0,1/12,4.60%,KAT2B
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3794145832724102,0.7563078842274444,0.7804878048780488,0.9528340718267246,1.0,2/19,15.15%,EPAS1;WASHC1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.44794367593350154,0.7562690424624187,0.8,0.9525256473896829,1.0,1/11,4.87%,NRG1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.4353769258752799,0.7557318293894277,0.7777777777777778,0.9529337379637743,1.0,3/9,13.82%,BIRC3;YBX3;FZD9
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.36655313008882656,-0.7556122091073388,0.8,1.0,1.0,7/40,12.60%,JUP;SFRP1;ADAM15;SPHK2;CFTR;AHR;BLM
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.3982007480052728,-0.7556121468645599,0.8852459016393442,1.0,1.0,5/15,13.06%,GSTP1;GSTO2;GSTM4;MGST3;GSTM3
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.3982007480052728,-0.7556121468645599,0.8852459016393442,1.0,1.0,5/15,13.06%,GSTP1;GSTO2;GSTM4;MGST3;GSTM3
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.4695288282681655,0.7555262390855618,0.803921568627451,0.9528158414693808,1.0,1/7,6.12%,AXL
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.5027672682295706,-0.7554787856789816,0.8181818181818182,1.0,1.0,1/5,3.87%,SLC22A2
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.44495504525849555,-0.7554230259029246,0.7959183673469388,1.0,1.0,2/8,14.78%,TAF7;PIH1D1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.4645807235530546,-0.7552514385259907,0.7647058823529411,1.0,1.0,1/10,5.49%,RACK1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.3511458565933785,0.755037456003628,0.8,0.9531057319830324,1.0,11/39,21.85%,DGKB;LPCAT4;GPAT4;PLA2G10;PLA2G4A;ABHD5;ACP6;ABHD8;DGKE;DGKA;GPAT3
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.4851762040293183,0.7547614257557432,0.717391304347826,0.9531780461538524,1.0,1/5,2.11%,GRM5
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.4156373682384066,-0.7547357722802523,0.7037037037037037,1.0,1.0,7/20,22.04%,ACTN2;WNK4;CASQ2;NEDD4;VIP;SYT11;INPP5K
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.43579872717142143,0.7546731292045391,0.7543859649122807,0.9529243954332731,1.0,2/10,3.08%,MYO7A;PROM1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.4676828627734213,0.7539171486375451,0.78,0.9535080267271936,1.0,2/8,9.62%,NCKAP1L;BST1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.469469382228081,0.7531748358395746,0.7777777777777778,0.9541997688216162,1.0,3/9,16.57%,CSGALNACT1;ST6GAL1;EXTL2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.31059661649998394,0.7531571563133266,0.8703703703703703,0.9538736771604981,1.0,13/75,19.82%,TRIM5;LRRK2;IRGM;DAPK1;TRIM22;PRKD1;SESN2;TP53INP1;WAC;KDR;TICAM1;TPCN1;ULK1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.49541327148306924,0.7529760480486084,0.9047619047619048,0.9537602568057416,1.0,3/8,15.30%,SLC40A1;SLC11A2;ABCC5
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.49083335113296944,0.7528655124377355,0.723404255319149,0.9535249381070399,1.0,2/5,19.29%,UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3215569690220038,0.7523216350251475,0.9111111111111111,0.953890456128392,1.0,12/56,19.63%,CSF1R;LEF1;SOX9;CCND1;CDKN2A;CBFB;MED14;MOV10;CDKN1A;RUNX2;PTEN;TNRC6A
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.4772641113613331,-0.7522634571808318,0.8148148148148148,1.0,1.0,1/5,1.96%,CELA2A
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.42038772994806844,0.7520802313776811,0.8431372549019608,0.9538719632214622,1.0,3/9,14.00%,LRCH1;DOCK8;CD200
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.5083354576602548,0.7520063950204385,0.7659574468085106,0.9536052800695295,1.0,2/5,26.22%,IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.3881150556465705,-0.7519505535418116,0.7647058823529411,1.0,1.0,1/22,1.52%,DPEP1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.39771704643342864,0.7515198001521979,0.8163265306122449,0.953862086008936,1.0,2/23,3.78%,NTNG1;ZNF804A
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.48632438268816797,-0.7515019025007476,0.8070175438596491,1.0,1.0,1/5,20.84%,NAPA
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.45457292211867023,-0.7513354540894082,0.7454545454545455,1.0,1.0,1/7,15.42%,ADI1
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.4951254499337071,0.7512303413592611,0.8666666666666667,0.9538661717870641,1.0,1/5,9.52%,DDO
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.3467057434968002,0.7511542474363753,0.9555555555555556,0.9535952859663998,1.0,5/28,17.75%,PER1;DUSP10;VEGFA;SPI1;SASH1
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.47722932112900884,-0.7511472902711517,0.7058823529411765,1.0,1.0,1/7,5.52%,HMGCL
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.33561510593482735,-0.7507780280959319,0.8867924528301887,1.0,1.0,5/68,6.52%,CXCR4;SELP;AQP9;CD9;LILRB3
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.4957377026266671,-0.7506720443472737,0.7818181818181819,1.0,1.0,3/6,30.56%,EXOSC5;EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.3821766863766234,0.750206676069175,0.8,0.9543609793579731,1.0,2/20,3.38%,CX3CR1;CLEC5A
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.4294840771749457,0.7500821633294803,0.8260869565217391,0.9541711881720676,1.0,4/11,21.77%,MT1M;GLRA2;ATP13A2;GLRA1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.4113231074575208,-0.7498692628793651,0.8125,1.0,1.0,6/14,20.67%,RIC3;NQO1;CHRNA7;CHRNA10;CHRNB4;CHRNA4
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.3206378734102512,0.7497973307827602,0.8636363636363636,0.9541751509085039,1.0,13/53,18.10%,ABHD3;LPCAT4;SLC44A5;PLAAT1;GPLD1;PLAAT2;GPAT4;PLA2G10;PLA2G4A;CHPT1;ACHE;MBOAT2;CHKA
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.3107642546522649,0.7495094746311488,0.925,0.9542466236410554,1.0,17/62,15.91%,NCKAP1L;SYNPO2;BAIAP2;CARMIL1;FCHSD2;BAIAP2L1;MYLK3;TENM1;VIL1;CX3CL1;CDC42EP4;CDC42EP3;SYNPO;HCLS1;PRKCE;NTRK3;FES
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.4667884209508807,-0.7495047779800876,0.7843137254901961,1.0,1.0,1/5,19.45%,ALOX5
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.4371587843303625,0.7491973030001995,0.8,0.9542955465421511,1.0,2/7,13.29%,MEF2C;GPC1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.3108284904074393,-0.7491175769206371,0.9692307692307692,1.0,1.0,14/94,17.87%,TRABD2B;RPS3;RACK1;PARP1;DHX33;BAK1;BAX;BRK1;PIH1D1;TPPP3;GTF2H2;PARK7;ATR;PSMC5
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.49145025877482795,0.7481044048415464,0.9038461538461539,0.955482291553946,1.0,2/6,18.03%,CLEC7A;LYST
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.40602369335830046,-0.7476493510467922,0.7586206896551724,1.0,1.0,2/11,6.98%,SLC22A2;APLN
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.3085075365455962,0.7474919588107529,1.0,0.9560117583191415,1.0,5/51,14.37%,FAP;ADAMTS7;AFG1L;CTSO;DENND3
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.4042917130349448,0.747334857493874,0.8679245283018868,0.9558712087093227,1.0,6/20,17.35%,PLSCR1;LPCAT4;PLA2G10;PLA2G4A;OSBPL5;MBOAT2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.3891454765460714,0.7472735627197374,0.7804878048780488,0.9556139633301907,1.0,8/18,20.00%,CITED2;ODAD3;DNAI2;DNAH11;ARL6;MKKS;CFAP53;PKD2
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.40305701680149797,0.7472117257692732,0.7906976744186046,0.9553299678532762,1.0,3/10,7.75%,ADGRV1;ADRA1A;WNT5A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3543849845173825,0.7471888473450791,0.8490566037735849,0.954996807575185,1.0,3/31,10.51%,TP73;ZNF385B;DYRK2
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.4695750966474759,0.7471551865857106,0.7755102040816326,0.9543536679681803,1.0,2/6,20.66%,PIK3R1;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.4695750966474759,0.7471551865857106,0.7755102040816326,0.9543536679681803,1.0,2/6,20.66%,PIK3R1;DUSP3
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.4680091468409164,0.7471183946893283,0.7857142857142857,0.9540436711837327,1.0,1/9,2.94%,BDH2
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.4626318023387678,-0.7470382693658797,0.7954545454545454,1.0,1.0,3/9,6.59%,ACTN2;CFL2;SEMA5A
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.32152549911554057,-0.7470085246292927,0.873015873015873,1.0,1.0,15/76,17.26%,HELZ2;EDF1;SQLE;NPC2;CERS2;OPA3;SC5D;IDI1;ADIPOR1;CARM1;FASN;HNF4A;GPAM;PMVK;TM7SF2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.33806434018552917,-0.7469644970219185,0.9411764705882353,1.0,1.0,5/44,13.09%,VAMP5;GOPC;CCDC22;RAB31;LLGL1
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.47130560267498506,0.7467975256886782,0.782608695652174,0.9540386995508773,1.0,3/5,37.44%,MLC1;CAV1;PACSIN2
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.39573493504665747,-0.745649777497823,0.8461538461538461,1.0,1.0,4/11,13.82%,MADCAM1;RHOG;CD81;RAC1
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.39449684674323904,-0.7456007093233945,0.76,1.0,1.0,3/13,10.72%,TF;WFDC3;H2BC21
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.4018453633234981,0.7455662752850725,0.8148148148148148,0.9552300374822479,1.0,5/13,26.85%,MAD2L2;SLC15A4;PAXIP1;HMCES;TFRC
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.4180898223799105,0.7455641680939742,0.7818181818181819,0.954879751113642,1.0,2/12,11.57%,CAMSAP3;SAXO2
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.41978869273494135,0.7454588175476637,0.8157894736842105,0.954659566260617,1.0,2/11,13.67%,VAPB;ATL2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.31243174972286875,0.7448632217050346,0.9411764705882353,0.9550974446344255,1.0,13/67,18.93%,KAT2B;LEF1;PER1;ACTL6B;KAT6B;TAF5L;KAT2A;SPI1;TADA2A;DR1;TAF10;JADE2;SUPT3H
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.47603589311141625,-0.744730150443627,0.8421052631578947,1.0,1.0,3/6,30.41%,PSAT1;PHGDH;SERINC3
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.49151891120474156,-0.744614583045367,0.7884615384615384,1.0,1.0,2/5,25.85%,PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.3638985589232439,-0.7444768784004641,0.864406779661017,1.0,1.0,5/32,19.36%,TINF2;PINX1;ATR;PARP3;CHMP7
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.4536231127280881,0.7444475325070912,0.7674418604651163,0.9552934080918384,1.0,1/9,5.13%,TSPYL2
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.4515167734264387,-0.7443544272830258,0.8113207547169812,1.0,1.0,2/5,29.94%,MGLL;FAAH
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4683350733362348,-0.7441914513962079,0.7884615384615384,1.0,1.0,1/7,1.71%,SFRP1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.38496493825037004,0.7437675814618042,0.7758620689655172,0.9558380507922452,1.0,1/14,7.23%,PER1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.29526281590055214,-0.7437617905894144,0.9272727272727272,1.0,1.0,10/82,9.06%,TNFAIP2;HELZ2;MARCKSL1;PARP12;LAMB3;ANXA5;NFIC;SCAMP2;HLA-C;ICAM1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.34732423193071676,0.7436897613969431,0.875,0.9555910140959978,1.0,3/43,8.77%,MIDEAS;PER1;TBL1XR1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.4544621302311165,-0.7436056952641285,0.7659574468085106,1.0,1.0,2/9,4.59%,VAMP8;SPX
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.4471902615341808,0.7434729568914094,0.7906976744186046,0.9554871636688459,1.0,4/9,13.09%,SLC26A4;SLC9A7;CLCN3;PDK4
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.3732821009227538,0.7429964204625589,0.8205128205128205,0.9558971077818312,1.0,6/18,28.55%,PLK1;MCM9;MACROH2A1;RUVBL2;MACROH2A2;TASOR
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.4668032327623086,0.7427921036894117,0.76,0.9557932204619789,1.0,2/9,26.28%,PIP4K2A;LRSAM1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.30791110441029407,-0.7427356617930189,0.9433962264150944,1.0,1.0,13/95,12.63%,PRDX1;SLC25A4;PRDX5;HMGCL;SOD1;TSPO;DHCR24;ECH1;FIS1;HRAS;IDI1;FABP6;EHHADH
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.31484216480897004,-0.7424514585878871,0.8867924528301887,1.0,1.0,25/137,17.33%,VAMP8;PSMG2;AP2S1;ADRM1;GPX4;USH1C;CCT2;SAMM50;CHMP2A;VBP1;MIS12;RPL38;PSMG3;CLTB;CASQ2;PFDN6;PSMD13;CHMP3;CENPF;EIF4B;VAMP3;BBS10;CYBA;DNAI4;BBS12
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.34414262150968605,-0.7424340263297499,0.8297872340425532,1.0,1.0,6/29,15.91%,USP27X;USP16;BRCC3;SPATA2;STAMBP;ABRAXAS1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.46693039964802346,-0.741737564357779,0.8545454545454545,1.0,1.0,3/9,15.93%,ANXA2;SCRIB;VAMP3
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.3947022671566143,-0.7415633015970902,0.8235294117647058,1.0,1.0,7/15,32.94%,ATG9A;WDR45B;ATG2A;ULK2;ATG3;ATG12;WIPI2
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.43801444914070686,-0.7413021199915661,0.8214285714285714,1.0,1.0,2/8,13.97%,RNF113A;PADI2
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.3979391137175302,-0.7410748503889389,0.8166666666666667,1.0,1.0,3/15,13.90%,PIGF;PIGW;DPM2
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.41653852590404583,-0.7404517986969368,0.8518518518518519,1.0,1.0,2/14,11.72%,BCKDK;ADIPOR1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.43820623203201176,-0.7399498517829818,0.7735849056603774,1.0,1.0,6/9,32.71%,YBX1;RTRAF;SIDT2;HNRNPA2B1;NXF5;CKAP5
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.33228670575305785,-0.7394615654724042,0.875,1.0,1.0,9/64,17.99%,CYB5A;SEC61B;BNIP1;LMAN1;REEP4;LMAN2;EMD;TRDN;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.4653125025865231,-0.7394440451038778,0.7894736842105263,1.0,1.0,1/6,5.49%,RACK1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.412225577016855,-0.7391961211635631,0.8103448275862069,1.0,1.0,8/17,31.34%,ACOX1;NUDT19;LDHD;ACAA1;ACBD5;CYP4F12;FAAH;LPIN1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.40671281337387016,0.7388961633760049,0.8333333333333334,0.9603540323849302,1.0,4/20,14.46%,ADGRB1;GRIN1;ABCD2;UCP1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.4656155373796035,-0.7388711796200103,0.8125,1.0,1.0,3/5,31.62%,DHODH;CTPS1;UMPS
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.4296051430019937,-0.7388402057753543,0.8163265306122449,1.0,1.0,3/9,14.92%,CALM1;DHFR;PTS
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.4575412270004912,0.7387693434083854,0.8775510204081632,0.9601102285450217,1.0,1/8,2.76%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.40470991976378906,0.7387395201379856,0.7678571428571429,0.9597863199700747,1.0,2/14,9.66%,CD44;BCL2
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.4095754006865895,0.7381840868890894,0.8260869565217391,0.9601002535992946,1.0,3/9,14.61%,NOS1;BMPR2;NOS2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.37810571842980467,0.7379652084851641,0.88,0.9600707578398222,1.0,4/21,14.26%,ITGAM;KCNB1;ANK3;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.44599219706824544,0.7379364613156215,0.8780487804878049,0.9597383167594771,1.0,2/9,17.73%,AXL;PROM2
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.31580238659766224,0.7379209316781637,0.9302325581395349,0.9593794019065379,1.0,14/57,16.81%,ROBO2;KLF9;MEF2C;NR4A3;SRC;LMO2;GHR;SRA1;NCOA1;UCP1;NSMF;ZFP36L1;RAMP1;THRB
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.45473064575310257,0.7377374740381414,0.78,0.9592923317721632,1.0,3/11,3.03%,IGFBP3;IGF1;IGFBP4
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.4186490251314886,-0.7373623400871211,0.8333333333333334,1.0,1.0,4/12,20.32%,DPAGT1;ALG3;ALG12;ALG1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.3958518811118416,0.7372975407025449,0.8043478260869565,0.9594011446625158,1.0,2/14,7.96%,PID1;GIT1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.31209319325475837,-0.7369613694960951,0.94,1.0,1.0,17/98,15.45%,PSMD7;PSMB6;PSME2;PSMD8;CALM1;PSMB4;PSMD3;PSMB3;CHUK;PSME1;VAV1;PSMA7;PSMD13;PSMB8;RAC1;NFATC1;PSMD2
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.41264968479376485,-0.7368880938371628,0.8333333333333334,1.0,1.0,2/17,4.07%,PRELID1;PSME2
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.5102736826434346,-0.7365815588964296,0.8490566037735849,1.0,1.0,2/5,22.67%,EPHX2;ACAA1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.3978731978506618,-0.7363162786197112,0.8333333333333334,1.0,1.0,3/13,18.50%,ENTPD2;ITPA;SMPDL3A
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.32478585427676443,0.7361448620936775,0.96,0.9606131651400013,1.0,2/33,3.14%,SIAH3;LRRK2
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.5040576994905125,-0.7360216141844657,0.86,1.0,1.0,2/5,19.51%,URM1;CTU2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.310797270510558,-0.7355266847151829,0.9016393442622951,1.0,1.0,18/92,14.78%,PKMYT1;CCNB3;CCNG1;BCCIP;CNPPD1;CALM1;RHOA;SYAP1;CCNB2;SNF8;CDKN2C;BLM;MST1;HMGA2;SLC8A3;HGS;CDC37;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.31161431534360223,0.735494614417223,0.8958333333333334,0.9610015698588322,1.0,9/67,10.96%,LRRK2;PRICKLE1;RNF217;RNF144B;LAPTM5;PLK1;RNF139;ARIH2;CSNK1D
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.35528391933708037,-0.7353907080712333,0.8444444444444444,1.0,1.0,3/22,20.43%,ABHD17A;SIRT6;ABHD10
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.3085100200814131,-0.7353158226310489,0.9038461538461539,1.0,1.0,1/76,0.36%,CRYAB
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.4067921788907888,-0.7352731129942952,0.7924528301886793,1.0,1.0,4/14,15.93%,TBC1D16;ANXA2;SCRIB;VAMP3
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.4545486342652505,-0.735259245177188,0.8703703703703703,1.0,1.0,1/10,1.96%,CELA2A
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.43016963770126354,0.7352148535883615,0.74,0.9610073781260464,1.0,6/12,23.78%,SCN4B;KCNH2;CAV3;SCN1B;CACNA2D1;KCNE4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.42530441309634903,-0.7350509713043997,0.86,1.0,1.0,2/13,4.77%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.48112911755915233,0.7348382233196139,0.7906976744186046,0.9608235289075822,1.0,1/5,14.01%,SHMT1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.48112911755915233,0.7348382233196139,0.7906976744186046,0.9608235289075822,1.0,1/5,14.01%,SHMT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4170157420019055,0.7346435989547638,0.84,0.9606384576348738,1.0,6/14,19.72%,SLC8A1;DMD;CAMK2D;CACNA1C;FKBP1B;ATP1A2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.3660674272562973,0.734332366953684,0.8222222222222222,0.9607154133288596,1.0,10/18,29.35%,STAT6;GHR;PIAS1;PKD2;STAT3;SOCS6;PKD1;STAT4;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.3308563688031945,0.7342550787677827,0.9245283018867925,0.960463963100462,1.0,9/46,23.34%,MSL2;LEF1;PER1;ACTL6B;JADE2;OGT;CHD5;KANSL1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.4332277832665355,0.7341813652348839,0.7872340425531915,0.9601860872297476,1.0,4/9,13.39%,SYK;ITGAM;MAPT;CLEC7A
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.40124249401281725,-0.7340548816191974,0.7818181818181819,1.0,1.0,3/12,13.94%,FOLH1B;AGBL1;FOLH1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3494525311713529,0.7337553459567352,0.8043478260869565,0.9602985961019761,1.0,2/20,4.87%,CBARP;GPR35
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.3232719480455007,-0.7331191291493051,0.9245283018867925,1.0,1.0,8/62,12.41%,CYB5A;PDZD11;SLC52A2;GSTO2;DHFR;CYB5R3;FLAD1;ABCC1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.4020739267656315,-0.7328849312402295,0.84,1.0,1.0,4/13,20.52%,FDXR;COQ7;COQ10B;COQ3
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.4020739267656315,-0.7328849312402295,0.84,1.0,1.0,4/13,20.52%,FDXR;COQ7;COQ10B;COQ3
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.3937227698604721,0.7325184087507955,0.8703703703703703,0.9614304246871032,1.0,4/19,22.73%,MSL2;JADE2;OGT;KANSL1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.464643556863152,-0.7322975614556116,0.8113207547169812,1.0,1.0,1/7,3.59%,PNRC2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.4845121418487772,0.7321802364127681,0.7872340425531915,0.9614537761230246,1.0,2/6,22.94%,DKK3;NF1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.432665051623388,-0.7320338512150463,0.8823529411764706,1.0,1.0,3/14,12.61%,PGP;GCK;MST1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.40820701525647474,-0.7318721948850754,0.8392857142857143,1.0,1.0,2/10,9.42%,HLA-B;SSC5D
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.4260767707492013,-0.7315877231371977,0.7333333333333333,1.0,1.0,2/9,5.68%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.41359307014363655,-0.7311088900010212,0.8518518518518519,1.0,1.0,2/13,5.49%,CFL1;RACK1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.388805854341045,0.7309969782213666,0.8636363636363636,0.962557759937877,1.0,2/22,6.98%,MAPKBP1;IRAK3
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.29653862098129247,0.7307527834151295,0.9523809523809523,0.9625009845008038,1.0,7/80,8.74%,E2F3;PRICKLE1;NUP62CL;SYK;SPRN;HEATR3;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4224765215224576,-0.73074350001457,0.8679245283018868,1.0,1.0,1/14,0.75%,PRELID1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.42695448673559006,0.7307158673403511,0.8076923076923077,0.9621698640123523,1.0,2/10,8.38%,KDM3A;KDM4D
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.2908411463497461,0.7306984998639283,0.8936170212765957,0.961834565570445,1.0,7/78,9.09%,PPARG;EPHA4;MAPKBP1;LRFN5;IRAK3;TNFRSF1A;FNDC4
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.3786204855784692,-0.7306759851609326,0.8431372549019608,1.0,1.0,1/20,0.58%,PDE3A
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.48423499437408396,-0.7300488636678033,0.8695652173913043,1.0,1.0,1/5,4.01%,KRT10
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.4769120946222688,-0.7299892549568184,0.8113207547169812,1.0,1.0,1/5,21.62%,ENG
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.3979206292981724,-0.7297321960860136,0.8771929824561403,1.0,1.0,2/18,10.56%,BHLHE41;SMYD1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.42708058743190547,-0.7295040531564915,0.7894736842105263,1.0,1.0,1/10,2.56%,PTH
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.3644436651875008,-0.7291634123047264,0.8541666666666666,1.0,1.0,5/22,15.64%,PDE3A;ZNF335;ATP6AP1;FAIM;BAD
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.4834751455401921,-0.7290932784258001,0.8,1.0,1.0,2/6,27.75%,TRDN;RYR1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.3837655160076135,0.7287375201903816,0.825,0.9638256533225006,1.0,1/13,3.40%,TBC1D10A
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3106138447642994,-0.7287233538283712,0.9649122807017544,1.0,1.0,10/98,11.68%,RPS3;SFRP1;RACK1;FNTA;GBA3;CALM1;RASGRF1;RHOA;HRAS;USP6NL
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.43646210962415444,-0.7287153107911247,0.8367346938775511,1.0,1.0,3/12,14.67%,NUMA1;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.3075940178917246,0.7286486272158964,0.9523809523809523,0.9635872439765564,1.0,7/53,12.84%,TRIM5;TRIM46;MAP2;SLC26A4;TRIM22;ATCAY;WDPCP
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.4140526404820848,0.7285462750953425,0.7727272727272727,0.9633445925256074,1.0,2/11,9.12%,SLC8A1;CAMK2D
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.48619580391404865,-0.7282306512758934,0.8695652173913043,1.0,1.0,2/6,19.61%,DDR1;AAMP
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.4013918581857157,0.7273883751493428,0.8863636363636364,0.9643654954972332,1.0,2/16,5.94%,WTIP;SHANK2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.44285355503543966,-0.7273772793276876,0.8260869565217391,1.0,1.0,1/11,3.34%,GFI1B
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3190402263981147,0.7272506024840975,0.9444444444444444,0.9641227354261066,1.0,3/32,11.10%,RAB27B;HSPB1;NEFL
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.3973654164527861,-0.7268240809713165,0.8163265306122449,1.0,1.0,3/12,11.45%,CYB5R3;DDAH2;NQO1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.3809624483595045,-0.7267423860716663,0.7727272727272727,1.0,1.0,7/21,17.99%,PRMT2;FAM98A;VCPKMT;CSKMT;SNRPB;FAM98B;ETF1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.3497088292389182,-0.7264292334975399,0.8727272727272727,1.0,1.0,7/34,15.59%,SRSF3;CDK11A;C9ORF78;CDK11B;RBM23;PTCD2;JMJD6
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.38554963082345795,-0.7263903011853957,0.8620689655172413,1.0,1.0,8/21,24.73%,AP2S1;MYLIP;NEDD4;BECN1;AP2A1;CLTA;AP2B1;ZNRF3
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.345928189912355,0.7262285712799615,0.8695652173913043,0.9649086449181691,1.0,2/29,2.21%,GRM5;CYFIP1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.3918469080085354,-0.726105093145401,0.7735849056603774,1.0,1.0,4/12,20.65%,AADAT;HYKK;ALDH7A1;PHYKPL
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.3918469080085354,-0.726105093145401,0.7735849056603774,1.0,1.0,4/12,20.65%,AADAT;HYKK;ALDH7A1;PHYKPL
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.4187557264735702,0.7260633580926465,0.8545454545454545,0.9646967508761195,1.0,4/14,6.91%,CSF1R;CYFIP1;CARMIL1;TPM1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.4086390337726711,0.7257769326468626,0.8936170212765957,0.9646482151971175,1.0,1/12,2.72%,CAMSAP3
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.30449892848062654,-0.7252133966100051,0.9375,1.0,1.0,7/62,15.75%,STMN1;DCTN3;SEPTIN4;RHOA;SEPTIN10;STAMBP;KIF4A
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.44558223743518877,-0.7251976870726432,0.875,1.0,1.0,1/8,12.60%,BLM
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.30796542545441685,-0.7251785680577117,0.9285714285714286,1.0,1.0,10/64,11.72%,HELZ2;B3GALT4;VAMP8;SIGIRR;PARP12;ADGRE5;HLA-C;LITAF;CDC42SE1;ADIPOR1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3605168647956595,0.7242948072778732,0.8260869565217391,0.9661693962560969,1.0,3/23,10.68%,KAT2B;CLOCK;MAPT
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.4431122574645254,-0.7240546470558165,0.8070175438596491,1.0,1.0,1/6,19.13%,REC8
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.3952582279134971,0.7239793433525809,0.8035714285714286,0.9661908728246341,1.0,3/12,12.73%,IGF1;GHR;BBS2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.39877052161706034,-0.7239556318669643,0.8392857142857143,1.0,1.0,2/14,6.75%,GLA;GBA3
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.48300409739047334,0.7238947741708013,0.8775510204081632,0.9659303524931973,1.0,2/6,16.02%,TNFRSF1B;ZBTB1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.35389417103906645,0.7238926044138511,0.851063829787234,0.9655731297297012,1.0,3/27,13.03%,LEF1;BCL9;TLE3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.3562116039007015,0.7238406582549114,0.8723404255319149,0.9652778088253702,1.0,3/31,7.88%,BMP6;MAP2K5;NOTCH4
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.3977643573620846,-0.7236206869959382,0.72,1.0,1.0,2/11,6.59%,THAP1;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.4782195400471041,-0.7235638218189855,0.8260869565217391,1.0,1.0,1/5,8.72%,ACVR1B
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.4914665885983923,-0.7235208526092455,0.8333333333333334,1.0,1.0,1/5,15.68%,ETS1
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.40857140379629797,-0.7228820163423861,0.8541666666666666,1.0,1.0,6/13,18.30%,RPS3;AGER;ICOSLG;FADD;HMGB1;TNFSF9
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.41068205053422785,0.7226895797792603,0.8297872340425532,0.9660873744152678,1.0,5/11,18.30%,KDM4D;PARP9;ZNF304;HMBOX1;GMNN
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.45209913580330413,0.7225670123970903,0.8181818181818182,0.9658492744894951,1.0,3/6,31.24%,CNOT2;CNOT6L;ATXN2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.2876983028453733,0.7223578735332579,0.98,0.9657037045951562,1.0,15/98,13.32%,NCKAP1L;ADD2;LAMC1;PPARGC1A;SOX9;SLC7A9;TEAD1;IL1RAP;DMTN;LIN7A;VIL1;DLG4;SHANK1;FANCC;HES1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3078787186365082,-0.7222546255203398,0.9387755102040817,1.0,1.0,11/75,12.60%,TINF2;MYADM;PTPA;DBI;BEX4;YWHAB;PNKP;PRKAA2;PPIA;EPHB2;ATG14
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.4756497175452617,0.7220774198381592,0.7735849056603774,0.9656461660678828,1.0,4/5,36.00%,PLBD2;PON1;ENPP2;ABHD12
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.40272749383190265,0.721878766160848,0.7636363636363637,0.9655271459884103,1.0,1/10,5.70%,TOP2A
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.26471580227355856,-0.7218543433343805,1.0,1.0,1.0,31/203,17.21%,DDIT3;EEF1A1;GAPDH;EXOC7;RAB8A;ATP6V1G1;ATP6V1G2;LAMTOR4;RRAGA;UBQLN2;CAPNS1;VPS29;ATP6V1E2;PRKAA2;SLC38A9;EIF4G2;CISD2;ATP6V0E1;KAT5;GOLGA2;UFL1;TMEM59;KEAP1;LAMTOR2;DAP;BAD;PRKACA;RAB39B;HMGB1;CPTP;TRIM14
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.3815310499071091,0.7214933405796242,0.8571428571428571,0.9655224304547982,1.0,7/17,24.16%,TAF5L;KAT2A;CNOT2;ZC3H13;ESRRB;TAF6L;ZNF706
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.4014619864836636,-0.7214512765855504,0.8727272727272727,1.0,1.0,1/10,7.61%,INTU
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.4495569904073957,-0.7213081035436081,0.8928571428571429,1.0,1.0,1/8,1.12%,SELENOS
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.3991361768624422,-0.7211594324867506,0.82,1.0,1.0,4/14,20.52%,FDXR;COQ7;COQ10B;COQ3
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.404356794994978,0.7207610522262076,0.7857142857142857,0.9660402868758091,1.0,3/11,12.36%,DLG4;NECAB2;RIN3
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.3606782164701884,-0.7205332170900172,0.8225806451612904,1.0,1.0,2/25,9.06%,MYADM;ICAM1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.4305283054188092,-0.720494466225493,0.803921568627451,1.0,1.0,2/8,16.72%,DPH1;DPH2
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),-0.4701718490148927,-0.7203898707687539,0.7678571428571429,1.0,1.0,1/6,8.19%,RHOA
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.4212342625616538,-0.7201261261092284,0.8541666666666666,1.0,1.0,3/10,21.68%,BLM;EXO1;TERF1
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.4212342625616538,-0.7201261261092284,0.8541666666666666,1.0,1.0,3/10,21.68%,BLM;EXO1;TERF1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.4212342625616538,-0.7201261261092284,0.8541666666666666,1.0,1.0,3/10,21.68%,BLM;EXO1;TERF1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.42895278059562114,-0.720084381851648,0.8163265306122449,1.0,1.0,1/7,7.61%,INTU
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3543865600847364,0.7200410634481222,0.8333333333333334,0.9665533718244567,1.0,9/21,19.75%,CACNB1;DMD;NOS1;CAMK2D;CACNB2;JPH4;FKBP1B;CAV3;HPCA
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4158473566424139,-0.7195925131048438,0.8979591836734694,1.0,1.0,2/14,11.65%,PHB2;NPM1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.30764611773310624,0.7195716336525821,0.96,0.966780852451413,1.0,10/59,12.83%,DEPP1;LRRK2;ITPR1;RRAGD;HSPB1;DAPK1;DRAM2;MAPT;ACER2;PIP4K2A
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.3692778210474328,-0.7195432281905231,0.8909090909090909,1.0,1.0,5/29,15.78%,CGAS;OTUB1;TFIP11;HMGA2;NUDT16L1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.3553295353239396,-0.7191797563051124,0.8333333333333334,1.0,1.0,4/20,21.10%,PRDX5;MAF1;ZC3H8;BRF2
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.3981776904692025,0.7191050268883015,0.9487179487179487,0.9669248223958035,1.0,1/13,4.61%,TNK2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.41050360186490864,0.718757113575789,0.8372093023255814,0.9669239857992094,1.0,5/12,20.38%,SLC8A1;CAMK2D;RGS2;ATP1A2;CHGA
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.3075508203084263,-0.7187509557845599,0.9387755102040817,1.0,1.0,5/55,11.39%,CDKN1C;GSTP1;PRDX3;TAF7;PPIA
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.4980576014275293,-0.7186194200794281,0.8392857142857143,1.0,1.0,3/5,19.88%,TLR1;CYBA;PJA2
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.36105109862961754,-0.7183054804145536,0.8571428571428571,1.0,1.0,4/29,13.82%,SERPINE1;TF;B2M;RAC1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.3551071062725201,-0.7182390737012264,0.9107142857142857,1.0,1.0,14/43,21.44%,SQLE;HSD17B10;HSD11B1;FDXR;AKR1D1;SC5D;SRD5A1;MSMO1;CYP7B1;PMVK;TM7SF2;STAR;PRLR;OSBPL7
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.4769859576120785,-0.7176350744899626,0.8409090909090909,1.0,1.0,2/6,7.07%,GSTP1;APOD
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.35014909774587866,0.717075423011074,0.9148936170212766,0.9685493357636445,1.0,7/25,14.51%,CAMSAP3;FGF13;SPEF1;TRPV4;TTBK2;APC2;STMN2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.40268449355996105,-0.7167661083955694,0.7708333333333334,1.0,1.0,2/9,15.68%,RHOA;ETS1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.42475504073026654,0.7165103125738207,0.7391304347826086,0.9687757472638727,1.0,3/7,26.88%,FERMT3;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.4362694800837331,0.7161299550285968,0.8181818181818182,0.9689012516174917,1.0,4/8,13.39%,SYK;ITGAM;MAPT;CLEC7A
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3519151566786601,0.7161266162298285,0.8695652173913043,0.9685537947541615,1.0,8/26,13.41%,BAIAP2;ADD2;MYO1B;BAIAP2L1;PAWR;DMTN;DPYSL3;SHROOM2
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.40501313288838714,0.7157954543035858,0.8222222222222222,0.9685786218696959,1.0,3/15,7.12%,NFATC4;PPP3CA;NMUR2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.4698477524129206,0.7155991464397637,0.8367346938775511,0.9684459235793905,1.0,1/5,20.59%,TMEM33
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.31285777750387705,0.7153622870143275,0.9555555555555556,0.9683658058607839,1.0,12/53,19.63%,CSF1R;LEF1;SOX9;CCND1;CDKN2A;CBFB;MED14;MOV10;CDKN1A;RUNX2;PTEN;TNRC6A
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.3465777829205704,0.7152740558579399,0.8979591836734694,0.9680890075657661,1.0,6/22,18.51%,ACADL;PRKAB2;PDK4;ADIPOR2;PRKAG2;MLXIPL
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.38072962753722694,-0.7149498595774605,0.8837209302325582,1.0,1.0,6/15,22.83%,RRAGA;PIH1D1;PIP4P1;LAMTOR5;TELO2;GPR137B
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.45488667212357126,-0.7148937425754444,0.896551724137931,1.0,1.0,1/7,13.34%,CARM1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.40149868064172495,0.7144424455502294,0.8409090909090909,0.9686821184967397,1.0,4/13,9.04%,SAMHD1;NUDT3;GDA;NT5C1A
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.3528609155838921,0.7139043360554952,0.78,0.9688859729415267,1.0,10/27,17.19%,SLC8A1;ADRA1A;TRPM1;ATP2B3;MAIP1;MICU3;JPH4;ITPR3;MCUB;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.4636255671803472,0.7137316124571611,0.8888888888888888,0.9687315693640859,1.0,2/5,14.00%,LRCH1;CD200
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3410044956708339,-0.7135343867943694,0.8448275862068966,1.0,1.0,4/31,12.29%,GSTP1;CCDC22;TRIM59;NLRX1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.34546483979534975,0.7134707332816027,0.8636363636363636,0.9686864183889708,1.0,5/28,14.26%,GUCY1A1;C3AR1;SGCZ;OLR1;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.329888548976313,-0.7130048455801887,0.8727272727272727,1.0,1.0,13/46,26.79%,PGAM1;GCK;RAE1;NUP37;NOA1;TPR;NUP210;POM121C;KHK;SLC2A6;NUP93;NUP42;NUP58
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.48269811436329585,0.7128049213012554,0.8478260869565217,0.9690995180288451,1.0,3/6,29.35%,GHR;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.3893614418393868,-0.712774911667971,0.8260869565217391,1.0,1.0,3/13,11.45%,CYB5R3;DDAH2;NQO1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.4559853057707156,-0.711986289870691,0.8627450980392157,1.0,1.0,1/7,1.67%,SLC25A45
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.3960485064613034,0.7117913933960438,0.8222222222222222,0.9698133191070385,1.0,2/12,8.70%,TUSC3;NIPAL2
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.4906882910489745,-0.7116213316355147,0.86,1.0,1.0,2/6,29.88%,FUZ;NPHP1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.37253845767859045,0.7116184444095198,0.8292682926829268,0.9696239158718561,1.0,1/17,4.57%,SRC
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4444934945679502,-0.7114189447713167,0.84,1.0,1.0,1/8,1.71%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.3485236077100766,0.7113562705885971,0.9183673469387755,0.9695959411134727,1.0,2/24,7.72%,LRRK2;HSPB1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.41407465270088184,-0.710872046941614,0.8235294117647058,1.0,1.0,3/10,20.06%,SPHK2;ING2;AKAP8
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.4308177587584512,0.7106001650558781,0.8260869565217391,0.970042964065514,1.0,3/7,26.17%,IL12RB1;STAT3;STAT4
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.411458902269897,-0.7104940871499834,0.7843137254901961,1.0,1.0,3/8,16.93%,CDC42EP1;CDC42EP5;CDC42
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.411458902269897,-0.7104940871499834,0.7843137254901961,1.0,1.0,3/8,16.93%,CDC42EP1;CDC42EP5;CDC42
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.2567028990639383,0.7103384347410202,1.0,0.9699974325165692,1.0,16/167,13.72%,SRGN;LRRK2;VAPB;GOLGA8O;HOOK1;DNM1;DYSF;CR1;CSNK1D;PRKD1;ALS2CL;DMPK;STX17;ANK3;ATL2;RAB29
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.44934488957030727,-0.710183133468675,0.8125,1.0,1.0,1/8,6.75%,GBA3
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.43337948992330366,-0.709690572415416,0.8181818181818182,1.0,1.0,3/9,26.98%,ROGDI;ANKRD11;HDAC1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.4145027457340303,-0.7092010146272375,0.8688524590163934,1.0,1.0,3/11,19.71%,DDX5;DAXX;TMF1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.45092390729140985,0.7088888316852736,0.847457627118644,0.9710579525762937,1.0,1/6,1.89%,CSF1R
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.38752730648019706,-0.7088827066366995,0.8245614035087719,1.0,1.0,1/13,1.71%,SFRP1
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.32528966940577264,-0.7086081519746543,0.875,1.0,1.0,8/43,13.34%,CYP2E1;MUC4;TMEM125;DUOXA1;ATP2C2;AHR;EHF;CARM1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.4452925166479506,0.7076472291770839,0.7692307692307693,0.9719566433844598,1.0,2/6,15.91%,PHACTR1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.4273532685142017,0.7073742294737256,0.8372093023255814,0.9718495454605838,1.0,2/8,22.12%,CRY2;CRY1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.4408822923168804,-0.7073184323844739,0.8461538461538461,1.0,1.0,2/7,7.04%,USH1C;SOD1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.4022707712089264,-0.7073074697832256,0.82,1.0,1.0,5/11,32.99%,NEDD4;TPR;IFI27;SIRT7;NUP214
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.45840574796822076,-0.7068249284359853,0.8863636363636364,1.0,1.0,2/7,16.19%,CD81;FADD
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3239837576806853,0.706672350789373,0.9607843137254902,0.972251432680009,1.0,4/38,8.57%,LRRK2;MAP2;LRCH1;NOS1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.4166791156298667,0.7062015230050824,0.7948717948717948,0.9723964918660154,1.0,2/6,9.10%,LOXL3;DMTN
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.39792991544507456,0.7056678696943156,0.8541666666666666,0.9726631459602905,1.0,2/10,9.40%,SLA2;CD70
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.4070733649025693,0.7053388973943696,0.8181818181818182,0.9726602234794753,1.0,1/8,4.57%,SRC
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.3536814950543489,-0.7050688919180832,0.9122807017543859,1.0,1.0,6/29,15.95%,TRMT112;KMT2B;PRDM5;SMYD1;DPY30;MEN1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.40960966115751984,-0.7050465428756234,0.8888888888888888,1.0,1.0,3/12,26.62%,TPR;NSUN2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.39634349281887105,0.7047486139302901,0.8863636363636364,0.9729830496204435,1.0,8/14,28.39%,ADCY7;SASH3;SAMSN1;TNFSF4;TRIM27;SKAP1;SIRT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.32227826924404945,0.7047208038859705,1.0,0.9726457015041833,1.0,3/29,14.36%,ADCY8;GPLD1;BAIAP3
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.4213153530056608,-0.7044921749253693,0.8148148148148148,1.0,1.0,1/9,3.11%,RAB7B
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.36241659614907007,0.7042450252350778,0.875,0.9727556317185457,1.0,4/18,10.37%,C5;SULF1;ARNT;C3
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.32946271729273946,-0.7042339063820127,0.9090909090909091,1.0,1.0,2/23,5.51%,TNFRSF21;NKX6-2
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.4139657852757025,0.7042179261338788,0.7857142857142857,0.9724272893208622,1.0,3/10,18.11%,DIAPH1;UBASH3B;FKBP1B
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.3427745577299811,-0.7038695564847481,0.78,1.0,1.0,1/25,1.69%,RNF8
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.30527930704409184,-0.7036198396152902,0.8936170212765957,1.0,1.0,6/54,7.53%,SLC25A4;SLC35B1;SLC25A11;SLC25A5;SLC25A1;SLC3A2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.31906591920905103,-0.7035541617015387,0.9622641509433962,1.0,1.0,3/40,7.04%,PAX8;HOXD3;SOD1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.37325396543537437,0.7032824715755384,0.8478260869565217,0.9731270455440293,1.0,2/19,7.14%,PTPRZ1;SOX9
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.3529913470330076,0.702932872067725,0.9534883720930233,0.9731846559058844,1.0,8/26,13.41%,BAIAP2;ADD2;MYO1B;BAIAP2L1;PAWR;DMTN;DPYSL3;SHROOM2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.4250178610196125,-0.7028782216075271,0.803921568627451,1.0,1.0,1/8,16.10%,PRKACA
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.4250178610196125,-0.7028782216075271,0.803921568627451,1.0,1.0,1/8,16.10%,PRKACA
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.40392878470398264,-0.7028782055214435,0.88,1.0,1.0,3/14,17.52%,PLK4;NPM1;STIL
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.3432000226115664,-0.7027044471007408,0.9,1.0,1.0,2/37,4.63%,RNF8;UBE2D4
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.38282735821259184,0.7014589533379644,0.8666666666666667,0.9743863484302887,1.0,5/13,19.68%,LILRB1;CR1;LGALS3;HAVCR2;FER
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.4034905773128134,-0.7012156153036212,0.8695652173913043,1.0,1.0,5/13,28.20%,GRWD1;SET;SMARCB1;SMARCA4;SMARCD1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.4034905773128134,-0.7012156153036212,0.8695652173913043,1.0,1.0,5/13,28.20%,GRWD1;SET;SMARCB1;SMARCA4;SMARCD1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.3871916388789097,0.7010353933331369,0.918918918918919,0.9744521232373055,1.0,3/17,8.16%,NELL1;DACT1;AMER1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.4430745939709566,0.7008485483864483,0.9347826086956522,0.9743359628442652,1.0,2/6,21.33%,ATP10A;WASL
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.30724624234444176,-0.7004764766269403,0.8545454545454545,1.0,1.0,13/42,22.43%,MYADM;SS18L2;ILK;LIMS2;RAC1;CRK;FBXW8;CDC42;PRKDC;FLNA;P4HB;TESK1;CALR
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.38989323254438335,-0.7004139954414101,0.9019607843137255,1.0,1.0,3/16,17.47%,RAB7B;BPIFB1;APPL2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.32610744946461045,-0.6999584127772233,0.9230769230769231,1.0,1.0,9/51,13.48%,ACAA2;ECHS1;HSD17B10;CROT;ADH4;ADIPOR1;CYP4V2;EHHADH;HADHA
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.43141052499810945,0.6999572806910425,0.9411764705882353,0.9748172995695704,1.0,1/9,5.70%,TOP2A
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3371394887606059,0.6998434175435024,0.8478260869565217,0.9745453007477471,1.0,6/22,14.87%,NEDD4L;NETO1;KCNS1;ATP1B2;FHL1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.2752895238563392,0.6995789861994212,1.0,0.9744638405498052,1.0,20/78,20.66%,PTPRC;SLC8A1;PTPRB;HSPB1;CORO1C;PTPRT;UBASH3B;DUSP10;PTPRO;THY1;ITGB1BP1;CDKN1A;PRKAG2;WWTR1;CAMK2N2;CAV3;YWHAG;PAK2;MACROH2A1;DUSP3
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.29288646506629695,-0.6991611404377911,0.9333333333333333,1.0,1.0,6/62,10.59%,SFRP1;STMN1;PFN1;ACTG1;RHOA;WASF2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.3774279965795449,-0.6989877386985761,0.9122807017543859,1.0,1.0,4/24,13.34%,PRMT2;TRMT112;SMYD1;CARM1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.4388940299359769,0.6989410389273952,0.8333333333333334,0.9748278487481568,1.0,2/7,16.39%,TDP1;APLF
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.33301070227325846,0.6988414833048215,0.9302325581395349,0.9745820790360846,1.0,8/28,19.48%,PTPN6;ID2;KIF14;MN1;CDKN1A;FAM83D;E2F1;PTEN
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.3770107668274346,-0.698593133197731,0.9090909090909091,1.0,1.0,7/18,30.45%,PARK7;VDAC1;PINK1;CSNK2A2;HDAC6;HAX1;HTRA2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.41103471240038186,0.6984190695810861,0.8863636363636364,0.9743372948691071,1.0,4/11,30.65%,TNIK;MINK1;RAP2C;RAP1A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.41103471240038186,0.6984190695810861,0.8863636363636364,0.9743372948691071,1.0,4/11,30.65%,TNIK;MINK1;RAP2C;RAP1A
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.46814414569327645,0.6982852043979068,0.8157894736842105,0.9741092427167642,1.0,1/8,2.94%,BDH2
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.3166723732879425,-0.6979707347791378,0.9375,1.0,1.0,8/64,13.48%,ACAA2;ECHS1;HSD17B10;CROT;ABHD1;EHHADH;GLYATL2;HADHA
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.4695364353442858,0.6978999064302222,0.8627450980392157,0.9741273977880679,1.0,1/6,2.48%,DACH1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.33081981993507953,0.6978174776995469,0.85,0.9738823270975613,1.0,2/19,4.87%,CBARP;GPR35
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.3794685785753736,0.697812512063893,0.8846153846153846,0.9735339123799162,1.0,4/12,22.12%,BMPER;VEGFA;JAK1;FGF1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.44405732458062924,-0.6974082866988335,0.8524590163934426,1.0,1.0,2/7,13.82%,CAPN10;GSN
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),0.4517531041784952,0.6972926080816876,0.8,0.9737506005005986,1.0,1/5,17.73%,PROM2
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.37386148146394105,0.697201942894386,0.86,0.9735317939285993,1.0,3/18,12.07%,SMYD2;SETMAR;SETD1A
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.43939469158164585,0.6970017323846118,0.8541666666666666,0.9733691589937125,1.0,2/7,18.03%,MVB12A;LYST
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.48348443375132516,0.6966711147622751,0.8269230769230769,0.9732927848557377,1.0,3/5,36.85%,FGF1;SCAP;PRKAA1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.40574780430530827,-0.6966047448232351,0.8571428571428571,1.0,1.0,3/11,19.56%,ZNF335;CTR9;BEND3
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.4515531035949637,-0.6963521070744475,0.8333333333333334,1.0,1.0,2/5,17.63%,SLC35B3;SLC35B2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.4515531035949637,-0.6963521070744475,0.8333333333333334,1.0,1.0,2/5,17.63%,SLC35B3;SLC35B2
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),0.4629488237232158,0.6958587582265452,0.88,0.9737977220427878,1.0,3/5,16.90%,CAMK1D;CLEC7A;LBP
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.40633682161943985,-0.6957696797236831,0.8333333333333334,1.0,1.0,5/7,19.23%,PYHIN1;RO60;IFNAR1;TPR;PDE12
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.3891545643813622,0.6957386466275014,0.8409090909090909,0.9735749107050011,1.0,1/14,4.57%,SRC
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.43415750964050404,0.6956092802118053,0.8333333333333334,0.9733522603580655,1.0,3/8,14.31%,NEDD4L;CAMK2D;WNK2
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.32973330022545977,-0.6952993433294757,0.9180327868852459,1.0,1.0,5/28,16.50%,PFDN2;TMED9;LMAN1;ANXA2;SURF4
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.33159538478098005,-0.6949610748853206,0.9649122807017544,1.0,1.0,7/43,13.67%,RPS14;RPS19;SLC25A5;EVI2B;PRDX3;GATA1;UFL1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.36702757214485815,-0.6946588596328437,0.8947368421052632,1.0,1.0,2/19,4.22%,PTPA;PPP1R1B
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3820607638774194,0.6943067969227134,0.9019607843137255,0.9743082272812269,1.0,5/16,17.20%,MET;RASIP1;KANK1;CUL3;KCTD13
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.35779081641044597,0.6940401129852334,0.94,0.9742144544557733,1.0,5/27,9.98%,P2RY12;ACTN1;PDGFRA;HSPB1;UBASH3B
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.3763048097169907,-0.6940180377696132,0.8979591836734694,1.0,1.0,3/14,10.75%,STMN1;KATNB1;STMN3
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.4058196243986185,-0.69387625196602,0.8260869565217391,1.0,1.0,3/8,30.08%,IKBKG;DAPK2;MAP3K7
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.39601409932054304,-0.6937917813322118,0.896551724137931,1.0,1.0,2/11,21.71%,PEX10;PEX16
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.3193071529607945,0.6935814142667955,0.9487179487179487,0.9742883647487443,1.0,10/41,19.63%,ZFP36;CPEB3;PUM1;NANOS3;RBM24;MOV10;GTPBP1;ZFP36L1;FTO;TNRC6A
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.42894991484519474,-0.693330166290922,0.8,1.0,1.0,1/8,3.11%,RAB7B
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.3227637741768238,-0.6931478605781037,0.9473684210526315,1.0,1.0,5/43,11.65%,GAPDH;LDHC;PGAM1;PDHB;GCK
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.41788981495447564,-0.6927638698663778,0.8214285714285714,1.0,1.0,2/7,17.83%,BLM;DDX11
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.37788301661764373,-0.6923698081418642,0.8928571428571429,1.0,1.0,1/12,6.91%,RBM15B
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.313448714088011,-0.6923440855333034,0.9152542372881356,1.0,1.0,7/52,12.36%,GREM1;PCNA;CCT7;CCT2;PNKP;CCT6A;DKC1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.31494649306538613,0.6923030814445928,0.9130434782608695,0.9751914040004357,1.0,12/33,18.54%,DMD;F2;DIAPH1;NOS1;CAMK2D;UBASH3B;CX3CL1;JPH4;THY1;FKBP1B;CAPN3;GPER1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.4171910583947921,0.6922248384320616,0.8113207547169812,0.9749342143188453,1.0,2/8,14.69%,DCUN1D4;UBA3
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.4178480742851375,-0.6918329250807231,0.8653846153846154,1.0,1.0,2/9,23.91%,TPR;NUP93
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.3727115039327398,-0.6918267058447876,0.9361702127659575,1.0,1.0,3/18,12.41%,SLC22A2;ABCA8;ABCC1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.2835917525458485,-0.6913432245224392,0.9833333333333333,1.0,1.0,10/83,14.43%,DDIT3;SELENOK;DDX5;MYBBP1A;BAK1;BAX;ATP2A3;IFI6;ARL6IP5;ZNF622
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.46041864981608177,0.6908845455210818,0.8518518518518519,0.9758835946954112,1.0,2/5,14.61%,H2BC11;NOS2
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.327810139624107,0.6904975663649674,0.9565217391304348,0.9759095889559904,1.0,4/29,10.39%,CAMSAP3;ANK1;LIN7A;ERBIN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.28945250242851006,-0.6895237998653095,0.9615384615384616,1.0,1.0,17/98,15.45%,PSMD7;PSMB6;PSME2;PSMD8;CALM1;PSMB4;PSMD3;PSMB3;CHUK;PSME1;VAV1;PSMA7;PSMD13;PSMB8;RAC1;NFATC1;PSMD2
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.423649737828964,-0.6894256539195355,0.8222222222222222,1.0,1.0,4/8,16.90%,LGALS1;HLA-B;AGER;HMGB1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.3175122066892726,-0.6893383377253116,0.9272727272727272,1.0,1.0,3/42,6.17%,C1GALT1C1L;MUC4;C1GALT1C1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4379423259164455,0.6887299253872097,0.84,0.9770638583329991,1.0,1/9,8.74%,ABCD2
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.3964475202850277,0.6884915418496106,0.9090909090909091,0.9769779066678214,1.0,3/12,14.06%,SLC1A2;SLC1A1;SLC25A22
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3953260749555667,-0.6884494760445028,0.8148148148148148,1.0,1.0,5/11,21.31%,GORASP1;GOLGA2;CDC20;UBE2S;SKP1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3619420282100757,-0.6882156742286909,0.873015873015873,1.0,1.0,5/17,16.91%,CORO1B;ARFIP2;WASF2;BRK1;WASF3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3884484830002704,0.6879640841520162,0.8085106382978723,0.9771320889973829,1.0,1/11,6.47%,HIRA
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.3556014528393753,0.687911288495779,0.9056603773584906,0.9768361871272273,1.0,2/19,10.71%,ZMYND10;CCP110
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.32357830310686936,0.6877958524955101,0.9387755102040817,0.9765619177254665,1.0,10/24,31.80%,CSNK1D;RIPOR1;ZDHHC15;GOLPH3;OBSL1;PAQR3;GAK;RAB33B;TMED10;ARL5B
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.34685094531739147,0.6871998598227612,0.88,0.9768060132399347,1.0,4/19,12.36%,PTPRC;WNT5A;LAPTM5;SASH3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3737225685241766,-0.6865405565865466,0.8679245283018868,1.0,1.0,5/22,11.03%,PTTG1IP;DDX5;YJU2;PLA2R1;KMT5A
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.3517808032466043,-0.6862997972659557,0.9056603773584906,1.0,1.0,2/18,7.53%,SLC22A2;SLC3A2
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.40700613413319725,0.6861993054708088,0.8571428571428571,0.9774052428372124,1.0,4/8,19.72%,SLC4A4;ATP1B2;ATP1B3;ATP1A2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.34860203510153265,0.6861629034999875,0.9069767441860465,0.977079713015883,1.0,2/22,6.67%,ANGPT1;ANO6
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.2895336930508198,0.6857155338141196,1.0,0.9771094713659069,1.0,12/68,17.65%,CHRM3;LOX;UBA7;ST8SIA4;ST3GAL6;CPE;PHKA2;UBA3;STK38;QPCT;ERO1A;PPP4R2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.28524889755258476,-0.685476121807606,0.9636363636363636,1.0,1.0,11/98,10.24%,DEGS1;ORMDL2;ORMDL1;PLPP2;KDSR;SPHK2;GLA;GBA3;ELOVL1;SMPD2;CERS2
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.40875371143446193,-0.6851621282521668,0.7884615384615384,1.0,1.0,2/10,7.80%,SLC22A2;SLC22A6
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.459393635134793,-0.6841751403573166,0.8727272727272727,1.0,1.0,3/5,39.74%,SRF;IFNGR1;HMGCR
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.4193755162498797,-0.6839667690803702,0.8863636363636364,1.0,1.0,3/9,19.95%,DHFR;ALOX5;PINK1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3107901940588137,-0.6839074709985972,0.9411764705882353,1.0,1.0,1/22,3.84%,PTK6
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.33105914734806857,0.6837316510127515,0.8958333333333334,0.9784947722458146,1.0,4/24,21.27%,TPTE2;PTEN;MTM1;PIP4P2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.41090739367406287,-0.6836779754432193,0.8813559322033898,1.0,1.0,5/11,24.37%,BAK1;BAX;PTPN1;XBP1;ERN1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.42855724984335053,0.6831964000679919,0.8545454545454545,0.9786607914565051,1.0,3/7,16.25%,ASMT;PNPO;TPK1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.3541546223730792,0.6831432078731958,0.8936170212765957,0.9783609172938563,1.0,1/22,0.99%,ANGPT1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.3788965393580924,-0.6830028231281899,0.9555555555555556,1.0,1.0,2/21,5.40%,TPX2;KATNB1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.32764779398261196,-0.6829214516783653,0.9803921568627451,1.0,1.0,10/32,22.97%,LAMTOR4;RRAGA;SLC38A9;CASTOR2;LAMTOR2;NEURL1;LAMTOR5;IPO5;CAPN2;XBP1
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.4405404178707003,-0.6828738438874475,0.8333333333333334,1.0,1.0,2/7,21.69%,LSM1;DCPS
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.37150815746033544,-0.6826095000503027,0.9180327868852459,1.0,1.0,3/15,15.11%,SOD1;DYNC1H1;MAP1A
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3617839834495885,-0.6816025073528037,0.8125,1.0,1.0,4/18,19.10%,BAK1;BAX;BCL2A1;CASP9
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.3284577020243358,0.6813976215760225,0.975609756097561,0.9795050676419764,1.0,1/30,0.60%,CX3CR1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.35108209305622595,0.6804453172088181,0.9130434782608695,0.9800676647562784,1.0,3/11,18.25%,VEGFD;VEGFA;KDR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.3610431210178817,0.6795742060236737,0.8823529411764706,0.9805572929986156,1.0,4/19,13.39%,PTPRC;CD4;CARD11;CLEC7A
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.4425631128980928,-0.6794252557696487,0.8545454545454545,1.0,1.0,2/5,23.67%,PTPN1;NCK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3873172639332956,0.6792044052893221,0.9411764705882353,0.9804918559687098,1.0,1/10,3.57%,NR4A3
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.34938847358876807,-0.6783158527846216,0.9272727272727272,1.0,1.0,6/17,27.59%,TOR1A;IKBKG;SYT11;TESK1;SNAPIN;TMEM230
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.4243170402009815,-0.6777931780877718,0.8793103448275862,1.0,1.0,2/6,15.69%,HSPA8;DCTN1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.3813456741100756,-0.6771891200453315,0.9038461538461539,1.0,1.0,9/16,26.56%,ZNF639;RRP1B;TAF11;CCNT1;JUN;CTDP1;SMARCB1;SMARCA4;SNW1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.3740802615969811,0.6770637439357279,0.9130434782608695,0.9819833753632692,1.0,2/14,8.74%,PICK1;ABCD2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.38555651824084647,-0.6770158639123446,0.9111111111111111,1.0,1.0,2/11,16.69%,KAT5;PARK7
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.3756084964675942,0.6767617848906037,0.8979591836734694,0.9819089466428285,1.0,1/14,0.99%,ANGPT1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.37632016709536853,0.6767020119777893,0.9423076923076923,0.9816640731085932,1.0,3/13,6.92%,PID1;PPARGC1A;AK4
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.45869536289395507,0.6764785971139329,0.9259259259259259,0.9815088542692915,1.0,3/5,25.48%,SFXN3;SFXN1;SLC1A4
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.4204592549885953,-0.6764508297378836,0.847457627118644,1.0,1.0,2/7,12.08%,ACTN2;CASQ2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.41491968409664026,-0.6763784837666135,0.8958333333333334,1.0,1.0,2/9,16.47%,PTGIS;DAGLB
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.32980965618501334,0.6754457143469921,0.9361702127659575,0.9819543223271643,1.0,5/27,19.39%,RUNX1T1;WNT5A;WWTR1;GPER1;E2F1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.2814963909217546,0.6754212786790007,0.9574468085106383,0.9816373112478327,1.0,6/47,14.98%,PPARG;ABCB4;PNPLA1;ABCA1;ABHD5;ACOX2
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.39464389938164274,0.6751610367359461,0.86,0.9815376010612161,1.0,2/11,6.92%,NMNAT2;AK4
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.34229367305117664,0.6751196581320932,0.8536585365853658,0.9812209653814646,1.0,4/21,13.82%,BIRC3;YBX3;MLKL;FZD9
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.40659551211898715,-0.6743841553716218,0.8679245283018868,1.0,1.0,1/6,16.33%,GPAM
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.39094570598207323,0.6739008244406899,0.9130434782608695,0.9819806454396749,1.0,1/9,4.45%,GINS1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.4027642672398912,0.6735588894469904,0.9,0.9819787108706943,1.0,3/8,19.29%,PIP4K2A;WASHC1;RUBCN
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.42884405921677743,-0.6733340398768546,0.9361702127659575,1.0,1.0,1/8,5.15%,CHAMP1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.4219884086414605,-0.6733054274065673,0.8695652173913043,1.0,1.0,2/6,28.35%,RYR1;MYORG
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.282703323021135,0.6732131885796087,1.0,0.981921524009531,1.0,6/47,11.70%,TP73;TP63;BCL2;YWHAH;ARIH2;BBC3
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.40383387062861775,-0.6730519761268848,0.9056603773584906,1.0,1.0,5/8,37.04%,MSN;EGF;EZR;DTX3L;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.40383387062861775,-0.6730519761268848,0.9056603773584906,1.0,1.0,5/8,37.04%,MSN;EGF;EZR;DTX3L;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.40383387062861775,-0.6730519761268848,0.9056603773584906,1.0,1.0,5/8,37.04%,MSN;EGF;EZR;DTX3L;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.3374553162883058,0.6730283787545602,0.9411764705882353,0.9817921489268798,1.0,3/20,13.62%,CD44;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.3126542117619907,-0.6720718912057074,0.9655172413793104,1.0,1.0,5/65,5.68%,PRELID1;ACAA2;NOC2L;GSTP1;SLC25A5
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.35515482526731096,-0.6715072990478118,0.819672131147541,1.0,1.0,1/15,3.93%,AADAT
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.4156645248339176,0.6714463381747215,0.88,0.982720431611126,1.0,1/7,3.74%,ADGRV1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.35167134765465646,-0.6714030158315841,0.9180327868852459,1.0,1.0,4/22,13.06%,MYADM;COL18A1;ICAM1;GSTM3
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.28984461353121893,-0.6710685234375074,0.9411764705882353,1.0,1.0,22/81,19.17%,NOC2L;PCNA;USP1;PARP1;SDE2;USF1;BAK1;NPM1;TRIAP1;ERCC8;CIRBP;UBE2A;MEN1;GTF2H2;ATR;COPS9;TMEM161A;PRIMPOL;NEDD4;ATF4;CASP9;SMPD1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.31127481882042846,-0.6710556411113201,0.9818181818181818,1.0,1.0,2/39,5.85%,CELA2A;EIF2B1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.37393657908507766,-0.6707491642169083,0.8620689655172413,1.0,1.0,2/14,4.58%,ACTN2;GOPC
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4510281601350608,0.6706517663293594,0.8846153846153846,0.9830706322155892,1.0,1/6,10.53%,PDE3B
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.4121798794121324,0.6702215305268885,0.9487179487179487,0.9830810453162837,1.0,2/5,19.47%,PFKM;PFKP
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.3688225501963764,-0.6701730583856995,0.8461538461538461,1.0,1.0,4/11,23.82%,TAF7;TAF11;BDP1;GTF2A2
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.3347259700055162,0.6699534076738128,0.9655172413793104,0.9829344706655191,1.0,1/17,2.21%,CYFIP1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.4074749571819084,-0.6686966854715498,0.8333333333333334,1.0,1.0,2/6,11.46%,CARNS1;HDC
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.4074749571819084,-0.6686966854715498,0.8333333333333334,1.0,1.0,2/6,11.46%,CARNS1;HDC
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.3654803439494059,-0.668309352788552,0.8043478260869565,1.0,1.0,3/10,16.21%,SERPINE1;TMEM59;GAS1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.3706120021602195,-0.6681011965340703,0.9047619047619048,1.0,1.0,4/16,22.60%,MCM4;BLM;MCM6;TWNK
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.3100211345146752,-0.667778015699014,0.8983050847457628,1.0,1.0,6/29,19.50%,NOC2L;TAF7;BRD7;THAP7;PARK7;SET
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.44619100671917744,0.6670564320249899,0.9056603773584906,0.9851461080244222,1.0,3/5,22.12%,RNF207;GJA1;FGF1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.30484580874938955,-0.666933608869381,0.9787234042553191,1.0,1.0,9/49,19.95%,SLC25A4;SLC25A5;PRKAA2;SCOC;HSPB8;SUPT5H;VDAC1;IKBKG;PINK1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.4386393706443091,-0.6664475426753036,0.953125,1.0,1.0,1/7,5.77%,PHB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.29216411677700743,-0.666389876517075,0.9827586206896551,1.0,1.0,9/62,16.21%,CDKN1C;BTG3;RNF167;HEXIM1;NPPC;BTG2;SCRIB;MEN1;GAS1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.44412691922532044,-0.6662967556783307,0.9272727272727272,1.0,1.0,4/7,27.91%,TFIP11;DHX8;ZFAND1;VCP
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.37910589204425926,0.6661043134108122,0.9056603773584906,0.985583979916333,1.0,3/10,14.52%,CNTNAP1;PRX;PARD3
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3053431307921343,-0.6660861562858913,0.9767441860465116,1.0,1.0,8/30,22.83%,RRAGA;CASTOR2;PIH1D1;PIP4P1;LAMTOR5;DGKQ;TELO2;GPR137B
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.4157925563484658,0.6660203860325301,0.9272727272727272,0.9853137637462246,1.0,2/7,19.02%,KNDC1;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.42960115433300866,-0.6654750209583895,0.8461538461538461,1.0,1.0,1/6,8.67%,NOP53
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.386181123450732,0.6642735692846364,0.92,0.9863867656105406,1.0,1/8,6.91%,TPM1
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.4361866262004054,-0.6633876493378368,0.8333333333333334,1.0,1.0,1/5,5.38%,MUC4
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.3761337103883806,-0.6633081770406396,0.88,1.0,1.0,2/14,8.29%,DDX4;ZSCAN21
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.3577147052443308,-0.6630704957844797,0.9433962264150944,1.0,1.0,6/27,12.42%,AQP9;CRHBP;CFTR;HCN2;AHR;AKAP9
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),-0.44057325346794324,-0.6629575020575954,0.8913043478260869,1.0,1.0,1/5,3.87%,SLC22A2
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),-0.44057325346794324,-0.6629575020575954,0.8913043478260869,1.0,1.0,1/5,3.87%,SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3705118998302912,0.6623525279041225,0.8888888888888888,0.9877385253863515,1.0,4/17,16.17%,KLHL15;RADX;UBQLN4;MAD2L2
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.30858392262523016,0.6622650247205383,0.9583333333333334,0.9875144017549974,1.0,7/40,14.31%,PID1;KIF16B;MKLN1;GNB3;ACACB;PDK4;STK17A
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.2875547772812108,-0.6621904871727066,0.9347826086956522,1.0,1.0,3/44,5.50%,GPC4;GPC2;PARP1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.4012977829021268,0.6620368309399164,0.9130434782608695,0.9873581519381907,1.0,3/6,15.52%,FSTL1;CHRDL1;NBL1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.4284711844057575,-0.662026141571558,0.9230769230769231,1.0,1.0,1/6,5.86%,FNTA
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.4203320827413036,-0.6619130234302941,0.8461538461538461,1.0,1.0,2/8,21.04%,VPS11;ANKFY1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.35104761936774487,-0.6614956996188364,0.9107142857142857,1.0,1.0,2/21,15.54%,UBQLN2;ANXA2
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.4056011704282477,0.6611593815415799,0.8636363636363636,0.9877308449134196,1.0,1/5,7.04%,DCTPP1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2837697226333122,-0.6610293017197761,0.9807692307692307,1.0,1.0,6/66,10.13%,CDKN1C;GSTP1;HYAL2;DUSP7;SPRY3;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.3953776329935397,0.660770464826909,0.8571428571428571,0.9876296081819501,1.0,7/11,15.79%,DMD;NOS1;ATP1B2;ANK3;WNK2;ATP1B3;GLRX
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.3620288615942777,0.6607173939792998,0.8461538461538461,0.9873212884476987,1.0,5/10,20.60%,FSTL1;BMPR2;KDM6B;KDR;TIE1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.36102025171680796,0.6604246104835496,0.9347826086956522,0.9871780073986751,1.0,4/13,18.54%,CIITA;ABCD2;ASXL3;GPER1
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.42829356535376706,0.6603860668239855,0.8043478260869565,0.9868531680026762,1.0,1/5,22.86%,RAD54L
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.3123670073511557,0.6600308843977554,0.9130434782608695,0.986735493490043,1.0,5/22,16.97%,AURKC;KIF14;CUL3;PRKCE;PKP4
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.3295191203811298,-0.6599305785501729,0.8928571428571429,1.0,1.0,4/23,9.46%,AADAT;DAO;HSD17B10;THNSL2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.27698049117603535,0.6597371349052281,1.0,0.9866474539971836,1.0,7/67,10.96%,LRRK2;PRICKLE1;RNF217;RNF144B;PLK1;ARIH2;CSNK1D
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.34581506422915415,0.6591795332593864,0.9411764705882353,0.9867831453824261,1.0,2/17,11.21%,LRRK2;ATCAY
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.43980538946477066,-0.659037757772533,0.8888888888888888,1.0,1.0,1/6,5.09%,METAP2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.3287407912207322,0.6587979295621791,0.9565217391304348,0.9867204633735097,1.0,2/24,3.86%,CAMSAP3;MAP2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.4564131094385319,0.6584593146337673,0.8958333333333334,0.986678911613324,1.0,3/5,24.54%,CLEC7A;IL12RB1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.3672510329704553,0.6584253059220492,0.94,0.9863675858481923,1.0,4/15,15.83%,CAMK2B;CD4;BCL2;IL16
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.4000669381380041,0.6578435810577437,0.8636363636363636,0.9865031842053414,1.0,6/6,60.01%,GPX1;ERCC2;CAT;SDF4;XPA;SCARA3
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.3415496244281153,-0.657768299562661,0.9803921568627451,1.0,1.0,6/32,12.42%,AQP9;CRHBP;CFTR;HCN2;AHR;AKAP9
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.4453631928414665,-0.657742030399674,0.9230769230769231,1.0,1.0,3/5,21.31%,SLC3A2;SLC36A4;SLC25A29
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.4455969033386369,-0.6575949136455354,0.8936170212765957,1.0,1.0,1/6,9.13%,KMT2B
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.35212749337404176,0.6573453145207266,0.9056603773584906,0.9865333692307948,1.0,5/19,17.13%,ABCD2;PRKAB2;ACACB;SLC25A20;PRKAG2
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.4077257121025363,0.6572887489402733,0.9069767441860465,0.9862097915719712,1.0,2/5,24.96%,VEGFA;CCBE1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.4057171593448734,0.6572030662461351,0.88,0.9859453787200869,1.0,3/8,10.90%,RTN4RL2;GAP43;NREP
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.32781370506067353,0.6569143538923015,0.9523809523809523,0.9858200243314995,1.0,7/24,17.79%,PLSCR1;WNT5A;IFNK;NLRC5;SPI1;LBP;SLC15A4
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.40905050944705545,0.6569046972332022,0.9166666666666666,0.9854970415429959,1.0,2/8,24.72%,HOMER1;STIM1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.46676733151714245,-0.6567795507406693,0.9272727272727272,1.0,1.0,1/5,5.51%,PMP22
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.32142894602766503,-0.6564627854859979,0.9491525423728814,1.0,1.0,3/29,10.97%,H2AX;HUS1;ZNF830
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.36050220002263156,-0.6563166136890376,0.8958333333333334,1.0,1.0,3/13,21.12%,ELOF1;PADI2;ZMIZ2
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.33400457822819396,0.6562047255801448,0.8979591836734694,0.9856200442359936,1.0,4/13,19.82%,KCNB1;UCP1;RPTOR;ULK1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.3217217588773432,0.6554224812525067,0.9772727272727273,0.9859825752100893,1.0,1/29,2.73%,NHEJ1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.37962627987920416,0.6553505662013356,0.8723404255319149,0.9857061021625744,1.0,3/8,24.42%,PFKM;PFKP;HK2
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.3802544647673617,0.6552952630845664,0.8604651162790697,0.985396217690953,1.0,3/10,13.48%,SLC8A1;CAMK2D;ANK3
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3596252697422352,0.654978932498517,0.9411764705882353,0.9853553086905716,1.0,2/14,9.40%,SLA2;CD70
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.3563423165203962,-0.6548410021299974,0.8653846153846154,1.0,1.0,1/15,3.96%,PDCD7
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.4210294503063312,0.6547374024367192,0.8043478260869565,0.9852262737447302,1.0,2/6,13.89%,DNAH11;DNAAF1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.3822947203865452,0.6540993827098455,0.9777777777777777,0.9852903626491888,1.0,3/12,11.21%,LRRK2;MAPT;ATCAY
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.29406731786583096,-0.6539291932382615,0.9692307692307692,1.0,1.0,11/36,22.10%,SLC25A45;SLC3A2;SLC38A7;SLC38A9;SLC7A11;SLC25A44;SLC36A4;SLC3A1;SLC38A3;SLC25A29;SLC7A14
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.35144836963862064,0.6537895174094425,0.8363636363636363,0.985190805708874,1.0,3/10,20.36%,PORCN;PIK3C3;UGCG
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.41705526702152473,0.6536281185656078,0.9130434782608695,0.9849864835649996,1.0,1/6,7.66%,NFKBIA
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.3549479778678915,0.6525304534754425,0.9361702127659575,0.9854739747866368,1.0,3/14,9.10%,FAP;F2;DMTN
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.35675631938203606,-0.6523871173998269,0.8867924528301887,1.0,1.0,3/23,11.96%,LACC1;SPHK2;B2M
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.41273585349716496,0.652131129795265,0.8775510204081632,0.9851116413688082,1.0,1/7,9.20%,DIO2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.41273585349716496,0.652131129795265,0.8775510204081632,0.9851116413688082,1.0,1/7,9.20%,DIO2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.39589468496497127,-0.65186498079607,0.8620689655172413,1.0,1.0,1/9,2.63%,GREM1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.31490405058748805,-0.6513072672661977,0.9814814814814815,1.0,1.0,1/32,0.75%,PRELID1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.41270566669400954,0.6510916287995572,0.9148936170212766,0.9855357616317032,1.0,1/10,7.32%,ACADL
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.32688536296220483,-0.6510809301120835,0.9642857142857143,1.0,1.0,6/34,15.23%,GAPDH;SERPINE1;SERPINB8;SERPINH1;KNG1;TIMP2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.2887541600257046,-0.6509839740812476,0.9821428571428571,1.0,1.0,6/44,13.82%,DCXR;CBR1;SPHK2;COQ7;NOXA1;RAC1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.36305229584430754,0.6492881342825948,0.8653846153846154,0.98652888555994,1.0,2/8,7.76%,PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.27030337542997346,0.6491513616102458,0.975,0.9862952320075117,1.0,11/62,16.97%,DCDC1;GIT1;AURKC;PLK1;KIF14;CCP110;BCL2L1;CUL3;PRKCE;KLHL9;PKP4
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.41523048170278676,0.6488683615119222,0.88,0.9861788694540762,1.0,1/5,6.34%,BCO1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.37630481114022296,-0.6485494703515164,0.9444444444444444,1.0,1.0,1/10,7.82%,PYHIN1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.2961857616523836,-0.6478295786027545,1.0,1.0,1.0,5/35,16.52%,ZNF598;KBTBD8;CTR9;RNF126;NEURL1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.4068027583548144,0.647762534220439,0.8163265306122449,0.9866020193134823,1.0,2/6,21.56%,PARD3;MAD2L1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.3076674785842736,-0.6475020155408419,0.9464285714285714,1.0,1.0,4/26,20.46%,VAMP5;RAB31;BLZF1;GOLGA7
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3691211543095071,0.6473473594191,0.9107142857142857,0.9865566935787038,1.0,1/16,2.76%,IL12A
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.37154282865211197,-0.6469369149971853,0.88,1.0,1.0,2/10,8.99%,NLRP1;CHMP5
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.4039158810732415,-0.6454389581538538,0.9111111111111111,1.0,1.0,6/6,59.63%,DDX3X;PRKN;PTPN22;BIRC2;MARCHF7;XIAP
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.33608219755811947,-0.6447322071295856,0.9038461538461539,1.0,1.0,3/18,14.17%,TMSB4X;ADIPOR1;UACA
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.3487048359786571,-0.6443132627718721,0.9137931034482759,1.0,1.0,1/16,4.23%,SLC39A6
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3415517303502451,0.6439552109542385,0.9387755102040817,0.9886843230456273,1.0,3/18,9.12%,SLC8A1;DMD;CAMK2D
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.2948569622056817,-0.6439003026993847,0.96,1.0,1.0,15/53,23.91%,SPHK2;PGAM1;FIS1;GCK;RAE1;NUP37;TPR;COX7A2;BEND3;PINK1;NUP210;POM121C;UQCC2;SLC2A6;NUP93
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.36415866623063625,-0.6434684828874874,0.9090909090909091,1.0,1.0,2/13,18.26%,DDX11;SIRT6
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.34364441667055584,0.6432012279389578,0.9272727272727272,0.988909818884651,1.0,3/16,8.35%,IL12A;ANO6;JAM2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.29268362461976655,0.6423521418880586,0.9574468085106383,0.9890599927594705,1.0,7/33,17.94%,SLC23A1;SLC7A9;SLC7A8;SLC38A6;ABCC5;SLC25A21;SLC16A7
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.3195181798419201,-0.642044597953115,0.9574468085106383,1.0,1.0,2/24,5.62%,HR;KDM8
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.4348430129256604,-0.6417436856386362,0.9555555555555556,1.0,1.0,1/7,9.13%,KMT2B
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.36737377252881487,-0.6416821448451316,0.8666666666666667,1.0,1.0,1/11,4.34%,GSTP1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.3223432039118472,-0.6413969418377061,0.9148936170212766,1.0,1.0,4/22,22.91%,DNMT3B;CTR9;DNMT1;PAF1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.31607608767715245,0.6413185009351077,0.975,0.9894479967352316,1.0,2/21,4.60%,BMPR1B;KAT2B
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.34458594995840763,0.6406685402358702,0.9583333333333334,0.9895519755385461,1.0,3/15,18.81%,CBFB;LYN;ELF1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.3944732583314501,0.6406075514416003,0.95,0.9892387434397363,1.0,3/8,12.91%,TESC;SCIN;MTURN
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.3256610929642646,-0.640487913711053,0.9285714285714286,1.0,1.0,3/21,8.87%,RPS19;PHPT1;CAVIN1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.311742507486721,-0.6402230775890311,0.9565217391304348,1.0,1.0,4/23,19.12%,GREM1;EPHB2;PARK7;HFE
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.34905765852025306,-0.6398597344597374,0.9259259259259259,1.0,1.0,8/24,24.01%,HSD17B10;NPC1;AKR1D1;CYP7B1;OSBPL7;ACAA1;OSBP;SLC27A5
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.4090646327430229,-0.6397139694035727,0.9122807017543859,1.0,1.0,2/7,11.59%,CCDC22;TMSB4X
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.44158158585274354,0.6392436360519012,0.8936170212765957,0.9898889822240429,1.0,2/6,21.77%,INSYN2A;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.3409132199667378,0.6386846407036684,0.9285714285714286,0.9899676867284507,1.0,4/10,14.61%,SYK;WNT5A;CLEC7A;NOS2
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.4187512978146578,0.6383802794129757,0.8775510204081632,0.9897879820330183,1.0,1/6,8.44%,F2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.3450238853122741,-0.6376892494119908,0.8979591836734694,1.0,1.0,1/10,4.75%,DDX5
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.42870520350380453,-0.6376557956506682,0.8958333333333334,1.0,1.0,3/6,26.62%,SLC36A4;SLC38A3;SLC36A1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.3841131533015718,-0.6373045117180411,0.8888888888888888,1.0,1.0,4/10,27.99%,BAX;BAD;BLOC1S2;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.37420506526832514,0.6371539559636964,0.9555555555555556,0.9902790557110746,1.0,7/7,62.59%,STAT3;NCOR2;ESR1;NCOR1;LIN28B;TGFB1;BCDIN3D
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.37357010987389677,0.6370790183468105,0.9038461538461539,0.9899661169969926,1.0,2/10,12.10%,TTLL4;TTLL6
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.3115207570042673,0.637074821774953,1.0,0.9896284212494784,1.0,4/23,15.19%,ZFP36;GRHL2;CBFB;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.34442287935748855,-0.6369859555097007,0.8541666666666666,1.0,1.0,4/17,19.95%,PPIA;MAPK7;PARK7;PINK1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.3556016680747774,0.6364308814822738,0.9090909090909091,0.9896196945565351,1.0,1/14,4.61%,TNFRSF1B
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.3854965004078804,0.6360140198371779,0.9,0.9895111405681242,1.0,1/8,8.74%,ABCD2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.3195506334411877,0.6354935012466759,1.0,0.9895315688248403,1.0,5/19,16.75%,DMTN;CORO1C;ITGB1BP1;PRKCE;ARHGEF7
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.2975379016222578,0.6354279316025047,0.975,0.9892152803337171,1.0,3/33,8.09%,SRC;NR3C2;KDM3A
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.35549979946710203,0.6348879834301066,0.9574468085106383,0.9892773512703066,1.0,2/16,8.31%,B4GALT6;CNTNAP1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.28148028407747133,0.6348765347535147,0.9615384615384616,0.9889364485637872,1.0,6/42,16.00%,SEPTIN6;PLK1;CENPA;ANK3;CKAP2;SNX33
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.3046372658499622,0.6346652642183425,0.9583333333333334,0.988707900348468,1.0,8/25,23.79%,ST8SIA6;B3GNT6;GK;ALG6;GCNT1;B4GALT5;GAL3ST2;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.3897480465291587,0.6338581031266526,0.9019607843137255,0.988969332444972,1.0,4/8,18.30%,KDM4D;PARP9;HMBOX1;GMNN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.364673846915611,-0.6331595604571275,0.84,1.0,1.0,4/9,23.49%,ETFB;ETFA;ACADS;IVD
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.3917868715089016,0.632972356553753,0.8974358974358975,0.9892513302537425,1.0,1/7,8.35%,JAM2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.2864785633519455,0.6329317853729934,0.9722222222222222,0.9889233559717727,1.0,6/30,19.32%,LRRK2;ICA1;FES;LEPR;WWC1;GAPVD1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.36583365757173114,0.632708704114926,0.9318181818181818,0.9886992773167363,1.0,5/11,30.32%,CCP110;LIMK2;YAP1;CEP97;ODF2L
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.33201851473074806,-0.6325074740621303,0.9433962264150944,1.0,1.0,6/25,24.22%,FIS1;PXMP4;PEX10;ATAD1;PEX16;ACBD5
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.3575317028005509,0.6317784641987565,0.9130434782608695,0.9889479126919064,1.0,3/11,15.73%,ACVR1C;VEGFA;GJA1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.42164596246012553,0.6317348027860921,0.8679245283018868,0.9886411053545453,1.0,3/8,31.79%,AGK;CPNE7;CPNE3
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.30098435935497686,-0.631035511919966,0.9107142857142857,1.0,1.0,6/30,15.33%,AWAT2;HMGCL;SLC25A1;HSD17B8;GGTA1;FASN
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.42406565864673984,0.6309903405672017,0.9259259259259259,0.9887860289416185,1.0,1/5,11.54%,CBFB
prerank,GO_Biological_Process_2021__negative regulation of protein sumoylation (GO:0033234),-0.4136192551416201,-0.6306305352917163,0.9347826086956522,1.0,1.0,2/5,22.87%,PARK7;PIAS3
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.3341638465989119,-0.6306020861810624,0.9807692307692307,1.0,1.0,5/25,23.14%,AP2S1;CLTB;AP2A1;CLTA;AP2B1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.33038975858756625,-0.6303499620838198,0.9019607843137255,1.0,1.0,6/17,23.87%,PTTG1IP;CD81;VPS11;VPS35;RNF128;MSN
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.377846228217139,0.6302733390946801,0.8596491228070176,0.9889267108253352,1.0,3/10,14.84%,EPHA4;SLIT1;CHN1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.35133407093096813,-0.6295208417211191,0.9259259259259259,1.0,1.0,1/13,11.71%,ERLEC1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.2920704121668068,-0.6294630632639517,1.0,1.0,1.0,2/28,11.81%,PRKAA2;CASTOR2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.4036412771729476,0.628580223132778,0.88,0.9895640328334113,1.0,2/5,19.65%,SLC11A2;TFR2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.376109452722998,0.6279207112925161,0.88,0.9896753803149679,1.0,1/7,2.35%,FSTL1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.3717112315130128,-0.6270771206640858,0.8771929824561403,1.0,1.0,3/9,22.23%,STIL;RIPPLY2;MESP1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.3725004237585542,0.6266989735018337,0.875,0.9900513932958405,1.0,4/10,15.52%,FSTL1;LTBP1;CHRDL1;NBL1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.3813152001014008,0.6263514540660439,0.9423076923076923,0.9898358157433305,1.0,1/7,8.01%,TAL1
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3246105879594271,0.6251671098484534,0.9795918367346939,0.9902528493612753,1.0,7/18,20.97%,ST3GAL6;CERKL;ACER1;AGMO;AGK;FUT2;CYP1B1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.39491298527443125,0.6251129969388378,0.9166666666666666,0.9899381762843827,1.0,5/5,60.52%,ATP8A1;ATP11B;TMEM30A;SCARB2;ATP8A2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.28224755276143765,-0.6247208567937431,0.9615384615384616,1.0,1.0,4/37,9.13%,GSTP1;HYAL2;DUSP7;SPRY3
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.3231731357906342,-0.624662512504133,0.9583333333333334,1.0,1.0,9/28,25.80%,ACOT1;ELOVL1;ACOT2;ACOX1;ELOVL2;ACAA1;SLC27A6;SLC27A5;CYP4F12
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3367353375596708,0.6245870761501734,1.0,0.9899294057154482,1.0,4/18,17.35%,LPCAT4;PLA2G10;PLA2G4A;MBOAT2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.346860863218612,-0.6244704164457352,0.9387755102040817,1.0,1.0,6/13,30.12%,PFAS;IMPDH2;ATIC;GART;LHPP;ADSS1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.3911732196551091,-0.6239655358438296,0.9259259259259259,1.0,1.0,1/7,4.01%,KRT10
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.23786414113788587,0.6232457663626287,1.0,0.9903707496868089,1.0,16/118,17.72%,KAT2B;KDM6A;SOX9;KDM4D;SATB2;PHF19;ACTL6B;KAT2A;KDM6B;SMARCA2;ZBTB1;SETD5;SMARCA1;SPI1;TADA2A;DR1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.36766386523044875,0.6230376947151263,1.0,0.9901636910648816,1.0,5/12,18.74%,NEDD4L;NOS1;KCNH2;BIN1;CAV3
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.4278088577157879,-0.622684322365867,0.9090909090909091,1.0,1.0,2/6,14.98%,HLA-DRA;CD46
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.4278088577157879,-0.622684322365867,0.9090909090909091,1.0,1.0,2/6,14.98%,HLA-DRA;CD46
prerank,GO_Biological_Process_2021__detection of molecule of bacterial origin (GO:0032490),0.4266963306982086,0.6221789728014598,0.9285714285714286,0.9903529270093031,1.0,4/5,19.62%,SCARB1;LBP;DMBT1;LY96
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.3411668161831292,0.622090925255875,0.86,0.9900470145389556,1.0,5/10,24.72%,NOS1;NOS2;CACNA1C;NF1;STIM1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.33624713308137605,0.6219252626934726,0.8863636363636364,0.9897743036469938,1.0,3/12,19.05%,DACT1;ACVR2A;LEMD3
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.34729808321111066,0.621669355609672,0.9019607843137255,0.9896048387618763,1.0,1/9,8.01%,TAL1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.39629892562719815,0.6211966240853288,0.9016393442622951,0.9892744995736783,1.0,2/7,27.40%,ITGB1BP1;GCLC
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.39629892562719815,0.6211966240853288,0.9016393442622951,0.9892744995736783,1.0,2/7,27.40%,ITGB1BP1;GCLC
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.39343359238661396,-0.6210433473883763,0.9130434782608695,1.0,1.0,1/6,7.53%,SLC3A2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.37085542754495004,0.6210165932410563,0.8837209302325582,0.9890394951075979,1.0,2/8,15.79%,ANK3;GLRX
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.37207939354684766,-0.6201162851970754,0.8695652173913043,1.0,1.0,1/6,10.80%,PLA2R1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3087043479421283,0.6201025107292084,0.8979591836734694,0.9892698276511008,1.0,2/18,8.92%,CARTPT;MAFB
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.3731376817821416,-0.6200474828125117,0.98,1.0,1.0,3/7,19.12%,CD274;TARM1;HFE
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.3597379688820923,0.6185291406229709,0.9574468085106383,0.9898250991640577,1.0,4/14,19.56%,ACACB;TDO2;MVD;ACSS1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.3598876612363075,0.617880577264614,0.9375,0.9897834940495308,1.0,3/8,22.05%,KIF14;AKNA;NUMBL
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.38756912327935017,0.6176689474029743,0.9387755102040817,0.9895568630664434,1.0,1/8,1.99%,NCKAP1L
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.3845388854431011,0.6172010472654623,0.9333333333333333,0.9894742702161663,1.0,3/9,13.72%,SLC22A3;ANTXR1;RAB29
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.3131651290493245,-0.6169994188334919,0.9661016949152542,1.0,1.0,5/19,28.96%,PNKP;PKIB;MAP2K7;TNKS2;NABP2
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.32897782580632134,0.6168612278826054,0.9361702127659575,0.9892972161778526,1.0,6/15,22.39%,GPAT4;DGAT1;GK;AGMO;GPAT3;LPGAT1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.4086570315521512,-0.6165476903017559,0.9347826086956522,1.0,1.0,1/8,11.60%,IDI1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.38450471001574454,-0.6159340389056961,0.8723404255319149,1.0,1.0,4/7,35.79%,CYP3A4;CYP2R1;CUBN;LGMN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.32893824214597467,0.6151835231758729,0.9423076923076923,0.9898597366860724,1.0,3/17,9.12%,SLC8A1;DMD;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.4049293197560381,-0.6151678519639269,0.8771929824561403,1.0,1.0,2/6,31.86%,CTTNBP2NL;PPIF
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.3805047659481084,0.6144829044397998,0.8780487804878049,0.9898797911450783,1.0,1/10,3.49%,EPHA4
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.354550170755339,-0.6143398195739341,0.9298245614035088,1.0,1.0,1/16,4.23%,SLC39A6
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.2766040771426974,0.6142737793489236,1.0,0.9896576228126284,1.0,10/32,21.06%,TIMELESS;CLOCK;SETMAR;RAD9A;PRPF19;DNA2;DOT1L;E2F1;MAP3K20;BRIP1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.31705194326386466,-0.6139897368844032,0.9846153846153847,1.0,1.0,3/18,19.22%,UBQLN2;RAC1;ANKRD13D
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3267408596765531,-0.6138426065440924,0.9622641509433962,1.0,1.0,4/16,13.73%,UNC5B;IFI6;GATA1;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3267408596765531,-0.6138426065440924,0.9622641509433962,1.0,1.0,4/16,13.73%,UNC5B;IFI6;GATA1;MAPK7
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.4183206954583812,-0.6134123795939808,0.9464285714285714,1.0,1.0,1/5,8.81%,LPA
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.30501923694127125,0.6131290041961714,0.9361702127659575,0.9899280662438636,1.0,6/21,20.80%,ABCB4;ABCA1;ATP10A;ATP9A;ABCB1;ATP8B4
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.3362567095009384,-0.6123477715199699,0.9444444444444444,1.0,1.0,5/13,28.96%,PNKP;PKIB;MAP2K7;TNKS2;NABP2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.4013833110218653,0.6114738699031068,0.8936170212765957,0.9903706245092979,1.0,5/5,59.87%,MTMR3;MTMR2;MTMR9;MTMR1;MTMR4
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.36991214080865775,-0.6103262561094849,0.94,1.0,1.0,2/11,13.15%,PTGIS;NUDT12
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.36662843485079444,0.609689312460936,0.96,0.9909564128340483,1.0,1/7,7.93%,ATP2B3
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.3079854386939023,-0.6092887343177672,0.9583333333333334,1.0,1.0,7/34,19.65%,MYBBP1A;PRKAA2;ATG14;EIF2AK3;BECN1;ATF4;TBL2
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.38769262485211475,-0.6090234890418429,0.8727272727272727,1.0,1.0,2/6,25.85%,PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.2889100707373303,-0.6083197897076065,1.0,1.0,1.0,2/35,8.19%,SFRP1;RHOA
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.323378467662446,-0.6082681330120024,0.9629629629629629,1.0,1.0,6/17,28.46%,CEP131;STIL;DCTN2;HOOK3;CCDC14;CEP192
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.3828069505952694,0.6082241025701881,0.9565217391304348,0.991057156772497,1.0,3/9,17.17%,KYNU;KMO;TDO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.3828069505952694,0.6082241025701881,0.9565217391304348,0.991057156772497,1.0,3/9,17.17%,KYNU;KMO;TDO2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.3232035566469747,0.607999497003065,0.8928571428571429,0.9908186549270263,1.0,4/18,23.25%,PUM1;RBM24;FTO;GIGYF2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.2920864789127115,-0.6079544587174236,0.9803921568627451,1.0,1.0,9/26,22.97%,LAMTOR4;RRAGA;SLC38A9;LAMTOR2;NEURL1;LAMTOR5;IPO5;CAPN2;XBP1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.39851485019863747,0.6077780132314641,0.864406779661017,0.9902193247529932,1.0,1/5,12.87%,SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.39851485019863747,0.6077780132314641,0.864406779661017,0.9902193247529932,1.0,1/5,12.87%,SCARB1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.3078573626965211,0.6075203399794845,0.9454545454545454,0.989973171620305,1.0,7/18,23.79%,CAMSAP3;PARD3;FERMT1;OPHN1;SYNE4;CLASP1;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.35088774358496516,-0.6073679991957992,1.0,1.0,1.0,1/10,4.30%,CD9
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.3905182749286824,0.6072657512145869,0.8666666666666667,0.989727187606911,1.0,1/6,16.51%,SPI1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.25682180758806933,0.6072533470128282,1.0,0.9894036676821552,1.0,11/57,20.11%,TNFRSF1B;IGF2BP2;SRRM4;RBM38;RBM20;PRX;HNRNPLL;CLK1;SNRNP70;NOVA1;MBNL1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.26147033978574796,-0.6068921863206258,1.0,1.0,1.0,9/65,18.82%,TBC1D16;UBQLN2;TBC1D19;NPM1;USP6NL;GSN;VPS11;STIL;TBC1D13
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.35958066658834775,0.6065719516293495,0.9130434782608695,0.989485114086314,1.0,6/14,23.78%,SCN4B;KCNH2;CAV3;SCN1B;CACNA2D1;KCNE4
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.38341278184913663,-0.6064916782203968,0.9215686274509803,1.0,1.0,2/6,13.82%,LIMA1;GSN
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.37268321484254235,-0.6064380248593207,0.9375,1.0,1.0,5/12,28.17%,IDH3B;IDH3G;ACLY;IDH2;IDH1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.3117998755729861,-0.6062399001596219,0.9454545454545454,1.0,1.0,7/29,13.27%,RHOA;DYNLT1;MAG;GORASP1;ARHGDIA;B2M;LINGO1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.3589918038994175,-0.6058031507769545,0.9636363636363636,1.0,1.0,3/12,26.97%,DYNC1H1;EIF4ENIF1;LSM3
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.3965487722435063,-0.6056951753454988,0.9210526315789473,1.0,1.0,2/8,12.60%,ZNF830;BLM
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.3395994369480841,0.6055408752388062,0.9318181818181818,0.9897054599497376,1.0,4/11,31.94%,IP6K3;IPMK;ITPKC;PPIP5K2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.3919795363520974,-0.605255114274736,0.9069767441860465,1.0,1.0,1/5,9.20%,DDR1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.3200117776302225,-0.6052402160103323,0.9795918367346939,1.0,1.0,3/16,19.88%,RELL1;AGER;PJA2
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.3643536708568733,0.6051117829339837,0.918918918918919,0.9895661288459123,1.0,1/12,8.85%,EDNRB
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.39652618435262554,0.6049849327659097,0.926829268292683,0.9892962014898447,1.0,2/5,24.50%,DYRK3;KLC1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.3663917852371714,0.6047427603624194,0.8780487804878049,0.9890795345542593,1.0,3/5,25.14%,ZNF304;ZNF274;ATRX
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.4222564603937224,-0.6042536422777246,0.975,1.0,1.0,1/5,8.50%,DHFR
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.3024135847355751,-0.6039116296031559,0.9787234042553191,1.0,1.0,2/25,6.70%,NRBP2;FEZ1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.3095584296989887,0.6035064944494536,1.0,0.989369099798982,1.0,3/25,15.22%,KAT2B;KAT6B;KAT2A
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.3629091967382927,-0.6031568148543893,0.9454545454545454,1.0,1.0,4/12,17.01%,QPRT;PM20D2;ACSF3;ASPA
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.3755644993460491,-0.6030664201055342,0.8367346938775511,1.0,1.0,1/6,7.46%,ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.3755644993460491,-0.6030664201055342,0.8367346938775511,1.0,1.0,1/6,7.46%,ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.3755644993460491,-0.6030664201055342,0.8367346938775511,1.0,1.0,1/6,7.46%,ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.3755644993460491,-0.6030664201055342,0.8367346938775511,1.0,1.0,1/6,7.46%,ELOVL1
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.3938282379121456,0.6025195352289249,0.9024390243902439,0.9895115894592738,1.0,2/5,18.27%,NMB;EDN1
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.30289302819521474,0.6021547358559559,0.9411764705882353,0.9893440136582747,1.0,7/19,23.34%,PPARGC1A;NOS1;TADA2A;ARRB1;PAXIP1;RPS6KA4;RUVBL2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.39249754769996764,-0.6016348213400307,0.94,1.0,1.0,1/7,3.87%,SLC22A2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.29458198696031196,0.6014565955533836,1.0,0.9892866350592445,1.0,4/16,17.36%,LAPTM5;SAMSN1;ZFP36L1;TNFSF4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.37538836726440716,0.6009215222197135,0.9565217391304348,0.9892007656030757,1.0,2/7,20.55%,CAMK2D;EPDR1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.3640014578277506,0.6008874301697278,0.9090909090909091,0.9888664202476452,1.0,4/10,19.26%,PDE3B;ASXL3;GPER1;CCDC3
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.3889538119068582,0.6004257177059275,0.9615384615384616,0.988756315567005,1.0,1/7,5.84%,PRDM15
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.3194146084652548,-0.5997374063690722,0.9814814814814815,1.0,1.0,1/22,3.31%,HOXD3
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.39312605640342274,-0.5989927351908324,0.88,1.0,1.0,3/5,18.42%,AJAP1;SAPCD2;PKHD1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.366415899299951,-0.59895766061709,0.9230769230769231,1.0,1.0,2/7,21.68%,BLM;TERF1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.36018399739690476,-0.598568992790369,0.9130434782608695,1.0,1.0,1/12,7.46%,ELOVL1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.3500390157968164,-0.5978161105013349,0.92,1.0,1.0,1/10,4.34%,GSTP1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.332119636430272,-0.597447480806154,0.9555555555555556,1.0,1.0,4/12,23.00%,RESF1;TRIM28;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.357046976307191,0.5959284835299129,0.9148936170212766,0.9904377693644425,1.0,3/9,19.56%,SULT2A1;ALDH1A1;ACSS1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.36698209760987394,-0.5958885684285449,0.9285714285714286,1.0,1.0,1/7,7.72%,DBF4B
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.24348185461589605,0.5957875417590442,1.0,0.9902010279162625,1.0,14/91,17.72%,KAT2B;KDM6A;SOX9;KDM4D;SATB2;ACTL6B;KAT2A;KDM6B;SMARCA2;ZBTB1;SMARCA1;MBD3;TADA2A;DR1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.32921073135907303,0.5955647071773912,0.9583333333333334,0.9900214110210069,1.0,4/14,31.96%,SAR1A;SEC23A;SCAP;RAB1A
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.3169091947426574,-0.5954553563486685,0.9818181818181818,1.0,1.0,5/17,20.65%,AADAT;HYKK;ASPA;ALDH7A1;PHYKPL
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.3528846256294429,-0.5949085618213074,0.9107142857142857,1.0,1.0,2/7,15.59%,P3H3;JMJD6
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.4095855122635761,-0.5946832374325808,0.8666666666666667,1.0,1.0,2/6,14.38%,GALT;GALK1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3229013730749295,-0.5944099531589229,0.9444444444444444,1.0,1.0,1/22,3.11%,RAB7B
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.329882053490254,-0.5943836573668776,0.9833333333333333,1.0,1.0,2/15,11.74%,AP2S1;CLTB
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.3541225036260181,-0.5943286574393583,0.8958333333333334,1.0,1.0,7/7,64.61%,ATM;TERF2;NBN;SMG6;ERCC1;RAD50;ERCC4
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.3494071217775935,-0.5923240831329544,0.9464285714285714,1.0,1.0,4/10,16.69%,ART3;PADI2;ART4;PARK7
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.3654253363307712,0.5922470584315703,0.9074074074074074,0.9912492306540728,1.0,3/7,14.38%,CAMK2D;PRKD1;VEGFA
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.3170281708370759,0.5922389549852787,0.9545454545454546,0.9909108048327501,1.0,1/17,7.46%,ATP6V0D2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.32924845288716204,-0.5920816076481644,0.9433962264150944,1.0,1.0,1/12,7.38%,PGAM1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.33073292987932523,-0.5919190674490707,0.9795918367346939,1.0,1.0,2/17,6.12%,SLC28A1;NPC2
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.3977387283912532,0.5918221755222355,0.96,0.9907920986709292,1.0,2/7,25.95%,PRKCD;RELA
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.3837376405492328,-0.591454457434448,0.9772727272727273,1.0,1.0,1/7,7.53%,CDSN
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.3662353020095763,-0.591356250925567,0.9791666666666666,1.0,1.0,3/8,19.45%,MGST3;FADS1;ALOX5
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.37233603450358144,0.5912512314528269,0.9245283018867925,0.9907384849960399,1.0,1/6,6.06%,MACROD1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.32524696041188444,-0.5910527480393967,0.9818181818181818,1.0,1.0,6/15,28.46%,CEP131;STIL;DCTN2;HOOK3;CCDC14;CEP192
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.26745321406112654,0.5906080027980525,0.9807692307692307,0.9907295880455111,1.0,12/37,23.60%,F2;PLK1;PARP9;NGFR;SESN2;ILRUN;OTUD7B;WWTR1;LIMK2;ATP13A2;GSK3B;YAP1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.3371719663494477,-0.5903239729982046,0.9433962264150944,1.0,1.0,2/9,22.97%,PRKAA2;XBP1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.37582894978422005,-0.5903034967273615,0.9636363636363636,1.0,1.0,1/7,5.21%,MGMT
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.35254099668725125,0.5873383703386824,0.9333333333333333,0.991922589537211,1.0,3/8,16.52%,PCGF2;PCGF3;PCGF5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.38890608874813193,-0.5871123875863706,0.9130434782608695,1.0,1.0,2/6,26.25%,TRDN;SLC8B1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.3089811785100691,0.5867177268013857,0.9772727272727273,0.9918321138054174,1.0,3/24,9.91%,DACH1;SRC;BMPR2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),0.3624736079426337,0.5861619013275912,0.9074074074074074,0.9918025649310876,1.0,1/5,13.32%,HES1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.31986647994322587,-0.5858732239132766,0.9824561403508771,1.0,1.0,6/17,18.11%,CALM1;SRI;SLC8A3;SMAD7;PRKACA;C12ORF57
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.3401523877414931,-0.585780974724773,0.9310344827586207,1.0,1.0,1/9,5.83%,SCARF1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.25401363778614083,0.5853354718250933,1.0,0.9918744436418188,1.0,13/56,24.29%,TBC1D10A;ODAD3;CCP110;TBC1D24;CDKL1;LIMK2;IFT140;RABGAP1;TBC1D5;BBS4;IFT88;YAP1;TBC1D8
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.3653054356472414,-0.5853025085504353,0.98,1.0,1.0,1/8,4.30%,CD9
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.28169618708068583,-0.5852651219961471,0.9811320754716981,1.0,1.0,10/29,22.43%,MYADM;ILK;LIMS2;RAC1;CRK;CDC42;FLNA;P4HB;TESK1;CALR
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.38330646143924985,-0.584578907377025,0.9545454545454546,1.0,1.0,1/5,22.43%,CALR
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3499252848729041,-0.584543249884928,0.9104477611940298,1.0,1.0,2/9,12.08%,ACTN2;CASQ2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.2567531018957622,-0.584521116468569,1.0,1.0,1.0,9/35,20.56%,LAMTOR4;RRAGA;SLC38A9;MIOS;LAMTOR2;PIH1D1;PIP4P1;LAMTOR5;TELO2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2735550703905263,0.5843630588708454,0.9787234042553191,0.9919178889854479,1.0,4/20,29.45%,MED14;PAXIP1;MED30;MED13
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.3417774299840596,0.5836920005229889,0.9555555555555556,0.9919045552364283,1.0,1/13,3.18%,KYNU
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.34500753944838614,-0.5835137805366983,0.9423076923076923,1.0,1.0,3/10,26.28%,DYNC1I2;SPAG17;SPA17
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.30971740584865665,-0.5832478920709382,0.94,1.0,1.0,4/19,13.73%,UNC5B;IFI6;GATA1;MAPK7
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.37620732054448724,0.5826467124523064,0.9787234042553191,0.9919965866630357,1.0,3/6,16.02%,EPHB3;HES1;ZBTB1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.3860780966580753,-0.5823588095624763,0.9166666666666666,1.0,1.0,3/6,24.79%,ATG9A;ATG2A;ULK2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.36029893086669396,-0.5822531391387136,0.9333333333333333,1.0,1.0,1/11,7.46%,ELOVL1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.3559800369030767,0.5817233414397631,0.9591836734693877,0.9920318445704706,1.0,2/8,27.06%,HDAC4;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.41383553483128116,-0.5815007584615767,0.9347826086956522,1.0,1.0,1/6,10.56%,SMYD1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.3358274398347477,-0.5813984322998034,0.9787234042553191,1.0,1.0,4/11,23.00%,RESF1;TRIM28;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.3331189925842263,-0.5812627301610297,0.9444444444444444,1.0,1.0,4/13,35.49%,TPR;NUP93;SEH1L;NUP54
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.394644576265736,0.5801914275820914,0.9090909090909091,0.9922857462163895,1.0,1/5,12.96%,SYNCRIP
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.3700866693866277,-0.5793189866050042,0.8928571428571429,1.0,1.0,1/6,7.72%,DBF4B
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.33648590485594765,0.578918375867935,0.9636363636363636,0.9925111390774518,1.0,2/11,14.38%,PRKD1;VEGFA
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.34318952568725275,0.5788387105386215,0.9821428571428571,0.9922305474853474,1.0,3/9,16.75%,PLA2G4A;GGT5;LTC4S
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.2728047677836126,0.5784945685125241,0.9782608695652174,0.9920108256481266,1.0,2/42,8.77%,MIDEAS;TBL1XR1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.27209196323110346,-0.5779946888132195,0.9636363636363636,1.0,1.0,16/32,27.91%,DAXX;POLR2D;PRKACA;IER5;TRPV1;SLU7;TPR;SUMO1;ZFAND1;HMOX1;ANO1;HIKESHI;HSP90AA1;HSBP1L1;YWHAE;VCP
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.31192804553996784,-0.5779609054989167,0.9807692307692307,1.0,1.0,4/16,19.23%,BLM;DAXX;DDX11;PDE12
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.3077907356762979,0.57666038289329,0.9285714285714286,0.9924180578530145,1.0,2/13,13.35%,TRMT9B;MOCS3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.34421924228016976,0.5764989927141978,0.9318181818181818,0.9921337410621053,1.0,2/9,14.00%,LRCH1;CD200
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.297062483517463,-0.5763743341117541,0.9833333333333333,1.0,1.0,4/21,18.18%,PTK6;CTR9;STAMBP;IFNAR1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.28679951869811615,0.5762639274499949,0.9787234042553191,0.9918981111167124,1.0,3/23,16.12%,GPR161;TULP3;GLIS2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.2985401242492476,0.5762064921137554,0.975609756097561,0.9915980044389647,1.0,7/20,20.48%,F2;CX3CL1;THY1;CAPN3;GPER1;PKD2;PLCG1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.3667220672983684,0.5748943962968154,0.9555555555555556,0.9917867497471728,1.0,4/6,32.71%,TPCN2;EPS15;PIKFYVE;CAV1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.3543758790974798,0.5738997053171777,0.9122807017543859,0.9918300333634893,1.0,1/6,15.91%,NLGN1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.36852967425256583,-0.5735575165430389,0.8372093023255814,1.0,1.0,5/5,63.16%,C17ORF75;TRIP11;TBC1D23;WDR11;FAM91A1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.387319092783187,-0.5730354708416628,0.8947368421052632,1.0,1.0,3/5,22.42%,HADHA;LCLAT1;HADHB
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.23962631720668714,-0.572829270917495,1.0,1.0,1.0,18/92,23.91%,RNF212;RNF113A;NDUFAB1;VCPKMT;KIAA1586;RAE1;KAT5;P3H3;NUP37;PARK7;TRIM28;TPR;NUP210;POM121C;LIPT2;PIAS3;SUMO1;NUP93
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.2985323705744454,-0.5725744559724374,1.0,1.0,1.0,3/23,13.91%,SLC22A2;SLC3A2;ARL6IP5
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.38028561865446836,-0.5711939995388648,0.9166666666666666,1.0,1.0,7/7,61.99%,AGO4;DDX3X;DHX36;DHX9;AGO1;AGO3;AGO2
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.3272063359874826,-0.5694298705112892,0.9411764705882353,1.0,1.0,5/14,34.22%,MSH3;SMC6;RAD52;XRCC3;GEN1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.37869837876059326,-0.5692523730163351,0.9827586206896551,1.0,1.0,3/7,19.88%,TLR1;CYBA;PJA2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.25012985450817143,0.5690364507160346,1.0,0.9934108817248707,1.0,2/27,10.09%,ABCD2;ZFAND6
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.29157069952738174,0.5675015382059925,0.9818181818181818,0.9936835416713108,1.0,4/25,17.36%,IL12A;ZBTB1;IL12RB1;TNFSF4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.33684178399062686,0.5652800132320951,0.8888888888888888,0.9942342902753868,1.0,2/7,19.09%,SIRT5;CLCN2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.3884091694751066,-0.5646529610705139,0.9787234042553191,1.0,1.0,1/5,8.19%,RHOA
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.3396000675561811,-0.5643817176956613,1.0,1.0,1.0,2/8,21.68%,BLM;TERF1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.3274380478210921,0.564259123442971,0.9302325581395349,0.994264591985802,1.0,3/8,29.54%,RHOT1;BNIP3L;ATF2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.33667321199865957,0.5640653117091549,0.8837209302325582,0.993972455815409,1.0,3/8,24.83%,MACROH2A1;RPS6KA4;FMR1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.3513928081677877,-0.5634821932916172,0.9642857142857143,1.0,1.0,2/10,16.37%,MUS81;REXO4
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3301277515222204,-0.5628165756180437,0.8846153846153846,1.0,1.0,2/10,15.69%,RANGRF;DCTN1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.26192811461693477,0.5625125208457703,1.0,0.9941800951661967,1.0,1/33,3.14%,LRRK2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.31954795362937183,-0.5623691931382875,0.9583333333333334,1.0,1.0,1/10,11.81%,CASTOR2
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.27349677517524595,0.5622235223434361,0.9803921568627451,0.9939687349859129,1.0,9/22,27.60%,MCM9;MTERF1;DNA2;WRN;MRE11;RECQL4;HMGB2;ZRANB3;POT1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.3652656863554849,0.5617066328171089,0.9090909090909091,0.9937414131942842,1.0,3/7,16.94%,CARTPT;BBS2;MKKS
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.2455053024193305,0.5616969793025424,1.0,0.9934055762854657,1.0,6/30,20.53%,PEX11A;RIN3;RPTOR;PTEN;RARG;ATP13A2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.25853900341754754,-0.559930702895148,1.0,1.0,1.0,9/67,13.34%,PCNA;TFDP1;BAX;RPS27L;BTG2;TRIAP1;GML;KAT5;CARM1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.33539418377913777,0.5586721336771964,0.9545454545454546,0.9942005443211671,1.0,1/8,7.79%,TIMELESS
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.3395123150159179,-0.5586513409733113,0.92,1.0,1.0,4/6,32.02%,ATF4;TFCP2;SUPT6H;MED1
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.39203073214874334,0.5583834387445249,0.9777777777777777,0.99396533045682,1.0,1/5,9.93%,AGBL4
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.2616406486342521,0.5581460233876915,1.0,0.9937222340281142,1.0,9/27,28.55%,AEBP2;PHF19;SPI1;MACROH2A1;TRIM27;CREBZF;MACROH2A2;MTF2;TASOR
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.29697996874840915,0.5580834178509945,0.9803921568627451,0.9934190116519444,1.0,4/17,28.48%,ABCD2;SIRT5;PLIN5;SLC18A2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.31852399300936163,-0.5578539475386763,0.8958333333333334,1.0,1.0,3/9,22.42%,HADHA;LCLAT1;HADHB
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.3008661766997399,-0.5569718359612749,0.9827586206896551,1.0,1.0,8/19,25.19%,RACK1;CNKSR3;SMAD7;INPP5K;NCK1;PDE4D;INPP5J;PPM1F
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.2920459311448551,-0.5566970594597364,1.0,1.0,1.0,6/17,30.66%,PARK7;MORC3;SKP1;SP100;CHCHD10;ARL2BP
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.39750761112853017,-0.555942158604925,0.98,1.0,1.0,1/5,6.92%,COMT
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.33526062144968816,-0.5549840106456011,0.9811320754716981,1.0,1.0,4/9,22.55%,CSRP1;SRPK3;ENG;POGLUT1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.36212986350611964,0.5543208915619892,0.9047619047619048,0.9942611180792266,1.0,2/6,25.24%,CDK6;STAT3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.26047721680150526,0.5542565114929601,0.9772727272727273,0.9939619351136405,1.0,3/33,10.82%,DACT1;PER1;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.305731324218802,0.55410550996797,1.0,0.9936870455115097,1.0,3/14,11.81%,F2;ABCD2;ADCY7
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.31503514003007926,-0.5540521507955226,1.0,1.0,1.0,5/20,24.22%,FIS1;PXMP4;ATAD1;PEX16;ACBD5
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.36908201270014085,-0.552493458896335,0.9361702127659575,1.0,1.0,1/5,13.66%,GOLGA2
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.344634144489566,0.5520947345633337,1.0,0.9940144287543876,1.0,2/7,14.61%,NOS1;NOS2
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.3506247211066489,0.5520467736348248,0.9245283018867925,0.9933568669549703,1.0,5/5,64.95%,PEX7;FAR1;AGPS;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.3506247211066489,0.5520467736348248,0.9245283018867925,0.9933568669549703,1.0,5/5,64.95%,PEX7;FAR1;AGPS;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3503321336253902,-0.5503980112003392,0.9821428571428571,1.0,1.0,1/9,7.72%,DBF4B
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.2876219182366452,-0.5502635659209105,0.9807692307692307,1.0,1.0,6/24,19.56%,KMT2B;ZNF335;CTR9;DPY30;MEN1;BEND3
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.2811821662478523,-0.5481245224631585,1.0,1.0,1.0,5/20,19.56%,HMGA2;POLE3;ZNFX1;EZH1;BEND3
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.378372714408107,-0.547999670676525,0.9583333333333334,1.0,1.0,2/5,18.07%,ABT1;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.378372714408107,-0.547999670676525,0.9583333333333334,1.0,1.0,2/5,18.07%,ABT1;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.378372714408107,-0.547999670676525,0.9583333333333334,1.0,1.0,2/5,18.07%,ABT1;NOP14
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.24995874022666,-0.5474849099425282,1.0,1.0,1.0,9/45,19.05%,MUC4;TMEM125;ATP2C2;EHF;TSPAN8;EPCAM;BPIFB1;C6ORF132;B3GNT3
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.3323164243028296,0.5470048338384284,0.9767441860465116,0.9946664469959373,1.0,1/9,7.79%,TIMELESS
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.3776773761713521,0.5466750558652856,0.9230769230769231,0.9943997999113049,1.0,5/5,62.24%,GLI3;LMBR1L;FAS;RIPK1;AKT1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.3480924095447848,-0.5459818336782118,0.9795918367346939,1.0,1.0,2/6,23.23%,CHRNA7;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.31197467187261513,-0.5459061088312386,0.967741935483871,1.0,1.0,4/10,25.19%,DNAJA1;SNX3;TERF1;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.29409731153486696,0.5453463427729011,0.9787234042553191,0.9944859627062055,1.0,1/9,15.37%,RPTOR
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.2813716253179985,0.5448926452710772,1.0,0.994295666217056,1.0,2/20,9.64%,DGKB;DGKI
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.3098953904011638,0.5443291210385673,0.9574468085106383,0.994133528986392,1.0,5/12,25.63%,ZFP36;TRIM32;TRIM62;TRIM27;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),-0.3841554306342824,-0.5435508664333909,0.9534883720930233,1.0,1.0,2/5,18.60%,HMGB1;PARP3
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.3430034371448041,0.5429788968679464,0.9615384615384616,0.9941836662879896,1.0,3/8,33.01%,CLMP;PKD1;COBL
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.3286270223243477,-0.5428036701380661,0.9622641509433962,1.0,1.0,3/13,15.35%,STX6;GOLGA2;TMED5
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.3495646423645132,0.5424322927687113,0.9464285714285714,0.9940176738767846,1.0,1/6,9.45%,CORO1C
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.334922707556927,-0.5423027394236447,0.9661016949152542,1.0,1.0,2/8,13.82%,EFS;GSN
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.3177197943557364,-0.5419445236006857,0.98,1.0,1.0,1/8,11.58%,EPHB2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.23966378144898215,-0.541698663473934,1.0,1.0,1.0,15/68,21.63%,TMED9;STMN3;FIS1;LMAN1;USP6NL;AKAP9;SAR1B;SQSTM1;VPS11;SURF4;VPS35;PINK1;PLXNB1;SYT11;CAPN2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3054904586541681,-0.540697205794795,0.9782608695652174,1.0,1.0,11/11,69.48%,UAP1;RENBP;GFPT2;GNPDA1;GNPNAT1;GFPT1;PGM3;NAGK;GNPDA2;AMDHD2;UAP1L1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.34542122894334476,0.5394620872763349,0.9230769230769231,0.9945598697800266,1.0,2/5,18.89%,FTO;ALKBH1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.3061775398554806,0.5391452737909427,0.9565217391304348,0.9943258779809028,1.0,3/9,27.42%,ADCY10;TSG101;CABYR
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.3412171584760417,-0.5390778176536057,0.9056603773584906,1.0,1.0,6/6,65.90%,ZFP57;KDM1B;CTCF;DNMT3A;MECP2;PRMT7
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.3457704974652157,-0.5390581499932117,0.9661016949152542,1.0,1.0,1/6,6.90%,VBP1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.34149667726038924,-0.5386514961199822,0.9772727272727273,1.0,1.0,1/7,13.66%,GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.29469200135506823,-0.537531436050197,0.9803921568627451,1.0,1.0,3/12,19.27%,ZNF830;BLM;MSH3
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.32884863057777014,-0.5362020988761304,0.9591836734693877,1.0,1.0,1/6,14.78%,PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.28120419253147744,-0.5345386003456227,1.0,1.0,1.0,3/20,22.97%,CREB3;ATF4;XBP1
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.36069462268088837,-0.5334412657602442,0.9375,1.0,1.0,2/5,24.41%,TMEM126A;ERBB3
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),-0.3108504443628457,-0.5311751283139631,0.9545454545454546,1.0,1.0,1/5,19.26%,STAR
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.20037877763912332,0.5301503047049753,1.0,0.9965906358572859,1.0,16/106,21.52%,TBC1D10A;HOOK1;DENND2A;KIF16B;LAPTM5;RAB29;BAIAP3;WASHC1;AP1G1;RIC1;RAB6B;PIK3C3;CCDC91;SORT1;EHD3;TBC1D5
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.2937461272800752,0.5287235928315619,0.972972972972973,0.9967078034156535,1.0,5/15,31.94%,IP6K3;IPMK;ISYNA1;ITPKC;PPIP5K2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.32514351605355263,0.5286566093460484,0.9807692307692307,0.9963894301728834,1.0,1/7,10.68%,MAPT
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.29903558469925584,-0.5270152116822874,0.95,1.0,1.0,2/10,17.25%,SOD1;TRDN
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.3010579272236739,0.5269471047376031,0.9583333333333334,0.9964985991689466,1.0,2/11,18.27%,RFK;EDN1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.3418760297247677,0.5265090901229018,0.9787234042553191,0.996296288752003,1.0,2/7,14.60%,MRTFB;MEGF10
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.28765798807082754,-0.5262284602967084,0.9818181818181818,1.0,1.0,6/21,24.01%,HSD17B10;AKR1D1;CYP7B1;OSBPL7;OSBP;SLC27A5
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.29564835155241576,0.523662805864397,0.975609756097561,0.9966847892564439,1.0,3/13,18.89%,TRMT9B;MOCS3;ALKBH1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.2926567385871974,0.5231490043915857,0.9591836734693877,0.9964546240284414,1.0,3/9,26.84%,SHANK1;SLC6A1;DRD2
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.3218952470980717,0.5228601660777495,0.9795918367346939,0.9961847292001912,1.0,2/9,15.13%,ACVR1C;ACVR2A
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.24448954583195404,-0.5224906905086243,0.9791666666666666,1.0,1.0,9/45,18.33%,USP1;USF1;ERCC8;CIRBP;UBE2A;MEN1;GTF2H2;OPN4;PRIMPOL
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.30727393996580654,-0.5207475304886005,0.9782608695652174,1.0,1.0,3/9,28.97%,ENG;TESK1;ENPP1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.30597556212687615,0.5200515663400785,0.9629629629629629,0.9966247083955839,1.0,10/10,69.42%,DROSHA;PUS10;SMAD2;SMAD3;SRRT;SMAD1;DGCR8;MRPL44;METTL3;HNRNPA2B1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.29065192225688935,-0.5195549729733598,1.0,1.0,1.0,8/16,36.00%,MORC3;PINK1;SKP1;CHCHD10;ARL2BP;HK1;HSPA5;SUPT7L
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.2999182771592629,0.516130354956317,0.9777777777777777,0.9972875926698475,1.0,4/6,35.33%,PLOD2;MTHFR;GOT1;MTR
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.30301316848633036,-0.51555677824413,0.9318181818181818,1.0,1.0,1/11,6.45%,CROT
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.273544315179083,0.514169390037775,0.9811320754716981,0.9973842523917358,1.0,6/18,32.86%,NGFR;SPPL2B;RELA;ADAM9;TRAF6;RHBDD1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.35847244446348386,-0.5133878566187824,0.96,1.0,1.0,3/5,33.51%,BDP1;GTF3C1;CRCP
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.3532739517410068,-0.5128687309132051,0.9814814814814815,1.0,1.0,1/6,10.28%,RFWD3
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.358962453652213,-0.5116566927508621,0.9607843137254902,1.0,1.0,1/5,13.07%,CAP1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.3307649527835833,-0.5113834221599319,0.9830508474576272,1.0,1.0,1/5,12.24%,CHADL
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.3132926264332119,-0.5101850639618694,1.0,1.0,1.0,1/9,10.28%,RFWD3
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.3299642086819421,0.5084507029305257,0.9310344827586207,0.9983730485740866,1.0,3/6,32.81%,USPL1;SENP7;SENP6
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.2659750414186727,0.5084087881121913,1.0,0.9980631464348365,1.0,2/19,10.05%,TOP2A;ACVR1C
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.3430550861734958,-0.508060754288025,0.92,1.0,1.0,2/6,27.70%,PYCR1;GLUL
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.2972439017045433,-0.5063793514393056,1.0,1.0,1.0,1/7,14.48%,SLC25A15
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.31170859597255535,0.506272883030764,0.9365079365079365,0.9982709006199929,1.0,6/6,68.84%,AGT;STARD4;ABCG1;APOE;LAMTOR1;ABCA2
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.2997273065779352,-0.502876388429253,1.0,1.0,1.0,3/11,20.06%,PARK7;UBE2N;AKAP8
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.3103753974259531,-0.5023060095968493,0.9811320754716981,1.0,1.0,2/8,29.04%,MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.31188741778400203,-0.5016227177607044,0.9666666666666667,1.0,1.0,1/8,5.96%,SPHK2
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3040054033995312,0.5015647566474895,1.0,0.9988246931839508,1.0,5/9,27.14%,PIH1D2;RUVBL2;NUFIP1;NAF1;SHQ1
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.3262054317365186,0.49870446687972486,0.9791666666666666,0.9990320542311248,1.0,1/5,19.10%,WRN
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.305306597740882,0.49821100504539484,0.9824561403508771,0.9988177793383556,1.0,3/8,16.96%,ITGB1BP1;MEGF10;CCN3
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.310222041671969,0.4978878479501657,0.9767441860465116,0.9985320963346229,1.0,1/8,10.24%,ROBO1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.257851511684149,-0.497212235590674,1.0,1.0,1.0,4/18,20.59%,BLM;KAT5;UBE2N;EXD2
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.2918641997246407,-0.49648482256545456,0.9787234042553191,1.0,1.0,1/11,7.51%,PCBP3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.30883639374642347,0.49596677391391536,0.9824561403508771,0.9985565555120762,1.0,1/7,16.25%,TPK1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.2374011609101469,-0.4958181908101336,1.0,1.0,1.0,7/27,30.59%,PNKP;SIRT6;PKIB;MAP2K7;TNKS2;NABP2;HNRNPA2B1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.32966603042295745,-0.49478674276962176,1.0,1.0,1.0,1/6,12.65%,ORAI1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.2524263291672988,0.4882279350245956,0.975,0.9995939634753658,1.0,5/23,19.90%,PLK1;NCAPG;CHMP1A;MCPH1;CSNK2A1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.2912296362419103,-0.4873831301966337,0.9818181818181818,1.0,1.0,9/9,70.90%,RAP2B;RAPGEF1;RAP1B;RAPGEF3;RAPGEF2;RAP2A;PLK2;RAP1A;RAP2C
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.2848119278789607,-0.4860927379867444,0.9583333333333334,1.0,1.0,1/7,21.26%,ACADS
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.3135256985540694,0.48608851967698075,1.0,0.999586283566813,1.0,3/5,27.32%,GAS6;CXCL13;HSD3B7
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.3004106798737055,-0.48584855844376273,0.9361702127659575,1.0,1.0,3/6,33.61%,C1QBP;TKFC;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.23509495852144358,0.4824096197673378,1.0,0.9998207643756841,1.0,4/19,18.54%,BBC3;CIDEB;MLLT11;GPER1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.2911809003179563,0.4814485261804958,0.9772727272727273,0.9996503079259963,1.0,6/6,70.89%,SNCA;MT3;OXA1L;PRKN;ETFBKMT;HDAC6
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.27574472546941287,-0.4798331551858623,0.9807692307692307,1.0,1.0,1/9,19.27%,MSH3
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.31364735389732556,0.4791574673867878,0.9787234042553191,0.9997179921870594,1.0,1/5,16.63%,SORD
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.3141827324330543,-0.47911289958590564,1.0,1.0,1.0,1/8,6.92%,COMT
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.2880340933775896,-0.4784650069194749,0.9565217391304348,1.0,1.0,1/11,16.40%,CHRNA7
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.32072629282796705,0.4772260793857114,1.0,0.999722178600838,1.0,2/5,15.40%,TAPBPL;HLA-DMA
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.2970401988726713,0.4767198372787459,0.9347826086956522,0.9994647066844968,1.0,2/8,17.87%,GAS6;NLRP12
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.2941938256209867,-0.47592032298954184,1.0,1.0,1.0,2/8,13.47%,SOD1;CLPTM1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.28201507289073413,-0.47503278685979805,0.9782608695652174,1.0,1.0,1/8,19.56%,BEND3
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.3271419009370816,-0.47313833524699594,0.9836065573770492,1.0,1.0,5/5,67.30%,SOD2;CIAO3;HIF1A;ALAS2;CAV1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.27051286566250815,-0.47312497875866605,1.0,1.0,1.0,3/11,27.59%,TOR1A;SNAPIN;TMEM230
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.2754223111580867,0.46659504999283735,1.0,1.0,1.0,1/10,13.20%,IMMP2L
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.3165026136700224,-0.4650768849968054,0.9629629629629629,1.0,1.0,1/5,19.03%,CCNK
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.2698359558085036,0.46471735037019396,1.0,1.0,1.0,11/11,73.03%,LRP1;ABCA7;CLU;LRPAP1;MYOCD;ROCK1;HMGCR;IFNGR1;SRF;APOE;HDAC1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.2730414296379745,-0.4625960443371818,0.9795918367346939,1.0,1.0,1/9,6.92%,COMT
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.30054371648728884,0.46249959984047156,0.9661016949152542,1.0,1.0,2/5,25.48%,SLC38A6;SLC1A4
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.28982759479920256,0.4622665319763304,0.9615384615384616,1.0,1.0,1/8,12.87%,SCARB1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.31155547779115556,0.4614877034099362,1.0,1.0,1.0,1/5,14.24%,ABCA1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.23215410562164285,-0.4597124431819675,1.0,1.0,1.0,7/22,28.30%,ALYREF;SUPT5H;CCNT1;CCNK;HMGN1;SUPT6H;THOC5
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.2660475029665502,-0.4589814347215631,0.9795918367346939,1.0,1.0,1/8,11.77%,GNPTG
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.301475735268761,-0.4585661857737005,1.0,1.0,1.0,2/7,27.99%,MUL1;BNIP3
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.29086380168088233,0.45855495705793853,0.9811320754716981,1.0,1.0,1/6,15.88%,CAMK4
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.26879244408371417,-0.4578499004091097,1.0,1.0,1.0,2/11,17.67%,HMGA2;YBX1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.2093324632376799,0.45777591970196485,1.0,0.999925646038742,1.0,10/25,31.70%,RBM24;NOCT;E2F1;DND1;NBAS;FMR1;TAF15;FUS;HNRNPU;GDNF
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.24491402554479702,-0.45738435415326734,1.0,1.0,1.0,2/26,9.99%,PYHIN1;CCDC22
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.3115052847479013,-0.45631543643907146,1.0,1.0,1.0,1/5,23.67%,NCK1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.2647175700226373,-0.4557650213728271,0.975609756097561,1.0,1.0,2/8,23.91%,PRKACA;ZDHHC8
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),-0.3050098124324932,-0.4557186831736812,0.9827586206896551,1.0,1.0,1/5,16.05%,NAA20
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.3083623244469474,-0.4543464498048824,1.0,1.0,1.0,2/5,23.15%,ATF4;BFSP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.20494248476121826,-0.45432101093228133,1.0,1.0,1.0,11/49,25.05%,BAK1;BAX;FIS1;BAD;PARK7;VPS35;PINK1;RALA;DCN;PLAUR;MUL1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.25820319581470474,-0.45416277614966893,1.0,1.0,1.0,2/13,17.67%,HMGA2;YBX1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.2461760344020985,0.4539950916946265,0.9615384615384616,1.0,1.0,4/11,30.86%,HES1;ESRRB;N4BP2L2;HNRNPU
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.22914780318094144,0.4537843618393902,0.967741935483871,0.9997955109855277,1.0,6/15,33.86%,INTS6;INTS10;INTS9;ZCCHC8;INTS1;MTREX
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.28018838375437904,0.45179263359152816,1.0,0.9994206477253745,1.0,3/7,28.73%,ATG2B;ULK1;ATG7
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.28018838375437904,0.45179263359152816,1.0,0.9994206477253745,1.0,3/7,28.73%,ATG2B;ULK1;ATG7
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.24539073551749174,-0.4502224981112808,0.9814814814814815,1.0,1.0,3/12,24.21%,DCTN1;HOOK3;CEP19
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.24783532438251377,-0.44968271618026723,1.0,1.0,1.0,5/17,26.60%,PCGF1;BMI1;SKP1;DDB2;DDB1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.2801817828890787,-0.4493540592390361,1.0,1.0,1.0,3/11,26.01%,ANXA2;GRN;PIP4K2C
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.26216469123784847,-0.44845726819376525,1.0,1.0,1.0,4/10,23.01%,UNC93B1;FADD;TNIP2;COLEC12
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.30245797285618503,-0.44772960257024663,1.0,1.0,1.0,2/7,29.37%,MTIF2;MTIF3
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.2720902758691095,0.44380024210045227,0.9777777777777777,1.0,1.0,3/9,24.74%,TBCD;PAK2;ZNF703
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.28214425168739893,-0.44372083520303923,1.0,1.0,1.0,6/6,71.80%,XBP1;PTN;MDK;CEACAM1;FBXW7;HPN
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.2698058469091723,0.44139110429320216,1.0,1.0,1.0,9/9,73.03%,HDAC4;SMARCAD1;RCOR1;HDAC2;HDAC3;HDAC9;SIRT2;REST;HDAC1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.2940815529648017,-0.4411606682423635,1.0,1.0,1.0,6/6,70.61%,TUT4;LIN28B;TENT4B;SND1;PARN;DIS3L2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.2524266428651121,-0.4397076861437367,1.0,1.0,1.0,7/7,74.77%,EIF4ENIF1;EIF4E2;DDX6;AGO2;EIF4G1;TNRC6B;STAT3
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.2524266428651121,-0.4397076861437367,1.0,1.0,1.0,7/7,74.77%,EIF4ENIF1;EIF4E2;DDX6;AGO2;EIF4G1;TNRC6B;STAT3
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.2995746088452501,0.4394071368378113,0.9622641509433962,1.0,1.0,3/5,29.59%,RAB3A;STXBP1;C2CD5
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.3044434134951547,0.43601822418823344,0.972972972972973,1.0,1.0,1/5,20.50%,NAB2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.20311965445942912,-0.43101566427878624,1.0,1.0,1.0,3/46,12.18%,H2AX;HUS1;TRIAP1
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.28391638377317957,-0.4299998509563351,0.9811320754716981,1.0,1.0,1/6,14.11%,VPS11
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.308881884102143,-0.4291808001560882,1.0,1.0,1.0,3/5,32.63%,SMAD7;JAK3;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.2674342177098134,-0.4282131509637639,1.0,1.0,1.0,3/6,29.76%,CD46;SERPINF2;ATP6AP2
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.2811642353990509,0.4277618651970971,1.0,1.0,1.0,1/5,22.09%,EFHD1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.2552062217717379,-0.42571548602915643,1.0,1.0,1.0,1/7,16.93%,CDC42
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.2648454975399981,0.42561184469555546,1.0,1.0,1.0,1/5,20.60%,ABCB1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.25251938002451035,-0.42279040190978134,0.9803921568627451,1.0,1.0,3/10,24.21%,DCTN1;HOOK3;CEP19
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.23370128239480803,-0.4219443218302127,0.9807692307692307,1.0,1.0,3/12,24.08%,CILK1;DYNC2I1;TTC21A
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.20014823206438814,-0.4205090388731583,1.0,1.0,1.0,8/28,24.76%,CEP131;PLK3;PTPN1;TPR;IFI27;B3GAT3;ZFAND1;NDEL1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.23681714190056372,0.4189227318994655,1.0,1.0,1.0,12/12,76.33%,NANP;UAP1L1;AMDHD2;GNPDA2;NAGK;PGM3;GFPT1;GNPNAT1;GNPDA1;GFPT2;RENBP;UAP1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.26413657246892697,0.4183015257339737,1.0,1.0,1.0,3/7,24.71%,PIH1D2;RUVBL2;NUFIP1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.24039767317730587,0.41811954413115643,0.9814814814814815,1.0,1.0,2/9,22.84%,PIAS1;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.2592592592592593,0.4152688838023665,1.0,1.0,1.0,5/5,74.08%,SLC6A9;LDB1;ABCB10;PRMT1;SLC25A37
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.2505021200624863,0.41462303921054666,0.9767441860465116,0.9999829999413204,1.0,9/9,74.96%,ILRUN;PCBP2;TSPAN6;TARBP2;TRAF3IP1;ITCH;RNF26;C1QBP;MUL1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.2265066964285713,0.41087989372231026,1.0,0.999943787712826,1.0,13/13,77.37%,DROSHA;AGO2;TUT7;PRKRA;AGO3;TARBP2;AGO1;LIN28B;ADAR;MRPL44;AGO4;TUT4;DICER1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.2376834235340066,-0.4102416081767484,1.0,1.0,1.0,10/10,76.25%,SMC6;XRCC3;TEP1;ERCC1;RAD50;RAD51;TPRKB;ERCC4;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.22557607543380023,0.409829600415085,0.98,0.9997079486152689,1.0,10/10,77.45%,TCAP;PROX1;EFEMP2;MYLK;HEY2;TTN;NOTCH1;TGFBR3;BMP2;ZFPM1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.2051410624439159,-0.4085683830826644,1.0,1.0,1.0,3/24,22.91%,SSU72;FIP1L1;PAF1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.2051410624439159,-0.4085683830826644,1.0,1.0,1.0,3/24,22.91%,SSU72;FIP1L1;PAF1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.27532004929002474,-0.4067922993425544,1.0,1.0,1.0,1/5,20.71%,PKN1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.23450084775839242,-0.40582737278042536,1.0,1.0,1.0,1/10,14.78%,PIH1D1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.25307679069056177,-0.40363934784820216,1.0,1.0,1.0,2/7,28.00%,DISP3;NR1H2
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.2706381079875056,-0.4001021543412111,1.0,1.0,1.0,5/5,72.95%,SUPT6H;HDAC2;SUPV3L1;MTHFR;SIRT1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.26080892608089273,0.39502744587797206,1.0,1.0,1.0,8/8,73.93%,NAB2;SORL1;CLU;C5AR1;EGR1;RB1;HSP90AB1;HSP90AA1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.20908426021008997,0.39312202297583,1.0,1.0,1.0,5/15,27.26%,KIF16B;SORT1;EPS15;AP1AR;DOP1B
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.2159500668607624,-0.39106973311380094,1.0,1.0,1.0,4/15,25.05%,PARK7;RASD2;PIAS3;MUL1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.22430532306662176,0.38952269608896467,1.0,0.9999875848299368,1.0,11/11,77.58%,DHRS3;PRAME;CTBP2;CYP26B1;EZH2;TRIM16;ASXL1;CNOT1;AKR1C3;SNW1;CALR
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.21709329991093687,0.38932786339181535,1.0,0.9993556658955803,1.0,3/15,22.73%,JADE2;OGT;KANSL1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.21709329991093687,0.38932786339181535,1.0,0.9993556658955803,1.0,3/15,22.73%,JADE2;OGT;KANSL1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.230471568357811,-0.3889474653704115,1.0,1.0,1.0,2/8,23.67%,PTPN1;NCK1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.21520206756057159,0.3857426123609655,1.0,0.9992186189695433,1.0,3/13,21.32%,NLGN1;KIF5A;RAB27A
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.23763308282843104,-0.38568712222988577,1.0,1.0,1.0,3/8,31.69%,TWNK;LRRC8D;LETM1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.2249850674115373,-0.3788866862292975,1.0,1.0,1.0,2/12,19.08%,ETS1;ZPR1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.2151250409580988,0.37602102363056755,1.0,0.999368113192258,1.0,3/9,29.00%,PTEN;ADAM9;EPB41L4B
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.23275696113010344,0.37550218710178057,1.0,0.9990467859426424,1.0,2/8,21.28%,RIOX1;RIOX2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.22300069993917024,-0.36690084758814023,0.9782608695652174,1.0,1.0,2/8,28.18%,GSTZ1;ASRGL1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.22794137408051024,-0.3657156149417888,1.0,1.0,1.0,4/7,35.64%,ENG;SOD2;KIT;CTH
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.22938748186990962,-0.35513818227795946,1.0,1.0,1.0,7/7,77.08%,ENG;SMO;MYLK;EFEMP2;PTCH1;PROX1;NF1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.20874791259911465,-0.35151865852746295,1.0,1.0,1.0,1/8,16.25%,HNF4A
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.15911989844040236,-0.318139898147145,1.0,0.9999650561024276,1.0,1/27,11.24%,SNIP1
